Reactants_SMILES,Products_SMILES,Reaction_SMILES,ROOT:RX_ID,ROOT:RX_NVAR,ROOT:RX_RANK,ROOT:RX_RTYP,ROOT:RX_RCT,ROOT:RX_PRO,ROOT:RX_BIN,ROOT:RXD:CL,ROOT:RXD:STP,ROOT:RXD:T,ROOT:RXD:TYP,ROOT:RXD:SUB,ROOT:RXD:SOL,ROOT:RXD:citation,ROOT:COPYRIGHT:COPYRIGHT,ROOT:RXD:TIM,ROOT:RXD:COND,ROOT:RXD:PH,ROOT:RXD:LCN,ROOT:RXD:COM,ROOT:RXD:RGT,ROOT:RXD:YPRO,ROOT:RXD:YD,ROOT:RXD:NYD,ROOT:RXD:PRT,ROOT:RXD:RXDES,ROOT:RXD:YDO,ROOT:RXD:SNR,ROOT:RXD:SRCT,ROOT:RXD:LB,ROOT:RXD:TI,ROOT:RXD:TXT,ROOT:RXD:CAT
N#Cc1ccc([CH-]S(=O)(=O)C(F)(F)F)cc1.[K+],CN1C(=O)C(=Cc2cc3c4c(c2)CCCN4CCC3)C(=O)N(C)C1=O.Cn1c([O-])c(C(c2cc3c4c(c2)CCCN4CCC3)C(c2ccc(C#N)cc2)S(=O)(=O)C(F)(F)F)c(=O)n(C)c1=O.[K+],N#Cc1ccc([CH-]S(=O)(=O)C(F)(F)F)cc1.[K+]>>CN1C(=O)C(=Cc2cc3c4c(c2)CCCN4CCC3)C(=O)N(C)C1=O.Cn1c([O-])c(C(c2cc3c4c(c2)CCCN4CCC3)C(c2ccc(C#N)cc2)S(=O)(=O)C(F)(F)F)c(=O)n(C)c1=O.[K+],11230251,1,56,full reaction,"C9H5F3NO2S(1-)*K(1+)|1,3-dimethyl-5-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-ylmethylene)pyrimidine-2,4,6(1H,3H,5H)-trione",C28H26N4O5SF3(1-)*K(1+),210162,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CCCN,CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CCCNC(c1ccc(N(C)C)cc1)C1C(=O)N(C)C(=O)N(C)C1=O,CCCN>>CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CCCNC(c1ccc(N(C)C)cc1)C1C(=O)N(C)C(=O)N(C)C1=O,11230252,1,56,full reaction,"propylamine|5-(4-dimethylamino-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione",C18H26N4O3,228547,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC1(C)CC(=O)C=C([O-])C1.[K+],CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CN(C)c1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C2C(=O)CC(C)(C)CC2=O)cc1.[K+],CC1(C)CC(=O)C=C([O-])C1.[K+]>>CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CN(C)c1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C2C(=O)CC(C)(C)CC2=O)cc1.[K+],11230253,1,56,full reaction,"dimedone potassium salt|5-(4-dimethylamino-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione",C23H28N3O5(1-)*K(1+),208860,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
N#Cc1ccc([CH-]S(=O)(=O)C(F)(F)F)cc1.[K+],CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CN(C)c1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C(c2ccc(C#N)cc2)S(=O)(=O)C(F)(F)F)cc1.[K+],N#Cc1ccc([CH-]S(=O)(=O)C(F)(F)F)cc1.[K+]>>CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CN(C)c1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C(c2ccc(C#N)cc2)S(=O)(=O)C(F)(F)F)cc1.[K+],11230254,1,56,full reaction,"C9H5F3NO2S(1-)*K(1+)|5-(4-dimethylamino-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione",C24H22N4O5SF3(1-)*K(1+),210162,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C1COCCN1,CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CN1C(=O)C(C(c2ccc(N(C)C)cc2)N2CCOCC2)C(=O)N(C)C1=O,C1COCCN1>>CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=O.CN1C(=O)C(C(c2ccc(N(C)C)cc2)N2CCOCC2)C(=O)N(C)C1=O,11230255,1,56,full reaction,"morpholine|5-(4-dimethylamino-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione",C19H26N4O4,228546,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CCCN,COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1.CCCNC(c1ccc(OC)cc1)C1C(=O)N(C)C(=O)N(C)C1=O,CCCN>>COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1.CCCNC(c1ccc(OC)cc1)C1C(=O)N(C)C(=O)N(C)C1=O,11230256,1,56,full reaction,"propylamine|5-(4-methoxy-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione",C17H23N3O4,228547,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1,CC1(C)OC(=O)[CH-]C(=O)O1.[K+].COc1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C2C(=O)OC(C)(C)OC2=O)cc1.[K+],COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1>>CC1(C)OC(=O)[CH-]C(=O)O1.[K+].COc1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C2C(=O)OC(C)(C)OC2=O)cc1.[K+],11230257,1,56,full reaction,"5-(4-methoxy-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione|potassium 2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-olate",C20H21N2O8(1-)*K(1+),217227,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1,CC1(C)CC(=O)C=C([O-])C1.[K+].COc1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C2C(=O)CC(C)(C)CC2=O)cc1.[K+],COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1>>CC1(C)CC(=O)C=C([O-])C1.[K+].COc1ccc(C(c2c([O-])n(C)c(=O)n(C)c2=O)C2C(=O)CC(C)(C)CC2=O)cc1.[K+],11230262,1,56,full reaction,"5-(4-methoxy-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione|dimedone potassium salt","1,3-dimethyl-2,4,6-trioxo-5-[1-(4,4-dimethyl-2,6-dioxocyclohexyl)-1-(4-methoxyphenyl)-methyl]-hexahydropyrimidine potassium salt",208860,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C1COCCN1,COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1.COc1ccc(C(C2C(=O)N(C)C(=O)N(C)C2=O)N2CCOCC2)cc1,C1COCCN1>>COc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1.COc1ccc(C(C2C(=O)N(C)C(=O)N(C)C2=O)N2CCOCC2)cc1,11230264,1,56,full reaction,"morpholine|5-(4-methoxy-benzylidene)-1,3-dimethyl-pyrimidine-2,4,6-trione",C18H23N3O5,228546,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CN1C(=O)C(=Cc2cc3c4c(c2)CCCN4CCC3)C(=O)N(C)C1=S,CC1(C)CC(=O)C=C([O-])C1.[K+].Cn1c([O-])c(C(c2cc3c4c(c2)CCCN4CCC3)C2C(=O)CC(C)(C)CC2=O)c(=O)n(C)c1=S.[K+],CN1C(=O)C(=Cc2cc3c4c(c2)CCCN4CCC3)C(=O)N(C)C1=S>>CC1(C)CC(=O)C=C([O-])C1.[K+].Cn1c([O-])c(C(c2cc3c4c(c2)CCCN4CCC3)C2C(=O)CC(C)(C)CC2=O)c(=O)n(C)c1=S.[K+],11230265,1,56,full reaction,"1,3-dimethyl-5-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-ylmethylene)-2-thioxo-dihydropyrimidine-4,6(1H,5H)-dione|dimedone potassium salt",C27H32N3O4S(1-)*K(1+),208860,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC1(C)OC(=O)[CH-]C(=O)O1.[K+],CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=S.CN(C)c1ccc(C(c2c([O-])n(C)c(=S)n(C)c2=O)C2C(=O)OC(C)(C)OC2=O)cc1.[K+],CC1(C)OC(=O)[CH-]C(=O)O1.[K+]>>CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=S.CN(C)c1ccc(C(c2c([O-])n(C)c(=S)n(C)c2=O)C2C(=O)OC(C)(C)OC2=O)cc1.[K+],11230266,1,56,full reaction,"potassium 2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-olate|5-(4-dimethylamino-benzylidene)-1,3-dimethyl-2-thioxo-dihydro-pyrimidine-4,6-dione",C21H24N3O6S(1-)*K(1+),217227,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC1(C)CC(=O)C=C([O-])C1.[K+],CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=S.CN(C)c1ccc(C(c2c([O-])n(C)c(=S)n(C)c2=O)C2C(=O)CC(C)(C)CC2=O)cc1.[K+],CC1(C)CC(=O)C=C([O-])C1.[K+]>>CN1C(=O)C(=Cc2ccc(N(C)C)cc2)C(=O)N(C)C1=S.CN(C)c1ccc(C(c2c([O-])n(C)c(=S)n(C)c2=O)C2C(=O)CC(C)(C)CC2=O)cc1.[K+],11230267,1,56,full reaction,"dimedone potassium salt|5-(4-dimethylamino-benzylidene)-1,3-dimethyl-2-thioxo-dihydro-pyrimidine-4,6-dione",C23H28N3O4S(1-)*K(1+),208860,Chemical behaviour,1,20,Michael addition,Kinetics,dimethyl sulfoxide,"7066603; Article; Seeliger, Florian; Berger, Stefan T. A.; Remennikov, Grygoriy Y.; Polborn, Kurt; Mayr, Herbert; Journal of Organic Chemistry; vol. 72; 24; (2007); p. 9170 - 9180;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CN(C)CCC(=O)c1ccccc1.[H]Cl,O=C1CCCCC1.O=C(CCC1CCCC(CCC(=O)c2ccccc2)C1=O)c1ccccc1.O=C(CCC1CCCCC1=O)c1ccccc1,CN(C)CCC(=O)c1ccccc1.[H]Cl>>O=C1CCCCC1.O=C(CCC1CCCC(CCC(=O)c2ccccc2)C1=O)c1ccccc1.O=C(CCC1CCCCC1=O)c1ccccc1,25945968,1,56,full reaction|has preparation,3-(dimethylamino)propiophenone hydrochloride|cyclohexanone,C24H26O3|2-(2-benzoylethyl)cyclohexanone,309132|308832,Preparation,1,,Michael addition,,various solvent(s),"7173165; Article; Rao, H. Surya Prakash; Poonguzhali; Senthilkumar; Synthetic Communications; vol. 38; 6; (2008); p. 937 - 942;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0333333,microwave irradiation,,,,,,,,,,,,,,,,
CN(C)CCC(=O)c1ccccc1.[H]Cl,O=C1CCCC1.O=C(CCC1CCCC1=O)c1ccccc1.O=C(CCC1CCC(CCC(=O)c2ccccc2)C1=O)c1ccccc1,CN(C)CCC(=O)c1ccccc1.[H]Cl>>O=C1CCCC1.O=C(CCC1CCCC1=O)c1ccccc1.O=C(CCC1CCC(CCC(=O)c2ccccc2)C1=O)c1ccccc1,25945969,1,56,full reaction|has preparation,3-(dimethylamino)propiophenone hydrochloride|cyclopentanone,"1-phenyl-3-(2-oxocyclopentyl)-1-propanone|2,5-di-(3-oxo-3-phenylpropyl)-1-cyclopentanone",309128|308832,Preparation,1,,Michael addition,,various solvent(s),"7173165; Article; Rao, H. Surya Prakash; Poonguzhali; Senthilkumar; Synthetic Communications; vol. 38; 6; (2008); p. 937 - 942;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0333333,microwave irradiation,,,,,,,,,,,,,,,,
O=C1CCCCC1,COc1ccc(C(=O)CCN(C)C)cc1.[H]Cl.COc1ccc(C(=O)CCC2CCCC(CCC(=O)c3ccc(OC)cc3)C2=O)cc1.COc1ccc(C(=O)CCC2CCCCC2=O)cc1,O=C1CCCCC1>>COc1ccc(C(=O)CCN(C)C)cc1.[H]Cl.COc1ccc(C(=O)CCC2CCCC(CCC(=O)c3ccc(OC)cc3)C2=O)cc1.COc1ccc(C(=O)CCC2CCCCC2=O)cc1,25945970,1,56,full reaction|has preparation,cyclohexanone|3-dimethylamino-1-(4-methoxy-phenyl)-propan-1-one; hydrochloride,C26H30O5|2-[3-(4-Methoxy-phenyl)-3-oxo-propyl]-cyclohexanone,62388|307398,Preparation,1,,Michael addition,,various solvent(s),"7173165; Article; Rao, H. Surya Prakash; Poonguzhali; Senthilkumar; Synthetic Communications; vol. 38; 6; (2008); p. 937 - 942;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0333333,microwave irradiation,,,,,,,,,,,,,,,,
COc1ccc(C(=O)CCN(C)C)cc1.[H]Cl,O=C1CCCC1.COc1ccc(C(=O)CCC2CCCC2=O)cc1.COc1ccc(C(=O)CCC2CCC(CCC(=O)c3ccc(OC)cc3)C2=O)cc1,COc1ccc(C(=O)CCN(C)C)cc1.[H]Cl>>O=C1CCCC1.COc1ccc(C(=O)CCC2CCCC2=O)cc1.COc1ccc(C(=O)CCC2CCC(CCC(=O)c3ccc(OC)cc3)C2=O)cc1,25945971,1,56,full reaction|has preparation,3-dimethylamino-1-(4-methoxy-phenyl)-propan-1-one; hydrochloride|cyclopentanone,"1-(p-Methoxyphenyl)-3-(2'-oxocyclopentyl)-1-propanone|2,5-di[3-(4-methoxyphenyl)-3-oxopropyl]cyclopentan-1-one",309128|308832,Preparation,1,,Michael addition,,various solvent(s),"7173165; Article; Rao, H. Surya Prakash; Poonguzhali; Senthilkumar; Synthetic Communications; vol. 38; 6; (2008); p. 937 - 942;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0333333,microwave irradiation,,,,,,,,,,,,,,,,
N#CC1=CC(=O)C(=O)C=C1,CC1(C)OC(=O)CC(=O)O1.CC1(C)OC(=O)C(c2cc(O)c(O)cc2C#N)=C(O)O1,N#CC1=CC(=O)C(=O)C=C1>>CC1(C)OC(=O)CC(=O)O1.CC1(C)OC(=O)C(c2cc(O)c(O)cc2C#N)=C(O)O1,27925359,1,56,full reaction,"3,4-dioxocyclohexa-1,5-diene-1-carbonitrile|cycl-isopropylidene malonate",C13H11NO6,162984,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
N#CC1=CC(=O)C(=O)C=C1,CC1C(=O)OC(C)(C)OC1=O.CC1(C)OC(=O)C(C)(c2cc(O)c(O)cc2C#N)C(=O)O1,N#CC1=CC(=O)C(=O)C=C1>>CC1C(=O)OC(C)(C)OC1=O.CC1(C)OC(=O)C(C)(c2cc(O)c(O)cc2C#N)C(=O)O1,27925360,1,56,full reaction,"3,4-dioxocyclohexa-1,5-diene-1-carbonitrile|2,2,5-trimethyl-1,3-dioxane-4,6-dione",C14H13NO6,292334,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1(C)OC(=O)CC(=O)O1,CCOC(=O)C1=CC(=O)C(=O)C=C1.CCOC(=O)c1cc(O)c(O)cc1C1=C(O)OC(C)(C)OC1=O,CC1(C)OC(=O)CC(=O)O1>>CCOC(=O)C1=CC(=O)C(=O)C=C1.CCOC(=O)c1cc(O)c(O)cc1C1=C(O)OC(C)(C)OC1=O,27925361,1,56,full reaction,"cycl-isopropylidene malonate|ethyl 3,4-dioxocyclohexa-1,5-diene-1-carboxylate",C15H16O8,162984,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,CCOC(=O)C1=CC(=O)C(=O)C=C1.CCOC(=O)c1cc(O)c(O)cc1C1(C)C(=O)OC(C)(C)OC1=O,CC1C(=O)OC(C)(C)OC1=O>>CCOC(=O)C1=CC(=O)C(=O)C=C1.CCOC(=O)c1cc(O)c(O)cc1C1(C)C(=O)OC(C)(C)OC1=O,27925362,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|ethyl 3,4-dioxocyclohexa-1,5-diene-1-carboxylate",C16H18O8,292334,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1(C)OC(=O)CC(=O)O1,CC1=CC(=O)C(=O)C=C1.Cc1cc(O)c(O)cc1C1=C(O)OC(C)(C)OC1=O,CC1(C)OC(=O)CC(=O)O1>>CC1=CC(=O)C(=O)C=C1.Cc1cc(O)c(O)cc1C1=C(O)OC(C)(C)OC1=O,27925366,1,56,full reaction,"cycl-isopropylidene malonate|4-methylbenzo-1,2-quinone",C13H14O6,162984,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1(C)OC(=O)CC(=O)O1,CC(C)(C)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(c2cc(O)c(O)cc2C(C)(C)C)=C(O)O1,CC1(C)OC(=O)CC(=O)O1>>CC(C)(C)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(c2cc(O)c(O)cc2C(C)(C)C)=C(O)O1,27925367,1,56,full reaction,"cycl-isopropylidene malonate|4-t-butyl-1,2-benzoquinone",C16H20O6,162984,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1(C)OC(=O)CC(=O)O1,O=C(O)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(c2cc(O)c(O)cc2C(=O)O)=C(O)O1,CC1(C)OC(=O)CC(=O)O1>>O=C(O)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(c2cc(O)c(O)cc2C(=O)O)=C(O)O1,27925368,1,56,full reaction,"cycl-isopropylidene malonate|3,4-dioxocyclohexa-1,5-diene-1-carboxylic acid",C13H12O8,162984,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,CC1=CC=CC(=O)C1=O.Cc1cc(C2(C)C(=O)OC(C)(C)OC2=O)cc(O)c1O,CC1C(=O)OC(C)(C)OC1=O>>CC1=CC=CC(=O)C1=O.Cc1cc(C2(C)C(=O)OC(C)(C)OC2=O)cc(O)c1O,27925371,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|6-methyl-1,2-benzoquinone",C14H16O6,291990,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,COC1=CC=CC(=O)C1=O.COc1cc(C2(C)C(=O)OC(C)(C)OC2=O)cc(O)c1O,CC1C(=O)OC(C)(C)OC1=O>>COC1=CC=CC(=O)C1=O.COc1cc(C2(C)C(=O)OC(C)(C)OC2=O)cc(O)c1O,27925372,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|3-methoxy-[1,2]benzoquinone",C14H16O7,291990,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,O=C1C=CC=CC1=O.CC1(C)OC(=O)C(C)(c2ccc(O)c(O)c2)C(=O)O1,CC1C(=O)OC(C)(C)OC1=O>>O=C1C=CC=CC1=O.CC1(C)OC(=O)C(C)(c2ccc(O)c(O)c2)C(=O)O1,27925373,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|ortoquinone",C13H14O6,291990,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,CC1=CC(=O)C(=O)C=C1.Cc1cc(O)c(O)cc1C1(C)C(=O)OC(C)(C)OC1=O,CC1C(=O)OC(C)(C)OC1=O>>CC1=CC(=O)C(=O)C=C1.Cc1cc(O)c(O)cc1C1(C)C(=O)OC(C)(C)OC1=O,27925374,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|4-methylbenzo-1,2-quinone",C14H16O6,292334,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,CC(C)(C)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(C)(c2cc(O)c(O)cc2C(C)(C)C)C(=O)O1,CC1C(=O)OC(C)(C)OC1=O>>CC(C)(C)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(C)(c2cc(O)c(O)cc2C(C)(C)C)C(=O)O1,27925375,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|4-t-butyl-1,2-benzoquinone",C17H22O6,292334,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,O=C(O)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(C)(c2cc(O)c(O)cc2C(=O)O)C(=O)O1,CC1C(=O)OC(C)(C)OC1=O>>O=C(O)C1=CC(=O)C(=O)C=C1.CC1(C)OC(=O)C(C)(c2cc(O)c(O)cc2C(=O)O)C(=O)O1,27925376,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|3,4-dioxocyclohexa-1,5-diene-1-carboxylic acid",C14H14O8,292334,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
CC1C(=O)OC(C)(C)OC1=O,O=C(O)C1=CC=CC(=O)C1=O.CC1(C)OC(=O)C(C)(c2cc(O)c(O)c(C(=O)O)c2)C(=O)O1,CC1C(=O)OC(C)(C)OC1=O>>O=C(O)C1=CC=CC(=O)C1=O.CC1(C)OC(=O)C(C)(c2cc(O)c(O)c(C(=O)O)c2)C(=O)O1,27925377,1,56,full reaction,"2,2,5-trimethyl-1,3-dioxane-4,6-dione|o-quinone-3-carboxilic acid",C14H14O8,291990,Chemical behaviour,1,25,Michael addition,Kinetics,phosphate buffer,8651409; Article; Nematollahi; Shayani-jam; Journal of Organic Chemistry; vol. 73; 9; (2008); p. 3428 - 3434;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.0,,,,,,,,,,,,,,,
N#Cc1c([S-])nn2ccccc12.[K+],C#CC(=O)OCC.N#Cc1c([S-])nn2ccccc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccccc2c1C#N.CCOC(=O)/C=C/Sc1nn2ccccc2c1C#N,N#Cc1c([S-])nn2ccccc12.[K+]>>C#CC(=O)OCC.N#Cc1c([S-])nn2ccccc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccccc2c1C#N.CCOC(=O)/C=C/Sc1nn2ccccc2c1C#N,28174257,1,56,full reaction|has preparation,"potassium 3-cyanopyrazolo[1,5-a]pyridine-2-thiolate|propynoic acid ethyl ester","(Z)-ethyl 3-[[3-cyanopyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-cyanopyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
Cc1cccc2c(C#N)c([S-])nn12.[K+],C#CC(=O)OCC.Cc1cccc2c(C#N)c([S-])nn12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2c(C)cccc2c1C#N.CCOC(=O)/C=C/Sc1nn2c(C)cccc2c1C#N,Cc1cccc2c(C#N)c([S-])nn12.[K+]>>C#CC(=O)OCC.Cc1cccc2c(C#N)c([S-])nn12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2c(C)cccc2c1C#N.CCOC(=O)/C=C/Sc1nn2c(C)cccc2c1C#N,28174259,1,56,full reaction|has preparation,C9H6N3S(1-)*K(1+)|propynoic acid ethyl ester,"(Z)-ethyl 3-[[3-cyano-7-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-cyano-7-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
Cc1ccn2nc([S-])c(C#N)c2c1.[K+],C#CC(=O)OCC.Cc1ccn2nc([S-])c(C#N)c2c1.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccc(C)cc2c1C#N.CCOC(=O)/C=C/Sc1nn2ccc(C)cc2c1C#N,Cc1ccn2nc([S-])c(C#N)c2c1.[K+]>>C#CC(=O)OCC.Cc1ccn2nc([S-])c(C#N)c2c1.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccc(C)cc2c1C#N.CCOC(=O)/C=C/Sc1nn2ccc(C)cc2c1C#N,28174261,1,56,full reaction|has preparation,C9H6N3S(1-)*K(1+)|propynoic acid ethyl ester,"(Z)-ethyl 3-[[3-cyano-5-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-cyano-5-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
Cc1cc(C)c2c(C#N)c([S-])nn2c1.[K+],C#CC(=O)OCC.Cc1cc(C)c2c(C#N)c([S-])nn2c1.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2cc(C)cc(C)c2c1C#N.CCOC(=O)/C=C/Sc1nn2cc(C)cc(C)c2c1C#N,Cc1cc(C)c2c(C#N)c([S-])nn2c1.[K+]>>C#CC(=O)OCC.Cc1cc(C)c2c(C#N)c([S-])nn2c1.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2cc(C)cc(C)c2c1C#N.CCOC(=O)/C=C/Sc1nn2cc(C)cc(C)c2c1C#N,28174263,1,56,full reaction|has preparation,C10H8N3S(1-)*K(1+)|propynoic acid ethyl ester,"(Z)-ethyl 3-[[3-cyano-4,6-dimethylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-cyano-4,6-dimethylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)c1c([S-])nn2ccccc12.[K+],COC(=O)C#Cc1ccccc1.CCOC(=O)c1c(S/C(=C\C(=O)OC)c2ccccc2)nn2ccccc12.CCOC(=O)c1c(S/C(=C/C(=O)OC)c2ccccc2)nn2ccccc12,CCOC(=O)c1c([S-])nn2ccccc12.[K+]>>COC(=O)C#Cc1ccccc1.CCOC(=O)c1c(S/C(=C\C(=O)OC)c2ccccc2)nn2ccccc12.CCOC(=O)c1c(S/C(=C/C(=O)OC)c2ccccc2)nn2ccccc12,28174264,1,56,full reaction|has preparation,"potassium 3-(ethoxycarbonyl)pyrazolo[1,5-a]pyridine-2-thiolate|phenylpropynoic acid methyl ester","methyl Z-3-[[3-(ethoxycarbonyl)pyrazolo[1,5-a]pyridin-2-yl]thio]-3-phenylacrylate|methyl E-3-[[3-(ethoxycarbonyl)pyrazolo[1,5-a]pyridin-2-yl]thio]-3-phenylacrylate",188542|188542,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)c1c([S-])nn2ccccc12.[K+],C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2ccccc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccccc2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2ccccc2c1C(=O)OCC,CCOC(=O)c1c([S-])nn2ccccc12.[K+]>>C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2ccccc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccccc2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2ccccc2c1C(=O)OCC,28174265,1,56,full reaction|has preparation,"potassium 3-(ethoxycarbonyl)pyrazolo[1,5-a]pyridine-2-thiolate|propynoic acid ethyl ester","(Z)-ethyl 3-[[3-(ethoxycarbonyl)pyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-(ethoxycarbonyl)pyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+],COC(=O)C#Cc1ccccc1.CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+].COC(=O)C#Cc1ccccc1.CCOC(=O)c1c(S/C(=C\C(=O)OC)c2ccccc2)nn2c(C)cccc12.CCOC(=O)c1c(S/C(=C/C(=O)OC)c2ccccc2)nn2c(C)cccc12,CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+]>>COC(=O)C#Cc1ccccc1.CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+].COC(=O)C#Cc1ccccc1.CCOC(=O)c1c(S/C(=C\C(=O)OC)c2ccccc2)nn2c(C)cccc12.CCOC(=O)c1c(S/C(=C/C(=O)OC)c2ccccc2)nn2c(C)cccc12,28174266,1,56,full reaction|has preparation,C11H11N2O2S(1-)*K(1+)|phenylpropynoic acid methyl ester,"methyl Z-3-[[3-ethoxycarbonyl-7-methylpyrazolo[1,5-a]pyridin-2-yl]thio]-3-phenylacrylate|methyl E-3-[[3-ethoxycarbonyl-7-methylpyrazolo[1,5-a]pyridin-2-yl]thio]-3-phenylacrylate",188542|188542,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+],C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2c(C)cccc2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2c(C)cccc2c1C(=O)OCC,CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+]>>C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2c(C)cccc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2c(C)cccc2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2c(C)cccc2c1C(=O)OCC,28174267,1,56,full reaction|has preparation,C11H11N2O2S(1-)*K(1+)|propynoic acid ethyl ester,"(Z)-ethyl 3-[[3-ethoxycarbonyl-7-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-ethoxycarbonyl-7-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)c1c([S-])nn2ccc(C)cc12.[K+],C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2ccc(C)cc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccc(C)cc2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2ccc(C)cc2c1C(=O)OCC,CCOC(=O)c1c([S-])nn2ccc(C)cc12.[K+]>>C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2ccc(C)cc12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2ccc(C)cc2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2ccc(C)cc2c1C(=O)OCC,28174269,1,56,full reaction|has preparation,C11H11N2O2S(1-)*K(1+)|propynoic acid ethyl ester,"(Z)-ethyl 3-[[3-ethoxycarbonyl-5-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-ethoxycarbonyl-5-methylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)c1c([S-])nn2cc(C)cc(C)c12.[K+],C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2cc(C)cc(C)c12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2cc(C)cc(C)c2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2cc(C)cc(C)c2c1C(=O)OCC,CCOC(=O)c1c([S-])nn2cc(C)cc(C)c12.[K+]>>C#CC(=O)OCC.CCOC(=O)c1c([S-])nn2cc(C)cc(C)c12.[K+].C#CC(=O)OCC.CCOC(=O)/C=C\Sc1nn2cc(C)cc(C)c2c1C(=O)OCC.CCOC(=O)/C=C/Sc1nn2cc(C)cc(C)c2c1C(=O)OCC,28174271,1,56,full reaction|has preparation,C12H13N2O2S(1-)*K(1+)|propynoic acid ethyl ester,"(Z)-ethyl 3-[[3-ethoxycarbonyl-4,6-dimethylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate|(E)-ethyl 3-[[3-ethoxycarbonyl-4,6-dimethylpyrazolo[1,5-a]pyridin-2-yl]thio]acrylate",189987|189987,Preparation,1,50 - 60,Michael addition,,,"8706433; Article; Isawa, Hidetoshi; Kakehi, Akikazu; Suga, Hiroyuki; Heterocyclic Communications; vol. 14; 3; (2008); p. 141 - 148;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,experimental part,,,,,,,,,,,,,,
CCOC(=O)C=Cc1ccccc1,NCc1ccccc1.CCOC(=O)CC(NCc1ccccc1)c1ccccc1.O=C(CC(NCc1ccccc1)c1ccccc1)NCc1ccccc1,CCOC(=O)C=Cc1ccccc1>>NCc1ccccc1.CCOC(=O)CC(NCc1ccccc1)c1ccccc1.O=C(CC(NCc1ccccc1)c1ccccc1)NCc1ccccc1,28601178,1,56,full reaction|has preparation,ethyl 3-phenyl-2-propenoate|benzylamine,rac-ethyl 3-benzylamino-3-phenylpropanoate|N-benzyl-3-(benzylamino)-3-phenylpropanamide,228573|210120,Preparation,1,60,aza-Michael addition,,,"8764151; Article; Weiß, Markus; Gröger, Harald; Synlett; 8; (2009); p. 1251 - 1254;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,Neat (no solvent),,experimental part,,,,,,,,,,,,,,
CCC=CC(=O)OCC,NCc1ccccc1.CCC(CC(=O)NCc1ccccc1)NCc1ccccc1.CCOC(=O)CC(CC)NCc1ccccc1,CCC=CC(=O)OCC>>NCc1ccccc1.CCC(CC(=O)NCc1ccccc1)NCc1ccccc1.CCOC(=O)CC(CC)NCc1ccccc1,28601183,1,56,full reaction|has preparation,ethyl 2-pentenoate|benzylamine,C19H24N2O|ethyl 3-(benzylamino)valerate,224464|210120,Preparation,1,60,aza-Michael addition,,,"8764151; Article; Weiß, Markus; Gröger, Harald; Synlett; 8; (2009); p. 1251 - 1254;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,30,Neat (no solvent),,experimental part,,,,,,,,,,,,,,
CCCC=CC(=O)OCC,NCc1ccccc1.CCCC(CC(=O)NCc1ccccc1)NCc1ccccc1.CCCC(CC(=O)OCC)NCc1ccccc1,CCCC=CC(=O)OCC>>NCc1ccccc1.CCCC(CC(=O)NCc1ccccc1)NCc1ccccc1.CCCC(CC(=O)OCC)NCc1ccccc1,28601185,1,56,full reaction|has preparation,ethyl hex-2-enoate|benzylamine,C20H26N2O|ethyl 3-(benzylamino)caproate,210120|224464,Preparation,1,60,aza-Michael addition,,,"8764151; Article; Weiß, Markus; Gröger, Harald; Synlett; 8; (2009); p. 1251 - 1254;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,30,Neat (no solvent),,experimental part,,,,,,,,,,,,,,
CCOC(=O)C=CC(F)(F)F,NCc1ccccc1.NCc1ccccc1.NCc1ccccc1.O=C(CC(NCc1ccccc1)C(F)(F)F)NCc1ccccc1.CCOC(=O)CC(NCc1ccccc1)C(F)(F)F,CCOC(=O)C=CC(F)(F)F>>NCc1ccccc1.NCc1ccccc1.NCc1ccccc1.O=C(CC(NCc1ccccc1)C(F)(F)F)NCc1ccccc1.CCOC(=O)CC(NCc1ccccc1)C(F)(F)F,28601187,1,56,full reaction|has preparation,"ethyl 4,4,4-trifluorobut-2-enoate|benzylamine","N-benzyl-4,4,4-trifluoro-3-benzylaminobutanamide|ethyl 3-(benzylamino)-4,4,4-trifluorobutanoate",224464|210120,Preparation,1,60,aza-Michael addition,,,"8764151; Article; Weiß, Markus; Gröger, Harald; Synlett; 8; (2009); p. 1251 - 1254;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,30,Neat (no solvent),,experimental part,,,,,,,,,,,,,,
C=CCNC,CC(=Cc1ccccc1)[N+](=O)[O-].C=CCN(C)[C@@H](c1ccccc1)[C@H](C)[N+](=O)[O-].C=CCN(C)[C@@H](c1ccccc1)[C@@H](C)[N+](=O)[O-],C=CCNC>>CC(=Cc1ccccc1)[N+](=O)[O-].C=CCN(C)[C@@H](c1ccccc1)[C@H](C)[N+](=O)[O-].C=CCN(C)[C@@H](c1ccccc1)[C@@H](C)[N+](=O)[O-],29337538,1,56,full reaction|has preparation,N-methyl-N-allylamine|(2-nitroprop-1-enyl)benzene,allyl-methyl-(2-nitro-1-phenyl-propyl)-amine|allyl-methyl-(2-nitro-1-phenyl-propyl)-amine,,Preparation,1,,Michael addition,,dichloromethane,"8865566; Article; Dumez, Estelle; Durand, Anne-Catherine; Guillaume, Martial; Roger, Pierre-Yves; Faure, Robert; Pons, Jean-Marc; Herbette, Gaetan; Dulcere, Jean-Pierre; Bonne, Damien; Rodriguez, Jean",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Reflux,,supporting information; experimental part,optical yield given as %de|diastereoselective reaction,,,,,,,,,,,,,
O=[N+]([O-])C1=CCCCC1,C=CCN.O=[N+]([O-])C1=CCCCC1.C=CCN.C=CCN[C@H]1CCCC[C@@H]1[N+](=O)[O-].C=CCN[C@H]1CCCC[C@H]1[N+](=O)[O-],O=[N+]([O-])C1=CCCCC1>>C=CCN.O=[N+]([O-])C1=CCCCC1.C=CCN.C=CCN[C@H]1CCCC[C@@H]1[N+](=O)[O-].C=CCN[C@H]1CCCC[C@H]1[N+](=O)[O-],29337593,1,56,full reaction|has preparation,1-nitrocyclohexene|1-amino-2-propene,allyl-(2-nitro-cyclohexyl)-amine|allyl-(2-nitro-cyclohexyl)-amine,,Preparation,1,,Michael addition,,dichloromethane,"8865566; Article; Dumez, Estelle; Durand, Anne-Catherine; Guillaume, Martial; Roger, Pierre-Yves; Faure, Robert; Pons, Jean-Marc; Herbette, Gaetan; Dulcere, Jean-Pierre; Bonne, Damien; Rodriguez, Jean",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,Reflux,,supporting information; experimental part,optical yield given as %de|diastereoselective reaction,,,,,,,,,,,,,
C=CCOC(=O)/C(C)=C/[C@@H](CO[Si](C)(C)C(C)(C)C)NC(=S)[C@@H](C)[C@H](C[C@H](C)C[C@H](OC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(C)(C)C)O[Si](C)(C)C(C)(C)C,C=CCOC(=O)C(C)C1SC([C@@H](C)[C@H](C[C@H](C)C[C@H](OC(=O)[C@@H]2CCCN2C(=O)OC(C)(C)C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=NC1CO[Si](C)(C)C(C)(C)C,C=CCOC(=O)/C(C)=C/[C@@H](CO[Si](C)(C)C(C)(C)C)NC(=S)[C@@H](C)[C@H](C[C@H](C)C[C@H](OC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(C)(C)C)O[Si](C)(C)C(C)(C)C>>C=CCOC(=O)C(C)C1SC([C@@H](C)[C@H](C[C@H](C)C[C@H](OC(=O)[C@@H]2CCCN2C(=O)OC(C)(C)C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=NC1CO[Si](C)(C)C(C)(C)C,29467011,1,56,full reaction|has preparation,C44H82N2O8SSi2,C44H82N2O8SSi2,,Preparation,1,,Michael addition,,,"8883534; Article; Numajiri, Yoshitaka; Takahashi, Takashi; Doi, Takayuki; Chemistry - An Asian Journal; vol. 4; 1; (2009); p. 111 - 125;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
O=C(C=Cc1ccc(Cl)cc1)c1ccccc1,CC[N+](=O)[O-].CC(C(CC(=O)c1ccccc1)c1ccc(Cl)cc1)[N+](=O)[O-].CC(C(CC(=O)c1ccccc1)c1ccc(Cl)cc1)[N+](=O)[O-],O=C(C=Cc1ccc(Cl)cc1)c1ccccc1>>CC[N+](=O)[O-].CC(C(CC(=O)c1ccccc1)c1ccc(Cl)cc1)[N+](=O)[O-].CC(C(CC(=O)c1ccccc1)c1ccc(Cl)cc1)[N+](=O)[O-],29799944,1,56,full reaction|has preparation,3-(4-chlorophenyl)-1-phenylprop-2-en-1-one|Nitroethane,3-(4-chlorophenyl)-4-nitro-1-phenylpentan-1-one|3-(4-chlorophenyl)-4-nitro-1-phenylpentan-1-one,,Preparation,1,,Michael addition,,,"8929933; Article; Vijaikumar, Sakthivel; Pitchumani, Kasi; Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry; vol. 49; 4; (2010); p. 469 - 474;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.1,Microwave irradiation,,experimental part,,hydrotalcite,,,,,,,,,,,,
Cc1ccc(C(=O)C=Cc2ccc(Cl)cc2)cc1,CC[N+](=O)[O-].Cc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C)[N+](=O)[O-])cc1.Cc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C)[N+](=O)[O-])cc1,Cc1ccc(C(=O)C=Cc2ccc(Cl)cc2)cc1>>CC[N+](=O)[O-].Cc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C)[N+](=O)[O-])cc1.Cc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C)[N+](=O)[O-])cc1,29799945,1,56,full reaction|has preparation,3-(4-chlorophenyl)-1-p-tolylprop-2-en-1-one|Nitroethane,3-(4-chlorophenyl)-4-nitro-1-p-tolylpentan-1-one|3-(4-chlorophenyl)-4-nitro-1-p-tolylpentan-1-one,,Preparation,1,,Michael addition,,,"8929933; Article; Vijaikumar, Sakthivel; Pitchumani, Kasi; Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry; vol. 49; 4; (2010); p. 469 - 474;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.1,Microwave irradiation,,experimental part,,hydrotalcite,,,,,,,,,,,,
CC[N+](=O)[O-],CC(=O)C=Cc1ccccc1.CC(=O)CC(c1ccccc1)C(C)[N+](=O)[O-].CC(=O)CC(c1ccccc1)C(C)[N+](=O)[O-],CC[N+](=O)[O-]>>CC(=O)C=Cc1ccccc1.CC(=O)CC(c1ccccc1)C(C)[N+](=O)[O-].CC(=O)CC(c1ccccc1)C(C)[N+](=O)[O-],29799947,1,56,full reaction|has preparation,Nitroethane|1-Phenylbut-1-en-3-one,5-nitro-4-phenylhexan-2-one|5-nitro-4-phenylhexan-2-one,,Preparation,1,,Michael addition,,,"8929933; Article; Vijaikumar, Sakthivel; Pitchumani, Kasi; Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry; vol. 49; 4; (2010); p. 469 - 474;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,Microwave irradiation,,experimental part,,hydrotalcite,,,,,,,,,,,,
COC(=O)C#CC(=O)OC,Nc1ccc(Br)cc1N.Nc1ccc(Br)cc1N.COC(=O)/C=C1\Nc2ccc(Br)cc2NC1=O.COC(=O)/C=C1\Nc2cc(Br)ccc2NC1=O,COC(=O)C#CC(=O)OC>>Nc1ccc(Br)cc1N.Nc1ccc(Br)cc1N.COC(=O)/C=C1\Nc2ccc(Br)cc2NC1=O.COC(=O)/C=C1\Nc2cc(Br)ccc2NC1=O,32053258,1,56,full reaction|has preparation,"dimethyl acetylenedicarboxylate|4-Bromo-benzene-1,2-diamine","(Z)-3-methoxycarbonylmethylene-7-bromo-3,4-dihydro-2(1H)-quinoxalinone|(Z)-3-methoxycarbonylmethylene-6-bromo-3,4-dihydro-2(1H)-quinoxalinone",182304|182304,Preparation,1,20,Michael addition,,,"20048951; Article; Choudhary, Garima; Peddinti, Rama Krishna; Green Chemistry; vol. 13; 11; (2011); p. 3290 - 3299;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.05,,,experimental part,,,,,,,,,,,,,,
Nc1ccc(Br)cc1N,CCOC(=O)C#CC(=O)OCC.Nc1ccc(Br)cc1N.CCOC(=O)/C=C1\Nc2cc(Br)ccc2NC1=O.CCOC(=O)/C=C1\Nc2ccc(Br)cc2NC1=O,Nc1ccc(Br)cc1N>>CCOC(=O)C#CC(=O)OCC.Nc1ccc(Br)cc1N.CCOC(=O)/C=C1\Nc2cc(Br)ccc2NC1=O.CCOC(=O)/C=C1\Nc2ccc(Br)cc2NC1=O,32053263,1,56,full reaction|has preparation,"4-Bromo-benzene-1,2-diamine|acetylenedicarboxylic acid diethyl ester","(Z)-3-ethoxycarbonylmethylene-6-bromo-3,4-dihydro-2(1H)-quinoxalinone|(Z)-3-ethoxycarbonylmethylene-7-bromo-3,4-dihydro-2(1H)-quinoxalinone",182304|182304,Preparation,1,20,Michael addition,,,"20048951; Article; Choudhary, Garima; Peddinti, Rama Krishna; Green Chemistry; vol. 13; 11; (2011); p. 3290 - 3299;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0666667,,,experimental part,,,,,,,,,,,,,,
CC/C(=C\c1ccc([N+](=O)[O-])cc1)C(C)=O,SCc1ccccc1.CC[C@H](C(C)=O)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1.CC[C@@H](C(C)=O)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1,CC/C(=C\c1ccc([N+](=O)[O-])cc1)C(C)=O>>SCc1ccccc1.CC[C@H](C(C)=O)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1.CC[C@@H](C(C)=O)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1,32108642,1,56,full reaction|has preparation,(E)-3-ethyl-4-(4-nitrophenyl)but‑3-en-2-one|phenylmethanethiol,C19H21NO3S|C19H21NO3S,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CCC(=O)/C(C)=C/c1ccc([N+](=O)[O-])cc1,SCc1ccccc1.CCC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1.CCC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1,CCC(=O)/C(C)=C/c1ccc([N+](=O)[O-])cc1>>SCc1ccccc1.CCC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1.CCC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1,32108647,1,56,full reaction|has preparation,(E)-2-methyl-1-(4-nitrophenyl)-1-penten-3-one|phenylmethanethiol,C19H21NO3S|C19H21NO3S,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CC(=O)/C(C)=C/c1ccsc1,SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccsc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccsc1,CC(=O)/C(C)=C/c1ccsc1>>SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccsc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccsc1,32108648,1,56,full reaction|has preparation,C9H10OS|phenylmethanethiol,C16H18OS2|C16H18OS2,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
C=CCS,C/C=C(\C)C(C)=O.C/C=C(\C)C(C)=O.C=CCS.C=CCS[C@@H](C)[C@H](C)C(C)=O.C=CCS[C@H](C)[C@H](C)C(C)=O,C=CCS>>C/C=C(\C)C(C)=O.C/C=C(\C)C(C)=O.C=CCS.C=CCS[C@@H](C)[C@H](C)C(C)=O.C=CCS[C@H](C)[C@H](C)C(C)=O,32108650,1,56,full reaction|has preparation,prop-2-ene-1-thiol|(E)-3-methylpent-3-en-2-one,C9H16OS|C9H16OS,221590|221590,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
C/C=C(\C)C(C)=O,COc1ccc(CS)cc1.COc1ccc(CS[C@H](C)[C@H](C)C(C)=O)cc1.COc1ccc(CS[C@H](C)[C@@H](C)C(C)=O)cc1,C/C=C(\C)C(C)=O>>COc1ccc(CS)cc1.COc1ccc(CS[C@H](C)[C@H](C)C(C)=O)cc1.COc1ccc(CS[C@H](C)[C@@H](C)C(C)=O)cc1,32108654,1,56,full reaction|has preparation,(E)-3-methylpent-3-en-2-one|p-methoxybenzylmercaptan,C14H20O2S|C14H20O2S,221590|221590,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
C/C=C(\C)C(C)=O,CCOC(=O)CS.C/C=C(\C)C(C)=O.CCOC(=O)CS.CCOC(=O)CS[C@@H](C)[C@H](C)C(C)=O.CCOC(=O)CS[C@@H](C)[C@@H](C)C(C)=O,C/C=C(\C)C(C)=O>>CCOC(=O)CS.C/C=C(\C)C(C)=O.CCOC(=O)CS.CCOC(=O)CS[C@@H](C)[C@H](C)C(C)=O.CCOC(=O)CS[C@@H](C)[C@@H](C)C(C)=O,32108657,1,56,full reaction|has preparation,(E)-3-methylpent-3-en-2-one|ethyl 2-sulfanylacetate,C10H18O3S|C10H18O3S,221590|221590,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
C/C=C(\C)C(C)=O,SCc1ccccc1.CC(=O)[C@@H](C)[C@H](C)SCc1ccccc1.CC(=O)[C@H](C)[C@H](C)SCc1ccccc1,C/C=C(\C)C(C)=O>>SCc1ccccc1.CC(=O)[C@@H](C)[C@H](C)SCc1ccccc1.CC(=O)[C@H](C)[C@H](C)SCc1ccccc1,32108664,1,56,full reaction|has preparation,(E)-3-methylpent-3-en-2-one|phenylmethanethiol,C13H18OS|C13H18OS,221590|221590,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
C/C=C(\C)C(C)=O,SCc1ccc(Cl)cc1.SCc1ccc(Cl)cc1.C/C=C(\C)C(C)=O.CC(=O)[C@@H](C)[C@@H](C)SCc1ccc(Cl)cc1.CC(=O)[C@H](C)[C@@H](C)SCc1ccc(Cl)cc1,C/C=C(\C)C(C)=O>>SCc1ccc(Cl)cc1.SCc1ccc(Cl)cc1.C/C=C(\C)C(C)=O.CC(=O)[C@@H](C)[C@@H](C)SCc1ccc(Cl)cc1.CC(=O)[C@H](C)[C@@H](C)SCc1ccc(Cl)cc1,32108667,1,56,full reaction|has preparation,(E)-3-methylpent-3-en-2-one|(4-chlorophenyl)methanethiol,C13H17ClOS|C13H17ClOS,221590|221590,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CCOC(=O)/C=C(\C)C(C)=O,SCc1ccccc1.CCOC(=O)[C@@H](SCc1ccccc1)[C@H](C)C(C)=O.CCOC(=O)[C@@H](SCc1ccccc1)[C@@H](C)C(C)=O,CCOC(=O)/C=C(\C)C(C)=O>>SCc1ccccc1.CCOC(=O)[C@@H](SCc1ccccc1)[C@H](C)C(C)=O.CCOC(=O)[C@@H](SCc1ccccc1)[C@@H](C)C(C)=O,32108670,1,56,full reaction|has preparation,(E)-ethyl 3-methyl-4-oxopent-2-enoate|phenylmethanethiol,C15H20O3S|C15H20O3S,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
[H]/C(CC)=C(\C(C)=O)c1ccccc1,SCc1ccccc1.[H]/C(CC)=C(\C(C)=O)c1ccccc1.SCc1ccccc1.CC[C@H](SCc1ccccc1)[C@@H](C(C)=O)c1ccccc1.CC[C@@H](SCc1ccccc1)[C@@H](C(C)=O)c1ccccc1,[H]/C(CC)=C(\C(C)=O)c1ccccc1>>SCc1ccccc1.[H]/C(CC)=C(\C(C)=O)c1ccccc1.SCc1ccccc1.CC[C@H](SCc1ccccc1)[C@@H](C(C)=O)c1ccccc1.CC[C@@H](SCc1ccccc1)[C@@H](C(C)=O)c1ccccc1,32108676,1,56,full reaction|has preparation,(E)-3-phenylhex-3-en-2-one|phenylmethanethiol,C19H22OS|C19H22OS,221588|221588,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CC(=O)/C(C)=C/c1ccc(Br)cc1,SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc(Br)cc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc(Br)cc1,CC(=O)/C(C)=C/c1ccc(Br)cc1>>SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc(Br)cc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc(Br)cc1,32108680,1,56,full reaction|has preparation,(E)-4-(4-bromophenyl)-3-methylbut-3-en-2-one|phenylmethanethiol,C18H19BrOS|C18H19BrOS,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CC(=O)/C(C)=C/c1ccc([N+](=O)[O-])cc1,SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1,CC(=O)/C(C)=C/c1ccc([N+](=O)[O-])cc1>>SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc([N+](=O)[O-])cc1,32108685,1,56,full reaction|has preparation,(E)-3-methyl-4-(4-nitrophenyl)-3-buten-2-one|phenylmethanethiol,C18H19NO3S|C18H19NO3S,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CC(=O)/C(C)=C/c1ccccc1,SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccccc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccccc1,CC(=O)/C(C)=C/c1ccccc1>>SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccccc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccccc1,32108688,1,56,full reaction|has preparation,(E)-3-methyl-4-phenyl-3-buten-2-one|phenylmethanethiol,C18H20OS|C18H20OS,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
COc1ccc(/C=C(\C)C(C)=O)cc1,SCc1ccccc1.COc1ccc([C@H](SCc2ccccc2)[C@H](C)C(C)=O)cc1.COc1ccc([C@H](SCc2ccccc2)[C@@H](C)C(C)=O)cc1,COc1ccc(/C=C(\C)C(C)=O)cc1>>SCc1ccccc1.COc1ccc([C@H](SCc2ccccc2)[C@H](C)C(C)=O)cc1.COc1ccc([C@H](SCc2ccccc2)[C@@H](C)C(C)=O)cc1,32108689,1,56,full reaction|has preparation,(E)-3-methyl-4-(4-methoxyphenyl)-3-buten-2-one|phenylmethanethiol,C19H22O2S|C19H22O2S,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CC(=O)/C(C)=C/CCc1ccccc1,SCc1ccccc1.CC(=O)[C@@H](C)[C@H](CCc1ccccc1)SCc1ccccc1.CC(=O)[C@H](C)[C@H](CCc1ccccc1)SCc1ccccc1,CC(=O)/C(C)=C/CCc1ccccc1>>SCc1ccccc1.CC(=O)[C@@H](C)[C@H](CCc1ccccc1)SCc1ccccc1.CC(=O)[C@H](C)[C@H](CCc1ccccc1)SCc1ccccc1,32108691,1,56,full reaction|has preparation,3-methyl-6-phenyl-trans-3-hexen-2-one|phenylmethanethiol,C20H24OS|C20H24OS,224264|224264,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
CC(=O)/C(C)=C/c1ccc(Cl)cc1,SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc(Cl)cc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc(Cl)cc1,CC(=O)/C(C)=C/c1ccc(Cl)cc1>>SCc1ccccc1.CC(=O)[C@@H](C)[C@@H](SCc1ccccc1)c1ccc(Cl)cc1.CC(=O)[C@H](C)[C@@H](SCc1ccccc1)c1ccc(Cl)cc1,32108693,1,56,full reaction|has preparation,(E)-3-methyl-4-(4-chlorophenyl)-3-buten-2-one|phenylmethanethiol,C18H19ClOS|C18H19ClOS,228308|228308,Preparation,1,,sulfa Michael addition,,toluene,"20052175; Article; Tian, Xu; Cassani, Carlo; Liu, Yankai; Moran, Antonio; Urakawa, Atsushi; Galzerano, Patrizia; Arceo, Elena; Melchiorre, Paolo; Journal of the American Chemical Society; vol. 133; 44",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; body text,,,,,,,,,,,,,,
C=C([N+]([O-])=NOC)[N+]([O-])=NOC,n1onc2c1Nc1nonc1N2.CON=[N+]([O-])C(CN1c2nonc2Nc2nonc21)[N+]([O-])=NOC.CON=[N+]([O-])C(CN1c2nonc2N(CC([N+]([O-])=NOC)[N+]([O-])=NOC)c2nonc21)[N+]([O-])=NOC,C=C([N+]([O-])=NOC)[N+]([O-])=NOC>>n1onc2c1Nc1nonc1N2.CON=[N+]([O-])C(CN1c2nonc2Nc2nonc21)[N+]([O-])=NOC.CON=[N+]([O-])C(CN1c2nonc2N(CC([N+]([O-])=NOC)[N+]([O-])=NOC)c2nonc21)[N+]([O-])=NOC,33731168,1,56,full reaction|has preparation,"1,1-bis-(methoxy-N,N,O-azoxy)ethene|4H,8H-bis-furazano-[3,4-b:3′,4′-e]pyrazine","4-[2,2-di(methoxy-NNO-azoxy)ethyl]-bisfurazano[3,4-b:3',4'-e]pyrazine|4,8-bis[2,2-di(methoxy-NNO-azoxy)ethyl]-bisfurazano[3,4-b:3'4'-e]pyrazine",228544|230534,Preparation,1,,Aza-Michael reaction,,,"20179744; Article; Zyuzin, Igor N.; Suponitsky, Kyrill Yu.; Sheremetev, Aleksei B.; Journal of Heterocyclic Chemistry; vol. 49; 3; (2012); p. 561 - 565;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,"4,8-bis[2,2-di(methoxy-NNO-azoxy)ethyl]-bisfurazano[3,4-b:3'4'-e]pyrazine|4-[2,2-di(methoxy-NNO-azoxy)ethyl]-bisfurazano[3,4-b:3',4'-e]pyrazine",43 percent|11 percent,43|11,,,,,,,,,
CC=CC(=O)c1ccccc1,Clc1ncnc2[nH]cnc12.CC(=O)C[C@@H](c1ccccc1)n1cnc2c(Cl)ncnc21.CC(=O)C[C@H](c1ccccc1)n1cnc2c(Cl)ncnc21,CC=CC(=O)c1ccccc1>>Clc1ncnc2[nH]cnc12.CC(=O)C[C@@H](c1ccccc1)n1cnc2c(Cl)ncnc21.CC(=O)C[C@H](c1ccccc1)n1cnc2c(Cl)ncnc21,34396751,1,56,full reaction,1-phenylbut-2-en-1-one|6-chloropurine,C15H13ClN4O|C15H13ClN4O,220514|287719,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"35344117; Article; Wu, Hao; Tian, Zhiqing; Zhang, Lili; Huang, Yaodong; Wang, Yongmei; Advanced Synthesis and Catalysis; vol. 354; 16; (2012); p. 2977 - 2984;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,Overall yield = 52 %; enantioselective reaction,"1-((1R,2R)-2-aminocyclohexyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea|benzoic acid",,,,Temperature,Experimental part,89 percent ee,,,,,,
Clc1ncnc2[nH]cnc12,O=C(/C=C/c1ccccc1)c1ccccc1.O=C(C[C@@H](c1ccccc1)n1cnc2c(Cl)ncnc21)c1ccccc1.O=C(C[C@H](c1ccccc1)n1cnc2c(Cl)ncnc21)c1ccccc1,Clc1ncnc2[nH]cnc12>>O=C(/C=C/c1ccccc1)c1ccccc1.O=C(C[C@@H](c1ccccc1)n1cnc2c(Cl)ncnc21)c1ccccc1.O=C(C[C@H](c1ccccc1)n1cnc2c(Cl)ncnc21)c1ccccc1,34396754,1,56,full reaction,"6-chloropurine|1,3-diphenyl-propen-3-one",C20H15ClN4O|C20H15ClN4O,228587|228587,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"35344117; Article; Wu, Hao; Tian, Zhiqing; Zhang, Lili; Huang, Yaodong; Wang, Yongmei; Advanced Synthesis and Catalysis; vol. 354; 16; (2012); p. 2977 - 2984;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,supporting information,Overall yield = 52 %; enantioselective reaction,Boc-Pro-OH|9-amino(9-deoxy)epi-quinine,,,,Temperature|Reagent/catalyst,Experimental part,87 percent ee,,,,,,
CCCC=CC(C)=O,Clc1nc(Cl)c2nc[nH]c2n1.CCC[C@H](CC(C)=O)n1cnc2c(Cl)nc(Cl)nc21.CCC[C@@H](CC(C)=O)n1cnc2c(Cl)nc(Cl)nc21,CCCC=CC(C)=O>>Clc1nc(Cl)c2nc[nH]c2n1.CCC[C@H](CC(C)=O)n1cnc2c(Cl)nc(Cl)nc21.CCC[C@@H](CC(C)=O)n1cnc2c(Cl)nc(Cl)nc21,34396824,1,56,full reaction,"3-hepten-2-one|2,6 dichloropurine",C12H14Cl2N4O|C12H14Cl2N4O,220171|220171,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"35344117; Article; Wu, Hao; Tian, Zhiqing; Zhang, Lili; Huang, Yaodong; Wang, Yongmei; Advanced Synthesis and Catalysis; vol. 354; 16; (2012); p. 2977 - 2984;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,Overall yield = 90 %; enantioselective reaction,"1-((1R,2R)-2-aminocyclohexyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea|benzoic acid",,,,Temperature,Experimental part,82 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,COC(=O)CC(C)=O.COC(=O)[C@@H](C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>COC(=O)CC(C)=O.COC(=O)[C@@H](C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,34468085,1,56,full reaction,(2-nitroethenyl)benzene|acetoacetic acid methyl ester,"methyl (2R,3S)-2-acetyl-4-nitro-3-phenylbutanoate|C13H15NO5",224814|224814,Chemical behaviour,1,40,Michael Addition,Catalytic behavior,toluene,"35392213; Article; Liu, Ketang; Jin, Ronghua; Cheng, Tanyu; Xu, Xiangming; Gao, Fei; Liu, Guohua; Li, Hexing; Chemistry - A European Journal; vol. 18; 48; (2012); p. 15546 - 15553;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,"heterogeneous (1R,2R)-1,2-diaminocyclohexane based ethylene bridged NiII periodic mesoporous organosilica",,,,,Experimental part,95 percent ee|93 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCOC(=O)CC(C)=O.CCOC(=O)[C@@H](C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCOC(=O)CC(C)=O.CCOC(=O)[C@@H](C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,34468086,1,56,full reaction,(2-nitroethenyl)benzene|ethyl acetoacetate,"(2R,3S)-ethyl 2-acetyl-4-nitro-3-phenylbutanoate|C14H17NO5",224813|224813,Chemical behaviour,1,40,Michael Addition,Catalytic behavior,toluene,"35392213; Article; Liu, Ketang; Jin, Ronghua; Cheng, Tanyu; Xu, Xiangming; Gao, Fei; Liu, Guohua; Li, Hexing; Chemistry - A European Journal; vol. 18; 48; (2012); p. 15546 - 15553;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,"heterogeneous (1R,2R)-1,2-diaminocyclohexane based ethylene bridged NiII periodic mesoporous organosilica",,,,,Experimental part,94 percent ee|93 percent ee,,,,,,
CC(=O)CC(=O)OC(C)C,O=[N+]([O-])C=Cc1ccccc1.CC(=O)[C@H](C(=O)OC(C)C)[C@H](C[N+](=O)[O-])c1ccccc1.CC(=O)C(C(=O)OC(C)C)C(C[N+](=O)[O-])c1ccccc1,CC(=O)CC(=O)OC(C)C>>O=[N+]([O-])C=Cc1ccccc1.CC(=O)[C@H](C(=O)OC(C)C)[C@H](C[N+](=O)[O-])c1ccccc1.CC(=O)C(C(=O)OC(C)C)C(C[N+](=O)[O-])c1ccccc1,34468087,1,56,full reaction,isopropyl acetoacetate|(2-nitroethenyl)benzene,C15H19NO5|C15H19NO5,224813|224813,Chemical behaviour,1,40,Michael Addition,Catalytic behavior,toluene,"35392213; Article; Liu, Ketang; Jin, Ronghua; Cheng, Tanyu; Xu, Xiangming; Gao, Fei; Liu, Guohua; Li, Hexing; Chemistry - A European Journal; vol. 18; 48; (2012); p. 15546 - 15553;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,"heterogeneous (1R,2R)-1,2-diaminocyclohexane based ethylene bridged NiII periodic mesoporous organosilica",,,,,Experimental part,95 percent ee|95 percent ee,,,,,,
CC(=O)CC(=O)OC(C)(C)C,O=[N+]([O-])C=Cc1ccccc1.CC(=O)[C@H](C(=O)OC(C)(C)C)[C@H](C[N+](=O)[O-])c1ccccc1.CC(=O)C(C(=O)OC(C)(C)C)C(C[N+](=O)[O-])c1ccccc1,CC(=O)CC(=O)OC(C)(C)C>>O=[N+]([O-])C=Cc1ccccc1.CC(=O)[C@H](C(=O)OC(C)(C)C)[C@H](C[N+](=O)[O-])c1ccccc1.CC(=O)C(C(=O)OC(C)(C)C)C(C[N+](=O)[O-])c1ccccc1,34468088,1,56,full reaction,tert-butyl acetoacetate|(2-nitroethenyl)benzene,"tert-butyl (2R,3S)-2-acetyl-4-nitro-3-phenylbutanoate|C16H21NO5",224813|224813,Chemical behaviour,1,40,Michael Addition,Catalytic behavior,toluene,"35392213; Article; Liu, Ketang; Jin, Ronghua; Cheng, Tanyu; Xu, Xiangming; Gao, Fei; Liu, Guohua; Li, Hexing; Chemistry - A European Journal; vol. 18; 48; (2012); p. 15546 - 15553;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,"heterogeneous (1R,2R)-1,2-diaminocyclohexane based ethylene bridged NiII periodic mesoporous organosilica",,,,,Experimental part,95 percent ee|92 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCOC(=O)CC(=O)C(C)C.CCOC(=O)[C@@H](C(=O)C(C)C)[C@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)C(C(=O)C(C)C)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCOC(=O)CC(=O)C(C)C.CCOC(=O)[C@@H](C(=O)C(C)C)[C@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)C(C(=O)C(C)C)C(C[N+](=O)[O-])c1ccccc1,34468089,1,56,full reaction,(2-nitroethenyl)benzene|ethyl 4-methyl-3-oxo-pentanoate,C16H21NO5|C16H21NO5,224813|224813,Chemical behaviour,1,40,Michael Addition,Catalytic behavior,toluene,"35392213; Article; Liu, Ketang; Jin, Ronghua; Cheng, Tanyu; Xu, Xiangming; Gao, Fei; Liu, Guohua; Li, Hexing; Chemistry - A European Journal; vol. 18; 48; (2012); p. 15546 - 15553;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,"heterogeneous (1R,2R)-1,2-diaminocyclohexane based ethylene bridged NiII periodic mesoporous organosilica",,,,,Experimental part,97 percent ee|97 percent ee,,,,,,
C=CS(=O)(=O)NCCCn1cccc(OCc2ccccc2)c1=O,C1CNCCNCCN1.O=c1c(OCc2ccccc2)cccn1CCCNS(=O)(=O)CCN1CCN(CCS(=O)(=O)NCCCn2cccc(OCc3ccccc3)c2=O)CCN(CCS(=O)(=O)NCCCn2cccc(OCc3ccccc3)c2=O)CC1.O=c1c(OCc2ccccc2)cccn1CCCNS(=O)(=O)CCN1CCNCCN(CCS(=O)(=O)NCCCn2cccc(OCc3ccccc3)c2=O)CC1,C=CS(=O)(=O)NCCCn1cccc(OCc2ccccc2)c1=O>>C1CNCCNCCN1.O=c1c(OCc2ccccc2)cccn1CCCNS(=O)(=O)CCN1CCN(CCS(=O)(=O)NCCCn2cccc(OCc3ccccc3)c2=O)CCN(CCS(=O)(=O)NCCCn2cccc(OCc3ccccc3)c2=O)CC1.O=c1c(OCc2ccccc2)cccn1CCCNS(=O)(=O)CCN1CCNCCN(CCS(=O)(=O)NCCCn2cccc(OCc3ccccc3)c2=O)CC1,34580336,1,56,full reaction|has preparation,"C17H20N2O4S|1,4,7-triazacyclononane",C57H75N9O12S3|C40H55N7O8S2,119777|58245,Preparation,1,,Michael Addition,,tetrahydrofuran|water,"35448495; Article; Martinez, Gloria; Arumugam, Jayanthi; Jacobs, Hollie K.; Gopalan, Aravamudan S.; Tetrahedron Letters; vol. 54; 7; (2013); p. 630 - 634;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,Reflux,,,,,,,,,Scheme or table,,,,,,,
C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1,C/C(=C\c1ccccc1)[N+](=O)[O-].CCC=O.CC1=[N+]([O-])O[C@@H](N2CCC[C@H]2C(O[Si](C)(C)C)(c2ccccc2)c2ccccc2)[C@H](C)[C@H]1c1ccccc1,C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1>>C/C(=C\c1ccccc1)[N+](=O)[O-].CCC=O.CC1=[N+]([O-])O[C@@H](N2CCC[C@H]2C(O[Si](C)(C)C)(c2ccccc2)c2ccccc2)[C@H](C)[C@H]1c1ccccc1,34668340,1,56,full reaction|has preparation,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|1-phenyl-2-nitroprop-1-ene|propionaldehyde,"(4S,5R,6R)-6-[(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidin-1-yl]-5,6-dihydro-3,5-dimethyl-4-phenyl-4H-1,2-oxazine 2-oxide",193682,Preparation,1,,Michael Addition,,(2)H8-toluene,"35452456; Article; Sahoo, Gokarneswar; Rahaman, Hasibur; Madarasz, Adam; Papai, Imre; Melarto, Mikko; Valkonen, Arto; Pihko, Petri M.; Angewandte Chemie - International Edition; vol. 51; 52; (2012); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,15,Molecular sieve,,supporting information,,,,,,,Experimental part,,,,,,,
C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1,C/C(=C\c1ccc(F)cc1)[N+](=O)[O-].CCC=O.CC1=[N+]([O-])O[C@@H](N2CCC[C@H]2C(O[Si](C)(C)C)(c2ccccc2)c2ccccc2)[C@H](C)[C@H]1c1ccc(F)cc1,C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1>>C/C(=C\c1ccc(F)cc1)[N+](=O)[O-].CCC=O.CC1=[N+]([O-])O[C@@H](N2CCC[C@H]2C(O[Si](C)(C)C)(c2ccccc2)c2ccccc2)[C@H](C)[C@H]1c1ccc(F)cc1,34668342,1,56,full reaction|has preparation,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|(E)-1-fluoro-4-(2-nitroprop-1-en-1-yl)benzene|propionaldehyde,"6((S)2-(diphenyl((trimethylsilyl)oxy)methyl)pyrrolidin1yl)-4-(4-fluorophenyl)-3,5-dimethyl5,6dihydro-4H-1,2-oxazine-2-oxide",193682,Preparation,1,,Michael Addition,,chloroform-d1,"35452456; Article; Sahoo, Gokarneswar; Rahaman, Hasibur; Madarasz, Adam; Papai, Imre; Melarto, Mikko; Valkonen, Arto; Pihko, Petri M.; Angewandte Chemie - International Edition; vol. 51; 52; (2012); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,21,Molecular sieve,,supporting information,,,,,,,Experimental part,,,,,,,
O=[N+]([O-])/C=C/c1ccccc1,CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])/C=C/c1ccccc1>>CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1ccccc1,34959018,1,56,full reaction,nitrostyrene|acetylacetone,"(R)-3-(2-nitro-1-phenylethyl)pentane-2,4-dione|(S)-3-(2-nitro-1-phenylethyl)pentane-2,4-dione",210162|210162,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"35466369; Article; Isik, Murat; Tanyeli, Cihangir; Journal of Organic Chemistry; vol. 78; 4; (2013); p. 1604 - 1611;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,30,,,,Overall yield = 90 %; enantioselective reaction,C28H43N5O4S,,,,Time|Solvent|Reagent/catalyst,Experimental part,82 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccccc1[N+](=O)[O-],CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-].CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],O=[N+]([O-])/C=C/c1ccccc1[N+](=O)[O-]>>CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-].CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],34959019,1,56,full reaction,(E)-1-nitro-2-(2-nitrovinyl)benzene|acetylacetone,"(R)-3-(2-nitro-1-(2-nitrophenyl)ethyl)pentane-2,4-dione|(S)-3-(2-nitro-1-(2-nitrophenyl)ethyl)pentane-2,4-dione",210162|210162,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"35466369; Article; Isik, Murat; Tanyeli, Cihangir; Journal of Organic Chemistry; vol. 78; 4; (2013); p. 1604 - 1611;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,58,,,,Overall yield = 87 %; Overall yield = 51 mg,C28H43N5O4S,,,,,Experimental part,86 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccccc1Cl,CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1ccccc1Cl,O=[N+]([O-])/C=C/c1ccccc1Cl>>CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1ccccc1Cl,34959020,1,56,full reaction,1-chloro-2-[(E)-2-nitrovinyl]benzene|acetylacetone,"(R)-3-(1-(2-chlorophenyl)-2-nitroethyl)pentane-2,4-dione|(S)-3-(1-(2-chlorophenyl)-2-nitroethyl)pentane-2,4-dione",210162|210162,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"35466369; Article; Isik, Murat; Tanyeli, Cihangir; Journal of Organic Chemistry; vol. 78; 4; (2013); p. 1604 - 1611;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,60,,,,Overall yield = 91 %; Overall yield = 52 mg,C28H43N5O4S,,,,,Experimental part,75 percent ee,,,,,,
O=[N+]([O-])/C=C/c1cccs1,CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1cccs1.CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1cccs1,O=[N+]([O-])/C=C/c1cccs1>>CC(=O)CC(C)=O.CC(=O)C(C(C)O)[C@@H](C[N+](=O)[O-])c1cccs1.CC(=O)C(C(C)O)[C@H](C[N+](=O)[O-])c1cccs1,34959023,1,56,full reaction,1-(2-thienyl)-2-nitroethene|acetylacetone,"(S)-3-(2-nitro-1-(thiophen-2-yl)ethyl)pentane-2,4-dione|(R)-3-(2-nitro-1-(thiophen-2-yl)ethyl)pentane-2,4-dione",210162|210162,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"35466369; Article; Isik, Murat; Tanyeli, Cihangir; Journal of Organic Chemistry; vol. 78; 4; (2013); p. 1604 - 1611;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,70,,,,Overall yield = 76 %; Overall yield = 39 mg,C28H43N5O4S,,,,,Experimental part,85 percent ee,,,,,,
O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O,[H]Cl.[H][C@](N)(CS)C(=O)O.N[C@@H](CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O>>[H]Cl.[H][C@](N)(CS)C(=O)O.N[C@@H](CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,35506916,1,56,full reaction,7-hydroxy-2-(quinolin-2-ylmethylene)malonic acid|l-cysteine hydrochloride,C16H16N2O7S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"35492231; Article; Song, Qin-Hua; Wu, Qing-Qing; Liu, Chang-Hui; Du, Xiao-Jiao; Guo, Qing-Xiang; Journal of Materials Chemistry B; vol. 1; 4; (2013); p. 438 - 442;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,3.8,,,,,,,pH-value,Scheme or table,,,,,,,
O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O,O=C(O)CS.O=C(O)CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O,O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O>>O=C(O)CS.O=C(O)CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O,35506920,1,56,full reaction,7-hydroxy-2-(quinolin-2-ylmethylene)malonic acid|mercaptoacetic acid,C15H13NO7S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,"1,4-dioxane","35492231; Article; Song, Qin-Hua; Wu, Qing-Qing; Liu, Chang-Hui; Du, Xiao-Jiao; Guo, Qing-Xiang; Journal of Materials Chemistry B; vol. 1; 4; (2013); p. 438 - 442;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,&#60; 7,,,,,,,Solvent,Body text,,,,,,,
C[N+](=O)[O-],CCOC(=O)/C=C1/C(=O)Nc2ccccc21.[H][C@@]1([C@H](C[N+](=O)[O-])C(=O)OCC)C(=O)Nc2ccccc21.[H][C@]1([C@H](C[N+](=O)[O-])C(=O)OCC)C(=O)Nc2ccccc21,C[N+](=O)[O-]>>CCOC(=O)/C=C1/C(=O)Nc2ccccc21.[H][C@@]1([C@H](C[N+](=O)[O-])C(=O)OCC)C(=O)Nc2ccccc21.[H][C@]1([C@H](C[N+](=O)[O-])C(=O)OCC)C(=O)Nc2ccccc21,36863770,1,56,full reaction,"nitromethane|(E)-(2-oxo-1,2-dihydroindol-3-ylidene)acetic acid ethyl ester",3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline|3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline,222167|222167,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"62154337; Article; Quintavalla, Arianna; Lanza, Francesco; Montroni, Elisa; Lombardo, Marco; Trombini, Claudio; Journal of Organic Chemistry; vol. 78; 23; (2013); p. 12049 - 12064;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1.5,,,,Overall yield = 85 %; Overall yield = 24 mg; Optical yield = 2 %de; enantioselective reaction,"1-(3,5-Bis-trifluoromethyl-phenyl)-3-[(R)-quinolin-4-yl-((2R,4S,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methyl]-thiourea",,,,,Experimental part,,,,,,,
Cc1ccc2c(c1)CNc1ccc(C)cc1CN2,C#CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1.Cc1ccc2c(c1)CN1c3ccc(C)cc3CN2C1CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1.Cc1ccc2c(c1)CN1c3ccc(C)cc3CN2C1CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1,Cc1ccc2c(c1)CNc1ccc(C)cc1CN2>>C#CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1.Cc1ccc2c(c1)CN1c3ccc(C)cc3CN2C1CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1.Cc1ccc2c(c1)CN1c3ccc(C)cc3CN2C1CC(=O)N1C(=O)OC[C@@H]1Cc1ccccc1,37200719,1,56,full reaction|has preparation,"2,8-dimethyl-5,6,11,12-tetrahydrodibenzo[b,f][1,5]diazocine|N-propynoyl-(4S)-4-benzyl-1,3-oxazolidin-2-one","(4S)-4-benzyl-3-(2-(2,8-dimethyl-6,12-dihydro-5,11-methanodibenzo[b,f][1,5]diazocin-13-yl)acetyl)oxazolidin-2-one|(4S)-4-benzyl-3-(2-(2,8-dimethyl-6,12-dihydro-5,11-methanodibenzo[b,f][1,5]diazocin-13",178896|178896,Preparation,1,20,Michael Addition,,,"62584169; Article; Lauber, Alex; Zelenay, Benjamin; Cvengros, Jan; Chemical Communications; vol. 50; 10; (2014); p. 1195 - 1197;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,supporting information,Overall yield = 57 %; diastereoselective reaction,,,,,Solvent|Time,Experimental part,40 percent de,,,,,,
Cc1ccc2c(c1)CNc1ccc(C)cc1CN2,[H][C@@]12OC(=O)N(C(=O)C#C)[C@]1([H])[C@@]1([H])CC[C@]2(C)C1(C)C.[H][C@@]12OC(=O)N(C(=O)CC3N4Cc5cc(C)ccc5N3Cc3cc(C)ccc34)[C@]1([H])[C@@]1([H])CC[C@]2(C)C1(C)C.[H][C@@]12OC(=O)N(C(=O)CC3N4Cc5cc(C)ccc5N3Cc3cc(C)ccc34)[C@]1([H])[C@@]1([H])CC[C@]2(C)C1(C)C,Cc1ccc2c(c1)CNc1ccc(C)cc1CN2>>[H][C@@]12OC(=O)N(C(=O)C#C)[C@]1([H])[C@@]1([H])CC[C@]2(C)C1(C)C.[H][C@@]12OC(=O)N(C(=O)CC3N4Cc5cc(C)ccc5N3Cc3cc(C)ccc34)[C@]1([H])[C@@]1([H])CC[C@]2(C)C1(C)C.[H][C@@]12OC(=O)N(C(=O)CC3N4Cc5cc(C)ccc5N3Cc3cc(C)ccc34)[C@]1([H])[C@@]1([H])CC[C@]2(C)C1(C)C,37200722,1,56,full reaction|has preparation,"2,8-dimethyl-5,6,11,12-tetrahydrodibenzo[b,f][1,5]diazocine|(3aS, 4R, 7S, 7aR)-7,8,8-trimethyl-3-propioloylhexahydro-4,7-methanobenzo[d]oxa- zol-2(3H)-one","(3aR,7aS)-3-(2-(2,8-dimethyl-6,12-dihydro-5,11-methanodibenzo[b,f][1,5]diazocin-13-yl)acetyl)-4,8,8-trimethylhexahydro-4,7-methanobenzo[d]oxazol-2(3H)-one|(3aR,7aS)-3-(2-(2,8-dimethyl-6,12-dihydro-5,1",178896|178896,Preparation,1,20,Michael Addition,,,"62584169; Article; Lauber, Alex; Zelenay, Benjamin; Cvengros, Jan; Chemical Communications; vol. 50; 10; (2014); p. 1195 - 1197;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,23,,,supporting information,Overall yield = 59 %; Overall yield = 60 mg; diastereoselective reaction,,,,,,Experimental part,30 percent ee,,,,,,
C1CNCCN1,O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1F.C1CNCCN1.C1CNCCN1.O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1F.O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1N1CCNCC1.O=C(C=Cc1ccccc1)c1c(F)c(F)c(N2CCNCC2)c(F)c1N1CCNCC1,C1CNCCN1>>O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1F.C1CNCCN1.C1CNCCN1.O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1F.O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1N1CCNCC1.O=C(C=Cc1ccccc1)c1c(F)c(F)c(N2CCNCC2)c(F)c1N1CCNCC1,38683009,1,56,full reaction|has preparation,"piperazine|1-(2,3,4,5,6-pentafluorophenyl)-3-phenyl-2-propen-1-one",C19H16F4N2O|C23H25F3N4O,277932|104268,Preparation,1,,Michael Addition,,benzene,"64133980; Article; Borodina; Orlova; Shelkovnikov; Russian Chemical Bulletin; vol. 62; 10; (2013); p. 2227 - 2233; Izv. Akad. Nauk, Ser. Khim.; 10; (2013); p. 2226 - 2233,8;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,Reflux,,,,,,,,,Experimental part,,,,,,,
C=C(C)c1ccccc1O,O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(C)c1ccccc1O.O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(C[C@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O.C=C(C[C@@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O,C=C(C)c1ccccc1O>>O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(C)c1ccccc1O.O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(C[C@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O.C=C(C[C@@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O,38909712,1,56,full reaction,"2-isopropenylphenol|1′-benzyl-3′-hydroxy-1′,3′-dihydro-1H,2′H-3,3′-biindol-2′-one",(S)-1-benzyl-3-(2-(2-hydroxyphenyl)allyl)-3-(1H-indol-3-yl)indolin-2-one|(R)-1-benzyl-3-(2-(2-hydroxyphenyl)allyl)-3-(1H-indol-3-yl)indolin-2-one,309357|309357,Chemical behaviour,1,35,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","64339145; Article; Liu, Yan; Zhang, Hong-Hao; Zhang, Yu-Chen; Jiang, Yan; Shi, Feng; Tu, Shu-Jiang; Chemical Communications; vol. 50; 81; (2014); p. 12054 - 12057;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,supporting information,Overall yield = 33 %; stereoselective reaction,"(R)-(3,3'-bis(1-naphthyl)-1,1'-binaphthanele-2,2'-yl)phosphoric acid",,,,Reagent/catalyst,Experimental part,76 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccc(Cl)cc1,O=C1Nc2ccccc2C1Sc1ccc2ccccc2c1.O=C1Nc2ccccc2C1Sc1ccc2ccccc2c1.O=[N+]([O-])C=Cc1ccc(Cl)cc1.O=C1Nc2ccccc2C1(Sc1ccc2ccccc2c1)C(C[N+](=O)[O-])c1ccc(Cl)cc1.O=C1Nc2ccccc2[C@@]1(Sc1ccc2ccccc2c1)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1,O=[N+]([O-])C=Cc1ccc(Cl)cc1>>O=C1Nc2ccccc2C1Sc1ccc2ccccc2c1.O=C1Nc2ccccc2C1Sc1ccc2ccccc2c1.O=[N+]([O-])C=Cc1ccc(Cl)cc1.O=C1Nc2ccccc2C1(Sc1ccc2ccccc2c1)C(C[N+](=O)[O-])c1ccc(Cl)cc1.O=C1Nc2ccccc2[C@@]1(Sc1ccc2ccccc2c1)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1,38909796,1,56,full reaction,1-chloro-4-(2-nitrovinyl)benzene|3-((2′-naphthyl)thio)indolin-2-one,C26H19ClN2O3S|C26H19ClN2O3S,221997|221997,Chemical behaviour,1,-20,Michael Addition,Catalytic behavior,diethyl ether,"64339150; Article; Gao, Wei-Ming; Yu, Jin-Sheng; Zhao, Yu-Lei; Liu, Yun-Lin; Zhou, Feng; Wu, Hai-Hong; Zhou, Jian; Chemical Communications; vol. 50; 96; (2014); p. 15179 - 15182;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,Molecular sieve,,supporting information,Overall yield = 95 %; stereoselective reaction,C29H44N3O3P,,,,Reagent/catalyst|Solvent|Temperature|Time,Experimental part,96 percent ee,,,,,,
CC(C)=C1C(=O)Nc2ccccc21,O=C(C=Cc1ccccc1)c1ccccc1.C/C(C[C@H](CC(=O)c1ccccc1)c1ccccc1)=C1/C(=O)Nc2ccccc21.C/C(CC(CC(=O)c1ccccc1)c1ccccc1)=C1\C(=O)Nc2ccccc21,CC(C)=C1C(=O)Nc2ccccc21>>O=C(C=Cc1ccccc1)c1ccccc1.C/C(C[C@H](CC(=O)c1ccccc1)c1ccccc1)=C1/C(=O)Nc2ccccc21.C/C(CC(CC(=O)c1ccccc1)c1ccccc1)=C1\C(=O)Nc2ccccc21,39090349,1,56,full reaction,"3-Isopropylidene-1,3-dihydro-indol-2-one|benzalacetophenone",C26H23NO2|C26H23NO2,229192|229192,Chemical behaviour,1,30|0,Michael Addition|Michael Addition,Catalytic behavior,dichloromethane|dichloromethane,"64354790; Article; Xiao, Xiao; Mei, Hongjiang; Chen, Quangang; Zhao, Xiaohu; Lin, Lili; Liu, Xiaohua; Feng, Xiaoming; Chemical Communications; vol. 51; 3; (2015); p. 580 - 583;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|48,Molecular sieve|Inert atmosphere|Inert atmosphere,,supporting information,Overall yield = 88 %; stereoselective reaction,C39H60N4O4|ytterbium(III) triflate|dmap,,,,Reagent/catalyst,Experimental part,96 percent ee,2,"benzalacetophenone|3-Isopropylidene-1,3-dihydro-indol-2-one",,,,
Cc1c[nH]c(C)c1C,C=CC(=O)c1ccccc1.C=CC(=O)c1ccccc1.Cc1c[nH]c(C)c1C.CC1=CC(C)=NC1(C)CCC(=O)c1ccccc1.CC1=CC(C)(CCC(=O)c2ccccc2)N=C1C,Cc1c[nH]c(C)c1C>>C=CC(=O)c1ccccc1.C=CC(=O)c1ccccc1.Cc1c[nH]c(C)c1C.CC1=CC(C)=NC1(C)CCC(=O)c1ccccc1.CC1=CC(C)(CCC(=O)c2ccccc2)N=C1C,39621282,1,56,full reaction,"2,3,4-trimethyl-1H-pyrrole|Phenyl vinyl ketone",C16H19NO|C16H19NO,226152|87820,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"65673211; Article; Zhou, Yong; Zhuo, Chun-Xiang; Gu, Qing; You, Shu-Li; Advanced Synthesis and Catalysis; vol. 357; 5; (2015); p. 912 - 916;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere|Schlenk technique|Green chemistry,,supporting information,Overall yield = 93 %; Overall yield = 67.1 mg; regioselective reaction,silica gel,,,,Solvent|Reagent/catalyst,Experimental part,,,,,,,
COc1ccc(/C=C/C(=O)c2nccn2C)cc1,COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccc(OC)cc1.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccc(OC)cc1,COc1ccc(/C=C/C(=O)c2nccn2C)cc1>>COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccc(OC)cc1.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccc(OC)cc1,39851187,1,56,full reaction,(E)-3-(4-methoxyphenyl)-1-(1-methyl-1H-imidazol-2-yl)prop-2-en-1-one|malonic acid dimethyl ester,(+)-dimethyl 2-(1-(4-methoxyphenyl)-3-(1-methyl-1H-imidazol-2-yl)-3-oxopropyl)malonate|(-)-dimethyl 2-(1-(4-methoxyphenyl)-3-(1-methyl-1H-imidazol-2-yl)-3-oxopropyl)malonate,229122|229122,Chemical behaviour,1,5,Michael Addition,Catalytic behavior,aq. buffer,"65827074; Article; Benedetti, Erica; Duchemin, Nicolas; Bethge, Lucas; Vonhoff, Stefan; Klussmann, Sven; Vasseur, Jean-Jacques; Cossy, Janine; Smietana, Michael; Arseniyadis, Stellios; Chemical Commun",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,Inert atmosphere,6.5,supporting information,Overall yield = > 99 %; enantioselective reaction,"4,4'-dimethyl-2,2'-bipyridines|copper(II) nitrate trihydrate",,,,Reagent/catalyst,Experimental part,81 percent ee,,,,,,
Cn1ccnc1C(=O)/C=C/c1ccco1,COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccco1.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccco1,Cn1ccnc1C(=O)/C=C/c1ccco1>>COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccco1.COC(=O)C(C(=O)OC)C(CC(=O)c1nccn1C)c1ccco1,39851190,1,56,full reaction,(E)-3-(furan-2-yl)-1-(1-methyl-1H-imidazole-2-yl)prop-2-en-1-one|malonic acid dimethyl ester,(+)-dimethyl 2-(1-(furan-2-yl)-3-(1-methyl-1H-imidazol-2-yl)-3-oxopropyl)malonate|(-)-dimethyl 2-(1-(furan-2-yl)-3-(1-methyl-1H-imidazol-2-yl)-3-oxopropyl)malonate,229135|229135,Chemical behaviour,1,5,Michael Addition,Catalytic behavior,aq. buffer,"65827074; Article; Benedetti, Erica; Duchemin, Nicolas; Bethge, Lucas; Vonhoff, Stefan; Klussmann, Sven; Vasseur, Jean-Jacques; Cossy, Janine; Smietana, Michael; Arseniyadis, Stellios; Chemical Commun",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,Inert atmosphere,6.5,supporting information,Overall yield = 25 %; enantioselective reaction,"4,4'-dimethyl-2,2'-bipyridines|copper(II) nitrate trihydrate",,,,Reagent/catalyst,Experimental part,89 percent ee,,,,,,
O=CC=Cc1ccc([N+](=O)[O-])cc1,COC(=O)CC(=O)OC.CC1CCCN1.COC(=O)C(C(=O)OC)C(C=CN1CCCC1C)c1ccc([N+](=O)[O-])cc1,O=CC=Cc1ccc([N+](=O)[O-])cc1>>COC(=O)CC(=O)OC.CC1CCCN1.COC(=O)C(C(=O)OC)C(C=CN1CCCC1C)c1ccc([N+](=O)[O-])cc1,40123552,1,56,full reaction|has preparation,3-(4-nitrophenyl)-2-propenal|malonic acid dimethyl ester|2-methyl-1-pyrrolidine,C19H24N2O6,28000,Preparation,1,,Michael Addition,,chloroform-d1,"64676674; Article; Akagawa, Kengo; Sakai, Nobutaka; Kudo, Kazuaki; Angewandte Chemie - International Edition; vol. 54; 6; (2015); p. 1822 - 1826; Angew. Chem.; vol. 127; 6; (2015); p. 1842 - 1846,5;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,10,,,supporting information,,,,,,,Experimental part,,,,,,,
C[N+](=O)[O-],CC(C)=CC/C(C)=C/C=O.CC(C)=CCC[C@](C)(CC=O)C[N+](=O)[O-].CC(C)=CCC[C@@](C)(CC=O)C[N+](=O)[O-],C[N+](=O)[O-]>>CC(C)=CC/C(C)=C/C=O.CC(C)=CCC[C@](C)(CC=O)C[N+](=O)[O-].CC(C)=CCC[C@@](C)(CC=O)C[N+](=O)[O-],40389969,1,56,full reaction,nitromethane|α-citral,C11H19NO3|C11H19NO3,91855|91855,Chemical behaviour,1,-5,Michael Addition,Catalytic behavior,toluene,"66418502; Article; Tian, Jin-Miao; Yuan, Yong-Hai; Tu, Yong-Qiang; Zhang, Fu-Min; Zhang, Xiao-Bo; Zhang, Shi-Heng; Wang, Shao-Hua; Zhang, Xiao-Ming; Chemical Communications; vol. 51; 49; (2015); p. 99",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,168,Inert atmosphere,,supporting information,enantioselective reaction,C24H33NOSi|benzoic acid,,,,Reagent/catalyst|Temperature|Solvent,Experimental part,88 percent ee,,,,,,
O=CC=Cc1ccccc1,O=C(Cc1ccccc1)Cc1ccccc1.O=C1[C@H](c2ccccc2)[C@H](O)C[C@@H](c2ccccc2)[C@@H]1c1ccccc1.O=C1[C@H](c2ccccc2)[C@@H](c2ccccc2)C[C@H](O)[C@@H]1c1ccccc1.O=CC[C@@H](c1ccccc1)[C@H](C(=O)Cc1ccccc1)c1ccccc1.O=CC[C@H](c1ccccc1)[C@@H](C(=O)Cc1ccccc1)c1ccccc1,O=CC=Cc1ccccc1>>O=C(Cc1ccccc1)Cc1ccccc1.O=C1[C@H](c2ccccc2)[C@H](O)C[C@@H](c2ccccc2)[C@@H]1c1ccccc1.O=C1[C@H](c2ccccc2)[C@@H](c2ccccc2)C[C@H](O)[C@@H]1c1ccccc1.O=CC[C@@H](c1ccccc1)[C@H](C(=O)Cc1ccccc1)c1ccccc1.O=CC[C@H](c1ccccc1)[C@@H](C(=O)Cc1ccccc1)c1ccccc1,40559249,1,56,full reaction,"3-phenyl-propenal|1,3-Diphenylpropanone","(2R,3R,5R,6R)-3-hydroxy-2,5,6-triphenylcyclohexanone|(2S,3S,5S,6S)-3-hydroxy-2,5,6-triphenylcyclohexanone|C24H22O2|C24H22O2",229135|121254|229135|121254,Chemical behaviour,1,-18,Michael Addition,Catalytic behavior,diethyl ether,"66827137; Article; Guevara-Pulido, James O.; Andrés, José M.; Ped",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,144,,,,stereoselective reaction,(S)-2-(1-pyrrolidinylmethyl)pyrrolidine,,,,Temperature,Experimental part,46 percent ee|83 percent ee,,,,,,
O=CC=Cc1ccccc1,O=C(Cc1ccccc1)Cc1ccccc1.O=C1[C@H](c2ccccc2)[C@H](O)C[C@@H](c2ccccc2)[C@@H]1c1ccccc1.O=C1[C@H](c2ccccc2)[C@@H](c2ccccc2)C[C@H](O)[C@@H]1c1ccccc1.O=CC[C@@H](c1ccccc1)[C@H](C(=O)Cc1ccccc1)c1ccccc1.O=C1C(c2ccccc2)C(O)CC(c2ccccc2)C1c1ccccc1,O=CC=Cc1ccccc1>>O=C(Cc1ccccc1)Cc1ccccc1.O=C1[C@H](c2ccccc2)[C@H](O)C[C@@H](c2ccccc2)[C@@H]1c1ccccc1.O=C1[C@H](c2ccccc2)[C@@H](c2ccccc2)C[C@H](O)[C@@H]1c1ccccc1.O=CC[C@@H](c1ccccc1)[C@H](C(=O)Cc1ccccc1)c1ccccc1.O=C1C(c2ccccc2)C(O)CC(c2ccccc2)C1c1ccccc1,40559250,1,56,full reaction,"3-phenyl-propenal|1,3-Diphenylpropanone","(2R,3R,5R,6R)-3-hydroxy-2,5,6-triphenylcyclohexanone|(2S,3S,5S,6S)-3-hydroxy-2,5,6-triphenylcyclohexanone|C24H22O2|3-hydroxy-2,5,6-triphenylcyclohexanone",229135|121254|121254|121254,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,dichloromethane,"66827137; Article; Guevara-Pulido, James O.; Andrés, José M.; Ped",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,,stereoselective reaction,(S)-2-(1-pyrrolidinylmethyl)pyrrolidine,,,,Solvent|Temperature,Experimental part,66 percent ee,,,,,,
[Li]c1ccc2c(c1[Si](C)(C)C)OCO2,CC(C)(C)OC(=O)/C=C/CCC1(/C=C/C(=O)OC(C)(C)C)OCCO1.CC(C)(C)OC(=O)CC1CC2(CC(c3ccc4c(c3[Si](C)(C)C)OCO4)C1C(=O)OC(C)(C)C)OCCO2.CC(C)(C)OC(=O)CC1CC2(CC(c3ccc4c(c3[Si](C)(C)C)OCO4)C1C(=O)OC(C)(C)C)OCCO2,[Li]c1ccc2c(c1[Si](C)(C)C)OCO2>>CC(C)(C)OC(=O)/C=C/CCC1(/C=C/C(=O)OC(C)(C)C)OCCO1.CC(C)(C)OC(=O)CC1CC2(CC(c3ccc4c(c3[Si](C)(C)C)OCO4)C1C(=O)OC(C)(C)C)OCCO2.CC(C)(C)OC(=O)CC1CC2(CC(c3ccc4c(c3[Si](C)(C)C)OCO4)C1C(=O)OC(C)(C)C)OCCO2,40834171,1,56,full reaction|has preparation,C10H13LiO2Si|C19H30O6,9|C29H44O8Si,182|182,Preparation,1,,Michael Addition,,,"65712039; Article; Nishimura, Katsumi; Fukuyama, Naoshi; Yasuhara, Tomohisa; Yamashita, Mitsuaki; Sumiyoshi, Takaaki; Yamamoto, Yasutomo; Yamada, Ken-Ichi; Tomioka, Kiyoshi; Tetrahedron; vol. 71; 39;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,diastereoselective reaction,"(1R,2R)-1,2-diphenyl-1,2-dimethoxyethane",,,,,Scheme or table,80 percent de,,,,,,
CCCCC/C=C/C(=O)c1ccccc1,O=[N+]([O-])C1([N+](=O)[O-])CNC1.CCCCC[C@H](CC(=O)c1ccccc1)N1CC([N+](=O)[O-])([N+](=O)[O-])C1.CCCCC[C@@H](CC(=O)c1ccccc1)N1CC([N+](=O)[O-])([N+](=O)[O-])C1,CCCCC/C=C/C(=O)c1ccccc1>>O=[N+]([O-])C1([N+](=O)[O-])CNC1.CCCCC[C@H](CC(=O)c1ccccc1)N1CC([N+](=O)[O-])([N+](=O)[O-])C1.CCCCC[C@@H](CC(=O)c1ccccc1)N1CC([N+](=O)[O-])([N+](=O)[O-])C1,41415133,1,56,full reaction,"(E)-1-phenyl-2-octen-1-one|3,3-dinitroazetidine","(R)-3-(3,3-dinitroazetidin-1-yl)-1-phenyloctan-1-one|(S)-3-(3,3-dinitroazetidin-1-yl)-1-phenyloctan-1-one",224440|224440,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"67618729; Article; Lee, Hyo-Jun; Cho, Chang-Woo; Journal of Organic Chemistry; vol. 80; 22; (2015); p. 11435 - 11440;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 96 %; enantioselective reaction,"1-[2,5-di(naphthalen-2-yl)benzyl]-2-[(S)-hydroxy(6-hydroxyquinolin-4-yl)methyl]-5-vinyl-1-azoniabicyclo[2.2.2]octane bromide|potassium hydroxide",,,,Reagent/catalyst|Temperature|Solvent,Experimental part,88 percent ee,,,,,,
CC(=O)/C=C/CCC1(C)C(=O)CCC1=O,CCOC(=O)C1CCCCC1=O.CCOC(=O)C1(C(CCC2(C)C(=O)CCC2=O)CC(C)=O)CCCCC1=O.CCOC(=O)[C@]1([C@@H](CCC2(C)C(=O)CCC2=O)CC(C)=O)CCCCC1=O,CC(=O)/C=C/CCC1(C)C(=O)CCC1=O>>CCOC(=O)C1CCCCC1=O.CCOC(=O)C1(C(CCC2(C)C(=O)CCC2=O)CC(C)=O)CCCCC1=O.CCOC(=O)[C@]1([C@@H](CCC2(C)C(=O)CCC2=O)CC(C)=O)CCCCC1=O,41576345,1,56,full reaction,"(E)-2-methyl-2-(5-oxohex-3-en-1-yl)cyclopentane-1,3-dione|ethyl 2-oxocyclohexane carboxylate","ethyl 1-(1-(1-methyl-2,5-dioxocyclopentyl)-5-oxohexan-3-yl)-2-oxocyclohexane-1-carboxylate|ethyl 1-(1-(1-methyl-2,5-dioxocyclopentyl)-5-oxohexan-3-yl)-2-oxocyclohexane-1-carboxylate",220273|220273,Chemical behaviour,1,-10,Michael Addition,Catalytic behavior,neat (no solvent),"67598739; Article; Cichowicz, Nathan R.; Kaplan, Will; Khomutnyk, Yaroslav; Bhattarai, Bijay; Sun, Zhankui; Nagorny, Pavel; Journal of the American Chemical Society; vol. 137; 45; (2015); p. 14341 - 1",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Inert atmosphere,,supporting information,Overall yield = 93 %; Overall yield = 404 mg; enantioselective reaction,"2,2'-(cyclopropane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole) copper(II) hexafluoroantimonate",,,,Temperature,Experimental part,92 percent ee,,,,,,
CC(=O)OC1(CCC(CC=O)O[Si](C(C)C)(C(C)C)C(C)C)C=CC(=O)C=C1,CC(=O)Oc1ccc(O)cc1.[H][C@@]12CC(=O)C=C[C@]1(OC(C)=O)CC[C@@H](O[Si](C(C)C)(C(C)C)C(C)C)[C@@H]2C=O.CC(=O)OC12C=CC(=O)CC1C(C=O)C(O[Si](C(C)C)(C(C)C)C(C)C)CC2,CC(=O)OC1(CCC(CC=O)O[Si](C(C)C)(C(C)C)C(C)C)C=CC(=O)C=C1>>CC(=O)Oc1ccc(O)cc1.[H][C@@]12CC(=O)C=C[C@]1(OC(C)=O)CC[C@@H](O[Si](C(C)C)(C(C)C)C(C)C)[C@@H]2C=O.CC(=O)OC12C=CC(=O)CC1C(C=O)C(O[Si](C(C)C)(C(C)C)C(C)C)CC2,41638118,1,56,full reaction,"4-oxo-1-(5-oxo-3-((triisopropylsilyl)oxy)pentyl)cyclohexa-2,5-dien-1-yl acetate","hydroquinone monoacetate|(1R,2R,4aR,8aS)-1-formyl-7-oxo-2-((triisopropylsilyl)oxy)-1,2,3,4,4a,7,8,8a-octahydronaphthalen-4a-yl acetate|1-formyl-7-oxo-2-((triisopropylsilyl)oxy)-1,2,3,4,4a,7,8,8a-octah",6329|296563,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,"1,2-dimethoxyethane","67799877; Article; Chen, Huan; Li, Xiao-Huan; Gong, Jing; Song, Hao; Liu, Xiao-Yu; Qin, Yong; Tetrahedron; vol. 72; 2; (2016); p. 347 - 353;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,10,,,supporting information,,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine,,,,Solvent,Scheme or table,> 99 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,COC(=O)C1CCC(c2ccccc2)=N1.COC(=O)[C@@]1([C@@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1,O=[N+]([O-])C=Cc1ccccc1>>COC(=O)C1CCC(c2ccccc2)=N1.COC(=O)[C@@]1([C@@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1,41724193,1,56,full reaction,"(2-nitroethenyl)benzene|5-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate de methyle","(S)-methyl 2-((R)-2-nitro-1-phenylethyl)-5-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate|(R)-methyl 2-((R)-2-nitro-1-phenylethyl)-5-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate",221952|221952,Chemical behaviour,1,-20,Michael Addition,Catalytic behavior,tetrahydrofuran,"68026777; Article; Li, Chun-Yan; Yang, Wu-Lin; Luo, Xiaoyan; Deng, Wei-Ping; Chemistry - A European Journal; vol. 21; 52; (2015); p. 19048 - 19057;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1.5,Molecular sieve,,,Overall yield = 98 %; stereoselective reaction,"(S,S)-[2-(4'-isopropyloxazolin-2'-yl)ferrocenyl]diphenylphosphine|copper(II) acetate monohydrate|triethylamine",,,,Reagent/catalyst|Temperature,Scheme or table,> 99 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,COC(=O)C1CCC(c2ccccc2)=N1.COC(=O)[C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1,O=[N+]([O-])C=Cc1ccccc1>>COC(=O)C1CCC(c2ccccc2)=N1.COC(=O)[C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)CCC(c2ccccc2)=N1,41724195,1,56,full reaction,"(2-nitroethenyl)benzene|5-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate de methyle","(S)-methyl 2-((S)-2-nitro-1-phenylethyl)-5-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate|(R)-methyl 2-((R)-2-nitro-1-phenylethyl)-5-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate",221952|221952,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"68026777; Article; Li, Chun-Yan; Yang, Wu-Lin; Luo, Xiaoyan; Deng, Wei-Ping; Chemistry - A European Journal; vol. 21; 52; (2015); p. 19048 - 19057;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,21,Inert atmosphere|Molecular sieve,,,Overall yield = 70 %; stereoselective reaction,"((1S,2S)-1-methyl-7-(trifluoromethyl)-1,2-dihydroimidazo[1,2-a]quinolin-2-yl)diphenylmethanol|copper(II) acetate monohydrate|triethylamine",,,,Reagent/catalyst|Solvent,Experimental part,89 percent ee,,,,,,
CCCS,C=C(C)C(=O)OC.CCCSC[C@H](C)C(=O)OC.CCCSC[C@@H](C)C(=O)OC,CCCS>>C=C(C)C(=O)OC.CCCSC[C@H](C)C(=O)OC.CCCSC[C@@H](C)C(=O)OC,41789910,1,56,full reaction,1-thiopropane|methacrylic acid methyl ester,methyl (2R)-2-methyl-3-(propylsulfanyl)propanoate|C8H16O2S,230273|230273,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"67918232; Article; Farley, Alistair J. M.; Sandford, Christopher; Dixon, Darren J.; Journal of the American Chemical Society; vol. 137; 51; (2015); p. 15992 - 15995;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,supporting information,Overall yield = > 99 %; enantioselective reaction,"1-[3,5-bis(trifluoromethyl)phenyl]-3-[(2S)-3,3-dimethyl-1-{[tris(4-methoxyphenyl)phosphoranylidene]amino}butan-2-yl]thiourea",,,,Solvent|Temperature|Time,Scheme or table,72 percent ee,,,,,,
c1cn[nH]c1,C/C=C/c1nc2ccccc2n1C(=O)OC(C)(C)C.C/C=C/c1nc2ccccc2n1C(=O)OC(C)(C)C.c1cn[nH]c1.C[C@@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)n1cccn1.C[C@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)n1cccn1,c1cn[nH]c1>>C/C=C/c1nc2ccccc2n1C(=O)OC(C)(C)C.C/C=C/c1nc2ccccc2n1C(=O)OC(C)(C)C.c1cn[nH]c1.C[C@@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)n1cccn1.C[C@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)n1cccn1,41799513,1,56,full reaction,NH-pyrazole|(E)-tert-butyl 2-(prop-1-en-1-yl)benzimidazole-1-carboxylate,(S)-tert-butyl 2-(2-(pyrazol-1-yl)propyl)benzimidazole-1-carboxylate|(R)-tert-butyl 2-(2-(pyrazol-1-yl)propyl)benzimidazole-1-carboxylate,220163|220163,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,tetrahydrofuran,"67981529; Article; Wang, Ya-Yi; Kanomata, Kyohei; Korenaga, Toshinobu; Terada, Masahiro; Angewandte Chemie - International Edition; vol. 55; 3; (2016); p. 927 - 931; Angew. Chem.; vol. 128; 3; (2016);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Inert atmosphere,,supporting information,Overall yield = 99 %; enantioselective reaction,"(R)-3,3'-bis(9-anthracenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate",,,,Reagent/catalyst|Solvent,Experimental part,82 percent ee,,,,,,
O=C(CC(=O)c1ccccc1)c1ccccc1,CC=CC=O.O=C(CC(=O)c1ccccc1)c1ccccc1.CC=CC=O.C[C@H](CC=O)C(C(=O)c1ccccc1)C(=O)c1ccccc1.C[C@@H](CC=O)C(C(=O)c1ccccc1)C(=O)c1ccccc1,O=C(CC(=O)c1ccccc1)c1ccccc1>>CC=CC=O.O=C(CC(=O)c1ccccc1)c1ccccc1.CC=CC=O.C[C@H](CC=O)C(C(=O)c1ccccc1)C(=O)c1ccccc1.C[C@@H](CC=O)C(C(=O)c1ccccc1)C(=O)c1ccccc1,41971137,1,56,full reaction,"1,3-diphenylpropanedione|crotonaldehyde",C19H18O3|C19H18O3,220323|220323,Chemical behaviour,1,-20,Michael Addition,Catalytic behavior,dichloromethane,"68316321; Article; Cakmak, Yusuf; Erbas-Cakmak, Sundus; Leigh, David A.; Journal of the American Chemical Society; vol. 138; 6; (2016); p. 1749 - 1751;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,enantioselective reaction,C47H53N5O4*C32H28N4O4,,,,Reagent/catalyst|Solvent|Temperature|Time,Experimental part,34 percent ee,,,,,,
O=C1CCCCC1c1ccccc1,C=C=CN(C(=O)C(C)(C)C)c1ccccc1.C=C=CN(C(=O)C(C)(C)C)c1ccccc1.O=C1CCCCC1c1ccccc1.CC(C)(C)C(=O)N(C=CC[C@]1(c2ccccc2)CCCCC1=O)c1ccccc1.CC(C)(C)C(=O)N(C=CC[C@@]1(c2ccccc2)CCCCC1=O)c1ccccc1,O=C1CCCCC1c1ccccc1>>C=C=CN(C(=O)C(C)(C)C)c1ccccc1.C=C=CN(C(=O)C(C)(C)C)c1ccccc1.O=C1CCCCC1c1ccccc1.CC(C)(C)C(=O)N(C=CC[C@]1(c2ccccc2)CCCCC1=O)c1ccccc1.CC(C)(C)C(=O)N(C=CC[C@@]1(c2ccccc2)CCCCC1=O)c1ccccc1,42252366,1,56,full reaction,(RS)-2-phenylcyclohexanone|C14H17NO,C26H31NO2|C26H31NO2,230796|230796,Chemical behaviour,1,40,Michael Addition,Catalytic behavior,dichloromethane,"68585820; Article; Yang, Xiaoyu; Toste, F. Dean; Chemical Science; vol. 7; 4; (2016); p. 2653 - 2656;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Molecular sieve,,,Overall yield = 15 %; enantioselective reaction,"(S)-3,3'-bis(2,4,6-tri-iso-propylphenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate",,,,Solvent|Reagent/catalyst,Scheme or table,86 percent ee,,,,,,
NCCS.[H]Cl,COc1ccc(C(=O)C=Cc2cccs2)cc1.COc1ccc(C(=O)CC(SCCN)c2cccs2)cc1.COc1ccc(C2=NCCSC(c3cccs3)C2)cc1,NCCS.[H]Cl>>COc1ccc(C(=O)C=Cc2cccs2)cc1.COc1ccc(C(=O)CC(SCCN)c2cccs2)cc1.COc1ccc(C2=NCCSC(c3cccs3)C2)cc1,42353997,1,56,full reaction,2-mercaptoethylamine hydrochloride|1-(4-methoxyphenyl)-3-(thiophen-2-yl)prop-2-en-1-one,"3-(2-aminoethylthio)-1-(4-methoxyphenyl)-3-(thiophen-2-yl)propan-1-one|5-(4-methoxyphenyl)-7-(thiophen-2-yl)-2,3,6,7-tetrahydro-1,4-thiazepine",77566|228310,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"68751515; Article; Gürdere, Meliha Burcu; Emeç, Ali Cemal; Aslan, Osman Nuri; Budak,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,,triethylamine,,,,Temperature,Scheme or table,,,,,,,
CC(=O)OCC(=Cc1ccccc1)[N+](=O)[O-],CC1=NN(c2ccccc2)C(=O)C1.Cc1nn(-c2ccccc2)c2c1[C@H](c1ccccc1)[C@@H]([N+](=O)[O-])CO2.Cc1nn(-c2ccccc2)c2c1C(c1ccccc1)C([N+](=O)[O-])CO2,CC(=O)OCC(=Cc1ccccc1)[N+](=O)[O-]>>CC1=NN(c2ccccc2)C(=O)C1.Cc1nn(-c2ccccc2)c2c1[C@H](c1ccccc1)[C@@H]([N+](=O)[O-])CO2.Cc1nn(-c2ccccc2)c2c1C(c1ccccc1)C([N+](=O)[O-])CO2,42798370,1,56,full reaction,acetic acid-(β-nitro-cinnamyl ester)|edaravone,"(4S,5R)-3-methyl-5-nitro-1,4-diphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole|3-methyl-5-nitro-1,4-diphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole",79724|79724,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,dichloromethane,"68972601; Article; Zheng, Yin; Cui, Lei; Wang, Youming; Zhou, Zhenghong; Journal of Organic Chemistry; vol. 81; 10; (2016); p. 4340 - 4346;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 59 %; stereoselective reaction,C31H27F6N3O2,,,,Solvent,Scheme or table,93 percent ee,,,,,,
CC(C=O)c1ccccc1,CC(C)(C)OC(=O)/C=C/C(=O)c1nccn1-c1ccccc1.CC(C)(C)OC(=O)[C@H](CC(=O)c1nccn1-c1ccccc1)[C@](C)(C=O)c1ccccc1.CC(C)(C)OC(=O)[C@H](CC(=O)c1nccn1-c1ccccc1)[C@@](C)(C=O)c1ccccc1,CC(C=O)c1ccccc1>>CC(C)(C)OC(=O)/C=C/C(=O)c1nccn1-c1ccccc1.CC(C)(C)OC(=O)[C@H](CC(=O)c1nccn1-c1ccccc1)[C@](C)(C=O)c1ccccc1.CC(C)(C)OC(=O)[C@H](CC(=O)c1nccn1-c1ccccc1)[C@@](C)(C=O)c1ccccc1,42913323,1,56,full reaction,2-Phenylpropanal|(E)-tert-butyl 4-(1-phenyl-1H-imidazol-2-yl)-4-oxobut-2-enoate,C26H28N2O4|C26H28N2O4,224853|224853,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","69065813; Article; Song, Liangliang; Gong, Lei; Meggers, Eric; Chemical Communications; vol. 52; 49; (2016); p. 7699 - 7702;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,14,Inert atmosphere,,supporting information,Overall yield = 87 %; Overall yield = 37.6 mg; stereoselective reaction,C43H42N3O4Rh|trifluoroacetic acid,,,,Solvent|Reagent/catalyst|Temperature,Experimental part,98.9 percent ee|90 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCCCC=CN1CCCC1.CCCCC1C(c2ccccc2)C([N+](=O)[O-])C1N1CCCC1.CCCCC(=CN1CCCC1)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCCCC=CN1CCCC1.CCCCC1C(c2ccccc2)C([N+](=O)[O-])C1N1CCCC1.CCCCC(=CN1CCCC1)C(C[N+](=O)[O-])c1ccccc1,44628043,1,56,full reaction|has preparation,(2-nitroethenyl)benzene|hexaldehyde enamine,1-(2-butyl-4-nitro-3-phenylcyclobutyl)-pyrrolidine|C18H26N2O2,224686|136212,Preparation,1,,Michael Addition,,(2)H8-toluene,"69554840; Article; Donadío, Lucía Gandolfi; Galetti, Mariana A.; Giorgi, Gianluca; Rasparini,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Molecular sieve|Inert atmosphere,,,,,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccccc1,O=CCc1ccccc1.O=C[C@@H](c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.O=C[C@H](c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>O=CCc1ccccc1.O=C[C@@H](c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.O=C[C@H](c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1,44628048,1,56,full reaction,(2-nitroethenyl)benzene|phenylacetaldehyde,"anti-4-nitro-2,3-diphenylbutanal|rac-4-nitro-2,3-diphenylbutyraldehyde",224822|224822,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"69554840; Article; Donadío, Lucía Gandolfi; Galetti, Mariana A.; Giorgi, Gianluca; Rasparini,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Inert atmosphere,,supporting information,Overall yield = 80.5 %; Overall yield = 7.6 g; diastereoselective reaction,pyrrolidine,,,,Concentration|Reagent/catalyst|Solvent|Time,Experimental part,92 percent de,,,,,,
CC/C=C/C=O,Cc1ccccc1C(=O)c1ccccc1.Cc1ccccc1C(=O)c1ccccc1.CC/C=C/C=O.CC[C@H](CC=O)Cc1ccccc1C(=O)c1ccccc1.CC[C@@H](CC=O)Cc1ccccc1C(=O)c1ccccc1,CC/C=C/C=O>>Cc1ccccc1C(=O)c1ccccc1.Cc1ccccc1C(=O)c1ccccc1.CC/C=C/C=O.CC[C@H](CC=O)Cc1ccccc1C(=O)c1ccccc1.CC[C@@H](CC=O)Cc1ccccc1C(=O)c1ccccc1,44814125,1,56,full reaction,trans-2-pentenal|2-Methylbenzophenone,(S)-3-(2-benzoylbenzyl)pentanal|3-(2-benzoylbenzyl)pentanal,222173|222173,Chemical behaviour,1,-78 - 25,Michael Addition,Catalytic behavior,"1,2-dichloro-benzene","70805172; Article; Dell'Amico, Luca; Fernández-Alvarez, Victor M.; Maseras, Feliu; Melchiorre, Paolo",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,20,Schlenk technique|Inert atmosphere|Irradiation|Sealed tube,,supporting information,Overall yield = 60 %; enantioselective reaction,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|diphenyl hydrogen phosphate,,,,Solvent|Reagent/catalyst,Experimental part,86 percent ee,,,,,,
O=[N+]([O-])/C(C#Cc1ccccc1)=C/c1ccccc1,CC1=NN(c2ccccc2)C(=O)C1.Cc1nn(-c2ccccc2)c2c1[C@@H](c1ccccc1)[C@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2.Cc1nn(-c2ccccc2)c2c1[C@H](c1ccccc1)[C@@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2,O=[N+]([O-])/C(C#Cc1ccccc1)=C/c1ccccc1>>CC1=NN(c2ccccc2)C(=O)C1.Cc1nn(-c2ccccc2)c2c1[C@@H](c1ccccc1)[C@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2.Cc1nn(-c2ccccc2)c2c1[C@H](c1ccccc1)[C@@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2,45425679,1,56,full reaction,"(E)-(2-nitrobut-1-en-3-yne-1,4-diyl)dibenzene|edaravone","(4R,5S)-6-((Z)-benzylidene)-3-methyl-5-nitro-1,4-diphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole|(4S,5R)-6-((Z)-benzylidene)-3-methyl-5-nitro-1,4-diphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole",113321|113321,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"71156224; Article; Rana, Nirmal K.; Jha, Rupesh K.; Joshi, Harshit; Singh, Vinod K.; Tetrahedron Letters; vol. 58; 22; (2017); p. 2135 - 2139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,supporting information,enantioselective reaction,C31H26F6N4O2,,,,Solvent,Scheme or table,88 percent ee,,,,,,
N#CC(C#N)=Cc1ccc([N+](=O)[O-])cc1,CCOC(=O)C=C(Nc1ccc(OC)cc1OC)C(=O)OCC.CCOC(=O)C1=C(C(=O)OCC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1.CCOC(=O)C1=C(C(=O)OCC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1,N#CC(C#N)=Cc1ccc([N+](=O)[O-])cc1>>CCOC(=O)C=C(Nc1ccc(OC)cc1OC)C(=O)OCC.CCOC(=O)C1=C(C(=O)OCC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1.CCOC(=O)C1=C(C(=O)OCC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1,45469464,1,56,full reaction,4-Nitrobenzylidenemalononitrile|C16H21NO6,"diethyl 6-amino-5-cyano-1-(2,4-dimethoxyphenyl)-4-(4-nitrophenyl)-1,4-dihydropyridine-2,3-dicarboxylate|diethyl 6-amino-5-cyano-1-(2,4-dimethoxyphenyl)-4-(4-nitrophenyl)-1,4-dihydropyridine-2,3-dicarb",117667|117667,Chemical behaviour,1,10,Michael Addition,Catalytic behavior,ethyl acetate|toluene,"71328619; Article; Auria-Luna, Fernando; Marqués-López, Eugenia; Gimeno, M. Concepción; Heiran, Rogh",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,,Overall yield = 97 %; Overall yield = 50.7 mg; enantioselective reaction,"(8a,9R,8′′′a,9′′′R)-9,9′-[(2,5-diphenylpyrimidine-4,6",,,,Reagent/catalyst|Solvent|Temperature,Experimental part,76 percent ee,,,,,,
N#CC(C#N)=Cc1ccc([N+](=O)[O-])cc1,COC(=O)C=C(Nc1ccc(OC)cc1OC)C(=O)OC.COC(=O)C1=C(C(=O)OC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1.COC(=O)C1=C(C(=O)OC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1,N#CC(C#N)=Cc1ccc([N+](=O)[O-])cc1>>COC(=O)C=C(Nc1ccc(OC)cc1OC)C(=O)OC.COC(=O)C1=C(C(=O)OC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1.COC(=O)C1=C(C(=O)OC)N(c2ccc(OC)cc2OC)C(N)=C(C#N)[C@H]1c1ccc([N+](=O)[O-])cc1,45469467,1,56,full reaction,"4-Nitrobenzylidenemalononitrile|dimethyl 2-(2,4-dimethoxyphenylamino)maleate","dimethyl 6-amino-5-cyano-1-(2,4-dimethoxyphenyl)-4-(4-nitrophenyl)-1,4-dihydropyridine-2,3-dicarboxylate|dimethyl 6-amino-5-cyano-1-(2,4-dimethoxyphenyl)-4-(4-nitrophenyl)-1,4-dihydropyridine-2,3-dica",117667|117667,Chemical behaviour,1,10,Michael Addition,Catalytic behavior,toluene,"71328619; Article; Auria-Luna, Fernando; Marqués-López, Eugenia; Gimeno, M. Concepción; Heiran, Rogh",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,,Overall yield = 88 %; Overall yield = 43.5 mg; enantioselective reaction,"(8a,9R,8′′′a,9′′′R)-9,9′-[(2,5-diphenylpyrimidine-4,6",,,,Reagent/catalyst|Solvent|Temperature,Experimental part,82 percent ee,,,,,,
COC(=O)C1Cc2ccccc2NC1=O,O=[N+]([O-])C=Cc1ccccc1.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)Cc2ccccc2NC1=O.COC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)Cc2ccccc2NC1=O,COC(=O)C1Cc2ccccc2NC1=O>>O=[N+]([O-])C=Cc1ccccc1.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)Cc2ccccc2NC1=O.COC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)Cc2ccccc2NC1=O,46790755,1,56,full reaction,"(±)-methyl 2-oxo-1,2,3,4-tetrahydroquinoline-3-carboxylate|(2-nitroethenyl)benzene","methyl (S)-3-((S)-2-nitro-1-phenylethyl)-2-oxo-1,2,3,4-tetrahydroquinoline-3-carboxylate|methyl (RS)-3-((SR)-2-nitro-1-phenylethyl)-2-oxo-1,2,3,4-tetrahydroquinoline-3-carboxylate",224795|224795,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"72287942; Article; Mukhopadhyay, Soumendranath; Nath, Utpal; Pan, Subhas Chandra; Advanced Synthesis and Catalysis; vol. 359; 22; (2017); p. 3911 - 3916;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,supporting information,Overall yield = 90 %; Overall yield = 63.7 mg; enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-quinolin-4-yl((1S,2R,4S,5R)-5-vinylquinu clidin-2-yl)methyl)thiourea",,,,Reagent/catalyst|Solvent,Experimental part,93 percent ee,,,,,,
[1*]C(=O)C=Cc1ccccc1N,[3*]C([4*])=NCC(=O)O[5*].[2*]C=O.[1*]C1=NC(C(=O)O[5*])[C@]2([H])c3ccccc3N[C@@H]([5*])[C@]12[H],[1*]C(=O)C=Cc1ccccc1N>>[3*]C([4*])=NCC(=O)O[5*].[2*]C=O.[1*]C1=NC(C(=O)O[5*])[C@]2([H])c3ccccc3N[C@@H]([5*])[C@]12[H],47318124,1,56,no reaction scheme,,,29024,Markush reaction,1,,Michael Addition,,,71623292; Patent; SOUTHWEST UNIVERSITY; CN106749235; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Acidic conditions,,Paragraph 0011,,magnesium sulfate,,,,,,,3,,,,,
CC(C)(C)OC(=O)C(=CC(=O)c1ccccc1)C(=O)OC(C)(C)C,SCc1ccccc1.CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)[C@H](SCc1ccccc1)C(=O)c1ccccc1.CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)[C@@H](SCc1ccccc1)C(=O)c1ccccc1,CC(C)(C)OC(=O)C(=CC(=O)c1ccccc1)C(=O)OC(C)(C)C>>SCc1ccccc1.CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)[C@H](SCc1ccccc1)C(=O)c1ccccc1.CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)[C@@H](SCc1ccccc1)C(=O)c1ccccc1,47629953,1,56,full reaction,di-tert-butyl 2-(2-oxo-2-phenylethylidene)malonate|phenylmethanethiol,di-tert-butyl (S)-2-(1-(benzylthio)-2-oxo-2-phenylethyl)malonate|di-tert-butyl (R)-2-(1-(benzylthio)-2-oxo-2-phenylethyl)malonate,228305|228305,Chemical behaviour,1,-60,Michael Addition,Catalytic behavior,diethyl ether,"73407512; Article; Fulton, Jennifer L.; Horwitz, Matthew A.; Bruske, Ericka L.; Johnson, Jeffrey S.; Journal of Organic Chemistry; vol. 83; 6; (2018); p. 3385 - 3391;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,Overall yield = 90 %; enantioselective reaction,C35H28F6N3PS,,,,Reagent/catalyst,Experimental part,82 percent ee,,,,,,
NC(CCS)C(=O)O,O=[N+]([O-])C=Cc1ccc2c(c1)[Ir@OH6+]13(c4cc(C=C[N+](=O)[O-])ccc4C4=N1C=CC=C4)(N1=C(C=CC=C1)C1=N3C=CC=C1)N1=C2C=CC=C1.[Cl-].N[C@@H](CCS[C@@H](C[N+](=O)[O-])c1ccc2c(c1)[Ir@OH6+]13(c4cc([C@H](C[N+](=O)[O-])SCC[C@H](N)C(=O)O)ccc4C4=N1C=CC=C4)(N1=C(C=CC=C1)C1=N3C=CC=C1)N1=C2C=CC=C1)C(=O)O.N[C@@H](CCS[C@@H](C[N+](=O)[O-])c1ccc2c(c1)[Ir@OH12+]13(c4cc(C=C[N+](=O)[O-])ccc4C4=N1C=CC=C4)(N1=C(C=CC=C1)C1=N3C=CC=C1)N1=C2C=CC=C1)C(=O)O,NC(CCS)C(=O)O>>O=[N+]([O-])C=Cc1ccc2c(c1)[Ir@OH6+]13(c4cc(C=C[N+](=O)[O-])ccc4C4=N1C=CC=C4)(N1=C(C=CC=C1)C1=N3C=CC=C1)N1=C2C=CC=C1.[Cl-].N[C@@H](CCS[C@@H](C[N+](=O)[O-])c1ccc2c(c1)[Ir@OH6+]13(c4cc([C@H](C[N+](=O)[O-])SCC[C@H](N)C(=O)O)ccc4C4=N1C=CC=C4)(N1=C(C=CC=C1)C1=N3C=CC=C1)N1=C2C=CC=C1)C(=O)O.N[C@@H](CCS[C@@H](C[N+](=O)[O-])c1ccc2c(c1)[Ir@OH12+]13(c4cc(C=C[N+](=O)[O-])ccc4C4=N1C=CC=C4)(N1=C(C=CC=C1)C1=N3C=CC=C1)N1=C2C=CC=C1)C(=O)O,47639048,1,56,full reaction|has preparation,2-amino-4-mercaptobutyric acid|C36H26IrN6O4(1+)*Cl(1-),C44H44IrN8O8S2(1+)|C40H35IrN7O6S(1+),,Preparation,1,,Michael Addition,,dimethylsulfoxide-d6|water-d2,"73490345; Article; Zhao, Mengying; Pan, Yaping; Wang, Xingbo; Gao, Xue-Wang; Chao, Duobin; New Journal of Chemistry; vol. 42; 7; (2018); p. 5508 - 5513;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
Cc1ccc(S(=O)(=O)NCCC2C(=O)Nc3ccccc32)cc1,C#CC(C)=O.Cc1ccc(S(=O)(=O)NCCC2C(=O)Nc3ccccc32)cc1.C#CC(C)=O.CC(=O)CC1N(S(=O)(=O)c2ccc(C)cc2)CCC12C(=O)Nc1ccccc12.CC(=O)C[C@H]1N(S(=O)(=O)c2ccc(C)cc2)CC[C@@]12C(=O)Nc1ccccc12,Cc1ccc(S(=O)(=O)NCCC2C(=O)Nc3ccccc32)cc1>>C#CC(C)=O.Cc1ccc(S(=O)(=O)NCCC2C(=O)Nc3ccccc32)cc1.C#CC(C)=O.CC(=O)CC1N(S(=O)(=O)c2ccc(C)cc2)CCC12C(=O)Nc1ccccc12.CC(=O)C[C@H]1N(S(=O)(=O)c2ccc(C)cc2)CC[C@@]12C(=O)Nc1ccccc12,47668727,1,56,full reaction,4-methyl-N-(2-(2-oxoindolin-3-yl)ethyl)benzenesulfonamide|methyl ethynyl ketone,C21H22N2O4S|C21H22N2O4S,178896|178896,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","73262825; Article; He, Weigang; Hu, Jiadong; Wang, Pengyan; Chen, Le; Ji, Kai; Yang, Siyu; Li, Yin; Xie, Zhilong; Xie, Weiqing; Angewandte Chemie - International Edition; vol. 57; 14; (2018); p. 3806",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,Molecular sieve,,supporting information,Overall yield = 83 %; Overall yield = 33 mg; stereoselective reaction,C33H48N4O4|sodium carbonate|scandium tris(trifluoromethanesulfonate),,,,Reagent/catalyst|Solvent,Experimental part,96 percent ee,,,,,,
N#CC(C#N)=Cc1ccccc1,CCOC(=O)C(Br)C(=O)OCC.CCOC(=O)C1(C(=O)OCC)C(c2ccccc2)C1(C#N)C#N.CCOC(=O)C1(C(=O)OCC)C(c2ccccc2)C1(C#N)C#N,N#CC(C#N)=Cc1ccccc1>>CCOC(=O)C(Br)C(=O)OCC.CCOC(=O)C1(C(=O)OCC)C(c2ccccc2)C1(C#N)C#N.CCOC(=O)C1(C(=O)OCC)C(c2ccccc2)C1(C#N)C#N,47741223,1,56,full reaction,Benzylidenemalononitrile|Diethyl 2-bromomalonate,"diethyl 2,2-dicyano-3-phenylcyclopropane-1,1-dicarboxylate|diethyl 2,2-dicyano-3-phenylcyclopropane-1,1-dicarboxylate",136167|136167,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tetrahydrofuran|diethyl ether,"72878859; Article; Nemcsok, Tamás; Rapi, Zsolt; Keglevich, György; Gr",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,30,,,,Overall yield = 84 %; enantioselective reaction,"3-((5R,6R)-5,6-bis((R)-2,2-diphenyl-1,3-dioxolan-4-yl)-1,4,7,10-tetraoxa-13-azacyclopentadecan-13-yl)propan-1-ol|sodium carbonate",,,,,Experimental part,85 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccccc1,COC(=O)C/N=C(\c1ccccc1)c1ccccc1O.COC(=O)[C@@H](/N=C(\c1ccccc1)c1ccccc1O)[C@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(/N=C(\c1ccccc1)c1ccccc1O)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])/C=C/c1ccccc1>>COC(=O)C/N=C(\c1ccccc1)c1ccccc1O.COC(=O)[C@@H](/N=C(\c1ccccc1)c1ccccc1O)[C@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(/N=C(\c1ccccc1)c1ccccc1O)C(C[N+](=O)[O-])c1ccccc1,47884718,1,56,full reaction,nitrostyrene|methyl (E)-2-{[(2-hydroxyphenyl)(phenyl)methylene]amino}acetate,"methyl (2S,3S)-2-(((E)-(2-hydroxyphenyl)(phenyl)methylene)amino)-4-nitro-3-phenylbutanoate|methyl 2-(((E)-(2-hydroxyphenyl)(phenyl)methylene)amino)-4-nitro-3-phenylbutanoate",221975|221975,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"73605169; Article; Guerrero-Corella, Andrea; Esteban, Francisco; Iniesta, Manuel; Martín-Somer, Ana;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,supporting information,enantioselective reaction,"1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea",,,,Reagent/catalyst|Solvent,Experimental part,97 percent ee,,,,,,
CCOC(=O)C(C)C#N,COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1,CCOC(=O)C(C)C#N>>COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1,47890203,1,56,full reaction,ethyl 2-cyanopropionate|4-(4-methoxyphenyl)-3-buten-2-one,ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate,228992|228992,Chemical behaviour,1,29,Michael Addition,Catalytic behavior,aq. phosphate buffer|acetonitrile,"73521241; Article; Garrabou, Xavier; Macdonald, Duncan Stuart; Wicky, Basile I. M.; Hilvert, Donald; Angewandte Chemie - International Edition; vol. 57; 19; (2018); p. 5288 - 5291; Angew. Chem.; vol.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Enzymatic reaction,7.5,supporting information,stereoselective reaction,retro-aldolase L9V·T53A·L131V·I133L·K210LS233A·S234K RA95.5-8 mutant|sodium chloride,,,,Reagent/catalyst|Temperature,Experimental part,,,,,,,
CCOC(=O)C(C)C#N,COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1,CCOC(=O)C(C)C#N>>COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1,47890204,1,56,full reaction,ethyl 2-cyanopropionate|4-(4-methoxyphenyl)-3-buten-2-one,ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate,228992|228992,Chemical behaviour,1,4,Michael Addition,Catalytic behavior,aq. phosphate buffer|acetonitrile,"73521241; Article; Garrabou, Xavier; Macdonald, Duncan Stuart; Wicky, Basile I. M.; Hilvert, Donald; Angewandte Chemie - International Edition; vol. 57; 19; (2018); p. 5288 - 5291; Angew. Chem.; vol.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Enzymatic reaction,7.5,supporting information,stereoselective reaction,retro-aldolase W8L·I133G·V134P·F180P·M182D mutant|sodium chloride,,,,Temperature|Reagent/catalyst,Experimental part,,,,,,,
Cn1c(C=CC(=O)c2ccccc2)cc2ccccc21,COC(=O)CN=C(c1ccccc1)c1ccccc1.COC(=O)[C@@H](N=C(c1ccccc1)c1ccccc1)[C@H](CC(=O)c1ccccc1)c1cc2ccccc2n1C.COC(=O)[C@H](N=C(c1ccccc1)c1ccccc1)[C@@H](CC(=O)c1ccccc1)c1cc2ccccc2n1C,Cn1c(C=CC(=O)c2ccccc2)cc2ccccc21>>COC(=O)CN=C(c1ccccc1)c1ccccc1.COC(=O)[C@@H](N=C(c1ccccc1)c1ccccc1)[C@H](CC(=O)c1ccccc1)c1cc2ccccc2n1C.COC(=O)[C@H](N=C(c1ccccc1)c1ccccc1)[C@@H](CC(=O)c1ccccc1)c1cc2ccccc2n1C,48320697,1,56,full reaction,3-(1-methyl-1H-indol-2-yl)-1-phenylprop-2-en-1-one|methyl N-(diphenylmethylene)glycinate,C34H30N2O3|C34H30N2O3,225070|225070,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,diethyl ether,"74003666; Article; Liu, Yang-Zi; Shang, Shao-Jing; Zhu, Jing-Yan; Yang, Wu-Lin; Deng, Wei-Ping; Advanced Synthesis and Catalysis; vol. 360; 11; (2018); p. 2191 - 2203;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,supporting information,stereoselective reaction,"(S,Sp)-Ph-Phosferrox|silver(I) acetate|1,8-diazabicyclo[5.4.0]undec-7-ene",,,,Reagent/catalyst|Solvent|Temperature,Scheme or table,87 percent ee,,,,,,
CCCS,C/C=C/c1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1.C/C=C/c1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1.CCCS.CCCS[C@@H](C)Cc1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1.CCCS[C@H](C)Cc1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1,CCCS>>C/C=C/c1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1.C/C=C/c1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1.CCCS.CCCS[C@@H](C)Cc1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1.CCCS[C@H](C)Cc1nc2ccccc2n1S(=O)(=O)c1ccc(C)cc1,48897022,1,56,full reaction,1-thiopropane|(E)-2-(prop-1-en-1-yl)-1-tosylbenzimidazole,C20H24N2O2S2|C20H24N2O2S2,221595|221595,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,diethyl ether,"74783746; Article; Formica, Michele; Sorin, Geoffroy; Farley, Alistair J. M.; Díaz, Jesús;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 93 %; enantioselective reaction,C47H57N4O4PS,,,,Reagent/catalyst|Temperature,Scheme or table,88 percent ee,,,,,,
CC(C)(C)OC(=O)/C(=N/Cc1ccc([N+](=O)[O-])cc1)c1ccccc1,C=CC(C)=O.CC(=O)CC[C@@](/N=C/c1ccc([N+](=O)[O-])cc1)(C(=O)OC(C)(C)C)c1ccccc1.CC(=O)CC[C@@](/N=C/c1ccc([N+](=O)[O-])cc1)(C(=O)OC(C)(C)C)c1ccccc1,CC(C)(C)OC(=O)/C(=N/Cc1ccc([N+](=O)[O-])cc1)c1ccccc1>>C=CC(C)=O.CC(=O)CC[C@@](/N=C/c1ccc([N+](=O)[O-])cc1)(C(=O)OC(C)(C)C)c1ccccc1.CC(=O)CC[C@@](/N=C/c1ccc([N+](=O)[O-])cc1)(C(=O)OC(C)(C)C)c1ccccc1,49777085,1,56,full reaction,C19H20N2O4|methyl vinyl ketone,tert-butyl (E)-2-((4-nitrobenzylidene)amino)-5-oxo-2-phenylhexanoate|tert-butyl (E)-2-((4-nitrobenzylidene)amino)-5-oxo-2-phenylhexanoate,210318|210318,Chemical behaviour,1,-80,Michael Addition,Catalytic behavior,water|toluene,"74876279; Article; Yoshida, Yasushi; Moriya, Yuta; Mino, Takashi; Sakamoto, Masami; Advanced Synthesis and Catalysis; vol. 360; 21; (2018); p. 4142 - 4146;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,45,Inert atmosphere,,supporting information,Overall yield = 60 %Spectr.; enantioselective reaction,"(1S,2R,4S,5R)-1-((2'-((tert-butyldimethylsilyl)oxy)-[1,1':3',1''-terphenyl]-5′-yl)methyl)-2-((S)-((6",,,,Reagent/catalyst|Temperature|Time,Experimental part,87 percent ee,,,,,,
CC1SC(=S)N(c2ccccc2)C1=O,Cc1ccc(S(=O)(=O)N=C2C(=Cc3ccccc3)Oc3ccccc32)cc1.Cc1ccc(S(=O)(=O)Nc2c(C(c3ccccc3)C3(C)SC(=S)N(c4ccccc4)C3=O)oc3ccccc23)cc1.[H][C@](c1ccccc1)(c1oc2ccccc2c1NS(=O)(=O)c1ccc(C)cc1)[C@]1(C)SC(=S)N(c2ccccc2)C1=O,CC1SC(=S)N(c2ccccc2)C1=O>>Cc1ccc(S(=O)(=O)N=C2C(=Cc3ccccc3)Oc3ccccc32)cc1.Cc1ccc(S(=O)(=O)Nc2c(C(c3ccccc3)C3(C)SC(=S)N(c4ccccc4)C3=O)oc3ccccc23)cc1.[H][C@](c1ccccc1)(c1oc2ccccc2c1NS(=O)(=O)c1ccc(C)cc1)[C@]1(C)SC(=S)N(c2ccccc2)C1=O,50585399,1,56,full reaction,5-methyl-3-phenyl-2-thioxothiazolidin-4-one|2-benzylidene-N-tosylbenzofuran-3(2H)-imine,4-methyl-N-(2-((5-methyl-4-oxo-3-phenyl-2-thioxothiazolidin-5-yl)(phenyl)methyl)benzofuran-3-yl)benzenesulfonamide|4-methyl-N-(2-((S)-((S)-5-methyl-4-oxo-3-phenyl-2-thioxothiazolidin-5-yl)(phenyl)meth,208926|208926,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,chlorobenzene,"75662637; Article; Lin, Wei; Zhang, Chen; Xu, Wen; Cheng, Yuyu; Li, Pengfei; Li, Wenjun; Advanced Synthesis and Catalysis; vol. 361; 3; (2019); p. 476 - 480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,supporting information,Overall yield = 72 %; enantioselective reaction,"3-(3,5-bis-trifluoromethyl-phenylamino)-4-{[(S)-(6-methoxy-quinolin-4-yl)-((R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methyl]-amino}-cyclobut-3-ene-1,2-dione",,,,Solvent,Experimental part,93 percent ee,,,,,,
C=CS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O,CCOP(=O)(O)CNCC(OC)OC.CCN(CC)CC.CCOP(=O)(O)CN(CCS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O)CC(OC)OC,C=CS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O>>CCOP(=O)(O)CNCC(OC)OC.CCN(CC)CC.CCOP(=O)(O)CN(CCS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O)CC(OC)OC,51613119,1,56,full reaction|has preparation,"4-chloro-6-[1-(vinylsulfonyl)pyrrolidin-2-yl]benzene-1,3-diol|N-ethoxy-hydroxyphosphonylmethyl-aminoacetaldehyde dimethylacetal|triethylamine",C19H32ClN2O9PS,230549,Preparation,1,,Michael Addition,,ethanol|water,"75574141; Article; Vagapova, Liliya I.; Murav’eva, Ekaterina A.; Matveeva, Victoria I.; Gazizov, Alm",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,,,,,Scheme or table,,,,,,,
C=CS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O,CCOP(=O)(CCNCC(OC)OC)OCC.CCN(CC)CC.CCN(CC)CC.CCOP(=O)(CCN(CCS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O)CC(OC)OC)OCC,C=CS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O>>CCOP(=O)(CCNCC(OC)OC)OCC.CCN(CC)CC.CCN(CC)CC.CCOP(=O)(CCN(CCS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O)CC(OC)OC)OCC,51613120,1,56,full reaction|has preparation,"4-chloro-6-[1-(vinylsulfonyl)pyrrolidin-2-yl]benzene-1,3-diol|diethyl {2-[(2,2-dimethoxyethyl)amino]ethyl}phosphonate|triethylamine",C22H38ClN2O9PS*C6H15N,230552,Preparation,1,,Michael Addition,,ethanol|water,"75574141; Article; Vagapova, Liliya I.; Murav’eva, Ekaterina A.; Matveeva, Victoria I.; Gazizov, Alm",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,,,,,Scheme or table,,,,,,,
CCOP(=O)(OCC)C(CNCC(OC)OC)P(=O)(OCC)OCC,C=CS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O.CCN(CC)CC.CCN(CC)CC.CCOP(=O)(OCC)C(CN(CCS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O)CC(OC)OC)P(=O)(OCC)OCC,CCOP(=O)(OCC)C(CNCC(OC)OC)P(=O)(OCC)OCC>>C=CS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O.CCN(CC)CC.CCN(CC)CC.CCOP(=O)(OCC)C(CN(CCS(=O)(=O)N1CCCC1c1cc(Cl)c(O)cc1O)CC(OC)OC)P(=O)(OCC)OCC,51613121,1,56,full reaction|has preparation,"tetraethyl {2-[(2,2-dimethoxyethyl)amino]ethane-1,1-diyl}bisphosphonate|4-chloro-6-[1-(vinylsulfonyl)pyrrolidin-2-yl]benzene-1,3-diol|triethylamine",C26H47ClN2O12P2S*C6H15N,230552,Preparation,1,,Michael Addition,,ethanol|water,"75574141; Article; Vagapova, Liliya I.; Murav’eva, Ekaterina A.; Matveeva, Victoria I.; Gazizov, Alm",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,,,,,Scheme or table,,,,,,,
C[Si](C)(C)C#N,O=C1Nc2ccccc2/C1=C\c1ccccc1.N#CC(c1ccccc1)C1C(=O)Nc2ccccc21,C[Si](C)(C)C#N>>O=C1Nc2ccccc2/C1=C\c1ccccc1.N#CC(c1ccccc1)C1C(=O)Nc2ccccc21,51614606,1,56,full reaction,"trimethylsilyl cyanide|(3E)-3-benzylidene-1,3-dihydro-2H-indol-2-one",(R/S)-2-(2-oxoindolin-3-yl)-2-phenylacetonitrile,214982,Chemical behaviour,1,,Michael Addition,Mechanism,water,"75824848; Article; Du, Yan; Li, Zheng; Synthetic Communications; vol. 49; 1; (2019); p. 65 - 72;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,,cerium(III) chloride heptahydrate,(R/S)-2-(2-oxoindolin-3-yl)-2-phenylacetonitrile,32 percent,32,,Scheme or table,,,,,,,
O=C(CC(=O)OCc1ccccc1)OCc1ccccc1,CCOC(=O)/C=C\C(=O)OCC.CCOC(=O)C[C@@H](C(=O)OCC)C(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1.CCOC(=O)C[C@H](C(=O)OCC)C(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1,O=C(CC(=O)OCc1ccccc1)OCc1ccccc1>>CCOC(=O)/C=C\C(=O)OCC.CCOC(=O)C[C@@H](C(=O)OCC)C(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1.CCOC(=O)C[C@H](C(=O)OCC)C(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1,51664739,1,56,full reaction,malonic acid dibenzyl ester|Diethyl maleate,"(R)-1,1-dibenzyl 2,3-diethyl propane-1,1,2,3-tetracarboxylate|(S)-1,1-dibenzyl 2,3-diethyl propane-1,1,2,3-tetracarboxylate",229136|229136,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tert-butyl methyl ether,"77059852; Article; Sakamoto, Midori; Kaneko, Tetsuya; Orito, Yuya; Shimoda, Yasushi; Nakajima, Makoto; Chemical and Pharmaceutical Bulletin; vol. 67; 5; (2019); p. 452 - 460;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,,Overall yield = 94 %; enantioselective reaction,"n-butyllithium|(R)-3,3'-dibromo-1,1'-bi-2-naphthol",,,,Reagent/catalyst|Solvent,Scheme or table,87 percent ee,,,,,,
O=S(=O)(C(=Cc1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1,Cc1ccc(CC(=O)Oc2ccc([N+](=O)[O-])cc2)cc1.NCc1ccccc1.Cc1ccc(C(C(=O)NCc2ccccc2)C(c2ccccc2)C(S(=O)(=O)c2ccccc2)S(=O)(=O)c2ccccc2)cc1,O=S(=O)(C(=Cc1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1>>Cc1ccc(CC(=O)Oc2ccc([N+](=O)[O-])cc2)cc1.NCc1ccccc1.Cc1ccc(C(C(=O)NCc2ccccc2)C(c2ccccc2)C(S(=O)(=O)c2ccccc2)S(=O)(=O)c2ccccc2)cc1,52508346,1,56,full reaction,"1,1-bis(phenylsulfonyl)-2-phenylethene|4'-nitrophenyl 2-(p-tolyl)acetate|benzylamine","N-benzyl-3-phenyl-4,4-bis(phenylsulfonyl)-2-(p-tolyl)butanamide",202859,Chemical behaviour,1,20 - 25|20 - 25,Michael Addition|Michael Addition,Catalytic behavior,dichloromethane|dichloromethane,"78161596; Article; McLaughlin, Calum; Slawin, Alexandra M. Z.; Smith, Andrew D.; Angewandte Chemie - International Edition; vol. 58; 42; (2019); p. 15111 - 15119; Angew. Chem.; vol. 131; (2019); p. 15",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24|24,Inert atmosphere|Sealed tube|Inert atmosphere|Sealed tube,,supporting information,,(±)-BTM,,,,,Experimental part,,2,"1,1-bis(phenylsulfonyl)-2-phenylethene|4'-nitrophenyl 2-(p-tolyl)acetate|benzylamine",,,,
CC(=C(C#N)C#N)c1ccccc1,Cn1ccnc1C(=O)C=Cc1ccccc1.Cn1ccnc1C(=O)C[C@@H](CC(=C(C#N)C#N)c1ccccc1)c1ccccc1.Cn1ccnc1C(=O)C[C@H](CC(=C(C#N)C#N)c1ccccc1)c1ccccc1,CC(=C(C#N)C#N)c1ccccc1>>Cn1ccnc1C(=O)C=Cc1ccccc1.Cn1ccnc1C(=O)C[C@@H](CC(=C(C#N)C#N)c1ccccc1)c1ccccc1.Cn1ccnc1C(=O)C[C@H](CC(=C(C#N)C#N)c1ccccc1)c1ccccc1,52764213,1,56,full reaction,2-(1-phenylethylidene)propanedinitrile|2-cinnamoyl-1-methyl-1H-imidazole,C24H20N4O|C24H20N4O,229193|229193,Chemical behaviour,1,20|50,Michael Addition,Catalytic behavior,methanol|methanol,"78549345; Article; Hu, Liangjian; Lin, Shaoxia; Li, Shiwu; Kang, Qiang; Du, Yu; ChemCatChem; vol. 12; 1; (2020); p. 118 - 121;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|18,Schlenk technique|Inert atmosphere|Schlenk technique|Inert atmosphere,,,Overall yield = 83 percent; enantioselective reaction,C54H42F12N4O2Rh(1+)*F6P(1-),,,,Reagent/catalyst,Experimental part,86 percent ee,2,2-cinnamoyl-1-methyl-1H-imidazole|2-(1-phenylethylidene)propanedinitrile,,,,
CC(C)(C)OC(=O)N1C(=O)C(c2ccccc2)c2ccccc21,O=C(C=CC(F)(F)F)Oc1ccc([N+](=O)[O-])cc1.CC1=NN(C(=O)OC(C)(C)C)C(=O)[C@@]1(C)[C@H](CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F.CC1=NN(C(=O)OC(C)(C)C)C(=O)C1(C)C(CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F,CC(C)(C)OC(=O)N1C(=O)C(c2ccccc2)c2ccccc21>>O=C(C=CC(F)(F)F)Oc1ccc([N+](=O)[O-])cc1.CC1=NN(C(=O)OC(C)(C)C)C(=O)[C@@]1(C)[C@H](CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F.CC1=NN(C(=O)OC(C)(C)C)C(=O)C1(C)C(CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F,52976228,1,56,full reaction,"tert-butyl 2-oxo-3-phenylindoline-1-carboxylate|4-nitrophenyl-4,4,4-trifluorobut-2-enoate",C20H22F3N3O7|C20H22F3N3O7,29527|29527,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tetrahydrofuran,"78679444; Article; Shu, Chang; Liu, Honglei; Slawin, Alexandra M. Z.; Carpenter-Warren, Cameron; Smith, Andrew D.; Chemical Science; vol. 11; 1; (2020); p. 241 - 247;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Overall yield = 86 percent; enantioselective reaction,"(2S,3R)-HyperBTM",,,,Reagent/catalyst|Temperature,Scheme or table,94 percent ee,,,,,,
O=C(C=CC(F)(F)F)c1ccccc1,CC1C(=O)N(c2ccccc2)N=C1c1ccccc1.C[C@@]1([C@H](CC(=O)c2ccccc2)C(F)(F)F)C(=O)N(c2ccccc2)N=C1c1ccccc1.C[C@]1([C@@H](CC(=O)c2ccccc2)C(F)(F)F)C(=O)N(c2ccccc2)N=C1c1ccccc1,O=C(C=CC(F)(F)F)c1ccccc1>>CC1C(=O)N(c2ccccc2)N=C1c1ccccc1.C[C@@]1([C@H](CC(=O)c2ccccc2)C(F)(F)F)C(=O)N(c2ccccc2)N=C1c1ccccc1.C[C@]1([C@@H](CC(=O)c2ccccc2)C(F)(F)F)C(=O)N(c2ccccc2)N=C1c1ccccc1,52988428,1,56,full reaction,"4,4,4-trifluoro-1-phenylbut-2-en-1-one|4-methyl-2,5-diphenyl-2,4-dihydro-3H-pyrazol-3-one","(S)-4-methyl-2,5-diphenyl-4-((S)-1,1,1-trifluoro-4-oxo-4-phenylbutan-2-yl)-2,4-dihydro-3H-pyrazol-3-one|C26H21F3N2O2",220273|220273,Chemical behaviour,1,0|0,Michael Addition|Michael Addition,Catalytic behavior,chlorobenzene|chlorobenzene,"78675922; Article; Xu, Xinyao; He, Yanmin; Zhou, Jingqi; Li, Xinjuan; Zhu, Bo; Chang, Junbiao; Journal of Organic Chemistry; vol. 85; 2; (2020); p. 574 - 584;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.25|72,,,,Overall yield = 79 percent; enantioselective reaction,C26H38F6N4OS,,,,Reagent/catalyst|Solvent|Temperature,Experimental part,88 percent ee,2,"4-methyl-2,5-diphenyl-2,4-dihydro-3H-pyrazol-3-one|4,4,4-trifluoro-1-phenylbut-2-en-1-one",,,,
C=C=C1C(=O)OC2(C)C=CC(=O)CC12,O=C1C(=Cc2ccccc2)C(=O)c2ccccc21.[H][C@]12C(=O)C=C[C@@]3(C)OC(=O)C(=C13)[C@@H](C[C@@H](c1ccccc1)C1C(=O)c3ccccc3C1=O)C1(C(=O)c3ccccc3C1=O)[C@@H]2c1ccccc1.CC12C=CC(=O)C3C1=C(C(=O)O2)C(CC(c1ccccc1)C1C(=O)c2ccccc2C1=O)C1(C(=O)c2ccccc2C1=O)C3c1ccccc1,C=C=C1C(=O)OC2(C)C=CC(=O)CC12>>O=C1C(=Cc2ccccc2)C(=O)c2ccccc21.[H][C@]12C(=O)C=C[C@@]3(C)OC(=O)C(=C13)[C@@H](C[C@@H](c1ccccc1)C1C(=O)c3ccccc3C1=O)C1(C(=O)c3ccccc3C1=O)[C@@H]2c1ccccc1.CC12C=CC(=O)C3C1=C(C(=O)O2)C(CC(c1ccccc1)C1C(=O)c2ccccc2C1=O)C1(C(=O)c2ccccc2C1=O)C3c1ccccc1,53704883,1,56,full reaction,"7a-methyl-3-vinylidene-3a,7a-dihydrobenzofuran-2,5(3H,4H)dione|2-benzylidene-indan-1,3-dione","3'-(2-(1,3-dioxo-2,3-dihydro-1H-inden-2-yl)-2-phenylethyl)-8a'-methyl-5'-phenyl-3',5',5a',8a'-tetrahydro-2'H,6'H-spiro[indene-2,4'-naphtho[1,8-bc]furan]1,2',3,6'-tetraone|3'-(2-(1,3-dioxo-2,3-dihydro-",83663|83663,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","79380444; Article; Shi, Wangyu; Mao, Biming; Xu, Jiaqing; Wang, Qijun; Wang, Wei; Wu, Yongjun; Li, Xuefeng; Guo, Hongchao; Organic Letters; vol. 22; 7; (2020); p. 2675 - 2680;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,supporting information,Overall yield = 88percent; Overall yield = 58.0 mg; diastereoselective reaction,benzyldiphenylphosphane,,,,Reagent/catalyst|Solvent,Experimental part,86.667 percent de,,,,,,
NC(CS)C(=O)O,C=CC(=O)Oc1cc2c(cc1C=CC(=O)c1ccccc1)C1(OC(=O)c3ccccc31)c1ccc(N(CC)CC)cc1O2.NC(CS)C(=O)O.CCN(CC)c1ccc2c(c1)Oc1cc(O)c(C(CC(=O)c3ccccc3)SCC(N)C(=O)O)cc1C21OC(=O)c2ccccc21.O=C1CCSCC(C(=O)O)N1,NC(CS)C(=O)O>>C=CC(=O)Oc1cc2c(cc1C=CC(=O)c1ccccc1)C1(OC(=O)c3ccccc31)c1ccc(N(CC)CC)cc1O2.NC(CS)C(=O)O.CCN(CC)c1ccc2c(c1)Oc1cc(O)c(C(CC(=O)c3ccccc3)SCC(N)C(=O)O)cc1C21OC(=O)c2ccccc21.O=C1CCSCC(C(=O)O)N1,53749664,1,56,full reaction|has preparation,rac-cysteine|C36H29NO6,"C36H34N2O7S|3-carboxy-5-oxoperhydro-1,4-thiazepine",122052|89762,Preparation,1,,Michael Addition,,water|acetonitrile,"79456556; Article; Hu, Linan;Chen, Zhu;Yu, Cheng;Zhang, Jie;Zhang, Hailiang;Xu, Pengfei;Xiao, Enhua; Journal of Materials Chemistry B; vol. 8; 12; (2020); p. 2438 - 2442;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
O=[N+]([O-])C=Cc1ccc(Cl)cc1,[N-]=[N+]=NC1Cc2ccccc2C1=O.[N-]=[N+]=N[C@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=NC1(C(C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O,O=[N+]([O-])C=Cc1ccc(Cl)cc1>>[N-]=[N+]=NC1Cc2ccccc2C1=O.[N-]=[N+]=N[C@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=NC1(C(C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O,53857823,1,56,full reaction,"1-chloro-4-(2-nitrovinyl)benzene|2-azido-2,3-dihydro-1H-inden-1-one",C17H13ClN4O3|C17H13ClN4O3,221952|221952,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","79606575; Article; Ding, Pei-Gang;Zhou, Feng;Wang, Xin;Zhao, Qiu-Hua;Yu, Jin-Sheng;Zhou, Jian; Chemical Science; vol. 11; 15; (2020); p. 3852 - 3861;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,60,,,,Overall yield = 99 percent; stereoselective reaction,"3-((S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-ylamino)-4-(3,5-bis(trifluoromethyl)phenylamino)cyclobut-3-ene-1,2-dione",,,,Time,Scheme or table,95 percent ee,,,,,,
CN(CCN)CCN,C=CC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCNCCN(C)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,CN(CCN)CCN>>C=CC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCNCCN(C)CCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,53929319,1,56,full reaction|has preparation,"1,5-diamino-3-azamethylpentane|2-(dodecyldisulfaneyl)ethyl acrylate",C73H143N3O8S8|C56H111N3O6S6,91284|91250,Preparation,1,,Michael Addition,,,"79112837; Article; Yang, Liu;Ma, Feihe;Liu, Fang;Chen, Jinjin;Zhao, Xuewei;Xu, Qiaobing; Molecular Therapy - Nucleic Acids; vol. 19; (2020); p. 1357 - 1367;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCNCCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC.CCCCCCCCCCCCSSCCOC(=O)CCNCCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCCCCCC)CCC(=O)OCCSSCCCCCCCCCCCC,53929325,1,56,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|2-(dodecyldisulfaneyl)ethyl acrylate",C75H147N3O8S8|C58H115N3O6S6,91250|91284,Preparation,1,,Michael Addition,,,"79112837; Article; Yang, Liu;Ma, Feihe;Liu, Fang;Chen, Jinjin;Zhao, Xuewei;Xu, Qiaobing; Molecular Therapy - Nucleic Acids; vol. 19; (2020); p. 1357 - 1367;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=CCCc1ccccc1,CCOC(=O)C(C#N)=Cc1ccccc1.CCOC(=O)C(C#N)C(c1ccccc1)C(C(C)=O)c1ccccc1.CCOC(=O)C(C#N)[C@@H](c1ccccc1)[C@H](C(C)=O)c1ccccc1,O=CCCc1ccccc1>>CCOC(=O)C(C#N)=Cc1ccccc1.CCOC(=O)C(C#N)C(c1ccccc1)C(C(C)=O)c1ccccc1.CCOC(=O)C(C#N)[C@@H](c1ccccc1)[C@H](C(C)=O)c1ccccc1,54168871,1,56,full reaction,3-phenyl-propionaldehyde|ethyl benzylidenecyanoacetate,C21H21NO3|C21H21NO3,8231|8231,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,acetonitrile,"79574488; Article; Hayashi, Yujiro;Odoh, Amaechi Shedrack;Kranidiotis-Hisatomi, Nektarios; ChemCatChem; vol. 12; 9; (2020); p. 2412 - 2415;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,enantioselective reaction,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|water,,,,Solvent|Reagent/catalyst,Scheme or table,> 99 percent ee,,,,,,
CC[N+](=O)[O-],CCOC(=O)C(=C[Si](C)(C)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)C(C(C)[N+](=O)[O-])[Si](C)(C)c1ccccc1.CCOC(=O)C(C(=O)OCC)C(C(C)[N+](=O)[O-])[Si](C)(C)c1ccccc1,CC[N+](=O)[O-]>>CCOC(=O)C(=C[Si](C)(C)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)C(C(C)[N+](=O)[O-])[Si](C)(C)c1ccccc1.CCOC(=O)C(C(=O)OCC)C(C(C)[N+](=O)[O-])[Si](C)(C)c1ccccc1,54183497,1,56,full reaction,Nitroethane|ethyl 2-ethoxycarbonyl-3-dimethyl(phenyl)silyl-2-propenoate,C18H27NO6Si|C18H27NO6Si,228975|228975,Chemical behaviour,1,20|-20,Michael Addition|Michael Addition,Catalytic behavior,toluene|toluene,"79751163; Article; Chowdhury, Raghunath;Dubey, Akhil K.;Ghosh, Sunil K.; European Journal of Organic Chemistry; vol. 2020; 19; (2020); p. 2962 - 2972;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|48,Inert atmosphere|Inert atmosphere,,,Overall yield = 70 percent; Overall yield = 53 mg; stereoselective reaction,C27H29N5O3S,,,,Temperature,Experimental part,80 percent ee,2,ethyl 2-ethoxycarbonyl-3-dimethyl(phenyl)silyl-2-propenoate|Nitroethane,,,,
C[N+](=O)[O-],O=C1OC/C(=C\c2ccccc2)C1=O.O=C1OCC([C@@H](C[N+](=O)[O-])c2ccccc2)=C1O.O=C1OCC([C@H](C[N+](=O)[O-])c2ccccc2)=C1O,C[N+](=O)[O-]>>O=C1OC/C(=C\c2ccccc2)C1=O.O=C1OCC([C@@H](C[N+](=O)[O-])c2ccccc2)=C1O.O=C1OCC([C@H](C[N+](=O)[O-])c2ccccc2)=C1O,54314343,1,56,full reaction,"nitromethane|E-4-benzylidene-(4H,5H)-2,3-furandione",3-hydroxy-4-((S)-2-nitro-1-phenylethyl)furan-2(5H)-one|3-hydroxy-4-(2-nitro-1-phenylethyl)furan-2(5H)-one,210674|210674,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,dichloromethane,"79754315; Article; Fofana, Mouhamadou; Dudognon, Yohan; Bertrand, Laura; Constantieux, Thierry; Rodriguez, Jean; Ndiaye, Ibrahima; Bonne, Damien; Bugaut, Xavier; European Journal of Organic Chemistry;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Inert atmosphere,,supporting information,Overall yield = 62 percent; Overall yield = 31 mg; enantioselective reaction,"3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione",,,,Reagent/catalyst|Solvent|Temperature,Experimental part,89 percent ee,,,,,,
CC1=CCC(=O)O1,COc1ccc2c(=O)ccoc2c1.[H][C@@]1([C@@]2(C)C=CC(=O)O2)CC(=O)c2ccc(OC)cc2O1.COc1ccc2c(c1)OC(C1(C)C=CC(=O)O1)CC2=O,CC1=CCC(=O)O1>>COc1ccc2c(=O)ccoc2c1.[H][C@@]1([C@@]2(C)C=CC(=O)O2)CC(=O)c2ccc(OC)cc2O1.COc1ccc2c(c1)OC(C1(C)C=CC(=O)O1)CC2=O,54566306,1,56,full reaction,5-methyl-2-furanone|7-methoxy-4H-chromen-4-one,C15H14O5|C15H14O5,210249|210249,Chemical behaviour,1,-20,Michael Addition,Catalytic behavior,2-methyltetrahydrofuran,"80319060; Article; Cui, Jin;Kumagai, Naoya;Watanabe, Takumi;Shibasaki, Masakatsu; Chemical Science; vol. 11; 27; (2020); p. 7170 - 7176;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 86 percentSpectr.; stereoselective reaction,"tetrakis(actonitrile)copper(I) hexafluorophosphate|2,2,5,7,8-pentameth",,,,Reagent/catalyst|Temperature,Scheme or table,> 99 percent ee,,,,,,
CC1=CCC(=O)O1,O=c1ccoc2ccccc12.[H][C@]1([C@@]2(C)C=CC(=O)O2)CC(=O)c2ccccc2O1.[H][C@@]1([C@]2(C)C=CC(=O)O2)CC(=O)c2ccccc2O1.[H][C@@]1([C@@]2(C)C=CC(=O)O2)CC(=O)c2ccccc2O1,CC1=CCC(=O)O1>>O=c1ccoc2ccccc12.[H][C@]1([C@@]2(C)C=CC(=O)O2)CC(=O)c2ccccc2O1.[H][C@@]1([C@]2(C)C=CC(=O)O2)CC(=O)c2ccccc2O1.[H][C@@]1([C@@]2(C)C=CC(=O)O2)CC(=O)c2ccccc2O1,54566308,2,56,full reaction|has preparation,5-methyl-2-furanone|1-benzopyran-4(4H)-one,(R)-2-[(R)-2-methyl-5-oxo-2H-fur-2-yl]-4-chromanone|C14H12O4|C14H12O4,210249|210249|210249,"['Preparation', 'Chemical behaviour']","['1', '1']","['-40', '-40']","['Michael Addition', 'Michael Addition']",Catalytic behavior,"['2-methyltetrahydrofuran', '2-methyltetrahydrofuran']","['80319060; Article; Cui, Jin;Kumagai, Naoya;Watanabe, Takumi;Shibasaki, Masakatsu; Chemical Science; vol. 11; 27; (2020); p. 7170 - 7176;', '80319060; Article; Cui, Jin;Kumagai, Naoya;Watanabe, Takumi;Shibasaki, Masakatsu; Chemical Science; vol. 11; 27; (2020); p. 7170 - 7176;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '24']",,,,"['Overall yield = 57 percentSpectr.; stereoselective reaction', 'Overall yield = 95 percentSpectr.; stereoselective reaction']","['tetrakis(actonitrile)copper(I) hexafluorophosphate|N,N,N′,N′-tetramethyl-N″-te', 'tetrakis(actonitrile)copper(I) hexafluorophosphate|N,']",,,,"['Reagent/catalyst|Solvent|Temperature', 'Reagent/catalyst|Solvent|Temperature']","['Scheme or table', 'Scheme or table']","['98 percent ee|37 percent ee', '> 99 percent ee|46 percent ee']",,,,,,
CCO,COC(=O)[C@@H]1CCCN1.CCOC(=O)C#Cc1ccccc1.CCOC(=O)/C=C(\c1ccccc1)N1CCC[C@H]1C(=O)OCC,CCO>>COC(=O)[C@@H]1CCCN1.CCOC(=O)C#Cc1ccccc1.CCOC(=O)/C=C(\c1ccccc1)N1CCC[C@H]1C(=O)OCC,54600243,1,56,full reaction|has preparation,ethanol|methyl (2S)-pyrrolidine carboxylate|phenylpropynoic acid ethyl ester,ethyl (E)-(3-ethoxy-3-oxo-1-phenylprop-1-en-1-yl)-L-prolinate,118213,Preparation,1,100,Michael Addition,,,"80329214; Article; Niedballa, Jonas; Reiss, Guido J.; Müller, Thomas J. J.; E",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,Schlenk technique|Inert atmosphere,,supporting information,,,ethyl (E)-(3-ethoxy-3-oxo-1-phenylprop-1-en-1-yl)-L-prolinate,85 mg,,,Experimental part,,,,,,,
CCOC(=O)C=CC(=O)c1ccccc1,CC(C)(C)OC(=O)C1Cc2ccccc2C1=O.CCOC(=O)[C@H](CC(=O)c1ccccc1)[C@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O.CCOC(=O)[C@@H](CC(=O)c1ccccc1)[C@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O.CCOC(=O)[C@H](CC(=O)c1ccccc1)[C@@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O.CCOC(=O)[C@@H](CC(=O)c1ccccc1)[C@@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O,CCOC(=O)C=CC(=O)c1ccccc1>>CC(C)(C)OC(=O)C1Cc2ccccc2C1=O.CCOC(=O)[C@H](CC(=O)c1ccccc1)[C@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O.CCOC(=O)[C@@H](CC(=O)c1ccccc1)[C@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O.CCOC(=O)[C@H](CC(=O)c1ccccc1)[C@@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O.CCOC(=O)[C@@H](CC(=O)c1ccccc1)[C@@]1(C(=O)OC(C)(C)C)Cc2ccccc2C1=O,54638647,1,56,full reaction,"ethyl 3-benzoyl acrylate|tert-butyl 2,3-dihydro-1-oxo-1H-indene-2-carboxylate","tert-butyl 2-(1-ethoxy-1,4-dioxo-4-phenylbutan-2-yl)-1-oxo-2,3-dihydro-1H-indene-2-carboxylate|tert-butyl 2-(1-ethoxy-1,4-dioxo-4-phenylbutan-2-yl)-1-oxo-2,3-dihydro-1H-indene-2-carboxylate|tert-butyl",228992|228992|228992|228992,Chemical behaviour,1,-20|-20,Michael Addition|Michael Addition,Catalytic behavior,dichloromethane|dichloromethane,"80326325; Article; Hong, Haoran; Wang, Hongyu; Zheng, Changwu; Zhao, Gang; Shang, Yongjia; Chinese Chemical Letters; vol. 32; 2; (2021); p. 708 - 712;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|72,,,supporting information,Overall yield = 76 percent; Optical yield = 42 percent ee,"(S)-N-((S)-1-(diphenylphosphanyl)-3,3-dimethylbutan-2-yl)-2-(3-(4-nitrophenyl)thioureido)-2-phenylacetamide|acrylic acid methyl ester",,,,Temperature|Reagent/catalyst,Scheme or table,84 percent ee,2,"tert-butyl 2,3-dihydro-1-oxo-1H-indene-2-carboxylate|ethyl 3-benzoyl acrylate",,,,
CCOC(=O)C(=O)C=Cc1ccccc1,CC(=C1C(=O)N(C(=O)OC(C)(C)C)c2ccccc21)c1ccccc1.CCOC(=O)C(=O)C[C@H](C/C(=C1\C(=O)N(C(=O)OC(C)(C)C)c2ccccc21)c1ccccc1)c1ccccc1.CCOC(=O)C(=O)C[C@@H](C/C(=C1\C(=O)N(C(=O)OC(C)(C)C)c2ccccc21)c1ccccc1)c1ccccc1,CCOC(=O)C(=O)C=Cc1ccccc1>>CC(=C1C(=O)N(C(=O)OC(C)(C)C)c2ccccc21)c1ccccc1.CCOC(=O)C(=O)C[C@H](C/C(=C1\C(=O)N(C(=O)OC(C)(C)C)c2ccccc21)c1ccccc1)c1ccccc1.CCOC(=O)C(=O)C[C@@H](C/C(=C1\C(=O)N(C(=O)OC(C)(C)C)c2ccccc21)c1ccccc1)c1ccccc1,54964280,1,56,full reaction,ethyl 4-phenyl-2-oxobut-3-enoate|C21H21NO3,"tert-butyl (E)-3-(6-ethoxy-5,6-dioxo-1,3-diphenylhexylidene)-2-oxoindoline-1-carboxylate|tert-butyl (E)-3-(6-ethoxy-5,6-dioxo-1,3-diphenylhexylidene)-2-oxoindoline-1-carboxylate",229193|229193,Chemical behaviour,1,-20,Michael Addition,Catalytic behavior,chloroform,"80673781; Article; Jaiswal, Manish K.; Kumar, Rajesh; Singh, Sanjay; Jain, Shailija; Vanka, Kumar; Singh, Ravi P.; European Journal of Organic Chemistry; vol. 2020; 35; (2020); p. 5690 - 5694;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,supporting information,Overall yield = 55 percent; stereoselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((S)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methyl)thiourea",,,,Reagent/catalyst|Solvent,Experimental part,88 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccccc1,CCCC=O.CCC(C=O)C(C[N+](=O)[O-])c1ccccc1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])/C=C/c1ccccc1>>CCCC=O.CCC(C=O)C(C[N+](=O)[O-])c1ccccc1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,55570176,2,56,full reaction|has preparation,nitrostyrene|butyraldehyde,"2-ethyl-4-nitro-3-phenylbutanal|(2S,3R)-2-ethyl-4-nitro-3-phenylbutanal|(2R,3S)-2-ethyl-4-nitro-3-phenylbutyraldehyde",224825|224825|224825,"['Preparation', 'Chemical behaviour']","['1', '1']","['25', '25']","['Michael Addition', 'Michael Addition']",Catalytic behavior,"['dichloromethane', 'dichloromethane']","['81355445; Article; Ochiai, Hidenori;Nishiyama, Akira;Haraguchi, Naoki;Itsuno, Shinichi; Organic Process Research and Development; vol. 24; 10; (2020); p. 2228 - 2233;', '81355445; Article; Ochiai, Hidenori;Nishiyama, Akira;Haraguchi, Naoki;Itsuno, Shinichi; Organic Process Research and Development; vol. 24; 10; (2020); p. 2228 - 2233;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '24']","['Inert atmosphere', 'Inert atmosphere']",,"['supporting information', 'supporting information']","['Overall yield = 95 percent; stereoselective reaction', 'Overall yield = 96 percent; stereoselective reaction']","['benzoic acid', 'benzoic acid']",,,,Reagent/catalyst,"['Experimental part', 'Experimental part']","['78.7 percent ee', '87 percent ee']",,,,,,
CC=Cc1nc2ccccc2n1C(=O)OC(C)(C)C,O=[PH](c1ccccc1)c1ccccc1.C[C@@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)P(=O)(c1ccccc1)c1ccccc1.C[C@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)P(=O)(c1ccccc1)c1ccccc1,CC=Cc1nc2ccccc2n1C(=O)OC(C)(C)C>>O=[PH](c1ccccc1)c1ccccc1.C[C@@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)P(=O)(c1ccccc1)c1ccccc1.C[C@H](Cc1nc2ccccc2n1C(=O)OC(C)(C)C)P(=O)(c1ccccc1)c1ccccc1,55942258,1,56,full reaction,C15H18N2O2|Diphenylphosphine oxide,tert-butyl (S)-2-(2-(diphenylphosphoryl)propyl)-1H-benzo[d]imidazole-1-carboxylate|C27H29N2O3P,219300|219300,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,diethyl ether,"81974286; Article; Hou, Linan; Kikuchi, Jun; Ye, Haiting; Bao, Ming; Terada, Masahiro; Journal of Organic Chemistry; vol. 85; 22; (2020); p. 14802 - 14809;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Inert atmosphere,,,Overall yield = 85 percent; enantioselective reaction,C32H11F10O4P,,,,Reagent/catalyst|Solvent,Experimental part,89 percent ee,,,,,,
CC1(CCCCC=O)C=CC(=O)C=C1,[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@@H]2C=O.[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@H]2C=O.[H][C@]12CC(=O)C=C[C@@]1(C)CCC[C@@H]2C=O,CC1(CCCCC=O)C=CC(=O)C=C1>>[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@@H]2C=O.[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@H]2C=O.[H][C@]12CC(=O)C=C[C@@]1(C)CCC[C@@H]2C=O,56795049,1,56,full reaction,C12H16O2,C12H16O2|C12H16O2|C12H16O2,42745|296563,Chemical behaviour,1,0 - 20,Michael Addition,Catalytic behavior,toluene,"83741138; Article; Lu, Xiao-Long; Qiu, Yuanyou; Yang, Baochao; He, Haibing; Gao, Shuanhu; Chemical Science; vol. 12; 13; (2021); p. 4747 - 4752;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,10,,,,Overall yield = 52 percentSpectr.; stereoselective reaction,(R)-2-(diphenyl(trimethylsilyloxy)methyl)pyrrolidine,,,,Solvent|Time,Scheme or table,96 percent ee|75 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCC=O.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCC=O.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,56885518,1,56,full reaction|has preparation,(2-nitroethenyl)benzene|propionaldehyde,"(2R, 3S)-2-methyl-4-nitro-3-phenylbutanal|2-methyl-4-nitro-3-phenylbutanal",224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Body text,,,,,,,
O=[N+]([O-])C=Cc1ccc(F)cc1,CCC=O.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,O=[N+]([O-])C=Cc1ccc(F)cc1>>CCC=O.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,56885519,1,56,full reaction|has preparation,4-fluoro-β-nitrostyrene|propionaldehyde,3-(4-fluorophenyl)-2-methyl-4-nitrobutanal|3-(4-fluorophenyl)-2-methyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
Cc1ccc(C=C[N+](=O)[O-])cc1,CCC=O.Cc1ccc([C@H](C[N+](=O)[O-])[C@H](C)C=O)cc1.Cc1ccc([C@H](C[N+](=O)[O-])[C@@H](C)C=O)cc1,Cc1ccc(C=C[N+](=O)[O-])cc1>>CCC=O.Cc1ccc([C@H](C[N+](=O)[O-])[C@H](C)C=O)cc1.Cc1ccc([C@H](C[N+](=O)[O-])[C@@H](C)C=O)cc1,56885521,1,56,full reaction|has preparation,4-methyl-β-nitrostyrene|propionaldehyde,2-methyl-4-nitro-3-(p-tolyl)butanal|2-methyl-4-nitro-3-(p-tolyl)butanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccccc1Cl,CCC=O.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,O=[N+]([O-])C=Cc1ccccc1Cl>>CCC=O.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,56885523,1,56,full reaction|has preparation,1-chloro-2-(2-nitrovinyl)benzene|propionaldehyde,3-(2-chlorophenyl)-2-methyl-4-nitrobutanal|3-(2-chlorophenyl)-2-methyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1cccc(Cl)c1,CCC=O.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,O=[N+]([O-])C=Cc1cccc(Cl)c1>>CCC=O.C[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1.C[C@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,56885525,1,56,full reaction|has preparation,3-chloroβ-nitrostyrene|propionaldehyde,3-(3-chlorophenyl)-2-methyl-4-nitrobutanal|3-(3-chlorophenyl)-2-methyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
COc1ccc(C=C[N+](=O)[O-])cc1,CCC=O.COc1ccc([C@H](C[N+](=O)[O-])[C@H](C)C=O)cc1.COc1ccc([C@H](C[N+](=O)[O-])[C@@H](C)C=O)cc1,COc1ccc(C=C[N+](=O)[O-])cc1>>CCC=O.COc1ccc([C@H](C[N+](=O)[O-])[C@H](C)C=O)cc1.COc1ccc([C@H](C[N+](=O)[O-])[C@@H](C)C=O)cc1,56885527,1,56,full reaction|has preparation,1-methoxy-4-(2-nitro-vinyl)-benzene|propionaldehyde,3-(4-methoxyphenyl)-2-methyl-4-nitrobutanal|3-(4-methoxyphenyl)-2-methyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,56885530,1,56,full reaction|has preparation,(2-nitroethenyl)benzene|butyraldehyde,"rac-(2R,3S)-2-ethyl-4-nitro-3-phenylbutanal|2-ethyl-4-nitro-3-phenylbutanal",224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccc(F)cc1,CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,O=[N+]([O-])C=Cc1ccc(F)cc1>>CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,56885531,1,56,full reaction|has preparation,4-fluoro-β-nitrostyrene|butyraldehyde,3-(4-fluorophenyl)-2-ethyl-4-nitrobutanal|3-(4-fluorophenyl)-2-ethyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
Cc1ccc(C=C[N+](=O)[O-])cc1,CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1,Cc1ccc(C=C[N+](=O)[O-])cc1>>CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1,56885533,1,56,full reaction|has preparation,4-methyl-β-nitrostyrene|butyraldehyde,2-ethyl-4-nitro-3-(p-tolyl)butanal|2-ethyl-4-nitro-3-(p-tolyl)butanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccccc1Cl,CCCC=O.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,O=[N+]([O-])C=Cc1ccccc1Cl>>CCCC=O.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,56885535,1,56,full reaction|has preparation,1-chloro-2-(2-nitrovinyl)benzene|butyraldehyde,3-(2-chlorophenyl)-2-ethyl-4-nitrobutanal|3-(2-chlorophenyl)-2-ethyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1cccc(Cl)c1,CCCC=O.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,O=[N+]([O-])C=Cc1cccc(Cl)c1>>CCCC=O.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,56885537,1,56,full reaction|has preparation,3-chloroβ-nitrostyrene|butyraldehyde,3-(3-chlorophenyl)-2-ethyl-4-nitrobutanal|3-(3-chlorophenyl)-2-ethyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
COc1ccc(C=C[N+](=O)[O-])cc1,CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1,COc1ccc(C=C[N+](=O)[O-])cc1>>CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1.CC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1,56885539,1,56,full reaction|has preparation,1-methoxy-4-(2-nitro-vinyl)-benzene|butyraldehyde,3-(4-methoxyphenyl)-2-ethyl-4-nitrobutanal|3-(4-methoxyphenyl)-2-ethyl-4-nitrobutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
CCCCC=O,O=[N+]([O-])C=Cc1ccccc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,CCCCC=O>>O=[N+]([O-])C=Cc1ccccc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,56885541,1,56,full reaction|has preparation,pentanal|(2-nitroethenyl)benzene,2-propyl-4-nitro-3-phenylbutyraldehyde|2-(2-nitro-1-phenylethyl)pentanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
CCCCC=O,O=[N+]([O-])C=Cc1ccc(F)cc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,CCCCC=O>>O=[N+]([O-])C=Cc1ccc(F)cc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,56885543,1,56,full reaction|has preparation,pentanal|4-fluoro-β-nitrostyrene,2-(1-(4-fluorophenyl)-2-nitroethyl)pentanal|2-(1-(4-fluorophenyl)-2-nitroethyl)pentanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
CCCCC=O,Cc1ccc(C=C[N+](=O)[O-])cc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1,CCCCC=O>>Cc1ccc(C=C[N+](=O)[O-])cc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1,56885545,1,56,full reaction|has preparation,pentanal|4-methyl-β-nitrostyrene,2-(2-nitro-1-(p-tolyl)ethyl)pentanal|2-(2-nitro-1-(p-tolyl)ethyl)pentanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
CCCCC=O,O=[N+]([O-])C=Cc1ccccc1Cl.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,CCCCC=O>>O=[N+]([O-])C=Cc1ccccc1Cl.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,56885547,1,56,full reaction|has preparation,pentanal|1-chloro-2-(2-nitrovinyl)benzene,2-(1-(2-chlorophenyl)-2-nitroethyl)pentanal|2-(1-(2-chlorophenyl)-2-nitroethyl)pentanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
CCCCC=O,COc1ccc(C=C[N+](=O)[O-])cc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1,CCCCC=O>>COc1ccc(C=C[N+](=O)[O-])cc1.CCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1.CCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1,56885549,1,56,full reaction|has preparation,pentanal|1-methoxy-4-(2-nitro-vinyl)-benzene,2-(1-(4-methoxyphenyl)-2-nitroethyl)pentanal|2-(1-(4-methoxyphenyl)-2-nitroethyl)pentanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CC(C)CC=O.CC(C)[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(C)[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CC(C)CC=O.CC(C)[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(C)[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,56885551,1,56,full reaction|has preparation,(2-nitroethenyl)benzene|isovaleraldehyde,2-isopropyl-4-nitro-3-phenylbutanal|2-isopropyl-4-nitro-3-phenylbutanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
CCCCCCC=O,O=[N+]([O-])C=Cc1ccccc1.CCCCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,CCCCCCC=O>>O=[N+]([O-])C=Cc1ccccc1.CCCCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1,56885552,1,56,full reaction|has preparation,heptanal|(2-nitroethenyl)benzene,2-(2-nitro-1-phenylethyl)heptanal|2-(2-nitro-1-phenylethyl)heptanal,224825|224825,Preparation,1,,Michael Addition,,,"83691902; Article; Gorde, Amol B.; Ansari, Anas; Ramapanicker, Ramesh; Tetrahedron; vol. 87; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,rac-Pro-OH,,,,,Experimental part,,,,,,,
COc1ccc(/C=C/C=O)cc1,O=C(/C=C/c1cccn1CC(=O)c1ccccc1)c1ccccc1.[H][C@@]12C=C(c3ccccc3)OC(=O)[C@]1([H])[C@@H](c1ccc(OC)cc1)[C@H](C(=O)c1ccccc1)n1cccc12.COc1ccc(C2C3C(=O)OC(c4ccccc4)=CC3c3cccn3C2C(=O)c2ccccc2)cc1,COc1ccc(/C=C/C=O)cc1>>O=C(/C=C/c1cccn1CC(=O)c1ccccc1)c1ccccc1.[H][C@@]12C=C(c3ccccc3)OC(=O)[C@]1([H])[C@@H](c1ccc(OC)cc1)[C@H](C(=O)c1ccccc1)n1cccc12.COc1ccc(C2C3C(=O)OC(c4ccccc4)=CC3c3cccn3C2C(=O)c2ccccc2)cc1,58655526,1,56,full reaction,4-methoxy-trans-cinnamaldehyde|(E)-3-(1-(2-oxo-2-phenylethyl)-1H-pyrrol-2-yl)-1-phenylprop-2-en-1-one,"(4aR,5S,6R,10bR)-6-benzoyl-5-(4-methoxyphenyl)-2-phenyl-4a,5,6,10b-tetrahydro-4H-pyrano[3,4-g]indolizin-4-one|6-benzoyl-5-(4-methoxyphenyl)-2-phenyl-4a,5,6,10b-tetrahydro-4H-pyrano[3,4-g]indolizin-4-o",192165|192165,Chemical behaviour,1,30,Michael Addition,Catalytic behavior,tetrahydrofuran,"96861630; Article; Ghosh, Arghya;Barik, Shilpa;Shee, Sayan;Biju, Akkattu T.; Chemical Communications; vol. 57; 63; (2021); p. 7794 - 7797;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Schlenk technique|Inert atmosphere,,supporting information,Overall yield = 45percent; Overall yield = 53 mg; enantioselective reaction,"dmap|(5aS,10bR)-5a,10b-dihydro-2-(2',4',6'-trimethylphenyl)-4H,6H-indeno[2,1-b]-1,2,4-triazolo[4,3-d]-1,4-oxazinium chloride monohydrate|3,5,3',5'-tetra-tert-butyl-4,4'-diphenoquinone|lithium chloride",,,,Reagent/catalyst|Solvent,Experimental part,>98 percent ee|98 percent ee,,,,,,
O=C1CC(=O)c2c(-c3ccccc3)ccc(-c3ccccc3)c21,O=C(C=Cc1ccccc1-c1ccccc1)C=Cc1ccccc1-c1ccccc1.O=C1C[C@H](c2ccccc2-c2ccccc2)C2(C(=O)c3c(-c4ccccc4)ccc(-c4ccccc4)c3C2=O)[C@@H](c2ccccc2-c2ccccc2)C1.O=C1C[C@H](c2ccccc2-c2ccccc2)C2(C(=O)c3c(-c4ccccc4)ccc(-c4ccccc4)c3C2=O)[C@H](c2ccccc2-c2ccccc2)C1,O=C1CC(=O)c2c(-c3ccccc3)ccc(-c3ccccc3)c21>>O=C(C=Cc1ccccc1-c1ccccc1)C=Cc1ccccc1-c1ccccc1.O=C1C[C@H](c2ccccc2-c2ccccc2)C2(C(=O)c3c(-c4ccccc4)ccc(-c4ccccc4)c3C2=O)[C@@H](c2ccccc2-c2ccccc2)C1.O=C1C[C@H](c2ccccc2-c2ccccc2)C2(C(=O)c3c(-c4ccccc4)ccc(-c4ccccc4)c3C2=O)[C@H](c2ccccc2-c2ccccc2)C1,58741973,1,56,full reaction|has preparation,"4,7-diphenyl-1,3-indanedione|1,5-di-(2-biphenylyl)penta-1,4-dien-3-one",C50H36O3|C50H36O3,207092|207092,Preparation,1,,Michael Addition,,,"107582934; Article; Seifert, Monika; Barth, Dieter; Kuck, Dietmar; European Journal of Organic Chemistry; vol. 2021; 46; (2021); p. 6435 - 6449;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,Reflux,,,Overall yield = 54 percent; Overall yield = 4.10 g,acetic acid,,,,,Experimental part,,,,,,,
O=C1C=CCCC1,CONC(=O)OC(C)(C)C.CON(C(=O)OC(C)(C)C)[C@@H]1CCCC(=O)C1.CON(C(=O)OC(C)(C)C)[C@@H]1CCCC(=O)C1,O=C1C=CCCC1>>CONC(=O)OC(C)(C)C.CON(C(=O)OC(C)(C)C)[C@@H]1CCCC(=O)C1.CON(C(=O)OC(C)(C)C)[C@@H]1CCCC(=O)C1,59487771,1,56,full reaction,cyclohexenone|N-(tert-butoxycarbonyl)-O-methylhydroxylamine,tert-butyl methoxy(3-oxocyclohexyl)carbamate|tert-butyl methoxy(3-oxocyclohexyl)carbamate,220177|220177,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,water|toluene,"115817869; Article; Lee, Jaeyong; Ban, Jeong Woo; Kim, Jeongseok; Yang, Sehun; Lee, Geumwoo; Dhorma, Lama Prema; Kim, Mi-Hyun; Ha, Min Woo; Hong, Suckchang; Park, Hyeung-Geun; Organic Letters; vol. 24",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,Overall yield = 97 percent; Overall yield = 49 mg; enantioselective reaction,C36H32F9N4O2(1+)*Br(1-)|potassium hydroxide,,,,Reagent/catalyst,Experimental part,58 percent ee,,,,,,
CC[Mg]Br,O=c1ccc2ccccc2o1.CC[C@H]1C=C([O-])Oc2ccccc21.[Br-].[Mg+2].CC[C@@H]1C=C([O-])Oc2ccccc21.[Br-].[Mg+2],CC[Mg]Br>>O=c1ccc2ccccc2o1.CC[C@H]1C=C([O-])Oc2ccccc21.[Br-].[Mg+2].CC[C@@H]1C=C([O-])Oc2ccccc21.[Br-].[Mg+2],59585138,1,56,full reaction,ethynylmagnesium bromide|2H-1-Benzopyran-2-one,C11H11O2(1-)*Mg(2+)*Br(1-)|C11H11O2(1-)*Mg(2+)*Br(1-),,Chemical behaviour,1,-78,Michael Addition,Catalytic behavior,tert-butyl methyl ether,"115917126; Article; Mudráková, Brigita; Kisszékelyi, Péter; Vargová, Denisa; Zakiewicz, Doro",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,copper(I) bromide dimethylsulfide complex|(R)-1-[(Sp)-2-(dicyclohexylphosphino)ferrocenylethyl]diphenylphosphine,,,,Reagent/catalyst,Experimental part,89 percent ee,,,,,,
Cc1ccc(S(=O)(=O)N2C=CC(=O)CC2)cc1,CC[Mg]Cl.CC[C@H]1C=C([O-])CCN1S(=O)(=O)c1ccc(C)cc1.[Cl-].[Mg+2].CC[C@@H]1C=C([O-])CCN1S(=O)(=O)c1ccc(C)cc1.[Cl-].[Mg+2],Cc1ccc(S(=O)(=O)N2C=CC(=O)CC2)cc1>>CC[Mg]Cl.CC[C@H]1C=C([O-])CCN1S(=O)(=O)c1ccc(C)cc1.[Cl-].[Mg+2].CC[C@@H]1C=C([O-])CCN1S(=O)(=O)c1ccc(C)cc1.[Cl-].[Mg+2],59585185,1,56,full reaction,"1-tosyl-2,3-dihydropyridin-4(1H)-one|ethylmagnesium chloride",C14H18NO3S(1-)*Mg(2+)*Cl(1-)|C14H18NO3S(1-)*Mg(2+)*Cl(1-),,Chemical behaviour,1,-78,Michael Addition,Catalytic behavior,tetrahydrofuran|2-methyltetrahydrofuran|diethyl ether,"115917126; Article; Mudráková, Brigita; Kisszékelyi, Péter; Vargová, Denisa; Zakiewicz, Doro",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Inert atmosphere|Schlenk technique,,supporting information,enantioselective reaction,copper (I) iodide|(R)-1-[(Sp)-2-(dicyclohexylphosphino)ferrocenylethyl]diphenylphosphine,,,,Reagent/catalyst,Experimental part,9 percent ee,,,,,,
COC(C)OC,O=[N+]([O-])/C=C/c1ccc(Cl)cc1.O=CC[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1.O=CC[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1,COC(C)OC>>O=[N+]([O-])/C=C/c1ccc(Cl)cc1.O=CC[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1.O=CC[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1,59786509,1,56,full reaction,"1,1-dimethoxyethane|1-nitro-2-(4-chlorophenyl)ethylene",(S)-3-(4-chlorophenyl)-4-nitrobutanal|(R)-3-(4-chlorophenyl)-4-nitrobutanal,146668|146668,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,water monomer,"116204720; Article; Nori, Valeria; Sinibaldi, Arianna; Giorgianni, Giuliana; Pesciaioli, Fabio; Di Donato, Francesca; Cocco, Emanuele; Biancolillo, Alessandra; Landa, Aitor; Carlone, Armando; Chemistr",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,Green chemistry,,supporting information,Overall yield = 56 percent; Overall yield = 63 percentSpectr.; enantioselective reaction,C47H73NOSi,,,,Reagent/catalyst|Solvent|Time,Experimental part,82 percent ee,,,,,,
O=C(/C=C/C(F)(F)F)Oc1ccc([N+](=O)[O-])cc1,COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)[C@@H](CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F.COC(=O)C(C(=O)OC)[C@H](CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F,O=C(/C=C/C(F)(F)F)Oc1ccc([N+](=O)[O-])cc1>>COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)[C@@H](CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F.COC(=O)C(C(=O)OC)[C@H](CC(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F,60432881,1,56,full reaction,"4-nitrophenyl (E)-4,4,4-trifluorobut-2-enoate|malonic acid dimethyl ester","1,1-dimethyl 3-(4-nitrophenyl) 2-(trifluoromethyl)propane-1,1,3-tricarboxylate|(S)-1,1-dimethyl 3-(4-nitrophenyl) 2-(trifluoromethyl)propane-1,1,3-tricarboxylate",220308|220308,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,"N,N-dimethyl-formamide","117974673; Article; Wu, Jiufeng;Young, Claire M.;Watts, Amy A.;Slawin, Alexandra M. Z.;Boyce, G",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,supporting information,Overall yield = 73 percent; enantioselective reaction,"(2S,3R)-HyperBTM|N-ethyl-N,N-diisopropylamine",,,,Solvent|Temperature,Experimental part,80 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CC1=NN(c2ccccc2)C(=O)C1.Cc1c[nH]c(O)c1[C@@H](C[N+](=O)[O-])c1ccccc1.Cc1c[nH]c(O)c1[C@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CC1=NN(c2ccccc2)C(=O)C1.Cc1c[nH]c(O)c1[C@@H](C[N+](=O)[O-])c1ccccc1.Cc1c[nH]c(O)c1[C@H](C[N+](=O)[O-])c1ccccc1,61255889,1,56,full reaction,(2-nitroethenyl)benzene|edaravone,C13H14N2O3|C13H14N2O3,17052|17052,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tetrahydrofuran,"119088156; Article; Ma, Zhi-Wei;Liu, Xiao-Feng;Chen, Xiao-Pei;Wang, Chuan-Chuan;Tao, Jing-Chao;Lv, Quan-Jian; Letters in Organic Chemistry; vol. 19; 10; (2022); p. 908 - 912;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,Overall yield = 94 percent; stereoselective reaction,C34H57N3O2S,,,,Reagent/catalyst|Solvent|Temperature|Time,Experimental part,78 percent ee,,,,,,
Cc1ccc(S(=O)(=O)C(c2ccccc2)c2c(C)[nH]c3ccccc23)cc1,O=[PH](c1ccccc1)c1ccccc1.Cc1[nH]c2ccccc2c1[C@H](c1ccccc1)P(=O)(c1ccccc1)c1ccccc1.Cc1[nH]c2ccccc2c1[C@@H](c1ccccc1)P(=O)(c1ccccc1)c1ccccc1,Cc1ccc(S(=O)(=O)C(c2ccccc2)c2c(C)[nH]c3ccccc23)cc1>>O=[PH](c1ccccc1)c1ccccc1.Cc1[nH]c2ccccc2c1[C@H](c1ccccc1)P(=O)(c1ccccc1)c1ccccc1.Cc1[nH]c2ccccc2c1[C@@H](c1ccccc1)P(=O)(c1ccccc1)c1ccccc1,61647879,1,56,full reaction,1-methyl-1-(2-methyl-1H-3-indolyl)ethyl (4-methylphenyl)sulfone|Diphenylphosphine oxide,(S)-((2-methyl-1H-indol-3-yl)(phenyl)methyl)diphenylphosphine oxide|C28H24NOP,243457|243457,Chemical behaviour,1,50,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","121134881; Article; Jia, Yun-Qing;Zhao, Jian-Qiang;Wang, Zhen-Hua;You, Yong;Zhang, Yan-Ping;Jin, Xin;Zhou, Ming-Qiang;Ge, Zhen-Zhen;Yuan, Wei-Cheng; Chemical Communications; vol. 58; 86; (2022); p. 12",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,Overall yield = 75 percent; Overall yield = 31.6 mg; enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)thiourea|potassium carbonate",,,,Solvent|Temperature|Reagent/catalyst,Experimental part,87 percent ee,,,,,,
CCOC(=O)C(C(=O)OCC)=C1C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,Cc1noc(CCl)c1[N+](=O)[O-].CCOC(=O)C1(C(=O)OCC)C(c2onc(C)c2[N+](=O)[O-])C12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12.CCOC(=O)C1(C(=O)OCC)[C@@H](c2onc(C)c2[N+](=O)[O-])[C@]12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12.CCOC(=O)C1(C(=O)OCC)[C@H](c2onc(C)c2[N+](=O)[O-])[C@@]12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12,CCOC(=O)C(C(=O)OCC)=C1C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>Cc1noc(CCl)c1[N+](=O)[O-].CCOC(=O)C1(C(=O)OCC)C(c2onc(C)c2[N+](=O)[O-])C12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12.CCOC(=O)C1(C(=O)OCC)[C@@H](c2onc(C)c2[N+](=O)[O-])[C@]12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12.CCOC(=O)C1(C(=O)OCC)[C@H](c2onc(C)c2[N+](=O)[O-])[C@@]12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12,62235880,2,56,full reaction|has preparation,diethyl 2-(1-(tert-butoxycarbonyl)-2-oxoindolin-3-ylidene)malonate|5-(chloromethyl)-3-methyl-4-nitroisoxazole,"1′-(tert-butyl) 2,2-diethyl 3-(3-methyl-4-nitroisoxazol-5-yl)-2′-oxospiro[cyclopropane-1,3′-indoline",136406|136406|136406,"['Preparation', 'Chemical behaviour']","['1', '1']","['20 - 25', '20 - 25']","['Michael Addition', 'Michael Addition']",Catalytic behavior,"['dichloromethane', 'acetonitrile']","['122166604; Article; Manna, Abhijit;Joshi, Harshit;Singh, Vinod K.; Journal of Organic Chemistry; vol. 87; 24; (2022); p. 16755 - 16766;', '122166604; Article; Manna, Abhijit;Joshi, Harshit;Singh, Vinod K.; Journal of Organic Chemistry; vol. 87; 24; (2022); p. 16755 - 16766;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Inert atmosphere', 'Inert atmosphere']",,"['supporting information', 'supporting information']","['Overall yield = 67 percent; stereoselective reaction', 'Overall yield = 60 percent; stereoselective reaction']","['9-amino-9-deoxy-epicinchonin-9-yl [3,5-bis(trifluoromethyl)phenyl]thiocarbamate|sodium hydrogencarbonate', '1-[3,5-bis(trifluoromethyl)phenyl]-3-[(8α,9S)-cinchonan-9-yl]urea|sodium hydrogencarbonate']",,,,Reagent/catalyst|Solvent,"['Experimental part', 'Experimental part']","['83percent ee', '88 percent ee']",,,,,,
Cc1ccc(/C=C/[N+](=O)[O-])cc1,COC(=O)C1CCCC1=O.COC(=O)[C@]1([C@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCC1=O.COC(=O)[C@@]1([C@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCC1=O.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCC1=O,Cc1ccc(/C=C/[N+](=O)[O-])cc1>>COC(=O)C1CCCC1=O.COC(=O)[C@]1([C@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCC1=O.COC(=O)[C@@]1([C@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCC1=O.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCC1=O,63066079,1,56,full reaction,(E)-2-(4-methylphenyl)-1-nitroethene|methyl 2-oxocyclopentane-1-carboxylate,methyl 1-(2-nitro-1-p-tolylethyl)-2-oxocyclopentanecarboxylate|C16H19NO5|C16H19NO5,224798|224798|224798,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,dichloromethane,"123394999; Article; Rahman, Mohammad Farhadur;Fujisawa, Ikuhide;Haraguchi, Naoki;Itsuno, Shinichi; Chirality; vol. 35; 3; (2023); p. 178 - 188;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Overall yield = 90 percent; stereoselective reaction,C-5' nitrocinchona urea polymer,,,,Reagent/catalyst,Experimental part,44 percent ee|> 99 percent ee,,,,,,
CC1(C)CC(=O)CC(=O)C1,O=Cc1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C=O)cc3)CC2)cc1.Nc1ccccc1.Nc1ccccc1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C2=C(C1)N(c1ccccc1)C1=C(C(=O)CC(C)(C)C1)C2c1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C4C5=C(CC(C)(C)CC5=O)N(c5ccccc5)C5=C4C(=O)CC(C)(C)C5)cc3)CC2)cc1,CC1(C)CC(=O)CC(=O)C1>>O=Cc1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C=O)cc3)CC2)cc1.Nc1ccccc1.Nc1ccccc1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C2=C(C1)N(c1ccccc1)C1=C(C(=O)CC(C)(C)C1)C2c1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C4C5=C(CC(C)(C)CC5=O)N(c5ccccc5)C5=C4C(=O)CC(C)(C)C5)cc3)CC2)cc1,63937812,1,56,full reaction|has preparation,"dimedone|piperazine-1,4-diylbis(2-oxoethane-2,1-diyl)bis(4-formylbenzoate)|aniline","piperazine-1,4-diylbis(2-oxoethane-2,1-diyl) bis(4-(3,3,6,6-tetramethyl-1,8-dioxo-10-phenyl-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-yl)benzoate)",11695,Preparation,1,,Michael Addition,,,"126411101; Article; Hammad, Hadeel F.;Darweesh, Ahmed F.;Abdelaziz, Mahfouz A.;Elwahy, Ahmed H. M.;Abdelhamid, Ismail A.; Synthetic Communications; vol. 53; 16; (2023); p. 1305 - 1318;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,trichloroacetic acid,,,,,Scheme or table,,,,,,,
Cc1ccc(N)cc1,CC1(C)CC(=O)CC(=O)C1.O=Cc1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C=O)cc3)CC2)cc1.Cc1ccc(N)cc1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.Cc1ccc(N2C3=C(C(=O)CC(C)(C)C3)C(c3ccc(C(=O)OCC(=O)N4CCN(C(=O)COC(=O)c5ccc(C6C7=C(CC(C)(C)CC7=O)N(c7ccc(C)cc7)C7=C6C(=O)CC(C)(C)C7)cc5)CC4)cc3)C3=C2CC(C)(C)CC3=O)cc1,Cc1ccc(N)cc1>>CC1(C)CC(=O)CC(=O)C1.O=Cc1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C=O)cc3)CC2)cc1.Cc1ccc(N)cc1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.Cc1ccc(N2C3=C(C(=O)CC(C)(C)C3)C(c3ccc(C(=O)OCC(=O)N4CCN(C(=O)COC(=O)c5ccc(C6C7=C(CC(C)(C)CC7=O)N(c7ccc(C)cc7)C7=C6C(=O)CC(C)(C)C7)cc5)CC4)cc3)C3=C2CC(C)(C)CC3=O)cc1,63937813,1,56,full reaction|has preparation,"p-toluidine|dimedone|piperazine-1,4-diylbis(2-oxoethane-2,1-diyl)bis(4-formylbenzoate)","piperazine-1,4-diylbis(2-oxoethane-2,1-diyl) bis(4-(3,3,6,6-tetramethyl-1,8-dioxo-10-(p-tolyl)-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-yl)benzoate)",,Preparation,1,,Michael Addition,,,"126411101; Article; Hammad, Hadeel F.;Darweesh, Ahmed F.;Abdelaziz, Mahfouz A.;Elwahy, Ahmed H. M.;Abdelhamid, Ismail A.; Synthetic Communications; vol. 53; 16; (2023); p. 1305 - 1318;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,trichloroacetic acid,,,,,Scheme or table,,,,,,,
Nc1ccc(Cl)cc1,CC1(C)CC(=O)CC(=O)C1.O=Cc1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C=O)cc3)CC2)cc1.Nc1ccc(Cl)cc1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C2=C(C1)N(c1ccc(Cl)cc1)C1=C(C(=O)CC(C)(C)C1)C2c1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C4C5=C(CC(C)(C)CC5=O)N(c5ccc(Cl)cc5)C5=C4C(=O)CC(C)(C)C5)cc3)CC2)cc1,Nc1ccc(Cl)cc1>>CC1(C)CC(=O)CC(=O)C1.O=Cc1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C=O)cc3)CC2)cc1.Nc1ccc(Cl)cc1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C2=C(C1)N(c1ccc(Cl)cc1)C1=C(C(=O)CC(C)(C)C1)C2c1ccc(C(=O)OCC(=O)N2CCN(C(=O)COC(=O)c3ccc(C4C5=C(CC(C)(C)CC5=O)N(c5ccc(Cl)cc5)C5=C4C(=O)CC(C)(C)C5)cc3)CC2)cc1,63937814,1,56,full reaction|has preparation,"4-chloro-aniline|dimedone|piperazine-1,4-diylbis(2-oxoethane-2,1-diyl)bis(4-formylbenzoate)","piperazine-1,4-diylbis(2-oxoethane-2,1-diyl) bis(4-(10-(4-chlorophenyl)-3,3,6,6-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-yl)benzoate)",,Preparation,1,,Michael Addition,,,"126411101; Article; Hammad, Hadeel F.;Darweesh, Ahmed F.;Abdelaziz, Mahfouz A.;Elwahy, Ahmed H. M.;Abdelhamid, Ismail A.; Synthetic Communications; vol. 53; 16; (2023); p. 1305 - 1318;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,trichloroacetic acid,,,,,Scheme or table,,,,,,,
O=S(=O)(Nc1ccccc1O)c1ccc2ccccc2c1,C=CC1OC(=O)OC1=C.CC(=O)C[C@H]1CN(S(=O)(=O)c2ccc3ccccc3c2)c2ccccc2O1.CC(=O)C[C@@H]1CN(S(=O)(=O)c2ccc3ccccc3c2)c2ccccc2O1,O=S(=O)(Nc1ccccc1O)c1ccc2ccccc2c1>>C=CC1OC(=O)OC1=C.CC(=O)C[C@H]1CN(S(=O)(=O)c2ccc3ccccc3c2)c2ccccc2O1.CC(=O)C[C@@H]1CN(S(=O)(=O)c2ccc3ccccc3c2)c2ccccc2O1,64844902,1,56,full reaction,"N-(2-hydroxyphenyl)naphthalene-2-sulfonamide|4-methylene-5-vinyl-1,3-dioxolan-2-one","(S)-1-(4-(naphthalen-2-ylsulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)propan-2-one|(R)-1-(4-(naphthalen-2-ylsulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)propan-2-one",145033|145033,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tetrahydrofuran,"128358256; Article; Yang, Zhenkun;Bao, Yu;Huang, Jiaxin;Han, Zhengyu;Sun, Jianwei;Huang, Hai; Organic Letters; vol. 25; 30; (2023); p. 5624 - 5629;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,supporting information,Overall yield = 90 percent; Overall yield = 102.9 mg; enantioselective reaction,"tetrakis(triphenylphosphine) palladium(0)|3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione",,,,Reagent/catalyst|Solvent,Experimental part,83 percent ee,,,,,,
O=[N+]([O-])C=CC#Cc1ccccc1,CN1C(=O)C(n2cccc2)c2ccccc21.CN1C(=O)[C@]([C@@H](C#Cc2ccccc2)C[N+](=O)[O-])(n2cccc2)c2ccccc21.CN1C(=O)C(C(C#Cc2ccccc2)C[N+](=O)[O-])(n2cccc2)c2ccccc21,O=[N+]([O-])C=CC#Cc1ccccc1>>CN1C(=O)C(n2cccc2)c2ccccc21.CN1C(=O)[C@]([C@@H](C#Cc2ccccc2)C[N+](=O)[O-])(n2cccc2)c2ccccc21.CN1C(=O)C(C(C#Cc2ccccc2)C[N+](=O)[O-])(n2cccc2)c2ccccc21,65533601,1,56,full reaction,1-Nitro-4-phenyl-1-buten-3-in|1-methyl-3-(1H-pyrrol-1-yl)indolin-2-one,(R)-1-methyl-3-((S)-1-nitro-4-phenylbut-3-yn-2-yl)-3-(1H-pyrrol-1-yl)indolin-2-one|1-methyl-3-(1-nitro-4-phenylbut-3-yn-2-yl)-3-(1H-pyrrol-1-yl)indolin-2-one,220243|220243,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"128920968; Article; Biswas, Subhankar;Purkayastha, Siddhartha K.;Guha, Ankur K.;Pan, Subhas Chandra; Chemical Communications; vol. 59; 81; (2023); p. 12156 - 12159;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,Overall yield = 95percent; Overall yield = 36.5 mg; stereoselective reaction,"3-((S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-ylamino)-4-(3,5-bis(trifluoromethyl)phenylamino)cyclobut-3-ene-1,2-dione",,,,Reagent/catalyst|Solvent|Concentration,Experimental part,90 percent ee,,,,,,
O=C1C=CC(=O)N1Cc1ccccc1,CC1(C)CCCC(C)(C)N1[O].O=c1[nH]c(-c2ccccc2)c(-c2ccccc2)c2ccccc12.O=C1CC2(C(=O)N1Cc1ccccc1)c1ccccc1-c1c(-c3ccccc3)c3ccccc3c(=O)n12,O=C1C=CC(=O)N1Cc1ccccc1>>CC1(C)CCCC(C)(C)N1[O].O=c1[nH]c(-c2ccccc2)c(-c2ccccc2)c2ccccc12.O=C1CC2(C(=O)N1Cc1ccccc1)c1ccccc1-c1c(-c3ccccc3)c3ccccc3c(=O)n12,66151709,1,56,full reaction,"1-benzyl-1H-pyrrole-2,5-dione|2,2,6,6-Tetramethyl-1-piperidinyloxy free radical|3,4-diphenyl-2H-isoquinolin-1-one","1'-benzyl-12-phenyl-5H-spiro[isoindolo[2,1-b]isoquinoline-7,3'-pyrrolidine]-2',5,5'-trione",225795,Chemical behaviour,1,110,Michael Addition,Mechanism,acetonitrile,"131798843; Article; Seal, Kaushik;Banerji, Biswadip; Advanced Synthesis and Catalysis; vol. 366; 8; (2024); p. 1788 - 1808;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Sealed tube|Inert atmosphere,,supporting information,,[Ru(p-cymene)Cl2]2|copper(II) acetate monohydrate,"1'-benzyl-12-phenyl-5H-spiro[isoindolo[2,1-b]isoquinoline-7,3'-pyrrolidine]-2',5,5'-trione",65 percent,,,Experimental part,,,,,,,
Oc1cc2ccccc2[nH]1,N#CC(C#N)=C1C(=O)Nc2ccccc21.[H]N([H])C1=C(C#N)C2(C(=O)Nc3ccccc32)c2c(n([H])c3ccccc23)O1,Oc1cc2ccccc2[nH]1>>N#CC(C#N)=C1C(=O)Nc2ccccc21.[H]N([H])C1=C(C#N)C2(C(=O)Nc3ccccc32)c2c(n([H])c3ccccc23)O1,67414454,1,56,full reaction|has preparation,"2-hydroxyindole|2-oxo-2,3-dihydroindolylidenemalononitrile",C19H12N4O2,117664,Preparation,1,,Michael Addition,,,"134292107; Article; Manikandan;Kumar;Swarnamughi;Asif, Mohd;Nasibullah, Malik;Jeba Reeda;Khaled, Jamal M;Muthu; Journal of Molecular Liquids; vol. 405; (2024);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C[N+](=O)[O-],C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)C[N+](=O)[O-].COC(=O)C[N+](=O)[O-].COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)[C@@H](C[C@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-],COC(=O)C[N+](=O)[O-]>>C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)C[N+](=O)[O-].COC(=O)C[N+](=O)[O-].COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)[C@@H](C[C@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-],67550786,2,56,full reaction,methyl 2-nitroacetate|tert-butyl 3-methylene-2-oxopyrrolidine-1-carboxylate,tert-butyl 3-(3-methoxy-2-nitro-3-oxopropyl)-2-oxopyrrolidine-1-carboxylate|tert-butyl 3-(3-methoxy-2-nitro-3-oxopropyl)-2-oxopyrrolidine-1-carboxylate|tert-butyl 3-(3-methoxy-2-nitro-3-oxopropyl)-2-o,230844|230844|230844,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['40', '20']","['Michael Addition', 'Michael Addition']","['Catalytic behavior', 'Catalytic behavior']","['2-methyltetrahydrofuran', 'toluene']","['134430900; Article; Szpera, Robert;Huang, Shanjun;Fenton, Harriet A. M.;Waddington, William;Gymer, Adam E. S.;Moses, Ian B.;Buck, Julia;Ingram, Heather;Fussell, Steven J.;Walton, Robert;Shanahan, Char', '134430900; Article; Szpera, Robert;Huang, Shanjun;Fenton, Harriet A. M.;Waddington, William;Gymer, Adam E. S.;Moses, Ian B.;Buck, Julia;Ingram, Heather;Fussell, Steven J.;Walton, Robert;Shanahan, Char']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Inert atmosphere', 'Inert atmosphere']",,"['supporting information', 'supporting information']",,"['3-[[3,5-bis(trifluoromethyl)phenyl]amino]-4-[[(1S,2S)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione', '1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea']",,,,"['Solvent|Reagent/catalyst|Time', 'Solvent']","['Experimental part', 'Experimental part']","['86 percent ee', '69 percent ee']",,,,,,
COC(=O)CN=C(c1ccccc1)c1ccccc1,C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)CN=C(c1ccccc1)c1ccccc1.C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1.COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1,COC(=O)CN=C(c1ccccc1)c1ccccc1>>C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)CN=C(c1ccccc1)c1ccccc1.C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1.COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1,67550805,1,56,full reaction,ethyl N-benzhydrylideneglycinate|tert-butyl 3-methylene-2-oxopyrrolidine-1-carboxylate,tert-butyl (S)-3-((S)-2-((diphenylmethylene)amino)-3-methoxy-3-oxopropyl)-2-oxopyrrolidine-1-carboxylate|C26H30N2O5,230844|230844,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,isopropyl alcohol,"134430900; Article; Szpera, Robert;Huang, Shanjun;Fenton, Harriet A. M.;Waddington, William;Gymer, Adam E. S.;Moses, Ian B.;Buck, Julia;Ingram, Heather;Fussell, Steven J.;Walton, Robert;Shanahan, Char",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Glovebox,,supporting information,,"tetrakis(actonitrile)copper(I) hexafluorophosphate|(R)-fesulphos|N-ethyl-N,N-diisopropylamine",,,,Reagent/catalyst|Solvent,Experimental part,97.8 percent ee,,,,,,
COc1ccc(N)cc1,Cc1ccc(C(=O)/C=C/COC2(c3ccccc3)C=CC(=O)C=C2)cc1.[H][C@]12CC(=O)C=C[C@@]1(c1ccccc1)OC[C@@H](CC(=O)c1ccc(C)cc1)N2c1ccc(OC)cc1.[H][C@@]12CC(=O)C=C[C@]1(c1ccccc1)OC[C@H](CC(=O)c1ccc(C)cc1)N2c1ccc(OC)cc1,COc1ccc(N)cc1>>Cc1ccc(C(=O)/C=C/COC2(c3ccccc3)C=CC(=O)C=C2)cc1.[H][C@]12CC(=O)C=C[C@@]1(c1ccccc1)OC[C@@H](CC(=O)c1ccc(C)cc1)N2c1ccc(OC)cc1.[H][C@@]12CC(=O)C=C[C@]1(c1ccccc1)OC[C@H](CC(=O)c1ccc(C)cc1)N2c1ccc(OC)cc1,67874674,1,56,full reaction,"4-methoxy-aniline|(E)-1-((4-oxo-4-(p-tolyl)but-2-en-1-yl)oxy)-[1,1'-biphenyl]-4(1H)-one","(3R,4aS,8aS)-4-(4-methoxyphenyl)-3-(2-oxo-2-(p-tolyl)ethyl)-8a-phenyl-3,4,4a,8a-tetrahydro-2H-benzo[b][1,4]oxazin-6(5H)-one|4-(4-methoxyphenyl)-3-(2-oxo-2-(p-tolyl)ethyl)-8a-phenyl-3,4,4a,8a-tetrahydr",46468|287709,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tert-butyl methyl ether,"134973183; Article; Gorad, Sachin S.;Ghorai, Prasanta; Organic Letters; vol. 26; 26; (2024); p. 5571 - 5576;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,Overall yield = 99 percentSpectr.; stereoselective reaction,C31H29F3N4O3,,,,Solvent|Reagent/catalyst|Temperature,Experimental part,89percent ee,,,,,,
CCCCSC(=O)CC(C)=O,O=[N+]([O-])C=Cc1ccccc1.CCCCSC(=O)[C@H](C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCSC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,CCCCSC(=O)CC(C)=O>>O=[N+]([O-])C=Cc1ccccc1.CCCCSC(=O)[C@H](C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCSC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,68621985,1,56,full reaction|has preparation,S-butyl 3-oxobutanethioate|(2-nitroethenyl)benzene,C16H21NO4S|C16H21NO4S,224811|224811,Preparation,1,,Michael Addition,,,"136739224; Article; Dajek, Maciej;Janicki, Mikołaj J.;Kubiak, Paulina D.;Bąkow",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Overall yield = 68 percent; stereoselective reaction,"3-{[3,5-bis(trifluoromethyl)benzyl]amino}-4-{[(R,R)-2-( piperidine-1-yl)cyclohexyl]amino}cyclobut-3-ene-1,2-dione|sodium chloride",,,,,Scheme or table,54.545 percent de,,,,,,
CCCCSC(=O)CC(C)=O,O=[N+]([O-])C(Br)=Cc1ccccc1.CCCCSC(=O)C(C(C)=O)C(c1ccccc1)C(Br)[N+](=O)[O-].CCCCSC(=O)C1=C(C)O[C@H]([N+](=O)[O-])[C@H]1c1ccccc1,CCCCSC(=O)CC(C)=O>>O=[N+]([O-])C(Br)=Cc1ccccc1.CCCCSC(=O)C(C(C)=O)C(c1ccccc1)C(Br)[N+](=O)[O-].CCCCSC(=O)C1=C(C)O[C@H]([N+](=O)[O-])[C@H]1c1ccccc1,68622008,1,56,full reaction,S-butyl 3-oxobutanethioate|(2-bromo-2-nitroethenyl)benzene,C16H20BrNO4S|C16H19NO4S,221939|157103,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane|water,"136739224; Article; Dajek, Maciej;Janicki, Mikołaj J.;Kubiak, Paulina D.;Bąkow",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,stereoselective reaction,"3-(3,5-bis(trifluoromethyl)anilino)-4-([(1R,2R)-2-(piperidin-1-yl)cyclohexyl]amino)cyclobut-3-ene-1,2-dione|sodium hydrogencarbonate",C16H19NO4S,72 percent,,Reagent/catalyst,Scheme or table,96 percent ee,,,,,,
CN(C)C=CC(=O)c1ccccc1O,CONC(=O)C(Cl)(Cl)Cl.CON1C(=O)c2oc3ccccc3c(=O)c2C1N(C)C,CN(C)C=CC(=O)c1ccccc1O>>CONC(=O)C(Cl)(Cl)Cl.CON1C(=O)c2oc3ccccc3c(=O)c2C1N(C)C,69512077,1,56,full reaction,"1-(2-hydroxyphenyl)-3-dimethylaminoprop-2-enone|2,2,2-trichloro-N-methoxyacetamide","1-(dimethylamino)-2-methoxy-1,2-dihydrochromeno[2,3-c]pyrrole-3,9-dione",160130,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"138071421; Article; Zhang, Wei-Min;Zhao, Qing-Sheng;Chen, Si-Yi;Zhang, Cong-Hai;Yan, Sheng-Jiao; Journal of Organic Chemistry; (2024);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,potassium carbonate,"1-(dimethylamino)-2-methoxy-1,2-dihydrochromeno[2,3-c]pyrrole-3,9-dione",78 percent,,Reagent/catalyst|Temperature|Time,Experimental part,,,,,,,
CN1C(=O)C(n2cccc2)c2ccccc21,CC(C)(C)c1ccccc1N1C(=O)C=CC1=O.[H][C@]1([C@@]2(n3cccc3)C(=O)N(C)c3ccccc32)CC(=O)N(c2ccccc2C(C)(C)C)C1=O.[H][C@@]1([C@]2(n3cccc3)C(=O)N(C)c3ccccc32)CC(=O)N(c2ccccc2C(C)(C)C)C1=O,CN1C(=O)C(n2cccc2)c2ccccc21>>CC(C)(C)c1ccccc1N1C(=O)C=CC1=O.[H][C@]1([C@@]2(n3cccc3)C(=O)N(C)c3ccccc32)CC(=O)N(c2ccccc2C(C)(C)C)C1=O.[H][C@@]1([C@]2(n3cccc3)C(=O)N(C)c3ccccc32)CC(=O)N(c2ccccc2C(C)(C)C)C1=O,69767976,1,56,full reaction,1-methyl-3-(1H-pyrrol-1-yl)indolin-2-one|N-(2-tert-butylphenyl)maleimide,"(R)-1-(2-(tert-butyl)phenyl)-3-((S)-1-methyl-2-oxo-3-(1H-pyrrol-1-yl)indolin-3-yl)pyrrolidine-2,5-dione|(S)-1-(2-(tert-butyl)phenyl)-3-((R)-1-methyl-2-oxo-3-(1H-pyrrol-1-yl)indolin-3-yl)pyrrolidine-2,",222059|222059,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,toluene,"137968684; Article; Biswas, Subhankar;Kundu, Subham;Chandra Pan, Subhas; Chemistry - An Asian Journal; vol. 20; 2; (2025);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,Overall yield = 68 percent; enantioselective reaction,"1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea",,,,Reagent/catalyst|Temperature,Experimental part,84 percent ee,,,,,,
O=C(C=Cc1ccccc1C=CC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1,ONCc1ccccc1.O=C(C[C@H]1ON(Cc2ccccc2)[C@@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1.O=C(C[C@@H]1ON(Cc2ccccc2)[C@@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1.O=C(C[C@@H]1ON(Cc2ccccc2)[C@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1.O=C(C[C@@H]1ON(Cc2ccccc2)[C@@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1,O=C(C=Cc1ccccc1C=CC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1>>ONCc1ccccc1.O=C(C[C@H]1ON(Cc2ccccc2)[C@@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1.O=C(C[C@@H]1ON(Cc2ccccc2)[C@@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1.O=C(C[C@@H]1ON(Cc2ccccc2)[C@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1.O=C(C[C@@H]1ON(Cc2ccccc2)[C@@H](CC(=O)c2ccc(Br)cc2)c2ccccc21)c1ccc(Br)cc1,70804078,1,56,full reaction,C24H16Br2O2|N-Benzylhydroxylamine,"2,2'-(3-benzyl-3,4-dihydro-1H-benzo[d][1,2]oxazine-1,4-diyl)bis(1-(4-bromophenyl)ethan-1-one)|C31H25Br2NO3|2,2'-(3-benzyl-3,4-dihydro-1H-benzo[d][1,2]oxazine-1,4-diyl)bis(1-(4-bromophenyl)ethan-1-one)",205294|205294|205294|205294,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,cyclohexane,"139788235; Article; Kamilya, Chandan;Das, Dipankar;Gorane, Nikhil L.;Ghorai, Prasanta; European Journal of Organic Chemistry; vol. 28; 9; (2025);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,Overall yield = 29 percentSpectr.; stereoselective reaction,C32H28F6N4O3,,,,,Scheme or table,83 percent ee|32 percent ee,,,,,,
CC=C(C(=O)OCC)C(=O)OCC,CCCC[Al](C)Cl.CCOC(=O)C(C(=O)OCC)C(C)C.CCCCC(C)C(C(=O)OCC)C(=O)OCC.CCOC(=O)C(CC)C(=O)OCC,CC=C(C(=O)OCC)C(=O)OCC>>CCCC[Al](C)Cl.CCOC(=O)C(C(=O)OCC)C(C)C.CCCCC(C)C(C(=O)OCC)C(=O)OCC.CCOC(=O)C(CC)C(=O)OCC,8554208,1,55,full reaction,diethyl ethylidenemalonate|n-butyl-methylaluminum chloride,diethyl isopropylmalonate|diethyl (1-methyl-pentyl)malonate|ethyl diethyl malonate,330384|298237,Chemical behaviour,1,-40,Reduction|Michael addition,Product distribution,hexane|toluene,"6235610; Article; Maas, Steffen; Kunz, Horst; Advanced Synthesis and Catalysis; vol. 342; 4; (2000); p. 396 - 403;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,,,,diethyl (1-methyl-pentyl)malonate|diethyl isopropylmalonate|ethyl diethyl malonate,42 percent Chromat.|13 percent Chromat.|45 percent Chromat.,,Further Variations:|Temperatures|Reaction partners,,,,,,,,
[H][C@]12O[C@H](/C=C\C(=O)OCC)[C@H](OCc3ccccc3)[C@@]1([H])OC(C)(C)O2,NCc1ccccc1.[H][C@]1([C@@H](CC(=O)OCC)NCc2ccccc2)O[C@@H]2OC(C)(C)O[C@@H]2[C@H]1OCc1ccccc1.[H][C@]1([C@H](CC(=O)OCC)NCc2ccccc2)O[C@@H]2OC(C)(C)O[C@@H]2[C@H]1OCc1ccccc1,[H][C@]12O[C@H](/C=C\C(=O)OCC)[C@H](OCc3ccccc3)[C@@]1([H])OC(C)(C)O2>>NCc1ccccc1.[H][C@]1([C@@H](CC(=O)OCC)NCc2ccccc2)O[C@@H]2OC(C)(C)O[C@@H]2[C@H]1OCc1ccccc1.[H][C@]1([C@H](CC(=O)OCC)NCc2ccccc2)O[C@@H]2OC(C)(C)O[C@@H]2[C@H]1OCc1ccccc1,8772844,1,55,full reaction,"ethyl (Z)-[3-O-benzyl-5,6-dideoxy-1,2-O-isopropyli","(1R,2R,3S,4R)-ethyl 3-O-benzyl-5,6-dideoxy-5-benzylamino-1,2-O-isopropylidene-α-D-glucoheptofurannur",224464|224464,Chemical behaviour,1,25,Michael addition,Product distribution,tetrahydrofuran,6278218; Article; Patil; Tilekar; Dhavale; Journal of Organic Chemistry; vol. 66; 4; (2001); p. 1065 - 1074;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,,,,,,,Further Variations:|Solvents|Temperatures,,,,,,,,
CC(C)C1C=CC(=O)CC1,Sc1ccccc1.CC(C)[C@H]1CCC(=O)C[C@@H]1Sc1ccccc1.CC(C)[C@@H]1CCC(=O)C[C@@H]1Sc1ccccc1.CC(C)C1=CCC(=O)CC1,CC(C)C1C=CC(=O)CC1>>Sc1ccccc1.CC(C)[C@H]1CCC(=O)C[C@@H]1Sc1ccccc1.CC(C)[C@@H]1CCC(=O)C[C@@H]1Sc1ccccc1.CC(C)C1=CCC(=O)CC1,10218301,1,55,full reaction|has preparation,cryptone|thiophenol,4-isopropyl-3-(phenylsulfanyl)cyclohexanone|4-isopropyl-3-(phenylsulfanyl)cyclohexanone|isopropyl-4 cyclohexene-3 one-1,221610|221610|325475,Preparation,1,,Michael addition,,dichloromethane,"6560084; Article; Isaksson, Dan; Sjoedin, Kristina; Hoegberg, Hans-Erik; Tetrahedron Asymmetry; vol. 17; 2; (2006); p. 275 - 280;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C1CCNC1,N#CC=CCN(Cc1ccccc1)Cc1ccccc1.N#CCC(CN(Cc1ccccc1)Cc1ccccc1)N1CCCC1.c1ccc(CNCc2ccccc2)cc1,C1CCNC1>>N#CC=CCN(Cc1ccccc1)Cc1ccccc1.N#CCC(CN(Cc1ccccc1)Cc1ccccc1)N1CCCC1.c1ccc(CNCc2ccccc2)cc1,11070183,1,55,full reaction|has preparation,"pyrrolidine|4-(N,N-dibenzylamino)-2-butenenitrile","4-(N,N-dibenzylamino)-3-(pyrrolidin-1-yl)butanenitrile|dibenzylamine",224440|288537,Preparation,1,,Michael addition,,,"7037035; Article; D'Hooghe, Matthias; Van Speybroeck, Veronique; Van Nieuwenhove, Andries; Waroquier, Michel; De Kimpe, Norbert; Journal of Organic Chemistry; vol. 72; 13; (2007); p. 4733 - 4740;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,Heating,,,,,,,,,,,,,,,,
C1CCNC1,N#CC=CCN(Cc1ccccc1)Cc1ccc(Br)cc1.N#CCC(CN(Cc1ccccc1)Cc1ccc(Br)cc1)N1CCCC1.Brc1ccc(CNCc2ccccc2)cc1,C1CCNC1>>N#CC=CCN(Cc1ccccc1)Cc1ccc(Br)cc1.N#CCC(CN(Cc1ccccc1)Cc1ccc(Br)cc1)N1CCCC1.Brc1ccc(CNCc2ccccc2)cc1,11070184,1,55,full reaction|has preparation,pyrrolidine|4-[N-benzyl-N-(4-bromobenzyl)amino]-2-butenenitrile,4-[N-benzyl-N-(4-bromobenzyl)amino]-3-(pyrrolidin-1-yl)butanenitrile|N-benzyl-1-(4-bromophenyl)methanamine,224440|288537,Preparation,1,,Michael addition,,,"7037035; Article; D'Hooghe, Matthias; Van Speybroeck, Veronique; Van Nieuwenhove, Andries; Waroquier, Michel; De Kimpe, Norbert; Journal of Organic Chemistry; vol. 72; 13; (2007); p. 4733 - 4740;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,9,Heating,,,,,,,,,,,,,,,,
O=[N+]([O-])/C=C/c1ccc(Cl)cc1,CCOP(=O)(Cc1ccccc1)OCC.CCOP(=O)(OCC)[C@H](c1ccccc1)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1.CCOP(=O)(OCC)[C@@H](c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1.CCOP(=O)(OCC)C(c1ccccc1)C(C[N+](=O)[O-])c1ccc(Cl)cc1,O=[N+]([O-])/C=C/c1ccc(Cl)cc1>>CCOP(=O)(Cc1ccccc1)OCC.CCOP(=O)(OCC)[C@H](c1ccccc1)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1.CCOP(=O)(OCC)[C@@H](c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1.CCOP(=O)(OCC)C(c1ccccc1)C(C[N+](=O)[O-])c1ccc(Cl)cc1,25946109,1,55,full reaction,"1-nitro-2-(4-chlorophenyl)ethylene|O,O-diethyl benzylphosphonate","diethyl (S,S)-2-(4-chlorophenyl)-3-nitro-1-phenylpropylphosphonate|diethyl (R,R)-2-(4-chlorophenyl)-3-nitro-1-phenylpropylphosphonate|diethyl 2-(4-chlorophenyl)-3-nitro-1-phenylpropylphosphonate",222013|222013|222013,Chemical behaviour,1,-78 - 20,Michael addition,Product distribution,tetrahydrofuran|hexane,"7173238; Article; Rai, Vishal; Mobin, Shaikh M.; Namboothiri, Irishi N.N.; Tetrahedron Asymmetry; vol. 18; 22; (2007); p. 2719 - 2726;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,,,L-proline|lithium diisopropyl amide,,,,Further Variations:|Reaction partners|Reagents,,,,,,,,
CCOC(=O)C(CCCC=CC(=O)OC(C)(C)C)C(=O)OCC,CCOC(=O)C1(C(=O)OCC)CCCC1CC(=O)OC(C)(C)C,CCOC(=O)C(CCCC=CC(=O)OC(C)(C)C)C(=O)OCC>>CCOC(=O)C1(C(=O)OCC)CCCC1CC(=O)OC(C)(C)C,28593446,1,55,full reaction|has preparation,C17H28O6,"2-tert-butoxycarbonylmethyl-cyclopentane-1,1-dicarboxylic acid diethyl ester",322063,Preparation,1,,intramolecular Michael addition,,,"8763590; Article; Beltrán-Rodil, Sandra; Donald, James R.; Edwards, Michael G.; Raw, Ste",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C1CCNC1,O=C1C=CCCN1.O=C1CC(N2CCCC2)CCN1,C1CCNC1>>O=C1C=CCCN1.O=C1CC(N2CCCC2)CCN1,29638032,1,55,full reaction,"pyrrolidine|5,6-dihydro-2(1H)-pyridinone",C9H16N2O,,Chemical behaviour,1,24.84,Michael addition,Kinetics,benzene,"8901863; Article; Simon, Luis; Muniz, Francisco M.; De Arriba, Angel Fuentes; Alcazar, Victoria; Raposo, Cesar; Moran, Joaquin R.; Organic and Biomolecular Chemistry; vol. 8; 8; (2010); p. 1763 - 1768",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; scheme or table,,,,,,Reagent/catalyst,,,,,,,,
COC(=O)/C=C/c1ccccc1C[C@@H](C)Nc1ccc(OC)cc1,CC(C)(C)[O-].[K+].COC(=O)C[C@@H]1c2ccccc2C[C@H](C)N1c1ccc(OC)cc1.COC(=O)C[C@H]1c2ccccc2C[C@H](C)N1c1ccc(OC)cc1.COc1ccc(N2C(CC(=O)OC(C)(C)C)c3ccccc3C[C@@H]2C)cc1,COC(=O)/C=C/c1ccccc1C[C@@H](C)Nc1ccc(OC)cc1>>CC(C)(C)[O-].[K+].COC(=O)C[C@@H]1c2ccccc2C[C@H](C)N1c1ccc(OC)cc1.COC(=O)C[C@H]1c2ccccc2C[C@H](C)N1c1ccc(OC)cc1.COc1ccc(N2C(CC(=O)OC(C)(C)C)c3ccccc3C[C@@H]2C)cc1,29757549,1,55,full reaction|has preparation,C20H23NO3|potassium tert-butylate,C20H23NO3|C20H23NO3|C23H29NO3,,Preparation,1,,Aza-Michael reaction,,tetrahydrofuran,"8924917; Article; Enders, Dieter; Liebich, Jens X.; Raabe, Gerhard; Chemistry - A European Journal; vol. 16; 32; (2010); p. 9763 - 9766;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,supporting information; scheme or table,optical yield given as %de|diastereoselective reaction,,,,,,,,2,C20H23NO3|potassium tert-butylate,,,,
CCOC(=O)C(S)CC(=Cc1ccccc1)C(=O)OC,CCOC(=O)C1CC(C(=O)OC)C(c2ccccc2)S1,CCOC(=O)C(S)CC(=Cc1ccccc1)C(=O)OC>>CCOC(=O)C1CC(C(=O)OC)C(c2ccccc2)S1,30027418,1,55,full reaction|has preparation,C15H18O4S,C15H18O4S,322619,Preparation,1,,Michael reaction,,,"8973939; Article; Lee, Hyun Seung; Kim, Se Hee; Kim, Jae Nyoung; Tetrahedron Letters; vol. 50; 47; (2009); p. 6480 - 6483;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
CCCN(CCC)C(=O)Nc1cccc(N(Cc2c(O)cccc2Cl)c2nc(OC)cc(OC)n2)c1.[H+],CCCN(CCC)C(=O)Nc1cccc(Nc2nc(OC)cc(OC)n2)c1.[H+],CCCN(CCC)C(=O)Nc1cccc(N(Cc2c(O)cccc2Cl)c2nc(OC)cc(OC)n2)c1.[H+]>>CCCN(CCC)C(=O)Nc1cccc(Nc2nc(OC)cc(OC)n2)c1.[H+],31081212,1,55,full reaction|has preparation,C26H32ClN5O4*H(1+),C19H27N5O3*H(1+),288418,Preparation,1,,Retro-Michael reaction,,,"9054378; Article; Xu, Chu; Wang, Haoyang; Zhao, Zhixiong; Qinghong, Tang; Guo, Yinlong; Lue, Long; Chinese Journal of Chemistry; vol. 28; 9; (2010); p. 1765 - 1772;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Gas phase,,scheme or table,,,,,,,,,,,,,,
CCCN(CCC)C(=O)Nc1cccc(N(Cc2c([O-])cccc2Cl)c2nc(OC)cc(OC)n2)c1,CCCN(CCC)C(=O)Nc1cccc([N-]c2nc(OC)cc(OC)n2)c1,CCCN(CCC)C(=O)Nc1cccc(N(Cc2c([O-])cccc2Cl)c2nc(OC)cc(OC)n2)c1>>CCCN(CCC)C(=O)Nc1cccc([N-]c2nc(OC)cc(OC)n2)c1,31081214,1,55,full reaction|has preparation,C26H31ClN5O4(1-),C19H26N5O3(1-),288418,Preparation,1,,Retro-Michael reaction,,,"9054378; Article; Xu, Chu; Wang, Haoyang; Zhao, Zhixiong; Qinghong, Tang; Guo, Yinlong; Lue, Long; Chinese Journal of Chemistry; vol. 28; 9; (2010); p. 1765 - 1772;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Gas phase,,scheme or table,,,,,,,,,,,,,,
COc1cc(OC)nc(N(Cc2c([O-])cccc2Cl)c2cccc(N=C=O)c2)n1,COc1cc(OC)nc([N-]c2cccc(N=C=O)c2)n1,COc1cc(OC)nc(N(Cc2c([O-])cccc2Cl)c2cccc(N=C=O)c2)n1>>COc1cc(OC)nc([N-]c2cccc(N=C=O)c2)n1,31081218,1,55,full reaction|has preparation,C20H16ClN4O4(1-),C13H11N4O3(1-),288418,Preparation,1,,Retro-Michael reaction,,,"9054378; Article; Xu, Chu; Wang, Haoyang; Zhao, Zhixiong; Qinghong, Tang; Guo, Yinlong; Lue, Long; Chinese Journal of Chemistry; vol. 28; 9; (2010); p. 1765 - 1772;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Gas phase,,scheme or table,,,,,,,,,,,,,,
COc1cc(OC)nc(N(Cc2c(O)cccc2Cl)c2cccc(N=C=O)c2)n1.[H+],COc1cc(OC)nc(Nc2cccc(N=C=O)c2)n1.[H+],COc1cc(OC)nc(N(Cc2c(O)cccc2Cl)c2cccc(N=C=O)c2)n1.[H+]>>COc1cc(OC)nc(Nc2cccc(N=C=O)c2)n1.[H+],31081226,1,55,full reaction|has preparation,C20H17ClN4O4*H(1+),C13H12N4O3*H(1+),288418,Preparation,1,,Retro-Michael reaction,,,"9054378; Article; Xu, Chu; Wang, Haoyang; Zhao, Zhixiong; Qinghong, Tang; Guo, Yinlong; Lue, Long; Chinese Journal of Chemistry; vol. 28; 9; (2010); p. 1765 - 1772;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Gas phase,,scheme or table,,,,,,,,,,,,,,
O=[N+]([O-])C=Cc1ccccc1[N+](=O)[O-],O=C1CCCCC1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccccc2[N+](=O)[O-])CCCCC1=O.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2[N+](=O)[O-])CCCCC1=O.O=C1CCCCC1C(C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],O=[N+]([O-])C=Cc1ccccc1[N+](=O)[O-]>>O=C1CCCCC1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccccc2[N+](=O)[O-])CCCCC1=O.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2[N+](=O)[O-])CCCCC1=O.O=C1CCCCC1C(C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],34018235,1,55,full reaction,1-nitro-2-(2-nitrovinyl)benzene|cyclohexanone,(S)-2-((R)-1-(2-nitrophenyl)-2-nitroethyl)cyclohexanone|(R)-2-((S)-2-nitro-(2-nitrophenyl)ethyl)cyclohexanone|(RS)-2-((RS)-2-nitro-1-(2-nitrophenyl)ethyl)cyclohexanone,224824|224824|224824,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dimethyl sulfoxide,"20198147; Article; Cao, Xiaohui; Wang, Ge; Wei, Yingying; Chen, Ligong; Journal of Chemical Research; vol. 36; 8; (2012); p. 444 - 446;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,,Overall yield = 81 %; stereoselective reaction,"(S)-2,2,6,6-tetramethyl-N-(pyrrolidin-2-ylmethyl)piperidin-4-amine|trifluoroacetic acid",,,,,Experimental part,89 percent ee,,,,,,
C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1,O=[N+]([O-])/C=C/c1ccccc1.CCC=O.C[C@@H]1[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1.C[C@@H]1[C@@H](c2ccccc2)C=[N+]([O-])O[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1,C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1>>O=[N+]([O-])/C=C/c1ccccc1.CCC=O.C[C@@H]1[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1.C[C@@H]1[C@@H](c2ccccc2)C=[N+]([O-])O[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1,34668338,1,55,full reaction|has preparation,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|nitrostyrene|propionaldehyde,"(2S)-(diphenyl((trimethylsilyl)oxy)methyl)-1-((1'S,2'R,3'S,4'S)-2'-methyl-4'-nitro-3'-phenylcyclobutyl)pyrrolidine|(4S,5R,6R)-6-[(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidin-1-yl]-5-methyl-4",193682|135546,Preparation,1,,Michael Addition,,(2)H8-toluene,"35452456; Article; Sahoo, Gokarneswar; Rahaman, Hasibur; Madarasz, Adam; Papai, Imre; Melarto, Mikko; Valkonen, Arto; Pihko, Petri M.; Angewandte Chemie - International Edition; vol. 51; 52; (2012); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Molecular sieve,,supporting information,,,,,,,Experimental part,,,,,,,
O=C1Oc2ccccc2C1c1ccccc1,CCOC(=O)/C=C/C(=O)c1ccccc1.CCOC(=O)[C@H](CC(=O)c1ccccc1)[C@]1(c2ccccc2)C(=O)Oc2ccccc21.CCOC(=O)C(CC(=O)c1ccccc1)C1(c2ccccc2)C(=O)Oc2ccccc21.CCOC(=O)[C@@H](CC(=O)c1ccccc1)[C@@]1(c2ccccc2)C(=O)Oc2ccccc21,O=C1Oc2ccccc2C1c1ccccc1>>CCOC(=O)/C=C/C(=O)c1ccccc1.CCOC(=O)[C@H](CC(=O)c1ccccc1)[C@]1(c2ccccc2)C(=O)Oc2ccccc21.CCOC(=O)C(CC(=O)c1ccccc1)C1(c2ccccc2)C(=O)Oc2ccccc21.CCOC(=O)[C@@H](CC(=O)c1ccccc1)[C@@]1(c2ccccc2)C(=O)Oc2ccccc21,37907248,1,55,full reaction,3-phenyl-3H-benzofuran-2-one|ethyl (E)-4-oxo-4-phenyl-2-butenoate,C26H22O5|C26H22O5|C26H22O5,222059|222059|222059,Chemical behaviour,1,23 - 25|10,Michael Addition|Michael Addition,Catalytic behavior,ethanol|ethanol,"63315543; Article; Wang, Zhen; Yao, Qian; Kang, Tengfei; Feng, Juhua; Liu, Xiaohua; Lin, Lili; Feng, Xiaoming; Chemical Communications; vol. 50; 38; (2014); p. 4918 - 4920;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333|3,Molecular sieve|Sealed tube|Molecular sieve|Sealed tube,,,Overall yield = 94 %; stereoselective reaction,C35H52N4O4|scandium tris(trifluoromethanesulfonate),,,,Reagent/catalyst,Experimental part,87 percent ee,2,3-phenyl-3H-benzofuran-2-one|ethyl (E)-4-oxo-4-phenyl-2-butenoate,,,,
C1CNCCN1,O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1F.O=C(C=Cc1ccccc1)c1c(F)c(F)c(N2CCNCC2)c(F)c1F.O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1N1CCNCC1.O=C(C=Cc1ccccc1)c1c(F)c(F)c(N2CCNCC2)c(F)c1N1CCNCC1,C1CNCCN1>>O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1F.O=C(C=Cc1ccccc1)c1c(F)c(F)c(N2CCNCC2)c(F)c1F.O=C(C=Cc1ccccc1)c1c(F)c(F)c(F)c(F)c1N1CCNCC1.O=C(C=Cc1ccccc1)c1c(F)c(F)c(N2CCNCC2)c(F)c1N1CCNCC1,38683008,1,55,full reaction|has preparation,"piperazine|1-(2,3,4,5,6-pentafluorophenyl)-3-phenyl-2-propen-1-one",C19H16F4N2O|C19H16F4N2O|C23H25F3N4O,277932|277923|104268,Preparation,1,,Michael Addition,,ethanol,"64133980; Article; Borodina; Orlova; Shelkovnikov; Russian Chemical Bulletin; vol. 62; 10; (2013); p. 2227 - 2233; Izv. Akad. Nauk, Ser. Khim.; 10; (2013); p. 2226 - 2233,8;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,Reflux,,,,,,,,,Experimental part,,,,,,,
O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12,C=C(CC)c1ccccc1O.O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(CC)c1ccccc1O.O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(CC)c1ccccc1O.C/C=C(/C[C@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O.C/C=C(\CC1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O.C/C=C(/C[C@@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O,O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12>>C=C(CC)c1ccccc1O.O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(CC)c1ccccc1O.O=C1N(Cc2ccccc2)c2ccccc2C1(O)c1c[nH]c2ccccc12.C=C(CC)c1ccccc1O.C/C=C(/C[C@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O.C/C=C(\CC1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O.C/C=C(/C[C@@]1(c2c[nH]c3ccccc23)C(=O)N(Cc2ccccc2)c2ccccc21)c1ccccc1O,38909715,1,55,full reaction,"1′-benzyl-3′-hydroxy-1′,3′-dihydro-1H,2′H-3,3′-biindol-2′-one|α-ethyl o-hydroxystyrene","(S,Z)-1-benzyl-3-(2-(2-hydroxyphenyl)but-2-en-1-yl)-3-(1H-indol-3-yl)indolin-2-one|(E)-1-benzyl-3-(2-(2-hydroxyphenyl)but-2-en-1-yl)-3-(1H-indol-3-yl)indolin-2-one|(R,Z)-1-benzyl-3-(2-(2-hydroxyphenyl",211101|211101|211101,Chemical behaviour,1,35,Michael Addition,Catalytic behavior,ethyl acetate,"64339145; Article; Liu, Yan; Zhang, Hong-Hao; Zhang, Yu-Chen; Jiang, Yan; Shi, Feng; Tu, Shu-Jiang; Chemical Communications; vol. 50; 81; (2014); p. 12054 - 12057;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,supporting information,Overall yield = 67 %; stereoselective reaction,"(R)-(3,3'-bis(1-naphthyl)-1,1'-binaphthanele-2,2'-yl)phosphoric acid",,,,Solvent|Temperature|Concentration,Experimental part,87 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCCC=O.CCC(C=O)C(C[N+](=O)[O-])c1ccccc1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCCC=O.CCC(C=O)C(C[N+](=O)[O-])c1ccccc1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,39185098,1,55,full reaction,(2-nitroethenyl)benzene|butyraldehyde,"2-ethyl-4-nitro-3-phenylbutanal|(2S,3R)-2-ethyl-4-nitro-3-phenylbutanal|(2R,3S)-2-ethyl-4-nitro-3-phenylbutyraldehyde",224825|224825|224825,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,ethanol,"64619620; Article; Scatena, Gabriel S.; De La Torre, Alexander F.; Cass, Quezia B.; Rivera, Daniel G.; Paixo, Mrcio W.; ChemCatChem; vol. 6; 11; (2014); p. 3208 - 3214;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,,silica supported N-cyclohexyl-2-methyl-2-[N-propyl-1-(2S)-pyrrolidin-2-ylformamido]propanamide (SiO2-4b),,,,Reagent/catalyst|Solvent,Experimental part,89 percent ee,,,,,,
CC(C)(C)OC(=O)N1C(=O)C(c2ccccc2)c2ccccc21,O=C/C=C/c1ccccc1.CCOC(=O)/C=C/C=C/[N+](=O)[O-].[H][C@@]1([C@@]2(c3ccccc3)C(=O)N(C(=O)OC(C)(C)C)c3ccccc32)[C@@H](CC(=O)OCC)[C@H](C=O)[C@@H](c2ccccc2)[C@H]1[N+](=O)[O-].CCOC(=O)CC1C(C=O)C(c2ccccc2)C([N+](=O)[O-])C1C1(c2ccccc2)C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,CC(C)(C)OC(=O)N1C(=O)C(c2ccccc2)c2ccccc21>>O=C/C=C/c1ccccc1.CCOC(=O)/C=C/C=C/[N+](=O)[O-].[H][C@@]1([C@@]2(c3ccccc3)C(=O)N(C(=O)OC(C)(C)C)c3ccccc32)[C@@H](CC(=O)OCC)[C@H](C=O)[C@@H](c2ccccc2)[C@H]1[N+](=O)[O-].CCOC(=O)CC1C(C=O)C(c2ccccc2)C([N+](=O)[O-])C1C1(c2ccccc2)C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,39299293,1,55,full reaction,"tert-butyl 2-oxo-3-phenylindoline-1-carboxylate|(E)-3-phenylpropenal|(E,E)-5-nitro-2,4-pentadienoicacid ethyl ester",C35H36N2O8|C35H36N2O8,208241|221334,Chemical behaviour,1,20,Michael Addition,Mechanism,chloroform,"64671774; Article; Zou, Liang-Hua; Philipps, Arne R.; Raabe, Gerhard; Enders, Dieter; Chemistry - A European Journal; vol. 21; 3; (2015); p. 1004 - 1008;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,22,Inert atmosphere,,supporting information,stereoselective reaction,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine,,,,Reagent/catalyst|Solvent|Temperature,Experimental part,99 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCOC(=O)C(F)C(=O)c1ccccc1.CCOC(=O)[C@](F)(C(=O)c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)[C@@](F)(C(=O)c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)C(F)(C(=O)c1ccccc1)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCOC(=O)C(F)C(=O)c1ccccc1.CCOC(=O)[C@](F)(C(=O)c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)[C@@](F)(C(=O)c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.CCOC(=O)C(F)(C(=O)c1ccccc1)C(C[N+](=O)[O-])c1ccccc1,40992231,1,55,full reaction,(2-nitroethenyl)benzene|ethyl 2-fluoro-3-oxo-3-phenylpropionate,"(2R,3R)-ethyl 2-benzoyl-2-fluoro-4-nitro-3-phenylbutanoate|C19H18FNO5|ethyl 2-benzoyl-2-fluoro-4-nitro-3-phenylbutanoate",221997|221997|221997,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,methanol,"66825514; Article; Kwon, Su Jin; Suh, Chang Won; Kim, Sun Mi; Kim, Dae Young; Bulletin of the Korean Chemical Society; vol. 36; 8; (2015); p. 1947 - 1948;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,,Overall yield = 75 %; enantioselective reaction,C40H48Br2F4N4Ni,,,,Reagent/catalyst|Solvent,Scheme or table,28.571 percent de,,,,,,
CCC1OC(c2ccccc2)=NC1=O,Cn1ccnc1C(=O)C=Cc1ccccc1.CC[C@]1([C@@H](CC(=O)c2nccn2C)c2ccccc2)OC(c2ccccc2)=NC1=O.CCC1(C(CC(=O)c2nccn2C)c2ccccc2)OC(c2ccccc2)=NC1=O.CC[C@@]1([C@H](CC(=O)c2nccn2C)c2ccccc2)OC(c2ccccc2)=NC1=O,CCC1OC(c2ccccc2)=NC1=O>>Cn1ccnc1C(=O)C=Cc1ccccc1.CC[C@]1([C@@H](CC(=O)c2nccn2C)c2ccccc2)OC(c2ccccc2)=NC1=O.CCC1(C(CC(=O)c2nccn2C)c2ccccc2)OC(c2ccccc2)=NC1=O.CC[C@@]1([C@H](CC(=O)c2nccn2C)c2ccccc2)OC(c2ccccc2)=NC1=O,41762767,1,55,full reaction,5-ethyl-2-phenyloxazol-4(5H)-one|2-cinnamoyl-1-methyl-1H-imidazole,C24H23N3O3|C24H23N3O3|C24H23N3O3,224862|224862|224862,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tetrahydrofuran,"68016079; Article; Zhang, Bangzhi; Han, Fengxia; Wang, Linqing; Li, Dan; Yang, Dongxu; Yang, Xiaoli; Yang, Junxian; Li, Xiaofang; Zhao, Depeng; Wang, Rui; Chemistry - A European Journal; vol. 21; 48;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,Inert atmosphere|Molecular sieve,,supporting information,Overall yield = 80 %; stereoselective reaction,C51H46N2O3S4|diethylzinc,,,,Solvent|Reagent/catalyst,Scheme or table,89 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CCOP(=O)(OCC)C(F)C(=O)c1ccccc1.CCOP(=O)(OCC)[C@](F)(C(=O)c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CCOP(=O)(OCC)[C@@](F)(C(=O)c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.CCOP(=O)(OCC)C(F)(C(=O)c1ccccc1)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCOP(=O)(OCC)C(F)C(=O)c1ccccc1.CCOP(=O)(OCC)[C@](F)(C(=O)c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CCOP(=O)(OCC)[C@@](F)(C(=O)c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.CCOP(=O)(OCC)C(F)(C(=O)c1ccccc1)C(C[N+](=O)[O-])c1ccccc1,41870107,1,55,full reaction,(2-nitroethenyl)benzene|diethyl (1-fluoro-2-oxo-2-phenylethyl)phosphonate,"diethyl ((2S,3R)-2-fluoro-4-nitro-1-oxo-1,3-diphenylbutan-2-yl)phosphonate|diethyl ((2R,3S)-2-fluoro-4-nitro-1-oxo-1,3-diphenylbutan-2-yl)phosphonate|C20H23FNO6P",220273|220273|220273,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"68001154; Article; Jeong, Hyun Jung; Kim, Dae Young; Bulletin of the Korean Chemical Society; vol. 36; 12; (2015); p. 2936 - 2939;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,,Overall yield = 85 %; stereoselective reaction,C40H31F6N3O2,,,,Reagent/catalyst|Solvent,Scheme or table,86 percent ee,,,,,,
O=CC1=CCCC1,CC(C)(C)OC(=O)CN=C(c1ccccc1)c1ccccc1.[H][C@]1([C@H](N=C(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)CCC[C@H]1C=O.[H][C@]1([C@H](N=C(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)CCC[C@@H]1C=O.[H][C@@]1([C@@H](N=C(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)CCC[C@@H]1C=O,O=CC1=CCCC1>>CC(C)(C)OC(=O)CN=C(c1ccccc1)c1ccccc1.[H][C@]1([C@H](N=C(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)CCC[C@H]1C=O.[H][C@]1([C@H](N=C(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)CCC[C@@H]1C=O.[H][C@@]1([C@@H](N=C(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)CCC[C@@H]1C=O,41979146,1,55,full reaction,1-cyclopentene-1-carboxaldehyde|N-(diphenylmethylene)glycine tert-butyl ester,"tert-butyl (S)-2-((diphenylmethylene)amino)-2-((1S,2R)-2-formylcyclopentyl)acetate|tert-butyl (S)-2-((diphenylmethylene)amino)-2-((1S,2S)-2-formylcyclopentyl)acetate|tert-butyl (R)-2-((diphenylmethyle",220292|220292|220292,Chemical behaviour,1,-20 - 20,Michael Addition,Catalytic behavior,dichloromethane|water,"68023583; Article; Bernardi, Luca; Fochi, Mariafrancesca; Carbone, Riccardo; Martinelli, Ada; Fox, Martin E.; Cobley, Christopher J.; Kandagatla, Bhaskar; Oruganti, Srinivas; Dahanukar, Vilas H.; Carl",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,stereoselective reaction,C36H35N2O(1+)*Br(1-)|potassium hydroxide,,,,Reagent/catalyst|Solvent,Experimental part,82 percent ee,,,,,,
O=[N+]([O-])/C(C#Cc1ccccc1)=C/c1ccccc1,CC1=NN(c2ccccc2)C(=O)C1.Cc1nn(-c2ccccc2)c2c1[C@@H](c1ccccc1)[C@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2.Cc1nn(-c2ccccc2)c2c1[C@H](c1ccccc1)[C@@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2.Cc1nn(-c2ccccc2)c2c1C(c1ccccc1)C([N+](=O)[O-])/C(=C\c1ccccc1)O2,O=[N+]([O-])/C(C#Cc1ccccc1)=C/c1ccccc1>>CC1=NN(c2ccccc2)C(=O)C1.Cc1nn(-c2ccccc2)c2c1[C@@H](c1ccccc1)[C@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2.Cc1nn(-c2ccccc2)c2c1[C@H](c1ccccc1)[C@@H]([N+](=O)[O-])/C(=C/c1ccccc1)O2.Cc1nn(-c2ccccc2)c2c1C(c1ccccc1)C([N+](=O)[O-])/C(=C\c1ccccc1)O2,45425680,1,55,full reaction,"(E)-(2-nitrobut-1-en-3-yne-1,4-diyl)dibenzene|edaravone","(4R,5S)-6-((Z)-benzylidene)-3-methyl-5-nitro-1,4-diphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole|(4S,5R)-6-((Z)-benzylidene)-3-methyl-5-nitro-1,4-diphenyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole|6-((",113321|113321|113321,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"71156224; Article; Rana, Nirmal K.; Jha, Rupesh K.; Joshi, Harshit; Singh, Vinod K.; Tetrahedron Letters; vol. 58; 22; (2017); p. 2135 - 2139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,40,,,supporting information,enantioselective reaction,C31H26F6N4O2,,,,Reagent/catalyst|Temperature,Scheme or table,,,,,,,
CC(=O)C/C=C/c1ccccc1,O=[N+]([O-])C=Cc1ccccc1.CC(=O)[C@H](/C=C/c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(=O)[C@@H](/C=C/c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(=O)[C@@H](/C=C/c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1,CC(=O)C/C=C/c1ccccc1>>O=[N+]([O-])C=Cc1ccccc1.CC(=O)[C@H](/C=C/c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(=O)[C@@H](/C=C/c1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.CC(=O)[C@@H](/C=C/c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1,45804675,1,55,full reaction,(E)-5-phenylpent-4-en-2-one|(2-nitroethenyl)benzene,"(E)-3-(2-nitro-1-phenylethyl)-5-phenylpent-4-en-2-one|(E)-3-(2-nitro-1-phenylethyl)-5-phenylpent-4-en-2-one|(S,E)-3-((S)-2-nitro-1-phenylethyl)-5-phenylpent-4-en-2-one",224822|224822|224822,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"71608146; Article; Iriarte, Igor; Olaizola, Olatz; Vera, Silvia; Gamboa, Iñaki; Oiarbide, Mikel; Pal",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,supporting information,stereoselective reaction,C29H28F6N4OS,,,,Temperature,Experimental part,41.176 percent de,,,,,,
CC1(Br)C(=O)Nc2ccccc21,CC(=C=N[Si](C(C)C)(C(C)C)C(C)C)c1ccccc1.C[C@](C#N)(c1ccccc1)[C@@]1(C)C(=O)Nc2ccccc21.CC(C#N)(c1ccccc1)C1(C)C(=O)Nc2ccccc21.C[C@@](C#N)(c1ccccc1)[C@]1(C)C(=O)Nc2ccccc21,CC1(Br)C(=O)Nc2ccccc21>>CC(=C=N[Si](C(C)C)(C(C)C)C(C)C)c1ccccc1.C[C@](C#N)(c1ccccc1)[C@@]1(C)C(=O)Nc2ccccc21.CC(C#N)(c1ccccc1)C1(C)C(=O)Nc2ccccc21.C[C@@](C#N)(c1ccccc1)[C@]1(C)C(=O)Nc2ccccc21,46381819,1,55,full reaction,"3-bromo-3-methyl-2-indolinone|N-[2-(2-methylphenyl)-1-propenylidene]-1,1,1-tris(1-methylethyl)silanamine",(S)-2-((S)-3-methyl-2-oxoindolin-3-yl)-2-phenylpropanenitrile|2-(3-methyl-2-oxoindolin-3-yl)-2-phenylpropanenitrile|2-(3-methyl-2-oxoindolin-3-yl)-2-phenylpropanenitrile,74514|74514|74514,Chemical behaviour,1,-20 - 35|-10,Michael Addition|Michael Addition,Catalytic behavior,ethyl acetate|ethyl acetate,"72050171; Article; Zheng, Jianfeng; Lin, Lili; Dai, Li; Tang, Qiong; Liu, Xiaohua; Feng, Xiaoming; Angewandte Chemie - International Edition; vol. 56; 42; (2017); p. 13107 - 13111; Angew. Chem.; vol.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|12,Inert atmosphere|Inert atmosphere,,supporting information,Overall yield = 58 %; stereoselective reaction,"nickel(II) tetrafluoroborate hexahydrate|C34H50N4O4|N-ethyl-N,N-diisopropylamine",,,,Reagent/catalyst|Solvent,Experimental part,95 percent ee,2,"3-bromo-3-methyl-2-indolinone|N-[2-(2-methylphenyl)-1-propenylidene]-1,1,1-tris(1-methylethyl)silanamine",,,,
Cc1ccc(S(=O)(=O)NCCC2C(=O)Nc3ccccc32)cc1,C#CC(C)=O.CC(=O)CC1N(S(=O)(=O)c2ccc(C)cc2)CCC12C(=O)Nc1ccccc12.CC(=O)C[C@H]1N(S(=O)(=O)c2ccc(C)cc2)CC[C@@]12C(=O)Nc1ccccc12.CC(=O)C[C@@H]1N(S(=O)(=O)c2ccc(C)cc2)CC[C@]12C(=O)Nc1ccccc12,Cc1ccc(S(=O)(=O)NCCC2C(=O)Nc3ccccc32)cc1>>C#CC(C)=O.CC(=O)CC1N(S(=O)(=O)c2ccc(C)cc2)CCC12C(=O)Nc1ccccc12.CC(=O)C[C@H]1N(S(=O)(=O)c2ccc(C)cc2)CC[C@@]12C(=O)Nc1ccccc12.CC(=O)C[C@@H]1N(S(=O)(=O)c2ccc(C)cc2)CC[C@]12C(=O)Nc1ccccc12,47668728,1,55,full reaction,4-methyl-N-(2-(2-oxoindolin-3-yl)ethyl)benzenesulfonamide|methyl ethynyl ketone,C21H22N2O4S|C21H22N2O4S|C21H22N2O4S,178896|178896|178896,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,"1,2-dichloro-ethane","73262825; Article; He, Weigang; Hu, Jiadong; Wang, Pengyan; Chen, Le; Ji, Kai; Yang, Siyu; Li, Yin; Xie, Zhilong; Xie, Weiqing; Angewandte Chemie - International Edition; vol. 57; 14; (2018); p. 3806",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Molecular sieve,,supporting information,Overall yield = 95 %; stereoselective reaction,potassium phosphate|C33H48N4O4|scandium tris(trifluoromethanesulfonate),,,,Reagent/catalyst|Solvent,Experimental part,87 percent ee,,,,,,
CCOC(=O)C(C)C#N,COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1,CCOC(=O)C(C)C#N>>COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1,47890200,1,55,full reaction,ethyl 2-cyanopropionate|4-(4-methoxyphenyl)-3-buten-2-one,ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate,228992|228992|228992,Chemical behaviour,1,4,Michael Addition,Catalytic behavior,aq. phosphate buffer|acetonitrile,"73521241; Article; Garrabou, Xavier; Macdonald, Duncan Stuart; Wicky, Basile I. M.; Hilvert, Donald; Angewandte Chemie - International Edition; vol. 57; 19; (2018); p. 5288 - 5291; Angew. Chem.; vol.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Enzymatic reaction,7.5,supporting information,stereoselective reaction,retro-aldolase I133G·V134P RA95.5-8 mutant|sodium chloride,,,,Temperature|Reagent/catalyst,Experimental part,,,,,,,
CCOC(=O)C(C)C#N,COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1,CCOC(=O)C(C)C#N>>COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1,47890202,1,55,full reaction,ethyl 2-cyanopropionate|4-(4-methoxyphenyl)-3-buten-2-one,ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate,228992|228992|228992,Chemical behaviour,1,29,Michael Addition,Kinetics|Catalytic behavior,aq. phosphate buffer|acetonitrile,"73521241; Article; Garrabou, Xavier; Macdonald, Duncan Stuart; Wicky, Basile I. M.; Hilvert, Donald; Angewandte Chemie - International Edition; vol. 57; 19; (2018); p. 5288 - 5291; Angew. Chem.; vol.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Enzymatic reaction,7.5,supporting information,stereoselective reaction,retro-aldolase 95.5-8|sodium chloride,,,,Temperature|Reagent/catalyst,Experimental part,,,,,,,
CCOC(=O)C(C)C#N,COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1,CCOC(=O)C(C)C#N>>COc1ccc(/C=C/C(C)=O)cc1.CCOC(=O)[C@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@@](C)(C#N)[C@@H](CC(C)=O)c1ccc(OC)cc1.CCOC(=O)[C@](C)(C#N)[C@H](CC(C)=O)c1ccc(OC)cc1,47890205,1,55,full reaction,ethyl 2-cyanopropionate|4-(4-methoxyphenyl)-3-buten-2-one,ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate|ethyl 2-cyano-3-(4-methoxyphenyl)-2-methyl-5-oxohexanoate,228992|228992|228992,Chemical behaviour,1,4,Michael Addition,Catalytic behavior,aq. phosphate buffer|acetonitrile,"73521241; Article; Garrabou, Xavier; Macdonald, Duncan Stuart; Wicky, Basile I. M.; Hilvert, Donald; Angewandte Chemie - International Edition; vol. 57; 19; (2018); p. 5288 - 5291; Angew. Chem.; vol.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Enzymatic reaction,7.5,supporting information,stereoselective reaction,retro-aldolase T53S·I133G·V134P·N135L·F180WF184L·K210L·S233E RA95.5-8 mutant|sodium chloride,,,,Temperature,Experimental part,,,,,,,
C[N+](=O)[O-],O=CC=Cc1ccccc1.O=CC[C@H](C[N+](=O)[O-])c1ccccc1.O=CC[C@@H](C[N+](=O)[O-])c1ccccc1.O=C(O)/C=C/c1ccccc1,C[N+](=O)[O-]>>O=CC=Cc1ccccc1.O=CC[C@H](C[N+](=O)[O-])c1ccccc1.O=CC[C@@H](C[N+](=O)[O-])c1ccccc1.O=C(O)/C=C/c1ccccc1,49744124,1,55,full reaction,nitromethane|3-phenyl-propenal,(S)-4-nitro-3-phenylbutanal|(3R)-4-nitro-3-phenylbutanal|(E)-3-phenylacrylic acid,225140|269713|307463,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,aq. phosphate buffer|water|ethyl acetate,"74743940; Article; Nödling, Alexander R.; Świderek, Katarzyna; Castillo, Raquel; Hall, Jonathan W.;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,7,supporting information,enantioselective reaction,"Streptavidin Streptomyces Avidinii Recombinant|(R)-3-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)pyrrolidin-1-ium formate",,,,Reagent/catalyst|Solvent|Temperature,Experimental part,84 percent ee,,,,,,
COC(=O)CC(=O)C=Cc1ccccc1,O=[N+]([O-])C=Cc1ccccc1.COC(=O)C(C(=O)C=Cc1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(C(=O)C=Cc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(C(=O)C=Cc1ccccc1)C(C[N+](=O)[O-])c1ccccc1,COC(=O)CC(=O)C=Cc1ccccc1>>O=[N+]([O-])C=Cc1ccccc1.COC(=O)C(C(=O)C=Cc1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(C(=O)C=Cc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1.COC(=O)C(C(=O)C=Cc1ccccc1)C(C[N+](=O)[O-])c1ccccc1,51960203,1,55,full reaction,C12H12O3|(2-nitroethenyl)benzene,C20H19NO5|C20H19NO5|C20H19NO5,224813|224813|224813,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,dichloromethane,"77259013; Article; Arai, Takayoshi; Iimori, Yuko; Shirasugi, Mayu; Shinohara, Ryota; Takagi, Yuri; Suzuki, Takumi; Ma, Junma; Kuwano, Satoru; Masu, Hyuma; Advanced Synthesis and Catalysis; vol. 361; 1",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,15,,,supporting information,Overall yield = 64 percent; stereoselective reaction,"cobalt(II) chloride hexahydrate|2,6-bis((2R,4S,5S)-1-benzyl-4,5-diphenylimidazolidin-2-yl)pyridine|triethylamine",,,,Reagent/catalyst|Solvent|Temperature|Time,Experimental part,81 percent ee,,,,,,
O=C(C=CC(F)(F)F)Oc1ccc([N+](=O)[O-])cc1,NCc1ccccc1.CC1=NN(c2ccccc2)C(=O)C1C.CC1=NN(c2ccccc2)C(=O)[C@@]1(C)[C@H](CC(=O)NCc1ccccc1)C(F)(F)F.CC1=NN(c2ccccc2)C(=O)[C@]1(C)[C@H](CC(=O)NCc1ccccc1)C(F)(F)F,O=C(C=CC(F)(F)F)Oc1ccc([N+](=O)[O-])cc1>>NCc1ccccc1.CC1=NN(c2ccccc2)C(=O)C1C.CC1=NN(c2ccccc2)C(=O)[C@@]1(C)[C@H](CC(=O)NCc1ccccc1)C(F)(F)F.CC1=NN(c2ccccc2)C(=O)[C@]1(C)[C@H](CC(=O)NCc1ccccc1)C(F)(F)F,52976237,1,55,full reaction,"4-nitrophenyl-4,4,4-trifluorobut-2-enoate|benzylamine|3,4-dimethyl-1-phenyl-pyrazolin-5-one",C22H22F3N3O2|C22H22F3N3O2,91318|91318,Chemical behaviour,1,0|20,Michael Addition|Michael Addition,Catalytic behavior,tetrahydrofuran|tetrahydrofuran,"78679444; Article; Shu, Chang; Liu, Honglei; Slawin, Alexandra M. Z.; Carpenter-Warren, Cameron; Smith, Andrew D.; Chemical Science; vol. 11; 1; (2020); p. 241 - 247;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,,Overall yield = 87 percent; enantioselective reaction,"(2S,3R)-HyperBTM",,,,Reagent/catalyst|Temperature,Scheme or table,91.837 percent ee|92 percent ee,2,"4-nitrophenyl-4,4,4-trifluorobut-2-enoate|3,4-dimethyl-1-phenyl-pyrazolin-5-one|benzylamine",,,,
O=[N+]([O-])c1cc2ccccc2o1,CN1C(=O)C(n2cccc2)c2ccccc21.CN1C(=O)C(C2c3ccccc3OC2[N+](=O)[O-])(n2cccc2)c2ccccc21.[H][C@@]1([C@]2(n3cccc3)C(=O)N(C)c3ccccc32)c2ccccc2O[C@H]1[N+](=O)[O-].[H][C@]1([C@@]2(n3cccc3)C(=O)N(C)c3ccccc32)c2ccccc2O[C@@H]1[N+](=O)[O-],O=[N+]([O-])c1cc2ccccc2o1>>CN1C(=O)C(n2cccc2)c2ccccc21.CN1C(=O)C(C2c3ccccc3OC2[N+](=O)[O-])(n2cccc2)c2ccccc21.[H][C@@]1([C@]2(n3cccc3)C(=O)N(C)c3ccccc32)c2ccccc2O[C@H]1[N+](=O)[O-].[H][C@]1([C@@]2(n3cccc3)C(=O)N(C)c3ccccc32)c2ccccc2O[C@@H]1[N+](=O)[O-],53557388,1,55,full reaction,2-nitro-benzofuran|1-methyl-3-(1H-pyrrol-1-yl)indolin-2-one,"1-methyl-3-(2-nitro-2,3-dihydrobenzofuran-3-yl)-3-(1H-pyrrol-1-yl)indolin-2-one|1-methyl-3-(2-nitro-2,3-dihydrobenzofuran-3-yl)-3-(1H-pyrrol-1-yl)indolin-2-one|(S)-1-methyl-3-((2S,3R)-2-nitro-2,3-dihy",220240|220240|220240,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,"5,5-dimethyl-1,3-cyclohexadiene","79227801; Article; Ge, Zhen-Zhen;Yang, Lei;You, Yong;Wang, Zhen-Hua;Xie, Ke-Xin;Zhou, Ming-Qiang;Zhao, Jian-Qiang;Yuan, Wei-Cheng; Chemical Communications; vol. 56; 17; (2020); p. 2586 - 2589;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,,Overall yield = 98 percent; stereoselective reaction,C37H35F6N5OS,,,,Solvent,Scheme or table,89 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccc(Cl)cc1,[N-]=[N+]=NC1Cc2ccccc2C1=O.[N-]=[N+]=N[C@@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=N[C@]1([C@@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=NC1(C(C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O,O=[N+]([O-])C=Cc1ccc(Cl)cc1>>[N-]=[N+]=NC1Cc2ccccc2C1=O.[N-]=[N+]=N[C@@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=N[C@]1([C@@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=NC1(C(C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O,53857818,1,55,full reaction,"1-chloro-4-(2-nitrovinyl)benzene|2-azido-2,3-dihydro-1H-inden-1-one",C17H13ClN4O3|C17H13ClN4O3|C17H13ClN4O3,221952|221952|221952,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"79606575; Article; Ding, Pei-Gang;Zhou, Feng;Wang, Xin;Zhao, Qiu-Hua;Yu, Jin-Sheng;Zhou, Jian; Chemical Science; vol. 11; 15; (2020); p. 3852 - 3861;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,,Overall yield = 80 percent; stereoselective reaction,C20H35N2O3P,,,,Temperature|Reagent/catalyst,Scheme or table,88 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccc(Cl)cc1,[N-]=[N+]=NC1Cc2ccccc2C1=O.[N-]=[N+]=N[C@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=N[C@@]1([C@@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=NC1(C(C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O,O=[N+]([O-])C=Cc1ccc(Cl)cc1>>[N-]=[N+]=NC1Cc2ccccc2C1=O.[N-]=[N+]=N[C@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=N[C@@]1([C@@H](C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O.[N-]=[N+]=NC1(C(C[N+](=O)[O-])c2ccc(Cl)cc2)Cc2ccccc2C1=O,53857822,1,55,full reaction,"1-chloro-4-(2-nitrovinyl)benzene|2-azido-2,3-dihydro-1H-inden-1-one",C17H13ClN4O3|C17H13ClN4O3|C17H13ClN4O3,221952|221952|221952,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"79606575; Article; Ding, Pei-Gang;Zhou, Feng;Wang, Xin;Zhao, Qiu-Hua;Yu, Jin-Sheng;Zhou, Jian; Chemical Science; vol. 11; 15; (2020); p. 3852 - 3861;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,,Overall yield = 80 percent; stereoselective reaction,"3-((S)-3-phenyl-1-(piperidin-1-yl)propan-2-ylamino)-4-(3,5-bis(trifluoromethyl)phenylamino)cyclobut-3-ene-1,2-dione",,,,Reagent/catalyst,Scheme or table,56 percent ee,,,,,,
O=C/C=C/c1ccccc1,O=C1C=CCCC1.[H][C@]12CC[C@]([H])(C(=O)C1)[C@H](c1ccccc1)[C@H]2C=O.[H][C@@]12CC[C@@]([H])(C(=O)C1)[C@@H](c1ccccc1)[C@@H]2C=O.O=CC1C2CCC(C(=O)C2)C1c1ccccc1,O=C/C=C/c1ccccc1>>O=C1C=CCCC1.[H][C@]12CC[C@]([H])(C(=O)C1)[C@H](c1ccccc1)[C@H]2C=O.[H][C@@]12CC[C@@]([H])(C(=O)C1)[C@@H](c1ccccc1)[C@@H]2C=O.O=CC1C2CCC(C(=O)C2)C1c1ccccc1,55161582,1,55,full reaction,(E)-3-phenylpropenal|cyclohexenone,C15H16O2|C15H16O2|C15H16O2,210017|210017|210017,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,isopropyl alcohol,"80418591; Article; Umekubo, Nariyoshi;Hayashi, Yujiro; European Journal of Organic Chemistry; vol. 2020; 34; (2020); p. 5596 - 5600;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,stereoselective reaction,"4-nitro-phenol|(-)-(S)-α,α-diphenylpyrrolidine-2-methan",,,,Reagent/catalyst|Solvent,Experimental part,,,,,,,
O=C1CCCCC1,O=CC=Cc1ccccc1.CCOC(=O)C=P(c1ccccc1)(c1ccccc1)c1ccccc1.[H][C@@]1([C@@H](CC=CC(=O)OCC)c2ccccc2)CCCCC1=O.CCOC(=O)C=CCC(c1ccccc1)C1CCCCC1=O,O=C1CCCCC1>>O=CC=Cc1ccccc1.CCOC(=O)C=P(c1ccccc1)(c1ccccc1)c1ccccc1.[H][C@@]1([C@@H](CC=CC(=O)OCC)c2ccccc2)CCCCC1=O.CCOC(=O)C=CCC(c1ccccc1)C1CCCCC1=O,55374091,1,55,full reaction,cyclohexanone|3-phenyl-propenal|ethyl (triphenylphosphoranylidene)acetate,C19H24O3|C19H24O3,11854|208478,Chemical behaviour,1,20,Michael Addition,Mechanism,ethanol|toluene,"81396789; Article; Umekubo, Nariyoshi; Terunuma, Takahiro; Kwon, Eunsang; Hayashi, Yujiro; Chemical Science; vol. 11; 41; (2020); p. 11293 - 11297;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,30,,,,Overall yield = 68 percent; stereoselective reaction,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|4-nitro-phenol|water|(2R)-methoxymethylpyrrolidine,,,,Reagent/catalyst,Scheme or table,93 percent ee,2,cyclohexanone|3-phenyl-propenal|ethyl (triphenylphosphoranylidene)acetate,,,,
CC(C)OC(=O)C(=O)C=Cc1ccc(Cl)cc1,[N-]=[N+]=NC1Cc2ccccc2C1=O.CC(C)OC(=O)C(=O)C[C@H](c1ccc(Cl)cc1)[C@@]1(N=[N+]=[N-])Cc2ccccc2C1=O.CC(C)OC(=O)C(=O)C[C@@H](c1ccc(Cl)cc1)[C@]1(N=[N+]=[N-])Cc2ccccc2C1=O.CC(C)OC(=O)C(=O)C[C@@H](c1ccc(Cl)cc1)[C@@]1(N=[N+]=[N-])Cc2ccccc2C1=O,CC(C)OC(=O)C(=O)C=Cc1ccc(Cl)cc1>>[N-]=[N+]=NC1Cc2ccccc2C1=O.CC(C)OC(=O)C(=O)C[C@H](c1ccc(Cl)cc1)[C@@]1(N=[N+]=[N-])Cc2ccccc2C1=O.CC(C)OC(=O)C(=O)C[C@@H](c1ccc(Cl)cc1)[C@]1(N=[N+]=[N-])Cc2ccccc2C1=O.CC(C)OC(=O)C(=O)C[C@@H](c1ccc(Cl)cc1)[C@@]1(N=[N+]=[N-])Cc2ccccc2C1=O,55712209,1,55,full reaction,"C13H13ClO3|2-azido-2,3-dihydro-1H-inden-1-one",C22H20ClN3O4|C22H20ClN3O4|C22H20ClN3O4,224862|224862|224862,Chemical behaviour,1,0|0,Michael Addition|Michael Addition,Catalytic behavior,dichloromethane|dichloromethane,"81532874; Article; Ding, Pei-Gang;Hu, Xiao-Si;Yu, Jin-Sheng;Zhou, Jian; Organic Letters; vol. 22; 21; (2020); p. 8578 - 8583;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|48,,,supporting information,Overall yield = 91 percent; stereoselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|C23H34N3O4P",,,,Reagent/catalyst|Temperature,Experimental part,99 percent ee|77 percent ee,2,"2-azido-2,3-dihydro-1H-inden-1-one|C13H13ClO3",,,,
O=C1c2ccccc2CC1SC(F)(F)F,CC(C)(C)OC(=O)/C=C/C(=O)c1ccccc1.CC(C)(C)OC(=O)[C@@H](CC(=O)c1ccccc1)[C@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)C(CC(=O)c1ccccc1)C1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@H](CC(=O)c1ccccc1)[C@@]1(SC(F)(F)F)Cc2ccccc2C1=O,O=C1c2ccccc2CC1SC(F)(F)F>>CC(C)(C)OC(=O)/C=C/C(=O)c1ccccc1.CC(C)(C)OC(=O)[C@@H](CC(=O)c1ccccc1)[C@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)C(CC(=O)c1ccccc1)C1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@H](CC(=O)c1ccccc1)[C@@]1(SC(F)(F)F)Cc2ccccc2C1=O,55876905,1,55,full reaction,"2-((trifluoromethyl)thio)-2,3-dihydro-1H-inden-1-one|tert-butyl trans-4-oxo-4-phenyl-2-butenoate","tert-butyl (R)-4-oxo-2-((R)-1-oxo-2-((trifluoromethyl)thio)-2,3-dihydro-1H-inden-2-yl)-4-phenylbutanoate|tert-butyl 4-oxo-2-(1-oxo-2-((trifluoromethyl)thio)-2,3-dihydro-1H-inden-2-yl)-4-phenylbutanoat",224862|224862|224862,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,toluene,"81689202; Article; Hong, Haoran;Zheng, Changwu;Zhao, Gang;Shang, Yongjia; Advanced Synthesis and Catalysis; vol. 362; 24; (2020); p. 5765 - 5771;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,60,,,supporting information,Overall yield = 35 percent; stereoselective reaction,"((S)-2-((R)-2-(3,5-bis(trifluoromethyl)benzamido)-N,3,3-trimethylbutanamido)-3-phenylpropyl)(3,5-bis(trifluoromethyl)benzyl)diphenylphosphonium bromide|potassium acetate",,,,Reagent/catalyst,Experimental part,3 percent ee,,,,,,
O=C1CCSCC1,O=[N+]([O-])/C=C/c1ccccc1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)CSCCC1=O.O=C1CCSC[C@H]1[C@H](C[N+](=O)[O-])c1ccccc1.O=C1CCSC[C@H]1[C@@H](C[N+](=O)[O-])c1ccccc1,O=C1CCSCC1>>O=[N+]([O-])/C=C/c1ccccc1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)CSCCC1=O.O=C1CCSC[C@H]1[C@H](C[N+](=O)[O-])c1ccccc1.O=C1CCSC[C@H]1[C@@H](C[N+](=O)[O-])c1ccccc1,56659031,1,55,full reaction,Tetrahydrothiopyran-4-one|nitrostyrene,(R)-3-((S)-2-nitro-1-phenylethyl)-tetrahydro-thiopyran-4-one|(S)-3-[(S)-2-nitro-1-phenyl-ethyl]-tetrahydro-thiopyran-4-one|(S)-3-((R)-2-nitro-1-phenylethyl)dihydro-2H-thiopyran-4(3H)-one,224813|224813|224813,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,tert-butyl methyl ether,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,Overall yield = 74 percent; Overall yield = 39 mg; stereoselective reaction,"N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide|triethylamine",,,,Reagent/catalyst|Solvent,Experimental part,89 percent ee,,,,,,
CC1(CCCCC=O)C=CC(=O)C=C1,[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@@H]2C=O.[H][C@]12CC(=O)C=C[C@@]1(C)CCC[C@H]2C=O.[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@H]2C=O.[H][C@]12CC(=O)C=C[C@@]1(C)CCC[C@@H]2C=O,CC1(CCCCC=O)C=CC(=O)C=C1>>[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@@H]2C=O.[H][C@]12CC(=O)C=C[C@@]1(C)CCC[C@H]2C=O.[H][C@@]12CC(=O)C=C[C@]1(C)CCC[C@H]2C=O.[H][C@]12CC(=O)C=C[C@@]1(C)CCC[C@@H]2C=O,56795047,1,55,full reaction,C12H16O2,C12H16O2|C12H16O2|C12H16O2|C12H16O2,42745|42745,Chemical behaviour,1,0 - 20,Michael Addition,Catalytic behavior,methanol|toluene,"83741138; Article; Lu, Xiao-Long; Qiu, Yuanyou; Yang, Baochao; He, Haibing; Gao, Shuanhu; Chemical Science; vol. 12; 13; (2021); p. 4747 - 4752;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,,Overall yield = 47 percentSpectr.; stereoselective reaction,(R)-2-(diphenyl(trimethylsilyloxy)methyl)pyrrolidine,,,,Solvent,Scheme or table,87 percent ee|38 percent ee,,,,,,
CCOC(=O)/C(=C\c1cccc(C)c1)P(=O)(OCC)OCC,N#CCC#N.CCOC(=O)[C@@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC,CCOC(=O)/C(=C\c1cccc(C)c1)P(=O)(OCC)OCC>>N#CCC#N.CCOC(=O)[C@@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC,57244241,2,55,full reaction|has preparation,C16H23O5P|malononitrile,C19H25N2O5P|C19H25N2O5P|C19H25N2O5P|C19H25N2O5P,224809|224809|224809|224809,"['Preparation', 'Chemical behaviour']","['1', '1']","['0', '0']","['Michael Addition', 'Michael Addition']",Catalytic behavior,"['toluene', 'toluene']","['90446093; Article; Kaasik, Mikk;Martõnova, Jevgenija;Erkman, Kristin;Metsala, Andrus', '90446093; Article; Kaasik, Mikk;Martõnova, Jevgenija;Erkman, Kristin;Metsala, Andrus']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['48', '48']",,,,"['stereoselective reaction', 'Overall yield = 95 percent; stereoselective reaction']","['C27H24F4IN3O2', 'C27H26F4IN3O2']",,,,Reagent/catalyst|Solvent|Temperature|Time,"['Scheme or table', 'Scheme or table']","['39 percent ee', '76 percent ee']",,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CC1=CC(=O)C(C(C)C)=CC1=O.Cc1cc(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(O)c(C(C)C)c1O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CC1=CC(=O)C(C(C)C)=CC1=O.Cc1cc(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(O)c(C(C)C)c1O,58067713,1,55,full reaction|has preparation,GLUTATHIONE|thymoquinone,C20H29N3O8S,238966,Preparation,1,,Michael Addition,,,"99403606; Article; Al-Hayali, Mohammed; Garces, Aimie; Stocks, Michael; Collins, Hilary; Bradshaw, Tracey D.; Molecules; vol. 26; 17; (2021);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
C[n+]1c(C=Cc2cc3c4c(c2O)CCCN4CCC3)sc2ccccc21,CN1C(=CC(c2cc3c4c(c2O)CCCN4CCC3)S(=O)(=O)[O-])Sc2ccccc21,C[n+]1c(C=Cc2cc3c4c(c2O)CCCN4CCC3)sc2ccccc21>>CN1C(=CC(c2cc3c4c(c2O)CCCN4CCC3)S(=O)(=O)[O-])Sc2ccccc21,61871537,1,55,full reaction,C22H23N2OS(1+),C22H23N2O4S2(1-),208298,Chemical behaviour,1,,Michael Addition,Kinetics,dimethyl sulfoxide,"121643283; Article; Liu, Lin;Zhang, Di;Li, Man;Shi, Jiacheng;Guo, Fengqi;Guo, Jie;Wang, Tieliang; Journal of Molecular Structure; vol. 1274; (2023);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,sodium sulfite,,,,,Scheme or table,,,,,,,
O=C1CC(=O)NC(=O)N1,N#CC(C#N)=C1C(=O)Nc2ccccc21.N#CC1=C(N)Oc2[nH]c(=O)[nH]c(=O)c2C12C(=O)Nc1ccccc12,O=C1CC(=O)NC(=O)N1>>N#CC(C#N)=C1C(=O)Nc2ccccc21.N#CC1=C(N)Oc2[nH]c(=O)[nH]c(=O)c2C12C(=O)Nc1ccccc12,61992655,1,55,full reaction|has preparation,"BARBITURIC ACID|2-oxo-2,3-dihydroindolylidenemalononitrile","7'-amino-2,2',4'-trioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile",113435,Preparation,1,,Michael Addition,,,"122002781; Article; Westphal, Regina;Venturini Filho, Eclair;Loureiro, Laiza Bruzadelle;Tormena, Clá",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC(N)=S,CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccccc1,CC(N)=S>>CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccccc1,62162663,1,55,full reaction|has preparation,thioacetamide|diethyl 2-(2-oxo-2-phenylethylidene)malonate,diethyl 2-(2-methyl-4-phenylthiazol-5-yl)malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-(2-methyl-4-phenylthiazol-5-yl)malonate,61 percent,,,Experimental part,,,,,,,
NC(=S)c1ccccc1,CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccccc1,NC(=S)c1ccccc1>>CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccccc1,62162664,1,55,full reaction|has preparation,benzenecarbothioamide|diethyl 2-(2-oxo-2-phenylethylidene)malonate,"diethyl 2-(2,4-diphenylthiazol-5-yl)malonate",150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,"diethyl 2-(2,4-diphenylthiazol-5-yl)malonate",74 percent,,,Experimental part,,,,,,,
COc1ccc(C(N)=S)cc1,CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccc(OC)cc2)nc1-c1ccccc1,COc1ccc(C(N)=S)cc1>>CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccc(OC)cc2)nc1-c1ccccc1,62162665,1,55,full reaction|has preparation,p-methoxythiobenzamide|diethyl 2-(2-oxo-2-phenylethylidene)malonate,diethyl 2-[2-(4-methoxyphenyl)-4-phenylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[2-(4-methoxyphenyl)-4-phenylthiazol-5-yl]malonate,70 percent,,,Experimental part,,,,,,,
Cc1cc(Br)ccc1C(N)=S,CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccc(Br)cc2C)nc1-c1ccccc1,Cc1cc(Br)ccc1C(N)=S>>CCOC(=O)C(=CC(=O)c1ccccc1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccc(Br)cc2C)nc1-c1ccccc1,62162666,1,55,full reaction|has preparation,4-bromo-2-methylthiobenzamide|diethyl 2-(2-oxo-2-phenylethylidene)malonate,diethyl 2-[2-(4-bromo-2-methylphenyl)-4-phenylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[2-(4-bromo-2-methylphenyl)-4-phenylthiazol-5-yl]malonate,61 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(C)cc1)C(=O)OCC,CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(C)cc1,CCOC(=O)C(=CC(=O)c1ccc(C)cc1)C(=O)OCC>>CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(C)cc1,62162667,1,55,full reaction|has preparation,diethyl 2-[2-(4-methylphenyl)-2-oxoethylidene]malonate|thioacetamide,diethyl 2-[4-(4-methylphenyl)-2-methylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-methylphenyl)-2-methylthiazol-5-yl]malonate,57 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(C)cc1)C(=O)OCC,NC(=S)c1ccccc1.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccc(C)cc1,CCOC(=O)C(=CC(=O)c1ccc(C)cc1)C(=O)OCC>>NC(=S)c1ccccc1.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccc(C)cc1,62162668,1,55,full reaction|has preparation,diethyl 2-[2-(4-methylphenyl)-2-oxoethylidene]malonate|benzenecarbothioamide,diethyl 2-[4-(4-methylphenyl)-2-phenylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-methylphenyl)-2-phenylthiazol-5-yl]malonate,65 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(OC)cc1)C(=O)OCC,CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(OC)cc1,CCOC(=O)C(=CC(=O)c1ccc(OC)cc1)C(=O)OCC>>CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(OC)cc1,62162669,1,55,full reaction|has preparation,diethyl 2-(2-(4-methoxyphenyl)-2-oxoethylidene)malonate|thioacetamide,diethyl 2-[4-(4-methoxyphenyl)-2-methylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-methoxyphenyl)-2-methylthiazol-5-yl]malonate,58 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1cc(OC)c(OC)c(OC)c1)C(=O)OCC,CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1cc(OC)c(OC)c(OC)c1,CCOC(=O)C(=CC(=O)c1cc(OC)c(OC)c(OC)c1)C(=O)OCC>>CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1cc(OC)c(OC)c(OC)c1,62162670,1,55,full reaction|has preparation,"diethyl 2-[2-oxo-2-(3,4,5-trimethoxyphenyl)ethylidene]malonate|thioacetamide","diethyl 2-[2-methyl-4-(3,4,5-trimethoxyphenyl)thiazol-5-yl]malonate",150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,"diethyl 2-[2-methyl-4-(3,4,5-trimethoxyphenyl)thiazol-5-yl]malonate",67 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(Cl)cc1)C(=O)OCC,CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(Cl)cc1,CCOC(=O)C(=CC(=O)c1ccc(Cl)cc1)C(=O)OCC>>CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(Cl)cc1,62162671,1,55,full reaction|has preparation,diethyl 2-[2-(4-chlorophenyl)-2-oxoethylidene]malonate|thioacetamide,diethyl 2-[4-(4-chlorophenyl)-2-methylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-chlorophenyl)-2-methylthiazol-5-yl]malonate,61 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(Cl)cc1)C(=O)OCC,NC(=S)c1ccccc1.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1,CCOC(=O)C(=CC(=O)c1ccc(Cl)cc1)C(=O)OCC>>NC(=S)c1ccccc1.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1,62162672,1,55,full reaction|has preparation,diethyl 2-[2-(4-chlorophenyl)-2-oxoethylidene]malonate|benzenecarbothioamide,diethyl 2-[4-(4-chlorophenyl)-2-phenylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-chlorophenyl)-2-phenylthiazol-5-yl]malonate,65 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(Br)cc1)C(=O)OCC,CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(Br)cc1,CCOC(=O)C(=CC(=O)c1ccc(Br)cc1)C(=O)OCC>>CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1ccc(Br)cc1,62162673,1,55,full reaction|has preparation,diethyl 2-(2-(4-bromophenyl)-2-oxoethylidene)malonate|thioacetamide,diethyl 2-[4-(4-bromophenyl)-2-methylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-bromophenyl)-2-methylthiazol-5-yl]malonate,64 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1ccc(Br)cc1)C(=O)OCC,NC(=S)c1ccccc1.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccc(Br)cc1,CCOC(=O)C(=CC(=O)c1ccc(Br)cc1)C(=O)OCC>>NC(=S)c1ccccc1.CCOC(=O)C(C(=O)OCC)c1sc(-c2ccccc2)nc1-c1ccc(Br)cc1,62162674,1,55,full reaction|has preparation,diethyl 2-(2-(4-bromophenyl)-2-oxoethylidene)malonate|benzenecarbothioamide,diethyl 2-[4-(4-bromophenyl)-2-phenylthiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[4-(4-bromophenyl)-2-phenylthiazol-5-yl]malonate,62 percent,,,Experimental part,,,,,,,
CCOC(=O)C(=CC(=O)c1cccc2ccccc12)C(=O)OCC,CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1cccc2ccccc12,CCOC(=O)C(=CC(=O)c1cccc2ccccc12)C(=O)OCC>>CC(N)=S.CCOC(=O)C(C(=O)OCC)c1sc(C)nc1-c1cccc2ccccc12,62162675,1,55,full reaction|has preparation,diethyl 2-(2-naphthalen-1-yl-2-oxoethylidene)malonate|thioacetamide,diethyl 2-[2-methyl-4-(naphthalen-1-yl)thiazol-5-yl]malonate,150300,Preparation,1,,Michael Addition,,,"121555231; Article; Meenakshi, Maniarasu;Srinivasan, Kannupal; Organic and Biomolecular Chemistry; vol. 103; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,supporting information,,,diethyl 2-[2-methyl-4-(naphthalen-1-yl)thiazol-5-yl]malonate,61 percent,,,Experimental part,,,,,,,
O=[N+]([O-])/C=C/c1ccc(F)cc1,COC(=O)C1CCCC1=O.COC(=O)[C@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O.COC(=O)[C@@]1([C@@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O.COC(=O)[C@@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O,O=[N+]([O-])/C=C/c1ccc(F)cc1>>COC(=O)C1CCCC1=O.COC(=O)[C@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O.COC(=O)[C@@]1([C@@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O.COC(=O)[C@@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O.COC(=O)[C@]1([C@@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCC1=O,63066077,1,55,full reaction,trans-1-(4-fluorophenyl)-2-nitro-ethene|methyl 2-oxocyclopentane-1-carboxylate,"methyl 1-(1-(4-fluorophenyl)-2-nitroethyl)-2-oxocyclopentanecarboxylate|(2R,3S)-methyl-1-(1-(4-fluorophenyl)-2-nitroethyl)-2-oxocyclopentanecarboxylate|C15H16FNO5|C15H16FNO5",224798|224798|224798|224798,Chemical behaviour,1,25,Michael Addition,Catalytic behavior,dichloromethane,"123394999; Article; Rahman, Mohammad Farhadur;Fujisawa, Ikuhide;Haraguchi, Naoki;Itsuno, Shinichi; Chirality; vol. 35; 3; (2023); p. 178 - 188;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Overall yield = 88 percent; stereoselective reaction,C-5' nitrocinchona urea polymer,,,,Reagent/catalyst,Experimental part,61 percent ee|57 percent ee,,,,,,
CCOC(=O)C(=Cc1cc2cc(OC)ccc2[nH]c1=O)C(=O)OCC,OCCS.CCOC(=O)C(C(=O)OCC)C(SCCO)c1cc2cc(OC)ccc2[nH]c1=O,CCOC(=O)C(=Cc1cc2cc(OC)ccc2[nH]c1=O)C(=O)OCC>>OCCS.CCOC(=O)C(C(=O)OCC)C(SCCO)c1cc2cc(OC)ccc2[nH]c1=O,64839541,1,55,full reaction|has preparation,C18H19NO6|2-hydroxyethanethiol,C20H25NO7S,228305,Preparation,1,,Michael Addition,,,"128358184; Article; Kolińska, Jolanta;Grzelakowska, Aleksandra;Sz",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COc1ccc2[nH]c(=O)c(C=C(C#N)C#N)cc2c1,OCCS.COc1ccc2[nH]c(=O)c(C(SCCO)C(C#N)C#N)cc2c1,COc1ccc2[nH]c(=O)c(C=C(C#N)C#N)cc2c1>>OCCS.COc1ccc2[nH]c(=O)c(C(SCCO)C(C#N)C#N)cc2c1,64839542,1,55,full reaction|has preparation,C14H9N3O2|2-hydroxyethanethiol,C16H15N3O3S,221588,Preparation,1,,Michael Addition,,,"128358184; Article; Kolińska, Jolanta;Grzelakowska, Aleksandra;Sz",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[2H]C([2H])([2H])C(=O)C([2H])([2H])[2H],[H][C@]12CC(C)(C)CC[C@]1(C(=O)O)CC[C@]1(C)[C@]2([H])C(=O)C=C2[C@@]3(C)C=C(C#N)C(=O)C(C)(C)C3CC[C@]21C.[H][C@]12CC(C)(C)CC[C@]1(C(=O)O)CC[C@]1(C)[C@]2([H])C(=O)C=C2[C@@]3(C)C(SC([2H])([2H])[2H])C(C#N)C(=O)C(C)(C)C3CC[C@]21C,[2H]C([2H])([2H])C(=O)C([2H])([2H])[2H]>>[H][C@]12CC(C)(C)CC[C@]1(C(=O)O)CC[C@]1(C)[C@]2([H])C(=O)C=C2[C@@]3(C)C=C(C#N)C(=O)C(C)(C)C3CC[C@]21C.[H][C@]12CC(C)(C)CC[C@]1(C(=O)O)CC[C@]1(C)[C@]2([H])C(=O)C=C2[C@@]3(C)C(SC([2H])([2H])[2H])C(C#N)C(=O)C(C)(C)C3CC[C@]21C,65695710,1,55,full reaction|has preparation,"[(2)H6]acetone|2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid",C32H42(2)H3NO4S,221588,Preparation,1,,Michael Addition,,,"128498014; Article; Varela, Kaitlyn;Arman, Hadi D.;Berger, Mitchel S.;Sponsel, Valerie M.;Lin, Chin-Hsing Annie;Yoshimoto, Francis K.; Journal of Natural Products; vol. 86; 7; (2023); p. 1654 - 1666;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Experimental part,,,,,,,
O=C1C=CC(=O)N1Cc1ccccc1,Cc1ccc(-c2[nH]c(=O)c3ccccc3c2-c2ccc(C)cc2)cc1.O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)c(-c2ccc(C(F)(F)F)cc2)c2ccccc12.O=C1C=CC(=O)N1Cc1ccccc1.Cc1ccc(-c2c3n(c(=O)c4ccccc24)C2(CC(=O)N(Cc4ccccc4)C2=O)c2cc(C)ccc2-3)cc1.O=C1CC2(C(=O)N1Cc1ccccc1)c1cc(C(F)(F)F)ccc1-c1c(-c3ccc(C(F)(F)F)cc3)c3ccccc3c(=O)n12,O=C1C=CC(=O)N1Cc1ccccc1>>Cc1ccc(-c2[nH]c(=O)c3ccccc3c2-c2ccc(C)cc2)cc1.O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)c(-c2ccc(C(F)(F)F)cc2)c2ccccc12.O=C1C=CC(=O)N1Cc1ccccc1.Cc1ccc(-c2c3n(c(=O)c4ccccc24)C2(CC(=O)N(Cc4ccccc4)C2=O)c2cc(C)ccc2-3)cc1.O=C1CC2(C(=O)N1Cc1ccccc1)c1cc(C(F)(F)F)ccc1-c1c(-c3ccc(C(F)(F)F)cc3)c3ccccc3c(=O)n12,66151692,1,55,full reaction,"1-benzyl-1H-pyrrole-2,5-dione|3,4-di-p-tolylisoquinolin-1(2H)-one|3,4-bis(4-(trifluoromethyl)phenyl)isoquinolin-1(2H)-one","1'-benzyl-9-methyl-12-(p-tolyl)-5H-spiro[isoindolo[2,1-b]isoquinoline-7,3'-pyrrolidine]-2',5,5'-trione|1'-benzyl-9-(trifluoromethyl)-12-(4-(trifluoromethyl)phenyl)-5H-spiro[isoindolo[2,1-b]isoquinolin",225795|275882,Chemical behaviour,1,110,Michael Addition,Mechanism,acetonitrile,"131798843; Article; Seal, Kaushik;Banerji, Biswadip; Advanced Synthesis and Catalysis; vol. 366; 8; (2024); p. 1788 - 1808;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Sealed tube|Inert atmosphere,,supporting information,,[Ru(p-cymene)Cl2]2|copper(II) acetate monohydrate,,,,,Experimental part,,,,,,,
O=C1OC(c2ccccc2)c2ccccc21,O=C(/C=C/c1ccccc1)N1C(=O)OC[C@@H]1c1ccccc1.O=C1O[C@@](c2ccccc2)([C@@H](CC(=O)N2C(=O)OC[C@@H]2c2ccccc2)c2ccccc2)c2ccccc21.O=C1O[C@](c2ccccc2)([C@H](CC(=O)N2C(=O)OC[C@@H]2c2ccccc2)c2ccccc2)c2ccccc21.O=C1OC(c2ccccc2)(C(CC(=O)N2C(=O)OC[C@@H]2c2ccccc2)c2ccccc2)c2ccccc21,O=C1OC(c2ccccc2)c2ccccc21>>O=C(/C=C/c1ccccc1)N1C(=O)OC[C@@H]1c1ccccc1.O=C1O[C@@](c2ccccc2)([C@@H](CC(=O)N2C(=O)OC[C@@H]2c2ccccc2)c2ccccc2)c2ccccc21.O=C1O[C@](c2ccccc2)([C@H](CC(=O)N2C(=O)OC[C@@H]2c2ccccc2)c2ccccc2)c2ccccc21.O=C1OC(c2ccccc2)(C(CC(=O)N2C(=O)OC[C@@H]2c2ccccc2)c2ccccc2)c2ccccc21,66467621,1,55,full reaction,"3-phenylphthalide|(4S)-4-phenyl-3-[(2E)-3-phenylprop-2-enoyl]-1,3-oxazolidin-2-one","(S)-3-((S)-3-((R)-3-oxo-1-phenyl-1,3-dihydroisobenzofuran-1-yl)-3-phenylpropanoyl)-4-phenyloxazolidin-2-one|3-(3-(3-oxo-1-phenyl-1,3-dihydroisobenzofuran-1-yl)-3-phenylpropanoyl)-4-phenyloxazolidin-2-",224887|224887|224887,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"132499639; Article; Schettini, Rosaria;Dentoni Litta, Antonella;Sinibaldi, Arianna;D'Amato, Assunta;Araszczuk, Alicja M.;Sicignano, Marina;Pagliarulo, Letizia;Naddeo, Simone;Pierri, Giovanni;De Riccar",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,Overall yield = 75 percent,perhydrodibenzo-18-crown-6|sodium hydroxide,,,,Solvent,Scheme or table,,,,,,,
CC1(C)CC(=O)CC(=O)C1,[H]/C(C(=O)c1ccccc1)=C(/[H])C(=O)c1ccccc1.CC1(C)CC(=O)C(C(CC(=O)c2ccccc2)C(=O)c2ccccc2)=C(O)C1,CC1(C)CC(=O)CC(=O)C1>>[H]/C(C(=O)c1ccccc1)=C(/[H])C(=O)c1ccccc1.CC1(C)CC(=O)C(C(CC(=O)c2ccccc2)C(=O)c2ccccc2)=C(O)C1,66789678,1,55,full reaction|has preparation,"dimedone|1,4-diphenylbut-2-ene-1,4-dione","2-(4,4-dimethyl-2,6-dioxocyclohexyl)-1,4-diphenylbutane-1,4-dione",164643,Preparation,1,,Michael Addition,,,"133011607; Article; Shibuya, Keisuke;Chikamatsu, Ayaka;Hisano, Kazuki;Nishino, Hiroshi; Bulletin of the Chemical Society of Japan; vol. 97; 3; (2024);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Body text,,,,,,,
Cc1ccc(C(=O)/C=C/C(=O)c2ccc(C)cc2)cc1,CC1(C)CC(=O)CC(=O)C1.Cc1ccc(C(=O)CC(C(=O)c2ccc(C)cc2)C2=C(O)CC(C)(C)CC2=O)cc1,Cc1ccc(C(=O)/C=C/C(=O)c2ccc(C)cc2)cc1>>CC1(C)CC(=O)CC(=O)C1.Cc1ccc(C(=O)CC(C(=O)c2ccc(C)cc2)C2=C(O)CC(C)(C)CC2=O)cc1,66789679,1,55,full reaction|has preparation,ditoluylethylene|dimedone,C26H28O4,164643,Preparation,1,,Michael Addition,,,"133011607; Article; Shibuya, Keisuke;Chikamatsu, Ayaka;Hisano, Kazuki;Nishino, Hiroshi; Bulletin of the Chemical Society of Japan; vol. 97; 3; (2024);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Body text,,,,,,,
[H]/C(C(=O)c1ccc(Cl)cc1)=C(/[H])C(=O)c1ccc(Cl)cc1,CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C(CC(=O)c2ccc(Cl)cc2)C(=O)c2ccc(Cl)cc2)=C(O)C1,[H]/C(C(=O)c1ccc(Cl)cc1)=C(/[H])C(=O)c1ccc(Cl)cc1>>CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C(CC(=O)c2ccc(Cl)cc2)C(=O)c2ccc(Cl)cc2)=C(O)C1,66789681,1,55,full reaction|has preparation,"(E)-1,4-bis(4-chlorophenyl)but-2-ene-1,4-dione|dimedone",C24H22Cl2O4,164643,Preparation,1,,Michael Addition,,,"133011607; Article; Shibuya, Keisuke;Chikamatsu, Ayaka;Hisano, Kazuki;Nishino, Hiroshi; Bulletin of the Chemical Society of Japan; vol. 97; 3; (2024);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Body text,,,,,,,
[2H]C([2H])([2H])C#N,C=CC(=O)OC.NNc1ccccc1.COC(=O)CCN(N)c1ccccc1.[2H]C([2H])(CN(N)c1ccccc1)C(=O)OC,[2H]C([2H])([2H])C#N>>C=CC(=O)OC.NNc1ccccc1.COC(=O)CCN(N)c1ccccc1.[2H]C([2H])(CN(N)c1ccccc1)C(=O)OC,67384185,1,55,full reaction,[D3]acetonitrile|acrylic acid methyl ester|phenylhydrazine,methyl 3-(1-phenylhydrazinyl)propanoate|C10H12(2)H2N2O2,230614|83546,Chemical behaviour,1,20,Michael Addition,Mechanism|Kinetics,acetonitrile,"134343708; Article; Xu, Qingyu;Zhang, Chengwei;Xu, Hang;Zheng, Changying;Li, Yue;Xu, Sen;Yao, Xiaoquan; Advanced Synthesis and Catalysis; vol. 366; 12; (2024); p. 2829 - 2834;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,,supporting information,Overall yield = 82 percent,tetrabutylammonium perchlorate,,,,Reagent/catalyst,Experimental part,,,,,,,
COC(=O)CN=C(c1ccccc1)c1ccccc1,C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1.COC(=O)[C@@H](C[C@H]1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1.COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1,COC(=O)CN=C(c1ccccc1)c1ccccc1>>C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1.COC(=O)[C@@H](C[C@H]1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1.COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)N=C(c1ccccc1)c1ccccc1,67550804,1,55,full reaction,ethyl N-benzhydrylideneglycinate|tert-butyl 3-methylene-2-oxopyrrolidine-1-carboxylate,tert-butyl (S)-3-((S)-2-((diphenylmethylene)amino)-3-methoxy-3-oxopropyl)-2-oxopyrrolidine-1-carboxylate|C26H30N2O5|C26H30N2O5,230844|230844|230844,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,"134430900; Article; Szpera, Robert;Huang, Shanjun;Fenton, Harriet A. M.;Waddington, William;Gymer, Adam E. S.;Moses, Ian B.;Buck, Julia;Ingram, Heather;Fussell, Steven J.;Walton, Robert;Shanahan, Char",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Glovebox,,supporting information,,"tetrakis(actonitrile)copper(I) hexafluorophosphate|(R)-fesulphos|N-ethyl-N,N-diisopropylamine",,,,Solvent,Experimental part,85.3 percent ee,,,,,,
CCCCSC(=O)CC(C)=O,O=[N+]([O-])C=Cc1ccccc1.CCCCSC(=O)[C@H](C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCSC(=O)[C@@H](C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1.CCCCSC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,CCCCSC(=O)CC(C)=O>>O=[N+]([O-])C=Cc1ccccc1.CCCCSC(=O)[C@H](C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCSC(=O)[C@@H](C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1.CCCCSC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,68621984,1,55,full reaction,S-butyl 3-oxobutanethioate|(2-nitroethenyl)benzene,C16H21NO4S|C16H21NO4S|C16H21NO4S,224811|224811|224811,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,dichloromethane,"136739224; Article; Dajek, Maciej;Janicki, Mikołaj J.;Kubiak, Paulina D.;Bąkow",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Overall yield = 89 percent; stereoselective reaction,"3-{[3,5-bis(trifluoromethyl)benzyl]amino}-4-{[(R,R)-2-( piperidine-1-yl)cyclohexyl]amino}cyclobut-3-ene-1,2-dione",,,,Reagent/catalyst,Scheme or table,54.545 percent de|12 percent ee,,,,,,
Cc1cc(O)c(C)c(O)c1C,C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c(C)c(C)c(O)c(C)c2O)c(O)c1C=O,Cc1cc(O)c(C)c(O)c1C>>C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c(C)c(C)c(O)c(C)c2O)c(O)c1C=O,69575742,1,55,full reaction|has preparation,"2,4,5-trimethyl-resorcinol|trichophenol o-QM",trichophenol H,218034,Preparation,1,,Michael Addition,,,"136348633; Article; Wang, Xiao-Xia;Deng, Bei-Qian;Ouyang, Zhi-Qiu;Yan, Yang;Lv, Jian-Ming;Qin, Sheng-Ying;Hu, Dan;Chen, Guo-Dong;Yao, Xin-Sheng;Gao, Hao; Journal of Natural Products; vol. 87; 9; (2024",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O,CCCN1C(=CC=C2CCCC(C=CC3=[N+](CCC)c4ccccc4C3(C)C)=C2Oc2ccc3nc4ccc(=O)cc-4oc3c2)C(C)(C)c2ccccc21.CCCN1C(=CC=C2CCCC(C=CC3=[N+](CCC)c4ccccc4C3(C)C)=C2Oc2ccc3c(c2)OC2=CC(=O)C(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2N3)C(C)(C)c2ccccc21.CCCN1C(=CC=C2CCCC(C=CC3=[N+](CCC)c4ccccc4C3(C)C)=C2Oc2ccc3nc4cc(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)c(=O)cc-4oc3c2)C(C)(C)c2ccccc21,NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O>>CCCN1C(=CC=C2CCCC(C=CC3=[N+](CCC)c4ccccc4C3(C)C)=C2Oc2ccc3nc4ccc(=O)cc-4oc3c2)C(C)(C)c2ccccc21.CCCN1C(=CC=C2CCCC(C=CC3=[N+](CCC)c4ccccc4C3(C)C)=C2Oc2ccc3c(c2)OC2=CC(=O)C(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2N3)C(C)(C)c2ccccc21.CCCN1C(=CC=C2CCCC(C=CC3=[N+](CCC)c4ccccc4C3(C)C)=C2Oc2ccc3nc4cc(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)c(=O)cc-4oc3c2)C(C)(C)c2ccccc21,69795325,1,55,full reaction|has preparation,glutathion|cy-res,C58H67N6O9S(1+)|C58H65N6O9S(1+),240370|213054,Preparation,1,,Michael Addition,,,"138394292; Article; Chen, Li;Yang, Jun;Su, Feijing;Liu, Zihang;Huang, Shuai;Zhang, Jifa;Li, Jinqi;Mao, Wuyu; European Journal of Medicinal Chemistry; vol. 283; (2025);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Body text,,,,,,,
C1CCNCC1,O=[N+]([O-])C=Cc1cccc([N+](=O)[O-])c1.O=[N+]([O-])CC(c1cccc([N+](=O)[O-])c1)N1CCCCC1,C1CCNCC1>>O=[N+]([O-])C=Cc1cccc([N+](=O)[O-])c1.O=[N+]([O-])CC(c1cccc([N+](=O)[O-])c1)N1CCCCC1,12052,2,54,full reaction|has preparation,piperidine|3-nitro-β-nitrostyrene,1-[2-nitro-1-(3-nitro-phenyl)-ethyl]-piperidine,224440,"['Preparation', 'Chemical behaviour']","['1', '1']",25,Michael Addition,Kinetics,acetonitrile,"['1076099; Article; Yu; Chia; Huaxue Xuebao/Acta Chimica Sinica; vol. 25; (1959); p. 417; Chem.Abstr.; (1960); p. 19547;', '35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,diethyl ether,,,,Concentration,Experimental part,,,,,,,
[H][C@]12CCCC[C@]1([H])N[C@@H](C)CC2,C=CC#N.[H][C@@]12CCCC[C@@]1([H])N(CCC#N)[C@H](C)CC2,[H][C@]12CCCC[C@]1([H])N[C@@H](C)CC2>>C=CC#N.[H][C@@]12CCCC[C@@]1([H])N(CCC#N)[C@H](C)CC2,8633732,1,54,full reaction|has preparation,2α-methyl-trans-decahydroquinoline|acrylonitrile,"3-((2R,4aS,8aR)-2-Methyl-octahydro-quinolin-1-yl)-propionitrile",230555,Preparation,1,,Addition|Michael reaction,,,"6252512; Article; Combrink, Keith D.; Gulgeze, H. Belgin; Yu, Kuo-Long; Pearce, Bradley C.; Trehan, Ashok K.; Wei, Jianmei; Deshpande, Milind; Krystal, Mark; Torri, Albert; Luo, Guangxiang; Cianci, Ch",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
[H][C@@]12CCCC[C@]1([H])N[C@H](C)CC2,C=CC#N.[H][C@]12CCCC[C@@]1([H])N(CCC#N)[C@@H](C)CC2,[H][C@@]12CCCC[C@]1([H])N[C@H](C)CC2>>C=CC#N.[H][C@]12CCCC[C@@]1([H])N(CCC#N)[C@@H](C)CC2,8633733,1,54,full reaction|has preparation,2α-methyl-cis-decahydroquinoline|acrylonitrile,"3-((2S,4aR,8aR)-2-Methyl-octahydro-quinolin-1-yl)-propionitrile",230555,Preparation,1,,Addition|Michael reaction,,,"6252512; Article; Combrink, Keith D.; Gulgeze, H. Belgin; Yu, Kuo-Long; Pearce, Bradley C.; Trehan, Ashok K.; Wei, Jianmei; Deshpande, Milind; Krystal, Mark; Torri, Albert; Luo, Guangxiang; Cianci, Ch",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C=C[S@@](=O)c1ccc(C)cc1,[Li+].c1ccc([P-]c2ccccc2)cc1.Cc1ccc([S@](=O)CCP(c2ccccc2)c2ccccc2)cc1,C=C[S@@](=O)c1ccc(C)cc1>>[Li+].c1ccc([P-]c2ccccc2)cc1.Cc1ccc([S@](=O)CCP(c2ccccc2)c2ccccc2)cc1,8639059,1,54,full reaction|has preparation,(R)-p-tolyl vinyl sulfoxide|lithium diphenylphosphide,Diphenyl-[2-((R)-toluene-4-sulfinyl)-ethyl]-phosphane,230347,Preparation,1,,Addition|Michael reaction,,,"6247789; Article; Hiroi, Kunio;Suzuki, Yoshio;Abe, Ikuko;Kawagishi, Ryoko; Tetrahedron; vol. 56; 27; (2000); p. 4701 - 4710;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C=CC#N,[H][C@]12CCCC[C@]1([H])NCCC2.[H][C@]12CCCC[C@]1([H])N(CCC#N)CCC2,C=CC#N>>[H][C@]12CCCC[C@]1([H])NCCC2.[H][C@]12CCCC[C@]1([H])N(CCC#N)CCC2,8640792,1,54,full reaction|has preparation,acrylonitrile|trans-decahydroquinoline,"(4aR,8aS)-3-(Octahydro-quinolin-1-yl)-propionitrile",230555,Preparation,1,,Addition|Michael reaction,,,"6252512; Article; Combrink, Keith D.; Gulgeze, H. Belgin; Yu, Kuo-Long; Pearce, Bradley C.; Trehan, Ashok K.; Wei, Jianmei; Deshpande, Milind; Krystal, Mark; Torri, Albert; Luo, Guangxiang; Cianci, Ch",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=[N+]([O-])C=Cc1ccc(Cl)cc1,[H][C@]1([C@@H](O)CO)OC(=O)C(O)=C1O.[H][C@]12OC(=O)[C@](O)(C(C[N+](=O)[O-])c3ccc(Cl)cc3)[C@@]1(O)OC[C@@H]2O,O=[N+]([O-])C=Cc1ccc(Cl)cc1>>[H][C@]1([C@@H](O)CO)OC(=O)C(O)=C1O.[H][C@]12OC(=O)[C@](O)(C(C[N+](=O)[O-])c3ccc(Cl)cc3)[C@@]1(O)OC[C@@H]2O,8641820,1,54,full reaction|has preparation,1-chloro-4-(2-nitrovinyl)benzene|ascorbic acid,"3-<1-(4-chlorophenyl)-2-nitro-ethyl>-perhydro-3,3a,6-trihydroxy-furo<3,2-b>furan-2-one",202113,Preparation,1,,Michael reaction,,,6253165; Article; Fathi; Krautheim; Kaap; Eger; Steinfelder; Bioorganic and Medicinal Chemistry Letters; vol. 10; 14; (2000); p. 1605 - 1608;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C/C=C/C(=O)Oc1ccccc1,CC1CCCC/C1=N\Cc1ccccc1.C[C@@H]1CC(=O)N(Cc2ccccc2)C2=CCCC[C@@]21C.C[C@H]1CC(=O)N(Cc2ccccc2)C2=CCCC[C@@]21C.C[C@@H]1CC(=O)N(Cc2ccccc2)C2=C1CCC[C@H]2C.C[C@@H]1CCCC2=C1N(Cc1ccccc1)C(=O)C[C@@H]2C,C/C=C/C(=O)Oc1ccccc1>>CC1CCCC/C1=N\Cc1ccccc1.C[C@@H]1CC(=O)N(Cc2ccccc2)C2=CCCC[C@@]21C.C[C@H]1CC(=O)N(Cc2ccccc2)C2=CCCC[C@@]21C.C[C@@H]1CC(=O)N(Cc2ccccc2)C2=C1CCC[C@H]2C.C[C@@H]1CCCC2=C1N(Cc1ccccc1)C(=O)C[C@@H]2C,8753673,2,54,full reaction|has preparation,phenyl (2E)-but-2-enoate|N-(2-methylcyclohexylidene)-benzenemethanamine,"trans-1-Benzyl-4,4a-dimethyl-2-oxo-1,2,3,4,4a,5,6,7-octahydroquinoline|cis-1-Benzyl-4,4a-dimethyl-2-oxo-1,2,3,4,4a,5,6,7-octahydroquinoline|cis-1-benzyl-4,8-dimethyl-3,4,5,6,7,8-hexahydroquinolin-2(1H",79916|87131|79916|87131,"['Chemical behaviour', 'Preparation']","['1', '1']","['110', '110']",Michael reaction,Product distribution,,"['6277685; Article; Jabin; Revial; Monnier-Benoit; Netchitailo; Journal of Organic Chemistry; vol. 66; 1; (2001); p. 256 - 261;', '6277685; Article; Jabin; Revial; Monnier-Benoit; Netchitailo; Journal of Organic Chemistry; vol. 66; 1; (2001); p. 256 - 261;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['168', '168']",,,,,"['hydroquinone', 'hydroquinone']",,,,Further Variations:|Reaction partners,,,,,,,,
c1cc[nH]c1,O=C1C=CCO1.O=C1CC(N2CCCC2)CO1,c1cc[nH]c1>>O=C1C=CCO1.O=C1CC(N2CCCC2)CO1,8866202,1,54,full reaction,pyrrole|2-buten-4-olide,4-pyrrolidin-1-yl-dihydrofurran-2-one,218886,Chemical behaviour,1,,hetero-Michael addition,Kinetics,chloroform,"6307033; Article; Nagasawa, Kazuo; Georgieva, Angelina; Takahashi, Hiroki; Nakata, Tadashi; Tetrahedron; vol. 57; 43; (2001); p. 8959 - 8964;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,"(1S,2S,2aS,4R,6'R,7R,8aS)-C21H36N3O4(1+)*Cl(1-)",,,,Further Variations:|Reagents,,,,,,,,
C1CCCNCC1,C=CC(=O)NCc1ccc2c(c1)OCO2.O=C(CCN1CCCCCC1)NCc1ccc2c(c1)OCO2,C1CCCNCC1>>C=CC(=O)NCc1ccc2c(c1)OCO2.O=C(CCN1CCCCCC1)NCc1ccc2c(c1)OCO2,8991959,1,54,full reaction|has preparation,"hexamethylene imine|N-(benzo[d][1,3]dioxol-5-ylmethyl)acrylamide","3-azepan-1-yl-N-benzo[1,3]dioxol-5-ylmethyl-propionamide",230562,Preparation,1,,Michael addition,,,"6335274; Article; Nantermet, Philippe G; Barrow, James C.; Lundell, George F.; Pellicore, Janetta M.; Rittle, Kenneth E.; Young, MaryBeth; Freidinger, Roger M.; Connolly, Thomas M.; Condra, Cindra; Ka",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CCN(CC)CC,COC(=O)C#CC(=O)OC.Cn1cccc1N.[H+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.COC(=O)/C=C(/C(=O)OC)c1ccc(N)n1C.COC(=O)/C=C(\C(=O)OC)c1ccc(N)n1C.CC[N+](CC)(CC)C(=CC(=O)OC)C(=O)OC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,CCN(CC)CC>>COC(=O)C#CC(=O)OC.Cn1cccc1N.[H+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.COC(=O)/C=C(/C(=O)OC)c1ccc(N)n1C.COC(=O)/C=C(\C(=O)OC)c1ccc(N)n1C.CC[N+](CC)(CC)C(=CC(=O)OC)C(=O)OC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,9084689,1,54,full reaction|has preparation,triethylamine|dimethyl acetylenedicarboxylate|1-methyl-2-ammoniopyrrole tetraphenylborate,2-(5-amino-1-methyl-1H-pyrrol-2-yl)-but-2-enedioic acid dimethyl ester|2-(5-amino-1-methyl-1H-pyrrol-2-yl)-but-2-enedioic acid dimethyl ester|2-triethylammonio-2-butenedioic acid dimethyl ester tetrap,175063,Preparation,1,,Michael addition,,[D3]acetonitrile|[D3]acetonitrile,"6343476; Article; De Rosa, Michael; LaRue, Michelle; Sellitto, Ian; Timken, Mark D.; Heterocyclic Communications; vol. 7; 6; (2001); p. 519 - 520;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Title compound not separated from byproducts,,,,,,,,2,triethylamine|1-methyl-2-ammoniopyrrole tetraphenylborate|dimethyl acetylenedicarboxylate,,,,
CCN(CC)CC,COC(=O)C#CC(=O)OC.CCn1cccc1N.[H+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.CCn1c(N)ccc1/C(=C\C(=O)OC)C(=O)OC.CCn1c(N)ccc1/C(=C/C(=O)OC)C(=O)OC.CC[N+](CC)(CC)C(=CC(=O)OC)C(=O)OC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,CCN(CC)CC>>COC(=O)C#CC(=O)OC.CCn1cccc1N.[H+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.CCn1c(N)ccc1/C(=C\C(=O)OC)C(=O)OC.CCn1c(N)ccc1/C(=C/C(=O)OC)C(=O)OC.CC[N+](CC)(CC)C(=CC(=O)OC)C(=O)OC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,9084690,1,54,full reaction|has preparation,triethylamine|dimethyl acetylenedicarboxylate|1-ethyl-2-aminopyrrole tetraphenylborate salt,2-(5-amino-1-ethyl-1H-pyrrol-2-yl)-but-2-enedioic acid dimethyl ester|2-(5-amino-1-ethyl-1H-pyrrol-2-yl)-but-2-enedioic acid dimethyl ester|2-triethylammonio-2-butenedioic acid dimethyl ester tetraphe,159662,Preparation,1,,Michael addition,,[D3]acetonitrile|[D3]acetonitrile,"6343476; Article; De Rosa, Michael; LaRue, Michelle; Sellitto, Ian; Timken, Mark D.; Heterocyclic Communications; vol. 7; 6; (2001); p. 519 - 520;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Title compound not separated from byproducts,,,,,,,,2,triethylamine|1-ethyl-2-aminopyrrole tetraphenylborate salt|dimethyl acetylenedicarboxylate,,,,
CCN(CC)CC,COC(=O)C#CC(=O)OC.CC(C)(C)n1cccc1N.[H+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.COC(=O)/C=C(/C(=O)OC)c1ccc(N)n1C(C)(C)C.COC(=O)/C=C(\C(=O)OC)c1ccc(N)n1C(C)(C)C.CC[N+](CC)(CC)C(=CC(=O)OC)C(=O)OC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,CCN(CC)CC>>COC(=O)C#CC(=O)OC.CC(C)(C)n1cccc1N.[H+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.COC(=O)/C=C(/C(=O)OC)c1ccc(N)n1C(C)(C)C.COC(=O)/C=C(\C(=O)OC)c1ccc(N)n1C(C)(C)C.CC[N+](CC)(CC)C(=CC(=O)OC)C(=O)OC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1,9084691,1,54,full reaction|has preparation,triethylamine|dimethyl acetylenedicarboxylate|1-t-butyl-2-ammoniopyrrole tetraphenylborate,2-(5-amino-1-tert-butyl-1H-pyrrol-2-yl)-but-2-enedioic acid dimethyl ester|2-(5-amino-1-tert-butyl-1H-pyrrol-2-yl)-but-2-enedioic acid dimethyl ester|2-triethylammonio-2-butenedioic acid dimethyl este,13788,Preparation,1,,Michael addition,,[D3]acetonitrile|[D3]acetonitrile,"6343476; Article; De Rosa, Michael; LaRue, Michelle; Sellitto, Ian; Timken, Mark D.; Heterocyclic Communications; vol. 7; 6; (2001); p. 519 - 520;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,Title compound not separated from byproducts,,,,,,,,2,triethylamine|1-t-butyl-2-ammoniopyrrole tetraphenylborate|dimethyl acetylenedicarboxylate,,,,
CCOP(=O)([CH-]C(=O)OC)OCC,[H][C@]12O[C@@H](c3ccccc3)[C@H](OCc3ccccc3)[C@@]1([H])OC(O)[C@@H]2O.[H][C@]1([C@@H](O)/C=C/C(=O)OC)O[C@@H](c2ccccc2)[C@H](OCc2ccccc2)[C@H]1O,CCOP(=O)([CH-]C(=O)OC)OCC>>[H][C@]12O[C@@H](c3ccccc3)[C@H](OCc3ccccc3)[C@@]1([H])OC(O)[C@@H]2O.[H][C@]1([C@@H](O)/C=C/C(=O)OC)O[C@@H](c2ccccc2)[C@H](OCc2ccccc2)[C@H]1O,9135074,1,54,full reaction|has preparation,"C7H14O5P(1-)|(3R,3aR,5S,6S,6aR)-6-Benzyloxy-5-phenyl-hexahydro-furo[3,2-b]furan-2,3-diol","(E)-(S)-4-((2R,3R,4R,5S)-4-Benzyloxy-3-hydroxy-5-phenyl-tetrahydro-furan-2-yl)-4-hydroxy-but-2-enoic acid methyl ester",167319,Preparation,1,,Michael addition,,,"6366526; Article; Yoda, Hidemi; Nakaseko, Yuka; Takabe, Kunihiko; Synlett; 9; (2002); p. 1532 - 1534;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=C/C=C/c1ccccc1,COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)C1=C(C#N)C=CC(c3ccccc3)N1CC2,O=C/C=C/c1ccccc1>>COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)C1=C(C#N)C=CC(c3ccccc3)N1CC2,9296000,1,54,full reaction|has preparation,"(E)-3-phenylpropenal|6,7-dimethoxy-1-cyanomethylene-1,2,3,4-tetrahydroisoquinoline","9,10-dimethoxy-4-phenyl-6,7-dihydro-4H-benzo[a]quinolizine-1-carbonitrile",91062,Preparation,1,,Michael reaction,,,"6401778; Article; Nemes, Péter; Vincze, Zoltán; Balázs, Barbara",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0666667,Heating|microwave irradiation,,,,,,,,,,,,,,,,
[H]C(=O)C1=CCCCC1,COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)C1=C(C#N)C=C3CCCCC3N1CC2,[H]C(=O)C1=CCCCC1>>COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)C1=C(C#N)C=C3CCCCC3N1CC2,9309225,1,54,full reaction|has preparation,"1-cyclohexene-1-carboxaldehyde|6,7-dimethoxy-1-cyanomethylene-1,2,3,4-tetrahydroisoquinoline","8,9-dimethoxy-2,3,4,4a,5,6-hexahydro-1H-4b-aza-chrysene-11-carbonitrile",91062,Preparation,1,,Michael reaction,,,"6401778; Article; Nemes, Péter; Vincze, Zoltán; Balázs, Barbara",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0666667,Heating|microwave irradiation,,,,,,,,,,,,,,,,
O=C/C=C/c1ccco1,COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)C1=C(C#N)C=CC(c3ccco3)N1CC2,O=C/C=C/c1ccco1>>COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)C1=C(C#N)C=CC(c3ccco3)N1CC2,9309310,1,54,full reaction|has preparation,"(E)-3-(2-furanyl)-2-propenal|6,7-dimethoxy-1-cyanomethylene-1,2,3,4-tetrahydroisoquinoline","4-furan-2-yl-9,10-dimethoxy-6,7-dihydro-4H-pyrido[2,1-a]isoquinoline-1-carbonitrile",192271,Preparation,1,,Michael reaction,,,"6401778; Article; Nemes, Péter; Vincze, Zoltán; Balázs, Barbara",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0666667,Heating|microwave irradiation,,,,,,,,,,,,,,,,
CC1(C)[C@H]2CC=C(C=O)[C@@H]1C2,COc1cc2c(cc1OC)/C(=C/C#N)NCC2.[H][C@]12CC3C(=CC(C#N)=C4c5cc(OC)c(OC)cc5CCN43)[C@]([H])(C1)C2(C)C,CC1(C)[C@H]2CC=C(C=O)[C@@H]1C2>>COc1cc2c(cc1OC)/C(=C/C#N)NCC2.[H][C@]12CC3C(=CC(C#N)=C4c5cc(OC)c(OC)cc5CCN43)[C@]([H])(C1)C2(C)C,9316234,1,54,full reaction|has preparation,"myrtenal|6,7-dimethoxy-1-cyanomethylene-1,2,3,4-tetrahydroisoquinoline",C23H26N2O2,91062,Preparation,1,,Michael reaction,,,"6401778; Article; Nemes, Péter; Vincze, Zoltán; Balázs, Barbara",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0666667,Heating|microwave irradiation,,,,,,,,,,,,,,,,
O=C1OC(c2ccccc2)=N/C1=C\c1ccc(Cl)cc1,S=C(S)Nc1ccccc1.[H]N([H])[H].O=C1OC(c2ccccc2)=N[C@H]1[C@H](SC(=S)Nc1ccccc1)c1ccc(Cl)cc1,O=C1OC(c2ccccc2)=N/C1=C\c1ccc(Cl)cc1>>S=C(S)Nc1ccccc1.[H]N([H])[H].O=C1OC(c2ccccc2)=N[C@H]1[C@H](SC(=S)Nc1ccccc1)c1ccc(Cl)cc1,9392616,1,54,full reaction|has preparation,(Z)-2-phenyl-4-(4-chlorobenzylidene)-5(4H)-oxazolone|ammonium phenyldithiocarbamate,"Phenyl-dithiocarbamic acid (R)-(4-chloro-phenyl)-((R)-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-methyl ester",224264,Preparation,1,,Michael addition,,,"6406297; Article; Yadav, Lal Dhar S.; Singh, Amrish; Tetrahedron Letters; vol. 44; 30; (2003); p. 5637 - 5640;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
COc1ccc(/C=C2\N=C(c3ccccc3)OC2=O)cc1,S=C(S)Nc1ccccc1.[H]N([H])[H].[H][C@@]1([C@H](SC(=S)Nc2ccccc2)c2ccc(OC)cc2)N=C(c2ccccc2)OC1=O,COc1ccc(/C=C2\N=C(c3ccccc3)OC2=O)cc1>>S=C(S)Nc1ccccc1.[H]N([H])[H].[H][C@@]1([C@H](SC(=S)Nc2ccccc2)c2ccc(OC)cc2)N=C(c2ccccc2)OC1=O,9393960,1,54,full reaction|has preparation,(4Z)-4-(4-methoxybenzylidene)-2-phenyl-oxazolin-5-one|ammonium phenyldithiocarbamate,"Phenyl-dithiocarbamic acid (R)-(4-methoxy-phenyl)-((R)-5-oxo-2-phenyl-4,5-dihydro-oxazol-4-yl)-methyl ester",224264,Preparation,1,,Michael addition,,,"6406297; Article; Yadav, Lal Dhar S.; Singh, Amrish; Tetrahedron Letters; vol. 44; 30; (2003); p. 5637 - 5640;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC1=N/C(=C\c2ccc(Cl)cc2)C(=O)O1,S=C(S)Nc1ccccc1.[H]N([H])[H].[H][C@@]1([C@H](SC(=S)Nc2ccccc2)c2ccc(Cl)cc2)N=C(C)OC1=O,CC1=N/C(=C\c2ccc(Cl)cc2)C(=O)O1>>S=C(S)Nc1ccccc1.[H]N([H])[H].[H][C@@]1([C@H](SC(=S)Nc2ccccc2)c2ccc(Cl)cc2)N=C(C)OC1=O,9396352,1,54,full reaction|has preparation,(Z)-4-(4-chlorobenzylidene)-2-methyloxazol-5(4H)-one|ammonium phenyldithiocarbamate,"Phenyl-dithiocarbamic acid (R)-(4-chloro-phenyl)-((R)-2-methyl-5-oxo-4,5-dihydro-oxazol-4-yl)-methyl ester",224264,Preparation,1,,Michael addition,,,"6406297; Article; Yadav, Lal Dhar S.; Singh, Amrish; Tetrahedron Letters; vol. 44; 30; (2003); p. 5637 - 5640;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C=CC(=O)c1ccccc1,CS(=O)(=O)c1ccc(CN2CCCNCC2)cc1.CS(=O)(=O)c1ccc(CN2CCCN(CCC(=O)c3ccccc3)CC2)cc1,C=CC(=O)c1ccccc1>>CS(=O)(=O)c1ccc(CN2CCCNCC2)cc1.CS(=O)(=O)c1ccc(CN2CCCN(CCC(=O)c3ccccc3)CC2)cc1,9738159,1,54,full reaction|has preparation,Phenyl vinyl ketone|1-[4-(methylsulfonyl)benzyl]homopiperazine,"3-[4-(4-methanesulfonyl-benzyl)-[1,4]diazepan-1-yl]-1-phenyl-propan-1-one",230562,Preparation,1,,Michael addition,,,"6472134; Article; Imai, Minoru; Shiota, Tatsuki; Kataoka, Ken-Ichiro; Tarby, Christine M.; Moree, Wilna J.; Tsutsumi, Takaharu; Sudo, Masaki; Ramirez-Weinhouse, Michele M.; Comer, Daniel; Sun, Chung-M",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=C(O)CCOc1ccccc1,C=CC(=O)O.Oc1ccccc1,O=C(O)CCOc1ccccc1>>C=CC(=O)O.Oc1ccccc1,9871244,1,54,full reaction,3-phenoxypropanoic acid,acrylic acid|phenol,267020|176421,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
COC(=O)CCOc1ccccc1,C=CC(=O)OC.Oc1ccccc1,COC(=O)CCOc1ccccc1>>C=CC(=O)OC.Oc1ccccc1,9874855,1,54,full reaction,methyl 3-phenoxypropanoate,acrylic acid methyl ester|phenol,267020|176420,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
COC(=O)CCSc1ccccc1,Sc1ccccc1.C=CC(=O)OC,COC(=O)CCSc1ccccc1>>Sc1ccccc1.C=CC(=O)OC,9876211,1,54,full reaction,methyl 3-phenylthiopropanoate,thiophenol|acrylic acid methyl ester,176343|242890,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
O=C(O)CCSc1ccccc1,Sc1ccccc1.C=CC(=O)O,O=C(O)CCSc1ccccc1>>Sc1ccccc1.C=CC(=O)O,9876833,1,54,full reaction,acide phenylthio-3 propanoique,thiophenol|acrylic acid,176343|242890,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
CCOC(=O)CCSc1ccccc1,Sc1ccccc1.C=CC(=O)O,CCOC(=O)CCSc1ccccc1>>Sc1ccccc1.C=CC(=O)O,9876915,1,54,full reaction,ethyl 3-(phenylthio)propionate,thiophenol|acrylic acid,115799|242890,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
N#CCCOc1ccccc1,C=CC#N.Oc1ccccc1,N#CCCOc1ccccc1>>C=CC#N.Oc1ccccc1,9877601,1,54,full reaction,3-phenoxypropionitrile,acrylonitrile|phenol,267020|176420,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
CCOC(=O)CCOc1ccccc1,C=CC(=O)O.Oc1ccccc1,CCOC(=O)CCOc1ccccc1>>C=CC(=O)O.Oc1ccccc1,9878133,1,54,full reaction,3-phenoxypropionic acid ethyl ester,acrylic acid|phenol,267020|115802,Chemical behaviour,1,326.85,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
O=C(O)CCCc1ccccc1,C=CC(=O)O.Cc1ccccc1,O=C(O)CCCc1ccccc1>>C=CC(=O)O.Cc1ccccc1,9895533,1,54,full reaction,4-Phenylbutyric acid,acrylic acid|toluene,176500|311132,Chemical behaviour,1,600,retro-Michael reaction,Kinetics,acetonitrile,6496021; Article; Al-Awadi; Abdallah; Dib; Ibrahim; Al-Awadi; El-Dusouqui; Tetrahedron; vol. 61; 24; (2005); p. 5769 - 5777;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Temperatures,,,,,,,,
CC1(C)COC(=S)N1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1.CC1(C)COC(=S)N1/C=C/S(=O)(=O)c1ccccc1,CC1(C)COC(=S)N1>>O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1.CC1(C)COC(=S)N1/C=C/S(=O)(=O)c1ccccc1,10488908,1,54,full reaction|has preparation,"4,4-dimethyloxazolidine-2-thione|1,2-Bis(phenylsulfonyl)ethylene","3-(2-benzenesulfonyl-vinyl)-4,4-dimethyl-oxazolidine-2-thione",284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
[H][C@@]1(CC)COC(=S)N1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1.CC[C@@H]1COC(=S)N1/C=C/S(=O)(=O)c1ccccc1,[H][C@@]1(CC)COC(=S)N1>>O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1.CC[C@@H]1COC(=S)N1/C=C/S(=O)(=O)c1ccccc1,10490288,1,54,full reaction|has preparation,"(4R)-4-ethyl-1,3-oxazolidine-2-thione|1,2-Bis(phenylsulfonyl)ethylene",3-(2-benzenesulfonyl-vinyl)-4-ethyl-oxazolidine-2-thione,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1,C[C@@H]1NC(=S)O[C@@H]1c1ccccc1.C[C@H]1[C@@H](c2ccccc2)OC(=S)N1/C=C/S(=O)(=O)c1ccccc1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1>>C[C@@H]1NC(=S)O[C@@H]1c1ccccc1.C[C@H]1[C@@H](c2ccccc2)OC(=S)N1/C=C/S(=O)(=O)c1ccccc1,10507475,1,54,full reaction|has preparation,"1,2-Bis(phenylsulfonyl)ethylene|(4S,5R)-4-methyl-5-phenyl-1,3-oxazolidine-2-thione",3-(2-benzenesulfonyl-vinyl)-4-methyl-5-phenyl-oxazolidine-2-thione,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1,S=C1N[C@@H](Cc2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@@H]1Cc1ccccc1)c1ccccc1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1>>S=C1N[C@@H](Cc2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@@H]1Cc1ccccc1)c1ccccc1,10507476,1,54,full reaction|has preparation,"1,2-Bis(phenylsulfonyl)ethylene|(4S)-4-benzyl-1,3-oxazolidine-2-thione",3-(2-benzenesulfonyl-vinyl)-4-benzyl-oxazolidine-2-thione,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1,S=C1N[C@H](c2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@@H]1c1ccccc1)c1ccccc1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1>>S=C1N[C@H](c2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@@H]1c1ccccc1)c1ccccc1,10507477,1,54,full reaction|has preparation,"1,2-Bis(phenylsulfonyl)ethylene|(R)-4-phenyl-1,3-oxazolidine-2-thione",3-(2-benzenesulfonyl-vinyl)-4-phenyl-oxazolidine-2-thione,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1,S=C1N[C@H](Cc2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@H]1Cc1ccccc1)c1ccccc1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1>>S=C1N[C@H](Cc2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@H]1Cc1ccccc1)c1ccccc1,10507478,1,54,full reaction|has preparation,"1,2-Bis(phenylsulfonyl)ethylene|(R)-4-benzyl-2-oxazolidinethione",3-(2-benzenesulfonyl-vinyl)-4-benzyl-oxazolidine-2-thione,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1,S=C1N[C@@H](c2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@H]1c1ccccc1)c1ccccc1,O=S(=O)(C=CS(=O)(=O)c1ccccc1)c1ccccc1>>S=C1N[C@@H](c2ccccc2)CO1.O=S(=O)(/C=C/N1C(=S)OC[C@H]1c1ccccc1)c1ccccc1,10507479,1,54,full reaction|has preparation,"1,2-Bis(phenylsulfonyl)ethylene|(S)-4-phenyl-1,3-oxazolidine-2-thione",3-(2-benzenesulfonyl-vinyl)-4-phenyl-oxazolidine-2-thione,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@@]23CNC(=S)O3)O1,O=S(=O)(/C=C/S(=O)(=O)c1ccccc1)c1ccccc1.CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@@]23CN(/C=C/S(=O)(=O)c2ccccc2)C(=S)O3)O1,CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@@]23CNC(=S)O3)O1>>O=S(=O)(/C=C/S(=O)(=O)c1ccccc1)c1ccccc1.CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@@]23CN(/C=C/S(=O)(=O)c2ccccc2)C(=S)O3)O1,10510720,1,54,full reaction|has preparation,"C14H21NO6S|(E)-1,2-bis(phenylsulfonyl)ethylene",C22H27NO8S2,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@]23CNC(=S)O3)O1,O=S(=O)(/C=C/S(=O)(=O)c1ccccc1)c1ccccc1.CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@]23CN(/C=C/S(=O)(=O)c2ccccc2)C(=S)O3)O1,CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@]23CNC(=S)O3)O1>>O=S(=O)(/C=C/S(=O)(=O)c1ccccc1)c1ccccc1.CC1(C)OCC([C@H]2O[C@@H]3OC(C)(C)O[C@@H]3[C@]23CN(/C=C/S(=O)(=O)c2ccccc2)C(=S)O3)O1,10510721,1,54,full reaction|has preparation,"C14H21NO6S|(E)-1,2-bis(phenylsulfonyl)ethylene",C22H27NO8S2,284082,Preparation,1,,Michael addition,,,"6655389; Article; Tardy, Sébastien; Tatibouët, Arnaud; Rollin,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,C=CS(C)(=O)=O.CS(=O)(=O)CCNC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1>>C=CS(C)(=O)=O.CS(=O)(=O)CCNC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,11205117,1,54,full reaction|has preparation,"[5-(4-amino-piperidin-1-ylmethyl)-pyrrolo[2,1-f][1,2,4]triazin-4-yl]-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-amine|methyl ethenyl sulphone",C29H33FN8O2S,230570,Preparation,1,,Michael addition,,,"7061582; Article; Mastalerz, Harold; Chang, Ming; Chen, Ping; Fink, Brian E.; Gavai, Ashvinikumar; Han, Wen-Ching; Johnson, Walter; Langley, David; Lee, Francis Y.; Leavitt, Kenneth; Marathe, Punit; N",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C=CC(=O)NCC(C)(C)CS(=O)(=O)[O-].[Na+],,C=CC(=O)NCC(C)(C)CS(=O)(=O)[O-].[Na+]>>,22875919,1,54,half reaction|has preparation,"N-(3-sulfo-2,2-dimethylpropyl)acrylamide sodium salt|perfluorooctylethylenethiols, mixture of",,,Preparation,1,,Michael Addition|Michael Addition,,,8815239; Patent; 3M INNOVATIVE PROPERTIES; US6365769; B1; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page column 25-26,,,,,,,,,2,"N-(3-sulfo-2,2-dimethylpropyl)acrylamide sodium salt|perfluorooctylethylenethiols, mixture of",48,,,
C=CC(=O)[O-].[Na+],,C=CC(=O)[O-].[Na+]>>,22875920,1,54,half reaction|has preparation,"perfluorooctylethylenethiols, mixture of|sodium 2-propenoate",,,Preparation,1,,Michael Addition|Michael Addition,,,8815239; Patent; 3M INNOVATIVE PROPERTIES; US6365769; B1; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page column 25-26,,,,,,,,,2,"perfluorooctylethylenethiols, mixture of|sodium 2-propenoate",49,,,
O=C(/C(Br)=C/c1ccccc1)C(F)(F)F,CCN(CC)[Si](C)(C)C.CCN(CC)C(/C(Br)=C(\O[Si](C)(C)C)C(F)(F)F)c1ccccc1,O=C(/C(Br)=C/c1ccccc1)C(F)(F)F>>CCN(CC)[Si](C)(C)C.CCN(CC)C(/C(Br)=C(\O[Si](C)(C)C)C(F)(F)F)c1ccccc1,25935151,1,54,full reaction|has preparation,"(Z)-3-bromo-4-phenyl-1,1,1-trifluorobut-3-en-2-one|N,N-diethyl-1,1,1-trimethylsilanamine",C17H25BrF3NOSi,192910,Preparation,1,,aza-Michael addition,,,"7171166; Article; Rulev, Alexander Yu.; Uchakov, Igor A.; Nenajdenko, Valentin G.; Balenkova, Elisabeth S.; Voronkov, Mikhail G.; European Journal of Organic Chemistry; 36; (2007); p. 6039 - 6045;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,microwave irradiation,,,,,,,,,,,,,,,,
O=C(CC(=O)OCc1ccccc1)OCc1ccccc1,O=C(C=Cc1ccccc1)c1ccccc1.O=C(CC(c1ccccc1)C(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1,O=C(CC(=O)OCc1ccccc1)OCc1ccccc1>>O=C(C=Cc1ccccc1)c1ccccc1.O=C(CC(c1ccccc1)C(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1)c1ccccc1,29035651,2,54,full reaction|has preparation,malonic acid dibenzyl ester|benzalacetophenone,"dibenzyl 2-(3-oxo-1,3-diphenylpropyl)malonate",229111,"['Preparation', 'Chemical behaviour']","['1', '1']",,"['Michael addition', 'Michael Addition']",Catalytic behavior,isopropyl alcohol,"['8827048; Article; Chen, Donghui; Chen, Zhenling; Xiao, Xiao; Yang, Zhigang; Lin, Lili; Liu, Xiaohua; Feng, Xiaoming; Chemistry - A European Journal; vol. 15; 28; (2009); p. 6807 - 6810;', '123081330; Article; Zhang, Tai-Song;Fei, Wenwen;Li, Na;Zhang, Ying;Xu, Chang;Luo, Qiquan;Li, Man-Bo; Nano Letters; vol. 23; 1; (2023); p. 235 - 242;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Molecular sieve|Inert atmosphere,,supporting information; experimental part,,"['potassium carbonate', 'C124H108Au8N4P8(1+)*Cl(1-)']","dibenzyl 2-(3-oxo-1,3-diphenylpropyl)malonate",99 percent,,,Scheme or table,,2,benzalacetophenone|malonic acid dibenzyl ester,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(Br)C(=O)Nc1cc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)NCCNC(=N)N)n(C)c4)n(C)c3)n(C)c2)n(C)c1.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(NC(=O)C(Br)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)cn4C)cn3C)cn2C)cc1C(=O)NCCNC(=N)N,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(Br)C(=O)Nc1cc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)NCCNC(=N)N)n(C)c4)n(C)c3)n(C)c2)n(C)c1.Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(NC(=O)C(Br)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)cn4C)cn3C)cn2C)cc1C(=O)NCCNC(=N)N,29742522,1,54,full reaction,GLUTATHIONE|N-(5-{[(5-{[(5-{[(2-{[amino(imino)methyl]amino}ethyl) amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)-4-[(2-bromoac,brostallicin-GSH,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8922795; Article; Pezzola, Silvia; Antonini, Giovanni; Geroni, Cristina; Beria, Italo; Colombo, Maristella; Broggini, Massimo; Mongelli, Nicola; Leboffe, Loris; MacArthur, Robert; Mozzi, Alessia Franc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,aq. phosphate buffer|Enzymatic reaction,6.5,experimental part,,ethylenediaminetetraacetic acid|recombinant human glutathione transferase M2-2,,,,,,,,,,,,
C1COCCN1,C=CC(=O)Nc1c(C(=O)NCC)noc1-c1cc(C(C)C)c(OCc2ccccc2)cc1OCc1ccccc1.CCNC(=O)c1noc(-c2cc(C(C)C)c(OCc3ccccc3)cc2OCc2ccccc2)c1NC(=O)CCN1CCOCC1,C1COCCN1>>C=CC(=O)Nc1c(C(=O)NCC)noc1-c1cc(C(C)C)c(OCc2ccccc2)cc1OCc1ccccc1.CCNC(=O)c1noc(-c2cc(C(C)C)c(OCc3ccccc3)cc2OCc2ccccc2)c1NC(=O)CCN1CCOCC1,32338352,2,54,full reaction|has preparation,morpholine|C32H33N3O5,"5-[2,4-bis(benzyloxy)-5-isopropyl-phenyl]-4-(3-morpholin-4-yl-propionylamino)isoxazole-3-carboxylic acid ethylamide",230562,"['Preparation', 'Preparation']","['1', '1']",,Michael addition,,,"['20071662; Article; Baruchello, Riccardo; Simoni, Daniele; Grisolia, Giuseppina; Barbato, Giuseppina; Marchetti, Paolo; Rondanin, Riccardo; Mangiola, Stefania; Giannini, Giuseppe; Brunetti, Tiziana; Al', '64368581; Article; Giannini, Giuseppe; Battistuzzi, Gianfranco; Bioorganic and Medicinal Chemistry Letters; vol. 25; 3; (2015); p. 462 - 465;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,"['Inert atmosphere|Reflux', 'Reflux']",,"['supporting information; experimental part', 'supporting information']",,,,,,,Scheme or table,,,,,,,
C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1,O=[N+]([O-])/C=C/c1ccccc1.CCC=O.C[C@@H]1[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1.C[C@@H]1[C@@H](c2ccccc2)C=[N+]([O-])O[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1.CC(=CN1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1,C[Si](C)(C)OC(c1ccccc1)(c1ccccc1)[C@@H]1CCCN1>>O=[N+]([O-])/C=C/c1ccccc1.CCC=O.C[C@@H]1[C@@H](c2ccccc2)[C@H]([N+](=O)[O-])[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1.C[C@@H]1[C@@H](c2ccccc2)C=[N+]([O-])O[C@H]1N1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1.CC(=CN1CCC[C@H]1C(O[Si](C)(C)C)(c1ccccc1)c1ccccc1)[C@H](C[N+](=O)[O-])c1ccccc1,34668337,1,54,full reaction|has preparation,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|nitrostyrene|propionaldehyde,"(2S)-(diphenyl((trimethylsilyl)oxy)methyl)-1-((1'S,2'R,3'S,4'S)-2'-methyl-4'-nitro-3'-phenylcyclobutyl)pyrrolidine|(4S,5R,6R)-6-[(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidin-1-yl]-5-methyl-4",193682|5028|12462,Preparation,1,,Michael Addition,,(2)H8-toluene,"35452456; Article; Sahoo, Gokarneswar; Rahaman, Hasibur; Madarasz, Adam; Papai, Imre; Melarto, Mikko; Valkonen, Arto; Pihko, Petri M.; Angewandte Chemie - International Edition; vol. 51; 52; (2012); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Molecular sieve,,supporting information,,,,,,,Experimental part,,,,,,,
C[N+](=O)[O-],CCOC(=O)/C=C/c1ccccc1C=O.CCOC(=O)C[C@@H]1c2ccccc2[C@H](O)[C@H]1[N+](=O)[O-].CCOC(=O)C[C@H]1c2ccccc2[C@@H](O)[C@@H]1[N+](=O)[O-].CCOC(=O)C[C@H]1c2ccccc2[C@H](O)[C@@H]1[N+](=O)[O-].CCOC(=O)C[C@@H]1c2ccccc2[C@@H](O)[C@H]1[N+](=O)[O-],C[N+](=O)[O-]>>CCOC(=O)/C=C/c1ccccc1C=O.CCOC(=O)C[C@@H]1c2ccccc2[C@H](O)[C@H]1[N+](=O)[O-].CCOC(=O)C[C@H]1c2ccccc2[C@@H](O)[C@@H]1[N+](=O)[O-].CCOC(=O)C[C@H]1c2ccccc2[C@H](O)[C@@H]1[N+](=O)[O-].CCOC(=O)C[C@@H]1c2ccccc2[C@@H](O)[C@H]1[N+](=O)[O-],35716502,1,54,full reaction,nitromethane|(E)-3-(2-formylphenyl)propenoic acid ethyl ester,"(1R,2S,3S)-ethyl (3-hydroxy-2-nitroindan-1-yl)acetate|(1S,2R,3R)-ethyl (3-hydroxy-2-nitroindan-1-yl)acetate|(1S,2R,3S)-ethyl (3-hydroxy-2-nitroindan-1-yl)acetate|(1S,2R,3S)-ethyl (3-hydroxy-2-nitroind",206533|206533|206533|206533,Chemical behaviour,1,4,Aldol Addition|Michael Addition,Catalytic behavior,tetrahydrofuran|tetrahydrofuran|nitromethane,"35501811; Article; Yuan, Hongling; Hu, Junhao; Gong, Yuefa; Tetrahedron Asymmetry; vol. 24; 12; (2013); p. 699 - 705;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24|12,,,,Overall yield = 82 %; enantioselective reaction,"C15H28N2|copper(II) acetate monohydrate|N-ethyl-N,N-diisopropylamine",,,,Concentration|Reagent/catalyst|Solvent|Temperature,Scheme or table,87 percent ee|73 percent ee,2,nitromethane|(E)-3-(2-formylphenyl)propenoic acid ethyl ester,,,,
[H][C@](N)(CS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,[H][C@](N)(CS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,37273747,1,54,full reaction,L-Cysteine|C20H16O4S,C23H23NO6S2,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@@](N)(CCS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCC[C@@H](N)C(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,[H][C@@](N)(CCS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCC[C@@H](N)C(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,37273748,1,54,full reaction,D-homocysteine|C20H16O4S,C24H25NO6S2,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)NCC(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,[H][C@](N)(CS)C(=O)NCC(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,37273749,1,54,full reaction,cysteinylglycine|C20H16O4S,C25H26N2O7S2,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,37273750,1,54,full reaction,γ-L-glutamyl-L-cysteine|C20H16O4S,C28H30N2O9S2,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(SC)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccc(SC)cc3)c(=O)oc2c1,37273751,1,54,full reaction,GLUTATHIONE|C20H16O4S,C30H33N3O10S2,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,[H][C@](N)(CS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,37273752,1,54,full reaction,L-Cysteine|C19H13NO6,C22H20N2O8S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@@](N)(CCS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCC[C@@H](N)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,[H][C@@](N)(CCS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCC[C@@H](N)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,37273753,1,54,full reaction,D-homocysteine|C19H13NO6,C23H22N2O8S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)NCC(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,[H][C@](N)(CS)C(=O)NCC(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,37273754,1,54,full reaction,cysteinylglycine|C19H13NO6,C24H23N3O9S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,37273755,1,54,full reaction,γ-L-glutamyl-L-cysteine|C19H13NO6,C27H27N3O11S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,37273756,1,54,full reaction,GLUTATHIONE|C19H13NO6,C29H30N4O12S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,[H][C@](N)(CS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,37273758,1,54,full reaction,L-Cysteine|C19H13BrO4,C22H20BrNO6S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@@](N)(CCS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCC[C@@H](N)C(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,[H][C@@](N)(CCS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCC[C@@H](N)C(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,37273759,1,54,full reaction,D-homocysteine|C19H13BrO4,C23H22BrNO6S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)NCC(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,[H][C@](N)(CS)C(=O)NCC(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,37273760,1,54,full reaction,cysteinylglycine|C19H13BrO4,C24H23BrN2O7S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,37273761,1,54,full reaction,γ-L-glutamyl-L-cysteine|C19H13BrO4,C27H27BrN2O9S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COc1ccc2cc(C(=O)C=Cc3ccc(Br)cc3)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccc(Br)cc3)c(=O)oc2c1,37273762,1,54,full reaction,GLUTATHIONE|C19H13BrO4,C29H30BrN3O10S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)O,CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)O)cc1,[H][C@](N)(CS)C(=O)O>>CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)O)cc1,37273763,1,54,full reaction,L-Cysteine|C21H18O5,C24H25NO7S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@@](N)(CCS)C(=O)O,CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SCC[C@@H](N)C(=O)O)cc1,[H][C@@](N)(CCS)C(=O)O>>CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SCC[C@@H](N)C(=O)O)cc1,37273764,1,54,full reaction,D-homocysteine|C21H18O5,C25H27NO7S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)NCC(=O)O,CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)NCC(=O)O)cc1,[H][C@](N)(CS)C(=O)NCC(=O)O>>CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)NCC(=O)O)cc1,37273765,1,54,full reaction,cysteinylglycine|C21H18O5,C26H28N2O8S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O,CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)cc1,[H][C@](N)(CCC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)O>>CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O)cc1,37273766,1,54,full reaction,γ-L-glutamyl-L-cysteine|C21H18O5,C29H32N2O10S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)cc1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCOc1ccc(C=CC(=O)c2cc3ccc(OC)cc3oc2=O)cc1.CCOc1ccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)cc1,37273767,1,54,full reaction,GLUTATHIONE|C21H18O5,C31H35N3O11S,228310,Chemical behaviour,1,30,Michael Addition,Kinetics,dimethyl sulfoxide,"62223629; Article; Aliaga, Margarita E.; Tiznado, William; Cassels, Bruce K.; Nunez, Marco T.; Millan, Daniela; Perez, Edwin G.; Garcia-Beltran, Olimpo; Pavez, Paulina; RSC Advances; vol. 4; 2; (2014)",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,6.8 - 7.4,,,,,,,,Experimental part,,,,,,,
C[N+](=O)[O-],O=C1CC(=Cc2ccc3ccc4cccc5ccc2c3c45)C(=O)N1[Ag]N1=C(O)C(=Cc2ccc3ccc4cccc5ccc2c3c45)CC1=O.O=C1CC(C(C[N+](=O)[O-])c2ccc3ccc4cccc5ccc2c3c45)C(=O)N1[Ag]N1=C(O)C(=Cc2ccc3ccc4cccc5ccc2c3c45)CC1=O,C[N+](=O)[O-]>>O=C1CC(=Cc2ccc3ccc4cccc5ccc2c3c45)C(=O)N1[Ag]N1=C(O)C(=Cc2ccc3ccc4cccc5ccc2c3c45)CC1=O.O=C1CC(C(C[N+](=O)[O-])c2ccc3ccc4cccc5ccc2c3c45)C(=O)N1[Ag]N1=C(O)C(=Cc2ccc3ccc4cccc5ccc2c3c45)CC1=O,37490240,1,54,full reaction|has preparation,nitromethane|C42H25AgN2O4,C43H28AgN3O6,208260,Preparation,1,,Michael Addition,,,"62447087; Article; Tong, Dingyi; Duan, Haifeng; Zhuang, Hejing; Cao, Jungang; Wei, Zhonglin; Lin, Yingjie; RSC Advances; vol. 4; 11; (2014); p. 5363 - 5366;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,,,,,,,,Scheme or table,,,,,,,
C[N+](=O)[O-],O=C1CC(=Cc2ccc3ccc4cccc5ccc2c3c45)C(=O)[N-]1.[Hg+2].O=C1CC(C(C[N+](=O)[O-])c2ccc3ccc4cccc5ccc2c3c45)C(=O)[N-]1.[Hg+2],C[N+](=O)[O-]>>O=C1CC(=Cc2ccc3ccc4cccc5ccc2c3c45)C(=O)[N-]1.[Hg+2].O=C1CC(C(C[N+](=O)[O-])c2ccc3ccc4cccc5ccc2c3c45)C(=O)[N-]1.[Hg+2],37490241,1,54,full reaction|has preparation,nitromethane|2C21H12NO2(1-)*Hg(2+),2C22H15N2O4(1-)*Hg(2+),225137,Preparation,1,,Michael Addition,,,"62447087; Article; Tong, Dingyi; Duan, Haifeng; Zhuang, Hejing; Cao, Jungang; Wei, Zhonglin; Lin, Yingjie; RSC Advances; vol. 4; 11; (2014); p. 5363 - 5366;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],Cc1ccc(N)c(C)c1C.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccc(C)c(C)c1C)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>Cc1ccc(N)c(C)c1C.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccc(C)c(C)c1C)[C@@]7([H])=[C@@]28[H],39609235,1,54,full reaction|has preparation,"acryloylferrocene|2,3,4-trimethylaniline",C22H25FeNO,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],Nc1ccccc1Br.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccccc1Br)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>Nc1ccccc1Br.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccccc1Br)[C@@]7([H])=[C@@]28[H],39609236,1,54,full reaction|has preparation,acryloylferrocene|2-bromoaniline,C19H18BrFeNO,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],Nc1cccc(Br)c1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1cccc(Br)c1)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>Nc1cccc(Br)c1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1cccc(Br)c1)[C@@]7([H])=[C@@]28[H],39609237,1,54,full reaction|has preparation,acryloylferrocene|m-Bromoaniline,C19H18BrFeNO,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],Nc1ccc(Br)cc1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccc(Br)cc1)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>Nc1ccc(Br)cc1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccc(Br)cc1)[C@@]7([H])=[C@@]28[H],39609238,1,54,full reaction|has preparation,acryloylferrocene|4-bromo-aniline,C19H18BrFeNO,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],COc1ccccc1N.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccccc1OC)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>COc1ccccc1N.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccccc1OC)[C@@]7([H])=[C@@]28[H],39609239,1,54,full reaction|has preparation,acryloylferrocene|2-methoxy-phenylamine,C20H21FeNO2,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],COc1cccc(N)c1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1cccc(OC)c1)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>COc1cccc(N)c1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1cccc(OC)c1)[C@@]7([H])=[C@@]28[H],39609240,1,54,full reaction|has preparation,acryloylferrocene|m-Anisidine,C20H21FeNO2,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H],COc1ccc(N)cc1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccc(OC)cc1)[C@@]7([H])=[C@@]28[H],[H]C([H])=C([H])C(=O)[C@]12=[C@]3([H])[C@]4([H])[C@]5([H])=[C@@]1([H])[Fe]42351678[C@]2([H])[C@@]1([H])=[C@@]6([H])[C@@]7([H])=[C@@]28[H]>>COc1ccc(N)cc1.[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@]2([H])=[C@@]1([H])[C@@-]6(C(=O)CCNc1ccc(OC)cc1)[C@@]7([H])=[C@@]28[H],39609241,1,54,full reaction|has preparation,acryloylferrocene|4-methoxy-aniline,C20H21FeNO2,,Preparation,1,,Michael Addition,,,"65685201; Article; Minić, Aleksandra; Stevanović, Dragana; Damljanović, Ivan; Pejović, Anka; Vukićev",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC1=CC(=O)C(=O)C=C1,,CC1=CC(=O)C(=O)C=C1>>,39951567,1,54,half reaction|has preparation,"4-methylbenzo-1,2-quinone|β-lactoglobulin","cysteine modified 3,4-dihydroxy-6-methylphenyl β-lactoglobulin A",,Preparation,1,,Michael Addition,,,"65873865; Article; Jongberg, Sisse; Lund, Marianne N.; Otte, Jeanette; Analytical Biochemistry; vol. 478; (2015); p. 40 - 48;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CC1=CC(=O)C(=O)C=C1,,CC1=CC(=O)C(=O)C=C1>>,39951568,1,54,half reaction|has preparation,"4-methylbenzo-1,2-quinone|β-lactoglobulin","cysteine modified 3,4-dihydroxy-6-methylphenyl β-lactoglobulin B",,Preparation,1,,Michael Addition,,,"65873865; Article; Jongberg, Sisse; Lund, Marianne N.; Otte, Jeanette; Analytical Biochemistry; vol. 478; (2015); p. 40 - 48;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
C1CCNC1,c1ccc2[nH]ccc2c1.C=O.c1ccc2c(CN3CCCC3)c[nH]c2c1,C1CCNC1>>c1ccc2[nH]ccc2c1.C=O.c1ccc2c(CN3CCCC3)c[nH]c2c1,39976479,1,54,full reaction,pyrrolidine|indole|formaldehyd,N-pyrrolyl-3-indolylmethylamine,275616,Chemical behaviour,1,,Michael Addition,Catalytic behavior,"water|N,N-dimethyl-formamide","65473807; Article; Bukhryakov, Konstantin V.; Desyatkin, Victor G.; O'Shea, John-Paul; Almahdali, Sarah R.; Solovyeva, Vera; Rodionov, Valentin O.; ACS Combinatorial Science; vol. 17; 2; (2015); p. 76",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,copper(II) bis(trifluoromethanesulfonate),,,,,Experimental part,,,,,,,
CCCSC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CCCSC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],41584231,2,54,full reaction|has preparation,C17H19NS*ClHO4,10-methylacridinium perchlorate,168295,"['Preparation', 'Chemical behaviour']","['1', '1']",20,Michael Addition,Equilibrium constant|Kinetics,dimethylsulfoxide-d6,"['67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;', '67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,regioselective reaction,iodine|triethylamine,,,,,"['Scheme or table', 'Scheme or table']",,,,,,,
c1c[nH]cn1,BrCCOCCBr.N#C[N-]C#N.[Na+].C=CC#N.CCOCC[N+]1=CN(CCC#N)CC1.N#C[N-]C#N,c1c[nH]cn1>>BrCCOCCBr.N#C[N-]C#N.[Na+].C=CC#N.CCOCC[N+]1=CN(CCC#N)CC1.N#C[N-]C#N,44085376,1,54,full reaction|has preparation,"1H-imidazole|1,1'-oxybis(2-bromo-ethane)|sodium dicyanamide|acrylonitrile",C10H18N3O(1+)*C2N3(1-),57652,Preparation,1,,Michael Addition,,,"70138485; Article; Raj, Jaganathan Joshua; Wilfred, Cecilia Devi; Shah, Syed Nasir; Pranesh, Matheswaran; Abdul Mutalib; Lethesh, Kallidanthiyil Chellappan; Journal of Molecular Liquids; vol. 225; (20",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,3,"1H-imidazole|acrylonitrile|1,1'-oxybis(2-bromo-ethane)|sodium dicyanamide",,,,
c1c[nH]cn1,BrCCOCCBr.C=CC#N.O=C(O)C(F)(F)F.CCOCC[N+]1=CN(CCC#N)CC1.O=C([O-])C(F)(F)F,c1c[nH]cn1>>BrCCOCCBr.C=CC#N.O=C(O)C(F)(F)F.CCOCC[N+]1=CN(CCC#N)CC1.O=C([O-])C(F)(F)F,44085377,1,54,full reaction|has preparation,"1H-imidazole|1,1'-oxybis(2-bromo-ethane)|acrylonitrile|trifluoroacetic acid",C10H18N3O(1+)*C2F3O2(1-),57652,Preparation,1,,Michael Addition,,,"70138485; Article; Raj, Jaganathan Joshua; Wilfred, Cecilia Devi; Shah, Syed Nasir; Pranesh, Matheswaran; Abdul Mutalib; Lethesh, Kallidanthiyil Chellappan; Journal of Molecular Liquids; vol. 225; (20",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,3,"1H-imidazole|acrylonitrile|1,1'-oxybis(2-bromo-ethane)|trifluoroacetic acid",,,,
c1c[nH]cn1,BrCCOCCBr.C=CC#N.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.[Li+].CCOCC[N+]1=CN(CCC#N)CC1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,c1c[nH]cn1>>BrCCOCCBr.C=CC#N.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.[Li+].CCOCC[N+]1=CN(CCC#N)CC1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,44085378,1,54,full reaction|has preparation,"1H-imidazole|1,1'-oxybis(2-bromo-ethane)|acrylonitrile|bis(trifluoromethane)sulfonimide lithium",C10H18N3O(1+)*C2F6NO4S2(1-),57652,Preparation,1,,Michael Addition,,,"70138485; Article; Raj, Jaganathan Joshua; Wilfred, Cecilia Devi; Shah, Syed Nasir; Pranesh, Matheswaran; Abdul Mutalib; Lethesh, Kallidanthiyil Chellappan; Journal of Molecular Liquids; vol. 225; (20",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,3,"1H-imidazole|acrylonitrile|1,1'-oxybis(2-bromo-ethane)|bis(trifluoromethane)sulfonimide lithium",,,,
O=[N+]([O-])C=Cc1ccccc1,CCCCC=CN1CCCC1.CCCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCC1C(c2ccccc2)C([N+](=O)[O-])C1N1CCCC1.CCCCC(=CN1CCCC1)C(C[N+](=O)[O-])c1ccccc1,O=[N+]([O-])C=Cc1ccccc1>>CCCCC=CN1CCCC1.CCCC[C@@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1.CCCCC1C(c2ccccc2)C([N+](=O)[O-])C1N1CCCC1.CCCCC(=CN1CCCC1)C(C[N+](=O)[O-])c1ccccc1,44628044,1,54,full reaction|has preparation,(2-nitroethenyl)benzene|hexaldehyde enamine,anti-(2-nitro-1-phenylethyl)hexanal|syn-(2-nitro-1-phenylethyl)hexanal|1-(2-butyl-4-nitro-3-phenylcyclobutyl)-pyrrolidine|C18H26N2O2,224686|211459|211459|136212,Preparation,1,,Michael Addition,,(2)H8-toluene,"69554840; Article; Donadío, Lucía Gandolfi; Galetti, Mariana A.; Giorgi, Gianluca; Rasparini,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,,,,,,,Experimental part,,,,,,,
Cc1ccc(S(=O)(=O)Nc2ccccc2/C=C/C(=O)c2ccccc2)cc1,O=[N+]([O-])C=CC(F)(F)F.Cc1ccc(S(=O)(=O)N2c3ccccc3[C@@H](CC(=O)c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2C(F)(F)F)cc1.Cc1ccc(S(=O)(=O)N2c3ccccc3[C@H](CC(=O)c3ccccc3)[C@@H]([N+](=O)[O-])[C@@H]2C(F)(F)F)cc1,Cc1ccc(S(=O)(=O)Nc2ccccc2/C=C/C(=O)c2ccccc2)cc1>>O=[N+]([O-])C=CC(F)(F)F.Cc1ccc(S(=O)(=O)N2c3ccccc3[C@@H](CC(=O)c3ccccc3)[C@H]([N+](=O)[O-])[C@H]2C(F)(F)F)cc1.Cc1ccc(S(=O)(=O)N2c3ccccc3[C@H](CC(=O)c3ccccc3)[C@@H]([N+](=O)[O-])[C@@H]2C(F)(F)F)cc1,45687331,1,54,full reaction,"4-methyl-N-(2-((E)-3-oxo-3-phenylprop-1-en-1-yl)phenyl)benzenesulfonamide|(E/Z)-3-Nitro-1,1,1-trifluoro-2-propene","2-(3-nitro-1-tosyl-2-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)-1-phenylethanone|2-((2R,3R,4S)-3-nitro-1-tosyl-2-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)-1-phenylethanone",219770|219770,Chemical behaviour,1,,Michael Addition,Catalytic behavior,toluene,"71540455; Article; Zhu, Yuanyuan; Li, Boyu; Wang, Cui; Dong, Zhenghao; Zhong, Xiaoling; Wang, Kairong; Yan, Wenjin; Wang, Rui; Organic and Biomolecular Chemistry; vol. 15; 21; (2017); p. 4544 - 4547;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Inert atmosphere,,supporting information,Overall yield = 77 %; Overall yield = 79.8 mg; stereoselective reaction,quinine thiourea,,,,Solvent|Reagent/catalyst,Experimental part,60 percent ee,,,,,,
CC(C)(C)OC(=O)NC(COCCCO)(COCCCO)COCCCO,C=CC(=O)OC.COC(=O)CCOCCCOCC(COCCCOCCC(=O)OC)(COCCCOCCC(=O)OC)NC(=O)OC(C)(C)C,CC(C)(C)OC(=O)NC(COCCCO)(COCCCO)COCCCO>>C=CC(=O)OC.COC(=O)CCOCCCOCC(COCCCOCCC(=O)OC)(COCCCOCCC(=O)OC)NC(=O)OC(C)(C)C,59008987,2,54,full reaction|has preparation,N-(BOC)-tris[(hydroxypropoxy)methyl]aminomethane|acrylic acid methyl ester,C30H55NO14,90309,"['Preparation', 'Preparation']","['1', '1']",,"['Michael Addition', 'Michael Addition']",,,"['99683594; Patent; VERVE THERAPEUTICS; WO2021/178725; A1; (2021);', '136842755; Patent; VERVE THERAPEUTICS; US2024/316212; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0466', 'Paragraph 0658']",,,,,,,,,,,"['1', '1']",,,
COC(=O)C[N+](=O)[O-],C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)C[N+](=O)[O-].COC(=O)C[N+](=O)[O-].COC(=O)C[N+](=O)[O-].COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)(CC1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)[C@@H](C[C@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-],COC(=O)C[N+](=O)[O-]>>C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.C=C1CCN(C(=O)OC(C)(C)C)C1=O.COC(=O)C[N+](=O)[O-].COC(=O)C[N+](=O)[O-].COC(=O)C[N+](=O)[O-].COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)(CC1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)[C@H](C[C@@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)[C@@H](C[C@H]1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-].COC(=O)C(CC1CCN(C(=O)OC(C)(C)C)C1=O)[N+](=O)[O-],67550787,1,54,full reaction,methyl 2-nitroacetate|tert-butyl 3-methylene-2-oxopyrrolidine-1-carboxylate,"di-tert-butyl 3,3'-(2-(methoxycarbonyl)-2-nitropropane-1,3-diyl)bis(2-oxopyrrolidine-1-carboxylate)|tert-butyl 3-(3-methoxy-2-nitro-3-oxopropyl)-2-oxopyrrolidine-1-carboxylate|tert-butyl 3-(3-methoxy-",,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"134430900; Article; Szpera, Robert;Huang, Shanjun;Fenton, Harriet A. M.;Waddington, William;Gymer, Adam E. S.;Moses, Ian B.;Buck, Julia;Ingram, Heather;Fussell, Steven J.;Walton, Robert;Shanahan, Char",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,supporting information,,"1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea","di-tert-butyl 3,3'-(2-(methoxycarbonyl)-2-nitropropane-1,3-diyl)bis(2-oxopyrrolidine-1-carboxylate)",0.7 g,,Solvent,Experimental part,76 percent ee,,,,,,
C1CNCCN1,O=C1C=CC(=O)c2c(O)cccc21.O=C1C(N2CCNCC2)=CC(=O)c2c(O)cccc21,C1CNCCN1>>O=C1C=CC(=O)c2c(O)cccc21.O=C1C(N2CCNCC2)=CC(=O)c2c(O)cccc21,67780472,1,54,full reaction|has preparation,"piperazine|5-hydroxynaphtho-1,4-quinone",C14H14N2O3,280992,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C=CC(=O)c2c(O)cccc21,Nc1ccc(Cl)c(O)c1.[H]N(C1=CC(=O)c2c(O)cccc2C1=O)c1ccc(Cl)c(O)c1,O=C1C=CC(=O)c2c(O)cccc21>>Nc1ccc(Cl)c(O)c1.[H]N(C1=CC(=O)c2c(O)cccc2C1=O)c1ccc(Cl)c(O)c1,67780474,1,54,full reaction|has preparation,"5-hydroxynaphtho-1,4-quinone|5-amino-2-chlorophenol",C16H10ClNO4,288664,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C1CNCCN1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21.O=C1C(Cl)=C(N2CCNCC2)C(=O)c2c(O)ccc(O)c21,C1CNCCN1>>O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21.O=C1C(Cl)=C(N2CCNCC2)C(=O)c2c(O)ccc(O)c21,67780475,1,54,full reaction|has preparation,"piperazine|2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone","2-chloro-5,8-dihydroxy-3-(piperazin-1-yl)-[1,4]naphthoquinone",277889,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21,NCCO.[H]N(CCO)C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21>>NCCO.[H]N(CCO)C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O,67780476,1,54,full reaction|has preparation,"2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone|ethanolamine",C12H10ClNO5,278776,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
NCCc1ccc(O)c(O)c1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21.[H]N(CCc1ccc(O)c(O)c1)C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O,NCCc1ccc(O)c(O)c1>>O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21.[H]N(CCc1ccc(O)c(O)c1)C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O,67780477,1,54,full reaction|has preparation,"3,4-dihydroxyphenylethylamine|2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone",C18H14ClNO6,278776,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21,Nc1cccc(O)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1cccc(O)c1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21>>Nc1cccc(O)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1cccc(O)c1,67780478,1,54,full reaction|has preparation,"2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone|3-Aminophenol",C16H10ClNO5,285264,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21,COc1ccc(N)cc1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1ccc(OC)cc1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21>>COc1ccc(N)cc1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1ccc(OC)cc1,67780479,1,54,full reaction|has preparation,"2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone|4-methoxy-aniline",C17H12ClNO5,285265,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21,CC(C)(C)OC(=O)Nc1cccc(N)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1cccc(NC(=O)OC(C)(C)C)c1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21>>CC(C)(C)OC(=O)Nc1cccc(N)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1cccc(NC(=O)OC(C)(C)C)c1,67780480,1,54,full reaction|has preparation,"2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone|(3-aminophenyl)carbamic acid tert-butyl ester",C21H19ClN2O6,285264,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21,Nc1ccc(O)c(C(=O)O)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1ccc(O)c(C(=O)O)c1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21>>Nc1ccc(O)c(C(=O)O)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1ccc(O)c(C(=O)O)c1,67780481,1,54,full reaction|has preparation,"2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone|5-Aminosalicylic Acid",C17H10ClNO7,285265,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21,Nc1ccc(Cl)c(O)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1ccc(Cl)c(O)c1,O=C1C(Cl)=C(Cl)C(=O)c2c(O)ccc(O)c21>>Nc1ccc(Cl)c(O)c1.[H]N(C1=C(Cl)C(=O)c2c(O)ccc(O)c2C1=O)c1ccc(Cl)c(O)c1,67780482,1,54,full reaction|has preparation,"2,3-dichloro-5,8-dihydroxy-[1,4]naphthoquinone|5-amino-2-chlorophenol",C16H9Cl2NO5,285264,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C1CNCCN1,O=C1C(Cl)=C(Cl)C(=O)c2c1cccc2[N+](=O)[O-].O=C1C(N2CCNCC2)=C(Cl)C(=O)c2c1cccc2[N+](=O)[O-],C1CNCCN1>>O=C1C(Cl)=C(Cl)C(=O)c2c1cccc2[N+](=O)[O-].O=C1C(N2CCNCC2)=C(Cl)C(=O)c2c1cccc2[N+](=O)[O-],67780483,1,54,full reaction|has preparation,"piperazine|2,3-dichloro-5-nitro-1,4-naphthoquinone",C14H12ClN3O4,68510,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C(Cl)=C(Cl)C(=O)c2c1cccc2[N+](=O)[O-],Nc1ccc(O)c(C(=O)O)c1.[H]N(C1=C(Cl)C(=O)c2c(cccc2[N+](=O)[O-])C1=O)c1ccc(O)c(C(=O)O)c1,O=C1C(Cl)=C(Cl)C(=O)c2c1cccc2[N+](=O)[O-]>>Nc1ccc(O)c(C(=O)O)c1.[H]N(C1=C(Cl)C(=O)c2c(cccc2[N+](=O)[O-])C1=O)c1ccc(O)c(C(=O)O)c1,67780484,1,54,full reaction|has preparation,"2,3-dichloro-5-nitro-1,4-naphthoquinone|5-Aminosalicylic Acid",C17H9ClN2O7,68510,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1C=C(Cl)C(=O)c2ccccc21,Nc1cccc(O)c1.O=C1C(Cl)=C(Nc2cccc(O)c2)C(=O)c2ccccc21,O=C1C=C(Cl)C(=O)c2ccccc21>>Nc1cccc(O)c1.O=C1C(Cl)=C(Nc2cccc(O)c2)C(=O)c2ccccc21,67780485,1,54,full reaction|has preparation,"2-chloro-1,4-naphthoquinone|3-Aminophenol","2-chloro-3-((3-hydroxyphenyl)amino)naphthalene-1,4-dione",288663,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
Nc1ccc(O)c(C(=O)O)c1,Nc1cccc2c1C(=O)C(Cl)=CC2=O.[H]N(C1=C(Cl)C(=O)c2c(N)cccc2C1=O)c1ccc(O)c(C(=O)O)c1,Nc1ccc(O)c(C(=O)O)c1>>Nc1cccc2c1C(=O)C(Cl)=CC2=O.[H]N(C1=C(Cl)C(=O)c2c(N)cccc2C1=O)c1ccc(O)c(C(=O)O)c1,67780486,1,54,full reaction|has preparation,5-Aminosalicylic Acid|C10H6ClNO2,C17H11ClN2O5,288663,Preparation,1,,Michael Addition,,,"134972290; Article; Ishikawa, Teruhiko;Eguchi, Yoko;Igarashi, Masayuki;Okajima, Toshihide;Mita, Kohei;Yamasaki, Yuri;Sumikura, Kaho;Okumura, Taisei;Tabuchi, Yuna;Hayashi, Chigusa;Pasqua, Martina;Coluc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
Cc1cc(=O)c2c(O)c3c(O)cc(O)cc3cc2o1,C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c(O)cc(O)c3c(O)c4c(=O)cc(C)oc4cc23)c(O)c1C=O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c3cc(O)cc(O)c3c(O)c3c(=O)cc(C)oc23)c(O)c1C=O,Cc1cc(=O)c2c(O)c3c(O)cc(O)cc3cc2o1>>C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c(O)cc(O)c3c(O)c4c(=O)cc(C)oc4cc23)c(O)c1C=O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c3cc(O)cc(O)c3c(O)c3c(=O)cc(C)oc23)c(O)c1C=O,69575741,1,54,full reaction|has preparation,Nor-rubrofusarin|trichophenol o-QM,trichophenol E|trichophenol D,3745|218034,Preparation,1,,Michael Addition,,,"136348633; Article; Wang, Xiao-Xia;Deng, Bei-Qian;Ouyang, Zhi-Qiu;Yan, Yang;Lv, Jian-Ming;Qin, Sheng-Ying;Hu, Dan;Chen, Guo-Dong;Yao, Xin-Sheng;Gao, Hao; Journal of Natural Products; vol. 87; 9; (2024",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O,CC1(O)CC(=O)c2c(cc3cc(O)cc(O)c3c2O)O1.CC1(O)CC(=O)c2c(cc3cc(O)cc(O)c3c2O)O1.C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c3c(c(O)c4c(O)cc(O)cc24)C(=O)CC(C)(O)O3)c(O)c1C=O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c(O)cc(O)c3c(O)c4c(cc23)OC(C)(O)CC4=O)c(O)c1C=O,C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O>>CC1(O)CC(=O)c2c(cc3cc(O)cc(O)c3c2O)O1.CC1(O)CC(=O)c2c(cc3cc(O)cc(O)c3c2O)O1.C=C1C(=O)C=C([C@H](C)C(C)=O)C(C=O)=C1O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c3c(c(O)c4c(O)cc(O)cc24)C(=O)CC(C)(O)O3)c(O)c1C=O.CC(=O)[C@@H](C)c1cc(O)c(Cc2c(O)cc(O)c3c(O)c4c(cc23)OC(C)(O)CC4=O)c(O)c1C=O,69575748,1,54,full reaction|has preparation,trichophenol o-QM|YWA1,trichophenol F|trichophenol G,218034|218034,Preparation,1,,Michael Addition,,,"136348633; Article; Wang, Xiao-Xia;Deng, Bei-Qian;Ouyang, Zhi-Qiu;Yan, Yang;Lv, Jian-Ming;Qin, Sheng-Ying;Hu, Dan;Chen, Guo-Dong;Yao, Xin-Sheng;Gao, Hao; Journal of Natural Products; vol. 87; 9; (2024",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
Nc1nc2ccccc2s1,C=C(C(=O)OC)C(=O)c1ccccc1.COC(=O)C(Cn1c(=N)sc2ccccc21)C(=O)c1ccccc1,Nc1nc2ccccc2s1>>C=C(C(=O)OC)C(=O)c1ccccc1.COC(=O)C(Cn1c(=N)sc2ccccc21)C(=O)c1ccccc1,69754278,1,54,full reaction,2-amino-benzthiazole|methyl 2-benzoylacrylate,methyl 2-((2-iminobenzo[d]thiazol-3(2H)-yl)methyl)-3-oxo-3-phenylpropanoate,199397,Chemical behaviour,1,20,Michael Addition,Mechanism,toluene,"138340546; Article; Kumari, Rajkiran;Kumawat, Suman;Easwar, Srinivasan; Synthesis (Germany); vol. 57; 1; (2024); p. 209 - 217;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,methyl 2-((2-iminobenzo[d]thiazol-3(2H)-yl)methyl)-3-oxo-3-phenylpropanoate,70 percent,,,Scheme or table,,,,,,,
C=CC(=O)OCC,O=S([O-])CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.[Na+].CCOC(=O)CCS(=O)(=O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,C=CC(=O)OCC>>O=S([O-])CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.[Na+].CCOC(=O)CCS(=O)(=O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F,8581055,1,53,full reaction|has preparation,ethyl acrylate|Sodium 2-(perfluorohexyl)ethanesulfinate,"3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-octane-1-sulfonyl)-propionic acid ethyl ester",141257,Preparation,1,,Addition|Michael addition,,,"6243735; Article; Brace, Neal O.; Journal of Fluorine Chemistry; vol. 102; 1-2; (2000); p. 21 - 41;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,"3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-octane-1-sulfonyl)-propionic acid ethyl ester",5.17 g,,,,,,,,,,
CC(C)O,C=CC=O.[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@]1([C@H](O)COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@]2(CCC(OC(C)C)O2)C1=O,CC(C)O>>C=CC=O.[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@]1([C@H](O)COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@]2(CCC(OC(C)C)O2)C1=O,8662021,1,53,full reaction|has preparation,isopropyl alcohol|acrolein|Ascorbyl palmitate,"Hexadecanoic acid (R)-2-hydroxy-2-((5S,8R)-2-isopropoxy-6,9-dioxo-1,7-dioxa-spiro[4.4]non-8-yl)-ethyl ester",28626,Preparation,1,,Michael reaction,,,6253165; Article; Fathi; Krautheim; Kaap; Eger; Steinfelder; Bioorganic and Medicinal Chemistry Letters; vol. 10; 14; (2000); p. 1605 - 1608;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CO,C=CC=O.[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@]1([C@H](O)COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@]2(O)CCC(O)O[C@@]21OC,CO>>C=CC=O.[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@]1([C@H](O)COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@]2(O)CCC(O)O[C@@]21OC,8662022,1,53,full reaction|has preparation,methanol|acrolein|Ascorbyl palmitate,"Hexadecanoic acid (R)-2-((4aS,7R,7aR)-2,4a-dihydroxy-7a-methoxy-5-oxo-hexahydro-furo[3,4-b]pyran-7-yl)-2-hydroxy-ethyl ester",196137,Preparation,1,,Michael reaction,,,6253165; Article; Fathi; Krautheim; Kaap; Eger; Steinfelder; Bioorganic and Medicinal Chemistry Letters; vol. 10; 14; (2000); p. 1605 - 1608;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CN1CCNCC1,CC=CC(=O)OC.COC(=O)CC(C)N1CCN(C)CC1,CN1CCNCC1>>CC=CC(=O)OC.COC(=O)CC(C)N1CCN(C)CC1,8800030,1,53,full reaction|has preparation,1-methyl-piperazine|methyl crotonate,Methyl 3-(4-methylpiperazinyl)butyrate,220160,Preparation,1,,Michael reaction,,,"6298729; Article; Abe, Takashi; Baba, Hajime; Soloshonok, Irina; Journal of Fluorine Chemistry; vol. 108; 1; (2001); p. 21 - 35;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CCN1CCNCC1,C=C(C)C(=O)OC.CCN1CCN(CC(C)C(=O)OC)CC1,CCN1CCNCC1>>C=C(C)C(=O)OC.CCN1CCN(CC(C)C(=O)OC)CC1,8800098,1,53,full reaction|has preparation,4-ethylpiperazine|methacrylic acid methyl ester,Methyl 3-(4-ethylpiperazinyl)-2-methylpropionate,230547,Preparation,1,,Michael reaction,,,"6298729; Article; Abe, Takashi; Baba, Hajime; Soloshonok, Irina; Journal of Fluorine Chemistry; vol. 108; 1; (2001); p. 21 - 35;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
O=C(/C=C/c1ccccc1)c1ccccc1O,O=C1CC(c2ccccc2)Oc2ccccc21.[H][C@]1([C@H](CC(=O)c2ccccc2O)c2ccccc2)C(=O)c2ccccc2O[C@@H]1c1ccccc1.[H][C@]1([C@@H](CC(=O)c2ccccc2O)c2ccccc2)C(=O)c2ccccc2O[C@@H]1c1ccccc1.O=C(c1ccccc1O)C1C(c2ccccc2)C(C(=O)c2ccccc2O)C2(O)c3ccccc3OC(c3ccccc3)C2C1c1ccccc1,O=C(/C=C/c1ccccc1)c1ccccc1O>>O=C1CC(c2ccccc2)Oc2ccccc21.[H][C@]1([C@H](CC(=O)c2ccccc2O)c2ccccc2)C(=O)c2ccccc2O[C@@H]1c1ccccc1.[H][C@]1([C@@H](CC(=O)c2ccccc2O)c2ccccc2)C(=O)c2ccccc2O[C@@H]1c1ccccc1.O=C(c1ccccc1O)C1C(c2ccccc2)C(C(=O)c2ccccc2O)C2(O)c3ccccc3OC(c3ccccc3)C2C1c1ccccc1,8812269,1,53,full reaction,(E)-2'-hydroxy-chalcone,"Flavanone|(2S,3R)-3-[(S)-3-(2-Hydroxy-phenyl)-3-oxo-1-phenyl-propyl]-2-phenyl-chroman-4-one|(2S,3R)-3-[(R)-3-(2-Hydroxy-phenyl)-3-oxo-1-phenyl-propyl]-2-phenyl-chroman-4-one|[10a-hydroxy-8-(2-hydroxy-",217764|217764|322650|57306,Chemical behaviour,1,110,Michael reaction,Product distribution,,"6288856; Article; Patonay, Tamás; Varma, Rajender S.; Vass, András; Lévai, Al",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,"1,8-diazabicyclo[5.4.0]undec-7-ene|sodium sulfate","Flavanone|(2S,3R)-3-[(R)-3-(2-Hydroxy-phenyl)-3-oxo-1-phenyl-propyl]-2-phenyl-chroman-4-one|(2S,3R)-3-[(S)-3-(2-Hydroxy-phenyl)-3-oxo-1-phenyl-propyl]-2-phenyl-chroman-4-one|[10a-hydroxy-8-(2-hydroxy-",3.0 percent|28 percent|13 percent|11 percent,3|28|13|11,,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCCCCC(O)/C=C/C=O.[H][C@](N)(CCC(=O)N[C@@]([H])(CSC(CC=O)C(O)CCCCC)C(=O)NCC(=O)O)C(=O)O.[H][C@](N)(CCC(=O)N[C@@]([H])(CSC1CC(O)OC1CCCCC)C(=O)NCC(=O)O)C(=O)O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCCCCC(O)/C=C/C=O.[H][C@](N)(CCC(=O)N[C@@]([H])(CSC(CC=O)C(O)CCCCC)C(=O)NCC(=O)O)C(=O)O.[H][C@](N)(CCC(=O)N[C@@]([H])(CSC1CC(O)OC1CCCCC)C(=O)NCC(=O)O)C(=O)O,9185815,1,53,full reaction,GLUTATHIONE|(E)-4-Hydroxy-2-nonenal,S-(4-hydroxynonanal-3-yl)glutathione|3-glutathionyl-4-hydroxynonanal hemiacetal,121860|224271,Chemical behaviour,1,37,Michael addition,Product distribution,phosphate buffer,"6373224; Article; Aldini, Giancarlo; Granata, Paola; Carini, Marina; Journal of Mass Spectrometry; vol. 37; 12; (2002); p. 1219 - 1228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCCC(O)/C=C/C=O,[H][C@@](Cc1cnc[nH]1)(NC(=O)CCN)C(=O)O.CCCCCC(O)C1C/C=N/CCC(=O)N[C@H](C(=O)O)Cc2cn1cn2.[H][C@@](Cc1cn(C2CC(O)OC2CCCCC)cn1)(NC(=O)CCN)C(=O)O,CCCCCC(O)/C=C/C=O>>[H][C@@](Cc1cnc[nH]1)(NC(=O)CCN)C(=O)O.CCCCCC(O)C1C/C=N/CCC(=O)N[C@H](C(=O)O)Cc2cn1cn2.[H][C@@](Cc1cn(C2CC(O)OC2CCCCC)cn1)(NC(=O)CCN)C(=O)O,9213702,1,53,full reaction,(E)-4-Hydroxy-2-nonenal|carnosine,"(E)-(S)-2-(1-Hydroxy-hexyl)-8-oxo-1,5,9,13-tetraaza-bicyclo[10.2.1]pentadeca-4,12(15),13-triene-10-carboxylic acid|N-(2-hydroxy-5-pentyltetrahydrofuran-yl)carnosine",119381|77460,Chemical behaviour,1,37,Michael addition,Product distribution,phosphate buffer,"6373224; Article; Aldini, Giancarlo; Granata, Paola; Carini, Marina; Journal of Mass Spectrometry; vol. 37; 12; (2002); p. 1219 - 1228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
O=CCc1ccccc1,COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)/C(=C(C#N)\C=C\c1ccccc1)NCC2.COc1cc2c(cc1OC)/C(=C(C#N)/C=C/c1ccccc1)NCC2,O=CCc1ccccc1>>COc1cc2c(cc1OC)/C(=C/C#N)NCC2.COc1cc2c(cc1OC)/C(=C(C#N)\C=C\c1ccccc1)NCC2.COc1cc2c(cc1OC)/C(=C(C#N)/C=C/c1ccccc1)NCC2,9321027,1,53,full reaction|has preparation,"phenylacetaldehyde|6,7-dimethoxy-1-cyanomethylene-1,2,3,4-tetrahydroisoquinoline","2-(6,7-dimethoxy-3,4-dihydro-2H-isoquinolin-1-ylidene)-4-phenyl-but-3-enenitrile|2-(6,7-dimethoxy-3,4-dihydro-2H-isoquinolin-1-ylidene)-4-phenyl-but-3-enenitrile",299125|299125,Preparation,1,,Michael reaction,,,"6401778; Article; Nemes, Péter; Vincze, Zoltán; Balázs, Barbara",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0666667,Heating|microwave irradiation,,,Title compound not separated from byproducts,,,,,,,,,,,,,
CCOC(=O)CC(=O)O,CC(C=O)c1ccccc1.NCc1ccccc1.CCOC(=O)C/C=C(\C)c1ccccc1.CCOC(=O)/C=C/C(C)c1ccccc1.C/C(=C/CC(=O)NCc1ccccc1)c1ccccc1.C/C(=C\CC(=O)NCc1ccccc1)c1ccccc1,CCOC(=O)CC(=O)O>>CC(C=O)c1ccccc1.NCc1ccccc1.CCOC(=O)C/C=C(\C)c1ccccc1.CCOC(=O)/C=C/C(C)c1ccccc1.C/C(=C/CC(=O)NCc1ccccc1)c1ccccc1.C/C(=C\CC(=O)NCc1ccccc1)c1ccccc1,9477831,1,53,full reaction|has preparation,hydrogen ethyl malonate|2-Phenylpropanal|benzylamine,ethyl (E)-4-phenyl-3-pentenoate|(E)-ethyl 4-phenylpent-2-enoate|(Z)-N-benzyl-4-phenyl-3-penteneamide|(E)-N-benzyl-4-phenyl-3-penteneamide,169682|160397,Preparation,1,120 - 140,Michael reaction,,,6416377; Article; Romanova; Gravis; Kudan; Leshcheva; Zyk; Russian Journal of Organic Chemistry; vol. 39; 5; (2003); p. 692 - 697;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,,Title compound not separated from byproducts,,,,,,,,,,,,,
C=CC(=O)OC(C)(C)C,CC(=O)CC(=O)OCc1ccccc1.CC(=O)C(CCC(=O)OC(C)(C)C)(CCC(=O)OC(C)(C)C)C(=O)OCc1ccccc1.CC(=O)C(CCC(=O)OC(C)(C)C)C(=O)OCc1ccccc1,C=CC(=O)OC(C)(C)C>>CC(=O)CC(=O)OCc1ccccc1.CC(=O)C(CCC(=O)OC(C)(C)C)(CCC(=O)OC(C)(C)C)C(=O)OCc1ccccc1.CC(=O)C(CCC(=O)OC(C)(C)C)C(=O)OCc1ccccc1,9946573,1,53,full reaction,tert-Butyl acrylate|benzyl acetoacetate,"di-t-butyl 4-acetyl-4-benzyloxycarbonyl-1,7-heptanedioate|t-butyl 4-acetyl-4-benzyloxycarbonylbutanoate",230855|230855,Chemical behaviour,1,,Michael addition,Product distribution,water,"6502762; Article; Iwamura, Michiko; Gotoh, Yuka; Hashimoto, Tomoyuki; Sakurai, Reiko; Tetrahedron Letters; vol. 46; 37; (2005); p. 6275 - 6277;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.25,,,,,potassium hydroxide,,,,Further Variations:|Temperatures|concentration of reagent,,,,,,,,
C=CC=O,[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@]1([C@@H](O)COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@](O)(CCC=O)C1=O,C=CC=O>>[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@]1([C@@H](O)COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@](O)(CCC=O)C1=O,10237649,1,53,full reaction|has preparation,acrolein|Ascorbyl palmitate,"Hexadecanoic acid (S)-2-hydroxy-2-[(2R,4S)-4-hydroxy-3,5-dioxo-4-(3-oxo-propyl)-tetrahydro-furan-2-yl]-ethyl ester",24678,Preparation,1,,Michael reaction,,,"6554093; Article; Guetschow, Michael; Hauschildt, Sunna; Benard, Stefan; Reichl, Sabine; Witt, Uta G.; Eger, Kurt; Arnhold, Juergen; Pharmacology; vol. 66; 3; (2002); p. 162 - 168;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC(=O)/C=C/C(=O)O,[H][C@](N)(CO)c1ccccc1.[H][C@](N)(CO)c1ccccc1.CC(=O)/C=C/C(=O)O.CC(=O)C[C@H](N[C@@H](CO)c1ccccc1)C(=O)O.CC(=O)C[C@@H](N[C@@H](CO)c1ccccc1)C(=O)O,CC(=O)/C=C/C(=O)O>>[H][C@](N)(CO)c1ccccc1.[H][C@](N)(CO)c1ccccc1.CC(=O)/C=C/C(=O)O.CC(=O)C[C@H](N[C@@H](CO)c1ccccc1)C(=O)O.CC(=O)C[C@@H](N[C@@H](CO)c1ccccc1)C(=O)O,11201122,1,53,full reaction,trans-4-oxo-2-pentenoic acid|D-2-phenylglycinol,C13H17NO4|C13H17NO4,228574|228574,Chemical behaviour,1,20,aza-Michael addition,Product distribution,"1,4-dioxane|diethyl ether","7061034; Article; Jakubec, Pavol; Berkes, Dusan; Kolarovic, Andrej; Povazanec, Frantisek; Synthesis; 23; (2006); p. 4032 - 4040;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,,,,,,,Further Variations:|Solvents,,,,,,,,
C=CC(=O)NCC(C)(C)CS(=O)(=O)[O-].[Na+],NCCN,C=CC(=O)NCC(C)(C)CS(=O)(=O)[O-].[Na+]>>NCCN,22846970,1,53,half reaction|has preparation,"N-(3-sulfo-2,2-dimethylpropyl)acrylamide sodium salt|ethylenediamine",,,Preparation,1,,Michael Addition,,,8815239; Patent; 3M INNOVATIVE PROPERTIES; US6365769; B1; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page column 27,,,,,,,,,,,56,,,
C=CC(=O)OCC[N+](C)(C)CC.CCOS(=O)(=O)[O-],NCCN,C=CC(=O)OCC[N+](C)(C)CC.CCOS(=O)(=O)[O-]>>NCCN,22846971,1,53,half reaction|has preparation,"acryloyloxyethyl-N-ethyl-N,N-dimethylammonium monoethyl-sulfate|ethylenediamine",,,Preparation,1,,Michael Addition,,,8815239; Patent; 3M INNOVATIVE PROPERTIES; US6365769; B1; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page column 27,,,,,,,,,,,61,,,
C=CC(=O)[O-].[K+],NCCN,C=CC(=O)[O-].[K+]>>NCCN,22846972,1,53,half reaction|has preparation,potassium acrylate|ethylenediamine,,,Preparation,1,,Michael Addition,,,8815239; Patent; 3M INNOVATIVE PROPERTIES; US6365769; B1; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page column 27,,,,,,,,,,,60,,,
O=S1(=O)CCCO1,CN(C)CCCN,O=S1(=O)CCCO1>>CN(C)CCCN,22863787,1,53,half reaction|has preparation,"1,3-propanesultone|1-amino-3-(dimethylamino)propane",,,Preparation,1,,Michael Addition,,,8815239; Patent; 3M INNOVATIVE PROPERTIES; US6365769; B1; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page column 27,,,,,,,,,,,62,,,
*OC(=O)C(C#N)=C[C],[6*]OC(=O)C(C#N)C([C])[C],*OC(=O)C(C#N)=C[C]>>[6*]OC(=O)C(C#N)C([C])[C],23415533,1,53,no reaction scheme,,,,Markush reaction,1,,Michael addition,,,353532; Patent; WYETH; WO2004/99150; A2; (2004);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page 24,,,,,,,,,,,1,Scheme 1,,
[C-]#N.[Na+],CC1(C)OC(=O)C(=Cc2ccccc2)C(=O)O1.CC1(C)OC(=O)C(C(C#N)c2ccccc2)=C([O-])O1.[Na+],[C-]#N.[Na+]>>CC1(C)OC(=O)C(=Cc2ccccc2)C(=O)O1.CC1(C)OC(=O)C(C(C#N)c2ccccc2)=C([O-])O1.[Na+],33281124,1,53,full reaction|has preparation,sodium cyanide|5-benzylidene Meldrum's acid,C14H12NO4(1-)*Na(1+),210648,Preparation,1,,Michael addition,,,"20146878; Article; Soleimani, Ebrahim; Khodaei, Mohammad Mehdi; Taheri Kal Koshvandi, Afsaneh; Comptes Rendus Chimie; vol. 15; 4; (2012); p. 273 - 277;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
NCCO,C=CC(N)=O.C=CC(N)=O.C=CC(N)=O.NCCO.NC(=O)CCN(CCO)CCC(N)=O.NC(=O)CCNCCO,NCCO>>C=CC(N)=O.C=CC(N)=O.C=CC(N)=O.NCCO.NC(=O)CCN(CCO)CCC(N)=O.NC(=O)CCNCCO,34200294,1,53,full reaction|has preparation,ethanolamine|2-propenamide,β-oxyethyliminodipropionamide|N-(ethanol-2-yl)aminopropionic acid amide,230589|207953,Preparation,1,,Michael Addition,,,"80558992; Article; Badu-Tawiah, Abraham K.; Campbell, Dahlia I.; Cooks, R. Graham; Journal of the American Society for Mass Spectrometry; vol. 23; 9; (2012); p. 1461 - 1468,8;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C(C#N)=Cc1cccc(F)c1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1cccc(F)c1)C(C#N)C(=O)OC)[N+](=O)[O-],COC(=O)C(C#N)=Cc1cccc(F)c1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1cccc(F)c1)C(C#N)C(=O)OC)[N+](=O)[O-],35927461,1,53,full reaction|has preparation,methyl 2-cyano-3-(3-fluorophenyl)-2-propenoate|nitenpiram,C22H23ClFN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C(C#N)=Cc1ccc(F)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(F)cc1)C(C#N)C(=O)OC)[N+](=O)[O-],COC(=O)C(C#N)=Cc1ccc(F)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(F)cc1)C(C#N)C(=O)OC)[N+](=O)[O-],35927462,1,53,full reaction|has preparation,Methyl 2-cyano-3-(4-fluorophenyl)-2-propenoate|nitenpiram,C22H23ClFN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C(C#N)=Cc1ccc(Cl)cc1Cl,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(Cl)cc1Cl)C(C#N)C(=O)OC)[N+](=O)[O-],COC(=O)C(C#N)=Cc1ccc(Cl)cc1Cl>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(Cl)cc1Cl)C(C#N)C(=O)OC)[N+](=O)[O-],35927463,1,53,full reaction|has preparation,"methyl 2-cyano-3-(2,4-dichlorophenyl)acrylate|nitenpiram",C22H22Cl3N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C(C#N)=Cc1ccc(Cl)c(Cl)c1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(Cl)c(Cl)c1)C(C#N)C(=O)OC)[N+](=O)[O-],COC(=O)C(C#N)=Cc1ccc(Cl)c(Cl)c1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(Cl)c(Cl)c1)C(C#N)C(=O)OC)[N+](=O)[O-],35927464,1,53,full reaction|has preparation,"methyl 2-cyano-3-(3,4-dichlorophenyl)-2-propenoate|nitenpiram",C22H22Cl3N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C(C#N)=Cc1ccc(C)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(C)cc1)C(C#N)C(=O)OC)[N+](=O)[O-],COC(=O)C(C#N)=Cc1ccc(C)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccc(C)cc1)C(C#N)C(=O)OC)[N+](=O)[O-],35927465,1,53,full reaction|has preparation,methyl (2-cyano-3-p-tolyl)acrylate|nitenpiram,C23H26ClN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
COC(=O)C(C#N)=Cc1ccccc1OC,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccccc1OC)C(C#N)C(=O)OC)[N+](=O)[O-],COC(=O)C(C#N)=Cc1ccccc1OC>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCN(Cc1ccc(Cl)nc1)C(NC)=C(C(c1ccccc1OC)C(C#N)C(=O)OC)[N+](=O)[O-],35927466,1,53,full reaction|has preparation,methyl 2-cyano-3-(2-methoxyphenyl)acrylate|nitenpiram,C23H26ClN5O5,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCOC(=O)C(C#N)=Cc1ccc(Cl)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)cc1,CCOC(=O)C(C#N)=Cc1ccc(Cl)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)cc1,35927467,1,53,full reaction|has preparation,ethyl 3-(4-chlorophenyl)-2-cyanoacrylate|nitenpiram,C23H25Cl2N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccccc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1,CCCOC(=O)C(C#N)=Cc1ccccc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1,35927468,1,53,full reaction|has preparation,propyl 2-cyano-3-p-tolylacrylate|nitenpiram,C24H28ClN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccccc1F,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1F,CCCOC(=O)C(C#N)=Cc1ccccc1F>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1F,35927469,1,53,full reaction|has preparation,C13H12FNO2|nitenpiram,C24H27ClFN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1cccc(F)c1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1cccc(F)c1,CCCOC(=O)C(C#N)=Cc1cccc(F)c1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1cccc(F)c1,35927470,1,53,full reaction|has preparation,C13H12FNO2|nitenpiram,C24H27ClFN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(F)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(F)cc1,CCCOC(=O)C(C#N)=Cc1ccc(F)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(F)cc1,35927471,1,53,full reaction|has preparation,C13H12FNO2|nitenpiram,C24H27ClFN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccccc1Cl,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1Cl,CCCOC(=O)C(C#N)=Cc1ccccc1Cl>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1Cl,35927472,1,53,full reaction|has preparation,C13H12ClNO2|nitenpiram,C24H29Cl2N5O4,212235,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1cccc(Cl)c1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1cccc(Cl)c1,CCCOC(=O)C(C#N)=Cc1cccc(Cl)c1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1cccc(Cl)c1,35927473,1,53,full reaction|has preparation,C13H12ClNO2|nitenpiram,C24H27Cl2N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(Cl)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)cc1,CCCOC(=O)C(C#N)=Cc1ccc(Cl)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)cc1,35927474,1,53,full reaction|has preparation,C13H12ClNO2|nitenpiram,C24H27Cl2N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(Cl)cc1Cl,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)cc1Cl,CCCOC(=O)C(C#N)=Cc1ccc(Cl)cc1Cl>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)cc1Cl,35927475,1,53,full reaction|has preparation,C13H11Cl2NO2|nitenpiram,C24H26Cl3N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(Cl)c(Cl)c1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)c(Cl)c1,CCCOC(=O)C(C#N)=Cc1ccc(Cl)c(Cl)c1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Cl)c(Cl)c1,35927476,1,53,full reaction|has preparation,C13H11Cl2NO2|nitenpiram,C24H26Cl3N5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(Br)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Br)cc1,CCCOC(=O)C(C#N)=Cc1ccc(Br)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(Br)cc1,35927477,1,53,full reaction|has preparation,C13H12BrNO2|nitenpiram,C24H27BrClN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccccc1OC,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1OC,CCCOC(=O)C(C#N)=Cc1ccccc1OC>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccccc1OC,35927478,1,53,full reaction|has preparation,C14H15NO3|nitenpiram,C25H32ClN5O5,212235,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(OC)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(OC)cc1,CCCOC(=O)C(C#N)=Cc1ccc(OC)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(OC)cc1,35927479,1,53,full reaction|has preparation,C14H15NO3|nitenpiram,C25H30ClN5O5,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCOC(=O)C(C#N)=Cc1ccc(C)cc1,CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(C)cc1,CCCOC(=O)C(C#N)=Cc1ccc(C)cc1>>CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC.CCCOC(=O)C(C#N)C(C(=C(NC)N(CC)Cc1ccc(Cl)nc1)[N+](=O)[O-])c1ccc(C)cc1,35927480,1,53,full reaction|has preparation,C14H15NO2|nitenpiram,C25H30ClN5O4,224696,Preparation,1,,Michael Addition,,,"35704510; Article; Sun, Chuanwen; Liu, Tianyan; Ding, Li; Chen, Yanxia; Zhang, Wanggeng; Monatshefte fur Chemie; vol. 144; 7; (2013); p. 1003 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccccc3OC)c(=O)oc2c1,[H][C@](N)(CS)C(=O)O>>COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)O)c3ccccc3OC)c(=O)oc2c1,36928851,1,53,full reaction,L-Cysteine|(E)-3-(3-(2-methoxyphenyl)acryloyl)-7-methoxy-2H-chromen-2-one,C23H23NO7S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
NC(CCS)C(=O)O,COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCCC(N)C(=O)O)c3ccccc3OC)c(=O)oc2c1,NC(CCS)C(=O)O>>COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SCCC(N)C(=O)O)c3ccccc3OC)c(=O)oc2c1,36928852,1,53,full reaction,2-amino-4-mercaptobutyric acid|(E)-3-(3-(2-methoxyphenyl)acryloyl)-7-methoxy-2H-chromen-2-one,C24H25NO7S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccccc3OC)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c3ccccc3OC)c(=O)oc2c1,36928853,1,53,full reaction,GLUTATHIONE|(E)-3-(3-(2-methoxyphenyl)acryloyl)-7-methoxy-2H-chromen-2-one,C30H33N3O11S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)NCC(=O)O,COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccccc3OC)c(=O)oc2c1,[H][C@](N)(CS)C(=O)NCC(=O)O>>COc1ccc2cc(C(=O)/C=C/c3ccccc3OC)c(=O)oc2c1.COc1ccc2cc(C(=O)CC(SC[C@H](N)C(=O)NCC(=O)O)c3ccccc3OC)c(=O)oc2c1,36928854,1,53,full reaction,cysteinylglycine|(E)-3-(3-(2-methoxyphenyl)acryloyl)-7-methoxy-2H-chromen-2-one,C25H26N2O8S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)O,COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)O)c1,[H][C@](N)(CS)C(=O)O>>COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)O)c1,36928855,1,53,full reaction,L-Cysteine|(E)-7-methoxy-3-(3-(3-methoxyphenyl)acryloyl)-2H-chromen-2-one,C23H23NO7S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
NC(CCS)C(=O)O,COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SCCC(N)C(=O)O)c1,NC(CCS)C(=O)O>>COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SCCC(N)C(=O)O)c1,36928856,1,53,full reaction,2-amino-4-mercaptobutyric acid|(E)-7-methoxy-3-(3-(3-methoxyphenyl)acryloyl)-2H-chromen-2-one,C24H25NO7S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c1,36928857,1,53,full reaction,GLUTATHIONE|(E)-7-methoxy-3-(3-(3-methoxyphenyl)acryloyl)-2H-chromen-2-one,C30H33N3O11S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)NCC(=O)O,COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)NCC(=O)O)c1,[H][C@](N)(CS)C(=O)NCC(=O)O>>COc1cccc(/C=C/C(=O)c2cc3ccc(OC)cc3oc2=O)c1.COc1cccc(C(CC(=O)c2cc3ccc(OC)cc3oc2=O)SC[C@H](N)C(=O)NCC(=O)O)c1,36928858,1,53,full reaction,Cysteinylglycin|(E)-7-methoxy-3-(3-(3-methoxyphenyl)acryloyl)-2H-chromen-2-one,C25H26N2O8S,228310,Chemical behaviour,1,25,Michael Addition,Kinetics|Quantum yield,water,"62262267; Conference Paper; Garcia-Beltran, Olimpo; Gonzalez, Christopher; Perezc, Edwin G.; Cassels, Bruce K.; Santos, Jose G.; Millan, Daniela; Mena, Natalia; Pavez, Paulina; Aliaga, Margarita E.; J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
COC(=O)/C=C/c1cccc(/C=C/C(=O)OC)c1-c1cc(C)[nH]n1,COC(=O)/C=C/c1cccc2c1-c1cc(C)nn1C2CC(=O)OC,COC(=O)/C=C/c1cccc(/C=C/C(=O)OC)c1-c1cc(C)[nH]n1>>COC(=O)/C=C/c1cccc2c1-c1cc(C)nn1C2CC(=O)OC,40509798,1,53,full reaction|has preparation,C18H18N2O4,C18H18N2O4,321607,Preparation,1,,Michael Addition,,,"64628277; Article; Algarra, Andrs G.; Davies, David L.; Khamker, Qudsia; Macgregor, Stuart A.; McMullin, Claire L.; Singh, Kuldip; Villa-Marcos, Barbara; Chemistry - A European Journal; vol. 21; 7; (2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,,,,,,,,Body text,,,,,,,
O=C(C=Cc1ccccc1)c1ccccc1,N=C(Nc1ccccc1)c1ccccc1.O=C(CC(N=C(Nc1ccccc1)c1ccccc1)c1ccccc1)c1ccccc1,O=C(C=Cc1ccccc1)c1ccccc1>>N=C(Nc1ccccc1)c1ccccc1.O=C(CC(N=C(Nc1ccccc1)c1ccccc1)c1ccccc1)c1ccccc1,40598933,1,53,full reaction,benzalacetophenone|N-phenylbenzamidine,"N'-(3-oxo-1,3-diphenylpropyl)-N-phenylbenzimidamide",228539,Chemical behaviour,1,,Michael Addition,Mechanism,,"66833742; Article; Zhu, Yuelu; Li, Cheng; Zhang, Jidong; She, Mengyao; Sun, Wei; Wan, Kerou; Wang, Yaqi; Yin, Bin; Liu, Ping; Li, Jianli; Organic Letters; vol. 17; 15; (2015); p. 3872 - 3875;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,iron(III) chloride,,,,,Scheme or table,,,,,,,
O=CCCCC/C=C/C(=O)c1ccccc1,O=C[C@H]1CCC[C@@H]1CC(=O)c1ccccc1,O=CCCCC/C=C/C(=O)c1ccccc1>>O=C[C@H]1CCC[C@@H]1CC(=O)c1ccccc1,40906035,1,53,full reaction,E-8-phenyl-8-oxo-6-octenal,"(1S,2R)-2-(2-Oxo-2-phenyl-ethyl)-cyclopentanecarbaldehyde",299061,Chemical behaviour,1,,Michael Addition,Kinetics,tetrahydrofuran-d8,"66779132; Article; Han, Junbin; Lu, Zhichao; Flach, Andrew L.; Paton, Robert S.; Hammond, Gerald B.; Xu, Bo; Chemistry - A European Journal; vol. 21; 33; (2015); p. 11687 - 11691;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,stereoselective reaction,C6H12BrN2O(1+)*Cl(1-),,,,Reagent/catalyst,Experimental part,97 percent ee,,,,,,
CN1c2ccccc2C(SCCC(=O)O)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CN1c2ccccc2C(SCCC(=O)O)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],41584216,1,53,full reaction,C17H17NO2S*ClHO4,10-methylacridinium perchlorate,168295,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
Cc1ccc(SC2c3ccccc3N(C)c3ccccc32)cc1.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],Cc1ccc(SC2c3ccccc3N(C)c3ccccc32)cc1.[O-][Cl@SP1+3]([O-])([O-])O>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],41584217,1,53,full reaction,C21H19NS*ClHO4,10-methylacridinium perchlorate,168295,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
CC(C)SC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CC(C)SC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],41584218,1,53,full reaction,C17H19NS*ClHO4,10-methylacridinium perchlorate,168295,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
CN1c2ccccc2C(SC(C)(C)C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CN1c2ccccc2C(SC(C)(C)C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],41584219,1,53,full reaction,C18H21NS*ClHO4,10-methylacridinium perchlorate,168295,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
CN1c2ccccc2C(SCCO)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CN1c2ccccc2C(SCCO)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],41584232,1,53,full reaction,C16H17NOS*ClHO4,10-methylacridinium perchlorate,168295,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3[N+](=O)[O-])c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3[N+](=O)[O-])SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3[N+](=O)[O-])c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3[N+](=O)[O-])SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,41667360,1,53,full reaction,GLUTATHIONE|C23H20N2O7,C33H37N5O13S,228310,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer,"67847730; Article; Chen, Jianwei; Jiang, Xiqian; Carroll, Shaina L.; Huang, Jia; Wang, Jin; Organic Letters; vol. 17; 24; (2015); p. 5978 - 5981;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,7.4,supporting information,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,41667363,1,53,full reaction,GLUTATHIONE|C23H21NO6,C33H38N4O12S,228310,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer,"67847730; Article; Chen, Jianwei; Jiang, Xiqian; Carroll, Shaina L.; Huang, Jia; Wang, Jin; Organic Letters; vol. 17; 24; (2015); p. 5978 - 5981;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,7.4,supporting information,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,41667364,1,53,full reaction,GLUTATHIONE|C23H21NO5,C33H38N4O11S,228310,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer,"67847730; Article; Chen, Jianwei; Jiang, Xiqian; Carroll, Shaina L.; Huang, Jia; Wang, Jin; Organic Letters; vol. 17; 24; (2015); p. 5978 - 5981;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,7.4,supporting information,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3Br)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3Br)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3Br)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3Br)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,41667365,1,53,full reaction,GLUTATHIONE|ThiolQuant Green,C33H37BrN4O11S,228310,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer,"67847730; Article; Chen, Jianwei; Jiang, Xiqian; Carroll, Shaina L.; Huang, Jia; Wang, Jin; Organic Letters; vol. 17; 24; (2015); p. 5978 - 5981;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,7.4,supporting information,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3F)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3F)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC(=O)c3ccc(C(=O)O)cc3F)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(=O)c3ccc(C(=O)O)cc3F)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,41667366,1,53,full reaction,GLUTATHIONE|C23H20FNO5,C33H37FN4O11S,228310,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer,"67847730; Article; Chen, Jianwei; Jiang, Xiqian; Carroll, Shaina L.; Huang, Jia; Wang, Jin; Organic Letters; vol. 17; 24; (2015); p. 5978 - 5981;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,7.4,supporting information,,,,,,,Experimental part,,,,,,,
CC(=O)c1ccc2cc(N3CCC[C@H]3C(=O)N3CCN(c4ccc(C=CC5=[N+](C)c6ccccc6C5(C)C)cc4)CC3)ccc2c1.[I-],CC(=O)c1ccc2cc(N3CCC[C@H]3C(=O)N3CCN(c4ccc(C(CC5=[N+](C)c6ccccc6C5(C)C)S(=O)(=O)[O-])cc4)CC3)ccc2c1,CC(=O)c1ccc2cc(N3CCC[C@H]3C(=O)N3CCN(c4ccc(C=CC5=[N+](C)c6ccccc6C5(C)C)cc4)CC3)ccc2c1.[I-]>>CC(=O)c1ccc2cc(N3CCC[C@H]3C(=O)N3CCN(c4ccc(C(CC5=[N+](C)c6ccccc6C5(C)C)S(=O)(=O)[O-])cc4)CC3)ccc2c1,44255433,1,53,full reaction,C40H43N4O2(1+)*I(1-),C40H44N4O5S,220075,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|ethanol,"69446613; Article; Yang, Xiaoguang; Zhou, Yibo; Zhang, Xiufang; Yang, Sheng; Chen, Yun; Guo, Jingru; Li, Xiaoxuan; Qing, Zhihe; Yang, Ronghua; Chemical Communications; vol. 52; 67; (2016); p. 10289 -",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,sodium hydrogen sulfite,,,,,Scheme or table,,,,,,,
CC(=O)c1cc(C)c(O)c(CO)c1O,CC(=O)c1cc(C)c(O)c(Cc2c(O)c(C)cc(C(C)=O)c2O)c1O,CC(=O)c1cc(C)c(O)c(CO)c1O>>CC(=O)c1cc(C)c(O)c(Cc2c(O)c(C)cc(C(C)=O)c2O)c1O,50864179,1,53,full reaction,hydroxyclavatol,"5,5'-diacetyl-2,6,2',6'-tetrahydroxy-3,3'-dimethyl-diphenylmethane",293841,Chemical behaviour,1,20,Michael Addition,Mechanism,aq. phosphate buffer,"76183500; Article; Fan, Jie; Liao, Ge; Kindinger, Florian; Ludwig-Radtke, Lena; Yin, Wen-Bing; Li, Shu-Ming; Journal of the American Chemical Society; vol. 141; 10; (2019); p. 4225 - 4229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,10,supporting information,,,,,,pH-value,Scheme or table,,,,,,,
Cc1oc(=O)n([C@@H](C)c2ccccc2)c1C,C=CC=O.CI.C[C@@H](c1ccccc1)N1C(=O)O[C@@]2(C)CC=CC=C12.C[C@@H](c1ccccc1)N1C(=O)O[C@]2(C)CC=CC=C12.C[C@@H](c1ccccc1)N1C(=O)O[C@@]2(C)CC(CCC=O)=CC=C12.C[C@@H](c1ccccc1)N1C(=O)O[C@]2(C)CC(CCC=O)=CC=C12,Cc1oc(=O)n([C@@H](C)c2ccccc2)c1C>>C=CC=O.CI.C[C@@H](c1ccccc1)N1C(=O)O[C@@]2(C)CC=CC=C12.C[C@@H](c1ccccc1)N1C(=O)O[C@]2(C)CC=CC=C12.C[C@@H](c1ccccc1)N1C(=O)O[C@@]2(C)CC(CCC=O)=CC=C12.C[C@@H](c1ccccc1)N1C(=O)O[C@]2(C)CC(CCC=O)=CC=C12,52041824,1,53,full reaction|has preparation,"4,5‐dimethyl‐3‐((S)‐1‐phenylethyl)oxazol‐2(3H)‐one|acrolein|methyl iodide","(7aS)‐7a‐methyl‐3‐((S)‐1‐phenylethyl)‐7,7a‐dihydrobenzo[d]oxazol‐2(3H)‐one|(7aR)‐7a‐methyl‐3‐((S)‐1‐",25182,Preparation,1,,Michael Addition,,"5,5-dimethyl-1,3-cyclohexadiene","77374469; Article; Santoyo, Blanca M.; González-Romero, Carlos; Zárate-Zárate, Daniel; Hernández-Ben",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Sealed tube|Inert atmosphere|Heating,,,Overall yield = 60 percent; Overall yield = 0.071 g,,,,,,Experimental part,66 percent de|72 percent de,,,,,,
CC(=O)C1=C(C)NC(=O)NC1c1ccccc1O,CC(=O)C1C2NC(=O)NC1(C)Oc1ccccc12,CC(=O)C1=C(C)NC(=O)NC1c1ccccc1O>>CC(=O)C1C2NC(=O)NC1(C)Oc1ccccc12,53330030,1,53,full reaction|has preparation,"5‐acetyl‐4‐(2‐hydroxyphenyl)‐6‐methyl‐3,4‐dihydropyrimidin‐2(1H)‐one","13-acetyl-9-methyl-11-oxo-8-oxa-10,12-diazatricyclo[7.3.1.02,7]trideca-2,4,6-triene",322472,Preparation,1,,Michael Addition,,,"78763644; Article; Kharaneko; Pekhtereva; Kharaneko; Russian Journal of Organic Chemistry; vol. 55; 11; (2019); p. 1674 - 1678; Zh. Org. Khim.; vol. 55; 11; (2019); p. 1703 - 1708,5;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCCCCCc1ccc(C2(c3ccc(CCCCCC)cc3)c3cc4c(cc3-c3sc5cc(C=C6C(=O)c7ccccc7C6=C(C#N)C#N)sc5c32)C(c2ccc(CCCCCC)cc2)(c2ccc(CCCCCC)cc2)c2c-4sc3cc(C=C4C(=O)c5ccccc5C4=C(C#N)C#N)sc23)cc1,NCCO.[H]C(NCCO)(c1cc2sc3c(c2s1)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1cc2c(cc1-3)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1c-2sc2cc(C([H])(NCCO)C3C(=O)c4ccccc4C3=C(C#N)C#N)sc12)C1C(=O)c2ccccc2C1=C(C#N)C#N.[H]C(NCCO)(c1cc2sc3c(c2s1)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1cc2c(cc1-3)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1c-2sc2cc(CNCCO)sc12)C1C(=O)c2ccccc2C1=C(C#N)C#N.CCCCCCc1ccc(C2(c3ccc(CCCCCC)cc3)c3cc4c(cc3-c3sc5cc(CNCCO)sc5c32)C(c2ccc(CCCCCC)cc2)(c2ccc(CCCCCC)cc2)c2c-4sc3cc(CNCCO)sc23)cc1.[H]C(NCCO)(c1cc2sc3c(c2s1)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1cc2c(cc1-3)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1c-2sc2cc(C=C3C(=O)c4ccccc4C3=C(C#N)C#N)sc12)C1C(=O)c2ccccc2C1=C(C#N)C#N.CCCCCCc1ccc(C2(c3ccc(CCCCCC)cc3)c3cc4c(cc3-c3sc5cc(C=C6C(=O)c7ccccc7C6=C(C#N)C#N)sc5c32)C(c2ccc(CCCCCC)cc2)(c2ccc(CCCCCC)cc2)c2c-4sc3cc(CNCCO)sc23)cc1,CCCCCCc1ccc(C2(c3ccc(CCCCCC)cc3)c3cc4c(cc3-c3sc5cc(C=C6C(=O)c7ccccc7C6=C(C#N)C#N)sc5c32)C(c2ccc(CCCCCC)cc2)(c2ccc(CCCCCC)cc2)c2c-4sc3cc(C=C4C(=O)c5ccccc5C4=C(C#N)C#N)sc23)cc1>>NCCO.[H]C(NCCO)(c1cc2sc3c(c2s1)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1cc2c(cc1-3)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1c-2sc2cc(C([H])(NCCO)C3C(=O)c4ccccc4C3=C(C#N)C#N)sc12)C1C(=O)c2ccccc2C1=C(C#N)C#N.[H]C(NCCO)(c1cc2sc3c(c2s1)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1cc2c(cc1-3)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1c-2sc2cc(CNCCO)sc12)C1C(=O)c2ccccc2C1=C(C#N)C#N.CCCCCCc1ccc(C2(c3ccc(CCCCCC)cc3)c3cc4c(cc3-c3sc5cc(CNCCO)sc5c32)C(c2ccc(CCCCCC)cc2)(c2ccc(CCCCCC)cc2)c2c-4sc3cc(CNCCO)sc23)cc1.[H]C(NCCO)(c1cc2sc3c(c2s1)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1cc2c(cc1-3)C(c1ccc(CCCCCC)cc1)(c1ccc(CCCCCC)cc1)c1c-2sc2cc(C=C3C(=O)c4ccccc4C3=C(C#N)C#N)sc12)C1C(=O)c2ccccc2C1=C(C#N)C#N.CCCCCCc1ccc(C2(c3ccc(CCCCCC)cc3)c3cc4c(cc3-c3sc5cc(C=C6C(=O)c7ccccc7C6=C(C#N)C#N)sc5c32)C(c2ccc(CCCCCC)cc2)(c2ccc(CCCCCC)cc2)c2c-4sc3cc(CNCCO)sc23)cc1,56107140,1,53,full reaction|has preparation,"2,2’-[[6,6,12,12-tetrakis(4-hexylphenyl)-6,12-dihydrodithieno[2,3-d:2’,3’-d’]-s-indaceno[1,2-b:5,6-b",C98H96N6O4S4|C86H92N4O3S4|C74H88N2O2S4|C96H89N5O3S4|C84H85N3O2S4,30762,Preparation,1,,Michael Addition,,dichloromethane,"82246962; Article; Liu, Hongtao; Wang, Wen; Zhou, Yinhua; Li, Zhong'An; Journal of Materials Chemistry A; vol. 9; 2; (2021); p. 1080 - 1088;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,supporting information,,,,,,,Scheme or table,,,,,,,
CCN(CC)c1ccc2cc3c([o+]c2c1)-c1ccccc1CC3,CCN(CC)c1ccc2c(c1)OC1=C(CCc3ccccc31)C2S(=O)(=O)O,CCN(CC)c1ccc2cc3c([o+]c2c1)-c1ccccc1CC3>>CCN(CC)c1ccc2c(c1)OC1=C(CCc3ccccc31)C2S(=O)(=O)O,56501256,1,53,full reaction,"10-Diethylamino-5,6-dihydro-benzo[c]xanthenylium",C21H23NO4S,208389,Chemical behaviour,1,,Michael Addition,Mechanism,aq. phosphate buffer|ethanol,"82992527; Article; Hu, Qian;Guo, Rui;Zhang, Liang;Liu, Qing;Cai, Shushun;Lin, Weiying; Luminescence; vol. 36; 4; (2021); p. 1006 - 1012;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,sodium hydrogensulfite,,,,,Experimental part,,,,,,,
[1*]OP(=O)(O[1*])C(=C)P(=O)(O[2*])O[2*],[1*]OP(=O)(O[1*])C(CNOCc1ccccc1)P(=O)(O[2*])O[2*],[1*]OP(=O)(O[1*])C(=C)P(=O)(O[2*])O[2*]>>[1*]OP(=O)(O[1*])C(CNOCc1ccccc1)P(=O)(O[2*])O[2*],67330841,1,53,no reaction scheme,,,230536,Markush reaction,1,,Michael Addition,,,132366934; Patent; CENTRAL CHINA NORMAL UNIVERSITY; CN117567508; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0102,,,,,,,,,,,,,,
C=CC(=O)OC,COC(=O)C[C@@H]1Cc2ccccc2CN1.COC(=O)CCN1Cc2ccccc2C[C@H]1CC(=O)OC,C=CC(=O)OC>>COC(=O)C[C@@H]1Cc2ccccc2CN1.COC(=O)CCN1Cc2ccccc2C[C@H]1CC(=O)OC,5335303,1,52,full reaction|has preparation,"acrylic acid methyl ester|methyl (S)-2-(1,2,3,4-tetrahydroisoquinolin-3-yl)acetate","(3S)-Methyl 3-[3-(2-methoxy-2-oxoethyl)-1,2,3,4-tetrahydroisoquinolin-2-yl]propanoate",230559,Preparation,1,,Alkylation|Michael addition,,,"6229799; Article; Harrison, Justin R.; O'Brien, Peter; Porter, David W.; Smith, Neil M.; Journal of the Chemical Society. Perkin transactions I; 24; (1999); p. 3623 - 3631;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,17,Heating,,,,,,,,,,,,,,,,
CC(=C(C#N)C#N)c1ccccc1,CCCC[N+](CCCC)(CCCC)CCCC.[C-]#N.CC(C#N)(c1ccccc1)C(C#N)C#N,CC(=C(C#N)C#N)c1ccccc1>>CCCC[N+](CCCC)(CCCC)CCCC.[C-]#N.CC(C#N)(c1ccccc1)C(C#N)C#N,8749888,1,52,full reaction|has preparation,2-(1-phenylethylidene)propanedinitrile|tetra-n-butylammonium cyanide,3-Cyano-2-methyl-2-phenylsuccinonitrile,222638,Preparation,1,,Michael addition,,,"6283655; Article; Karlsen, Hege; Songe, Pal H.; Sunsby, Lise Kristin; Hagen, Lise Cathrine; Kolsaker, Per; Romming, Christian; Journal of the Chemical Society. Perkin Transactions 1 (2001); 5; (2001);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CC(=C(C#N)C#N)C1CC1,CCCC[N+](CCCC)(CCCC)CCCC.[C-]#N.CC(C#N)(C(C#N)C#N)C1CC1,CC(=C(C#N)C#N)C1CC1>>CCCC[N+](CCCC)(CCCC)CCCC.[C-]#N.CC(C#N)(C(C#N)C#N)C1CC1,8751064,1,52,full reaction|has preparation,2-(1-cyclopropylethylidene)malononitrile|tetra-n-butylammonium cyanide,3-Cyano-2-cyclopropyl-2-methylsuccinonitrile,219697,Preparation,1,,Michael addition,,,"6283655; Article; Karlsen, Hege; Songe, Pal H.; Sunsby, Lise Kristin; Hagen, Lise Cathrine; Kolsaker, Per; Romming, Christian; Journal of the Chemical Society. Perkin Transactions 1 (2001); 5; (2001);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C=CC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(C)c2ccccc2C1(C)C,CCO[Si](CCCN)(OCC)OCC.CCO[Si](CCCNCCC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(C)c2ccccc2C1(C)C)(OCC)OCC,C=CC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(C)c2ccccc2C1(C)C>>CCO[Si](CCCN)(OCC)OCC.CCO[Si](CCCNCCC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(C)c2ccccc2C1(C)C)(OCC)OCC,10287356,1,52,full reaction|has preparation,"1,3,3-trimethylspiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine]-9'-yl acrylate|3-aminopropyltriethoxysilane",C34H45N3O6Si,230585,Preparation,1,,Michael addition,,,"6586720; Article; Goto, Kouhei; Kaga, Harumi; Ichmura, Kunihiro; Molecular Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and Liquid Crystals; vol. 345; (2000); p.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
C=CC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(CCCCCC)c2ccccc2C1(C)C,CCO[Si](CCCN)(OCC)OCC.CCCCCCN1c2ccccc2C(C)(C)C12C=Nc1c(ccc3ccc(OC(=O)CCNCCC[Si](OCC)(OCC)OCC)cc13)O2,C=CC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(CCCCCC)c2ccccc2C1(C)C>>CCO[Si](CCCN)(OCC)OCC.CCCCCCN1c2ccccc2C(C)(C)C12C=Nc1c(ccc3ccc(OC(=O)CCNCCC[Si](OCC)(OCC)OCC)cc13)O2,10287357,1,52,full reaction|has preparation,C30H32N2O3|3-aminopropyltriethoxysilane,C39H55N3O6Si,230585,Preparation,1,,Michael addition,,,"6586720; Article; Goto, Kouhei; Kaga, Harumi; Ichmura, Kunihiro; Molecular Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and Liquid Crystals; vol. 345; (2000); p.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,
CCC(CC)CO,C=CC#N.CCC(CC)COCCC#N,CCC(CC)CO>>C=CC#N.CCC(CC)COCCC#N,22834873,1,52,full reaction|has preparation,2-ethyl-1-butanol|acrylonitrile,C9H17NO,230417,Preparation,1,,Michael addition,,,8815291; Patent; 3M INNOVATIVE PROPERTIES; EP1170275; A2; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page 16,,,,,,,,,,,,,,
CC(C)C(O)C(C)C,C=CC#N.CC(C)C(OCCC#N)C(C)C,CC(C)C(O)C(C)C>>C=CC#N.CC(C)C(OCCC#N)C(C)C,22834874,1,52,full reaction|has preparation,"2,4-dimethyl-3-pentanol|acrylonitrile",C10H19NO,230417,Preparation,1,,Michael addition,,,8815291; Patent; 3M INNOVATIVE PROPERTIES; EP1170275; A2; (2002);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page 21,,,,,,,,,,,,,,
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full reaction|has preparation,acrylonitrile|C86H204N30,C182H300N62,,Preparation,1,,Michael addition,,,"8775856; Article; Gajbhiye, Virendra; Vijayaraj Kumar; Tekade, Rakesh Kumar; Jain; European Journal of Medicinal Chemistry; vol. 44; 3; (2009); p. 1155 - 1166;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
CCCC1CCC(CC=NC2CCCCC2)CC1,C=CC(=O)OCC.CCCC1CCC(C(C=O)CCC(=O)OCC)CC1,CCCC1CCC(CC=NC2CCCCC2)CC1>>C=CC(=O)OCC.CCCC1CCC(C(C=O)CCC(=O)OCC)CC1,29104792,1,52,full reaction|has preparation,C17H31N|ethyl acrylate,C16H28O3,203093,Preparation,1,,Michael addition,,,"8834660; Conference Paper; Goto, Mayumi; Masukawa, Tokifumi; Kondo, Tomoyuki; Fujita, Atsuko; Molecular Crystals and Liquid Crystals; vol. 494; (2008); p. 58 - 67;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux|Neat (no solvent)|Acidic conditions,,scheme or table,,,,,,,,,2,C17H31N|ethyl acrylate,,,,
CCCCCCC=NC1CCCCC1,C=CC(=O)OCC.CCCCCC(C=O)CCC(=O)OCC,CCCCCCC=NC1CCCCC1>>C=CC(=O)OCC.CCCCCC(C=O)CCC(=O)OCC,29104799,1,52,full reaction|has preparation,Oenanthaldehyd-cyclohexylimid|ethyl acrylate,C12H22O3,203093,Preparation,1,,Michael addition,,,"8834660; Conference Paper; Goto, Mayumi; Masukawa, Tokifumi; Kondo, Tomoyuki; Fujita, Atsuko; Molecular Crystals and Liquid Crystals; vol. 494; (2008); p. 58 - 67;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux|Neat (no solvent)|Acidic conditions,,scheme or table,,,,,,,,,2,Oenanthaldehyd-cyclohexylimid|ethyl acrylate,,,,
C=CC(=O)OC,CC(C)(C)OC(=O)N[C@@H]1CNC[C@H]1NC(=O)OC(C)(C)C.COC(=O)CCN1C[C@@H](NC(=O)OC(C)(C)C)[C@H](NC(=O)OC(C)(C)C)C1,C=CC(=O)OC>>CC(C)(C)OC(=O)N[C@@H]1CNC[C@H]1NC(=O)OC(C)(C)C.COC(=O)CCN1C[C@@H](NC(=O)OC(C)(C)C)[C@H](NC(=O)OC(C)(C)C)C1,29174755,1,52,full reaction|has preparation,"acrylic acid methyl ester|di-tert-butyl ((3R,4R)-pyrrolidine-3,4-diyl)dicarbamate",C18H33N3O6,230562,Preparation,1,,Michael addition,,,"8846790; Article; Couty, François; David, Olivier R. P.; Synlett; 12; (2009); p. 1945 - 1948;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
CC1=CC(=O)CC(=O)O1,O=C(C=Cc1ccccc1)c1ccccc1.CC1=CC(=O)C(C(CC(=O)c2ccccc2)c2ccccc2)C(=O)O1,CC1=CC(=O)CC(=O)O1>>O=C(C=Cc1ccccc1)c1ccccc1.CC1=CC(=O)C(C(CC(=O)c2ccccc2)c2ccccc2)C(=O)O1,29277274,1,52,full reaction|has preparation,"6-methyl-pyran-2,4-dione|benzalacetophenone",C21H18O4,,Preparation,1,,Michael addition,,,"8859432; Article; Ye, Yang; Wang, Linfei; Fan, Renhua; Journal of Organic Chemistry; vol. 75; 5; (2010); p. 1760 - 1763;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CC(=O)c2cc(F)ccc2O1,O=C(C=Cc1ccccc1)c1ccccc1.O=C(CC(c1ccccc1)C1C(=O)Oc2ccc(F)cc2C1=O)c1ccccc1,O=C1CC(=O)c2cc(F)ccc2O1>>O=C(C=Cc1ccccc1)c1ccccc1.O=C(CC(c1ccccc1)C1C(=O)Oc2ccc(F)cc2C1=O)c1ccccc1,29277275,1,52,full reaction|has preparation,"6-fluorochroman-2,4-dione|benzalacetophenone",C24H17FO4,,Preparation,1,,Michael addition,,,"8859432; Article; Ye, Yang; Wang, Linfei; Fan, Renhua; Journal of Organic Chemistry; vol. 75; 5; (2010); p. 1760 - 1763;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CC(=O)c2ccccc2O1,O=C(C=Cc1ccccc1)c1ccccc1.O=C(CC(c1ccccc1)C1C(=O)Oc2ccccc2C1=O)c1ccccc1,O=C1CC(=O)c2ccccc2O1>>O=C(C=Cc1ccccc1)c1ccccc1.O=C(CC(c1ccccc1)C1C(=O)Oc2ccccc2C1=O)c1ccccc1,29277284,1,52,full reaction|has preparation,"3H-chromene-2,4-dione|benzalacetophenone","3-(3-oxo-1,3-diphenylpropan-1-yl)-2H-chromene-2,4(3H)-dione",,Preparation,1,,Michael addition,,,"8859432; Article; Ye, Yang; Wang, Linfei; Fan, Renhua; Journal of Organic Chemistry; vol. 75; 5; (2010); p. 1760 - 1763;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
CC1(C)CC(=O)CC(=O)C1,O=C(C=Cc1ccccc1)c1ccccc1.CC1(C)CC(=O)C(C(CC(=O)c2ccccc2)c2ccccc2)C(=O)C1,CC1(C)CC(=O)CC(=O)C1>>O=C(C=Cc1ccccc1)c1ccccc1.CC1(C)CC(=O)C(C(CC(=O)c2ccccc2)c2ccccc2)C(=O)C1,29277293,1,52,full reaction|has preparation,dimedone|benzalacetophenone,"2-(2'-benzoyl-1'-phenylethyl)-5,5-dimethyl-1,3-cyclohexanedione",,Preparation,1,,Michael addition,,,"8859432; Article; Ye, Yang; Wang, Linfei; Fan, Renhua; Journal of Organic Chemistry; vol. 75; 5; (2010); p. 1760 - 1763;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
COc1ccc(C=CC(=N)c2ccccc2)cc1,[C-]#[N+]C1C(=O)NC(c2ccccc2)=CC1c1ccc(OC)cc1.[C-]#[N+]C1(C(CC(=N)c2ccccc2)c2ccc(OC)cc2)C(=O)NC(c2ccccc2)=CC1c1ccc(OC)cc1,COc1ccc(C=CC(=N)c2ccccc2)cc1>>[C-]#[N+]C1C(=O)NC(c2ccccc2)=CC1c1ccc(OC)cc1.[C-]#[N+]C1(C(CC(=N)c2ccccc2)c2ccc(OC)cc2)C(=O)NC(c2ccccc2)=CC1c1ccc(OC)cc1,29313889,1,52,full reaction|has preparation,C16H15NO|C19H16N2O2,C35H31N3O3,,Preparation,1,,Michael addition,,,"8863376; Article; Scheffelaar, Rachel; Parayidino, Monica; Znabet, Anass; Schmitz, Rob F.; De Kanter, Frans J. J.; Lutz, Martin; Spek, Anthony L.; Guerra, Celia Fonseca; Bickelhaupt, F. Matthias; Groe",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
CC1(C)OC(=O)C(c2ccccc2)C(=O)O1,COc1cccc(O)c1O.COC1=CC(C2(c3ccccc3)C(=O)OC(C)(C)OC2=O)C=C(O)C1=O,CC1(C)OC(=O)C(c2ccccc2)C(=O)O1>>COc1cccc(O)c1O.COC1=CC(C2(c3ccccc3)C(=O)OC(C)(C)OC2=O)C=C(O)C1=O,29323178,1,52,full reaction,"2.2-dimethyl-5-phenyl-1,3-dioxane-4,6-dione|3-methocycatechol",C19H18O7,,Chemical behaviour,1,25,Michael addition,Kinetics,aq. acetate buffer,"8864500; Article; Nematollahi, Davood; Bamzadeh, Maryam; Shayani-Jam, Hasan; Chemical and Pharmaceutical Bulletin; vol. 58; 1; (2010); p. 23 - 26;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5,scheme or table,,,,,,,,,,,,,,
CC1(C)OC(=O)C(c2ccccc2)C(=O)O1,CC(C)(C)c1ccc(O)c(O)c1.CC1(C)OC(=O)C(c2ccccc2)(C2C=C(O)C(=O)C=C2C(C)(C)C)C(=O)O1,CC1(C)OC(=O)C(c2ccccc2)C(=O)O1>>CC(C)(C)c1ccc(O)c(O)c1.CC1(C)OC(=O)C(c2ccccc2)(C2C=C(O)C(=O)C=C2C(C)(C)C)C(=O)O1,29323180,1,52,full reaction,"2.2-dimethyl-5-phenyl-1,3-dioxane-4,6-dione|4-tert-Butylcatechol",C22H24O6,,Chemical behaviour,1,25,Michael addition,Kinetics,aq. acetate buffer,"8864500; Article; Nematollahi, Davood; Bamzadeh, Maryam; Shayani-Jam, Hasan; Chemical and Pharmaceutical Bulletin; vol. 58; 1; (2010); p. 23 - 26;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5,scheme or table,,,,,,,,,,,,,,
CC1(C)OC(=O)C(c2ccccc2)C(=O)O1,Oc1ccccc1O.CC1(C)OC(=O)C(c2ccccc2)(C2C=CC(=O)C(O)=C2)C(=O)O1,CC1(C)OC(=O)C(c2ccccc2)C(=O)O1>>Oc1ccccc1O.CC1(C)OC(=O)C(c2ccccc2)(C2C=CC(=O)C(O)=C2)C(=O)O1,29323181,1,52,full reaction,"2.2-dimethyl-5-phenyl-1,3-dioxane-4,6-dione|benzene-1,2-diol",C18H16O6,,Chemical behaviour,1,25,Michael addition,Kinetics,aq. acetate buffer,"8864500; Article; Nematollahi, Davood; Bamzadeh, Maryam; Shayani-Jam, Hasan; Chemical and Pharmaceutical Bulletin; vol. 58; 1; (2010); p. 23 - 26;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5,scheme or table,,,,,,,,,,,,,,
CC1(C)OC(=O)C(c2ccccc2)C(=O)O1,Cc1ccc(O)c(O)c1.CC1=CC(=O)C(O)=CC1C1(c2ccccc2)C(=O)OC(C)(C)OC1=O,CC1(C)OC(=O)C(c2ccccc2)C(=O)O1>>Cc1ccc(O)c(O)c1.CC1=CC(=O)C(O)=CC1C1(c2ccccc2)C(=O)OC(C)(C)OC1=O,29323184,1,52,full reaction,"2.2-dimethyl-5-phenyl-1,3-dioxane-4,6-dione|4-methyl-1,2-dihydroxybenzene",C19H18O6,,Chemical behaviour,1,25,Michael addition,Kinetics,aq. acetate buffer,"8864500; Article; Nematollahi, Davood; Bamzadeh, Maryam; Shayani-Jam, Hasan; Chemical and Pharmaceutical Bulletin; vol. 58; 1; (2010); p. 23 - 26;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5,scheme or table,,,,,,,,,,,,,,
CC1(C)OC(=O)C(c2ccccc2)C(=O)O1,Cc1cccc(O)c1O.CC1=CC(C2(c3ccccc3)C(=O)OC(C)(C)OC2=O)C=C(O)C1=O,CC1(C)OC(=O)C(c2ccccc2)C(=O)O1>>Cc1cccc(O)c1O.CC1=CC(C2(c3ccccc3)C(=O)OC(C)(C)OC2=O)C=C(O)C1=O,29323185,1,52,full reaction,"2.2-dimethyl-5-phenyl-1,3-dioxane-4,6-dione|3-methylbenzene-1,2-diol",C19H18O6,,Chemical behaviour,1,25,Michael addition,Kinetics,aq. acetate buffer,"8864500; Article; Nematollahi, Davood; Bamzadeh, Maryam; Shayani-Jam, Hasan; Chemical and Pharmaceutical Bulletin; vol. 58; 1; (2010); p. 23 - 26;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5,scheme or table,,,,,,,,,,,,,,
COc1ccc(S)cc1,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl.CCC(CSc1ccc(OC)cc1)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,COc1ccc(S)cc1>>C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl.CCC(CSc1ccc(OC)cc1)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,29990919,1,52,full reaction,4-Methoxybenzenethiol|ethacrynic acid,C20H20Cl2O5S,230296,Chemical behaviour,1,25,Michael addition,Kinetics,dimethylsulfoxide-d6|water-d2,"8968359; Article; Paasche, Alexander; Schiller, Markus; Schirmeister, Tanja; Engels, Bernd; ChemMedChem; vol. 5; 6; (2010); p. 869 - 880;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,aq. phosphate buffer,7.6,experimental part,,,,,,,,,,,,,,
Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C=CC(=O)c1ccccc1,Nc1ccccc1S.Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C1CC(c2ccccc2)=Nc2ccccc2S1,Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C=CC(=O)c1ccccc1>>Nc1ccccc1S.Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C1CC(c2ccccc2)=Nc2ccccc2S1,30318566,1,52,full reaction|has preparation,C25H20N2O2|2-amino-benzenethiol,C31H25N3OS,77536,Preparation,1,,Michael addition,,,"9003571; Article; Zhou, Ying-Lei; Shen, Song-Wei; Liu, Fang-Ming; Journal of Heterocyclic Chemistry; vol. 48; 1; (2011); p. 105 - 112;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C=CC(=O)c1ccc(Cl)cc1,Nc1ccccc1S.Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C1CC(c2ccc(Cl)cc2)=Nc2ccccc2S1,Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C=CC(=O)c1ccc(Cl)cc1>>Nc1ccccc1S.Cc1nn(-c2ccccc2)c(Oc2ccccc2)c1C1CC(c2ccc(Cl)cc2)=Nc2ccccc2S1,30318569,1,52,full reaction|has preparation,C25H19ClN2O2|2-amino-benzenethiol,C31H24ClN3OS,77536,Preparation,1,,Michael addition,,,"9003571; Article; Zhou, Ying-Lei; Shen, Song-Wei; Liu, Fang-Ming; Journal of Heterocyclic Chemistry; vol. 48; 1; (2011); p. 105 - 112;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
COc1ccc(C(=O)C=Cc2c(C)nn(-c3ccccc3)c2Oc2ccccc2)cc1,Nc1ccccc1S.COc1ccc(C2=Nc3ccccc3SC(c3c(C)nn(-c4ccccc4)c3Oc3ccccc3)C2)cc1,COc1ccc(C(=O)C=Cc2c(C)nn(-c3ccccc3)c2Oc2ccccc2)cc1>>Nc1ccccc1S.COc1ccc(C2=Nc3ccccc3SC(c3c(C)nn(-c4ccccc4)c3Oc3ccccc3)C2)cc1,30318572,1,52,full reaction|has preparation,C26H22N2O3|2-amino-benzenethiol,C32H27N3O2S,77536,Preparation,1,,Michael addition,,,"9003571; Article; Zhou, Ying-Lei; Shen, Song-Wei; Liu, Fang-Ming; Journal of Heterocyclic Chemistry; vol. 48; 1; (2011); p. 105 - 112;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
CCOC(=O)C[N+](=O)[O-],CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O[C@H]1C=CC(=O)O1.[H][C@@]1(C(C(=O)OCC)=[N+]([O-])O)CC(=O)O[C@H]1O[C@@H]1C[C@H](C)CC[C@H]1C(C)C,CCOC(=O)C[N+](=O)[O-]>>CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O[C@H]1C=CC(=O)O1.[H][C@@]1(C(C(=O)OCC)=[N+]([O-])O)CC(=O)O[C@H]1O[C@@H]1C[C@H](C)CC[C@H]1C(C)C,30340240,1,52,full reaction|has preparation,nitroacetic acid ethyl ester|(5R)-(L-menthyloxy)-2(5H)-furanone,"[(2R,3S)-2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexyloxy)-5-oxo-tetrahydro-furan-3-yl]-aci-nitro-acetic acid ethyl ester",164227,Preparation,1,,Michael addition,,,"9005849; Article; Feng, Zhiqiang; Yin, Chenglie; Synthetic Communications; vol. 41; 4; (2011); p. 507 - 515;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
COC(=O)C[N+](=O)[O-],CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O[C@H]1C=CC(=O)O1.COC(=O)C([C@@H]1CC(=O)O[C@H]1O[C@@H]1C[C@H](C)CC[C@H]1C(C)C)=[N+]([O-])O,COC(=O)C[N+](=O)[O-]>>CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O[C@H]1C=CC(=O)O1.COC(=O)C([C@@H]1CC(=O)O[C@H]1O[C@@H]1C[C@H](C)CC[C@H]1C(C)C)=[N+]([O-])O,30340252,1,52,full reaction|has preparation,methyl 2-nitroacetate|(5R)-(L-menthyloxy)-2(5H)-furanone,C17H27NO7,164227,Preparation,1,,Michael addition,,,"9005849; Article; Feng, Zhiqiang; Yin, Chenglie; Synthetic Communications; vol. 41; 4; (2011); p. 507 - 515;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
CCCCCC1CCC(CC=NC2CCCCC2)CC1,C=CC(=O)OCC.CCCCCC1CCC(C(C=O)CCC(=O)OCC)CC1,CCCCCC1CCC(CC=NC2CCCCC2)CC1>>C=CC(=O)OCC.CCCCCC1CCC(C(C=O)CCC(=O)OCC)CC1,31115638,1,52,full reaction|has preparation,cyclohexyl-(2-(4-pentylcyclohexyl)ethylidene)amine|ethyl acrylate,C18H32O3,203093,Preparation,1,,Michael addition,,,"9056478; Article; Fujita, Atsuko; Masukawa, Tokifumi; Kawasaki, Subaru; Demus, Dietrich; Molecular Crystals and Liquid Crystals; vol. 509; 1; (2009); p. 245 - 262;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,10,Reflux,,scheme or table,,,,,,,,,,,,,,
O=c1cc(O)c2ccccc2o1,Cc1ccc(S(=O)(=O)Nc2ccccc2C(=O)C=Cc2ccccc2)cc1.Cc1ccc(S(=O)(=O)Nc2ccccc2C(=O)CC(c2ccccc2)c2c(O)c3ccccc3oc2=O)cc1,O=c1cc(O)c2ccccc2o1>>Cc1ccc(S(=O)(=O)Nc2ccccc2C(=O)C=Cc2ccccc2)cc1.Cc1ccc(S(=O)(=O)Nc2ccccc2C(=O)CC(c2ccccc2)c2c(O)c3ccccc3oc2=O)cc1,31417575,1,52,full reaction|has preparation,4-hydroxy[1]benzopyran-2-one|N-(2-cinnamoylphenyl)-4-methylbenzenesulfonamide,C31H25NO6S,228901,Preparation,1,,Michael addition,,,"9076956; Article; Sun, Yi; Gan, Jianhong; Fan, Renhua; Advanced Synthesis and Catalysis; vol. 353; 10; (2011); p. 1735 - 1740;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
Cc1ccc(C=CC(=O)c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1,CCOC(=O)CC(=O)OCC.CCOC(=O)C(C(=O)OCC)C(CC(=O)c1ccccc1NS(=O)(=O)c1ccc(C)cc1)c1ccc(C)cc1,Cc1ccc(C=CC(=O)c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1>>CCOC(=O)CC(=O)OCC.CCOC(=O)C(C(=O)OCC)C(CC(=O)c1ccccc1NS(=O)(=O)c1ccc(C)cc1)c1ccc(C)cc1,31417590,1,52,full reaction|has preparation,N-Ts-1-(2-aminophenyl)-3-p-tolylprop-2-en-1-one|diethyl malonate,C30H33NO7S,229113,Preparation,1,,Michael addition,,,"9076956; Article; Sun, Yi; Gan, Jianhong; Fan, Renhua; Advanced Synthesis and Catalysis; vol. 353; 10; (2011); p. 1735 - 1740;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
CCCCCCCCN,C=CS(=O)(=O)N(Cc1ccc(OC)cc1)C(=C)C(=O)OC.CCCCCCCCN1CCS(=O)(=O)N(Cc2ccc(OC)cc2)C(C(=O)OC)C1,CCCCCCCCN>>C=CS(=O)(=O)N(Cc1ccc(OC)cc1)C(=C)C(=O)OC.CCCCCCCCN1CCS(=O)(=O)N(Cc2ccc(OC)cc2)C(C(=O)OC)C1,31583905,1,52,full reaction|has preparation,n-Octylamine|C14H17NO5S,"methyl 2-(4-methoxybenzyl)-5-octyl-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccc(OC)cc1)C(=C)C(=O)OC,NC1CCCC1.COC(=O)C1CN(C2CCCC2)CCS(=O)(=O)N1Cc1ccc(C)cc1,C=CS(=O)(=O)N(Cc1ccc(OC)cc1)C(=C)C(=O)OC>>NC1CCCC1.COC(=O)C1CN(C2CCCC2)CCS(=O)(=O)N1Cc1ccc(C)cc1,31583906,1,52,full reaction|has preparation,C14H17NO5S|Cyclopentamine,"methyl 5-cyclopentyl-2-(4-methylbenzyl)-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",89313,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccccc1)C(=C)C(=O)OC,CCCCN.CCCCN1CCS(=O)(=O)N(Cc2ccccc2)C(C(=O)OC)C1,C=CS(=O)(=O)N(Cc1ccccc1)C(=C)C(=O)OC>>CCCCN.CCCCN1CCS(=O)(=O)N(Cc2ccccc2)C(C(=O)OC)C1,31583907,1,52,full reaction|has preparation,C13H15NO4S|N-butylamine,"methyl 2-benzyl-5-butyl-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccccc1)C(=C)C(=O)OC,NCc1ccc(F)cc1.COC(=O)C1CN(Cc2ccc(F)cc2)CCS(=O)(=O)N1Cc1ccccc1,C=CS(=O)(=O)N(Cc1ccccc1)C(=C)C(=O)OC>>NCc1ccc(F)cc1.COC(=O)C1CN(Cc2ccc(F)cc2)CCS(=O)(=O)N1Cc1ccccc1,31583908,1,52,full reaction|has preparation,C13H15NO4S|para-fluorobenzylamine,"methyl 2-benzyl-5-(4-fluorobenzyl)-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccc(Cl)cc1)C(=C)C(=O)OC,NCCc1ccccc1.COC(=O)C1CN(CCc2ccccc2)CCS(=O)(=O)N1Cc1ccc(Cl)cc1,C=CS(=O)(=O)N(Cc1ccc(Cl)cc1)C(=C)C(=O)OC>>NCCc1ccccc1.COC(=O)C1CN(CCc2ccccc2)CCS(=O)(=O)N1Cc1ccc(Cl)cc1,31583909,1,52,full reaction|has preparation,C13H14ClNO4S|phenethylamine,"methyl 2-(4-chlorobenzyl)-5-phenethyl-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccc(Cl)cc1)C(=C)C(=O)OC,COc1ccc(CN)cc1.COC(=O)C1CN(Cc2ccc(OC)cc2)CCS(=O)(=O)N1Cc1ccc(Cl)cc1,C=CS(=O)(=O)N(Cc1ccc(Cl)cc1)C(=C)C(=O)OC>>COc1ccc(CN)cc1.COC(=O)C1CN(Cc2ccc(OC)cc2)CCS(=O)(=O)N1Cc1ccc(Cl)cc1,31583910,1,52,full reaction|has preparation,C13H14ClNO4S|4-methoxy-benzylamine,"methyl 2-(4-chlorobenzyl)-5-(4-methoxybenzyl)-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,experimental part,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccc(F)cc1)C(=C)C(=O)OC,CC(C)CN.COC(=O)C1CN(CC(C)C)CCS(=O)(=O)N1Cc1ccc(F)cc1,C=CS(=O)(=O)N(Cc1ccc(F)cc1)C(=C)C(=O)OC>>CC(C)CN.COC(=O)C1CN(CC(C)C)CCS(=O)(=O)N1Cc1ccc(F)cc1,31583911,1,52,full reaction|has preparation,C13H14FNO4S|isobutylamine,"methyl 2-(4-fluorobenzyl)-5-isobutyl-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
C=CS(=O)(=O)N(Cc1ccc(C(F)(F)F)cc1)C(=C)C(=O)OC,NCc1ccccc1.COC(=O)C1CN(Cc2ccccc2)CCS(=O)(=O)N1Cc1ccc(C(F)(F)F)cc1,C=CS(=O)(=O)N(Cc1ccc(C(F)(F)F)cc1)C(=C)C(=O)OC>>NCc1ccccc1.COC(=O)C1CN(Cc2ccccc2)CCS(=O)(=O)N1Cc1ccc(C(F)(F)F)cc1,31583912,1,52,full reaction|has preparation,C14H14F3NO4S|benzylamine,"methyl 5-benzyl-2-[4-(trifluoromethyl)benzyl]-1,2,5-thiadiazepane-3-carboxylate 1,1-dioxide",207952,Preparation,1,,Double aza-Michael reaction,,,"20010246; Article; Zang, Qin; Javed, Salim; Ullah, Farman; Zhou, Aihua; Knudtson, Christopher A.; Bi, Danse; Basha, Fatima Z.; Organ, Michael G.; Hanson, Paul R.; Synthesis; 17; (2011); p. 2743 - 2750",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,scheme or table,,,,,,,,,,,,,,
Cc1ccc(C=CC(=O)c2ccccc2)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccc(C)cc2)CCCCC1=O,Cc1ccc(C=CC(=O)c2ccccc2)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccc(C)cc2)CCCCC1=O,31767641,1,52,full reaction|has preparation,4-methyl-chalcone|cyclohexanone,C22H24O2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccc(Cl)cc1)c1ccccc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccc(Cl)cc2)CCCCC1=O,O=C(C=Cc1ccc(Cl)cc1)c1ccccc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccc(Cl)cc2)CCCCC1=O,31767642,1,52,full reaction|has preparation,3-(4-chlorophenyl)-1-phenylprop-2-en-1-one|cyclohexanone,C21H21ClO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
Cc1ccc(C(=O)C=Cc2ccc(Cl)cc2)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(C)cc2)c2ccc(Cl)cc2)CCCCC1=O,Cc1ccc(C(=O)C=Cc2ccc(Cl)cc2)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(C)cc2)c2ccc(Cl)cc2)CCCCC1=O,31767645,1,52,full reaction|has preparation,3-(4-chlorophenyl)-1-p-tolylprop-2-en-1-one|cyclohexanone,C22H23ClO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccc(F)cc1)c1ccc(Br)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2ccc(F)cc2)CCCCC1=O,O=C(C=Cc1ccc(F)cc1)c1ccc(Br)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2ccc(F)cc2)CCCCC1=O,31767647,1,52,full reaction|has preparation,1-(4-bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one|cyclohexanone,C21H20BrFO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccc(Cl)cc1)c1cccc(Cl)c1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2cccc(Cl)c2)c2ccc(Cl)cc2)CCCCC1=O,O=C(C=Cc1ccc(Cl)cc1)c1cccc(Cl)c1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2cccc(Cl)c2)c2ccc(Cl)cc2)CCCCC1=O,31767649,1,52,full reaction|has preparation,1-(3-chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one|cyclohexanone,C21H20Cl2O2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccc(Cl)cc1Cl)c1ccc(Br)cc1,O=C1CCCCC1.[H][C@]1([C@@H](CC(=O)c2ccc(Br)cc2)c2ccc(Cl)cc2Cl)CCCCC1=O,O=C(C=Cc1ccc(Cl)cc1Cl)c1ccc(Br)cc1>>O=C1CCCCC1.[H][C@]1([C@@H](CC(=O)c2ccc(Br)cc2)c2ccc(Cl)cc2Cl)CCCCC1=O,31767671,1,52,full reaction|has preparation,"1-(4-bromophenyl)-3-(2,4-dichlorophenyl) prop-2-en-1-one|cyclohexanone",C21H19BrCl2O2,228988,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
COc1ccc(C(=O)C=Cc2ccc(Cl)cc2)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(OC)cc2)c2ccc(Cl)cc2)CCCCC1=O,COc1ccc(C(=O)C=Cc2ccc(Cl)cc2)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(OC)cc2)c2ccc(Cl)cc2)CCCCC1=O,31767672,1,52,full reaction|has preparation,4-chloro-4'-methoxy-chalcone|cyclohexanone,C22H23ClO3,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccccc1)c1ccc(Br)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2ccccc2)CCCCC1=O,O=C(C=Cc1ccccc1)c1ccc(Br)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2ccccc2)CCCCC1=O,31767675,1,52,full reaction|has preparation,1-(4-bromophenyl)-3-phenyl-2-propen-1-one|cyclohexanone,C21H21BrO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccc(Cl)cc1)c1ccc(Br)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2ccc(Cl)cc2)CCCCC1=O,O=C(C=Cc1ccc(Cl)cc1)c1ccc(Br)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2ccc(Cl)cc2)CCCCC1=O,31767677,1,52,full reaction|has preparation,1-(4-bromophenyl)-3-(4-chlorophenyl)prop-2-en-1-one|cyclohexanone,C21H20BrClO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C(C=Cc1ccc(Cl)cc1)c1ccc(Cl)cc1,O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2ccc(Cl)cc2)CCCCC1=O,O=C(C=Cc1ccc(Cl)cc1)c1ccc(Cl)cc1>>O=C1CCCCC1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2ccc(Cl)cc2)CCCCC1=O,31767679,1,52,full reaction|has preparation,"1,3-bis(4-chlorophenyl)prop-2-en-1-one|cyclohexanone",C21H20Cl2O2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,O=C(C=Cc1ccc(F)cc1)c1ccc(Cl)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2ccc(F)cc2)CCCCC1=O,O=C1CCCCC1>>O=C(C=Cc1ccc(F)cc1)c1ccc(Cl)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2ccc(F)cc2)CCCCC1=O,31767686,1,52,full reaction|has preparation,cyclohexanone|1-(4-chlorophenyl)-3-(4-fluorophenyl)prop-2-en-1-one,C21H20ClFO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,O=C(C=Cc1cccc(Br)c1)c1ccc(Cl)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2cccc(Br)c2)CCCCC1=O,O=C1CCCCC1>>O=C(C=Cc1cccc(Br)c1)c1ccc(Cl)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2cccc(Br)c2)CCCCC1=O,31767688,1,52,full reaction|has preparation,cyclohexanone|3-Bromo-4'-chlorochalcone,C21H20BrClO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,O=C(C=Cc1ccccc1)c1ccccc1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccccc2)CCCCC1=O,O=C1CCCCC1>>O=C(C=Cc1ccccc1)c1ccccc1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccccc2)CCCCC1=O,31767690,1,52,full reaction|has preparation,cyclohexanone|benzalacetophenone,"2-(3-oxo-1,3-diphenylpropyl)-1-cyclohexanone",228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,O=C(C=Cc1ccccc1)c1ccc(Cl)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2ccccc2)CCCCC1=O,O=C1CCCCC1>>O=C(C=Cc1ccccc1)c1ccc(Cl)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Cl)cc2)c2ccccc2)CCCCC1=O,31767691,1,52,full reaction|has preparation,cyclohexanone|4'-chlorochalcone,C21H21ClO2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,[H]C(C(=O)c1ccc(OC)cc1)=C([H])c1ccccc1.[H][C@@]1([C@H](CC(=O)c2ccc(OC)cc2)c2ccccc2)CCCCC1=O,O=C1CCCCC1>>[H]C(C(=O)c1ccc(OC)cc1)=C([H])c1ccccc1.[H][C@@]1([C@H](CC(=O)c2ccc(OC)cc2)c2ccccc2)CCCCC1=O,31767693,1,52,full reaction|has preparation,cyclohexanone|4'-methoxychalcone,C22H24O3,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,Cc1ccc(C(=O)C=Cc2ccccc2)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(C)cc2)c2ccccc2)CCCCC1=O,O=C1CCCCC1>>Cc1ccc(C(=O)C=Cc2ccccc2)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(C)cc2)c2ccccc2)CCCCC1=O,31767695,1,52,full reaction|has preparation,cyclohexanone|3-phenyl-1-p-tolylprop-2-en-1-one,C22H24O2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,O=C(C=Cc1cccc(Br)c1)c1ccc(Br)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2cccc(Br)c2)CCCCC1=O,O=C1CCCCC1>>O=C(C=Cc1cccc(Br)c1)c1ccc(Br)cc1.[H][C@@]1([C@H](CC(=O)c2ccc(Br)cc2)c2cccc(Br)c2)CCCCC1=O,31767697,1,52,full reaction|has preparation,cyclohexanone|3-(3-bromophenyl)-1-(4-bromophenyl)prop-2-en-1-one,C21H20Br2O2,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
O=C1CCCCC1,COc1ccc(C=CC(=O)c2ccccc2)cc1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccc(OC)cc2)CCCCC1=O,O=C1CCCCC1>>COc1ccc(C=CC(=O)c2ccccc2)cc1.[H][C@@]1([C@H](CC(=O)c2ccccc2)c2ccc(OC)cc2)CCCCC1=O,31767699,1,52,full reaction|has preparation,cyclohexanone|3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one,C22H24O3,228987,Preparation,1,,Michael addition,,,"20026774; Article; Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Green Chemistry; vol. 13; 10; (2011); p. 2777 - 2785;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,body text,,,,,,,,,,,,,,
CC(=O)c1ccccn1,COc1cc(C=CC(=O)c2ccccc2)cc(OC)c1.COc1cc(OC)cc(C(CC(=O)c2ccccc2)CC(=O)c2ccccn2)c1,CC(=O)c1ccccn1>>COc1cc(C=CC(=O)c2ccccc2)cc(OC)c1.COc1cc(OC)cc(C(CC(=O)c2ccccc2)CC(=O)c2ccccn2)c1,31913010,1,52,full reaction|has preparation,"2-acetylpyridine|3-(3,5-dimethoxyphenyl)-1-phenylprop-2-en-1-one",C24H23NO4,229192,Preparation,1,,Michael addition,,,"20039220; Article; Costa, Ruben D.; Orti, Enrique; Bolink, Henk J.; Graber, Stefan; Housecroft, Catherine E.; Constable, Edwin C.; Advanced Functional Materials; vol. 20; 9; (2010); p. 1511 - 1520;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Neat (no solvent),,experimental part,,,,,,,,,,,,,,
CN1CCNCC1,C=CC(=O)Nc1c(C(=O)NCC)noc1-c1cc(C(C)C)c(OCc2ccccc2)cc1OCc1ccccc1.CCNC(=O)c1noc(-c2cc(C(C)C)c(OCc3ccccc3)cc2OCc2ccccc2)c1NC(=O)CCN1CCN(C)CC1,CN1CCNCC1>>C=CC(=O)Nc1c(C(=O)NCC)noc1-c1cc(C(C)C)c(OCc2ccccc2)cc1OCc1ccccc1.CCNC(=O)c1noc(-c2cc(C(C)C)c(OCc3ccccc3)cc2OCc2ccccc2)c1NC(=O)CCN1CCN(C)CC1,32338353,1,52,full reaction|has preparation,1-methyl-piperazine|C32H33N3O5,"5-[2,4-bis(benzyloxy)-5-isopropylphenyl]-4-[3-(4-methylpiperazin-1-yl)propionylamino]isoxazole-3-carboxylic acid ethylamide",230562,Preparation,1,,Michael addition,,,"20071662; Article; Baruchello, Riccardo; Simoni, Daniele; Grisolia, Giuseppina; Barbato, Giuseppina; Marchetti, Paolo; Rondanin, Riccardo; Mangiola, Stefania; Giannini, Giuseppe; Brunetti, Tiziana; Al",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Inert atmosphere|Reflux,,supporting information; experimental part,,,,,,,,,,,,,,
c1c[nH]cn1,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2ccnc2)C1(C)C.F[P](F)(F)(F)(F)F.[H+],c1c[nH]cn1>>CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2ccnc2)C1(C)C.F[P](F)(F)(F)(F)F.[H+],32979362,1,52,full reaction,1H-imidazole|C22H25N2O(1+)*F6P(1-),C25H28N4O*F6P(1-)*H(1+),,Chemical behaviour,1,20,aza-Michael addition,Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
Cn1ccnc1,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2cc[n+](C)c2)C1(C)C.F[P](F)(F)(F)(F)F,Cn1ccnc1>>CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2cc[n+](C)c2)C1(C)C.F[P](F)(F)(F)(F)F,32979364,1,52,full reaction,1-methyl-1H-imidazole|C22H25N2O(1+)*F6P(1-),C26H31N4O(1+)*F6P(1-),199390,Chemical behaviour,1,20,aza-Michael addition,Equilibrium constant|Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
c1ccc2[nH]cnc2c1,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2cnc3ccccc32)C1(C)C.F[P](F)(F)(F)(F)F.[H+],c1ccc2[nH]cnc2c1>>CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2cnc3ccccc32)C1(C)C.F[P](F)(F)(F)(F)F.[H+],32979365,1,52,full reaction,benzoimidazole|C22H25N2O(1+)*F6P(1-),C29H30N4O*F6P(1-)*H(1+),,Chemical behaviour,1,20,aza-Michael addition,Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
Cc1ncc[nH]1,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.Cc1nccn1C(C=CN1[C@@H](Cc2ccccc2)C(=O)N(C)C1(C)C)c1ccccc1.F[P](F)(F)(F)(F)F.[H+],Cc1ncc[nH]1>>CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.Cc1nccn1C(C=CN1[C@@H](Cc2ccccc2)C(=O)N(C)C1(C)C)c1ccccc1.F[P](F)(F)(F)(F)F.[H+],32979367,1,52,full reaction,2-methylimidazole|C22H25N2O(1+)*F6P(1-),C26H30N4O*F6P(1-)*H(1+),,Chemical behaviour,1,20,aza-Michael addition,Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
Cc1c[nH]cn1,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.Cc1cn(C(C=CN2[C@@H](Cc3ccccc3)C(=O)N(C)C2(C)C)c2ccccc2)cn1.F[P](F)(F)(F)(F)F.[H+],Cc1c[nH]cn1>>CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.Cc1cn(C(C=CN2[C@@H](Cc3ccccc3)C(=O)N(C)C2(C)C)c2ccccc2)cn1.F[P](F)(F)(F)(F)F.[H+],32979368,1,52,full reaction,4-methyl-1H-imidazole|C22H25N2O(1+)*F6P(1-),C26H30N4O*F6P(1-)*H(1+),,Chemical behaviour,1,20,aza-Michael addition,Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
Cc1c[nH]c(C)n1,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.Cc1cn(C(C=CN2[C@@H](Cc3ccccc3)C(=O)N(C)C2(C)C)c2ccccc2)c(C)n1.F[P](F)(F)(F)(F)F.[H+],Cc1c[nH]c(C)n1>>CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F.Cc1cn(C(C=CN2[C@@H](Cc3ccccc3)C(=O)N(C)C2(C)C)c2ccccc2)c(C)n1.F[P](F)(F)(F)(F)F.[H+],32979369,1,52,full reaction,"2,4-Dimethylimidazole|C22H25N2O(1+)*F6P(1-)",C27H32N4O*F6P(1-)*H(1+),,Chemical behaviour,1,20,aza-Michael addition,Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F,C[Si](C)(C)n1ccnc1.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2cc[n+]([Si](C)(C)C)c2)C1(C)C.F[P](F)(F)(F)(F)F,CN1C(=O)[C@H](Cc2ccccc2)[N+](=CC=Cc2ccccc2)C1(C)C.F[P](F)(F)(F)(F)F>>C[Si](C)(C)n1ccnc1.CN1C(=O)[C@H](Cc2ccccc2)N(C=CC(c2ccccc2)n2cc[n+]([Si](C)(C)C)c2)C1(C)C.F[P](F)(F)(F)(F)F,32979370,1,52,full reaction,C22H25N2O(1+)*F6P(1-)|1-(Trimethylsilyl)imidazole,C28H37N4OSi(1+)*F6P(1-),199248,Chemical behaviour,1,20,aza-Michael addition,Equilibrium constant|Kinetics,acetonitrile,"20120836; Article; Lakhdar, Sami; Baidya, Mahiuddin; Mayr, Herbert; Chemical Communications; vol. 48; 37; (2012); p. 4504 - 4506;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information; experimental part,,,,,,Concentration,,,,,,,,
O=c1cc(O)c2ccccc2o1,CC(=O)C=Cc1ccc(C)cc1.[H]C(CC(C)=O)(c1ccc(C)cc1)c1c(O)c2ccccc2oc1=O,O=c1cc(O)c2ccccc2o1>>CC(=O)C=Cc1ccc(C)cc1.[H]C(CC(C)=O)(c1ccc(C)cc1)c1c(O)c2ccccc2oc1=O,34167369,1,52,full reaction|has preparation,4-hydroxy[1]benzopyran-2-one|4-(p-tolyl)-3-buten-2-one,4-hydroxy-3-(3-oxo-1-(p-tolyl)butyl)-2H-chromen-2-one,228901,Preparation,1,,Michael Addition,,,"20204895; Article; Zhang, Jia; Chai, Yunfeng; Jiang, Kezhi; Yang, Huameng; Pan, Yuanjiang; Sun, Cuirong; Journal of Mass Spectrometry; vol. 47; 8; (2012); p. 1059 - 1064;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
Nc1nc2ccccc2[nH]1,Cc1ccc(C=C2C(=O)OC(C)(C)OC2=O)cc1.Cc1ccc(C2CC(=O)n3c(nc4ccccc43)N2)cc1,Nc1nc2ccccc2[nH]1>>Cc1ccc(C=C2C(=O)OC(C)(C)OC2=O)cc1.Cc1ccc(C2CC(=O)n3c(nc4ccccc43)N2)cc1,34591872,1,52,full reaction|has preparation,"1H-benzimidazol-2-amine|2,2-dimethyl-5-(4-methylbenzylidene)-1,3-dioxane-4,6-dione","2-(4-methylphenyl)-1,2-dihydropyrimido[1,2-a]benzimidazol-4-(3H)-one",209958,Preparation,1,,Michael Addition,,,"35449079; Article; Sheibani, Hassan; Saidi, Kazem; Lakaei, Molod; Journal of Heterocyclic Chemistry; vol. 49; 6; (2012); p. 1386 - 1390;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,regioselective reaction,,,,,,Scheme or table,,,,,,,
COC(=O)C=CC(=O)Nc1cc2ccccc2oc1=O,OCCS.COC(=O)CC(SCCO)C(=O)Nc1cc2ccccc2oc1=O,COC(=O)C=CC(=O)Nc1cc2ccccc2oc1=O>>OCCS.COC(=O)CC(SCCO)C(=O)Nc1cc2ccccc2oc1=O,34816963,1,52,full reaction|has preparation,C14H11NO5|2-hydroxyethanethiol,C16H17NO6S,228310,Preparation,1,,Michael Addition,,,"35458219; Article; Baud, Matthias G.J.; Leiser, Thomas; Petrucci, Vanessa; Gunaratnam, Mekala; Neidle, Stephen; Meyer-Almes, Franz-Josef; Fuchter, Matthew J.; Beilstein Journal of Organic Chemistry; v",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC(C)=CCC[C@@H](C)C1=C(O)C(=O)C(C)=CC1=O,[H][C@@]12CC[C@@H](C)[C@@]13C(=O)C(O)=C(C)[C@@H](C3=O)C2(C)C.[H][C@@]12CC[C@@H](C)[C@]13C(=O)C(O)=C(C)[C@H](C3=O)C2(C)C,CC(C)=CCC[C@@H](C)C1=C(O)C(=O)C(C)=CC1=O>>[H][C@@]12CC[C@@H](C)[C@@]13C(=O)C(O)=C(C)[C@@H](C3=O)C2(C)C.[H][C@@]12CC[C@@H](C)[C@]13C(=O)C(O)=C(C)[C@H](C3=O)C2(C)C,35274690,1,52,full reaction|has preparation,(-)-perezone,α-pipitzol|β-pipitzol,15728|15728,Preparation,1,,Michael Addition,,,"35480363; Article; Zepeda, L. Gerardo; Burgueño-Tapia, Eleuterio; Pérez-Hernández, Nury; Cuevas,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,stereoselective reaction,,,,,,Scheme or table,80 percent de,,,,,,
[H][C@@](C)(CCC=C(C)C)C1=C(OC)C(=O)C(C)=CC1=O,[H][C@@]12CC[C@@H](C)[C@@]13C(=O)C(O)=C(C)[C@@H](C3=O)C2(C)C.[H][C@@]12CC[C@@H](C)[C@]13C(=O)C(O)=C(C)[C@H](C3=O)C2(C)C,[H][C@@](C)(CCC=C(C)C)C1=C(OC)C(=O)C(C)=CC1=O>>[H][C@@]12CC[C@@H](C)[C@@]13C(=O)C(O)=C(C)[C@@H](C3=O)C2(C)C.[H][C@@]12CC[C@@H](C)[C@]13C(=O)C(O)=C(C)[C@H](C3=O)C2(C)C,35274691,1,52,full reaction|has preparation,O-methylperezone,α-pipitzol|β-pipitzol,15728|15728,Preparation,1,,Michael Addition,,,"35480363; Article; Zepeda, L. Gerardo; Burgueño-Tapia, Eleuterio; Pérez-Hernández, Nury; Cuevas,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,stereoselective reaction,,,,,,Scheme or table,77.778 percent de,,,,,,
C=CCOC(=O)C=C,CC(C)(C)OC(=O)NCCN.C=CCOC(=O)CCNCCNC(=O)OC(C)(C)C,C=CCOC(=O)C=C>>CC(C)(C)OC(=O)NCCN.C=CCOC(=O)CCNCCNC(=O)OC(C)(C)C,35638782,1,52,full reaction|has preparation,"allyl acrylate|N-BOC-1,2-diaminoethane",C13H24N2O4,22658,Preparation,1,,Michael Addition,,,"35498071; Article; Pascale, Lise; Azoulay, Stephane; Di Giorgio, Audrey; Zenacker, Laura; Gaysinski, Marc; Clayette, Pascal; Patino, Nadia; Nucleic Acids Research; vol. 41; 11; (2013); p. 5851 - 5863;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
C1CCNCC1,COc1cccc(C=C[N+](=O)[O-])c1.COc1cccc(C(C[N+](=O)[O-])N2CCCCC2)c1,C1CCNCC1>>COc1cccc(C=C[N+](=O)[O-])c1.COc1cccc(C(C[N+](=O)[O-])N2CCCCC2)c1,35882569,1,52,full reaction,piperidine|1-methoxy-3-(2-nitrovinyl)benzene,C14H20N2O3,224440,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Concentration,Experimental part,,,,,,,
C1CCNCC1,O=[N+]([O-])C=Cc1cccc(O)c1.O=[N+]([O-])CC(c1cccc(O)c1)N1CCCCC1,C1CCNCC1>>O=[N+]([O-])C=Cc1cccc(O)c1.O=[N+]([O-])CC(c1cccc(O)c1)N1CCCCC1,35882570,1,52,full reaction,piperidine|3-hydroxy-β-nitrostyrene,C13H18N2O3,224440,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Concentration,Experimental part,,,,,,,
C1CCNCC1,Cc1ccc(C=C[N+](=O)[O-])cc1.Cc1ccc(C(C[N+](=O)[O-])N2CCCCC2)cc1,C1CCNCC1>>Cc1ccc(C=C[N+](=O)[O-])cc1.Cc1ccc(C(C[N+](=O)[O-])N2CCCCC2)cc1,35882571,1,52,full reaction,piperidine|4-methyl-β-nitrostyrene,C14H20N2O2,224440,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Concentration,Experimental part,,,,,,,
O=[N+]([O-])C=Cc1ccccc1,CC1CCCNC1.CC1CCCN(C(C[N+](=O)[O-])c2ccccc2)C1,O=[N+]([O-])C=Cc1ccccc1>>CC1CCCNC1.CC1CCCN(C(C[N+](=O)[O-])c2ccccc2)C1,35882572,1,52,full reaction,(2-nitroethenyl)benzene|3-Methylpiperidine,C14H20N2O2,224440,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Concentration,Experimental part,,,,,,,
C1CNCCN1,O=[N+]([O-])C=Cc1ccccc1.O=[N+]([O-])CC(c1ccccc1)N1CCNCC1,C1CNCCN1>>O=[N+]([O-])C=Cc1ccccc1.O=[N+]([O-])CC(c1ccccc1)N1CCNCC1,35882573,1,52,full reaction,piperazine|(2-nitroethenyl)benzene,C12H17N3O2,224440,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Concentration,Experimental part,,,,,,,
OCCN1CCNCC1,O=[N+]([O-])C=Cc1ccccc1.O=[N+]([O-])CC(c1ccccc1)N1CCN(CCO)CC1,OCCN1CCNCC1>>O=[N+]([O-])C=Cc1ccccc1.O=[N+]([O-])CC(c1ccccc1)N1CCN(CCO)CC1,35882574,1,52,full reaction,1-(2-hydroxyethyl)piperazine|(2-nitroethenyl)benzene,C14H21N3O3,224440,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"35691953; Article; Um, Ik-Hwan; Kang, Ji-Sun; Park, Jong-Yoon; Journal of Organic Chemistry; vol. 78; 11; (2013); p. 5604 - 5610;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Concentration,Experimental part,,,,,,,
C[N+](=O)[O-],COC(=O)C(=Cc1ccc(OC)cc1)C(=O)OC.COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc(OC)cc1,C[N+](=O)[O-]>>COC(=O)C(=Cc1ccc(OC)cc1)C(=O)OC.COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc(OC)cc1,36641711,1,52,full reaction|has preparation,nitromethane|dimethyl 2-(4-methoxybenzylidene)malonate,dimethyl 2-(1-(4-methoxyphenyl)-2-nitroethyl)malonate,225137,Preparation,1,,Michael Addition,,,"61510596; Article; Li, Yun; Zhou, Zhengquan; Ye, Weijian; Liu, Juanjuan; Yao, Juan; Wang, Cunde; Journal of Chemical Research; vol. 37; 9; (2013); p. 526 - 530;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Alkaline conditions,,,,,,,,,Body text,,,,,,,
C[N+](=O)[O-],COC(=O)C(=Cc1ccc(Br)cc1)C(=O)OC.COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc(Br)cc1,C[N+](=O)[O-]>>COC(=O)C(=Cc1ccc(Br)cc1)C(=O)OC.COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc(Br)cc1,36641714,1,52,full reaction|has preparation,nitromethane|dimethyl 2-(4-bromobenzylidene)malonate,methyl 2-carbomethoxy-4-nitro-3-(4-bromo-phenyl)-butyrate,225137,Preparation,1,,Michael Addition,,,"61510596; Article; Li, Yun; Zhou, Zhengquan; Ye, Weijian; Liu, Juanjuan; Yao, Juan; Wang, Cunde; Journal of Chemical Research; vol. 37; 9; (2013); p. 526 - 530;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Alkaline conditions,,,,,,,,,Body text,,,,,,,
C[N+](=O)[O-],COC(=O)C(=Cc1ccc([N+](=O)[O-])cc1)C(=O)OC.COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1,C[N+](=O)[O-]>>COC(=O)C(=Cc1ccc([N+](=O)[O-])cc1)C(=O)OC.COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1,36641717,1,52,full reaction|has preparation,nitromethane|dimethyl (4-nitrobenzylidene)malonate,dimethyl 2-[2-nitro-1-(4-nitrophenyl)ethyl]malonate,225137,Preparation,1,,Michael Addition,,,"61510596; Article; Li, Yun; Zhou, Zhengquan; Ye, Weijian; Liu, Juanjuan; Yao, Juan; Wang, Cunde; Journal of Chemical Research; vol. 37; 9; (2013); p. 526 - 530;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Alkaline conditions,,,,,,,,,Body text,,,,,,,
c1nc[nH]n1,C=C(C(=O)OC)N(C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(C)cc1.COC(=O)C(=Cn1cncn1)N(C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(C)cc1,c1nc[nH]n1>>C=C(C(=O)OC)N(C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(C)cc1.COC(=O)C(=Cn1cncn1)N(C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(C)cc1,36713713,1,52,full reaction|has preparation,"1,2,4-Triazole|N-(4-toluenesulfonyl)-N-(tert-butoxycarbonyl)-α,β-didehydroalanine methylester",C18H22N4O6S,287234,Preparation,1,,Michael Addition,,,"61783326; Article; Pereira, Goreti; Castanheira, Elisabete M.S.; Schellenberg, Peter; Belsley;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
C=C(NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C,OCCS.CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)C(CSCCO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,C=C(NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C>>OCCS.CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)C(CSCCO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,37456696,1,52,full reaction|has preparation,C69H114N24O21|2-hydroxyethanethiol,C71H120N24O22S,,Preparation,1,,Michael Addition,,,"61754340; Article; Chen, Rong-Chun; Chuang, Lea-Yea; Tseng, Wei-Lung; Tyan, Yu-Chang; Lu, Chi-Yu; Analytical Biochemistry; vol. 443; 2; (2013); p. 187 - 196;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
Oc1ccccc1O,CCOP(OCC)OCC.CCOP(=O)(OCC)c1ccc(O)c(O)c1,Oc1ccccc1O>>CCOP(OCC)OCC.CCOP(=O)(OCC)c1ccc(O)c(O)c1,38076141,1,52,full reaction,"benzene-1,2-diol|triethyl phosphite","(3,4-dihydroxyphenyl)phosphonic acid diethyl ester",144401,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|acetonitrile,"63487042; Article; Shoaei, Seyed Mohammad; Aghaei, Hossein; Monajjemi, Majid; Aghaei, Mehran; Phosphorus, Sulfur and Silicon and the Related Elements; vol. 189; 5; (2014); p. 652 - 660;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,7,,,water,,,,,Scheme or table,,,,,,,
Cc1cccc(O)c1O,CCOP(OCC)OCC.CCOP(=O)(OCC)c1cc(C)c(O)c(O)c1,Cc1cccc(O)c1O>>CCOP(OCC)OCC.CCOP(=O)(OCC)c1cc(C)c(O)c(O)c1,38076143,1,52,full reaction,"3-methylbenzene-1,2-diol|triethyl phosphite",C11H17O5P,144401,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|acetonitrile,"63487042; Article; Shoaei, Seyed Mohammad; Aghaei, Hossein; Monajjemi, Majid; Aghaei, Mehran; Phosphorus, Sulfur and Silicon and the Related Elements; vol. 189; 5; (2014); p. 652 - 660;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,7,,,water,,,,,Scheme or table,,,,,,,
COc1cccc(O)c1O,CCOP(OCC)OCC.CCOP(=O)(OCC)c1cc(O)c(O)c(OC)c1,COc1cccc(O)c1O>>CCOP(OCC)OCC.CCOP(=O)(OCC)c1cc(O)c(O)c(OC)c1,38076144,1,52,full reaction,3-methocycatechol|triethyl phosphite,C11H17O6P,144401,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|acetonitrile,"63487042; Article; Shoaei, Seyed Mohammad; Aghaei, Hossein; Monajjemi, Majid; Aghaei, Mehran; Phosphorus, Sulfur and Silicon and the Related Elements; vol. 189; 5; (2014); p. 652 - 660;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,7,,,water,,,,,Scheme or table,,,,,,,
c1ccc(P(c2ccccc2)c2ccccc2)cc1,C=CC(=O)O.C=CC(=O)O.C=CC(=O)[O-].O=C(O)CC[P+](c1ccccc1)(c1ccccc1)c1ccccc1,c1ccc(P(c2ccccc2)c2ccccc2)cc1>>C=CC(=O)O.C=CC(=O)O.C=CC(=O)[O-].O=C(O)CC[P+](c1ccccc1)(c1ccccc1)c1ccccc1,38082573,1,52,full reaction,triphenylphosphine|acrylic acid,C21H20O2P(1+)*C3H3O2(1-),230356,Chemical behaviour,1,30,Michael Addition,Kinetics,acetic acid methyl ester,"63553501; Article; Salin, Alexey V.; Fatkhutdinov, Albert R.; Ii'In, Anton V.; Galkin, Vladimir I.; Shamsutdinova, Fanuza G.; Heteroatom Chemistry; vol. 25; 3; (2014); p. 205 - 216;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Solvent,Experimental part,,,,,,,
[C-]#N.[K+],O=C1c2ccccc2C(=O)c2c(O)ccc(O)c21.N#Cc1cc(=O)c2c(=O)c3ccccc3c(=O)c=2c1=O,[C-]#N.[K+]>>O=C1c2ccccc2C(=O)c2c(O)ccc(O)c21.N#Cc1cc(=O)c2c(=O)c3ccccc3c(=O)c=2c1=O,38239976,1,52,full reaction,"potassium cyanide|1,4-dihydroxy-9,10-anthracenedione",C15H5NO4,292059,Chemical behaviour,1,25,Michael Addition,Kinetics,acetonitrile,"63116271; Article; Sayadi, Azam; Varmaghani, Fahimeh; Journal of the Indian Chemical Society; vol. 90; 12; (2013); p. 2187 - 2191;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5,,,,,,,,Scheme or table,,,,,,,
[Li+].c1ccc(C[N-]Cc2ccccc2)cc1,CC(C)(C)OC(=O)C1=CC[C@H]2C[C@@H]1C2(C)C.[H][C@]12C[C@H](N(Cc3ccccc3)Cc3ccccc3)[C@@]([Li])(C(=O)OC(C)(C)C)[C@]([H])(C1)C2(C)C,[Li+].c1ccc(C[N-]Cc2ccccc2)cc1>>CC(C)(C)OC(=O)C1=CC[C@H]2C[C@@H]1C2(C)C.[H][C@]12C[C@H](N(Cc3ccccc3)Cc3ccccc3)[C@@]([Li])(C(=O)OC(C)(C)C)[C@]([H])(C1)C2(C)C,38266011,1,52,full reaction|has preparation,"lithium dibenzylamide|(-)-(1R,5S)-tert-butyl 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate",C28H36LiNO2,216193,Preparation,1,,Michael Addition,,,"64006886; Article; Ilisz, Istvan; Pataj, Zoltan; Gecse, Zsanett; Szakonyi, Zsolt; Fueloep, Ferenc; Lindner, Wolfgang; Peter, Antal; Chirality; vol. 26; 8; (2014); p. 385 - 393;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,stereoselective reaction,,,,,,Experimental part,,,,,,,
[H][C@@]12CC=C(C(=O)OC(C)(C)C)[C@@]([H])(C1)C2(C)C,[Li+].c1ccc(C[N-]Cc2ccccc2)cc1.[H][C@@]12C[C@@H](N(Cc3ccccc3)Cc3ccccc3)[C@]([Li])(C(=O)OC(C)(C)C)[C@@]([H])(C1)C2(C)C,[H][C@@]12CC=C(C(=O)OC(C)(C)C)[C@@]([H])(C1)C2(C)C>>[Li+].c1ccc(C[N-]Cc2ccccc2)cc1.[H][C@@]12C[C@@H](N(Cc3ccccc3)Cc3ccccc3)[C@]([Li])(C(=O)OC(C)(C)C)[C@@]([H])(C1)C2(C)C,38266012,1,52,full reaction|has preparation,"tert-butyl (1S,5R)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate|lithium dibenzylamide",C28H36LiNO2,216193,Preparation,1,,Michael Addition,,,"64006886; Article; Ilisz, Istvan; Pataj, Zoltan; Gecse, Zsanett; Szakonyi, Zsolt; Fueloep, Ferenc; Lindner, Wolfgang; Peter, Antal; Chirality; vol. 26; 8; (2014); p. 385 - 393;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,stereoselective reaction,,,,,,Experimental part,,,,,,,
[Li][Si](C)(C)C,O=C1C=CCC1.C[Si](C)(C)C1CCC(=O)C1,[Li][Si](C)(C)C>>O=C1C=CCC1.C[Si](C)(C)C1CCC(=O)C1,38572320,1,52,full reaction|has preparation,trimethylsilyl lithium|cyclopent-2-enone,β-(trimethylsilyl)cyclopentanone,214748,Preparation,1,,Michael Addition,,,"64129496; Article; Mercadante, Michael A.; Kelly, Christopher B.; Hamlin, Trevor A.; Delle Chiaie, Kayla R.; Drago, Michael D.; Duffy, Katherine K.; Dumas, Megan T.; Fager, Diana C.; Glod, Bryanna L.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)OC(C)C,CC(=O)CC(C)=O.CC(=O)C(CCC(=O)OC(C)C)C(C)=O,C=CC(=O)OC(C)C>>CC(=O)CC(C)=O.CC(=O)C(CCC(=O)OC(C)C)C(C)=O,39387340,1,52,full reaction|has preparation,isopropyl acrylate|acetylacetone,C11H18O4,230854,Preparation,1,,Michael Addition,,,"65221711; Article; Taguchi, Hiroyasu; Yanagisawa, Daijiro; Morikawa, Shigehiro; Hirao, Koichi; Shirai, Nobuaki; Tooyama, Ikuo; Australian Journal of Chemistry; vol. 68; 2; (2015); p. 224 - 229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,,,,,,,Body text,,,,,,,
C=CC(=O)N(C)C,CC(=O)CC(C)=O.CC(=O)C(CCC(=O)N(C)C)C(C)=O,C=CC(=O)N(C)C>>CC(=O)CC(C)=O.CC(=O)C(CCC(=O)N(C)C)C(C)=O,39387343,1,52,full reaction|has preparation,"N,N-Dimethylacrylamide|acetylacetone",C10H17NO3,230854,Preparation,1,,Michael Addition,,,"65221711; Article; Taguchi, Hiroyasu; Yanagisawa, Daijiro; Morikawa, Shigehiro; Hirao, Koichi; Shirai, Nobuaki; Tooyama, Ikuo; Australian Journal of Chemistry; vol. 68; 2; (2015); p. 224 - 229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,,,,,,,Body text,,,,,,,
CCCCOC(=O)CS,C=CC(=O)OCC.CCCCOC(=O)CSCCC(=O)OCC,CCCCOC(=O)CS>>C=CC(=O)OCC.CCCCOC(=O)CSCCC(=O)OCC,39550075,1,52,full reaction,butyl thioglycolate|ethyl acrylate,C11H20O4S,230286,Chemical behaviour,1,,Michael Addition,Catalytic behavior,neat (no solvent),"65119423; Article; Xi, Weixian; Peng, Haiyan; Aguirre-Soto, Alan; Kloxin, Christopher J.; Stansbury, Jeffery W.; Bowman, Christopher N.; Macromolecules; vol. 47; 18; (2014); p. 6159 - 6165;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,Irradiation,,,,"2-(Nitrophenyl)propoxycarbonyl-1,1,3,3-tetramethylguanidine",C11H20O4S,97 percentSpectr.,,Reagent/catalyst,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,C=C(C(=O)OC)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.[H][C@@]1(C(CSC[C@H](N)C(=O)O)C(=O)OC)[C@@H](CCCCCCCC)OC(=O)[C@@H]1O,[H][C@](N)(CS)C(=O)O>>C=C(C(=O)OC)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.[H][C@@]1(C(CSC[C@H](N)C(=O)O)C(=O)OC)[C@@H](CCCCCCCC)OC(=O)[C@@H]1O,39898813,1,52,full reaction|has preparation,L-Cysteine|neosartolactone 7-methyl ester,C19H33NO7S,230267,Preparation,1,,Michael Addition,,,"64371497; Article; Chang, Ching-Ming; Chern, Jeffy; Chen, Ming-Yi; Huang, Kai-Fa; Chen, Chein-Hung; Yang, Yu-Liang; Wu, Shih-Hsiung; Journal of the American Chemical Society; vol. 137; 1; (2015); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,C=C(C(=O)O)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.[H][C@]1(C(CSC[C@H](N)C(=O)O)C(=O)O)[C@@H](O)OC(=O)[C@@H]1CCCCCCCC,[H][C@](N)(CS)C(=O)O>>C=C(C(=O)O)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.[H][C@]1(C(CSC[C@H](N)C(=O)O)C(=O)O)[C@@H](O)OC(=O)[C@@H]1CCCCCCCC,39898814,1,52,full reaction|has preparation,L-Cysteine|neosartolactone,C18H31NO7S,27960,Preparation,1,,Michael Addition,,,"64371497; Article; Chang, Ching-Ming; Chern, Jeffy; Chen, Ming-Yi; Huang, Kai-Fa; Chen, Chein-Hung; Yang, Yu-Liang; Wu, Shih-Hsiung; Journal of the American Chemical Society; vol. 137; 1; (2015); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C(=O)OC)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.CCCCCCCC[C@H]1OC(=O)[C@H](O)[C@@H]1C(CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)OC,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C(=O)OC)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.CCCCCCCC[C@H]1OC(=O)[C@H](O)[C@@H]1C(CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)OC,39898815,1,52,full reaction|has preparation,GLUTATHIONE|neosartolactone 7-methyl ester,C26H43N3O11S,230267,Preparation,1,,Michael Addition,,,"64371497; Article; Chang, Ching-Ming; Chern, Jeffy; Chen, Ming-Yi; Huang, Kai-Fa; Chen, Chein-Hung; Yang, Yu-Liang; Wu, Shih-Hsiung; Journal of the American Chemical Society; vol. 137; 1; (2015); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C(=O)O)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.CCCCCCCC[C@H]1C(=O)O[C@H](O)[C@@H]1C(CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C(=O)O)[C@@H]1[C@@H](CCCCCCCC)OC(=O)[C@@H]1O.CCCCCCCC[C@H]1C(=O)O[C@H](O)[C@@H]1C(CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)O,39898816,1,52,full reaction|has preparation,GLUTATHIONE|neosartolactone,C25H41N3O11S,27960,Preparation,1,,Michael Addition,,,"64371497; Article; Chang, Ching-Ming; Chern, Jeffy; Chen, Ming-Yi; Huang, Kai-Fa; Chen, Chein-Hung; Yang, Yu-Liang; Wu, Shih-Hsiung; Journal of the American Chemical Society; vol. 137; 1; (2015); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@@]12OC(=O)C(=C)[C@]1([H])[C@@H](CCCCCCCC)OC2=O,[H][C@](N)(CS)C(=O)O.[H][C@@]12OC(=O)C(CSC[C@H](N)C(=O)O)[C@]1([H])[C@@H](CCCCCCCC)OC2=O,[H][C@@]12OC(=O)C(=C)[C@]1([H])[C@@H](CCCCCCCC)OC2=O>>[H][C@](N)(CS)C(=O)O.[H][C@@]12OC(=O)C(CSC[C@H](N)C(=O)O)[C@]1([H])[C@@H](CCCCCCCC)OC2=O,39898817,1,52,full reaction|has preparation,"(3aR,4R,6aR)-avenaciolide|L-Cysteine",C18H29NO6S,230267,Preparation,1,,Michael Addition,,,"64371497; Article; Chang, Ching-Ming; Chern, Jeffy; Chen, Ming-Yi; Huang, Kai-Fa; Chen, Chein-Hung; Yang, Yu-Liang; Wu, Shih-Hsiung; Journal of the American Chemical Society; vol. 137; 1; (2015); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@@]12OC(=O)C(=C)[C@]1([H])[C@@H](CCCCCCCC)OC2=O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O.[H][C@@]12OC(=O)C(CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@]1([H])[C@@H](CCCCCCCC)OC2=O,[H][C@@]12OC(=O)C(=C)[C@]1([H])[C@@H](CCCCCCCC)OC2=O>>[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O.[H][C@@]12OC(=O)C(CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@]1([H])[C@@H](CCCCCCCC)OC2=O,39898818,1,52,full reaction|has preparation,"(3aR,4R,6aR)-avenaciolide|GLUTATHIONE",C25H39N3O10S,230267,Preparation,1,,Michael Addition,,,"64371497; Article; Chang, Ching-Ming; Chern, Jeffy; Chen, Ming-Yi; Huang, Kai-Fa; Chen, Chein-Hung; Yang, Yu-Liang; Wu, Shih-Hsiung; Journal of the American Chemical Society; vol. 137; 1; (2015); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333,,,supporting information,,,,,,,Scheme or table,,,,,,,
CC1=NNC(=O)C1=C1C(=O)Nc2ccc(Cl)cc21,Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(Cl)cc21,CC1=NNC(=O)C1=C1C(=O)Nc2ccc(Cl)cc21>>Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(Cl)cc21,40054677,1,52,full reaction|has preparation,"5-chloro-3-(3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)-1,3-dihydro-2H-indol-2-one|3-hydroxy-5-methyl-1H-pyrazole","5-chloro-3,3-bis(3-hydroxy-5-methyl-1H-pyrazol-4-yl)indolin-2-one",208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
CC1=NNC(=O)C1=C1C(=O)Nc2ccc(Br)cc21,Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(Br)cc21,CC1=NNC(=O)C1=C1C(=O)Nc2ccc(Br)cc21>>Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(Br)cc21,40054678,1,52,full reaction|has preparation,C12H8BrN3O2|3-hydroxy-5-methyl-1H-pyrazole,"5-bromo-3,3-bis(3-hydroxy-5-methyl-1H-pyrazol-4-yl)indolin-2-one",208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
CC1=NNC(=O)C1=C1C(=O)Nc2ccc(C(F)(F)F)cc21,Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(C(F)(F)F)cc21,CC1=NNC(=O)C1=C1C(=O)Nc2ccc(C(F)(F)F)cc21>>Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(C(F)(F)F)cc21,40054679,1,52,full reaction|has preparation,C13H8F3N3O2|3-hydroxy-5-methyl-1H-pyrazole,C17H14F3N5O3,208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
COc1ccc2c(c1)C(=C1C(=O)NN=C1C)C(=O)N2,Cc1cc(O)n[nH]1.COc1ccc2c(c1)C(c1c(O)n[nH]c1C)(c1c(O)n[nH]c1C)C(=O)N2,COc1ccc2c(c1)C(=C1C(=O)NN=C1C)C(=O)N2>>Cc1cc(O)n[nH]1.COc1ccc2c(c1)C(c1c(O)n[nH]c1C)(c1c(O)n[nH]c1C)C(=O)N2,40054680,1,52,full reaction|has preparation,C13H11N3O3|3-hydroxy-5-methyl-1H-pyrazole,"3,3-bis(3-hydroxy-5-methyl-1H-pyrazol-4-yl)-5-methoxyindolin-2-one",208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
CC1=NNC(=O)C1=C1C(=O)Nc2ccc(C)cc21,Cc1cc(O)n[nH]1.Cc1ccc2c(c1)C(c1c(O)n[nH]c1C)(c1c(O)n[nH]c1C)C(=O)N2,CC1=NNC(=O)C1=C1C(=O)Nc2ccc(C)cc21>>Cc1cc(O)n[nH]1.Cc1ccc2c(c1)C(c1c(O)n[nH]c1C)(c1c(O)n[nH]c1C)C(=O)N2,40054681,1,52,full reaction|has preparation,C13H11N3O2|3-hydroxy-5-methyl-1H-pyrazole,"3,3-bis(3-hydroxy-5-methyl-1H-pyrazol-4-yl)-5-methylindolin-2-one",208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
CC1=NNC(=O)C1=C1C(=O)Nc2ccccc21,Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccccc21,CC1=NNC(=O)C1=C1C(=O)Nc2ccccc21>>Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccccc21,40054682,1,52,full reaction|has preparation,"3-(3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)-1,3-dihydro-2H-indol-2-one|3-hydroxy-5-methyl-1H-pyrazole","3,3-bis(3-hydroxy-5-methyl-1H-pyrazol-4-yl)indolin-2-one",208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
CC1=NNC(=O)C1=C1C(=O)Nc2ccc(F)cc21,Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(F)cc21,CC1=NNC(=O)C1=C1C(=O)Nc2ccc(F)cc21>>Cc1cc(O)n[nH]1.Cc1[nH]nc(O)c1C1(c2c(O)n[nH]c2C)C(=O)Nc2ccc(F)cc21,40054683,1,52,full reaction|has preparation,C12H8FN3O2|3-hydroxy-5-methyl-1H-pyrazole,"5-fluoro-3,3-bis(3-hydroxy-5-methyl-1H-pyrazol-4-yl)indolin-2-one",208378,Preparation,1,,Michael Addition,,,"66074943; Article; Cao, Xiaoji; Zhu, Kundan; Song, Qingbao; Wang, Chenlu; Wang, Ye; Cai, Ruonan; Lin, Yan; Tang, Fangliang; Zhang, Ming; Mo, Weimin; Rapid Communications in Mass Spectrometry; vol. 29;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
O=CCCCCC=O,O=CC1=CCCC1.O=CC1CCCC1O,O=CCCCCC=O>>O=CC1=CCCC1.O=CC1CCCC1O,40906037,1,52,full reaction,hexanedial,1-cyclopentene-1-carboxaldehyde|2-hydroxy-cyclopentanecarboxyaldehyde,322461|314368,Chemical behaviour,1,20,Michael Addition,Kinetics,,"66779132; Article; Han, Junbin; Lu, Zhichao; Flach, Andrew L.; Paton, Robert S.; Hammond, Gerald B.; Xu, Bo; Chemistry - A European Journal; vol. 21; 33; (2015); p. 11687 - 11691;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,pyridine N-oxide|C6H11BrN2O*C32H12BF24(1-)*H(1+),,,,Reagent/catalyst,Experimental part,,,,,,,
CCCS,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-].CCCSC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,CCCS>>C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-].CCCSC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,41584223,1,52,full reaction,1-thiopropane|10-methylacridinium perchlorate,C17H19NS*ClHO4,216853,Chemical behaviour,1,20,Michael Addition,Equilibrium constant|Kinetics,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,regioselective reaction,,,,,Reagent/catalyst,Scheme or table,,,,,,,
C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],OCCS.CN1c2ccccc2C(SCCO)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]>>OCCS.CN1c2ccccc2C(SCCO)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,41584224,1,52,full reaction,10-methylacridinium perchlorate|2-hydroxyethanethiol,C16H17NOS*ClHO4,216853,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],Cc1ccc(S)cc1.Cc1ccc(SC2c3ccccc3N(C)c3ccccc32)cc1.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]>>Cc1ccc(S)cc1.Cc1ccc(SC2c3ccccc3N(C)c3ccccc32)cc1.[O-][Cl@SP1+3]([O-])([O-])O,41584225,1,52,full reaction,10-methylacridinium perchlorate|para-thiocresol,C21H19NS*ClHO4,216857,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CC(C)S.CC(C)SC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]>>CC(C)S.CC(C)SC1c2ccccc2N(C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,41584226,1,52,full reaction,10-methylacridinium perchlorate|2-propanethiol,C17H19NS*ClHO4,216853,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],O=C(O)CCS.CN1c2ccccc2C(SCCC(=O)O)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]>>O=C(O)CCS.CN1c2ccccc2C(SCCC(=O)O)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,41584227,1,52,full reaction,10-methylacridinium perchlorate|3-mercaptopropionic acid,C17H17NO2S*ClHO4,216853,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-],CC(C)(C)S.CN1c2ccccc2C(SC(C)(C)C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,C[n+]1c2ccccc2cc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]>>CC(C)(C)S.CN1c2ccccc2C(SC(C)(C)C)c2ccccc21.[O-][Cl@SP1+3]([O-])([O-])O,41584228,1,52,full reaction,10-methylacridinium perchlorate|2-methylpropan-2-thiol,C18H21NS*ClHO4,216853,Chemical behaviour,1,20,Michael Addition,Equilibrium constant,dimethylsulfoxide-d6,"67579155; Article; Ren, Yulong; You, Lei; Journal of the American Chemical Society; vol. 137; 44; (2015); p. 14220 - 14228;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
[H][C@@](CS)(NC(C)=O)C(=O)OC,[H][C@@]12Oc3c(O)ccc4c3[C@@]13CCN(C)[C@H](C4)[C@]3([H])C=CC2=O.[H][C@@]12[C@@H](SC[C@H](NC(C)=O)C(=O)OC)CC(=O)[C@]3([H])Oc4c(O)ccc5c4[C@]13CCN(C)[C@]2([H])C5,[H][C@@](CS)(NC(C)=O)C(=O)OC>>[H][C@@]12Oc3c(O)ccc4c3[C@@]13CCN(C)[C@H](C4)[C@]3([H])C=CC2=O.[H][C@@]12[C@@H](SC[C@H](NC(C)=O)C(=O)OC)CC(=O)[C@]3([H])Oc4c(O)ccc5c4[C@]13CCN(C)[C@]2([H])C5,41635585,1,52,full reaction,Ac-Cys-OMe|dihydromorphinone,"S-[4,5-epoxy-3-hydroxy-17-methyl-6-oxomorphinan-(8S)-yl]-N-acetylcysteine methyl ester",224269,Chemical behaviour,1,20,Michael Addition,Kinetics,aq. buffer,"67770858; Article; Gallagher, Ryan; Chebib, Mary; Balle, Thomas; McLeod, Malcolm D.; Australian Journal of Chemistry; vol. 68; 12; (2015); p. 1834 - 1841;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,7.5,,,,,,,,Scheme or table,,,,,,,
[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C,[H][C@](O)(C(=O)NCCC(=O)NCCS)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O.[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)CC(SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2OP(=O)(O)O)C1=O)C(C)C,[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C>>[H][C@](O)(C(=O)NCCC(=O)NCCS)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O.[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)CC(SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2OP(=O)(O)O)C1=O)C(C)C,41955109,1,52,full reaction|has preparation,"(S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-y",C70H112N13O27P3S,,Preparation,1,,Michael Addition,,,"67759422; Article; Grünewald, Jan; Klock, Heath E.; Cellitti, Susan E.; Bursulaya, Badry; McMullan,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CC1C(=O)N(C)C(=O)N(C)C1=O,C=CC(C)=O.CC(=O)CCC1(C)C(=O)N(C)C(=O)N(C)C1=O,CC1C(=O)N(C)C(=O)N(C)C1=O>>C=CC(C)=O.CC(=O)CCC1(C)C(=O)N(C)C(=O)N(C)C1=O,42157531,1,52,full reaction|has preparation,"1,3,5-trimethylbarbituric acid|methyl vinyl ketone","1,3,5-trimethyl-5-(3-oxobutyl)pyrimidine-2,4,6(1H,3H,5H)-trione",230815,Preparation,1,,Michael Addition,,,"68572953; Article; Kise, Naoki; Tuji, Takashi; Sakurai, Toshihiko; Tetrahedron Letters; vol. 57; 16; (2016); p. 1790 - 1793;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
O=C1CSC(=O)N1Cc1ccc(-c2ccccc2)cc1,CCOC(=O)C(C#N)=Cc1ccc([N+](=O)[O-])cc1.O=C1SC(=Cc2ccc([N+](=O)[O-])cc2)C(=O)N1Cc1ccc(-c2ccccc2)cc1,O=C1CSC(=O)N1Cc1ccc(-c2ccccc2)cc1>>CCOC(=O)C(C#N)=Cc1ccc([N+](=O)[O-])cc1.O=C1SC(=Cc2ccc([N+](=O)[O-])cc2)C(=O)N1Cc1ccc(-c2ccccc2)cc1,42385798,1,52,full reaction|has preparation,"3-(biphenyl-4-ylmethyl)-thiazolidine-2,4-dione|2-cyano-3-(4-nitrophenyl)-2-propenoic acid ethyl ester","3-biphenyl-4-ylmethyl-5-(4-nitrobenzylidene)thiazolidine-2,4-dione",166937,Preparation,1,,Michael Addition,,,"68798618; Article; Rudnicki, Martina; Tripodi, Gustavo L.; Ferrer, Renila; Boscá, Lisardo; Pitta, Ma",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CCOC(=O)C(C#N)=Cc1ccc(Cl)cc1,O=C1CSC(=O)N1Cc1c(Cl)cccc1Cl.O=C1SC(=Cc2ccc(Cl)cc2)C(=O)N1Cc1c(Cl)cccc1Cl,CCOC(=O)C(C#N)=Cc1ccc(Cl)cc1>>O=C1CSC(=O)N1Cc1c(Cl)cccc1Cl.O=C1SC(=Cc2ccc(Cl)cc2)C(=O)N1Cc1c(Cl)cccc1Cl,42385799,1,52,full reaction|has preparation,ethyl 3-(4-chlorophenyl)-2-cyanoacrylate|C10H7Cl2NO2S,"5-(4-chlorobenzylidene)-3-(2,6-dichlorobenzyl)thiazolidine-2,4-dione",166937,Preparation,1,,Michael Addition,,,"68798618; Article; Rudnicki, Martina; Tripodi, Gustavo L.; Ferrer, Renila; Boscá, Lisardo; Pitta, Ma",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
O=C1CSC(=O)N1Cc1ccc(Cl)cc1,CCOC(=O)C(C#N)=Cc1c[nH]c2ccc(Br)cc12.O=C1SC(=Cc2c[nH]c3ccc(Br)cc23)C(=O)N1Cc1ccc(Cl)cc1,O=C1CSC(=O)N1Cc1ccc(Cl)cc1>>CCOC(=O)C(C#N)=Cc1c[nH]c2ccc(Br)cc12.O=C1SC(=Cc2c[nH]c3ccc(Br)cc23)C(=O)N1Cc1ccc(Cl)cc1,42385800,1,52,full reaction|has preparation,"3-(4-chlorobenzyl)-thiazolidine-2,4-dione|C14H11BrN2O2","5-(5-bromo-1H-indol-3-ylmethylene)-3-(4-chlorobenzyl)thiazolidine-2,4-dione",163228,Preparation,1,,Michael Addition,,,"68798618; Article; Rudnicki, Martina; Tripodi, Gustavo L.; Ferrer, Renila; Boscá, Lisardo; Pitta, Ma",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
O=C(/C=C/C=C/c1ccccc1)c1ccccc1,N#CCC#N.N#CC(C#N)C(C=Cc1ccccc1)CC(=O)c1ccccc1,O=C(/C=C/C=C/c1ccccc1)c1ccccc1>>N#CCC#N.N#CC(C#N)C(C=Cc1ccccc1)CC(=O)c1ccccc1,42928112,1,52,full reaction|has preparation,cinnamylideneacetophenone|malononitrile,C20H16N2O,220308,Preparation,1,,Michael Addition,,,"69007792; Article; Silva, Eduarda M.P.; Melo, Tânia; Sousa, Bebiana C.; Resende, Diana I.S.P.; Magal",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
,*C(*)=C(*)*,>>*C(*)=C(*)*,43686343,1,52,no reaction scheme,,,222727,Markush reaction,1,,Michael Addition,,,69685099; Patent; LG CHEM; CN104159884; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0046,,,,,,,,,,,,,,
CC(=O)C(Cc1ccc(Br)cc1)C(C)=O,C=CC(C)=O.CC(=O)CCC(Cc1ccc(Br)cc1)(C(C)=O)C(C)=O,CC(=O)C(Cc1ccc(Br)cc1)C(C)=O>>C=CC(C)=O.CC(=O)CCC(Cc1ccc(Br)cc1)(C(C)=O)C(C)=O,44452577,1,52,full reaction|has preparation,"3-(4-bromobenzyl)-2,4-pentanedione|methyl vinyl ketone","3-acetyl-3-(4-bromobenzyl)heptane-2,6-dione",230806,Preparation,1,,Michael Addition,,,"70393368; Article; Yaremenko, Ivan A.; Syroeshkin, Mikhail A.; Levitsky, Dmitri O.; Fleury, Fab",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CCNCC,C=CC(=O)OCC.CCNCCC(=O)OCC,CCNCC>>C=CC(=O)OCC.CCNCCC(=O)OCC,44628049,1,52,full reaction,diethylamine|ethyl acrylate,ethyl 3-(ethylamino)propanoate,218034,Chemical behaviour,1,25,Michael Addition,Mechanism,tetrahydrofuran,"70268338; Article; Desmet, Gilles B.; D'Hooge, Dagmar R.; Omurtag, Pinar Sinem; Espeel, Pieter; Mari",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Concentration,Experimental part,,,,,,,
Nc1ccc2cc3ccc(N)cc3nc2c1,[C-]#N.N#CC1c2ccc(N)cc2Nc2cc(N)ccc21,Nc1ccc2cc3ccc(N)cc3nc2c1>>[C-]#N.N#CC1c2ccc(N)cc2Nc2cc(N)ccc21,44651399,1,52,full reaction|has preparation,proflavine|cyanide(1-),C14H12N4,210650,Preparation,1,,Michael Addition,,,"70516643; Article; Karmakar, Avishek; Joarder, Biplab; Mallick, Abhik; Samanta, Partha; Desai, Aamod V.; Basu, Sudipta; Ghosh, Sujit K.; Chemical Communications; vol. 53; 7; (2017); p. 1253 - 1256;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
O=C1C=C[C@H]2CO[C@@H]1O2,O=C1CCCCC1.[H][C@@]12OC[C@@]([H])(O1)[C@@H](C1CCCCC1=O)CC2=O,O=C1C=C[C@H]2CO[C@@H]1O2>>O=C1CCCCC1.[H][C@@]12OC[C@@]([H])(O1)[C@@H](C1CCCCC1=O)CC2=O,45413544,1,52,full reaction|has preparation,(-)-levoglucosenone|cyclohexanone,"1,6-anhydro-3,4-dideoxy-4-[(1RS)-2-oxocyclohexyl]-β-D-erythro-hex-2-ulose",222020,Preparation,1,,Michael Addition,,,"71149228; Article; Galimova, Yu. S.; Tagirov; Faizullina, L. Kh.; Salikhov, Sh. M.; Valeev; Russian Journal of Organic Chemistry; vol. 53; 3; (2017); p. 374 - 380; Zh. Org. Khim.; vol. 53; 3; (2017);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
SCCCS,C=CC=O.O=CCCSCCCS,SCCCS>>C=CC=O.O=CCCSCCCS,46219713,1,52,full reaction|has preparation,1.3-propanedithiol|acrolein,C6H12OS2,230290,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
NCCS,C=CC=O.NCCSCCC=O,NCCS>>C=CC=O.NCCSCCC=O,46219714,1,52,full reaction|has preparation,Cysteamine|acrolein,C5H11NOS,230290,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
O=C(O)CS,C=CC=O.O=CCCSCC(=O)O,O=C(O)CS>>C=CC=O.O=CCCSCC(=O)O,46219715,1,52,full reaction|has preparation,mercaptoacetic acid|acrolein,C5H8O3S,230290,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CC(C)(C)OC(=O)NC(CS)C(=O)O,C=CC=O.CC(C)(C)OC(=O)NC(CSCCC=O)C(=O)O,CC(C)(C)OC(=O)NC(CS)C(=O)O>>C=CC=O.CC(C)(C)OC(=O)NC(CSCCC=O)C(=O)O,46219716,1,52,full reaction|has preparation,boc-cysteine|acrolein,C11H19NO5S,230290,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CC(C)OP(=O)(COCC(CO)CO)OC(C)C,C=CP(=O)(OCC)OCC.C=CP(=O)(OCC)OCC.CCOP(=O)(CCOCC(COCCP(=O)(OCC)OCC)COCP(=O)(OC(C)C)OC(C)C)OCC,CC(C)OP(=O)(COCC(CO)CO)OC(C)C>>C=CP(=O)(OCC)OCC.C=CP(=O)(OCC)OCC.CCOP(=O)(CCOCC(COCCP(=O)(OCC)OCC)COCP(=O)(OC(C)C)OC(C)C)OCC,46233302,1,52,full reaction|has preparation,diisopropyl {[3-hydroxy-2-(hydroxymethyl)propoxy]-methyl}phosphonate|Diethyl vinylphosphonate,C23H51O12P3,121533,Preparation,1,,Michael Addition,,,"72084749; Article; Špaček, Petr; Keough, Dianne T.; Chavchich, Marina; Dračínský, Martin; Janeba, Zl",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Alkaline conditions,,,,,,,,,Body text,,,,,,,
CCC=CC(C)=O,CC(=O)S.CCC(CC(C)=O)SC(C)=O,CCC=CC(C)=O>>CC(=O)S.CCC(CC(C)=O)SC(C)=O,46424760,1,52,full reaction|has preparation,hex-3-en-2-one|tiolacetic acid,4-acetylthio-2-hexanone,221613,Preparation,1,,Michael Addition,,,"72344338; Article; Nörenberg, Svenja; Kiske, Christiane; Reichardt, Bastian; Andelfinger, Verena; Pf",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CCCCC=CC(C)=O,CC(=O)S.CCCCC(CC(C)=O)SC(C)=O,CCCCC=CC(C)=O>>CC(=O)S.CCCCC(CC(C)=O)SC(C)=O,46424761,1,52,full reaction|has preparation,3-octen-2-one|tiolacetic acid,thioacetic acid S-[1-(2-oxo-propyl)-pentyl] ester,221612,Preparation,1,,Michael Addition,,,"72344338; Article; Nörenberg, Svenja; Kiske, Christiane; Reichardt, Bastian; Andelfinger, Verena; Pf",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CCCCCC=CC(C)=O,CC(=O)S.CCCCCC(CC(C)=O)SC(C)=O,CCCCCC=CC(C)=O>>CC(=O)S.CCCCCC(CC(C)=O)SC(C)=O,46424762,1,52,full reaction|has preparation,Non-3-en-2-on|tiolacetic acid,4-acetylthio-2-nonanone,221612,Preparation,1,,Michael Addition,,,"72344338; Article; Nörenberg, Svenja; Kiske, Christiane; Reichardt, Bastian; Andelfinger, Verena; Pf",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CCCCCCC=CC(C)=O,CC(=O)S.CCCCCCC(CC(C)=O)SC(C)=O,CCCCCCC=CC(C)=O>>CC(=O)S.CCCCCCC(CC(C)=O)SC(C)=O,46424763,1,52,full reaction|has preparation,dec-3-en-2-one|tiolacetic acid,4-acetylthio-2-decanone,221612,Preparation,1,,Michael Addition,,,"72344338; Article; Nörenberg, Svenja; Kiske, Christiane; Reichardt, Bastian; Andelfinger, Verena; Pf",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
CC=CC(C)=O,CC(=O)S.CC(=O)CC(C)SC(C)=O,CC=CC(C)=O>>CC(=O)S.CC(=O)CC(C)SC(C)=O,46424764,1,52,full reaction|has preparation,3-penten-2-one|tiolacetic acid,4-acetylsulfanyl-2-pentanone,221614,Preparation,1,,Michael Addition,,,"72344338; Article; Nörenberg, Svenja; Kiske, Christiane; Reichardt, Bastian; Andelfinger, Verena; Pf",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
N#CC(C#N)=C1C(=O)N(CCCCN2C(=O)C(=C(C#N)C#N)c3ccccc32)c2ccccc21,CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C2C(C(C#N)C#N)c3ccccc3N2CCCCN2c3ccccc3C(C(C#N)C#N)C2C2=C(O)CC(C)(C)CC2=O)=C(O)C1,N#CC(C#N)=C1C(=O)N(CCCCN2C(=O)C(=C(C#N)C#N)c3ccccc32)c2ccccc21>>CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C2C(C(C#N)C#N)c3ccccc3N2CCCCN2c3ccccc3C(C(C#N)C#N)C2C2=C(O)CC(C)(C)CC2=O)=C(O)C1,46736217,1,52,full reaction|has preparation,"2,2'-(butane-1,4-diylbis(2-oxoindoline-1-yl-3-ylidene))dimalononitrile|dimedone",C42H44N6O4,78741,Preparation,1,,Michael Addition,,,"71504048; Article; Ghozlan, Said Ahmed Soliman; Ramadan, Muhammed Aly; Abdelmoniem, Amr Mohamed; Elwahy, Ahmed H. M.; Abdelhamid, Ismail Abdelshafy; Turkish Journal of Chemistry; vol. 41; 3; (2017); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
N#CC(C#N)=C1C(=O)N(Cc2ccccc2CN2C(=O)C(=C(C#N)C#N)c3ccccc32)c2ccccc21,CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C2C(C(C#N)C#N)c3ccccc3N2Cc2ccccc2CN2c3ccccc3C(C(C#N)C#N)C2C2=C(O)CC(C)(C)CC2=O)=C(O)C1,N#CC(C#N)=C1C(=O)N(Cc2ccccc2CN2C(=O)C(=C(C#N)C#N)c3ccccc32)c2ccccc21>>CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C2C(C(C#N)C#N)c3ccccc3N2Cc2ccccc2CN2c3ccccc3C(C(C#N)C#N)C2C2=C(O)CC(C)(C)CC2=O)=C(O)C1,46736219,1,52,full reaction|has preparation,"2,2'-((1,2-phenylenebis(methylene))bis(2-oxoindoline-1-yl-3-ylidene))dimalononitrile|dimedone",C46H44N6O4,78741,Preparation,1,,Michael Addition,,,"71504048; Article; Ghozlan, Said Ahmed Soliman; Ramadan, Muhammed Aly; Abdelmoniem, Amr Mohamed; Elwahy, Ahmed H. M.; Abdelhamid, Ismail Abdelshafy; Turkish Journal of Chemistry; vol. 41; 3; (2017); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
N#CC(C#N)=C1C(=O)N(Cc2ccc(CN3C(=O)C(=C(C#N)C#N)c4ccccc43)cc2)c2ccccc21,CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C2C(C(C#N)C#N)c3ccccc3N2Cc2ccc(CN3c4ccccc4C(C(C#N)C#N)C3C3=C(O)CC(C)(C)CC3=O)cc2)=C(O)C1,N#CC(C#N)=C1C(=O)N(Cc2ccc(CN3C(=O)C(=C(C#N)C#N)c4ccccc43)cc2)c2ccccc21>>CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)C(C2C(C(C#N)C#N)c3ccccc3N2Cc2ccc(CN3c4ccccc4C(C(C#N)C#N)C3C3=C(O)CC(C)(C)CC3=O)cc2)=C(O)C1,46736220,1,52,full reaction|has preparation,"2,2'-((1,4-phenylenebis(methylene))bis(2-oxoindoline-1-yl-3-ylidene))dimalononitrile|dimedone",C46H44N6O4,78741,Preparation,1,,Michael Addition,,,"71504048; Article; Ghozlan, Said Ahmed Soliman; Ramadan, Muhammed Aly; Abdelmoniem, Amr Mohamed; Elwahy, Ahmed H. M.; Abdelhamid, Ismail Abdelshafy; Turkish Journal of Chemistry; vol. 41; 3; (2017); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC1=C[C@@H](C)[C@@H](c2cc(O)cc(O)c2)OC(=O)[C@H](C)[C@H](O)[C@H](C)C1=O,Nc1ccccc1C(=O)O.C[C@@H]1[C@@H](Nc2ccccc2C(=O)O)[C@@H](C)C(=O)[C@@H](C)[C@@H](O)[C@@H](C)C(=O)O[C@@H]1c1cc(O)cc(O)c1,CC1=C[C@@H](C)[C@@H](c2cc(O)cc(O)c2)OC(=O)[C@H](C)[C@H](O)[C@H](C)C1=O>>Nc1ccccc1C(=O)O.C[C@@H]1[C@@H](Nc2ccccc2C(=O)O)[C@@H](C)C(=O)[C@@H](C)[C@@H](O)[C@@H](C)C(=O)O[C@@H]1c1cc(O)cc(O)c1,46788468,1,52,full reaction|has preparation,presaccharothriolide X|anthranilic acid,saccharothriolide A,221749,Preparation,1,,Michael Addition,,,"71258893; Article; Lu, Shan; Nishimura, Shinichi; Ito, Masashi; Kato, Taira; Kakeya, Hideaki; Journal of Antibiotics; vol. 70; 5; (2017); p. 718 - 720;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC1=C[C@@H](C)[C@@H](c2cc(O)cc(O)c2)OC(=O)[C@H](C)[C@H](O)[C@H](C)C1=O,Nc1ccccc1O.C[C@@H]1[C@@H](Nc2ccccc2O)[C@@H](C)C(=O)[C@@H](C)[C@@H](O)[C@@H](C)C(=O)O[C@@H]1c1cc(O)cc(O)c1,CC1=C[C@@H](C)[C@@H](c2cc(O)cc(O)c2)OC(=O)[C@H](C)[C@H](O)[C@H](C)C1=O>>Nc1ccccc1O.C[C@@H]1[C@@H](Nc2ccccc2O)[C@@H](C)C(=O)[C@@H](C)[C@@H](O)[C@@H](C)C(=O)O[C@@H]1c1cc(O)cc(O)c1,46788469,1,52,full reaction|has preparation,presaccharothriolide X|2-amino-phenol,saccharothriolide B,221749,Preparation,1,,Michael Addition,,,"71258893; Article; Lu, Shan; Nishimura, Shinichi; Ito, Masashi; Kato, Taira; Kakeya, Hideaki; Journal of Antibiotics; vol. 70; 5; (2017); p. 718 - 720;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C[N+](=O)[O-],O=C(C=CC(=O)Oc1ccc([N+](=O)[O-])cc1)OCc1ccc(F)cc1.O=C(C[C@H](C[N+](=O)[O-])C(=O)OCc1ccc(F)cc1)Oc1ccc([N+](=O)[O-])cc1,C[N+](=O)[O-]>>O=C(C=CC(=O)Oc1ccc([N+](=O)[O-])cc1)OCc1ccc(F)cc1.O=C(C[C@H](C[N+](=O)[O-])C(=O)OCc1ccc(F)cc1)Oc1ccc([N+](=O)[O-])cc1,46805443,1,52,full reaction,nitromethane|C17H12FNO6,C18H15FN2O8,225140,Chemical behaviour,1,20,Michael Addition,Mechanism,,"71963444; Article; Matviitsuk, Anastassia; Greenhalgh, Mark D.; Antúnez, Diego-Javier Barrios; Slawi",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,C19H19FN2S,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCCCCCC=CC=C(CCCCCCCC(=O)O)[N+](=O)[O-].CCCCCCC=CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(CCCCCCCC(=O)O)[N+](=O)[O-],[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCCCCCC=CC=C(CCCCCCCC(=O)O)[N+](=O)[O-].CCCCCCC=CC(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(CCCCCCCC(=O)O)[N+](=O)[O-],47082042,1,52,full reaction,"GLUTATHIONE|9-nitrooctadec-9,11-dienoic acid",C28H48N4O10S,224264,Chemical behaviour,1,25,Michael Addition,Kinetics|Equilibrium constant,aq. phosphate buffer,"71553649; Article; Turell, Lucía; Vitturi, Darío A.; Coitiño, E. Laura; Lebrato, Lourdes; Möller, Ma",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCCCCCC(=CC=CCCCCCCCC(=O)O)[N+](=O)[O-].CCCCCCC(C(C=CCCCCCCCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[N+](=O)[O-],[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCCCCCC(=CC=CCCCCCCCC(=O)O)[N+](=O)[O-].CCCCCCC(C(C=CCCCCCCCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[N+](=O)[O-],47082043,1,52,full reaction,"GLUTATHIONE|12-nitrooctadec-9,11-dienoic acid",C28H48N4O10S,224264,Chemical behaviour,1,25,Michael Addition,Kinetics|Equilibrium constant,aq. phosphate buffer,"71553649; Article; Turell, Lucía; Vitturi, Darío A.; Coitiño, E. Laura; Lebrato, Lourdes; Möller, Ma",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
CCCCCCCC/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-],[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O.CCCCCCCCC(C(CCCCCCCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[N+](=O)[O-],CCCCCCCC/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-]>>[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O.CCCCCCCCC(C(CCCCCCCC(=O)O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[N+](=O)[O-],47082044,1,52,full reaction,10-Nitrooleic Acid|GLUTATHIONE,C28H50N4O10S,224264,Chemical behaviour,1,25,Michael Addition,Kinetics|Equilibrium constant,aq. phosphate buffer,"71553649; Article; Turell, Lucía; Vitturi, Darío A.; Coitiño, E. Laura; Lebrato, Lourdes; Möller, Ma",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
[1*]C([3*])=C([2*])C(=O)O,[4*]C(S)C(=O)O.[1*]C([3*])(SC([4*])C(=O)O)C([2*])C(=O)O,[1*]C([3*])=C([2*])C(=O)O>>[4*]C(S)C(=O)O.[1*]C([3*])(SC([4*])C(=O)O)C([2*])C(=O)O,48842646,1,52,no reaction scheme,,,204564,Markush reaction,1,,Michael Addition,,,74551445; Patent; ASYMCHEM LABORATORIES TIANJIN; CN108084148; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0033,,,,,,,,,,,,,,
[2*]/C([3*])=C/CC(C)C,[1*]NC(=O)OC.[1*]NC[C@@H](CC(C)C)C([2*])[3*],[2*]/C([3*])=C/CC(C)C>>[1*]NC(=O)OC.[1*]NC[C@@H](CC(C)C)C([2*])[3*],49063551,1,52,no reaction scheme,,,225408,Markush reaction,1,,Michael Addition,,,74746604; Patent; GUIZHOU NORMAL UNIVERSITY; CN108358799; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0011,,,,,,,,,,,,,,
[1*][C]N([C])C([C])C(=O)[C]N([4*])C([C])C(=O)[C]N([4*])C([C])C(=O)[C][2*],[C][C]1[C]([C])[C]1[C].*[C]C(=O)C1[C][C]2[C]3[C]C(C(=O)[C]N1*)N(*)[C]C(=O)C(N([C])[C]*)[C][C]23,[1*][C]N([C])C([C])C(=O)[C]N([4*])C([C])C(=O)[C]N([4*])C([C])C(=O)[C][2*]>>[C][C]1[C]([C])[C]1[C].*[C]C(=O)C1[C][C]2[C]3[C]C(C(=O)[C]N1*)N(*)[C]C(=O)C(N([C])[C]*)[C][C]23,49850807,1,52,no reaction scheme,,,,Markush reaction,1,,Michael Addition,,,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0181,,,,,,,,,,,II.A-1,,,
[2*]C(=O)C=Cc1ccccc1O.[3*],[1*]OC(=O)C1NC(=O)c2ccccc21.[1*]OC(=O)[C@]12c3ccccc3C(=O)N1[C@]1([2*])C[C@@]2([H])c2ccccc2O1.[3*],[2*]C(=O)C=Cc1ccccc1O.[3*]>>[1*]OC(=O)C1NC(=O)c2ccccc21.[1*]OC(=O)[C@]12c3ccccc3C(=O)N1[C@]1([2*])C[C@@]2([H])c2ccccc2O1.[3*],50394894,1,52,no reaction scheme,,,,Markush reaction,1,,Michael Addition,,,75713776; Patent; HENAN UNIVERSITY; CN108948034; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Acidic conditions,,Paragraph 0008,,,,,,,,,,,,,,
C=C(C/C=C/c1ccccc1)C(C)=O,Cc1ccc(S)cc1.CC(=O)C(C/C=C/c1ccccc1)CSc1ccc(C)cc1,C=C(C/C=C/c1ccccc1)C(C)=O>>Cc1ccc(S)cc1.CC(=O)C(C/C=C/c1ccccc1)CSc1ccc(C)cc1,50473015,1,52,full reaction|has preparation,(E)-3-methylene-6-phenylhex-5-en-2-one|para-thiocresol,(E)-6-phenyl-3-((p-tolylthio)methyl)hex-5-en-2-one,230296,Preparation,1,,Michael Addition,,,"75861086; Article; Ma, Xiantao; Yu, Jing; Han, Cuijie; Zhou, Qiuju; Ren, Mengjuan; Li, Lixin; Tang, Lin; Advanced Synthesis and Catalysis; vol. 361; 5; (2019); p. 1023 - 1027;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,(E)-6-phenyl-3-((p-tolylthio)methyl)hex-5-en-2-one,82.8 mg,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCCCCCC.CCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCCCCCC.CCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCC,50799893,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|n-tetradecyl acrylate",C75H147N3O8,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCC,50799894,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|hexadecyl acrylate",C83H163N3O8,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCCCCCCC,50799895,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|octadecylacrylate",C91H179N3O8,,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCC.CCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCC)CCC(=O)OCCCCCC)CCC(=O)OCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCC.CCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCC)CCC(=O)OCCCCCC)CCC(=O)OCCCCCC,50799896,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|n-hexyl acrylate",C43H83N3O8,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCC.CCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCC)CCC(=O)OCCCCCCCC)CCC(=O)OCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCC.CCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCC)CCC(=O)OCCCCCCCC)CCC(=O)OCCCCCCCC,50799897,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|octyl acrylate",C51H99N3O8,,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCC.CCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCC)CCC(=O)OCCCCCCCCC)CCC(=O)OCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCC.CCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCC)CCC(=O)OCCCCCCCCC)CCC(=O)OCCCCCCCCC,50799898,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|n-nonyl acrylate",C55H107N3O8,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCC.C=CC(=O)OCCCCCCCCCC.C=CC(=O)OCCCCCCCCCC.C=CC(=O)OCCCCCCCCCC.CCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCC)CCC(=O)OCCCCCCCCCC)CCC(=O)OCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCC.C=CC(=O)OCCCCCCCCCC.C=CC(=O)OCCCCCCCCCC.C=CC(=O)OCCCCCCCCCC.CCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCC)CCC(=O)OCCCCCCCCCC)CCC(=O)OCCCCCCCCCC,50799899,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|decyl acrylate","3,3',3'',3'''-(((methylazanediyl)bis(propane-3,1-diyl))bis(azanetriyl))tetrapropanoic acid tetrakis(decyl) ester",91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCC(C)C.CC(C)CCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCC(C)C.CC(C)CCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C,50799900,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|iso-decyl acrylate","3,3',3'',3'''-(((methylazanediyl)bis(propan-3,1-diyl))bis(azanetriyl))tetrapropanoic acid tetrakis(8-methylnonyl) ester",91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCCC.CCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCCC.CCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCC,50799901,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|undecanyl acrylate",C63H123N3O8,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCC.CCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCC.C=CC(=O)OCCCCCCCCCCCC.CCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCC,50799902,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|lauryl acrylate",dodecyl 3-[3-[3-[bis(3-dodecoxy-3-oxo-propyl)amino]propyl-methyl-amino]propyl-(3-dodecoxy-3-oxo-propyl)amino]propanoate,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCCCCCCCCCCCC.CCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCCCCCCCCCCCC.CCCCCCCCCCCCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCC)CCC(=O)OCCCCCCCCCCCCC,50799903,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|2-propenoic acid, tridecyl ester",C71H139N3O8,91284,Preparation,1,,Michael Addition,,,"75795961; Article; Hajj, Khalid A.; Ball, Rebecca L.; Deluty, Sarah B.; Singh, Shridhar R.; Strelkova, Daria; Knapp, Christopher M.; Whitehead, Kathryn A.; Small; vol. 15; 6; (2019);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC(=O)c1cc(C)c(O)c(CO)c1O,C[C@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@@H](C)OC2=O)c1O,CC(=O)c1cc(C)c(O)c(CO)c1O>>C[C@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@@H](C)OC2=O)c1O,50864173,1,52,full reaction,"1-(2,4-dihydroxy-3-(hydroxymethyl)-5-methylphenyl)ethan-1-one|(R)-5-methyltetronic acid",peniphenone D,164324,Chemical behaviour,1,20,Michael Addition,Mechanism,water,"76183500; Article; Fan, Jie; Liao, Ge; Kindinger, Florian; Ludwig-Radtke, Lena; Yin, Wen-Bing; Li, Shu-Ming; Journal of the American Chemical Society; vol. 141; 10; (2019); p. 4225 - 4229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,,,peniphenone D,42.9 percentChromat.,,Time|Solvent,Scheme or table,,,,,,,
CC(=O)c1cc(C)c(O)c(CO)c1O,O=C(O)C[C@@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@H](CC(=O)O)OC2=O)c1O,CC(=O)c1cc(C)c(O)c(CO)c1O>>O=C(O)C[C@@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@H](CC(=O)O)OC2=O)c1O,50864176,1,52,full reaction,"1-(2,4-dihydroxy-3-(hydroxymethyl)-5-methylphenyl)ethan-1-one|(S)-5-carboxylmethyltetronic acid",penilactone D,164324,Chemical behaviour,1,20,Michael Addition,Mechanism,water,"76183500; Article; Fan, Jie; Liao, Ge; Kindinger, Florian; Ludwig-Radtke, Lena; Yin, Wen-Bing; Li, Shu-Ming; Journal of the American Chemical Society; vol. 141; 10; (2019); p. 4225 - 4229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,supporting information,,,penilactone D,37.9 percentChromat.,,Time|Solvent,Scheme or table,,,,,,,
N#CC(=CC1CCCCC1)C(N)=S,Oc1cccc(O)c1.N#CC1=C(N)Oc2cc(O)ccc2C1C1CCCCC1,N#CC(=CC1CCCCC1)C(N)=S>>Oc1cccc(O)c1.N#CC1=C(N)Oc2cc(O)ccc2C1C1CCCCC1,51497470,1,52,full reaction|has preparation,cyclohexylidenecyanothioaceamide|recorcinol,2-amino-4-cyclohexyl-7-hydroxy-4H-chromene-3-carbonitrile,90541,Preparation,1,,Michael Addition,,,76500687; Article; Dyachenko; Dyachenko; Dorovatovskii; Khrustalev; Nenaidenko; Russian Journal of Organic Chemistry; vol. 55; 2; (2019); p. 215 - 226; Zh. Org. Khim.; vol. 22; 2; (2019); p. 266 - 278,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,chemoselective reaction,,,,,,Scheme or table,,,,,,,
[2*]c1ccc(-c2ccc(N)cc2)cc1,[1*]OC1OC(=O)C(F)=C1F.[1*]OC1OC(=O)C(F)=C1Nc1ccc(-c2ccc([2*])cc2)cc1,[2*]c1ccc(-c2ccc(N)cc2)cc1>>[1*]OC1OC(=O)C(F)=C1F.[1*]OC1OC(=O)C(F)=C1Nc1ccc(-c2ccc([2*])cc2)cc1,52118150,1,52,no reaction scheme,,,285380,Markush reaction,1,,Michael Addition,,,77747285; Patent; SOUTH CHINA NORMAL UNIVERSITY; CN106800544; B; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0009-0010; 0020-0021,,,,,,,,,,,Formula II,,,
NC(CS)C(=O)O,C#CC(=O)n1nc(C)cc1-c1cc2ccc(N(CC)CC)cc2oc1=O.CCN(CC)c1ccc2cc(-c3cc(C)nn3C(=O)C=CSC(CN)C(=O)O)c(=O)oc2c1,NC(CS)C(=O)O>>C#CC(=O)n1nc(C)cc1-c1cc2ccc(N(CC)CC)cc2oc1=O.CCN(CC)c1ccc2cc(-c3cc(C)nn3C(=O)C=CSC(CN)C(=O)O)c(=O)oc2c1,52190645,1,52,full reaction|has preparation,rac-cysteine|C20H19N3O3,C23H26N4O5S,182478,Preparation,1,,Michael Addition,,,"77625598; Article; Cheng, Tianyi; Huang, Wenming; Gao, Di; Yang, Zhe; Zhang, Congjie; Zhang, Haixia; Zhang, Jianjian; Li, Hua; Yang, Xiao-Feng; Analytical Chemistry; vol. 91; 16; (2019); p. 10894 - 10",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
NC(CCS)C(=O)O,C#CC(=O)n1nc(C)cc1-c1cc2ccc(N(CC)CC)cc2oc1=O.CCN(CC)c1ccc2cc(-c3cc(C)nn3C(=O)C=CSC(CCN)C(=O)O)c(=O)oc2c1,NC(CCS)C(=O)O>>C#CC(=O)n1nc(C)cc1-c1cc2ccc(N(CC)CC)cc2oc1=O.CCN(CC)c1ccc2cc(-c3cc(C)nn3C(=O)C=CSC(CCN)C(=O)O)c(=O)oc2c1,52190646,1,52,full reaction|has preparation,2-amino-4-mercaptobutyric acid|C20H19N3O3,C24H28N4O5S,20404,Preparation,1,,Michael Addition,,,"77625598; Article; Cheng, Tianyi; Huang, Wenming; Gao, Di; Yang, Zhe; Zhang, Congjie; Zhang, Haixia; Zhang, Jianjian; Li, Hua; Yang, Xiao-Feng; Analytical Chemistry; vol. 91; 16; (2019); p. 10894 - 10",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O,C#CC(=O)n1nc(C)cc1-c1cc2ccc(N(CC)CC)cc2oc1=O.CCN(CC)c1ccc2cc(-c3cc(C)nn3C(=O)C=CSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O>>C#CC(=O)n1nc(C)cc1-c1cc2ccc(N(CC)CC)cc2oc1=O.CCN(CC)c1ccc2cc(-c3cc(C)nn3C(=O)C=CSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,52190647,1,52,full reaction|has preparation,glutathion|C20H19N3O3,C30H36N6O9S,189970,Preparation,1,,Michael Addition,,,"77625598; Article; Cheng, Tianyi; Huang, Wenming; Gao, Di; Yang, Zhe; Zhang, Congjie; Zhang, Haixia; Zhang, Jianjian; Li, Hua; Yang, Xiao-Feng; Analytical Chemistry; vol. 91; 16; (2019); p. 10894 - 10",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,NCCCN(CCO)CCO.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.CCCCCCCCCCCCOCCSC(C)(C)SCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC>>NCCCN(CCO)CCO.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.CCCCCCCCCCCCOCCSC(C)(C)SCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,52519398,1,52,full reaction|has preparation,"2-((2-((2-(2-(dodecyloxy)ethyl)thio)propane-2-yl)thio)ethyl)acrylate|2,2'-[(3-aminopropyl)imino]bis-ethanol",C51H102N2O8S4,207953,Preparation,1,,Michael Addition,,,"78031192; Article; Chang, Jin;Cai, Weiqi;Liang, Chunjing;Tang, Qiao;Chen, Xianghan;Jiang, Ying;Mao, Lanqun;Wang, Ming; Journal of the American Chemical Society; vol. 141; 45; (2019); p. 18136 - 18141;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
CN(CCCN)CCCN,C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.CCCCCCCCCCCCOCCSC(C)(C)SCCOC(=O)CCNCCCN(C)CCCN(CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC)CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,CN(CCCN)CCCN>>C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.CCCCCCCCCCCCOCCSC(C)(C)SCCOC(=O)CCNCCCN(C)CCCN(CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC)CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,52519399,1,52,full reaction|has preparation,"3,3'-Diamino-N-methyldipropylamine|2-((2-((2-(2-(dodecyloxy)ethyl)thio)propane-2-yl)thio)ethyl)acrylate",C73H145N3O9S6,91250,Preparation,1,,Michael Addition,,,"78031192; Article; Chang, Jin;Cai, Weiqi;Liang, Chunjing;Tang, Qiao;Chen, Xianghan;Jiang, Ying;Mao, Lanqun;Wang, Ming; Journal of the American Chemical Society; vol. 141; 45; (2019); p. 18136 - 18141;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
CN(C)CCCN(C)CCCN,C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.CCCCCCCCCCCCOCCSC(C)(C)SCCOC(=O)CCN(CCCN(C)CCCN(C)C)CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,CN(C)CCCN(C)CCCN>>C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.C=CC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC.CCCCCCCCCCCCOCCSC(C)(C)SCCOC(=O)CCN(CCCN(C)CCCN(C)C)CCC(=O)OCCSC(C)(C)SCCOCCCCCCCCCCCC,52519400,1,52,full reaction|has preparation,"N-(3-aminopropyl)-N,N',N'-trimethyl-1,3-propanediamine|2-((2-((2-(2-(dodecyloxy)ethyl)thio)propane-2-yl)thio)ethyl)acrylate",C53H107N3O6S4,207953,Preparation,1,,Michael Addition,,,"78031192; Article; Chang, Jin;Cai, Weiqi;Liang, Chunjing;Tang, Qiao;Chen, Xianghan;Jiang, Ying;Mao, Lanqun;Wang, Ming; Journal of the American Chemical Society; vol. 141; 45; (2019); p. 18136 - 18141;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Scheme or table,,,,,,,
C=CC(=O)N(CCCSCCOCCOCCSC(C)=O)CCOCCOCCOCCOC,CC(C)(C)OC(=O)CN(CCCSCCOCCOCCS)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSC(C)=O)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,C=CC(=O)N(CCCSCCOCCOCCSC(C)=O)CCOCCOCCOCCOC>>CC(C)(C)OC(=O)CN(CCCSCCOCCOCCS)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSC(C)=O)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,52805816,1,52,full reaction|has preparation,C23H43NO8S2|C20H39NO6S2,C43H82N2O14S4,230288,Preparation,1,,Michael Addition,,,"78356891; Article; Walker, Joshua A.; Sorkin, Michelle R.; Ledesma, Francis; Kabaria, Sneha R.; Barfield, Robyn M.; Rabuka, David; Alabi, Christopher A.; Bioconjugate Chemistry; vol. 30; 11; (2019); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)N(CCCSCCOCCOCCSC(C)=O)CCOCCOCCOCCOC,COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSC(C)=O)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C,C=CC(=O)N(CCCSCCOCCOCCSC(C)=O)CCOCCOCCOCCOC>>COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSC(C)=O)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C,52805817,1,52,full reaction|has preparation,C23H43NO8S2|C23H47NO8S2,C46H90N2O16S4,230288,Preparation,1,,Michael Addition,,,"78356891; Article; Walker, Joshua A.; Sorkin, Michelle R.; Ledesma, Francis; Kabaria, Sneha R.; Barfield, Robyn M.; Rabuka, David; Alabi, Christopher A.; Bioconjugate Chemistry; vol. 30; 11; (2019); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)N(CCCSCCOCCOCCSC(C)=O)CC(=O)OC(C)(C)C,COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSCCC(=O)N(CCCSCCOCCOCCSC(C)=O)CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,C=CC(=O)N(CCCSCCOCCOCCSC(C)=O)CC(=O)OC(C)(C)C>>COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSCCC(=O)N(CCCSCCOCCOCCSC(C)=O)CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,52805820,1,52,full reaction|has preparation,C20H35NO6S2|C23H47NO8S2,C43H82N2O14S4,230288,Preparation,1,,Michael Addition,,,"78356891; Article; Walker, Joshua A.; Sorkin, Michelle R.; Ledesma, Francis; Kabaria, Sneha R.; Barfield, Robyn M.; Rabuka, David; Alabi, Christopher A.; Bioconjugate Chemistry; vol. 30; 11; (2019); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)N(CCCSCCOCCOC)CCOCCOCCOCCOC,COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOC)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,C=CC(=O)N(CCCSCCOCCOC)CCOCCOCCOCCOC>>COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOC)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,52805827,1,52,full reaction|has preparation,C20H39NO7S|C41H80N2O13S4,C61H119N3O20S5,230288,Preparation,1,,Michael Addition,,,"78356891; Article; Walker, Joshua A.; Sorkin, Michelle R.; Ledesma, Francis; Kabaria, Sneha R.; Barfield, Robyn M.; Rabuka, David; Alabi, Christopher A.; Bioconjugate Chemistry; vol. 30; 11; (2019); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)N(CCCSCCOCCOC)CCOCCOCCOCCOC,COCCOCCOCCOCCN(CCCSCCOCCOCCSCCC(=O)N(CCCSCCOCCOCCS)CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOC)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C,C=CC(=O)N(CCCSCCOCCOC)CCOCCOCCOCCOC>>COCCOCCOCCOCCN(CCCSCCOCCOCCSCCC(=O)N(CCCSCCOCCOCCS)CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOC)C(=O)CCSCCOCCOCCSCCCN(CC(=O)OC(C)(C)C)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C,52805828,1,52,full reaction|has preparation,C20H39NO7S|C41H80N2O13S4,C61H119N3O20S5,230288,Preparation,1,,Michael Addition,,,"78356891; Article; Walker, Joshua A.; Sorkin, Michelle R.; Ledesma, Francis; Kabaria, Sneha R.; Barfield, Robyn M.; Rabuka, David; Alabi, Christopher A.; Bioconjugate Chemistry; vol. 30; 11; (2019); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
C=CC(=O)N(CCCSCCOCCOC)CC(=O)OC(C)(C)C,COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSCCC(=O)N(CCCSCCOCCOC)CC(=O)OC(C)(C)C)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C,C=CC(=O)N(CCCSCCOCCOC)CC(=O)OC(C)(C)C>>COCCOCCOCCOCCN(CCCSCCOCCOCCS)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C.COCCOCCOCCOCCN(CCCSCCOCCOCCSCCC(=O)N(CCCSCCOCCOC)CC(=O)OC(C)(C)C)C(=O)CCSCCOCCOCCSCCCN(CCOCCOCCOCCOC)C(=O)OC(C)(C)C,52805829,1,52,full reaction|has preparation,C17H31NO5S|C44H88N2O15S4,C61H119N3O20S5,230288,Preparation,1,,Michael Addition,,,"78356891; Article; Walker, Joshua A.; Sorkin, Michelle R.; Ledesma, Francis; Kabaria, Sneha R.; Barfield, Robyn M.; Rabuka, David; Alabi, Christopher A.; Bioconjugate Chemistry; vol. 30; 11; (2019); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC=O,CC(C)CC=C[N+](=O)[O-].CC(C)C[C@@H](CC=O)C[N+](=O)[O-],CC=O>>CC(C)CC=C[N+](=O)[O-].CC(C)C[C@@H](CC=O)C[N+](=O)[O-],53512292,1,52,full reaction,acetaldehyde|4-methyl-1-nitropent-1-ene,(S)-5-methyl-3-(nitromethyl)hexanal,221986,Chemical behaviour,1,,Michael Addition,Catalytic behavior,aq. phosphate buffer|ethanol,"79127463; Article; Guo, Chao; Biewenga, Lieuwe; Lubberink, Max; van Merkerk, Ronald; Poelarends, Gerrit J.; ChemBioChem; vol. 21; 10; (2020); p. 1499 - 1504;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.833333,Enzymatic reaction,7.3,,enantioselective reaction,4-oxalocrotonate tautomerase L8F/A33I/M45Y/F50A mutant,,,,Reagent/catalyst,Experimental part,98 percent ee,,,,,,
CC=CC(=O)CCC,CC(=O)S.CCCC(=O)CC(C)SC(C)=O,CC=CC(=O)CCC>>CC(=O)S.CCCC(=O)CC(C)SC(C)=O,53521449,1,52,full reaction|has preparation,hept-2-en-4-one|tiolacetic acid,(+/-)-S-(1-methyl-3-oxohexyl) ethanethioate,221613,Preparation,1,,Michael Addition,,,"79203823; Article; Riegel, Anja Devenie;Kiske, Christiane;Dudko, Viktoriia;Poplacean, Iulia;Eisenreich, Wolfgang;Engel, Karl-Heinz; Journal of Agricultural and Food Chemistry; vol. 68; 9; (2020); p. 2",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
C=C(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)C(C)C,OCCS.CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)NC(CSCCO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)C(C)C,C=C(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)C(C)C>>OCCS.CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)NC(CSCCO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)C(C)C,54344499,1,52,full reaction,H-GFL-Dha-EYV-NH2|2-hydroxyethanethiol,C41H60N8O11S,230265,Chemical behaviour,1,37,Michael Addition,Kinetics,aq. buffer,"79541412; Article; Chambers, Kaitlin A.;Abularrage, Nile S.;Hill, Caitlin J.;Khan, Imran H.;Scheck, Rebecca A.; Angewandte Chemie - International Edition; vol. 59; 19; (2020); p. 7350 - 7355; Angew. C",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,8,supporting information,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Br)cc(Br)c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc(Br)cc(Br)c2O)C2=C(CCC(C)(C)C2=O)N1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Br)cc(Br)c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc(Br)cc(Br)c2O)C2=C(CCC(C)(C)C2=O)N1,54712202,1,52,full reaction|has preparation,"GLUTATHIONE|2-(methacryloyloxy)ethyl 4-(3,5-dibromo-2-hydroxyphenyl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate",C35H44Br2N4O12S,230273,Preparation,1,,Michael Addition,,,"77482765; Article; Aygün Cevher;Schaller;Gandini, Maria A.;Kaplan, Ozan;Gambeta, Eder;Zhang, Fang Xi",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Cl)cc(Br)c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc(Cl)cc(Br)c2O)C2=C(CCC(C)(C)C2=O)N1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Cl)cc(Br)c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc(Cl)cc(Br)c2O)C2=C(CCC(C)(C)C2=O)N1,54712203,1,52,full reaction|has preparation,"GLUTATHIONE|2-(methacryloyloxy)ethyl 4-(3-bromo-5-chloro-2-hydroxyphenyl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate",C35H44BrClN4O12S,230273,Preparation,1,,Michael Addition,,,"77482765; Article; Aygün Cevher;Schaller;Gandini, Maria A.;Kaplan, Ozan;Gambeta, Eder;Zhang, Fang Xi",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Br)cc([N+](=O)[O-])c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc(Br)cc([N+](=O)[O-])c2O)C2=C(CCC(C)(C)C2=O)N1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Br)cc([N+](=O)[O-])c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc(Br)cc([N+](=O)[O-])c2O)C2=C(CCC(C)(C)C2=O)N1,54712204,1,52,full reaction|has preparation,"GLUTATHIONE|2-(methacryloyloxy)ethyl 4-(5-bromo-2-hydroxy-3-nitrophenyl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate",C35H44BrN5O14S,230273,Preparation,1,,Michael Addition,,,"77482765; Article; Aygün Cevher;Schaller;Gandini, Maria A.;Kaplan, Ozan;Gambeta, Eder;Zhang, Fang Xi",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc([N+](=O)[O-])cc(Br)c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc([N+](=O)[O-])cc(Br)c2O)C2=C(CCC(C)(C)C2=O)N1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc([N+](=O)[O-])cc(Br)c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc([N+](=O)[O-])cc(Br)c2O)C2=C(CCC(C)(C)C2=O)N1,54712205,1,52,full reaction|has preparation,"GLUTATHIONE|2-(methacryloyloxy)ethyl 4-(3-bromo-2-hydroxy-5-nitrophenyl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate",C35H44BrN5O14S,230273,Preparation,1,,Michael Addition,,,"77482765; Article; Aygün Cevher;Schaller;Gandini, Maria A.;Kaplan, Ozan;Gambeta, Eder;Zhang, Fang Xi",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2O)C2=C(CCC(C)(C)C2=O)N1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O.CC1=C(C(=O)OCCOC(=O)C(C)CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2O)C2=C(CCC(C)(C)C2=O)N1,54712206,1,52,full reaction|has preparation,"GLUTATHIONE|2-(methacryloyloxy)ethyl 4-(2-hydroxy-3,5-dinitrophenyl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate",C35H44N6O16S,230273,Preparation,1,,Michael Addition,,,"77482765; Article; Aygün Cevher;Schaller;Gandini, Maria A.;Kaplan, Ozan;Gambeta, Eder;Zhang, Fang Xi",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,,,,,,,,Body text,,,,,,,
[C]=NCS(=O)(=O)c1ccc(C)cc1,[1*]c1c([2*])cccc1C=C(C#N)C(N)=O.[1*]c1c([2*])cccc1-c1c[nH]cc1C#N,[C]=NCS(=O)(=O)c1ccc(C)cc1>>[1*]c1c([2*])cccc1C=C(C#N)C(N)=O.[1*]c1c([2*])cccc1-c1c[nH]cc1C#N,54768344,1,52,no reaction scheme,[(p-methylphenyl)sulfonylmethyl]isonitrile,,276608,Markush reaction,1,,Michael Addition,,,80504932; Patent; HEILONGJIANG UNIVERSITY; CN111499554; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0079; 0129,,,,,,,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCOC(=O)C(=CC1=[N+]2C(=C(c3ccccc3)c3ccc(C=C(C(=O)OCC)C(=O)OCC)n3[B-]2(F)F)C=C1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C1=N2C(=C(c3ccccc3)c3ccc(C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(C(=O)OCC)C(=O)OCC)n3[B]2(F)F)C=C1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCOC(=O)C(=CC1=[N+]2C(=C(c3ccccc3)c3ccc(C=C(C(=O)OCC)C(=O)OCC)n3[B-]2(F)F)C=C1)C(=O)OCC.CCOC(=O)C(C(=O)OCC)C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C1=N2C(=C(c3ccccc3)c3ccc(C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(C(=O)OCC)C(=O)OCC)n3[B]2(F)F)C=C1,54889805,1,52,full reaction,GLUTATHIONE|C31H31BF2N2O8,C51H65BF2N8O20S2,120758,Chemical behaviour,1,24.84,Michael Addition,Kinetics,aq. phosphate buffer,"80691673; Article; Liu, Hanzhuang;Song, Wenting;Zhang, Shuren;Chan, Kin Shing;Guo, Zijian;Shen, Zhen; Chemical Science; vol. 11; 32; (2020); p. 8495 - 8501;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C(O)c1cc(S)ccc1[N+](=O)[O-],O=C1C=CC(=O)C=C1.O=C(Oc1cc(O)ccc1O)c1cc(S)ccc1[N+](=O)[O-],O=C(O)c1cc(S)ccc1[N+](=O)[O-]>>O=C1C=CC(=O)C=C1.O=C(Oc1cc(O)ccc1O)c1cc(S)ccc1[N+](=O)[O-],55341405,1,52,full reaction|has preparation,5-thio-2-nitrobenzoic acid|benzoquinone,"2,5-dihydroxyphenyl 5-mercapto-2-nitrobenzoate",264747,Preparation,1,,Michael Addition,,,"80597351; Article; Wang, Chenlei;Fei, Jinbo;Wang, Keqing;Li, Junbai; Angewandte Chemie - International Edition; vol. 59; 43; (2020); p. 18960 - 18963; Angew. Chem.; vol. 132; 43; (2020); p. 19122 - 19",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Experimental part,,,,,,,
CCOc1cc2c(OCC)cc1CC1=CC(=O)C(=CC1=O)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)C2,NCCN.CCOc1cc2c(OCC)cc1CC1=C(NCCN)C(=O)C(=C(NCCN)C1=O)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)C2,CCOc1cc2c(OCC)cc1CC1=CC(=O)C(=CC1=O)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)C2>>NCCN.CCOc1cc2c(OCC)cc1CC1=C(NCCN)C(=O)C(=C(NCCN)C1=O)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)Cc1cc(OCC)c(cc1OCC)C2,55474329,1,52,full reaction|has preparation,C51H60O10|ethylenediamine,C55H72N4O10,128060,Preparation,1,,Michael Addition,,,"81209118; Article; Li, Errui;Jie, Kecheng;Fang, Yu;Cai, Peiyu;Huang, Feihe; Journal of the American Chemical Society; vol. 142; 36; (2020); p. 15560 - 15568;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,Sealed tube,,,,,,,,,Experimental part,,,,,,,
NCCN,O=C1C=CC(=O)C=C1.c1cnc2cc3c(cc2n1)NCCN3,NCCN>>O=C1C=CC(=O)C=C1.c1cnc2cc3c(cc2n1)NCCN3,55474330,1,52,full reaction|has preparation,ethylenediamine|p-benzoquinone,"1,2,3,4-tetrahydropyrazino[2,3-g]quinoxaline",8841,Preparation,1,,Michael Addition,,,"81209118; Article; Li, Errui;Jie, Kecheng;Fang, Yu;Cai, Peiyu;Huang, Feihe; Journal of the American Chemical Society; vol. 142; 36; (2020); p. 15560 - 15568;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,Sealed tube,,,,,,,,,Experimental part,,,,,,,
[H][C@@](N)(CS)C(=O)O,N#Cc1nc2ccc(S/C=C\C(=O)OCc3ccccc3)cc2s1.O=C(O)[C@H]1CSC(c2nc3ccc(S)cc3s2)=N1,[H][C@@](N)(CS)C(=O)O>>N#Cc1nc2ccc(S/C=C\C(=O)OCc3ccccc3)cc2s1.O=C(O)[C@H]1CSC(c2nc3ccc(S)cc3s2)=N1,56574443,1,52,full reaction|has preparation,D-cysteine|benzyl (Z)-3-((2-cyanobenzo[d]thiazol-6-yl)thio)acrylate,"(S)-2-(6-mercaptobenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid",151252,Preparation,1,,Michael Addition,,,"83273705; Article; Rylands, Marwaan; Jardine, Anwar; Arkivoc; vol. 2020; (2021); p. 176 - 189;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,regioselective reaction,,,,,,Scheme or table,,,,,,,
CCOC(=O)/C(=C\c1cccc(C)c1)P(=O)(OCC)OCC,N#CCC#N.CCOC(=O)CP(=O)(OCC)OCC.Cc1cccc(C=C(C#N)C#N)c1.CCOC(=O)[C@@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC,CCOC(=O)/C(=C\c1cccc(C)c1)P(=O)(OCC)OCC>>N#CCC#N.CCOC(=O)CP(=O)(OCC)OCC.Cc1cccc(C=C(C#N)C#N)c1.CCOC(=O)[C@@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@@H]([C@@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC.CCOC(=O)[C@H]([C@H](c1cccc(C)c1)C(C#N)C#N)P(=O)(OCC)OCC,57244242,1,52,full reaction,C16H23O5P|malononitrile,diethoxyphosphoryl-acetic acid ethyl ester|2-(3-methylbenzylidene)malononitrile|C19H25N2O5P|C19H25N2O5P|C19H25N2O5P|C19H25N2O5P,230142|310137,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,toluene,"90446093; Article; Kaasik, Mikk;Martõnova, Jevgenija;Erkman, Kristin;Metsala, Andrus",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,,stereoselective reaction,C27H26F4IN3O2,,,,Temperature|Time,Scheme or table,76 percent ee,,,,,,
[2*]N,Cn1cc(C2=CC(=O)c3ccccc3C2=O)c2ccccc21.[1*].[1*].[2*]NC1=C(c2cn(C)c3ccccc23)C(=O)c2ccccc2C1=O,[2*]N>>Cn1cc(C2=CC(=O)c3ccccc3C2=O)c2ccccc21.[1*].[1*].[2*]NC1=C(c2cn(C)c3ccccc23)C(=O)c2ccccc2C1=O,57396064,1,52,no reaction scheme,,,,Markush reaction,1,,Michael Addition,,,92393837; Patent; CHENGDU NORMAL UNIVERSITY; CN112979529; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Alkaline conditions,,Paragraph 0027,,,,,,,,,,,,,,
C=CC(=O)OC(C)(C)C,Cc1nn(CCOCCOCCOCCO)c(C)c1N=Nc1ccccc1.Cc1nn(CCOCCOCCOCCOCCC(=O)OC(C)(C)C)c(C)c1N=Nc1ccccc1,C=CC(=O)OC(C)(C)C>>Cc1nn(CCOCCOCCOCCO)c(C)c1N=Nc1ccccc1.Cc1nn(CCOCCOCCOCCOCCC(=O)OC(C)(C)C)c(C)c1N=Nc1ccccc1,59223803,1,52,full reaction|has preparation,tert-Butyl acrylate|C19H28N4O4,C26H40N4O6,230421,Preparation,1,,Michael Addition,,,"113847057; Article; Arndt, Niklas B.; Schlüter, Friederike; Böckmann, Marcus; Adolphs, Thorsten; Arl",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
C=CC(=O)OC(C)(C)C,COc1ccc(N=Nc2c(C)nn(CCOCCOCCOCCO)c2C)cc1.COc1ccc(N=Nc2c(C)nn(CCOCCOCCOCCOCCC(=O)OC(C)(C)C)c2C)cc1,C=CC(=O)OC(C)(C)C>>COc1ccc(N=Nc2c(C)nn(CCOCCOCCOCCO)c2C)cc1.COc1ccc(N=Nc2c(C)nn(CCOCCOCCOCCOCCC(=O)OC(C)(C)C)c2C)cc1,59223804,1,52,full reaction|has preparation,tert-Butyl acrylate|C20H30N4O5,C27H42N4O7,230421,Preparation,1,,Michael Addition,,,"113847057; Article; Arndt, Niklas B.; Schlüter, Friederike; Böckmann, Marcus; Adolphs, Thorsten; Arl",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
C=CC(=O)OC(C)(C)C,Cc1nn(CCOCCOCCOCCO)c(C)c1N=Nc1ccc(C(F)(F)F)cc1.Cc1nn(CCOCCOCCOCCOCCC(=O)OC(C)(C)C)c(C)c1N=Nc1ccc(C(F)(F)F)cc1,C=CC(=O)OC(C)(C)C>>Cc1nn(CCOCCOCCOCCO)c(C)c1N=Nc1ccc(C(F)(F)F)cc1.Cc1nn(CCOCCOCCOCCOCCC(=O)OC(C)(C)C)c(C)c1N=Nc1ccc(C(F)(F)F)cc1,59223805,1,52,full reaction|has preparation,tert-Butyl acrylate|C20H27F3N4O4,C27H39F3N4O6,230421,Preparation,1,,Michael Addition,,,"113847057; Article; Arndt, Niklas B.; Schlüter, Friederike; Böckmann, Marcus; Adolphs, Thorsten; Arl",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C(=Cc1ccccc1)C=NCCNCCN=CC=Cc1ccccc1.N[C@@H](CCC(=O)N[C@@H](CSC(CC=NCCNCCN=CC=Cc1ccccc1)c1ccccc1)C(=O)NCC(=O)O)C(=O)O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C(=Cc1ccccc1)C=NCCNCCN=CC=Cc1ccccc1.N[C@@H](CCC(=O)N[C@@H](CSC(CC=NCCNCCN=CC=Cc1ccccc1)c1ccccc1)C(=O)NCC(=O)O)C(=O)O,60276203,1,52,full reaction|has preparation,L-glutathione|C22H25N3,C32H42N6O6S,228310,Preparation,1,,Michael Addition,,,"116759867; Article; Zhou, Zhanwei;Liang, Huan;Yang, Ruoxi;Yang, Ying;Dong, Jingwen;Di, Yongxiang;Sun, Minjie; Angewandte Chemie - International Edition; vol. 61; 22; (2022); Angew. Chem.; vol. 134; 22",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,,Experimental part,,,,,,,
[1*].[2*]c1cn2ccccc2n1,[3*]C(=O)C=C.[1*].[2*]c1nc2ccccn2c1CCC([3*])=O,[1*].[2*]c1cn2ccccc2n1>>[3*]C(=O)C=C.[1*].[2*]c1nc2ccccn2c1CCC([3*])=O,60609398,1,52,no reaction scheme,,,,Markush reaction,1,,Michael Addition,,,108044178; Patent; GUILIN UNIVERSITY OF TECHNOLOGY; CN113735852; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Acidic conditions,,Paragraph 0004; 0009; 0018,,,,,,,,,,,,,,
CC1(C)CC(=O)CC(O)C1,CC1(C)CC(=O)C(=Cc2ccc(C(F)(F)F)cc2)C(=O)C1.CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2ccc(C(F)(F)F)cc2)=C(O)C1,CC1(C)CC(=O)CC(O)C1>>CC1(C)CC(=O)C(=Cc2ccc(C(F)(F)F)cc2)C(=O)C1.CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2ccc(C(F)(F)F)cc2)=C(O)C1,61723667,1,52,full reaction|has preparation,"3-hydroxy-5,5-dimethyl-1-cyclohexanone|C16H15F3O2","2,2'-((4-(trifluoromethyl)phenyl)methylene)bis(3-hydroxy-5,5-dimethylcyclohex-2-enone)",169192,Preparation,1,,Michael Addition,,,"121243229; Article; Veljović, Elma;Rimac, Hrvoje;Salihović, Mirsada;Špirtović-Halilović, Selma;Osman",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,"2,2'-((4-(trifluoromethyl)phenyl)methylene)bis(3-hydroxy-5,5-dimethylcyclohex-2-enone)",74 percent,,,Scheme or table,,,,,,,
CC1(C)CC(=O)CC(O)C1,CC(=O)Nc1ccc(C=C2C(=O)CC(C)(C)CC2=O)cc1.CC(=O)Nc1ccc(C(C2=C(O)CC(C)(C)CC2=O)C2=C(O)CC(C)(C)CC2=O)cc1,CC1(C)CC(=O)CC(O)C1>>CC(=O)Nc1ccc(C=C2C(=O)CC(C)(C)CC2=O)cc1.CC(=O)Nc1ccc(C(C2=C(O)CC(C)(C)CC2=O)C2=C(O)CC(C)(C)CC2=O)cc1,61723668,1,52,full reaction|has preparation,"3-hydroxy-5,5-dimethyl-1-cyclohexanone|C17H19NO3",C25H31NO5,169192,Preparation,1,,Michael Addition,,,"121243229; Article; Veljović, Elma;Rimac, Hrvoje;Salihović, Mirsada;Špirtović-Halilović, Selma;Osman",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,C25H31NO5,68 percent,,,Scheme or table,,,,,,,
CC1(C)CC(=O)CC(O)C1,COc1cc(C=C2C(=O)CC(C)(C)CC2=O)cc([N+](=O)[O-])c1O.COc1cc(C(C2=C(O)CC(C)(C)CC2=O)C2=C(O)CC(C)(C)CC2=O)cc([N+](=O)[O-])c1O,CC1(C)CC(=O)CC(O)C1>>COc1cc(C=C2C(=O)CC(C)(C)CC2=O)cc([N+](=O)[O-])c1O.COc1cc(C(C2=C(O)CC(C)(C)CC2=O)C2=C(O)CC(C)(C)CC2=O)cc([N+](=O)[O-])c1O,61723669,1,52,full reaction|has preparation,"3-hydroxy-5,5-dimethyl-1-cyclohexanone|C16H17NO6",C24H29NO8,169192,Preparation,1,,Michael Addition,,,"121243229; Article; Veljović, Elma;Rimac, Hrvoje;Salihović, Mirsada;Špirtović-Halilović, Selma;Osman",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,C24H29NO8,71 percent,,,Scheme or table,,,,,,,
CC1(C)CC(=O)C(=Cc2ccc([N+](=O)[O-])cc2)C(=O)C1,CC1(C)CC(=O)CC(O)C1.CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2ccc([N+](=O)[O-])cc2)=C(O)C1,CC1(C)CC(=O)C(=Cc2ccc([N+](=O)[O-])cc2)C(=O)C1>>CC1(C)CC(=O)CC(O)C1.CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2ccc([N+](=O)[O-])cc2)=C(O)C1,61723670,1,52,full reaction|has preparation,"C15H15NO4|3-hydroxy-5,5-dimethyl-1-cyclohexanone","2,2'-(4-nitrophenylmethylene)bis(3-hydroxy-5,5-dimethyl-2-cyclohexene-1-one)",169192,Preparation,1,,Michael Addition,,,"121243229; Article; Veljović, Elma;Rimac, Hrvoje;Salihović, Mirsada;Špirtović-Halilović, Selma;Osman",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,"2,2'-(4-nitrophenylmethylene)bis(3-hydroxy-5,5-dimethyl-2-cyclohexene-1-one)",77 percent,,,Scheme or table,,,,,,,
CC1(C)CC(=O)CC(O)C1,CC1(C)CC(=O)C(=Cc2cc(Br)cc(Br)c2)C(=O)C1.CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2cc(Br)cc(Br)c2)=C(O)C1,CC1(C)CC(=O)CC(O)C1>>CC1(C)CC(=O)C(=Cc2cc(Br)cc(Br)c2)C(=O)C1.CC1(C)CC(=O)C(C(C2=C(O)CC(C)(C)CC2=O)c2cc(Br)cc(Br)c2)=C(O)C1,61723671,1,52,full reaction|has preparation,"3-hydroxy-5,5-dimethyl-1-cyclohexanone|C15H14Br2O2",C23H26Br2O4,169192,Preparation,1,,Michael Addition,,,"121243229; Article; Veljović, Elma;Rimac, Hrvoje;Salihović, Mirsada;Špirtović-Halilović, Selma;Osman",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux,,,,,C23H26Br2O4,69 percent,,,Scheme or table,,,,,,,
NC(CS)C(=O)O,CN1c2ccc(C(F)(F)F)cc2C(C)(C)c2nc3cc(N4C(=O)C=CC4=O)ccc3nc21.CN1c2ccc(C(F)(F)F)cc2C(C)(C)c2nc3cc(N4C(=O)CC(SCC(N)C(=O)O)C4=O)ccc3nc21,NC(CS)C(=O)O>>CN1c2ccc(C(F)(F)F)cc2C(C)(C)c2nc3cc(N4C(=O)C=CC4=O)ccc3nc21.CN1c2ccc(C(F)(F)F)cc2C(C)(C)c2nc3cc(N4C(=O)CC(SCC(N)C(=O)O)C4=O)ccc3nc21,63596485,1,52,full reaction|has preparation,rac-cysteine|C23H17F3N4O2,C26H24F3N5O4S,228317,Preparation,1,,Michael Addition,,,"125470578; Article; Zhang, Yong;Wang, Yuesong;Ni, Hui;Huang, Weiye;Xu, Pengnan;Ji, Min; Tetrahedron; vol. 139; (2023);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
O=C1C=CC(=O)N1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O.N[C@@H](CCC(=O)N[C@@H](CSC1CC(=O)NC1=O)C(=O)NCC(=O)O)C(=O)O,O=C1C=CC(=O)N1>>[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O.N[C@@H](CCC(=O)N[C@@H](CSC1CC(=O)NC1=O)C(=O)NCC(=O)O)C(=O)O,65666052,1,52,full reaction|has preparation,Maleimide|GLUTATHIONE,"(S)-2-Amino-4-[(R)-1-(carboxymethyl-carbamoyl)-2-(2,5-dioxo-pyrrolidin-3-ylsulfanyl)-ethylcarbamoyl]-butyric acid",228317,Preparation,1,,Michael Addition,,,"130680375; Article; Chang, Xiaowei;Zhu, Zeren;Weng, Lin;Tang, Xiaoyu;Liu, Tao;Zhu, Man;Liu, Jie;Tang, Wenjun;Zhang, Yanmin;Chen, Xin; Small; vol. 20; 16; (2024);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
[H][C@@](CS)(NC(C)=O)C(=O)OC,C#CCCCCNC(=O)c1ccc2c(ccn2C(=O)C=C)c1.C#CCCCCNC(=O)c1ccc2c(ccn2C(=O)CCSC[C@H](NC(C)=O)C(=O)OC)c1,[H][C@@](CS)(NC(C)=O)C(=O)OC>>C#CCCCCNC(=O)c1ccc2c(ccn2C(=O)C=C)c1.C#CCCCCNC(=O)c1ccc2c(ccn2C(=O)CCSC[C@H](NC(C)=O)C(=O)OC)c1,66778216,1,52,full reaction|has preparation,Ac-Cys-OMe|C18H18N2O2,C24H29N3O5S,230288,Preparation,1,,Michael Addition,,,130562228; Patent; THE UNIVERSITY OF HONG KONG; CN117126096; A; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 84,,,,,,,,,,,,,,
CCO(CC)=B(F)(F)F,C1=C(c2ccccc2)C(=Nc2[nH]c(-c3ccccc3)cc2-c2ccccc2)N=C1c1ccccc1.[1*].[1*].[2*].[2*].F[B-]1(F)n2c(-c3ccccc3)cc(-c3ccccc3)c2N=C2C(c3ccccc3)=CC(c3ccccc3)=[N+]21.[1*].[1*].[2*].[2*],CCO(CC)=B(F)(F)F>>C1=C(c2ccccc2)C(=Nc2[nH]c(-c3ccccc3)cc2-c2ccccc2)N=C1c1ccccc1.[1*].[1*].[2*].[2*].F[B-]1(F)n2c(-c3ccccc3)cc(-c3ccccc3)c2N=C2C(c3ccccc3)=CC(c3ccccc3)=[N+]21.[1*].[1*].[2*].[2*],68827796,1,52,no reaction scheme,boron trifluoride diethyl etherate,,,Markush reaction,1,,Michael Addition,,,133353243; Patent; INNOVATION ACADEMY PRECISION MEASUREMENT SCIENCE AND TECHNOLOGY CAS; CN117820344; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0034,,,,,,,,,,,,,,
[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@@]2([H])=[C@]1([H])[C@-]6([H])[C@]7([H])=[C@]28C=C1C(=O)C=C(C)OC1=O,Cn1cc[n+](CC(=O)c2ccccc2)c1.[Br-].[H][C@@]1(C(=O)c2ccccc2)Oc2cc(C)oc(=O)c2[C@@]1([H])[C@]12=[C@]3([H])[C@-]4([H])[C@]5([H])=[C@@]1([H])[Fe+2]25341678[C@]2([H])=[C@@]1([H])[C@@-]6([H])[C@@]7([H])=[C@@]28[H],[H][C@@]12=[C@@]3([H])[C@@-]4([H])[C@@]5([H])=[C@]1([H])[Fe+2]23541678[C@@]2([H])=[C@]1([H])[C@-]6([H])[C@]7([H])=[C@]28C=C1C(=O)C=C(C)OC1=O>>Cn1cc[n+](CC(=O)c2ccccc2)c1.[Br-].[H][C@@]1(C(=O)c2ccccc2)Oc2cc(C)oc(=O)c2[C@@]1([H])[C@]12=[C@]3([H])[C@-]4([H])[C@]5([H])=[C@@]1([H])[Fe+2]25341678[C@]2([H])=[C@@]1([H])[C@@-]6([H])[C@@]7([H])=[C@@]28[H],68850370,1,52,full reaction,"3-ferrocenylidine-6-methyl-2H-pyran-2,4(3H)-dione|1-methyl-3-phenacylimidazolium bromide","2-benzoyl-3-ferrocenyl-6-methyl--2H-furo[3, 2-c]pyran-4(3H)-one",,Chemical behaviour,1,80,Michael Addition,Mechanism,,"137076202; Article; Srivastava, Suman; Applied Organometallic Chemistry; vol. 39; 2; (2025);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,diastereoselective reaction,1-n-butyl-3-methylimidazolim bromide,"2-benzoyl-3-ferrocenyl-6-methyl--2H-furo[3, 2-c]pyran-4(3H)-one",75 percent,,,Scheme or table,,,,,,,
CC[N+](=O)[O-],O=C(/C=C/c1ccccc1)c1ccccc1.C[C@@H]([C@@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-].C[C@H]([C@@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-].C[C@@H]([C@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-].C[C@H]([C@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-],CC[N+](=O)[O-]>>O=C(/C=C/c1ccccc1)c1ccccc1.C[C@@H]([C@@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-].C[C@H]([C@@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-].C[C@@H]([C@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-].C[C@H]([C@H](CC(=O)c1ccccc1)c1ccccc1)[N+](=O)[O-],3763713,2,51,full reaction|has preparation,"Nitroethane|1,3-diphenyl-propen-3-one","(3S,4S)-4-nitro-1,3-diphenylpentan-1-one|(3S,4R)-4-nitro-1,3-diphenylpentan-1-one|(3R,4S)-4-nitro-1,3-diphenylpentan-1-one|(3R,4R)-4-nitro-1,3-diphenylpentan-1-one",224860|224860|224860|224860,"['Chemical behaviour', 'Preparation']","['1', '1']",50,Michael addition,,toluene,"['5628357; Article; Colonna, Stefano; Re, Alberto; Wynberg, Hans; Journal of the Chemical Society. Perkin transactions I; (1981); p. 547 - 552;', '9051296; Article; Manzano, Ruben; Andres, Jose M.; Alvarez, Rosana; Muruzabal, Maria D.; De Lera, Angel R.; Pedrosa, Rafael; Chemistry - A European Journal; vol. 17; 21; (2011); p. 5931 - 5938;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['288', '120']","['reaction stereospecificity', 'neat (no solvent)']",,supporting information; experimental part,optical yield given as %ee|stereoselective reaction,"['potassium fluoride|(-)-N-dodecyl-N-methylephedrinium bromide', '(S)-1-(3,5-bis(trifluoromethyl)phenyl)-3-(1-(dimethylamino)-3-methylbutan-2-yl)thiourea']",,,,,,,,,,,,
NCc1ccccc1,C=C(C(=O)OC)[C@@H](CC(C)C)C(=O)OC(C)(C)C.C=C(C(=O)OC)[C@@H](CC(C)C)C(=O)OC(C)(C)C.NCc1ccccc1.COC(=O)[C@@H](CNCc1ccccc1)[C@@H](CC(C)C)C(=O)OC(C)(C)C.COC(=O)[C@H](CNCc1ccccc1)[C@@H](CC(C)C)C(=O)OC(C)(C)C,NCc1ccccc1>>C=C(C(=O)OC)[C@@H](CC(C)C)C(=O)OC(C)(C)C.C=C(C(=O)OC)[C@@H](CC(C)C)C(=O)OC(C)(C)C.NCc1ccccc1.COC(=O)[C@@H](CNCc1ccccc1)[C@@H](CC(C)C)C(=O)OC(C)(C)C.COC(=O)[C@H](CNCc1ccccc1)[C@@H](CC(C)C)C(=O)OC(C)(C)C,5339182,1,51,full reaction,benzylamine|1-tert-Butyl 4-methyl (2R)-2-isobutyl-3-methylenebutanedioate,"(2R,3R)-1-tert-Butyl 4-methyl 3-(benzylaminomethyl)-2-isobutylbutanedioate|(2R,3S)-1-tert-Butyl 4-methyl 3-(benzylaminomethyl)-2-isobutylbutanedioate",230539|230539,Chemical behaviour,1,20,Addition|Michael addition,Product distribution,methanol,"6229796; Article; Chernaga, Alexander N.; Davies, Stephen G.; Lewis, Christopher N.; Todd, Richard S.; Journal of the Chemical Society. Perkin transactions I; 24; (1999); p. 3603 - 3608;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|Solvents|Temperatures,,,,,,,,
C/C=C/CC#N,CC(=O)/C=C/c1ccccc1.CC(=O)CC(c1ccccc1)C(C)/C=C\C#N.C/C=C/C(C#N)C(CC(C)=O)c1ccccc1.CC(=O)C[C@@H](c1ccccc1)[C@H](C)/C=C/C#N.CC(=O)C[C@@H](c1ccccc1)[C@@H](C)/C=C/C#N,C/C=C/CC#N>>CC(=O)/C=C/c1ccccc1.CC(=O)CC(c1ccccc1)C(C)/C=C\C#N.C/C=C/C(C#N)C(CC(C)=O)c1ccccc1.CC(=O)C[C@@H](c1ccccc1)[C@H](C)/C=C/C#N.CC(=O)C[C@@H](c1ccccc1)[C@@H](C)/C=C/C#N,9268659,1,51,full reaction,3-Pentenenitrile|(E)-benzalacetone,"(Z)-4-Methyl-7-oxo-5-phenyl-oct-2-enenitrile|5-Oxo-3-phenyl-2-((E)-propenyl)-hexanenitrile|(E)-(4R,5R)-4-Methyl-7-oxo-5-phenyl-oct-2-enenitrile|(E)-(4S,5R)-4-Methyl-7-oxo-5-phenyl-oct-2-enenitrile",209265|228988|209265|209265,Chemical behaviour,1,-60,Michael addition,Product distribution,,6383975; Article; Wroblewski; Bansal; Kisanga; Verkade; Tetrahedron; vol. 59; 4; (2003); p. 561 - 566;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,,,Isobutyronitrile|P(i-PrNCH2CH2)3N,5-Oxo-3-phenyl-2-((E)-propenyl)-hexanenitrile|(Z)-4-Methyl-7-oxo-5-phenyl-oct-2-enenitrile,50 percent Spectr.|14 percent Spectr.,,Further Variations:|Reaction partners,,,,,,,,
O=C(/C=C/c1ccc(Cl)cc1)c1ccccc1,CCOC(=O)CC(C)=O.CCOC(=O)C1C(=O)C=C(c2ccccc2)CC1c1ccc(Cl)cc1.CCOC(=O)C(C(C)=O)C(CC(=O)c1ccccc1)c1ccc(Cl)cc1.CCOC(=O)C1C(=O)CC(O)(c2ccccc2)CC1c1ccc(Cl)cc1,O=C(/C=C/c1ccc(Cl)cc1)c1ccccc1>>CCOC(=O)CC(C)=O.CCOC(=O)C1C(=O)C=C(c2ccccc2)CC1c1ccc(Cl)cc1.CCOC(=O)C(C(C)=O)C(CC(=O)c1ccccc1)c1ccc(Cl)cc1.CCOC(=O)C1C(=O)CC(O)(c2ccccc2)CC1c1ccc(Cl)cc1,9529216,1,51,full reaction,4-chlorochalcone|ethyl acetoacetate,6-(4-chlorophenyl)-2-oxo-4-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester|3-benzoyl-1-acetyl-1-ethoxycarbonyl-2-(4'-chlorophenyl)propane|2-(4-chloro-phenyl)-4-hydroxy-6-oxo-4-phenyl-cyclohexanecar,80262|119873|229122,Chemical behaviour,1,,Michael reaction,Product distribution,,"6438658; Article; Zhang, Ze; Dong, Ya-Wei; Wang, Guan-Wu; Komatsu, Koichi; Synlett; 1; (2004); p. 61 - 64;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,high-speed vibration milling,,,,sodium hydroxide,3-benzoyl-1-acetyl-1-ethoxycarbonyl-2-(4'-chlorophenyl)propane|2-(4-chloro-phenyl)-4-hydroxy-6-oxo-4-phenyl-cyclohexanecarboxylic acid ethyl ester|6-(4-chlorophenyl)-2-oxo-4-phenyl-3-cyclohexene-1-car,26 percent|44 percent|23 percent,26|44|23,Further Variations:|Reagents,,,,,,,,
CCCCCCCCCCCN,C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.C=CC(=O)OCC1(COC(=O)C=C)COC(=O)CCN(CCCCCCCCCCC)CCC(=O)OC1.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCN(CCCCCCCCCCC)CCC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C,CCCCCCCCCCCN>>C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.C=CC(=O)OCC1(COC(=O)C=C)COC(=O)CCN(CCCCCCCCCCC)CCC(=O)OC1.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCN(CCCCCCCCCCC)CCC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C,11210559,1,51,full reaction,1-undecylamine|pentaerythritol tetraacrylate,C28H45NO8|C45H65NO16,207953|230585,Chemical behaviour,1,4 - 20,Michael addition,Product distribution,methanol,"7062859; Article; Swanson, Douglas R.; Huang, Baohua; Abdelhady, Hosam G.; Tomalia, Donald A.; New Journal of Chemistry; vol. 31; 7; (2007); p. 1368 - 1378;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|educt ratio,,,,,,,,
CCCCCN,C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.CCCCCN.C=CC(=O)OCC1(COC(=O)C=C)COC(=O)CCN(CCCCC)CCC(=O)OC1.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCN(CCCCC)CCC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C,CCCCCN>>C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C.CCCCCN.C=CC(=O)OCC1(COC(=O)C=C)COC(=O)CCN(CCCCC)CCC(=O)OC1.C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCN(CCCCC)CCC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C,11210567,1,51,full reaction,n-Pentylamine|pentaerythritol tetraacrylate,C22H33NO8|C39H53NO16,207953|230585,Chemical behaviour,1,4 - 20,Michael addition,Product distribution,methanol,"7062859; Article; Swanson, Douglas R.; Huang, Baohua; Abdelhady, Hosam G.; Tomalia, Donald A.; New Journal of Chemistry; vol. 31; 7; (2007); p. 1368 - 1378;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Further Variations:|educt ratio,,,,,,,,
N#CC(C#N)=C1CCCc2ccccc21,COc1ccc(C=C[N+](=O)[O-])cc1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(OC)cc2)CCc2ccccc2C1=C(C#N)C#N.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccc(OC)cc2)CCc2ccccc2C1=C(C#N)C#N,N#CC(C#N)=C1CCCc2ccccc21>>COc1ccc(C=C[N+](=O)[O-])cc1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(OC)cc2)CCc2ccccc2C1=C(C#N)C#N.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccc(OC)cc2)CCc2ccccc2C1=C(C#N)C#N,33492983,1,51,full reaction|has preparation,"1,2,3,4-tetrahydro-1-naphthylidene malononitrile|1-methoxy-4-(2-nitro-vinyl)-benzene","2-[2-(1-(4-methoxyphenyl)-2-nitroethyl)-3,4-dihydro-2H-naphthalen-1-ylidene]malononitrile|(S,R)-2-{2-[1-(4-methoxyphenyl)-2-nitroethyl]-3,4-dihydro-2H-naphthalen-1-ylidene}malononitrile",224825|224825,Preparation,1,,Michael reaction,,,"20162743; Article; Chen, Wei-Yi; Ouyang, Luo; Chen, Rui-Ye; Li, Xin-Sheng; Synthetic Communications; vol. 42; 17; (2012); p. 2585 - 2594;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,experimental part,optical yield given as %ee,,,,,,,,,,,,,
[H][C@](N)(CCS)C(=O)O,O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O.N[C@@H](CCSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,[H][C@](N)(CCS)C(=O)O>>O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O.N[C@@H](CCSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,35506918,1,51,full reaction,L-homocysteine|7-hydroxy-2-(quinolin-2-ylmethylene)malonic acid,C17H18N2O7S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"35492231; Article; Song, Qin-Hua; Wu, Qing-Qing; Liu, Chang-Hui; Du, Xiao-Jiao; Guo, Qing-Xiang; Journal of Materials Chemistry B; vol. 1; 4; (2013); p. 438 - 442;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,&#60; 7,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O.N[C@@H](CCC(=O)N[C@@H](CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)NCC(=O)O)C(=O)O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O.N[C@@H](CCC(=O)N[C@@H](CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)NCC(=O)O)C(=O)O,35506919,1,51,full reaction,GLUTATHIONE|7-hydroxy-2-(quinolin-2-ylmethylene)malonic acid,C23H26N4O11S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"35492231; Article; Song, Qin-Hua; Wu, Qing-Qing; Liu, Chang-Hui; Du, Xiao-Jiao; Guo, Qing-Xiang; Journal of Materials Chemistry B; vol. 1; 4; (2013); p. 438 - 442;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,&#60; 7,,,,,,,,Body text,,,,,,,
[Li][Si](C)(C)C,O=C1C=CCC1.C[Si](C)(C)C(F)(F)F.C[Si](C)(C)[C@@H]1CC[C@@](O)(C(F)(F)F)C1,[Li][Si](C)(C)C>>O=C1C=CCC1.C[Si](C)(C)C(F)(F)F.C[Si](C)(C)[C@@H]1CC[C@@](O)(C(F)(F)F)C1,38572300,1,51,full reaction|has preparation,trimethylsilyl lithium|cyclopent-2-enone|(trifluoromethyl)trimethylsilane,C9H17F3OSi,89221,Preparation,1,,Michael Addition,,,"64129496; Article; Mercadante, Michael A.; Kelly, Christopher B.; Hamlin, Trevor A.; Delle Chiaie, Kayla R.; Drago, Michael D.; Duffy, Katherine K.; Dumas, Megan T.; Fager, Diana C.; Glod, Bryanna L.",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,2,trimethylsilyl lithium|cyclopent-2-enone|(trifluoromethyl)trimethylsilane,,,,
O=[N+]([O-])C=Cc1cccc([N+](=O)[O-])c1,CCCC=O.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1,O=[N+]([O-])C=Cc1cccc([N+](=O)[O-])c1>>CCCC=O.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1,39185101,1,51,full reaction,3-nitro-β-nitrostyrene|butyraldehyde,"(2R,3S)-2-ethyl-4-nitro-3-(3-nitrophenyl)butanal|(2S,3R)-2-ethyl-4-nitro-3-(3-nitrophenyl)butanal",224825|224825,Chemical behaviour,1,,Michael Addition,Catalytic behavior,hexane|isopropyl alcohol,"64619620; Article; Scatena, Gabriel S.; De La Torre, Alexander F.; Cass, Quezia B.; Rivera, Daniel G.; Paixo, Mrcio W.; ChemCatChem; vol. 6; 11; (2014); p. 3208 - 3214;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 86 %,silica supported N-cyclohexyl-2-methyl-2-[N-propyl-1-(2S)-pyrrolidin-2-ylformamido]propanamide (SiO2-4b),,,,,Experimental part,86 percent ee,,,,,,
O=[N+]([O-])C=Cc1ccccc1Br,CCCC=O.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1Br.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Br,O=[N+]([O-])C=Cc1ccccc1Br>>CCCC=O.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1Br.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccccc1Br,39185102,1,51,full reaction,o-bromonitrostyrene|butyraldehyde,"(2R,3S)-3-(2-bromophenyl)-2-ethyl-4-nitrobutanal|(2S,3R)-3-(2-bromophenyl)-2-ethyl-4-nitrobutanal",224825|224825,Chemical behaviour,1,,Michael Addition,Catalytic behavior,hexane|isopropyl alcohol,"64619620; Article; Scatena, Gabriel S.; De La Torre, Alexander F.; Cass, Quezia B.; Rivera, Daniel G.; Paixo, Mrcio W.; ChemCatChem; vol. 6; 11; (2014); p. 3208 - 3214;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 91 %,silica supported N-cyclohexyl-2-methyl-2-[N-propyl-1-(2S)-pyrrolidin-2-ylformamido]propanamide (SiO2-4b),,,,,Experimental part,86 percent ee,,,,,,
C1CCNC1,O=CC=Cc1ccc([N+](=O)[O-])cc1.COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)C(/C=C/N1CCCC1)c1ccc([N+](=O)[O-])cc1,C1CCNC1>>O=CC=Cc1ccc([N+](=O)[O-])cc1.COC(=O)CC(=O)OC.COC(=O)C(C(=O)OC)C(/C=C/N1CCCC1)c1ccc([N+](=O)[O-])cc1,40123550,1,51,full reaction,pyrrolidine|3-(4-nitrophenyl)-2-propenal|malonic acid dimethyl ester,C18H22N2O6,28000,Chemical behaviour,1,20,Michael Addition,Kinetics,chloroform,"64676674; Article; Akagawa, Kengo; Sakai, Nobutaka; Kudo, Kazuaki; Angewandte Chemie - International Edition; vol. 54; 6; (2015); p. 1822 - 1826; Angew. Chem.; vol. 127; 6; (2015); p. 1842 - 1846,5;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,10,,,supporting information,,,,,,Concentration|Solvent,Experimental part,,,,,,,
[H][C@@](CS)(NC(C)=O)C(=O)OC,[H][C@]12CC(=O)C=C[C@]13CCN(C)Cc1ccc(OC)c(c13)O2.[H][C@@]12CC(=O)C[C@H](SC[C@H](NC(C)=O)C(=O)OC)[C@@]13CCN(C)Cc1ccc(OC)c(c13)O2.[H][C@]12CC(=O)C[C@@H](SC[C@H](NC(C)=O)C(=O)OC)[C@]13CCN(C)Cc1ccc(OC)c(c13)O2,[H][C@@](CS)(NC(C)=O)C(=O)OC>>[H][C@]12CC(=O)C=C[C@]13CCN(C)Cc1ccc(OC)c(c13)O2.[H][C@@]12CC(=O)C[C@H](SC[C@H](NC(C)=O)C(=O)OC)[C@@]13CCN(C)Cc1ccc(OC)c(c13)O2.[H][C@]12CC(=O)C[C@@H](SC[C@H](NC(C)=O)C(=O)OC)[C@]13CCN(C)Cc1ccc(OC)c(c13)O2,41635584,1,51,full reaction,"Ac-Cys-OMe|(4aS,8aS)-rel-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-one",C23H30N2O6S|C23H30N2O6S,224268|224268,Chemical behaviour,1,20,Michael Addition,Kinetics,methanol|chloroform,"67770858; Article; Gallagher, Ryan; Chebib, Mary; Balle, Thomas; McLeod, Malcolm D.; Australian Journal of Chemistry; vol. 68; 12; (2015); p. 1834 - 1841;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,,,,,,,,Scheme or table,,,,,,,
SCCCS,CON.C=CC=O.CON=CCCSCCCS,SCCCS>>CON.C=CC=O.CON=CCCSCCCS,46219709,1,51,full reaction|has preparation,1.3-propanedithiol|O-Methylhydroxylamin|acrolein,C7H15NOS2,77596,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,2,1.3-propanedithiol|acrolein|O-Methylhydroxylamin,,,,
CON,NCCS.C=CC=O.CON=CCCSCCN,CON>>NCCS.C=CC=O.CON=CCCSCCN,46219710,1,51,full reaction|has preparation,O-Methylhydroxylamin|Cysteamine|acrolein,C6H14N2OS,77596,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,2,Cysteamine|acrolein|O-Methylhydroxylamin,,,,
CON,O=C(O)CS.C=CC=O.CON=CCCSCC(=O)O,CON>>O=C(O)CS.C=CC=O.CON=CCCSCC(=O)O,46219711,1,51,full reaction|has preparation,O-Methylhydroxylamin|mercaptoacetic acid|acrolein,C6H11NO3S,77596,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,2,mercaptoacetic acid|acrolein|O-Methylhydroxylamin,,,,
CON,CC(C)(C)OC(=O)NC(CS)C(=O)O.C=CC=O.CON=CCCSCC(NC(=O)OC(C)(C)C)C(=O)O,CON>>CC(C)(C)OC(=O)NC(CS)C(=O)O.C=CC=O.CON=CCCSCC(NC(=O)OC(C)(C)C)C(=O)O,46219712,1,51,full reaction|has preparation,O-Methylhydroxylamin|boc-cysteine|acrolein,C12H22N2O5S,77596,Preparation,1,,Michael Addition,,,"72062122; Article; Munneke, Stefan; Dangerfield, Emma M.; Stocker, Bridget L.; Timmer, Mattie S. M.; Glycoconjugate Journal; vol. 34; 5; (2017); p. 633 - 642;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,2,boc-cysteine|acrolein|O-Methylhydroxylamin,,,,
NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCC(=O)N1,C=CC(=O)OC.COC(=O)CC[C@H](c1c[nH]c2ccccc12)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O.COC(=O)CC[C@@H](c1c[nH]c2ccccc12)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCC(=O)N1>>C=CC(=O)OC.COC(=O)CC[C@H](c1c[nH]c2ccccc12)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O.COC(=O)CC[C@@H](c1c[nH]c2ccccc12)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,48324589,1,51,full reaction,C25H27N5O4|acrylic acid methyl ester,C29H33N5O6|C29H33N5O6,230794|230794,Chemical behaviour,1,,Michael Addition,Catalytic behavior,"water|N,N-dimethyl-formamide","73887542; Article; Yu, Younong; Zhang, Li-Kang; Buevich, Alexei V.; Li, Guoqing; Tang, Haiqun; Vachal, Petr; Colletti, Steven L.; Shi, Zhi-Cai; Journal of the American Chemical Society; vol. 140; 22;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,Inert atmosphere|Irradiation,,supporting information,chemoselective reaction,dipotassium hydrogenphosphate|[Ir(dF(CF3)ppy)2(dtbbpy)](PF6),,,,Time,Experimental part,,,,,,,
CCOC(=O)/C=C/c1ccccc1C(=O)OCC,NCc1ccccc1.CCOC(=O)CC1c2ccccc2C(=O)N1Cc1ccccc1.CCOC(=O)/C=C/c1ccccc1C(=O)NCc1ccccc1,CCOC(=O)/C=C/c1ccccc1C(=O)OCC>>NCc1ccccc1.CCOC(=O)CC1c2ccccc2C(=O)N1Cc1ccccc1.CCOC(=O)/C=C/c1ccccc1C(=O)NCc1ccccc1,49854099,1,51,full reaction|has preparation,(E)-ethyl 2-(3-ethoxy-3-oxoprop-1-en-1-yl)benzoate|benzylamine,"ethyl (2-benzyl-3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetate|C19H19NO3",279907|210108,Preparation,1,,Michael Addition,,,"74904684; Article; Lee, Kun Jung; Kim, Guncheol; Bulletin of the Korean Chemical Society; vol. 39; 11; (2018); p. 1239 - 1240;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
CC(=O)c1cc(C)c(O)c(CO)c1O,C[C@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@@H](C)OC2=O)c1O.CC(=O)c1cc(C)c(O)c(Cc2c(O)c(C)cc(C(C)=O)c2O)c1O,CC(=O)c1cc(C)c(O)c(CO)c1O>>C[C@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@@H](C)OC2=O)c1O.CC(=O)c1cc(C)c(O)c(Cc2c(O)c(C)cc(C(C)=O)c2O)c1O,50864174,1,51,full reaction,hydroxyclavatol|(R)-5-methyltetronic acid,"peniphenone D|5,5'-diacetyl-2,6,2',6'-tetrahydroxy-3,3'-dimethyl-diphenylmethane",164324|8235,Chemical behaviour,1,20,Michael Addition,Mechanism,aq. phosphate buffer,"76183500; Article; Fan, Jie; Liao, Ge; Kindinger, Florian; Ludwig-Radtke, Lena; Yin, Wen-Bing; Li, Shu-Ming; Journal of the American Chemical Society; vol. 141; 10; (2019); p. 4225 - 4229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,10,supporting information,,,,,,pH-value,Scheme or table,,,,,,,
CC(=O)c1cc(C)c(O)c(CO)c1O,O=C(O)C[C@@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@H](CC(=O)O)OC2=O)c1O.CC(=O)c1cc(C)c(O)c(Cc2c(O)c(C)cc(C(C)=O)c2O)c1O,CC(=O)c1cc(C)c(O)c(CO)c1O>>O=C(O)C[C@@H]1OC(=O)CC1=O.CC(=O)c1cc(C)c(O)c(CC2=C(O)[C@H](CC(=O)O)OC2=O)c1O.CC(=O)c1cc(C)c(O)c(Cc2c(O)c(C)cc(C(C)=O)c2O)c1O,50864175,1,51,full reaction,hydroxyclavatol|(S)-5-carboxylmethyltetronic acid,"penilactone D|5,5'-diacetyl-2,6,2',6'-tetrahydroxy-3,3'-dimethyl-diphenylmethane",164324|41420,Chemical behaviour,1,20,Michael Addition,Mechanism,aq. phosphate buffer,"76183500; Article; Fan, Jie; Liao, Ge; Kindinger, Florian; Ludwig-Radtke, Lena; Yin, Wen-Bing; Li, Shu-Ming; Journal of the American Chemical Society; vol. 141; 10; (2019); p. 4225 - 4229;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,10,supporting information,,,,,,pH-value,Scheme or table,,,,,,,
CC(C)(C)[Si](C)(C)ONC(=O)OCc1ccccc1,C/C=C/C=O.CC1C[C@H](O)ON1C(=O)OCc1ccccc1.CC1C[C@@H](O)ON1C(=O)OCc1ccccc1,CC(C)(C)[Si](C)(C)ONC(=O)OCc1ccccc1>>C/C=C/C=O.CC1C[C@H](O)ON1C(=O)OCc1ccccc1.CC1C[C@@H](O)ON1C(=O)OCc1ccccc1,53415133,1,51,full reaction,benzyl (tert‐butyldimethylsilyl)oxycarbamate|trans-Crotonaldehyde,(5R)-benzyl 5-hydroxy-3-methylisoxazolidine-2-carboxylate|benzyl 5-hydroxy-3-methylisoxazolidine-2-carboxylate,204579|204579,Chemical behaviour,1,20|20,Michael Addition|Michael Addition,Catalytic behavior,,"78963010; Article; Xu, Fang-Fang; Chen, Ling-Yan; Sun, Peng; Lv, Yixin; Zhang, Yan-Xue; Li, Jia-Yu; Yin, Xiaoying; Li, Ya; Chirality; vol. 32; 3; (2020); p. 378 - 386;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|24,,,supporting information,Overall yield = 72 percent; Overall yield = 34 mg; enantioselective reaction,C11H20N2O2S|trichloroacetic acid,,,,Reagent/catalyst,Experimental part,76 percent ee,2,trans-Crotonaldehyde|benzyl (tert‐butyldimethylsilyl)oxycarbamate,,,,
CCCN,C=C1C(=O)O[C@]2(C)N1C(=O)O[C@@]2(C)OC.C=C1C(=O)O[C@]2(C)N1C(=O)O[C@@]2(C)OC.CCCN.CCCN.CCCNC[C@@H]1C(=O)O[C@]2(C)N1C(=O)O[C@@]2(C)OC.CCCNC[C@H](C(=O)NCCC)N1C(=O)O[C@@](C)(OC)[C@]1(C)O,CCCN>>C=C1C(=O)O[C@]2(C)N1C(=O)O[C@@]2(C)OC.C=C1C(=O)O[C@]2(C)N1C(=O)O[C@@]2(C)OC.CCCN.CCCN.CCCNC[C@@H]1C(=O)O[C@]2(C)N1C(=O)O[C@@]2(C)OC.CCCNC[C@H](C(=O)NCCC)N1C(=O)O[C@@](C)(OC)[C@]1(C)O,53499577,1,51,full reaction,propylamine|C9H11NO5,"(3R,7R,7aS)-7-methoxy-7,7adimethyl-3-((propylamino)methyl)dihydro-5H-oxazolo[4,3-b]-oxazole-2,5(3H)-dione|(R)-2-((4S,5R)-4-hydroxy-5-methoxy-4,5-dimethyl-2-oxooxazolidin-3-yl)-N-propyl-3-propylaminopr",230537|91169,Chemical behaviour,1,20,Michael Addition,Kinetics,dichloromethane,"79204888; Article; Navo, Claudio D.; Mazo, Nuria; Oroz, Paula; Gutiérrez-Jiménez, Marta I.; Marín, J",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,,,,"(3R,7R,7aS)-7-methoxy-7,7adimethyl-3-((propylamino)methyl)dihydro-5H-oxazolo[4,3-b]-oxazole-2,5(3H)-dione|(R)-2-((4S,5R)-4-hydroxy-5-methoxy-4,5-dimethyl-2-oxooxazolidin-3-yl)-N-propyl-3-propylaminopr",50 percentSpectr.|30 percentSpectr.,,,Experimental part,,,,,,,
Cc1ccc(/C=C/[N+](=O)[O-])cc1,O=C1CCCCC1.Cc1ccc([C@@H](C[N+](=O)[O-])[C@H]2CCCCC2=O)cc1.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCCC1=O,Cc1ccc(/C=C/[N+](=O)[O-])cc1>>O=C1CCCCC1.Cc1ccc([C@@H](C[N+](=O)[O-])[C@H]2CCCCC2=O)cc1.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccc(C)cc2)CCCCC1=O,56659020,1,51,full reaction,(E)-2-(4-methylphenyl)-1-nitroethene|cyclohexanone,(R)-2-((S)-2-nitro-1-(p-tolyl)ethyl)cyclohexanone|anti-2-(2-nitro-1-(4-methylphenyl)ethyl)cyclohexanone,224824|224824,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,Overall yield = 96 percent; Overall yield = 36 mg; stereoselective reaction,"N,N-diethylnmethylamine|N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide",,,,Reagent/catalyst,Experimental part,95 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccccc1,CC(C)(C)C1CCC(=O)CC1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](C(C)(C)C)CCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](C(C)(C)C)CCC1=O,O=[N+]([O-])/C=C/c1ccccc1>>CC(C)(C)C1CCC(=O)CC1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](C(C)(C)C)CCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](C(C)(C)C)CCC1=O,56659025,1,51,full reaction,nitrostyrene|4-tercbutyl-cyclohexanone,"(2R,4R,1'S)-4-(tert-butyl)-2-(2-nitro-1-phenylethyl)cyclohexan-1-one|(4R,1'S)-4-(tert-butyl)-2-(2-nitro-1-phenylethyl)cyclohexan-1-one",224822|224822,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,Overall yield = 43 percent; Overall yield = 26 mg; stereoselective reaction,"N,N-diethylnmethylamine|N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide",,,,Reagent/catalyst,Experimental part,> 99 percent ee,,,,,,
O=c1ccnc[nH]1,CCOC(=O)/C=C/C(=O)c1ccccc1.CCOC(=O)[C@H](CC(=O)c1ccccc1)n1cnccc1=O.CCOC(=O)[C@@H](CC(=O)c1ccccc1)n1cnccc1=O,O=c1ccnc[nH]1>>CCOC(=O)/C=C/C(=O)c1ccccc1.CCOC(=O)[C@H](CC(=O)c1ccccc1)n1cnccc1=O.CCOC(=O)[C@@H](CC(=O)c1ccccc1)n1cnccc1=O,60587159,1,51,full reaction,pyrimidin-4(3H)-one|ethyl 4-oxo-4-phenylbut-trans-2-enoate,ethyl 4-oxo-2-(6-oxopyrimidin-1(6H)-yl)-4-phenylbutanoate|ethyl 4-oxo-2-(6-oxopyrimidin-1(6H)-yl)-4-phenylbutanoate,228587|228587,Chemical behaviour,1,10|10,Michael Addition|Michael Addition,Catalytic behavior,,"118335055; Article; Chen, Yong-Sin;Huang, Ming-Hsuan;Cheng, Yan-Peng;Hou, Duen-Ren; Journal of the Chinese Chemical Society; vol. 69; 8; (2022); p. 1462 - 1474;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|48,,,,Overall yield = 40 percent; Overall yield = 3 mg; enantioselective reaction,CD-N-SQA,,,,Reagent/catalyst|Temperature,Experimental part,88 percent ee,2,pyrimidin-4(3H)-one|ethyl 4-oxo-4-phenylbut-trans-2-enoate,,,,
C1CCNCC1,C=C(CC(=O)OC)C(=O)OC.C=C(CC(=O)OC)C(=O)OC.COC(=O)/C=C(\C)C(=O)OC.COC(=O)CC(CN1CCCCC1)C(=O)OC,C1CCNCC1>>C=C(CC(=O)OC)C(=O)OC.C=C(CC(=O)OC)C(=O)OC.COC(=O)/C=C(\C)C(=O)OC.COC(=O)CC(CN1CCCCC1)C(=O)OC,60993705,1,51,full reaction,piperidine|Dimethyl itakonate,mesaconic acid dimethyl ester|dimethyl 2-(1-piperidinylmethyl)butanedioate,325814|230547,Chemical behaviour,1,50,Michael Addition,Kinetics|Mechanism,methanol,"118671251; Article; Day, Daniel M.;Farmer, Thomas J.;Sherwood, James;Clark, James H.; Tetrahedron; vol. 121; (2022);",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Sealed tube,,supporting information,,,,,,Time|Solvent,Scheme or table,,,,,,,
CCOC(=O)C(C(=O)OCC)=C1C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,Cc1noc(CCl)c1[N+](=O)[O-].CCOC(=O)C1(C(=O)OCC)C(c2onc(C)c2[N+](=O)[O-])C12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12.CCOC(=O)C1(C(=O)OCC)[C@H](c2onc(C)c2[N+](=O)[O-])[C@@]12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12,CCOC(=O)C(C(=O)OCC)=C1C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>Cc1noc(CCl)c1[N+](=O)[O-].CCOC(=O)C1(C(=O)OCC)C(c2onc(C)c2[N+](=O)[O-])C12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12.CCOC(=O)C1(C(=O)OCC)[C@H](c2onc(C)c2[N+](=O)[O-])[C@@]12C(=O)N(C(=O)OC(C)(C)C)c1ccccc12,62235879,1,51,full reaction,diethyl 2-(1-(tert-butoxycarbonyl)-2-oxoindolin-3-ylidene)malonate|5-(chloromethyl)-3-methyl-4-nitroisoxazole,"1′-(tert-butyl) 2,2-diethyl 3-(3-methyl-4-nitroisoxazol-5-yl)-2′-oxospiro[cyclopropane-1,3′-indoline",136406|136406,Chemical behaviour,1,20 - 25,Michael Addition,Catalytic behavior,,"122166604; Article; Manna, Abhijit;Joshi, Harshit;Singh, Vinod K.; Journal of Organic Chemistry; vol. 87; 24; (2022); p. 16755 - 16766;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,supporting information,Overall yield = 90 percent; stereoselective reaction,"1-[3,5-bis(trifluoromethyl)phenyl]-3-[(8α,9S)-cinchonan-9-yl]urea|sodium hydrogencarbonate",,,,Reagent/catalyst|Solvent,Experimental part,99 percent ee,,,,,,
[H][C@](N)(CC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,[H][C@@]12[C@H](C)C(=O)O[C@]1([H])C[C@@H](C)[C@]1([H])C=CC(=O)[C@@]1(C)[C@H]2OC(C)=O.[H][C@@]12[C@H](C)C(=O)O[C@]1([H])C[C@@H](C)[C@]1([H])[C@H](SC[C@]([H])(NC(=O)C[C@]([H])(N)C(=O)O)C(=O)NCC(=O)O)CC(=O)[C@@]1(C)[C@H]2OC(C)=O,[H][C@](N)(CC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>[H][C@@]12[C@H](C)C(=O)O[C@]1([H])C[C@@H](C)[C@]1([H])C=CC(=O)[C@@]1(C)[C@H]2OC(C)=O.[H][C@@]12[C@H](C)C(=O)O[C@]1([H])C[C@@H](C)[C@]1([H])[C@H](SC[C@]([H])(NC(=O)C[C@]([H])(N)C(=O)O)C(=O)NCC(=O)O)CC(=O)[C@@]1(C)[C@H]2OC(C)=O,5360009,2,50,full reaction|has preparation,β-Asp-Cys-Gly|arnicolide A,"2β-S-glutathionyl-2,3,11α,13-tetrahydrohelenalin acetate",224271,"['Chemical behaviour', 'Preparation']","['1', '1']",,"['Michael addition', 'Michael addition']",Kinetics,"['phosphate buffer|ethanol', 'ethanol|water']","['6222127; Article; Schmidt, Thomas J.; Lyss, Guido; Pahl, Heike L.; Merfort, Irmgard; Bioorganic and Medicinal Chemistry; vol. 7; 12; (1999); p. 2849 - 2855;', '6222127; Article; Schmidt, Thomas J.; Lyss, Guido; Pahl, Heike L.; Merfort, Irmgard; Bioorganic and Medicinal Chemistry; vol. 7; 12; (1999); p. 2849 - 2855;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,8.0,,,,,,,Further Variations:|pH-values,,,,,,,,
CCCCCCCCCCCCCCCCS,C1=CC(=Nc2ccccc2)C=CC1=Nc1ccccc1.CCCCCCCCCCCCCCCCSc1cc(Nc2ccccc2)ccc1Nc1ccccc1,CCCCCCCCCCCCCCCCS>>C1=CC(=Nc2ccccc2)C=CC1=Nc1ccccc1.CCCCCCCCCCCCCCCCSc1cc(Nc2ccccc2)ccc1Nc1ccccc1,9245421,1,50,full reaction,"16-mercaptohexadecanoate|N,N'-diphenyl-1,4-phenylenediamine","2-hexadecylsulfanyl-N1,N4-diphenyl-benzene-1,4-diamine",239905,Chemical behaviour,1,,Michael addition,Kinetics,,"6383898; Article; Yamamoto, Kimihisa; Higuchi, Masayoshi; Nishiumi, Toyohiko; Takai, Hirokazu; Bulletin of the Chemical Society of Japan; vol. 75; 8; (2002); p. 1827 - 1832;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,1-methyl-pyrrolidin-2-one,,,,,,,,,,,,
C1=CC(=Nc2ccccc2)C=CC1=Nc1ccccc1,C[O-].[Na+].COc1cc(Nc2ccccc2)ccc1Nc1ccccc1,C1=CC(=Nc2ccccc2)C=CC1=Nc1ccccc1>>C[O-].[Na+].COc1cc(Nc2ccccc2)ccc1Nc1ccccc1,9249127,1,50,full reaction,"N,N'-diphenyl-1,4-phenylenediamine|sodium methylate","2-methoxy-N1,N4-diphenyl-benzene-1,4-diamine",257156,Chemical behaviour,1,,Michael addition,Kinetics,,"6383898; Article; Yamamoto, Kimihisa; Higuchi, Masayoshi; Nishiumi, Toyohiko; Takai, Hirokazu; Bulletin of the Chemical Society of Japan; vol. 75; 8; (2002); p. 1827 - 1832;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,1-methyl-pyrrolidin-2-one,,,,,,,,,,,,
CCOC(=O)CC(=O)O,CC(C=O)c1ccccc1.NCc1ccccc1.CCOC(=O)C/C=C(\C)c1ccccc1.CCOC(=O)C=CC(C)c1ccccc1.CCOC(=O)C/C=C(/C)c1ccccc1.CCOC(=O)CC(NCc1ccccc1)C(C)c1ccccc1,CCOC(=O)CC(=O)O>>CC(C=O)c1ccccc1.NCc1ccccc1.CCOC(=O)C/C=C(\C)c1ccccc1.CCOC(=O)C=CC(C)c1ccccc1.CCOC(=O)C/C=C(/C)c1ccccc1.CCOC(=O)CC(NCc1ccccc1)C(C)c1ccccc1,9477832,1,50,full reaction|has preparation,hydrogen ethyl malonate|2-Phenylpropanal|benzylamine,ethyl (E)-4-phenyl-3-pentenoate|ethyl 4-phenyl-2-pentenoate|ethyl (Z)-4-phenyl-3-pentenoate|ethyl 3-benzylamino-4-phenylpentanoate,226634|169682|166604,Preparation,1,,Michael reaction,,,6416377; Article; Romanova; Gravis; Kudan; Leshcheva; Zyk; Russian Journal of Organic Chemistry; vol. 39; 5; (2003); p. 692 - 697;,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,microwave irradiation,,,,,ethyl 4-phenyl-2-pentenoate|ethyl 3-benzylamino-4-phenylpentanoate,7 percent|4 percent,7|4,,,,,,,,,
O=C1CC(=O)NC(=O)N1,Nc1ccc(N2CCOCC2)cc1.Nc1ccc(N2CCOCC2)c2oc3[nH]c(=O)[nH]c(=O)c3c12,O=C1CC(=O)NC(=O)N1>>Nc1ccc(N2CCOCC2)cc1.Nc1ccc(N2CCOCC2)c2oc3[nH]c(=O)[nH]c(=O)c3c12,35377449,1,50,full reaction,BARBITURIC ACID|4-morpholino-4-yl-phenylamine,C14H14N4O4,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,pH-value,Experimental part,,,,,,,
O=C1CC(=O)NC(=S)N1,Nc1ccc(N2CCOCC2)cc1.Nc1ccc(N2CCOCC2)c2oc3[nH]c(=S)[nH]c(=O)c3c12,O=C1CC(=O)NC(=S)N1>>Nc1ccc(N2CCOCC2)cc1.Nc1ccc(N2CCOCC2)c2oc3[nH]c(=S)[nH]c(=O)c3c12,35377451,1,50,full reaction,"4,6-dihydroxy-2-mercaptopyrimidine|4-morpholino-4-yl-phenylamine",C14H14N4O3S,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,pH-value,Experimental part,,,,,,,
O=C1CC(=O)NC(=O)N1,CCN(CC)c1ccc(N)cc1.CCN(CC)c1ccc(N)c2c1oc1[nH]c(=O)[nH]c(=O)c12,O=C1CC(=O)NC(=O)N1>>CCN(CC)c1ccc(N)cc1.CCN(CC)c1ccc(N)c2c1oc1[nH]c(=O)[nH]c(=O)c12,35377452,1,50,full reaction,"BARBITURIC ACID|N,N-diethylaniline",C14H16N4O3,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,,Experimental part,,,,,,,
CN1C(=O)CC(=O)N(C)C1=O,CCN(CC)c1ccc(N)cc1.CCN(CC)c1ccc(N)c2c1oc1c2c(=O)n(C)c(=O)n1C,CN1C(=O)CC(=O)N(C)C1=O>>CCN(CC)c1ccc(N)cc1.CCN(CC)c1ccc(N)c2c1oc1c2c(=O)n(C)c(=O)n1C,35377453,1,50,full reaction,"1,3-dimethylbarbituric acid|N,N-diethylaniline",C16H20N4O3,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,,Experimental part,,,,,,,
O=C1CC(=O)NC(=S)N1,CCN(CC)c1ccc(N)cc1.CCN(CC)c1ccc(N)c2c1oc1[nH]c(=S)[nH]c(=O)c12,O=C1CC(=O)NC(=S)N1>>CCN(CC)c1ccc(N)cc1.CCN(CC)c1ccc(N)c2c1oc1[nH]c(=S)[nH]c(=O)c12,35377454,1,50,full reaction,"4,6-dihydroxy-2-mercaptopyrimidine|N,N-diethylaniline",C14H16N4O2S,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,,Experimental part,,,,,,,
O=C1CC(=O)NC(=O)N1,CN(C)c1ccc(N)cc1.CN(C)c1ccc(N)c2c1oc1[nH]c(=O)[nH]c(=O)c12,O=C1CC(=O)NC(=O)N1>>CN(C)c1ccc(N)cc1.CN(C)c1ccc(N)c2c1oc1[nH]c(=O)[nH]c(=O)c12,35377455,1,50,full reaction,"BARBITURIC ACID|4-amino-N,N-dimethylaniline",C12H12N4O3,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction|Electrolysis,2,,,,,,,,Experimental part,,,,,,,
CN1C(=O)CC(=O)N(C)C1=O,CN(C)c1ccc(N)cc1.CN(C)c1ccc(N)c2c1oc1c2c(=O)n(C)c(=O)n1C,CN1C(=O)CC(=O)N(C)C1=O>>CN(C)c1ccc(N)cc1.CN(C)c1ccc(N)c2c1oc1c2c(=O)n(C)c(=O)n1C,35377456,1,50,full reaction,"1,3-dimethylbarbituric acid|4-amino-N,N-dimethylaniline",C14H16N4O3,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,,Experimental part,,,,,,,
O=C1CC(=O)NC(=S)N1,CN(C)c1ccc(N)cc1.CN(C)c1ccc(N)c2c1oc1[nH]c(=S)[nH]c(=O)c12,O=C1CC(=O)NC(=S)N1>>CN(C)c1ccc(N)cc1.CN(C)c1ccc(N)c2c1oc1[nH]c(=S)[nH]c(=O)c12,35377457,1,50,full reaction,"4,6-dihydroxy-2-mercaptopyrimidine|4-amino-N,N-dimethylaniline",C12H12N4O2S,159549,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. phosphate buffer,"35486372; Article; Esmaili, Roya; Nematollahi, Davood; Journal of the Electrochemical Society; vol. 159; 10; (2012); p. H792-H799;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrolysis,2,,,,,,,,Experimental part,,,,,,,
[H][C@](N)(CS)C(=O)O,CCOC(=O)c1cc2ccc3c(c2oc1=O)C=C(C(C)=O)C(C)(O)O3.CCOC(=O)c1cc2ccc(O)c(C(SC[C@H](N)C(=O)O)C(C(C)=O)C(C)=O)c2oc1=O,[H][C@](N)(CS)C(=O)O>>CCOC(=O)c1cc2ccc3c(c2oc1=O)C=C(C(C)=O)C(C)(O)O3.CCOC(=O)c1cc2ccc(O)c(C(SC[C@H](N)C(=O)O)C(C(C)=O)C(C)=O)c2oc1=O,36867627,1,50,full reaction,L-Cysteine|ethyl 8-(2-acetyl-3-oxobut-1-en-1-yl)-7-hydroxy-2-oxo-2H-chromene-3-carboxylate,C21H23NO9S,121860,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"61930318; Article; Long, Lingliang; Zhou, Liping; Wang, Lin; Meng, Suci; Gong, Aihua; Du, Fengyi; Zhang, Chi; Organic and Biomolecular Chemistry; vol. 11; 47; (2013); p. 8214 - 8220;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,supporting information,,,,,,pH-value,Body text,,,,,,,
[H][C@@](N)(CCS)C(=O)O,CCOC(=O)c1cc2ccc3c(c2oc1=O)C=C(C(C)=O)C(C)(O)O3.CCOC(=O)c1cc2ccc(O)c(C(SCC[C@@H](N)C(=O)O)C(C(C)=O)C(C)=O)c2oc1=O,[H][C@@](N)(CCS)C(=O)O>>CCOC(=O)c1cc2ccc3c(c2oc1=O)C=C(C(C)=O)C(C)(O)O3.CCOC(=O)c1cc2ccc(O)c(C(SCC[C@@H](N)C(=O)O)C(C(C)=O)C(C)=O)c2oc1=O,36867628,1,50,full reaction,D-homocysteine|ethyl 8-(2-acetyl-3-oxobut-1-en-1-yl)-7-hydroxy-2-oxo-2H-chromene-3-carboxylate,C22H25NO9S,121860,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"61930318; Article; Long, Lingliang; Zhou, Liping; Wang, Lin; Meng, Suci; Gong, Aihua; Du, Fengyi; Zhang, Chi; Organic and Biomolecular Chemistry; vol. 11; 47; (2013); p. 8214 - 8220;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,supporting information,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCOC(=O)c1cc2ccc3c(c2oc1=O)C=C(C(C)=O)C(C)(O)O3.CCOC(=O)c1cc2ccc(O)c(C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(C(C)=O)C(C)=O)c2oc1=O,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCOC(=O)c1cc2ccc3c(c2oc1=O)C=C(C(C)=O)C(C)(O)O3.CCOC(=O)c1cc2ccc(O)c(C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(C(C)=O)C(C)=O)c2oc1=O,36867629,1,50,full reaction,GLUTATHIONE|ethyl 8-(2-acetyl-3-oxobut-1-en-1-yl)-7-hydroxy-2-oxo-2H-chromene-3-carboxylate,C28H33N3O13S,121860,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"61930318; Article; Long, Lingliang; Zhou, Liping; Wang, Lin; Meng, Suci; Gong, Aihua; Du, Fengyi; Zhang, Chi; Organic and Biomolecular Chemistry; vol. 11; 47; (2013); p. 8214 - 8220;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,supporting information,,,,,,,Body text,,,,,,,
COc1ccc(C=C[N+](=O)[O-])cc1,CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(OC)cc1.CCC(C=O)C(C[N+](=O)[O-])c1ccc(OC)cc1,COc1ccc(C=C[N+](=O)[O-])cc1>>CCCC=O.CC[C@H](C=O)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1.CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(OC)cc1.CCC(C=O)C(C[N+](=O)[O-])c1ccc(OC)cc1,39185100,1,50,full reaction,1-methoxy-4-(2-nitro-vinyl)-benzene|butyraldehyde,"(2S,3R)-2-ethyl-4-nitro-3-(4-methoxylphenyl)butanal|(2R,3S)-2-ethyl-4-nitro-3-(4-methoxyphenyl)butanal|C13H17NO4",224825|224825|224825,Chemical behaviour,1,,Michael Addition,Catalytic behavior,hexane|isopropyl alcohol,"64619620; Article; Scatena, Gabriel S.; De La Torre, Alexander F.; Cass, Quezia B.; Rivera, Daniel G.; Paixo, Mrcio W.; ChemCatChem; vol. 6; 11; (2014); p. 3208 - 3214;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 78 %,silica supported N-cyclohexyl-2-methyl-2-[N-propyl-1-(2S)-pyrrolidin-2-ylformamido]propanamide (SiO2-4b),,,,,Experimental part,86 percent ee,,,,,,
CCCC=O,CC(C)CC=C[N+](=O)[O-].CC[C@H](C=O)[C@H](CC(C)C)C[N+](=O)[O-].CC[C@@H](C=O)[C@@H](CC(C)C)C[N+](=O)[O-].CCC(C=O)C(CC(C)C)C[N+](=O)[O-],CCCC=O>>CC(C)CC=C[N+](=O)[O-].CC[C@H](C=O)[C@H](CC(C)C)C[N+](=O)[O-].CC[C@@H](C=O)[C@@H](CC(C)C)C[N+](=O)[O-].CCC(C=O)C(CC(C)C)C[N+](=O)[O-],39185103,1,50,full reaction,butyraldehyde|4-methyl-1-nitropent-1-ene,"(2S,3S)-2-ethyl-5-methyl-3-(nitromethyl)hexanal|(2R,3R)-2-ethyl-5-methyl-3-(nitromethyl)hexanal|2-ethyl-5-methyl-3-(nitromethyl)hexanal",221975|221975|221975,Chemical behaviour,1,,Michael Addition,Catalytic behavior,hexane|isopropyl alcohol,"64619620; Article; Scatena, Gabriel S.; De La Torre, Alexander F.; Cass, Quezia B.; Rivera, Daniel G.; Paixo, Mrcio W.; ChemCatChem; vol. 6; 11; (2014); p. 3208 - 3214;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 84 %,silica supported N-cyclohexyl-2-methyl-2-[N-propyl-1-(2S)-pyrrolidin-2-ylformamido]propanamide (SiO2-4b),,,,,Experimental part,84 percent ee,,,,,,
CCCC=C[N+](=O)[O-],CCCC=O.CCC[C@@H](C[N+](=O)[O-])[C@H](C=O)CC.CCCC(C[N+](=O)[O-])C(C=O)CC.CCC[C@H](C[N+](=O)[O-])[C@@H](C=O)CC,CCCC=C[N+](=O)[O-]>>CCCC=O.CCC[C@@H](C[N+](=O)[O-])[C@H](C=O)CC.CCCC(C[N+](=O)[O-])C(C=O)CC.CCC[C@H](C[N+](=O)[O-])[C@@H](C=O)CC,39185104,1,50,full reaction,1-nitropent-1-ene|butyraldehyde,"(2R,3R)-2-ethyl-3-(nitromethyl)hexanal|2-ethyl-3-(nitromethyl)hexanal|(2S,3S)-2-ethyl-3-(nitromethyl)hexanal",221975|221975|221975,Chemical behaviour,1,,Michael Addition,Catalytic behavior,hexane|isopropyl alcohol,"64619620; Article; Scatena, Gabriel S.; De La Torre, Alexander F.; Cass, Quezia B.; Rivera, Daniel G.; Paixo, Mrcio W.; ChemCatChem; vol. 6; 11; (2014); p. 3208 - 3214;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,,Overall yield = 87 %,silica supported N-cyclohexyl-2-methyl-2-[N-propyl-1-(2S)-pyrrolidin-2-ylformamido]propanamide (SiO2-4b),,,,,Experimental part,85 percent ee,,,,,,
CC1(C)CC(=O)CC(=O)C1,Nc1ccccc1.O=C1Nc2ccccc2/C1=C\C(=O)c1ccc(Cl)cc1.CC1(C)CC(=O)c2c(C3C(=O)Nc4ccccc43)c(-c3ccc(Cl)cc3)n(-c3ccccc3)c2C1,CC1(C)CC(=O)CC(=O)C1>>Nc1ccccc1.O=C1Nc2ccccc2/C1=C\C(=O)c1ccc(Cl)cc1.CC1(C)CC(=O)c2c(C3C(=O)Nc4ccccc43)c(-c3ccc(Cl)cc3)n(-c3ccccc3)c2C1,40538882,1,50,full reaction,dimedone|aniline|(E)-3-(2-(4-chlorophenyl)-2-oxoethylidene)indolin-2-one,"3-(2-(4-chlorophenyl)-4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-1-phenyl-1H-indol-3-yl)indolin-2-one",14437,Chemical behaviour,1,70,Michael Addition,Quantum yield,,"66437486; Article; Vivekanand, Thavaraj; Vinoth, Perumal; Agieshkumar; Sampath, Natarajan; Sudalai,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Green chemistry,,,,,"3-(2-(4-chlorophenyl)-4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-1-phenyl-1H-indol-3-yl)indolin-2-one",26percent,26,,Experimental part,,,,,,,
O=[N+]([O-])/C=C/c1ccc(F)cc1,O=C1CCCCC1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O.[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O,O=[N+]([O-])/C=C/c1ccc(F)cc1>>O=C1CCCCC1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O.[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O,56659021,1,50,full reaction,trans-1-(4-fluorophenyl)-2-nitro-ethene|cyclohexanone,"(S)-2-[(R)-1-(4-fluorophenyl)-2-nitroethyl]cyclohexan-1-one|(2R,1'S)-2-(1-(4-fluorophenyl)-2-nitroethyl)cyclohexan-1-one|(1'S)-2-(1-(4-fluorophenyl)-2-nitroethyl)cyclohexan-1-one",224824|224824|224824,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,supporting information,Overall yield = 75 percent; Overall yield = 40 mg; stereoselective reaction,"N,N-diethylnmethylamine|N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide",,,,Reagent/catalyst,Experimental part,76 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccco1,O=C1CCCCC1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O,O=[N+]([O-])/C=C/c1ccco1>>O=C1CCCCC1.[H][C@]1([C@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O,56659022,1,50,full reaction,2-[(E)-2-nitroethenyl]furan|cyclohexanone,(2R)-2-((1R)-1-(furan-2-yl)-2-nitroethyl)cyclohexanone|(S)-2-((R)-1-(furan-2-yl)-2-nitroethyl)cyclohexanone|(S)-2-[(S)-1-(2-furyl)-2-nitroethyl]cyclohexanone,224828|224828|224828,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,25,,,supporting information,Overall yield = 85 percent; stereoselective reaction,"N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide|triethylamine",,,,Reagent/catalyst,Experimental part,87 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccc2ccccc2c1,O=C1CCCCC1.O=C1CCCC[C@H]1[C@H](C[N+](=O)[O-])c1ccc2ccccc2c1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccc3ccccc3c2)CCCCC1=O.O=C1CCCC[C@@H]1[C@H](C[N+](=O)[O-])c1ccc2ccccc2c1,O=[N+]([O-])/C=C/c1ccc2ccccc2c1>>O=C1CCCCC1.O=C1CCCC[C@H]1[C@H](C[N+](=O)[O-])c1ccc2ccccc2c1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccc3ccccc3c2)CCCCC1=O.O=C1CCCC[C@@H]1[C@H](C[N+](=O)[O-])c1ccc2ccccc2c1,56659024,1,50,full reaction,(E)-2-(2-nitrovinyl)naphthalene|cyclohexanone,"(1'S)-2-(1-(naphthalen-2-yl)-2-nitroethyl)cyclohexan-1-one|(S)-2-((R)-1-naphthalen-2-yl-2-nitro-ethyl)-cyclohexanone|(2R,1'S)-2-(1-(naphthalen-2-yl)-2-nitroethyl)cyclohexan-1-one",224824|224824|224824,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,supporting information,Overall yield = 64 percent; Overall yield = 38 mg; stereoselective reaction,"N,N-diethylnmethylamine|N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide",,,,Reagent/catalyst,Experimental part,87 percent ee,,,,,,
O=[N+]([O-])/C=C/c1ccccc1,O=C1CCC(c2ccccc2)CC1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccccc2)C[C@@H](c2ccccc2)CCC1=O.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](c2ccccc2)CCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](c2ccccc2)CCC1=O,O=[N+]([O-])/C=C/c1ccccc1>>O=C1CCC(c2ccccc2)CC1.[H][C@@]1([C@@H](C[N+](=O)[O-])c2ccccc2)C[C@@H](c2ccccc2)CCC1=O.[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](c2ccccc2)CCC1=O.[H][C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)C[C@H](c2ccccc2)CCC1=O,56659026,1,50,full reaction,nitrostyrene|1-phenyl-4-cyclohexanone,"(2S,4S)-2-((R)-2-nitro-1-phenylethyl)-4-phenylcyclohexanone|(2R,4R,1'S)-2-(2-nitro-1-phenylethyl)-4-phenylcyclohexan-1-one|(4R,1'S)-2-(2-nitro-1-phenylethyl)-4-phenylcyclohexan-1-one",224822|224822|224822,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,Overall yield = 95 percent; Overall yield = 59 mg; stereoselective reaction,"N,N-diethylnmethylamine|N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide",,,,Reagent/catalyst,Experimental part,82 percent ee,,,,,,
O=C1CCOCC1,O=[N+]([O-])/C=C/c1ccccc1.O=C1CCOC[C@H]1[C@H](C[N+](=O)[O-])c1ccccc1.O=C1CCOC[C@@H]1[C@H](C[N+](=O)[O-])c1ccccc1.O=C1CCOC[C@H]1[C@@H](C[N+](=O)[O-])c1ccccc1,O=C1CCOCC1>>O=[N+]([O-])/C=C/c1ccccc1.O=C1CCOC[C@H]1[C@H](C[N+](=O)[O-])c1ccccc1.O=C1CCOC[C@@H]1[C@H](C[N+](=O)[O-])c1ccccc1.O=C1CCOC[C@H]1[C@@H](C[N+](=O)[O-])c1ccccc1,56659029,1,50,full reaction,Tetrahydro-4H-pyran-4-one|nitrostyrene,"(2R,1'S)-3-(2-nitro-1-phenylethyl)tetrahydro-4H-pyran-4-one|(3S)-tetrahydro-3-((1S)-2-nitro-1-phenylethyl)pyran-4-one|(R)-tetrahydro-3-((R)-2-nitro-1-phenylethyl)pyran-4-one",224818|224818|224818,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,,"83584560; Article; Lu, Hanbin; Lv, Jiamin; Zhou, Canhua; Zhou, Mi; Fang, Yanxiong; Dong, Jinxiang; Kato, Terumasa; Liu, Yan; Maruoka, Keiji; European Journal of Organic Chemistry; vol. 2021; 12; (2021",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,,,supporting information,Overall yield = 76 percent; stereoselective reaction,"N-(2-((2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)phenyl)-1,1,1-trifluoromethanesulfonamide|triethylamine",,,,,Experimental part,86 percent ee,,,,,,
O=Cc1coc2ccc(Cl)cc2c1=O,CC(=O)ON=C(C=Cc1cccc(F)c1)c1cccc(Br)c1.O=C(c1cc(Cl)ccc1O)c1cnc(-c2cccc(Br)c2)cc1-c1cccc(F)c1,O=Cc1coc2ccc(Cl)cc2c1=O>>CC(=O)ON=C(C=Cc1cccc(F)c1)c1cccc(Br)c1.O=C(c1cc(Cl)ccc1O)c1cnc(-c2cccc(Br)c2)cc1-c1cccc(F)c1,67791519,1,50,full reaction,6-Chloro-4-oxo-4H-chromene-3-carbaldehyde|C17H13BrFNO2,(6-(3-bromophenyl)-4-(3-fluorophenyl)pyridin-3-yl)(5-chloro-2-hydroxyphenyl)-methanone,271760,Chemical behaviour,1,,Michael Addition,Catalytic behavior,,"134728187; Article; Yang, Jing;Hu, Xing-Mei;Zhao, Ke-Hua;Huang, Kun;Yan, Sheng-Jiao; New Journal of Chemistry; vol. 48; 26; (2024); p. 11682 - 11687;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Reflux|Green chemistry,,supporting information,regioselective reaction,copper diacetate|triethylamine,(6-(3-bromophenyl)-4-(3-fluorophenyl)pyridin-3-yl)(5-chloro-2-hydroxyphenyl)-methanone,80 percent,,Reagent/catalyst|Time|Temperature,Experimental part,,,,,,,
C1CCNCC1,S=C(NCc1ccccc1)C1=CCCCC1.[H][C@]1(C(=S)NCc2ccccc2)CCCC[C@]1([H])N1CCCCC1.[H][C@@]1(C(=S)NCc2ccccc2)CCCC[C@]1([H])N1CCCCC1,C1CCNCC1>>S=C(NCc1ccccc1)C1=CCCCC1.[H][C@]1(C(=S)NCc2ccccc2)CCCC[C@]1([H])N1CCCCC1.[H][C@@]1(C(=S)NCc2ccccc2)CCCC[C@]1([H])N1CCCCC1,8861999,2,49,full reaction|has preparation,piperidine|cyclohex-1-enecarbothioic acid benzylamide,trans-2-piperidin-1-yl-cyclohexanecarbothioic acid benzylamide|cis-2-piperidin-1-yl-cyclohexanecarbothioic acid benzylamide,224438|224438,"['Chemical behaviour', 'Preparation']","['1', '1']","['80', '20']","['Michael addition', 'Michael addition']",Product distribution,,"['6306127; Article; Sośnicki, Jacek G; Jagodziński, Tadeusz S; Hans', '6306127; Article; Sośnicki, Jacek G; Jagodziński, Tadeusz S; Hans']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['72', '48']",,,,,,,,,Further Variations:|Reaction partners|Temperatures|reaction time,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC(C)=O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(C)=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC(C)=O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC(C)=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,38033472,1,49,full reaction,GLUTATHIONE|C17H19NO3,C27H36N4O9S,228310,Chemical behaviour,1,,Michael Addition,Kinetics|Quantum yield,dimethyl sulfoxide,"63389326; Article; Kim, Gun-Joong; Yoon, Doo-Ha; Yun, Mi-Yeon; Kwon, Hyockman; Ha, Hyun-Joon; Kim, Hae-Jo; RSC Advances; vol. 4; 36; (2014); p. 18731 - 18736;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=CC=O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=CC=O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(CC=O)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)c(=O)oc2c1,38033473,1,49,full reaction,GLUTATHIONE|3-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)acrylaldehyde,C26H34N4O9S,228310,Chemical behaviour,1,,Michael Addition,Kinetics|Quantum yield,dimethyl sulfoxide,"63389326; Article; Kim, Gun-Joong; Yoon, Doo-Ha; Yun, Mi-Yeon; Kwon, Hyockman; Ha, Hyun-Joon; Kim, Hae-Jo; RSC Advances; vol. 4; 36; (2014); p. 18731 - 18736;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C=C(C(C)=O)C(C)=O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(C(C)=O)C(C)=O)c(=O)oc2c1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C=C(C(C)=O)C(C)=O)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(C(C)=O)C(C)=O)c(=O)oc2c1,38033474,1,49,full reaction,GLUTATHIONE|C19H21NO4,C29H38N4O10S,228305,Chemical behaviour,1,,Michael Addition,Kinetics|Quantum yield,dimethyl sulfoxide,"63389326; Article; Kim, Gun-Joong; Yoon, Doo-Ha; Yun, Mi-Yeon; Kwon, Hyockman; Ha, Hyun-Joon; Kim, Hae-Jo; RSC Advances; vol. 4; 36; (2014); p. 18731 - 18736;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
O=C1Nc2ccccc2/C1=C\C(=O)c1ccccc1,CC1(C)CC(=O)CC(=O)C1.Nc1ccccc1.CC1(C)CC(=O)c2c(C3C(=O)Nc4ccccc43)c(-c3ccccc3)n(-c3ccccc3)c2C1,O=C1Nc2ccccc2/C1=C\C(=O)c1ccccc1>>CC1(C)CC(=O)CC(=O)C1.Nc1ccccc1.CC1(C)CC(=O)c2c(C3C(=O)Nc4ccccc43)c(-c3ccccc3)n(-c3ccccc3)c2C1,40538854,1,49,full reaction,(E)-3-(2-oxo-2-phenylethylidene)indolin-2-one|dimedone|aniline,"3-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-1,2-diphenyl-1H-indol-3-yl)indolin-2-one",14437,Chemical behaviour,1,70,Michael Addition,Quantum yield,,"66437486; Article; Vivekanand, Thavaraj; Vinoth, Perumal; Agieshkumar; Sampath, Natarajan; Sudalai,",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Green chemistry,,,,,"3-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-1,2-diphenyl-1H-indol-3-yl)indolin-2-one",22 percent,22,,Experimental part,,,,,,,
CCN(CC)c1ccc2cc(C(=O)NC(=O)c3ccccc3O)c(=O)oc2c1,CCCC[N+](CCCC)(CCCC)CCCC.[C-]#N.CCN(CC)c1ccc2c(c1)OC(=O)[C-](C(=O)NC(=O)c1ccccc1O)C2C#N,CCN(CC)c1ccc2cc(C(=O)NC(=O)c3ccccc3O)c(=O)oc2c1>>CCCC[N+](CCCC)(CCCC)CCCC.[C-]#N.CCN(CC)c1ccc2c(c1)OC(=O)[C-](C(=O)NC(=O)c1ccccc1O)C2C#N,45215415,1,49,full reaction,C21H20N2O5|tetra-n-butylammonium cyanide,C22H20N3O5(1-),224639,Chemical behaviour,1,,Michael Addition,Mechanism,[D3]acetonitrile,"71035050; Article; Wang, Zian; Wu, Qianqian; Li, Jiale; Qiu, Shuang; Cao, Duxia; Xu, Yongxiao; Liu, Zhiqiang; Yu, Xueying; Sun, Yatong; Spectrochimica Acta Part A: Molecular and Biomolecular Spectrosc",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Solvent,Scheme or table,,,,,,,
O=C1c2ccccc2CC1SC(F)(F)F,CC(C)(C)OC(=O)/C=C/C(=O)c1ccccc1.CC(C)(C)OC(=O)[C@@H](CC(=O)c1ccccc1)[C@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@@H](CC(=O)c1ccccc1)[C@@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@H](CC(=O)c1ccccc1)[C@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@H](CC(=O)c1ccccc1)[C@@]1(SC(F)(F)F)Cc2ccccc2C1=O,O=C1c2ccccc2CC1SC(F)(F)F>>CC(C)(C)OC(=O)/C=C/C(=O)c1ccccc1.CC(C)(C)OC(=O)[C@@H](CC(=O)c1ccccc1)[C@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@@H](CC(=O)c1ccccc1)[C@@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@H](CC(=O)c1ccccc1)[C@]1(SC(F)(F)F)Cc2ccccc2C1=O.CC(C)(C)OC(=O)[C@H](CC(=O)c1ccccc1)[C@@]1(SC(F)(F)F)Cc2ccccc2C1=O,55876906,1,49,full reaction,"2-((trifluoromethyl)thio)-2,3-dihydro-1H-inden-1-one|tert-butyl trans-4-oxo-4-phenyl-2-butenoate","tert-butyl (R)-4-oxo-2-((R)-1-oxo-2-((trifluoromethyl)thio)-2,3-dihydro-1H-inden-2-yl)-4-phenylbutanoate|tert-butyl (R)-4-oxo-2-((S)-1-oxo-2-((trifluoromethyl)thio)-2,3-dihydro-1H-inden-2-yl)-4-phenyl",224862|224862|224862|224862,Chemical behaviour,1,,Michael Addition,Catalytic behavior,toluene,"81689202; Article; Hong, Haoran;Zheng, Changwu;Zhao, Gang;Shang, Yongjia; Advanced Synthesis and Catalysis; vol. 362; 24; (2020); p. 5765 - 5771;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,supporting information,Overall yield = 89 percent; stereoselective reaction,C45H40F12N2O2P(1+)*Br(1-)|potassium acetate,,,,Reagent/catalyst|Solvent,Experimental part,87 percent ee,,,,,,
CCOP(=O)(Cc1ccccc1O)OCC,,CCOP(=O)(Cc1ccccc1O)OCC>>,7879877,3,48,half reaction|has preparation,,diethyl 2-hydroxybenzylphosphonate,,"['Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1']",20,Michael Addition,,dichloromethane,"['75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);', '5056301; Article; Vogt; Phosphorus and Sulfur and the Related Elements; vol. 5; (1978); p. 123;', '7094183; Patent; OCCIDENTAL CHEMICAL; US3983178; A; (1976);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00382; 00409,"['1-o-Hydroxy-benzylalkohol, Triaethylphosphit', 'o-Chlormethylphenol, Triethylphosphit']","2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl 2-hydroxybenzylphosphonate,91 percent,91,,,,,,f.xix,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
[C-]#N.[Na+],O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12.N#CC1=CC(O)C(O)C=C1c1oc2cc(O)cc(O)c2c(=O)c1O,[C-]#N.[Na+]>>O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12.N#CC1=CC(O)C(O)C=C1c1oc2cc(O)cc(O)c2c(=O)c1O,33027655,1,48,full reaction,sodium cyanide|quercetol,C16H11NO7,291862,Chemical behaviour,1,,Michael addition,Kinetics,acetonitrile,"20126049; Article; Khalafi, Lida; Rafiee, Mohammad; Yadaei, Farzaneh; Research on Chemical Intermediates; vol. 37; 8; (2011); p. 1047 - 1055;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction|aq. phosphate buffer,6,body text,,,,,,pH-value,,,,,,,,
[C-]#N.[Na+],O=C1CCC2Oc3ccc(N=Nc4ccc([N+](=O)[O-])cc4)cc3C=C12.N#CC(C1=CCCC1=O)c1cc(N=Nc2ccc([N+](=O)[O-])cc2)ccc1[O-].[Na+],[C-]#N.[Na+]>>O=C1CCC2Oc3ccc(N=Nc4ccc([N+](=O)[O-])cc4)cc3C=C12.N#CC(C1=CCCC1=O)c1cc(N=Nc2ccc([N+](=O)[O-])cc2)ccc1[O-].[Na+],34989913,1,48,full reaction,sodium cyanide|C18H13N3O4,C19H13N4O4(1-)*Na(1+),122001,Chemical behaviour,1,25,Michael Addition,Kinetics,,"35467882; Conference Paper; Hong, Keum-Hee; Kim, Hae-Jo; Supramolecular Chemistry; vol. 25; 1; (2013); p. 24 - 27;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,,,,,,,,,,Scheme or table,,,,,,,
CC1=CC(=O)OC1,C[C@@]1(O)COC(=O)C1,CC1=CC(=O)OC1>>C[C@@]1(O)COC(=O)C1,40922033,1,48,full reaction,4-methyl-2(5H)-furanone,(S)-4-hydroxy-4-methyfuran-2-one,223376,Chemical behaviour,1,,Michael Addition,Catalytic behavior|Kinetics,,"64628286; Article; Chen, Bi-Shuang; Resch, Verena; Otten, Linda G.; Hanefeld, Ulf; Chemistry - A European Journal; vol. 21; 7; (2015); p. 3020 - 3030;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Enzymatic reaction,,,enantioselective reaction,water,,,,Concentration|pH-value|Temperature|Time,Experimental part,95 percent ee,,,,,,
CC1=CC(=O)OC1,[2H]C1C(=O)OC[C@@]1(C)O,CC1=CC(=O)OC1>>[2H]C1C(=O)OC[C@@]1(C)O,40922041,1,48,full reaction,4-methyl-2(5H)-furanone,C5H7(2)HO3,223376,Chemical behaviour,1,,Michael Addition,Mechanism,,"64628286; Article; Chen, Bi-Shuang; Resch, Verena; Otten, Linda G.; Hanefeld, Ulf; Chemistry - A European Journal; vol. 21; 7; (2015); p. 3020 - 3030;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Enzymatic reaction,,,diastereoselective reaction,water-d2,,,,,Scheme or table,,,,,,,
[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Nc1ccc(Br)cc1.N[C@@H](CC1=CC(=O)C(=O)C=C1Nc1ccc(Br)cc1)C(=O)O,[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Nc1ccc(Br)cc1.N[C@@H](CC1=CC(=O)C(=O)C=C1Nc1ccc(Br)cc1)C(=O)O,36724376,1,47,full reaction,levodopa|4-bromo-aniline,C15H13BrN2O4,281875,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer,"61586818; Article; Khalafi, Lida; Rafiee, Mohammad; Khoshnam, Mojgan; Shoaei, Seyed Mohammad; Journal of the Iranian Chemical Society; vol. 10; 6; (2013); p. 1257 - 1262;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,5,,,,,,,,Scheme or table,,,,,,,
[C-]#N.[Na+],N#CC(=Cc1ccc(N)cc1)C(=O)O.N#CC(C(=O)O)C(C#N)c1ccc(N)cc1,[C-]#N.[Na+]>>N#CC(=Cc1ccc(N)cc1)C(=O)O.N#CC(C(=O)O)C(C#N)c1ccc(N)cc1,38919019,1,47,full reaction,sodium cyanide|3-(4-amino-phenyl)-2-cyanoacrylic acid,C11H9N3O2,224639,Chemical behaviour,1,,Michael Addition,Kinetics,dimethyl sulfoxide,"64340440; Article; Manivannan; Satheshkumar; Elango, Kuppanagounder P.; Tetrahedron Letters; vol. 55; 45; (2014); p. 6281 - 6285;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Scheme or table,,,,,,,
CC1=CC(=O)OC1,C[C@@]1(O)COC(=O)C1.C[C@]1(O)COC(=O)C1,CC1=CC(=O)OC1>>C[C@@]1(O)COC(=O)C1.C[C@]1(O)COC(=O)C1,40922031,1,47,full reaction,4-methyl-2(5H)-furanone,"(S)-4-hydroxy-4-methyfuran-2-one|(R)-4-hydroxy-4-methyl-(3H)-4,5-dihydro-2-furanone",223376|223376,Chemical behaviour,1,,Michael Addition,Catalytic behavior,,"64628286; Article; Chen, Bi-Shuang; Resch, Verena; Otten, Linda G.; Hanefeld, Ulf; Chemistry - A European Journal; vol. 21; 7; (2015); p. 3020 - 3030;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Enzymatic reaction,,,enantioselective reaction,water,,,,,Experimental part,86 percent ee,,,,,,
[H][C@](N)(CS)C(=O)O,O=C(O)C(=Cc1ccc2ccc([N+](=O)[O-])cc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccc([N+](=O)[O-])cc2n1)C(C(=O)O)C(=O)O)C(=O)O,[H][C@](N)(CS)C(=O)O>>O=C(O)C(=Cc1ccc2ccc([N+](=O)[O-])cc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccc([N+](=O)[O-])cc2n1)C(C(=O)O)C(=O)O)C(=O)O,41718853,1,47,full reaction,L-Cysteine|2-((7-nitroquinolin-2-yl)methylene)malonic acid,C16H15N3O8S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"67864108; Article; Dai, Chun-Guang; Du, Xiao-Jiao; Song, Qin-Hua; Journal of Organic Chemistry; vol. 80; 24; (2015); p. 12088 - 12099;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,3,,,,,,,pH-value,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,O=C(O)C(=Cc1ccc2ccc(Cl)cc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccc(Cl)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,[H][C@](N)(CS)C(=O)O>>O=C(O)C(=Cc1ccc2ccc(Cl)cc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccc(Cl)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,41718854,1,47,full reaction,L-Cysteine|2-((7-chloroquinolin-2-yl)methylene)malonic acid,C16H15ClN2O6S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"67864108; Article; Dai, Chun-Guang; Du, Xiao-Jiao; Song, Qin-Hua; Journal of Organic Chemistry; vol. 80; 24; (2015); p. 12088 - 12099;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,3,,,,,,,pH-value,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,O=C(O)C(=Cc1ccc2ccccc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccccc2n1)C(C(=O)O)C(=O)O)C(=O)O,[H][C@](N)(CS)C(=O)O>>O=C(O)C(=Cc1ccc2ccccc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccccc2n1)C(C(=O)O)C(=O)O)C(=O)O,41718855,1,47,full reaction,L-Cysteine|2-(quinolin-2-ylmethylene)malonic acid,C16H16N2O6S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"67864108; Article; Dai, Chun-Guang; Du, Xiao-Jiao; Song, Qin-Hua; Journal of Organic Chemistry; vol. 80; 24; (2015); p. 12088 - 12099;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,3,,,,,,,pH-value,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,CCN(CC)c1ccc2ccc(C=C(C(=O)O)C(=O)O)nc2c1.CCN(CC)c1ccc2ccc(C(SC[C@H](N)C(=O)O)C(C(=O)O)C(=O)O)nc2c1,[H][C@](N)(CS)C(=O)O>>CCN(CC)c1ccc2ccc(C=C(C(=O)O)C(=O)O)nc2c1.CCN(CC)c1ccc2ccc(C(SC[C@H](N)C(=O)O)C(C(=O)O)C(=O)O)nc2c1,41718869,1,47,full reaction,L-Cysteine|2-((7-(diethylamino)quinolin-2-yl)methylene)malonic acid,C20H25N3O6S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"67864108; Article; Dai, Chun-Guang; Du, Xiao-Jiao; Song, Qin-Hua; Journal of Organic Chemistry; vol. 80; 24; (2015); p. 12088 - 12099;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,3,,,,,,,pH-value,Scheme or table,,,,,,,
[H][C@](N)(CS)C(=O)O,O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,[H][C@](N)(CS)C(=O)O>>O=C(O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)O.N[C@@H](CSC(c1ccc2ccc(O)cc2n1)C(C(=O)O)C(=O)O)C(=O)O,41718899,1,47,full reaction,L-Cysteine|7-hydroxy-2-(quinolin-2-ylmethylene)malonic acid,C16H16N2O7S,228305,Chemical behaviour,1,20,Michael Addition,Kinetics,,"67864108; Article; Dai, Chun-Guang; Du, Xiao-Jiao; Song, Qin-Hua; Journal of Organic Chemistry; vol. 80; 24; (2015); p. 12088 - 12099;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,3,,,,,,,pH-value,Scheme or table,,,,,,,
NC(CS)C(=O)O,CCN(CC)c1ccc2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(=O)CC(SCC(N)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,NC(CS)C(=O)O>>CCN(CC)c1ccc2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1.CCN(CC)c1ccc2cc(C(=O)CC(SCC(N)C(=O)O)c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,41832294,1,47,full reaction,rac-cysteine|(E)-7-(diethylamino)-3-(3-(4-nitrophenyl)acryloyl)-2H-benzopyran-2-one,C25H27N3O7S,228310,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"67995773; Article; Liu, Mengqiang;Jiang, Qian;Lu, Zhiyun;Huang, Yan;Tan, Yanfei;Jiang, Qing; Luminescence; vol. 30; 8; (2015); p. 1395 - 1402;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Experimental part,,,,,,,
[C-]#N.[K+],CCN(CC)c1ccc2c(c1)OC(=O)C(=CNc1ccncc1)C2=O.CCN(CC)c1ccc2c([O-])c(C(C#N)Nc3ccncc3)c(=O)oc2c1,[C-]#N.[K+]>>CCN(CC)c1ccc2c(c1)OC(=O)C(=CNc1ccncc1)C2=O.CCN(CC)c1ccc2c([O-])c(C(C#N)Nc3ccncc3)c(=O)oc2c1,46525120,1,47,full reaction,potassium cyanide|C19H19N3O3,C20H19N4O3(1-),210648,Chemical behaviour,1,,Michael Addition,Kinetics,dimethyl sulfoxide,"64844499; Article; Davis, Aaron B.; Lambert, Rachel E.; Fronczek, Frank R.; Cragg, Peter J.; Wallace, Karl J.; New Journal of Chemistry; vol. 38; 10; (2014); p. 4678 - 4683;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Scheme or table,,,,,,,
O=C1CCCC(C[N+](=O)[O-])C1,,O=C1CCCC(C[N+](=O)[O-])C1>>,25140802,2,46,half reaction|has preparation,,3-(nitromethyl)cyclohexanone,,"['Preparation', 'Preparation (half reaction)']","['1', '1']",30,Michael Addition,,ethyl acetate,"['70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);', '7084703; Patent; BAYER YAKUHIN; US4827032; A; (1989);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086-0089,enantioselective reaction,benzoic acid,3-(nitromethyl)cyclohexanone,91 percent,91,,,99 percent ee,,,"['2', '47']","['Specific applications:', '3-(Nitromethyl)cyclohexanone STR65']","['General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz', 'Example 47 3-(Nitromethyl)cyclohexanone STR65 21.9 g of cyclohexanone are left to stand together with 175 ml of nitromethane and 2.1 g of 5-diazabicyclo[4.3.0.]non-5-ene (DBN) in 250 ml of isopropanol']",
CCOC(=O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)OCC,[H]Cl.[H][C@](N)(CS)C(=O)O.CCOC(=O)C(C(=O)OCC)C(SC[C@H](N)C(=O)O)c1ccc2ccc(O)cc2n1,CCOC(=O)C(=Cc1ccc2ccc(O)cc2n1)C(=O)OCC>>[H]Cl.[H][C@](N)(CS)C(=O)O.CCOC(=O)C(C(=O)OCC)C(SC[C@H](N)C(=O)O)c1ccc2ccc(O)cc2n1,35506917,1,46,full reaction,C17H17NO5|l-cysteine hydrochloride,C20H24N2O7S,228305,Chemical behaviour,1,,Michael Addition,Kinetics,,"35492231; Article; Song, Qin-Hua; Wu, Qing-Qing; Liu, Chang-Hui; Du, Xiao-Jiao; Guo, Qing-Xiang; Journal of Materials Chemistry B; vol. 1; 4; (2013); p. 438 - 442;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,&#62; 7,,,,,,,pH-value,Body text,,,,,,,
[H]/C(C)=C(/[H])C(=O)OCC,NCc1ccccc1.CC(CC(=O)ONCc1ccccc1)NCc1ccccc1.CCOC(=O)CC(C)NCc1ccccc1,[H]/C(C)=C(/[H])C(=O)OCC>>NCc1ccccc1.CC(CC(=O)ONCc1ccccc1)NCc1ccccc1.CCOC(=O)CC(C)NCc1ccccc1,36284948,1,46,full reaction,ethyl (E)-crotonate|benzylamine,N-benzyl-3-(benzylamino)butanamide|ethyl 3-(benzylamino)butanoate,90580|221727,Chemical behaviour,1,40 - 80,Michael Addition,Kinetics,,"61420407; Article; Strompen, Simon; Weiss, Markus; Groeger, Harald; Hilterhaus, Lutz; Liese, Andreas; Advanced Synthesis and Catalysis; vol. 355; 11-12; (2013); p. 2391 - 2399;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,,,,,,Temperature,Experimental part,,,,,,,
CCOC(=O)C(C(=O)OCC)C(C)C1CCCCC1,,CCOC(=O)C(C(=O)OCC)C(C)C1CCCCC1>>,45455577,2,46,half reaction|has preparation,,diethyl 2-(1-cyclohexylethyl)malonate,,"['Preparation', 'Preparation']","['1', '1']",40,Michael Addition,,"['acetone', 'N,N-dimethyl-formamide']","['74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);', '71281848; Patent; PRINCETON UNIVERSITY; WO2016/196931; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,"['Irradiation', 'Inert atmosphere|Irradiation']",,"['Paragraph 0108; 0109; 0121', 'Page/Page column 37; 58; 49']",,"[""dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate"", 'dipotassium hydrogenphosphate|[Ir(dF(CF3)ppy)2(dtbbpy)](PF6)']","['diethyl 2-(1-cyclohexylethyl)malonate', 'diethyl 2-(1-cyclohexylethyl)malonate']","['89 percent', '75percent']","['89', '75']",,,,,,47,Examples 39-66,"['General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction', 'General procedure: An oven-dried 8 mL vial equipped with a Teflon septum and magnetic stir bar was c']",
[2H]C([2H])([2H])O,O=CC=Cc1ccccc1.COC(=O)CC(=O)OC.[2H]C([2H])([2H])OC(O)C[C@@H](c1ccccc1)C(C(=O)OC)C(=O)OC,[2H]C([2H])([2H])O>>O=CC=Cc1ccccc1.COC(=O)CC(=O)OC.[2H]C([2H])([2H])OC(O)C[C@@H](c1ccccc1)C(C(=O)OC)C(=O)OC,45622350,1,46,full reaction,"1,1,1-trideuteromethanol|3-phenyl-propenal|malonic acid dimethyl ester",C15H17(2)H3O6,28000,Chemical behaviour,1,,Michael Addition,Catalytic behavior,,"71525155; Article; Companyó, Xavier; Burés, Jordi; Journal of the",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,enantioselective reaction,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|acetic acid,,,,Reagent/catalyst,Experimental part,91 percent ee,,,,,,
C[N+](=O)[O-],[2H]C([2H])([2H])O.O=CC=Cc1ccccc1.[2H]C([2H])([2H])OC(O)C[C@H](C[N+](=O)[O-])c1ccccc1,C[N+](=O)[O-]>>[2H]C([2H])([2H])O.O=CC=Cc1ccccc1.[2H]C([2H])([2H])OC(O)C[C@H](C[N+](=O)[O-])c1ccccc1,45622352,1,46,full reaction,"nitromethane|1,1,1-trideuteromethanol|3-phenyl-propenal",C11H12(2)H3NO4,121244,Chemical behaviour,1,,Michael Addition,Catalytic behavior,,"71525155; Article; Companyó, Xavier; Burés, Jordi; Journal of the",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,supporting information,enantioselective reaction,(2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine|acetic acid,,,,Reagent/catalyst,Experimental part,95 percent ee,,,,,,
COC(=O)c1cc(O)c2ccc(F)cc2c1O,,COC(=O)c1cc(O)c2ccc(F)cc2c1O>>,52730297,2,46,half reaction|has preparation,,"methyl 7-fluoro-1,4-dihydroxy-2-naphthoate",,"['Preparation', 'Preparation']","['1', '1']","['-60 - 20', '-60 - 20']",Michael Addition,,"['tetrahydrofuran', 'tetrahydrofuran']","['78622836; Patent; KOREA PHARMA; KR2019/79852; A; (2019);', '80757806; Patent; KOREA PHARMA; KR2020/41852; A; (2020);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['9', '9']","['Inert atmosphere', 'Inert atmosphere']",,"['Paragraph 0135-0136; 0148-0149; 0150', 'Paragraph 0133-0135; 0148; 0150']",,"['lithium tert-butoxide', 'lithium tert-butoxide']","['methyl 7-fluoro-1,4-dihydroxy-2-naphthoate', 'methyl 7-fluoro-1,4-dihydroxy-2-naphthoate']","['95 percent', '95 percent']","['95', '95']",,,,,,,"Methyl fluoro-1,4-dihydroxy-2-naphthoate (13a-b)","['General procedure: Methyl fluoro-1,4-dihydroxy-2-naphthoate (13a-b).Under inert gas, LiOtBu (6 ml. 1 M in THF, 6.0 mmol) was added to a stirred solution of phthalide (0.35 g, 2.0 mmol) in dry THF (10', 'General procedure: Under inert gas, -60C dry THF (10 mL)As a stirred solution of phthalide (0.35 g, 2.0 mmol) in LiOtBu (6ml. 1M in THF, 6.0 mmol) was added.The obtained solution was dissolved in meth']",
CCOC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,,CCOC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1>>,7699373,2,45,half reaction|has preparation,,ethyl 2-acetyl-4-nitro-3-phenylbutyrate,,"['Preparation', 'Preparation (half reaction)']","['1', '1']",20,Michael Addition,,dichloromethane|water,"['66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);', '4820201; Article; Pathak; Pathak; Journal of the Indian Chemical Society; vol. 37; (1960); p. 693;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0120-0121,"β-Nitro-styrol, Acetessigsaeure-aethylester in aethanol. Na-aethylat",potassium hydroxide,ethyl 2-acetyl-4-nitro-3-phenylbutyrate,80 percent,80,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
N#CCCn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,C=CC#N.Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,N#CCCn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O>>C=CC#N.Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,31664121,1,45,full reaction,C13H16N6O5,acrylonitrile|G,176474|288438,Chemical behaviour,1,,Michael addition,Kinetics,,"20011541; Article; Manso, Jose A.; Cespedes Camacho, Isaac F.; Calle, Emilio; Casado, Julio; Organic and Biomolecular Chemistry; vol. 9; 18; (2011); p. 6226 - 6233;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,37.5,,9.6,scheme or table,,,,,,,,,,,,,,
C=CC#N,Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1.N#CCCn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,C=CC#N>>Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1.N#CCCn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,31664122,1,45,full reaction,acrylonitrile|G,C13H16N6O5,230555,Chemical behaviour,1,,Michael addition,Kinetics,,"20011541; Article; Manso, Jose A.; Cespedes Camacho, Isaac F.; Calle, Emilio; Casado, Julio; Organic and Biomolecular Chemistry; vol. 9; 18; (2011); p. 6226 - 6233;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,37.5,,9.6,scheme or table,,,,,,,,,,,,,,
C=CC(N)=O,Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1.NC(=O)CCn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,C=CC(N)=O>>Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1.NC(=O)CCn1c(N)nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1=O,31664123,1,45,full reaction,2-propenamide|G,1-(2-formamidoethyl)guanosine,230616,Chemical behaviour,1,,Michael addition,Kinetics,,"20011541; Article; Manso, Jose A.; Cespedes Camacho, Isaac F.; Calle, Emilio; Casado, Julio; Organic and Biomolecular Chemistry; vol. 9; 18; (2011); p. 6226 - 6233;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,37.5,,9.6,scheme or table,,,,,,,,,,,,,,
[H][C@](N)(CS)C(=O)O,O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2c(C=C[N+](=O)[O-])c(O)ccc12.N[C@@H](CSC(C[N+](=O)[O-])c1c(O)ccc2c(-c3ccccc3C(=O)O)c3ccc(=O)cc-3oc12)C(=O)O,[H][C@](N)(CS)C(=O)O>>O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2c(C=C[N+](=O)[O-])c(O)ccc12.N[C@@H](CSC(C[N+](=O)[O-])c1c(O)ccc2c(-c3ccccc3C(=O)O)c3ccc(=O)cc-3oc12)C(=O)O,34144544,1,45,full reaction,L-Cysteine|fluorescein-monoaldehyde,C25H20N2O9S,224268,Chemical behaviour,1,,Michael Addition,Kinetics,,"20203650; Article; Wang, Huilin; Zhou, Guodong; Mao, Chun; Chen, Xiaoqiang; Dyes and Pigments; vol. 96; 1; (2013); p. 232 - 236;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,Concentration,Scheme or table,,,,,,,
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(C)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(C)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502553,2,45,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(p-tolyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0059', 'Paragraph 0038; 0059; 0060; 0089; 0090']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(p-tolyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(p-tolyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['78 percent', '78 percent']","['78', '78']",,,"['93 percent ee', '93 percent ee']","['3', '3']",,"['15', '15']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc3ccccc3c2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc3ccccc3c2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502554,2,45,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(naphthalen-2-yl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0060', 'Paragraph 0038; 0059; 0060; 0091; 0092']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(naphthalen-2-yl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(naphthalen-2-yl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['79 percent', '79 percent']","['79', '79']",,,"['92 percent ee', '92 percent ee']","['3', '3']",,"['16', '16']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(Br)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(Br)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502555,2,45,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-(4-Bromophenyl)((tert-butoxycarbonyl)-amino)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0061', 'Paragraph 0038; 0059; 0060; 0093; 0094']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-(4-Bromophenyl)((tert-butoxycarbonyl)-amino)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-(4-Bromophenyl)((tert-butoxycarbonyl)-amino)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['76 percent', '76 percent']","['76', '76']",,,"['100 percent ee', '100 percent ee']","['3', '3']",,"['17', '17']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
CCOC(=O)C1C(=O)Oc2ccccc2C1C(C)C,,CCOC(=O)C1C(=O)Oc2ccccc2C1C(C)C>>,6485366,3,44,half reaction|has preparation,,trans-ethyl 4-isopropyl-2-oxochromane-3-carboxylate,,"['Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1']",40,Michael Addition,,acetone,"['74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);', '3263814; Article; Gustafsson et al.; Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry; vol. 29; (1975); p. 273;', '3263814; Article; Gustafsson et al.; Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry; vol. 29; (1975); p. 273;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0132,"['/BRN= 287862/, (CH3)2CH-MgBr', '3,4-Dihydrocumarin-3-carbonsaeureethylester, i-PrMgBr']","dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",trans-ethyl 4-isopropyl-2-oxochromane-3-carboxylate,58 percent,58,,,90.476 percent de,,,57,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,C=CC=O.O=c1c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2nc2n1CCC(O)N2.O=c1c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2nc2n1C(O)CCN2,Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1>>C=CC=O.O=c1c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2nc2n1CCC(O)N2.O=c1c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2nc2n1C(O)CCN2,31664124,1,44,full reaction,G|acrolein,"3H-6-hydroxy-3-(β-D-ribofuranosyl)-5,6,7,8-tetrahydropyrido[3,2-a]purine-9-one",38973|119884,Chemical behaviour,1,,Michael addition,Kinetics,,"20011541; Article; Manso, Jose A.; Cespedes Camacho, Isaac F.; Calle, Emilio; Casado, Julio; Organic and Biomolecular Chemistry; vol. 9; 18; (2011); p. 6226 - 6233;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,37.5,,7.2,scheme or table,,,,,,,,,,,,,,
CC(C)(C)OC(=O)[C@H](CCC(=O)OCc1ccccc1)N=C(c1ccccc1)c1ccccc1,,CC(C)(C)OC(=O)[C@H](CCC(=O)OCc1ccccc1)N=C(c1ccccc1)c1ccccc1>>,35415110,1,44,half reaction|has preparation,,"N-(diphenylmethylene)-L-glutamic acid 1-(1,1-dimethylethyl) 5-benzyl ester",,Preparation,1,23,Michael Addition,,ethyl acetate,35479075; Patent; COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; WO2013/59118; A1; (2013);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 0208; 0213,,"(S)-2-(2,3-bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol","N-(diphenylmethylene)-L-glutamic acid 1-(1,1-dimethylethyl) 5-benzyl ester",97 percent,97,,,98 percent ee,,,11,,"General procedure: [0208] Specifically, cyclopropenimine 5 (3.6 mg, 0.00677 mmol, 0.1 equiv) and terf-Butyl glycinate benzophenone Schiff base (20 mg, 0.0677 mmol, 1 .0 equiv) were dissolved in ethyl",
CC(C)(C)OC(=O)[C@@H](N=C(c1ccccc1)c1ccccc1)C(CC(=O)c1ccccc1)c1ccccc1,,CC(C)(C)OC(=O)[C@@H](N=C(c1ccccc1)c1ccccc1)C(CC(=O)c1ccccc1)c1ccccc1>>,35415111,1,44,half reaction|has preparation,,"tert-butyl 2-(diphenylmethyleneamino)-5-oxo-3,5-diphenylpentanoate:",,Preparation,1,23,Michael Addition,,ethyl acetate,35479075; Patent; COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; WO2013/59118; A1; (2013);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 0208; 0225,,"(S)-2-(2,3-bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol","tert-butyl 2-(diphenylmethyleneamino)-5-oxo-3,5-diphenylpentanoate:",97 percent,97,,,95 percent ee,,,11,,"General procedure: [0208] Specifically, cyclopropenimine 5 (3.6 mg, 0.00677 mmol, 0.1 equiv) and terf-Butyl glycinate benzophenone Schiff base (20 mg, 0.0677 mmol, 1 .0 equiv) were dissolved in ethyl",
CCOC(=O)C(C(=O)OCC)[C@H]1CCCC(=O)C1,,CCOC(=O)C(C(=O)OCC)[C@H]1CCCC(=O)C1>>,39144546,1,44,half reaction|has preparation,,(S)-3-[bis(ethoxycarbonyl)methyl]cyclohexenone,,Preparation,1,0,Michael Addition,,tetrahydrofuran,64344155; Patent; UNIVERSITY OF PENNSYLVANIA; WO2014/205437; A1; (2014);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12.33,Inert atmosphere|Schlenk technique,,Page/Page column 12-16; 27; 28,,C60H36LaO6(3-)*3C5H13N3*0.5C5H12*3H(1+)|water|sodium iodide,(S)-3-[bis(ethoxycarbonyl)methyl]cyclohexenone,90percent,90,,,96percent ee,,,,General Procedure D: Asymmetric Michael addition of symmetrical malonates (3a-d) to cyclohexenone (2a). (S)-3-|bis(methoxycarbonyl)methyl]cyclohexanone (4a),General procedure: General Procedure D: Asymmetric Michael addition of symmetrical malonates (3a-d) to cyclohexenone (2a). (S)-3-|bis(methoxycarbonyl)methyl]cyclohexanone (4a) Under an N2 flow on a Sc,
CC(C(=O)OCc1ccccc1)(C(=O)OCc1ccccc1)[C@H]1CCCC(=O)C1,,CC(C(=O)OCc1ccccc1)(C(=O)OCc1ccccc1)[C@H]1CCCC(=O)C1>>,39144547,1,44,half reaction|has preparation,,"(S)-3-<1,1-bis(benzyloxycarbonyl)ethyl>cyclohexanone",,Preparation,1,0,Michael Addition,,tetrahydrofuran,64344155; Patent; UNIVERSITY OF PENNSYLVANIA; WO2014/205437; A1; (2014);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12.33,Inert atmosphere|Schlenk technique,,Page/Page column 12-16; 27-29,,C60H36LaO6(3-)*3C5H13N3*0.5C5H12*3H(1+)|water|sodium iodide,"(S)-3-<1,1-bis(benzyloxycarbonyl)ethyl>cyclohexanone",87percent,87,,,96percent ee,,,,General Procedure D: Asymmetric Michael addition of symmetrical malonates (3a-d) to cyclohexenone (2a). (S)-3-|bis(methoxycarbonyl)methyl]cyclohexanone (4a),General procedure: General Procedure D: Asymmetric Michael addition of symmetrical malonates (3a-d) to cyclohexenone (2a). (S)-3-|bis(methoxycarbonyl)methyl]cyclohexanone (4a) Under an N2 flow on a Sc,
CON[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1,,CON[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1>>,39144549,1,44,half reaction|has preparation,,3-(methoxyamino)-3-(4-methylphenyl)-1-phenyl-1-propanone,,Preparation,1,-20,Michael Addition,,tetrahydrofuran|tetrahydrofuran,64344155; Patent; UNIVERSITY OF PENNSYLVANIA; WO2014/205437; A1; (2014);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Inert atmosphere|Inert atmosphere,,Page/Page column 16-18,,calcium sulfate|C60H36O6Y(3-)*3C5H13N3*0.5C5H12*3H(1+)|lithium iodide,3-(methoxyamino)-3-(4-methylphenyl)-1-phenyl-1-propanone,91percent,91,,,94percent ee,2,,2,,General procedure: A key attribute of the REMB system is the diversity observed in the catalytic reactions upon changing RE and M combinations. To establish that our precatalyst is amenable to differe,
CON[C@H](CC(=O)c1ccc(Cl)cc1)c1ccccc1,,CON[C@H](CC(=O)c1ccc(Cl)cc1)c1ccccc1>>,39144550,1,44,half reaction|has preparation,,1-(4-chlorophenyl)-3-(methoxyamino)-3-phenyl-1-propanone,,Preparation,1,-20,Michael Addition,,tetrahydrofuran|tetrahydrofuran,64344155; Patent; UNIVERSITY OF PENNSYLVANIA; WO2014/205437; A1; (2014);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Inert atmosphere|Inert atmosphere,,Page/Page column 16-18,,calcium sulfate|C60H36O6Y(3-)*3C5H13N3*0.5C5H12*3H(1+)|lithium iodide,1-(4-chlorophenyl)-3-(methoxyamino)-3-phenyl-1-propanone,96percent,96,,,94percent ee,2,,2,,General procedure: A key attribute of the REMB system is the diversity observed in the catalytic reactions upon changing RE and M combinations. To establish that our precatalyst is amenable to differe,
CON[C@H](CC(=O)c1ccccc1)c1cccs1,,CON[C@H](CC(=O)c1ccccc1)c1cccs1>>,39144551,1,44,half reaction|has preparation,,3-(methoxyamino)-1-phenyl-3-(2-thienyl)-1-propanone,,Preparation,1,-20,Michael Addition,,tetrahydrofuran|tetrahydrofuran,64344155; Patent; UNIVERSITY OF PENNSYLVANIA; WO2014/205437; A1; (2014);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Inert atmosphere|Inert atmosphere,,Page/Page column 16-18,,calcium sulfate|C60H36O6Y(3-)*3C5H13N3*0.5C5H12*3H(1+)|lithium iodide,3-(methoxyamino)-1-phenyl-3-(2-thienyl)-1-propanone,93percent,93,,,93percent ee,2,,2,,General procedure: A key attribute of the REMB system is the diversity observed in the catalytic reactions upon changing RE and M combinations. To establish that our precatalyst is amenable to differe,
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1cccc(OC)c1OC,,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1cccc(OC)c1OC>>,40051225,1,44,half reaction|has preparation,,"(S)-ethyl-2-carboethoxy-4-nitro-3-(2,3-dimethoxyphenyl)butyrate",,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H44CuF12N7O3S(2+)*2ClO4(1-)|triethylamine,"(S)-ethyl-2-carboethoxy-4-nitro-3-(2,3-dimethoxyphenyl)butyrate",97 percent,97,,,,,,11.3,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1cccc(OC)c1OC,,CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1cccc(OC)c1OC>>,40051231,1,44,half reaction|has preparation,,"(R)-ethyl 2-carboethoxy-4-nitro-3-(2,3-dimethoxyphenyl)butyrate",,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H45CuF12N7O3S(1+)*F6P(1-)|triethylamine,"(R)-ethyl 2-carboethoxy-4-nitro-3-(2,3-dimethoxyphenyl)butyrate",98 percent,98,,,,,,11.3,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(Cl)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(Cl)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502551,2,44,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(4-chlorophenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0057', 'Paragraph 0038; 0059; 0060; 0085; 0086']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(4-chlorophenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(4-chlorophenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['67 percent', '67 percent']","['67', '67']",,,"['94 percent ee', '94 percent ee']","['3', '3']",,"['13', '13']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(C(F)(F)F)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(C(F)(F)F)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502552,2,44,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(4-(trifluoromethyl)phenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0058', 'Paragraph 0038; 0059; 0060; 0087; 0088']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(4-(trifluoromethyl)phenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(4-(trifluoromethyl)phenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['68 percent', '68 percent']","['68', '68']",,,"['99 percent ee', '99 percent ee']","['3', '3']",,"['14', '14']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(F)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccc(F)cc2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502556,2,44,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(4-fluorophenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0062', 'Paragraph 0038; 0059; 0060; 0095; 0096']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(4-fluorophenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-((tert-Butoxycarbonyl)amino)(4-fluorophenyl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['71 percent', '71 percent']","['71', '71']",,,"['92 percent ee', '92 percent ee']","['3', '3']",,"['18', '18']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
CC1(C[N+](=O)[O-])CCCC(=O)C1,,CC1(C[N+](=O)[O-])CCCC(=O)C1>>,44359705,1,44,half reaction|has preparation,,(+/-)-3-methyl-3-(nitromethyl)cyclohexanone,,Preparation,1,30,Michael Addition,,ethyl acetate,70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086; 0087; 0090-0093,enantioselective reaction,benzoic acid,(+/-)-3-methyl-3-(nitromethyl)cyclohexanone,88 percent,88,,,99 percent ee,,,3; 4,Specific applications:,"General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz",
COC(=O)C(C(=O)OC)C(CC(C)=O)c1ccccc1,,COC(=O)C(C(=O)OC)C(CC(C)=O)c1ccccc1>>,44359706,1,44,half reaction|has preparation,,methyl 2-methoxycarbonyl-3-phenyl-5-oxohexanoate,,Preparation,1,30,Michael Addition,,ethyl acetate,70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086; 0087; 0094; 0095,enantioselective reaction,benzoic acid,methyl 2-methoxycarbonyl-3-phenyl-5-oxohexanoate,98 percent,98,,,99 percent ee,,,5,Specific applications:,"General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz",
COC(=O)C(C(=O)OC)C1CCCC(=O)C1,,COC(=O)C(C(=O)OC)C1CCCC(=O)C1>>,44359707,1,44,half reaction|has preparation,,dimethyl 2-(3-oxocyclohexyl)malonate,,Preparation,1,30,Michael Addition,,ethyl acetate,70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086; 0087; 0096; 0097,enantioselective reaction,benzoic acid,dimethyl 2-(3-oxocyclohexyl)malonate,87 percent,87,,,99 percent ee,,,6,Specific applications:,"General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz",
CCC1(C(CC(C)=O)c2ccccc2)OC(c2ccccc2)=NC1=O,,CCC1(C(CC(C)=O)c2ccccc2)OC(c2ccccc2)=NC1=O>>,44359708,1,44,half reaction|has preparation,,C21H21NO3,,Preparation,1,30,Michael Addition,,ethyl acetate,70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086; 0087; 0098; 0099,enantioselective reaction,benzoic acid,C21H21NO3,99 percent,99,,,96 percent ee,,,7,Specific applications:,"General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz",
CCC1(C(C)CC(C)=O)OC(c2ccccc2)=NC1=O,,CCC1(C(C)CC(C)=O)OC(c2ccccc2)=NC1=O>>,44359709,1,44,half reaction|has preparation,,C16H19NO3,,Preparation,1,30,Michael Addition,,ethyl acetate,70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086; 0087; 0098-0101,enantioselective reaction,benzoic acid,C16H19NO3,95 percent,95,,,97 percent ee,,,8,Specific applications:,"General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz",
CCC1(C2CCCC(=O)C2)OC(c2ccccc2)=NC1=O,,CCC1(C2CCCC(=O)C2)OC(c2ccccc2)=NC1=O>>,44359710,1,44,half reaction|has preparation,,C17H19NO3,,Preparation,1,30,Michael Addition,,ethyl acetate,70474532; Patent; EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CN103360341; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0086; 0087; 0098; 0099; 0102; 0103,enantioselective reaction,benzoic acid,C17H19NO3,93 percent,93,,,98 percent ee,,,9,Specific applications:,"General procedure: The catalyst was added in 0.8mL of ethyl acetate-tert-leucine cyclohexylamine catalyst (4mg, 0.02 mmol, R1Is hydrogen, R2A cyclohexyl group), benzoic acid (2.4mg, 0.02 mmol), dibenz",
C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc2c(c1)OCO2,,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc2c(c1)OCO2>>,44715967,1,44,half reaction|has preparation,,"(2R,3S)-3-(benzo[d][1,3]dioxol-5-yl)-2-methyl-4-nitrobutanal",,Preparation,1,20,Michael Addition,,dichloromethane,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2.25,,,Page/Page column 26; 27; 28,,4-nitro-phenol,"(2R,3S)-3-(benzo[d][1,3]dioxol-5-yl)-2-methyl-4-nitrobutanal",99 percent,99,,,95 percent ee,,,2.B,B) Substrate scope study,"General procedure: Nitroalkene (0.15 mmol), catalyst la (10 mol%) and 4-nitrophenol (2.1 mg, 0.015 mmol) were weighed in a vial and CH2CI2 (0.3 ml_) was added, followed by the aldehyde (0.45 mmol). Th",
Cc1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1,,Cc1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1>>,46311862,1,44,half reaction|has preparation,,"5-methyl-7-phenyl-4-(p-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-phenyl-4-(p-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",95percent,95,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
CCc1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1,,CCc1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1>>,46311863,1,44,half reaction|has preparation,,"4-(4-ethylphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(4-ethylphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",96percent,96,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
COc1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1,,COc1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1>>,46311864,1,44,half reaction|has preparation,,"4-(4-methoxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(4-methoxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",87percent,87,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1ccc(-c3ccccc3)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1ccc(-c3ccccc3)cc1)CS(=O)(=O)O2>>,46311865,1,44,half reaction|has preparation,,"4-([1,1'-biphenyl]-4-yl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-([1,1'-biphenyl]-4-yl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",90percent,90,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1ccc(F)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1ccc(F)cc1)CS(=O)(=O)O2>>,46311866,1,44,half reaction|has preparation,,"4-(4-fluorophenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(4-fluorophenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",93percent,93,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1ccc(C#N)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1ccc(C#N)cc1)CS(=O)(=O)O2>>,46311867,1,44,half reaction|has preparation,,"4-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)benzonitrile",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)benzonitrile",96percent,96,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
CCOC(=O)c1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1,,CCOC(=O)c1ccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)cc1>>,46311868,1,44,half reaction|has preparation,,"ethyl 4-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)benzoate",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","ethyl 4-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)benzoate",99percent,99,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1ccc([N+](=O)[O-])cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1ccc([N+](=O)[O-])cc1)CS(=O)(=O)O2>>,46311869,1,44,half reaction|has preparation,,"5-methyl-4-(4-nitrophenyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-4-(4-nitrophenyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",90percent,90,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1cccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1,,Cc1cccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1>>,46311870,1,44,half reaction|has preparation,,"5-methyl-7-phenyl-4-(m-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-phenyl-4-(m-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",92percent,92,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
COc1cccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1,,COc1cccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1>>,46311871,1,44,half reaction|has preparation,,"4-(3-methoxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(3-methoxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",94percent,94,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccc(O)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccc(O)c1)CS(=O)(=O)O2>>,46311872,1,44,half reaction|has preparation,,"4-(3-hydroxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(3-hydroxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",88percent,88,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccc(F)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccc(F)c1)CS(=O)(=O)O2>>,46311873,1,44,half reaction|has preparation,,"4-(3-fluorophenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(3-fluorophenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",95percent,95,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
CC(=O)c1cccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1,,CC(=O)c1cccc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1>>,46311874,1,44,half reaction|has preparation,,"1-(3-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)phenyl)ethan-1-one",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","1-(3-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)phenyl)ethan-1-one",91 percent,91,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccc(C(F)(F)F)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccc(C(F)(F)F)c1)CS(=O)(=O)O2>>,46311875,1,44,half reaction|has preparation,,"5-methyl-7-phenyl-4-(3-(trifluoromethyl)phenyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-phenyl-4-(3-(trifluoromethyl)phenyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",95percent,95,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccc([N+](=O)[O-])c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccc([N+](=O)[O-])c1)CS(=O)(=O)O2>>,46311876,1,44,half reaction|has preparation,,"5-methyl-4-(3-nitrophenyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-4-(3-nitrophenyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",88percent,88,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1cc(C)cc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1,,Cc1cc(C)cc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1>>,46311880,1,44,half reaction|has preparation,,"4-(3,5-dimethylphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(3,5-dimethylphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",94percent,94,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1cc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)ccc1Br,,Cc1cc(C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)ccc1Br>>,46311881,1,44,half reaction|has preparation,,"4-(4-bromo-3-methylphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(4-bromo-3-methylphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",99percent,99,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1ccc3ccccc3c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1ccc3ccccc3c1)CS(=O)(=O)O2>>,46311882,1,44,half reaction|has preparation,,"5-methyl-4-(naphthalen-2-yl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-4-(naphthalen-2-yl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",93percent,93,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccc(C3CS(=O)(=O)Oc4c3c(C)nn4-c3ccccc3)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccc(C3CS(=O)(=O)Oc4c3c(C)nn4-c3ccccc3)c1)CS(=O)(=O)O2>>,46311883,1,44,half reaction|has preparation,,"5-methyl-4-(3-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)phenyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-4-(3-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)phenyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",93percent,93,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccs1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccs1)CS(=O)(=O)O2>>,46311884,1,44,half reaction|has preparation,,"5-methyl-7-phenyl-4-(thiophen-2-yl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-phenyl-4-(thiophen-2-yl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",87percent,87,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cccc3c1sc1ccccc13)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cccc3c1sc1ccccc13)CS(=O)(=O)O2>>,46311885,1,44,half reaction|has preparation,,C24H18N2O3S2,,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene",C24H18N2O3S2,94percent,94,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cc3ccccc3s1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cc3ccccc3s1)CS(=O)(=O)O2>>,46311886,1,44,half reaction|has preparation,,"4-(benzo[b]thiophen-2-yl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(benzo[b]thiophen-2-yl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",85percent,85,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cc3ccccc3o1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cc3ccccc3o1)CS(=O)(=O)O2>>,46311887,1,44,half reaction|has preparation,,"4-(benzofuran-2-yl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(benzofuran-2-yl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",97percent,97,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1ccc(S(=O)(=O)n2c(C3CS(=O)(=O)Oc4c3c(C)nn4-c3ccccc3)cc3ccccc32)cc1,,Cc1ccc(S(=O)(=O)n2c(C3CS(=O)(=O)Oc4c3c(C)nn4-c3ccccc3)cc3ccccc32)cc1>>,46311888,1,44,half reaction|has preparation,,C27H23N3O5S2,,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene",C27H23N3O5S2,96percent,96,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(c1cnn(-c3ccccc3)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1cnn(-c3ccccc3)c1)CS(=O)(=O)O2>>,46311889,1,44,half reaction|has preparation,,"5-methyl-7-phenyl-4-(1-phenyl-1H-pyrazol-4-yl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-phenyl-4-(1-phenyl-1H-pyrazol-4-yl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",95percent,95,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccc(F)cc2)c2c1C(c1ccccc1)CS(=O)(=O)O2,,Cc1nn(-c2ccc(F)cc2)c2c1C(c1ccccc1)CS(=O)(=O)O2>>,46311892,1,44,half reaction|has preparation,,"7-(4-fluorophenyl)-5-methyl-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","7-(4-fluorophenyl)-5-methyl-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",89percent,89,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccc(Br)cc2)c2c1C(c1ccccc1)CS(=O)(=O)O2,,Cc1nn(-c2ccc(Br)cc2)c2c1C(c1ccccc1)CS(=O)(=O)O2>>,46311893,1,44,half reaction|has preparation,,"7-(4-bromophenyl)-5-methyl-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","7-(4-bromophenyl)-5-methyl-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",89percent,89,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2cccc([N+](=O)[O-])c2)c2c1C(c1ccccc1)CS(=O)(=O)O2,,Cc1nn(-c2cccc([N+](=O)[O-])c2)c2c1C(c1ccccc1)CS(=O)(=O)O2>>,46311895,1,44,half reaction|has preparation,,"5-methyl-7-(3-nitrophenyl)-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-(3-nitrophenyl)-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",85 percent,85,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1ccc(-n2nc(C)c3c2OS(=O)(=O)CC3c2ccccc2)cc1C,,Cc1ccc(-n2nc(C)c3c2OS(=O)(=O)CC3c2ccccc2)cc1C>>,46311896,1,44,half reaction|has preparation,,"7-(3,4-dimethylphenyl)-5-methyl-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","7-(3,4-dimethylphenyl)-5-methyl-4-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",93percent,93,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(Cl)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(Cl)cc1)CS(=O)(=O)O2>>,46311904,1,44,half reaction|has preparation,,"(E)-4-(4-chlorostyryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-4-(4-chlorostyryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",99percent,99,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(Br)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(Br)cc1)CS(=O)(=O)O2>>,46311905,1,44,half reaction|has preparation,,"(E)-4-(4-bromostyryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-4-(4-bromostyryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",88percent,88,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(C(F)(F)F)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(C(F)(F)F)cc1)CS(=O)(=O)O2>>,46311906,1,44,half reaction|has preparation,,"(E)-5-methyl-7-phenyl-4-(4-(trifluoromethyl)styryl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-5-methyl-7-phenyl-4-(4-(trifluoromethyl)styryl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",99percent,99,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1cccc(C#N)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1cccc(C#N)c1)CS(=O)(=O)O2>>,46311908,1,44,half reaction|has preparation,,"(E)-3-(2-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)vinyl)benzonitrile",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-3-(2-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)vinyl)benzonitrile",96percent,96,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccccc1C(F)(F)F)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccccc1C(F)(F)F)CS(=O)(=O)O2>>,46311910,1,44,half reaction|has preparation,,"(E)-5-methyl-7-phenyl-4-(2-(trifluoromethyl)styryl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-5-methyl-7-phenyl-4-(2-(trifluoromethyl)styryl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",98percent,98,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(F)c(F)c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(F)c(F)c1)CS(=O)(=O)O2>>,46311911,1,44,half reaction|has preparation,,"(E)-4-(3,4-difluorostyryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-4-(3,4-difluorostyryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",99percent,99,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1Br,,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1Br>>,46359697,1,44,half reaction|has preparation,,"3-((R)-1-(2-bromophenyl)-2-nitroethyl)pentane-2,4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0082,stereoselective reaction,C20H29FeN3OS,"3-((R)-1-(2-bromophenyl)-2-nitroethyl)pentane-2,4-dione",93 percent,93,,,92 percent ee,,,12.3,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1Cl,,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1Cl>>,46359698,1,44,half reaction|has preparation,,"(R)-3-(1-(2,4-dichlorophenyl)-2-nitroethyl)pentane-2,4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0083,stereoselective reaction,C20H29FeN3OS,"(R)-3-(1-(2,4-dichlorophenyl)-2-nitroethyl)pentane-2,4-dione",96 percent,96,,,92 percent ee,,,12.5,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
COc1ccccc1[C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O,,COc1ccccc1[C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O>>,46359699,1,44,half reaction|has preparation,,"(R)-3-[1-(2-methoxyphenyl)-2-nitroethyl]-pentane-2,4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0083,stereoselective reaction,C20H29FeN3OS,"(R)-3-[1-(2-methoxyphenyl)-2-nitroethyl]-pentane-2,4-dione",94 percent,94,,,92 percent ee,,,12.6,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410274,1,44,half reaction|has preparation,,C28H24ClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0027,,tetrabutylammomium bromide|potassium carbonate,C28H24ClN3O4,85 percent,85,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(Cl)cc2Cl)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(Cl)cc2Cl)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410275,1,44,half reaction|has preparation,,C28H23Cl2N3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0028,,tetrabutylammomium bromide|potassium carbonate,C28H23Cl2N3O4,86 percent,86,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(C(C)(C)C)cc2)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(C(C)(C)C)cc2)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410276,1,44,half reaction|has preparation,,C32H33N3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0029,,tetrabutylammomium bromide|potassium carbonate,C32H33N3O4,91 percent,91,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1ccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c(C)c1,,Cc1ccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c(C)c1>>,46410283,1,44,half reaction|has preparation,,C30H28ClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0035,,tetrabutylammomium bromide|potassium carbonate,C30H28ClN3O4,85 percent,85,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(C(C)(C)C)cc2)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(C(C)(C)C)cc2)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410286,1,44,half reaction|has preparation,,C32H32BrN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0038,,tetrabutylammomium bromide|potassium carbonate,C32H32BrN3O4,90 percent,90,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2cccc(Br)c2)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2cccc(Br)c2)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410287,1,44,half reaction|has preparation,,C28H23Br2N3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0039,,tetrabutylammomium bromide|potassium carbonate,C28H23Br2N3O4,89 percent,89,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1ccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c(C)c1,,Cc1ccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c(C)c1>>,46410289,1,44,half reaction|has preparation,,C30H28BrN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0041,,tetrabutylammomium bromide|potassium carbonate,C30H28BrN3O4,88 percent,88,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccccc2)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410290,1,44,half reaction|has preparation,,C28H24FN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0042,,tetrabutylammomium bromide|potassium carbonate,C28H24FN3O4,90 percent,90,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(Cl)cc2Cl)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(Cl)cc2Cl)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410293,1,44,half reaction|has preparation,,C28H22Cl2FN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0024; 0045,,tetrabutylammomium bromide|potassium carbonate,C28H22Cl2FN3O4,89 percent,89,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(C(C)(C)C)cc2)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(C(C)(C)C)cc2)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410294,1,44,half reaction|has preparation,,C32H32FN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0024; 0046,,tetrabutylammomium bromide|potassium carbonate,C32H32FN3O4,90 percent,90,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(F)cc2)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(F)cc2)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410297,1,44,half reaction|has preparation,,C28H24FN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0025,,tetrabutylammomium bromide|potassium carbonate,C28H24FN3O4,85 percent,85,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc(Br)cc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc(Br)cc2C1=O>>,46690564,1,44,half reaction|has preparation,,"methyl (S)-5-bromo-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0058-0060,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-5-bromo-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",86 percent,86,,,97 percent ee,2,,23,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCC(=O)CC[C@]1(C(=O)OC)Oc2cc(I)ccc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2cc(I)ccc2C1=O>>,46690566,1,44,half reaction|has preparation,,"methyl (S)-6-iodo-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0064-0066,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-6-iodo-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",85 percent,85,,,> 99 percent ee,2,,25,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc(OC)cc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc(OC)cc2C1=O>>,46690567,1,44,half reaction|has preparation,,"methyl (S)-5-methoxy-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0067-0069,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-5-methoxy-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",85 percent,85,,,98 percent ee,2,,26,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCC(=O)CC[C@]1(C(=O)OC)Oc2cc(OC)ccc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2cc(OC)ccc2C1=O>>,46690568,1,44,half reaction|has preparation,,"methyl (S)-6-methoxy-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0070-0072,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-6-methoxy-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",85 percent,85,,,99 percent ee,2,,27,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc3ccccc3c2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc3ccccc3c2C1=O>>,46690570,1,44,half reaction|has preparation,,"methyl (S)-1-oxo-2-(3-oxopentyl)-1,2-dihydronaphtho[2,1-b]furan-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0076-0078,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-1-oxo-2-(3-oxopentyl)-1,2-dihydronaphtho[2,1-b]furan-2-carboxylate",88 percent,88,,,98 percent ee,2,,29,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
COC(=O)[C@@]1(CCC(=O)c2ccccc2)Oc2ccccc2C1=O,,COC(=O)[C@@]1(CCC(=O)c2ccccc2)Oc2ccccc2C1=O>>,46690574,1,44,half reaction|has preparation,,"methyl (S)-3-oxo-2-(3-oxo-3-phenylpropyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0088-0090,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-3-oxo-2-(3-oxo-3-phenylpropyl)-2,3-dihydrobenzofuran-2-carboxylate",89 percent,89,,,93 percent ee,2,,33,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
COc1ccc(SC(=O)C(C(=O)Sc2ccc(OC)cc2)[C@@H](C[N+](=O)[O-])c2ccccc2)cc1,,COc1ccc(SC(=O)C(C(=O)Sc2ccc(OC)cc2)[C@@H](C[N+](=O)[O-])c2ccccc2)cc1>>,47883734,1,44,half reaction|has preparation,,(R)-2-(2-nitro-1-phenylethyl)malonic acid bis-4-methoxyphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1.5,,,Paragraph 0088-0093; 0100-0105; 0112-114,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(2-nitro-1-phenylethyl)malonic acid bis-4-methoxyphenyl dithioester,92 percent,92,,,92 percent ee,,,,,"General procedure: All reactions except Reaction 2 were carried out between 0.30 mmol and 0.15 mmol of trans-Nitrostyrene (1a) at 25  C and 1.5 mL of toluene, and Reaction 2 was carried out using CH2C",
O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1,,O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,47883736,1,44,half reaction|has preparation,,(R)-2-(1-(4-bromophenyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(1-(4-bromophenyl)-2-nitroethyl)malonic acid diphenyl dithioester,98 percent,98,,,> 99 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1Br,,O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1Br>>,47883737,1,44,half reaction|has preparation,,(R)-2-(1-(2-bromophenyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(1-(2-bromophenyl)-2-nitroethyl)malonic acid diphenyl dithioester,98 percent,98,,,97 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc(C(F)(F)F)cc1,,O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc(C(F)(F)F)cc1>>,47883738,1,44,half reaction|has preparation,,(R)-2-(1-(4-trifluoromethylphenyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1.5,,,Paragraph 0088-0093; 0100-0105; 0112; 0114-0115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(1-(4-trifluoromethylphenyl)-2-nitroethyl)malonic acid diphenyl dithioester,88 percent,88,,,> 99 percent ee,,,,,"General procedure: All reactions except Reaction 2 were carried out between 0.30 mmol and 0.15 mmol of trans-Nitrostyrene (1a) at 25  C and 1.5 mL of toluene, and Reaction 2 was carried out using CH2C",
Cc1ccc([C@H](C[N+](=O)[O-])C(C(=O)Sc2ccccc2)C(=O)Sc2ccccc2)cc1,,Cc1ccc([C@H](C[N+](=O)[O-])C(C(=O)Sc2ccccc2)C(=O)Sc2ccccc2)cc1>>,47883739,1,44,half reaction|has preparation,,(R)-2-(1-(4-methylphenyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(1-(4-methylphenyl)-2-nitroethyl)malonic acid diphenyl dithioester,94 percent,94,,,93 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
COc1ccccc1[C@H](C[N+](=O)[O-])C(C(=O)Sc1ccccc1)C(=O)Sc1ccccc1,,COc1ccccc1[C@H](C[N+](=O)[O-])C(C(=O)Sc1ccccc1)C(=O)Sc1ccccc1>>,47883740,1,44,half reaction|has preparation,,(R)-2-(1-(2-methoxyphenyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(1-(2-methoxyphenyl)-2-nitroethyl)malonic acid diphenyl dithioester,98 percent,98,,,94 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1cccs1,,O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1cccs1>>,47883741,1,44,half reaction|has preparation,,(S)-2-(1-(2-thiophenyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(S)-2-(1-(2-thiophenyl)-2-nitroethyl)malonic acid diphenyl dithioester,99 percent,99,,,90 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccco1,,O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccco1>>,47883742,1,44,half reaction|has preparation,,(S)-2-(1-(2-furyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(S)-2-(1-(2-furyl)-2-nitroethyl)malonic acid diphenyl dithioester,98 percent,98,,,93 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc2ccccc2c1,,O=C(Sc1ccccc1)C(C(=O)Sc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccc2ccccc2c1>>,47883743,1,44,half reaction|has preparation,,(R)-2-(1-(2-naphthyl)-2-nitroethyl)malonic acid diphenyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0111-01115,enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",(R)-2-(1-(2-naphthyl)-2-nitroethyl)malonic acid diphenyl dithioester,92 percent,92,,,> 99 percent ee,,,,,General procedure: All reactions in Table 3 were carried out in the presence of 5 mol% of catalyst 9,
O=[N+]([O-])C[C@](NCCc1ccccn1)(c1ccccc1)C(F)(F)F,,O=[N+]([O-])C[C@](NCCc1ccccn1)(c1ccccc1)C(F)(F)F>>,48084641,1,44,half reaction|has preparation,,"(R)-1,1,1-trifluoro-3-nitro-2-phenyl-N-(2-(pyridin-2-yl)ethyl)propan-2-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0160-0164,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-1,1,1-trifluoro-3-nitro-2-phenyl-N-(2-(pyridin-2-yl)ethyl)propan-2-amine",87 percent,87,,,93 percent ee,3,,13,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
CN(C)CCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,,CN(C)CCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F>>,48084647,1,44,half reaction|has preparation,,"(R)-N1,N1-dimethyl-N2-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)ethane-1,2-diamine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0170-0174,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N1,N1-dimethyl-N2-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)ethane-1,2-diamine",99 percent,99,,,91 percent ee,3,,15,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
O=[N+]([O-])C[C@](NCCc1cccs1)(c1ccccc1)C(F)(F)F,,O=[N+]([O-])C[C@](NCCc1cccs1)(c1ccccc1)C(F)(F)F>>,48084648,1,44,half reaction|has preparation,,"(R)-1,1,1-trifluoro-3-nitro-2-phenyl-N-(2-(thiophen-2-yl)ethyl)propan-2-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0175-0179,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-1,1,1-trifluoro-3-nitro-2-phenyl-N-(2-(thiophen-2-yl)ethyl)propan-2-amine",88 percent,88,,,96 percent ee,3,,16,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
COc1ccc(CN[C@@](C[N+](=O)[O-])(c2ccccc2)C(F)(F)F)cc1,,COc1ccc(CN[C@@](C[N+](=O)[O-])(c2ccccc2)C(F)(F)F)cc1>>,48084656,1,44,half reaction|has preparation,,"(R)-1,1,1-trifluoro-N-(4-methoxybenzyl)-3-nitro-2-phenylpropan-2-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0110-0114,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-1,1,1-trifluoro-N-(4-methoxybenzyl)-3-nitro-2-phenylpropan-2-amine",89 percent,89,,,92 percent ee,3,,3,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
CCCCCCCCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,,CCCCCCCCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F>>,48084658,1,44,half reaction|has preparation,,"(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)octan-1-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0135-0139,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)octan-1-amine",87 percent,87,,,95 percent ee,3,,8,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
COC(=O)C(CC(C)(C)C)c1ccccc1,,COC(=O)C(CC(C)(C)C)c1ccccc1>>,48936256,1,44,half reaction|has preparation,,"methyl 4,4-dimethyl-2-phenylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","methyl 4,4-dimethyl-2-phenylpentanoate",90 percent,90,,,,,,26,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
COC(=O)C(CC(C)(C)C)c1ccccc1Br,,COC(=O)C(CC(C)(C)C)c1ccccc1Br>>,48936258,1,44,half reaction|has preparation,,"methyl 2-(2-bromophenyl)-4,4-dimethylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","methyl 2-(2-bromophenyl)-4,4-dimethylpentanoate",85 percent,85,,,,,,28,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CC(C)(C)CC(C(=O)O)c1ccccc1,,CC(C)(C)CC(C(=O)O)c1ccccc1>>,48936263,1,44,half reaction|has preparation,,"4,4-dimethyl-2-phenylpentanoic acid",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","4,4-dimethyl-2-phenylpentanoic acid",86 percent,86,,,,,,33,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C1CCCC1,,CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C1CCCC1>>,48936268,1,44,half reaction|has preparation,,diethyl 2-(cyclopentyl(phenyl)methyl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0111,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(cyclopentyl(phenyl)methyl)malonate,86 percent,86,,,,,,40,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)CC(CC1CCCC1)C(=O)OCC,,CCOC(=O)CC(CC1CCCC1)C(=O)OCC>>,48936270,1,44,half reaction|has preparation,,diethyl 2-(cyclopentylmethyl)succinate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0112,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(cyclopentylmethyl)succinate,90 percent,90,,,,,,42,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
O=C(O)C(Cc1ccccc1)CC1CCCC1,,O=C(O)C(Cc1ccccc1)CC1CCCC1>>,48936271,1,44,half reaction|has preparation,,2-benzyl-3-cyclopentylpropanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0112,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-3-cyclopentylpropanoic acid,93 percent,93,,,,,,43,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
O=S(=O)(CCC1CCCC1)c1ccccc1,,O=S(=O)(CCC1CCCC1)c1ccccc1>>,48936272,1,44,half reaction|has preparation,,((2-cyclopentylethyl)sulfonyl)benzene,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0112,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",((2-cyclopentylethyl)sulfonyl)benzene,85 percent,85,,,,,,44,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C1CCCCC1,,CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C1CCCCC1>>,48936275,1,44,half reaction|has preparation,,diethyl 2-(cyclohexyl(phenyl)methyl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0121,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(cyclohexyl(phenyl)methyl)malonate,90 percent,90,,,,,,48,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(C)C(C)C,,CCOC(=O)C(C(=O)OCC)C(C)C(C)C>>,48936282,1,44,half reaction|has preparation,,diethyl 2-(3-methylbutan-2-yl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0131,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(3-methylbutan-2-yl)malonate,91 percent,91,,,,,,55,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C(C)C,,CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C(C)C>>,48936283,1,44,half reaction|has preparation,,diethyl 2-(2-methyl-1-phenylpropyl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0132,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(2-methyl-1-phenylpropyl)malonate,96 percent,96,,,,,,56,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CC(C)CC(Cc1ccccc1)C(=O)O,,CC(C)CC(Cc1ccccc1)C(=O)O>>,48936284,1,44,half reaction|has preparation,,2-benzyl-4-methylpentanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0132,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-4-methylpentanoic acid,85 percent,85,,,,,,58,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(C)C1CCN(C(=O)OC(C)(C)C)CC1,,CCOC(=O)C(C(=O)OCC)C(C)C1CCN(C(=O)OC(C)(C)C)CC1>>,48936286,1,44,half reaction|has preparation,,diethyl 2-{1-[1-(tert-butoxycarbonyl)piperidin-4-yl]ethyl}malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0138,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-{1-[1-(tert-butoxycarbonyl)piperidin-4-yl]ethyl}malonate,93 percent,93,,,,,,60,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CC(C)(C)OC(=O)N1CCC(CC(Cc2ccccc2)C(=O)O)CC1,,CC(C)(C)OC(=O)N1CCC(CC(Cc2ccccc2)C(=O)O)CC1>>,48936288,1,44,half reaction|has preparation,,2-benzyl-3-(1-(tert-butoxycarbonyl)piperidin-4-yl)propanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0138,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-3-(1-(tert-butoxycarbonyl)piperidin-4-yl)propanoic acid,87 percent,87,,,,,,62,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
COC(=O)C(CCCNC(=O)OC(C)(C)C)c1ccccc1Br,,COC(=O)C(CCCNC(=O)OC(C)(C)C)c1ccccc1Br>>,48936299,1,44,half reaction|has preparation,,methyl 2-(2-bromophenyl)-5-((tert-butoxycarbonyl)amino)pentanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 2-(2-bromophenyl)-5-((tert-butoxycarbonyl)amino)pentanoate,86 percent,86,,,,,,76,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCOP(=O)(OCC)C(c1ccccc1)c1cc(C)ccc1O,,CCOP(=O)(OCC)C(c1ccccc1)c1cc(C)ccc1O>>,50300898,1,44,half reaction|has preparation,,diethyl ((2-hydroxy-5-methylphenyl)(phenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00365; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((2-hydroxy-5-methylphenyl)(phenyl)methyl)phosphonate,99 percent,99,,,,,,f.ii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccccc1)c1cc(OC)ccc1O,,CCOP(=O)(OCC)C(c1ccccc1)c1cc(OC)ccc1O>>,50300899,1,44,half reaction|has preparation,,diethyl ((2-hydroxy-5-methoxyphenyl)(phenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00366; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((2-hydroxy-5-methoxyphenyl)(phenyl)methyl)phosphonate,95 percent,95,,,,,,f.iii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccccc1)c1cc(Cl)ccc1O,,CCOP(=O)(OCC)C(c1ccccc1)c1cc(Cl)ccc1O>>,50300900,1,44,half reaction|has preparation,,diethyl ((5-chloro-2-hydroxyphenyl)(phenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00367; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((5-chloro-2-hydroxyphenyl)(phenyl)methyl)phosphonate,90 percent,90,,,,,,f.iv,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccccc1)c1cc(Br)ccc1O,,CCOP(=O)(OCC)C(c1ccccc1)c1cc(Br)ccc1O>>,50300901,1,44,half reaction|has preparation,,diethyl ((5-bromo-2-hydroxyphenyl)(phenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00368; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((5-bromo-2-hydroxyphenyl)(phenyl)methyl)phosphonate,92 percent,92,,,,,,f.v,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccc(C)cc1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccc(C)cc1)c1ccccc1O>>,50300903,1,44,half reaction|has preparation,,diethyl ((2-hydroxyphenyl)(p-tolyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00370; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((2-hydroxyphenyl)(p-tolyl)methyl)phosphonate,94 percent,94,,,,,,f.vii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccc(SC)cc1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccc(SC)cc1)c1ccccc1O>>,50300904,1,44,half reaction|has preparation,,diethyl ((2-hydroxyphenyl)(4-(methylthio)phenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00371; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((2-hydroxyphenyl)(4-(methylthio)phenyl)methyl)phosphonate,90 percent,90,,,,,,f.viii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccc(F)cc1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccc(F)cc1)c1ccccc1O>>,50300905,1,44,half reaction|has preparation,,diethyl ((4-fluorophenyl)(2-hydroxyphenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00372; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((4-fluorophenyl)(2-hydroxyphenyl)methyl)phosphonate,90 percent,90,,,,,,f.ix,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccc(Cl)cc1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccc(Cl)cc1)c1ccccc1O>>,50300906,1,44,half reaction|has preparation,,diethyl ((4-chlorophenyl)(2-hydroxyphenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00373; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((4-chlorophenyl)(2-hydroxyphenyl)methyl)phosphonate,93 percent,93,,,,,,f.x,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccc(-c2ccccc2)cc1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccc(-c2ccccc2)cc1)c1ccccc1O>>,50300907,1,44,half reaction|has preparation,,"diethyl ([1,1'-biphenyl]-4-yl(2-hydroxyphenyl)methyl)phosphonate",,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00374; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide","diethyl ([1,1'-biphenyl]-4-yl(2-hydroxyphenyl)methyl)phosphonate",85 percent,85,,,,,,f.xi,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1ccc(Cl)c(Cl)c1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccc(Cl)c(Cl)c1)c1ccccc1O>>,50300908,1,44,half reaction|has preparation,,"diethyl ((3,4-dichlorophenyl)(2-hydroxyphenyl)methyl)phosphonate",,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00375; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide","diethyl ((3,4-dichlorophenyl)(2-hydroxyphenyl)methyl)phosphonate",93 percent,93,,,,,,f.xii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(c1cc(C(C)(C)C)cc(C(C)(C)C)c1)c1ccccc1O,,CCOP(=O)(OCC)C(c1cc(C(C)(C)C)cc(C(C)(C)C)c1)c1ccccc1O>>,50300909,1,44,half reaction|has preparation,,"diethyl ((3,5-di-tert-butylphenyl)(2-hydroxyphenyl)methyl)phosphonate",,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00376; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide","diethyl ((3,5-di-tert-butylphenyl)(2-hydroxyphenyl)methyl)phosphonate",88 percent,88,,,,,,f.xiii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCCCC(c1ccccc1O)P(=O)(OCC)OCC,,CCCCC(c1ccccc1O)P(=O)(OCC)OCC>>,50300912,1,44,half reaction|has preparation,,diethyl (1-(2-hydroxyphenyl)pentyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00380; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl (1-(2-hydroxyphenyl)pentyl)phosphonate,86 percent,86,,,,,,f.xvii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
COc1ccc(C(=O)C2CC(c3ccccc3)=NN2S(=O)(=O)c2ccc(C)cc2)cc1,,COc1ccc(C(=O)C2CC(c3ccccc3)=NN2S(=O)(=O)c2ccc(C)cc2)cc1>>,51864135,1,44,half reaction|has preparation,,"(4-methoxyphenyl)(3-phenyl-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0052; 0053,,Trimethylacetic acid,"(4-methoxyphenyl)(3-phenyl-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)methanone",86 percent,86,,,,,,3,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1C)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1C)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118744,1,44,half reaction|has preparation,,C36H33N3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0035,,C31H33F5N4OS,C36H33N3O8,85 percent,85,,,94 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118745,1,44,half reaction|has preparation,,C35H30ClN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0036,,C31H33F5N4OS,C35H30ClN3O8,87 percent,87,,,98 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118746,1,44,half reaction|has preparation,,C35H30ClN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0037,,C31H33F5N4OS,C35H30ClN3O8,90 percent,90,,,95 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(Cl)cc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(Cl)cc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118747,1,44,half reaction|has preparation,,C35H29Cl2N3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0038,,C31H33F5N4OS,C35H29Cl2N3O8,88 percent,88,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(Br)c1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(Br)c1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118748,1,44,half reaction|has preparation,,C35H30BrN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0039,,C31H33F5N4OS,C35H30BrN3O8,92 percent,92,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Br)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Br)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118749,1,44,half reaction|has preparation,,C35H30BrN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0040,,C31H33F5N4OS,C35H30BrN3O8,85 percent,85,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(C)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(C)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118751,1,44,half reaction|has preparation,,C36H32FN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0042,,C31H33F5N4OS,C36H32FN3O8,92 percent,92,,,92 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1C)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1C)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118752,1,44,half reaction|has preparation,,C36H32FN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0043,,C31H33F5N4OS,C36H32FN3O8,92 percent,92,,,95 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118753,1,44,half reaction|has preparation,,C35H29ClFN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0044,,C31H33F5N4OS,C35H29ClFN3O8,92 percent,92,,,92 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118754,1,44,half reaction|has preparation,,C35H29ClFN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0045,,C31H33F5N4OS,C35H29ClFN3O8,92 percent,92,,,93 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(Br)c1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(Br)c1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118755,1,44,half reaction|has preparation,,C35H29BrFN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0046,,C31H33F5N4OS,C35H29BrFN3O8,92 percent,92,,,91 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Br)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Br)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118756,1,44,half reaction|has preparation,,C35H29BrFN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0047,,C31H33F5N4OS,C35H29BrFN3O8,92 percent,92,,,90 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(F)c1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(F)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(F)c1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118757,1,44,half reaction|has preparation,,C35H29F2N3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0048,,C31H33F5N4OS,C35H29F2N3O8,92 percent,92,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(C)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(C)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Cl)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118758,1,44,half reaction|has preparation,,C36H32ClN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0049,,C31H33F5N4OS,C36H32ClN3O8,87 percent,87,,,90 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccc(C)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Br)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccc(C)cc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccccc1Br)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118759,1,44,half reaction|has preparation,,C36H32BrN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0050,,C31H33F5N4OS,C36H32BrN3O8,86 percent,86,,,91 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](c1ccc(C)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](c1ccc(C)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118761,1,44,half reaction|has preparation,,C36H32FN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0052,,C31H33F5N4OS,C36H32FN3O8,86 percent,86,,,98 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118762,1,44,half reaction|has preparation,,C35H29ClFN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0053,,C31H33F5N4OS,C35H29ClFN3O8,92 percent,92,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(OC)cc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(OC)cc31)[C@H](c1ccc(Cl)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118763,1,44,half reaction|has preparation,,C36H32ClN3O9,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0054,,C31H33F5N4OS,C36H32ClN3O9,87 percent,87,,,99 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(C)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1ccc(C)cc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118765,1,44,half reaction|has preparation,,C36H33N3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0033,,C31H33F5N4OS,C36H33N3O8,90 percent,90,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(C)c1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(C)c1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118766,1,44,half reaction|has preparation,,C36H33N3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0034,,C31H33F5N4OS,C36H33N3O8,88 percent,88,,,90 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(OC)cc2)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(OC)cc2)C=C(c2ccccc2)C(=O)O1>>,54358756,1,44,half reaction|has preparation,,C24H22N2O4,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0102-0106,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C24H22N2O4,92 percent,92,,,,,,6,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccccc2)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccccc2)C=C(c2ccccc2)C(=O)O1>>,54358757,1,44,half reaction|has preparation,,C23H20N2O3,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0107-0112,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C23H20N2O3,99 percent,99,,,,,,7,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc3c(c2)CCO3)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc3c(c2)CCO3)C=C(c2ccccc2)C(=O)O1>>,54358758,1,44,half reaction|has preparation,,C25H22N2O4,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0113-0117,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C25H22N2O4,97 percent,97,,,,,,8,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(C#N)cc2)C=C(c2ccc3ccccc3c2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(C#N)cc2)C=C(c2ccc3ccccc3c2)C(=O)O1>>,54358760,1,44,half reaction|has preparation,,C28H21N3O3,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0123-0127,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C28H21N3O3,93 percent,93,,,,,,10,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(C#N)cc2)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(C#N)cc2)C=C(c2ccccc2)C(=O)O1>>,54358766,1,44,half reaction|has preparation,,C24H19N3O3,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0092-0096,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C24H19N3O3,98 percent,98,,,,,,4,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc([N+](=O)[O-])cc2)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc([N+](=O)[O-])cc2)C=C(c2ccccc2)C(=O)O1>>,54358767,1,44,half reaction|has preparation,,C23H19N3O5,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0097-0101,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C23H19N3O5,96 percent,96,,,,,,5,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@]12CCCN1c1cccc(F)c1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cccc(F)c1C[C@@]21Oc2ccccc2C1=O>>,54590676,1,44,half reaction|has preparation,,"(2R,3a'R)-6'-fluoro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0124-0130,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-6'-fluoro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",89 percent,89,,,,,,12,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
O=C1c2ccccc2OC12Cc1ccccc1N1CCCCCC12,,O=C1c2ccccc2OC12Cc1ccccc1N1CCCCCC12>>,54590680,1,44,half reaction|has preparation,,C21H21NO2,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0152-0158,,scandium tris(trifluoromethanesulfonate),C21H21NO2,88 percent,88,,,,,,16,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
O=C1c2ccccc2OC12Cc1ccccc1N1CCc3ccccc3C12,,O=C1c2ccccc2OC12Cc1ccccc1N1CCc3ccccc3C12>>,54590682,1,44,half reaction|has preparation,,C24H19NO2,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0166-0172,,scandium tris(trifluoromethanesulfonate),C24H19NO2,95 percent,95,,,,,,18,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
CCN1c2cc(Br)ccc2CC2(Oc3ccccc3C2=O)C1C,,CCN1c2cc(Br)ccc2CC2(Oc3ccccc3C2=O)C1C>>,54590684,1,44,half reaction|has preparation,,C19H18BrNO2,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0180-0186,,scandium tris(trifluoromethanesulfonate),C19H18BrNO2,93 percent,93,,,,,,20,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cc(Br)ccc1C[C@@]21Sc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(Br)ccc1C[C@@]21Sc2ccccc2C1=O>>,54590691,1,44,half reaction|has preparation,,"(2R,3a'R)-8'-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0232-0238,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-8'-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",93 percent,93,,,,,,27,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cccc(OC)c1C[C@@]21Sc2ccccc2C1=O,,[H][C@]12CCCN1c1cccc(OC)c1C[C@@]21Sc2ccccc2C1=O>>,54590692,1,44,half reaction|has preparation,,"(2R,3a'R)-6'-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0239-0245,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-6'-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",87 percent,87,,,,,,28,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1ccc([N+](=O)[O-])cc1C[C@@]21Sc2ccccc2C1=O,,[H][C@]12CCCN1c1ccc([N+](=O)[O-])cc1C[C@@]21Sc2ccccc2C1=O>>,54590693,1,44,half reaction|has preparation,,"(2R,3a'R)-7'-nitro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0246-0252,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-7'-nitro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",92 percent,92,,,,,,29,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1ccc3ccccc3c1C[C@@]21Sc2ccccc2C1=O,,[H][C@]12CCCN1c1ccc3ccccc3c1C[C@@]21Sc2ccccc2C1=O>>,54590694,1,44,half reaction|has preparation,,"(2R,12a'R)-1',2',3',12a'-tetrahydro-3H,11'H-spiro[benzo[b]thiophene-2,12'-benzo[f]pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0253-0259,,scandium tris(trifluoromethanesulfonate),"(2R,12a'R)-1',2',3',12a'-tetrahydro-3H,11'H-spiro[benzo[b]thiophene-2,12'-benzo[f]pyrrolo[1,2-a]quinolin]-3-one",89 percent,89,,,,,,30,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
CCN1c2ccc([N+](=O)[O-])cc2CC2(Sc3ccccc3C2=O)C1C,,CCN1c2ccc([N+](=O)[O-])cc2CC2(Sc3ccccc3C2=O)C1C>>,54590696,1,44,half reaction|has preparation,,C19H18N2O3S,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0267-0273,,scandium tris(trifluoromethanesulfonate),C19H18N2O3S,86 percent,86,,,,,,32,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
Cc1nc(-c2ccccc2)nc(-c2ccc3c(c2)CCO3)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2ccc3c(c2)CCO3)c1-c1ccccc1>>,70507576,1,44,half reaction|has preparation,,C25H20N2O,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C25H20N2O,95 percent,95,,,,,,11,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
CC(C)(C)C1CCC(=O)C1,,CC(C)(C)C1CCC(=O)C1>>,7244126,3,43,half reaction|has preparation,,3-tert-Butyl-cyclopentanone,,"['Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1']",40,Michael Addition,,acetone,"['74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);', '4455106; Article; Richer; Belanger; Canadian Journal of Chemistry; vol. 44; (1966); p. 2057,2065;', '2862791; Article; Brown et al.; Journal of the American Chemical Society; vol. 99; (1977); p. 3427;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,"['Cyclopent-1-en-2-on, t-Butylmagnesiumchlorid, Ae.', 'β-tert-Butyl-adipinsaeure, Ba(OH)2 (S.3430)']","dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",3-tert-Butyl-cyclopentanone,36 percent,36,,,,,,37,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
[C-]#N.[Na+],Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2.N#Cc1cc(O)c(O)cc1[C@H]1Oc2cc(O)cc(O)c2C[C@@H]1O,[C-]#N.[Na+]>>Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2.N#Cc1cc(O)c(O)cc1[C@H]1Oc2cc(O)cc(O)c2C[C@@H]1O,33027656,1,43,full reaction,sodium cyanide|catechin,C16H13NO6,293878,Chemical behaviour,1,,Michael addition,Kinetics,,"20126049; Article; Khalafi, Lida; Rafiee, Mohammad; Yadaei, Farzaneh; Research on Chemical Intermediates; vol. 37; 8; (2011); p. 1047 - 1055;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction|aq. phosphate buffer,6,body text,,,,,,,,,,,,,,
CC(C)OC(=O)C(C(=O)OC(C)C)[C@@H](C[N+](=O)[O-])c1ccccc1,,CC(C)OC(=O)C(C(=O)OC(C)C)[C@@H](C[N+](=O)[O-])c1ccccc1>>,37326749,4,43,half reaction|has preparation,,(R)-1-methylethyl 2-(1-methylethoxycarbo)-4-nitro-3-phenylbutyrate,,"['Preparation', 'Preparation', 'Preparation', 'Preparation']","['1', '1', '1', '1']","['20', '-35', '0 - 20', '0 - 20']","['Michael Addition', 'Michael Addition']",,"['acetonitrile', 'dichloromethane-d2|1,2-dichloro-ethane']","['66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);', '62686890; Patent; TEXAS A M UNIVERSITY SYSTEM; WO2014/18978; A2; (2014);', '132736901; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; WO2024/49236; A1; (2024);', '132736901; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; WO2024/49236; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,"['Sealed tube', 'Inert atmosphere', 'Inert atmosphere']",,"['Paragraph 0115', 'Paragraph 00194; 00195; 00196; 00197', 'Paragraph 210-214; 218-219; 222-225; 229-231', 'Paragraph 210-214; 218-219; 222-225; 229-231']",,"['C55H45CuF12N7O3S(1+)*F6P(1-)|triethylamine', 'Λ-[Co(en)2(S)-enCH2CH2CH2NMe2]3+3BArf-.6.5H2O', 'sodium tetrahydroborate|nickel(II) chloride hexahydrate', 'sodium tetrahydroborate|nickel(II) chloride hexahydrate']","['(R)-1-methylethyl 2-(1-methylethoxycarbo)-4-nitro-3-phenylbutyrate', '(R)-1-methylethyl 2-(1-methylethoxycarbo)-4-nitro-3-phenylbutyrate', '(R)-1-methylethyl 2-(1-methylethoxycarbo)-4-nitro-3-phenylbutyrate']","['30 percent', '97 percent', '97 percent']",30,,,,,,"['11.7', '12', '3.3.1; 3.3.1.3', '3.3.1; 3.3.1.3']",,"['General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only', 'General procedure: EXAMPLE 12 Procedures for reactions catalyzed using Type 2 Transition metal compl', 'General procedure: Under argon atmosphere, NaBH4 (10 equiv) was added to a suspension of the obtained Michael addition product (1.0 equiv, >99% ee) and NiCl2*6H2O (1.0 equiv) in MeOH (8.0 mL) at 0 C.', 'General procedure: Under argon atmosphere, NaBH4 (10 equiv) was added to a suspension of the obtained Michael addition product (1.0 equiv, >99% ee) and NiCl2*6H2O (1.0 equiv) in MeOH (8.0 mL) at 0 C.']",
CC[C@](CCC(C)=O)(C(C)=O)C(=O)OCc1ccccc1,,CC[C@](CCC(C)=O)(C(C)=O)C(=O)OCc1ccccc1>>,39144548,1,43,half reaction|has preparation,,benzyl (S)-2-acetyl-2-ethyl-5-oxohexanoate,,Preparation,1,-50,Michael Addition,,dichloromethane,64344155; Patent; UNIVERSITY OF PENNSYLVANIA; WO2014/205437; A1; (2014);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,28,Inert atmosphere|Schlenk technique,,Page/Page column 12-16; 29-30,,C60H36LaO6(3-)*3C5H13N3*0.5C5H12*3H(1+)|water|sodium iodide,benzyl (S)-2-acetyl-2-ethyl-5-oxohexanoate,84percent,84,,,>99percent ee,,,,General Procedure E: Asymmetric Michael addition of beta-ketoesters (3e- f) to methyl vinyl ketone (2b). Ethyl (S -2-oxo-l-(3-oxobutyI)-cycIohexanecarboxylate (4e).,General procedure: General Procedure E: Asymmetric Michael addition of beta-ketoesters (3e- f) to methyl vinyl ketone (2b). Ethyl (S -2-oxo-l-(3-oxobutyI)-cycIohexanecarboxylate (4e). Under an N2 flow,
COc1ccc(C(C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1,,COc1ccc(C(C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1>>,39933730,1,43,half reaction|has preparation,,"3-(1-(4-methoxyphenyl)-2-nitroethyl)pentane-2,4-dione",,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.266667,,,Paragraph 0093; 0104-01035,,potassium hydroxide,"3-(1-(4-methoxyphenyl)-2-nitroethyl)pentane-2,4-dione",77 percent,77,,,,,,,,"General procedure: [0093] To further explore the methodology of this Example, this Example carried o",
CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccc(Cl)cc1,,CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccc(Cl)cc1>>,39933732,1,43,half reaction|has preparation,,"3-[1-(4-chlorophenyl)-2-nitroethyl]pentane-2,4-dione",,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.266667,,,Paragraph 0093; 0108-0109,,potassium hydroxide,"3-[1-(4-chlorophenyl)-2-nitroethyl]pentane-2,4-dione",79 percent,79,,,,,,,,"General procedure: [0093] To further explore the methodology of this Example, this Example carried o",
CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccc(Br)cc1,,CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccc(Br)cc1>>,39933733,1,43,half reaction|has preparation,,"3-(1-(4-bromophenyl)-2-nitroethyl)pentane-2,4-dione",,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.266667,,,Paragraph 0093; 0110-0111,,potassium hydroxide,"3-(1-(4-bromophenyl)-2-nitroethyl)pentane-2,4-dione",75 percent,75,,,,,,,,"General procedure: [0093] To further explore the methodology of this Example, this Example carried o",
CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1cccs1,,CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1cccs1>>,39933734,1,43,half reaction|has preparation,,"3-(2-nitro-1-(thiophen-2-yl)ethyl)pentane-2,4-dione",,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.266667,,,Paragraph 0093; 0112-0113,,potassium hydroxide,"3-(2-nitro-1-(thiophen-2-yl)ethyl)pentane-2,4-dione",78 percent,78,,,,,,,,"General procedure: [0093] To further explore the methodology of this Example, this Example carried o",
COC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1,,COC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccccc1>>,39933735,1,43,half reaction|has preparation,,methyl 2-acetyl-4-nitro-3-phenylbutyrate,,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0118-0119,,potassium hydroxide,methyl 2-acetyl-4-nitro-3-phenylbutyrate,79 percent,79,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
CC(=O)C(C(=O)OC(C)(C)C)C(C[N+](=O)[O-])c1ccccc1,,CC(=O)C(C(=O)OC(C)(C)C)C(C[N+](=O)[O-])c1ccccc1>>,39933736,1,43,half reaction|has preparation,,"1',1'-dimethylethyl 2-acetyl-4-nitro-3-phenylbutyrate",,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0122-0123,,potassium hydroxide,"1',1'-dimethylethyl 2-acetyl-4-nitro-3-phenylbutyrate",83 percent,83,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
COC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)CCCC1=O,,COC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)CCCC1=O>>,39933738,1,43,half reaction|has preparation,,1-[2-nitro-1-phenylethyl]-2-oxo-cyclopentanecarboxylic acid methyl ester,,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0126-0127,,potassium hydroxide,1-[2-nitro-1-phenylethyl]-2-oxo-cyclopentanecarboxylic acid methyl ester,82 percent,82,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
CCOC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)CCCC1=O,,CCOC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)CCCC1=O>>,39933739,1,43,half reaction|has preparation,,ethyl 1-(2-nitro-1-phenylethyl)-2-oxocyclopentane-1-carboxylate,,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0128-0129,,potassium hydroxide,ethyl 1-(2-nitro-1-phenylethyl)-2-oxocyclopentane-1-carboxylate,81 percent,81,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1,,CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,40051232,3,43,half reaction|has preparation,,(R)-ethyl 2-carboethoxy-4-nitro-3-(4-bromophenyl)butyrate,,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '0 - 20', '0 - 20']",Michael Addition,,acetonitrile,"['66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);', '132736901; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; WO2024/49236; A1; (2024);', '132736901; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; WO2024/49236; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,"['Inert atmosphere', 'Inert atmosphere']",,"['Paragraph 0115', 'Paragraph 210-214; 218-219; 222-225; 241-242', 'Paragraph 210-214; 218-219; 222-225; 241-242']",,"['C55H45CuF12N7O3S(1+)*F6P(1-)|triethylamine', 'sodium tetrahydroborate|nickel(II) chloride hexahydrate', 'sodium tetrahydroborate|nickel(II) chloride hexahydrate']","['(R)-ethyl 2-carboethoxy-4-nitro-3-(4-bromophenyl)butyrate', '(R)-ethyl 2-carboethoxy-4-nitro-3-(4-bromophenyl)butyrate', '(R)-ethyl 2-carboethoxy-4-nitro-3-(4-bromophenyl)butyrate']","['48 percent', '98 percent', '98 percent']",48,,,,,,"['11.4', '3.3.1; 3.3.1.7', '3.3.1; 3.3.1.7']",,"['General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only', 'General procedure: Under argon atmosphere, NaBH4 (10 equiv) was added to a suspension of the obtained Michael addition product (1.0 equiv, >99% ee) and NiCl2*6H2O (1.0 equiv) in MeOH (8.0 mL) at 0 C.', 'General procedure: Under argon atmosphere, NaBH4 (10 equiv) was added to a suspension of the obtained Michael addition product (1.0 equiv, >99% ee) and NiCl2*6H2O (1.0 equiv) in MeOH (8.0 mL) at 0 C.']",
COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccccc1,,COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccccc1>>,40051234,1,43,half reaction|has preparation,,methyl (R)-2-methoxycarbonyl-4-nitro-3-phenylbutanoate,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H45CuF12N7O3S(1+)*F6P(1-)|triethylamine,methyl (R)-2-methoxycarbonyl-4-nitro-3-phenylbutanoate,77 percent,77,,,,,,11.6,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccco2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC,,[H][C@]1([C@@H](NC(=O)OC(C)(C)C)c2ccco2)CN(S(=O)(=O)c2ccc(C)cc2)[C@H](C(=O)OCC)[C@@H]1CC(=O)OCC>>,40502557,2,43,half reaction|has preparation,,"ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(furan-2-yl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate",,"['Preparation', 'Preparation']","['1', '1']","['0|0|50', '0|0|50']","['Mannich Aminomethylation|Wittig Olefination|Michael Addition', 'Wittig Olefination|Michael Addition']",,"['acetonitrile|acetonitrile|acetonitrile', 'acetonitrile|acetonitrile|acetonitrile']","['66601673; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2015/102024; A2; (2015);', '70085784; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; US2016/326110; A1; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Paragraph 0030, 0044, 0056; 0063', 'Paragraph 0038; 0059; 0060; 0097; 0098']",enantioselective reaction,"['L-proline|caesium carbonate', 'L-proline|caesium carbonate']","['ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(furan-2-yl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate', 'ethyl (2S,3R,4R)-4-((R)-((tert-butoxycarbonyl)amino)(furan-2-yl)methyl)-3-(2-ethoxy-2-oxoethyl)-1-tosylpyrrolidine-2-carboxylate']","['60 percent', '60 percent']","['60', '60']",,,"['92 percent ee', '92 percent ee']","['3', '3']",,"['19', '19']",[0044] (c) Sequential s n-Mannich/Wittig olefination/N-alkylation/Michael addition:,"['General procedure: To a cooled solution of N-Boc imines (Ila-h, 2.5 mmol) and L-proline (10 mol %) i', 'General procedure: To a cooled solution of N-Hoc imines (ha-h, 2.5 mmol) and L-proline (10 mol %) in dry CH3CN (20 mL) at 0 C. was added 3-amino aldehyde III (568 mg, 2.75 mmol), and the mixture was s']",
Cc1nn(-c2ccccc2)c2c1C(c1ccccc1C=O)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(c1ccccc1C=O)CS(=O)(=O)O2>>,46311879,1,43,half reaction|has preparation,,"2-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)benzaldehyde",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","2-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)benzaldehyde",78percent,78,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1ccc(-n2nc(C)c3c2OS(=O)(=O)CC3c2ccccc2)cc1,,Cc1ccc(-n2nc(C)c3c2OS(=O)(=O)CC3c2ccccc2)cc1>>,46311891,1,43,half reaction|has preparation,,"5-methyl-4-phenyl-7-(p-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-4-phenyl-7-(p-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",78percent,78,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1cccc(-n2nc(C)c3c2OS(=O)(=O)CC3c2ccccc2)c1,,Cc1cccc(-n2nc(C)c3c2OS(=O)(=O)CC3c2ccccc2)c1>>,46311894,1,43,half reaction|has preparation,,"5-methyl-4-phenyl-7-(m-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-4-phenyl-7-(m-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",81 percent,81,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(C(C)(C)C)cc1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc(C(C)(C)C)cc1)CS(=O)(=O)O2>>,46311903,1,43,half reaction|has preparation,,"(E)-4-(4-(tert-butyl)styryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-4-(4-(tert-butyl)styryl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",75percent,75,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1cccc(/C=C/C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1,,Cc1cccc(/C=C/C2CS(=O)(=O)Oc3c2c(C)nn3-c2ccccc2)c1>>,46311907,1,43,half reaction|has preparation,,"(E)-5-methyl-4-(3-methylstyryl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-5-methyl-4-(3-methylstyryl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",76percent,76,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1ccc(-c2c(C3C(=O)N(Cc4ccccc4)c4ccc(F)cc43)cc(-c3ccccc3)c3c4ccccc4n(C)c23)cc1,,Cc1ccc(-c2c(C3C(=O)N(Cc4ccccc4)c4ccc(F)cc43)cc(-c3ccccc3)c3c4ccccc4n(C)c23)cc1>>,46362246,1,43,half reaction|has preparation,,1-benzyl-5-fluoro-3-(9-methyl-4-phenyl-1-(p-tolyl)-9H-carbazol-2-yl)indolin-2-one,,Preparation,1,80,Michael Addition,,toluene,72289018; Patent; YANGZHOU UNIVERSITY; CN107162954; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,Inert atmosphere|Schlenk technique,,Paragraph 0019; 0020; 0023; 0024,,trifluorormethanesulfonic acid,1-benzyl-5-fluoro-3-(9-methyl-4-phenyl-1-(p-tolyl)-9H-carbazol-2-yl)indolin-2-one,78percent,78,,,,,,3,Example 1: Preparation of 1-benzyl-3- (9-methyl-4-phenyl-1- (p-methylphenyl) -9H-carbazol-2-yl) indoline-2-one,"General procedure: Under the protection of nitrogen,To a 10 mL Schlenck tube was added 0.5 mmol (0.066 g)N-methylindole,1.5 mmolketone,2 mL dry toluene,0.5 mmol (0.176 g)1-benzyl-3- (2-oxo-2- (p-methy",
Cc1ccc(-c2c(C3C(=O)N(Cc4ccccc4)c4ccccc43)cc(-c3ccc(Cl)cc3)c3c4ccccc4n(C)c23)cc1,,Cc1ccc(-c2c(C3C(=O)N(Cc4ccccc4)c4ccccc43)cc(-c3ccc(Cl)cc3)c3c4ccccc4n(C)c23)cc1>>,46362248,1,43,half reaction|has preparation,,1-benzyl-3-(4-(4-chlorophenyl)-9-methyl-1-(p-methylphenyl)-9H-carbazol-2-yl)indolin-2-one,,Preparation,1,80,Michael Addition,,toluene,72289018; Patent; YANGZHOU UNIVERSITY; CN107162954; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,Inert atmosphere|Schlenk technique,,Paragraph 0019; 0020; 0029; 0030,,trifluorormethanesulfonic acid,1-benzyl-3-(4-(4-chlorophenyl)-9-methyl-1-(p-methylphenyl)-9H-carbazol-2-yl)indolin-2-one,84percent,84,,,,,,6,Example 1: Preparation of 1-benzyl-3- (9-methyl-4-phenyl-1- (p-methylphenyl) -9H-carbazol-2-yl) indoline-2-one,"General procedure: Under the protection of nitrogen,To a 10 mL Schlenck tube was added 0.5 mmol (0.066 g)N-methylindole,1.5 mmolketone,2 mL dry toluene,0.5 mmol (0.176 g)1-benzyl-3- (2-oxo-2- (p-methy",
CCCCN1C(=O)C(c2cc(-c3ccccc3)c3c4ccccc4n(C)c3c2-c2ccc(OC)cc2)c2cc(Cl)ccc21,,CCCCN1C(=O)C(c2cc(-c3ccccc3)c3c4ccccc4n(C)c3c2-c2ccc(OC)cc2)c2cc(Cl)ccc21>>,46362249,1,43,half reaction|has preparation,,1-n-butyl-5-chloro-3-(1-(4-methoxyphenyl)-9-methyl-4-phenyl-9H-carbazol-2-yl)indolin-2-one,,Preparation,1,80,Michael Addition,,toluene,72289018; Patent; YANGZHOU UNIVERSITY; CN107162954; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,Inert atmosphere|Schlenk technique,,Paragraph 0019; 0020; 0021; 0022,,trifluorormethanesulfonic acid,1-n-butyl-5-chloro-3-(1-(4-methoxyphenyl)-9-methyl-4-phenyl-9H-carbazol-2-yl)indolin-2-one,80percent,80,,,,,,2,Example 1: Preparation of 1-benzyl-3- (9-methyl-4-phenyl-1- (p-methylphenyl) -9H-carbazol-2-yl) indoline-2-one,"General procedure: Under the protection of nitrogen,To a 10 mL Schlenck tube was added 0.5 mmol (0.066 g)N-methylindole,1.5 mmolketone,2 mL dry toluene,0.5 mmol (0.176 g)1-benzyl-3- (2-oxo-2- (p-methy",
Cc1noc(CC(c2ccccc2)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410277,1,43,half reaction|has preparation,,C28H24ClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0030,,tetrabutylammomium bromide|potassium carbonate,C28H24ClN3O4,84 percent,84,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410278,1,43,half reaction|has preparation,,C28H23ClFN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0031,,tetrabutylammomium bromide|potassium carbonate,C28H23ClFN3O4,79 percent,79,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccc(Cl)cc2Cl)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccc(Cl)cc2Cl)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410280,1,43,half reaction|has preparation,,C28H22Cl3N3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0033,,tetrabutylammomium bromide|potassium carbonate,C28H22Cl3N3O4,76 percent,76,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2cccc(Br)c2)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2cccc(Br)c2)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410281,1,43,half reaction|has preparation,,C28H23BrClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0034,,tetrabutylammomium bromide|potassium carbonate,C28H23BrClN3O4,79 percent,79,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410284,1,43,half reaction|has preparation,,C28H23BrFN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0036,,tetrabutylammomium bromide|potassium carbonate,C28H23BrFN3O4,84 percent,84,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1cccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1,,Cc1cccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1>>,46410288,1,43,half reaction|has preparation,,C29H26BrN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0040,,tetrabutylammomium bromide|potassium carbonate,C29H26BrN3O4,75 percent,75,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410291,1,43,half reaction|has preparation,,C28H23F2N3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0024; 0043,,tetrabutylammomium bromide|potassium carbonate,C28H23F2N3O4,83 percent,83,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410292,1,43,half reaction|has preparation,,C28H23ClFN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0024; 0044,,tetrabutylammomium bromide|potassium carbonate,C28H23ClFN3O4,80 percent,80,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1cccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1,,Cc1cccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(F)cc3)C(=O)N(C)c3ccccc32)c1>>,46410295,1,43,half reaction|has preparation,,C29H26FN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0024; 0047,,tetrabutylammomium bromide|potassium carbonate,C29H26FN3O4,81 percent,81,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccc(Br)cc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccc(Br)cc32)c1[N+](=O)[O-]>>,46410296,1,43,half reaction|has preparation,,C28H22Br2ClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0023; 0024; 0048,,tetrabutylammomium bromide|potassium carbonate,C28H22Br2ClN3O4,82 percent,82,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2cccc(F)c2)C2(Cc3ccccc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410298,1,43,half reaction|has preparation,,C28H24FN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0026,,tetrabutylammomium bromide|potassium carbonate,C28H24FN3O4,81 percent,81,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc(I)cc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2ccc(I)cc2C1=O>>,46690565,1,43,half reaction|has preparation,,"methyl (S)-5-iodo-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0061-0063,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-5-iodo-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",82 percent,82,,,98 percent ee,2,,24,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCC(=O)CC[C@]1(C(=O)OC)Oc2c(OC)cccc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2c(OC)cccc2C1=O>>,46690569,1,43,half reaction|has preparation,,"methyl (S)-7-methoxy-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0073-0075,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-7-methoxy-3-oxo-2-(3-oxopentyl)-2,3-dihydrobenzofuran-2-carboxylate",83 percent,83,,,99 percent ee,2,,28,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCC(=O)CC[C@]1(C(=O)OC)Oc2cc3ccccc3cc2C1=O,,CCC(=O)CC[C@]1(C(=O)OC)Oc2cc3ccccc3cc2C1=O>>,46690571,1,43,half reaction|has preparation,,"methyl (S)-3-oxo-2-(3-oxopentyl)-2,3-dihydronaphtho[2,3-b]furan-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0079-0081,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-3-oxo-2-(3-oxopentyl)-2,3-dihydronaphtho[2,3-b]furan-2-carboxylate",82 percent,82,,,99 percent ee,2,,30,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCCCCC(=O)CC[C@]1(C(=O)OC)Oc2ccccc2C1=O,,CCCCCC(=O)CC[C@]1(C(=O)OC)Oc2ccccc2C1=O>>,46690573,1,43,half reaction|has preparation,,"methyl (S)-3-oxo-2-(3-oxooctyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0085-0087,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-3-oxo-2-(3-oxooctyl)-2,3-dihydrobenzofuran-2-carboxylate",76 percent,76,,,99 percent ee,2,,32,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
O=[N+]([O-])C[C@](NC1CC1)(c1ccccc1)C(F)(F)F,,O=[N+]([O-])C[C@](NC1CC1)(c1ccccc1)C(F)(F)F>>,48084639,1,43,half reaction|has preparation,,"(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)cyclopropanamine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0150-0154,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)cyclopropanamine",79 percent,79,,,97 percent ee,3,,11,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
O=[N+]([O-])C[C@](NC1CCC1)(c1ccccc1)C(F)(F)F,,O=[N+]([O-])C[C@](NC1CCC1)(c1ccccc1)C(F)(F)F>>,48084640,1,43,half reaction|has preparation,,"(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)cyclobutanamine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0155-0159,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)cyclobutanamine",78 percent,78,,,94 percent ee,3,,12,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
COCCCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,COCCCN[C@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,COCCCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F>>COCCCN[C@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,48084644,1,43,half reaction|has preparation,,"(R)-3-methoxy-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine|(S)-3-methoxy-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine",,Preparation,1,-78|-78|70,Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0115; 0116; 0117; 0118; 0119; 0165; 0166-0169,,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-3-methoxy-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine|(S)-3-methoxy-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine",87 percent|87 percent,87|87,,,87 percent ee|87 percent ee,3,,14,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
O=[N+]([O-])C[C@](NC1CC1)(c1ccc(F)cc1)C(F)(F)F,,O=[N+]([O-])C[C@](NC1CC1)(c1ccc(F)cc1)C(F)(F)F>>,48084652,1,43,half reaction|has preparation,,"(R)-N-(1,1,1-trifluoro-2-(4-fluorophenyl)-3-nitropropan-2-yl)cyclopropanamine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0185-0189,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N-(1,1,1-trifluoro-2-(4-fluorophenyl)-3-nitropropan-2-yl)cyclopropanamine",77 percent,77,,,90 percent ee,3,,18,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
O=[N+]([O-])C[C@](NCCc1ccccc1)(c1ccccc1)C(F)(F)F,O=[N+]([O-])C[C@@](NCCc1ccccc1)(c1ccccc1)C(F)(F)F,O=[N+]([O-])C[C@](NCCc1ccccc1)(c1ccccc1)C(F)(F)F>>O=[N+]([O-])C[C@@](NCCc1ccccc1)(c1ccccc1)C(F)(F)F,48084654,1,43,half reaction|has preparation,,"(R)-1,1,1-trifluoro-3-nitro-N-phenethyl-2-phenylpropan-2-amine|(S)-1,1,1-trifluoro-3-nitro-N-phenethyl-2-phenylpropan-2-amine",,Preparation,1,-78|-78|70,Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0115; 0116; 0117; 0118; 0119; 0120; 0121-0124,,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-1,1,1-trifluoro-3-nitro-N-phenethyl-2-phenylpropan-2-amine|(S)-1,1,1-trifluoro-3-nitro-N-phenethyl-2-phenylpropan-2-amine",85 percent|85 percent,85|85,,,86 percent ee|86 percent ee,3,,5,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
O=[N+]([O-])C[C@@](NCCc1ccc(Br)cc1)(c1ccccc1)C(F)(F)F,O=[N+]([O-])C[C@](NCCc1ccc(Br)cc1)(c1ccccc1)C(F)(F)F,O=[N+]([O-])C[C@@](NCCc1ccc(Br)cc1)(c1ccccc1)C(F)(F)F>>O=[N+]([O-])C[C@](NCCc1ccc(Br)cc1)(c1ccccc1)C(F)(F)F,48084655,1,43,half reaction|has preparation,,"(S)-N-(4-bromophenethyl)-1,1,1-trifluoro-3-nitro-2-phenylpropan-2-amine|(R)-N-(4-bromophenethyl)-1,1,1-trifluoro-3-nitro-2-phenylpropan-2-amine",,Preparation,1,-78|-78|70,Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0115; 0116; 0117; 0118; 0119; 0125; 0126-0129,,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N-(4-bromophenethyl)-1,1,1-trifluoro-3-nitro-2-phenylpropan-2-amine|(S)-N-(4-bromophenethyl)-1,1,1-trifluoro-3-nitro-2-phenylpropan-2-amine",85 percent|85 percent,85|85,,,86percent ee|86percent ee,3,,6,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
CCCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,,CCCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F>>,48084657,1,43,half reaction|has preparation,,"(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0130-0134,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine",80 percent,80,,,92 percent ee,3,,7,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
O=[N+]([O-])C[C@](NCCCc1ccccc1)(c1ccccc1)C(F)(F)F,,O=[N+]([O-])C[C@](NCCCc1ccccc1)(c1ccccc1)C(F)(F)F>>,48084659,1,43,half reaction|has preparation,,"(R)-3-phenyl-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0140-0144,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-3-phenyl-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)propan-1-amine",82 percent,82,,,93 percent ee,3,,9,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
COC(=O)C(Cc1ccccc1)CC(C)(C)C,,COC(=O)C(Cc1ccccc1)CC(C)(C)C>>,48936260,1,43,half reaction|has preparation,,"methyl 2-benzyl-4,4-dimethylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","methyl 2-benzyl-4,4-dimethylpentanoate",80 percent,80,,,,,,30,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CC(C)(C)CC(Cc1ccccc1)C(=O)O,,CC(C)(C)CC(Cc1ccccc1)C(=O)O>>,48936264,1,43,half reaction|has preparation,,"2-benzyl-4,4-dimethylpentanoic acid",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","2-benzyl-4,4-dimethylpentanoic acid",76 percent,76,,,,,,34,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
COC(=O)C(CC1CCCC1)c1ccccc1Br,,COC(=O)C(CC1CCCC1)c1ccccc1Br>>,48936269,1,43,half reaction|has preparation,,methyl 2-(2-bromophenyl)-3-cyclopentylpropanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0112,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 2-(2-bromophenyl)-3-cyclopentylpropanoate,77 percent,77,,,,,,41,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
COC(=O)C(CC1CCCCC1)c1ccccc1Br,,COC(=O)C(CC1CCCCC1)c1ccccc1Br>>,48936277,1,43,half reaction|has preparation,,methyl 2-(2-bromophenyl)-3-cyclohexylpropanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0122,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 2-(2-bromophenyl)-3-cyclohexylpropanoate,82 percent,82,,,,,,50,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)CC(CC1CCCCC1)C(=O)OCC,,CCOC(=O)CC(CC1CCCCC1)C(=O)OCC>>,48936279,1,43,half reaction|has preparation,,2-(Cyclohexylmethyl)butandisaeure-diethylester,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0122,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-(Cyclohexylmethyl)butandisaeure-diethylester,75 percent,75,,,,,,52,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
COC(=O)C(CCCO[Si](C)(C)C(C)(C)C)c1ccccc1Br,,COC(=O)C(CCCO[Si](C)(C)C(C)(C)C)c1ccccc1Br>>,48936305,1,43,half reaction|has preparation,,methyl 2-(2-bromophenyl)-5-((tert-butyldimethylsilyl)oxy)pentanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0166,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 2-(2-bromophenyl)-5-((tert-butyldimethylsilyl)oxy)pentanoate,75 percent,75,,,,,,82,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCOP(=O)(OCC)C(c1ccsc1)c1ccccc1O,,CCOP(=O)(OCC)C(c1ccsc1)c1ccccc1O>>,50300911,1,43,half reaction|has preparation,,diethyl ((2-hydroxyphenyl)(thiophen-3-yl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00379; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((2-hydroxyphenyl)(thiophen-3-yl)methyl)phosphonate,78 percent,78,,,,,,f.xvi,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CCOP(=O)(OCC)C(Cc1ccccc1)c1ccccc1O,,CCOP(=O)(OCC)C(Cc1ccccc1)c1ccccc1O>>,50300913,1,43,half reaction|has preparation,,diethyl (1-(2-hydroxyphenyl)-2-phenylethyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00381; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl (1-(2-hydroxyphenyl)-2-phenylethyl)phosphonate,78 percent,78,,,,,,f.xviii,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
COP(=O)(c1ccccc1)C(c1ccc(C)cc1)c1ccccc1O,,COP(=O)(c1ccccc1)C(c1ccc(C)cc1)c1ccccc1O>>,50300914,1,43,half reaction|has preparation,,methyl ((2-hydroxyphenyl)(p- tolyl)methyl)(phenyl)phosphinate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00385-00386; 00392; 00411; 00412,diastereoselective reaction,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",methyl ((2-hydroxyphenyl)(p- tolyl)methyl)(phenyl)phosphinate,84 percent,84,,,60 percent de,,,g.vii,Methyl ((2-hydroxyphenyl)(phenyl)methyl)(phenyl)phosphinate (4a as example):,"General procedure: A mixture of alcohol 1 (20.2 mg, 0.1 mmol), dimethyl phenylphosphonite 2d (173 mg, 0.1 mmol), NHPA1 (0.4 mg, 0.015 mmol) and DCM (0.5 mL) in a 2-dram vial with a PTFE cap was stirre",
COP(=O)(c1ccccc1)C(c1ccc(SC)cc1)c1ccccc1O,,COP(=O)(c1ccccc1)C(c1ccc(SC)cc1)c1ccccc1O>>,50300915,1,43,half reaction|has preparation,,methyl ((2-hydroxyphenyl)(4- (methylthio)phenyl)methyl)(phenyl)phosphinate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00385-00386; 00393; 00411; 00412,diastereoselective reaction,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",methyl ((2-hydroxyphenyl)(4- (methylthio)phenyl)methyl)(phenyl)phosphinate,82 percent,82,,,60 percent de,,,g.viii,Methyl ((2-hydroxyphenyl)(phenyl)methyl)(phenyl)phosphinate (4a as example):,"General procedure: A mixture of alcohol 1 (20.2 mg, 0.1 mmol), dimethyl phenylphosphonite 2d (173 mg, 0.1 mmol), NHPA1 (0.4 mg, 0.015 mmol) and DCM (0.5 mL) in a 2-dram vial with a PTFE cap was stirre",
COP(=O)(c1ccccc1)C(c1ccc(F)cc1)c1ccccc1O,,COP(=O)(c1ccccc1)C(c1ccc(F)cc1)c1ccccc1O>>,50300916,1,43,half reaction|has preparation,,methyl ((4-fluorophenyl)(2- hydroxyphenyl)methyl)(phenyl)phosphinate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00385-00386; 00394; 00411; 00412,diastereoselective reaction,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",methyl ((4-fluorophenyl)(2- hydroxyphenyl)methyl)(phenyl)phosphinate,81 percent,81,,,60 percent de,,,g.ix,Methyl ((2-hydroxyphenyl)(phenyl)methyl)(phenyl)phosphinate (4a as example):,"General procedure: A mixture of alcohol 1 (20.2 mg, 0.1 mmol), dimethyl phenylphosphonite 2d (173 mg, 0.1 mmol), NHPA1 (0.4 mg, 0.015 mmol) and DCM (0.5 mL) in a 2-dram vial with a PTFE cap was stirre",
[H][C@]12C[C@](C)(Oc3ccccc31)N1C(=O)c3ccccc3[C@@]12C(=O)OCC,,[H][C@]12C[C@](C)(Oc3ccccc31)N1C(=O)c3ccccc3[C@@]12C(=O)OCC>>,50394874,1,43,half reaction|has preparation,,C21H19NO4,,Preparation,1,35,Michael Addition,,acetonitrile,75713776; Patent; HENAN UNIVERSITY; CN108948034; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0023; 0024; 0025; 0026; 0027; 0028-0033; 0051,,toluene-4-sulfonic acid,C21H19NO4,80 percent,80,,,,,,1,Example 1,"General procedure: Preparation of chroman bridged isoindole 3a:Add isoxanthone 1a to a 10 mL hard glass reaction tube(0.22 mmol, 45.2 mg), o-hydroxychalcone 2a (0.20 mmol, 44.9 mg), p-toluenesulfonic",
[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)N3CCN(CCO)CC3)C(=O)O[C@]21[H],,[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)N3CCN(CCO)CC3)C(=O)O[C@]21[H]>>,51490858,1,43,half reaction|has preparation,,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxireno[",,Preparation,1,20,Michael Addition,,methanol|dichloromethane|methanol|dichloromethane,76478382; Patent; NANKAI UNIVERSITY; CN109651388; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|8,Cooling,,Paragraph 0014; 0015; 0034-0037,,triethylamine,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxireno[",75percent,75,,,,2,,1,Synthesis of Compound 10:,"General procedure: The reaction vial was placed in an ice water bath, and the reaction solvent dichloromethane (2 mL) and methanol (0.5 mL), carbon disulfide (0.lmL, l-5 mmol) and triethylamine (0.15",
[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)N(C)Cc3cccnc3)C(=O)O[C@]21[H],,[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)N(C)Cc3cccnc3)C(=O)O[C@]21[H]>>,51490860,1,43,half reaction|has preparation,,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxireno",,Preparation,1,20,Michael Addition,,methanol|dichloromethane|methanol|dichloromethane,76478382; Patent; NANKAI UNIVERSITY; CN109651388; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|8,Cooling,,Paragraph 0014; 0015; 0034; 0035; 0040; 0041,,triethylamine,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxireno",77percent,77,,,,2,,1,Synthesis of Compound 10:,"General procedure: The reaction vial was placed in an ice water bath, and the reaction solvent dichloromethane (2 mL) and methanol (0.5 mL), carbon disulfide (0.lmL, l-5 mmol) and triethylamine (0.15",
COc1ccc(C2=NN(S(=O)(=O)c3ccc(C)cc3)C(C(=O)c3ccccc3)C2)cc1,,COc1ccc(C2=NN(S(=O)(=O)c3ccc(C)cc3)C(C(=O)c3ccccc3)C2)cc1>>,51864131,1,43,half reaction|has preparation,,"(3-(4-methoxyphenyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0061; 0062,,Trimethylacetic acid,"(3-(4-methoxyphenyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methanone",80 percent,80,,,,,,6,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
CCc1ccc(C2=NN(S(=O)(=O)c3ccc(C)cc3)C(C(=O)c3ccccc3)C2)cc1,,CCc1ccc(C2=NN(S(=O)(=O)c3ccc(C)cc3)C(C(=O)c3ccccc3)C2)cc1>>,51864132,1,43,half reaction|has preparation,,"(3-(4-ethylphenyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0064; 0065,,Trimethylacetic acid,"(3-(4-ethylphenyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methanone",80 percent,80,,,,,,7,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
Cc1ccc(S(=O)(=O)N2N=C(c3ccccc3)CC2C(=O)c2cccc(C)c2)cc1,,Cc1ccc(S(=O)(=O)N2N=C(c3ccccc3)CC2C(=O)c2cccc(C)c2)cc1>>,51864133,1,43,half reaction|has preparation,,"(3-phenyl-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)(m-tolyl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0067; 0068,,Trimethylacetic acid,"(3-phenyl-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)(m-tolyl)methanone",78 percent,78,,,,,,8,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
Cc1ccc(C2=NN(S(=O)(=O)c3ccc(C)cc3)C(C(=O)c3ccccc3)C2)cc1,,Cc1ccc(C2=NN(S(=O)(=O)c3ccc(C)cc3)C(C(=O)c3ccccc3)C2)cc1>>,51864134,1,43,half reaction|has preparation,,"phenyl(3-(p-tolyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0049; 0050,,Trimethylacetic acid,"phenyl(3-(p-tolyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)methanone",82 percent,82,,,,,,2,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(F)c1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccccc31)[C@H](c1cccc(F)c1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118750,1,43,half reaction|has preparation,,C35H30FN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0030; 0041,,C31H33F5N4OS,C35H30FN3O8,84 percent,84,,,> 99 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](c1ccccc1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](c1ccccc1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118760,1,43,half reaction|has preparation,,C35H30FN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0051,,C31H33F5N4OS,C35H30FN3O8,82 percent,82,,,97 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](C1CC1)[C@H]2c1onc(C)c1[N+](=O)[O-],,[H][C@@]12Oc3ccccc3C(=O)[C@@]1([H])C[C@]1(C(=O)N(C(=O)OC(C)(C)C)c3ccc(F)cc31)[C@H](C1CC1)[C@H]2c1onc(C)c1[N+](=O)[O-]>>,52118764,1,43,half reaction|has preparation,,C32H30FN3O8,,Preparation,1,20,Michael Addition,,dichloromethane,77794914; Patent; GUIZHOU UNIVERSITY; CN110092793; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027; 0028; 0032; 0055,,C31H33F5N4OS,C32H30FN3O8,76 percent,76,,,96 percent ee,,,,,General procedure: Embodiments of the invention: 39.1 mg of bifunctional cerium oxide-chromone synthon 1a (0.10 mmol) was sequentially added to the reaction tube.27.6 mg of (E)-nitroisoxazole olefin c,
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1,,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1>>,52469901,1,43,half reaction|has preparation,,C15H18ClNO6,,Preparation,1,20,Michael Addition,,toluene,77728702; Patent; NANNING NORMAL UNIVERSITY; CN110078658; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,Paragraph 0063-0070,enantioselective reaction,C26H25F6N5OS|copper(II) bis(trifluoromethanesulfonate),C15H18ClNO6,79 percent,79,,,90 percent ee,,,3,Example 3,"General procedure: Catalytic effect experiments: The thiourea-dipyridylamide chiral catalysts 6a-6d of the present invention are used in an asymmetric reaction, for example, compound 6d is in an asymm",
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(OC)cc1,,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(OC)cc1>>,52469902,1,43,half reaction|has preparation,,C16H21NO7,,Preparation,1,20,Michael Addition,,toluene,77728702; Patent; NANNING NORMAL UNIVERSITY; CN110078658; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,14,,,Paragraph 0063-0070,enantioselective reaction,C26H25F6N5OS|copper(II) bis(trifluoromethanesulfonate),C16H21NO7,77 percent,77,,,93 percent ee,,,3,Example 3,"General procedure: Catalytic effect experiments: The thiourea-dipyridylamide chiral catalysts 6a-6d of the present invention are used in an asymmetric reaction, for example, compound 6d is in an asymm",
CC(C)(C)OC(=O)CCOCCOCCOCCOCCO,,CC(C)(C)OC(=O)CCOCCOCCOCCOCCO>>,53390932,2,43,half reaction|has preparation,,"tert-butyl 1-hydroxy-3,6,9,12-tetraoxapentadecan-15-oate",,"['Preparation', 'Preparation']","['1', '1']","['20', '20']",Michael Addition,,"['water|acetonitrile', 'tetrahydrofuran']","['79061590; Patent; YALE UNIVERSITY; WO2020/23851; A1; (2020);', '116897878; Patent; TSINGHUA UNIVERSITY CHINA; CN114349738; A; (2022);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,"['Paragraph 00399; 00413; 00415', 'Paragraph 0251-0253']",,"['N-benzyl-trimethylammonium hydroxide', 'N-benzyl-trimethylammonium hydroxide']","tert-butyl 1-hydroxy-3,6,9,12-tetraoxapentadecan-15-oate",60 percent,60,,,,,,,"['GP1: Michael-Addition', '(25) Preparation of intermediates 24-1, 24-2, 24-3, 24-4']","['General procedure: To a solution of the diol (5.0 eq.) and tert-Butyl acrylate (1.0 eq.) in Acetonitrile (30 mL) was added Triton B (40 wt. % in water, 0.037 eq.) was added the reaction mixture was st', 'General procedure: tert-butyl acrylate (7.3ml, 50mmol), 4eq ethylene glycol/diethylene glycol/triethylene glycol/ethylene glycol,Mix 0.1eq benzyltrimethylammonium hydroxide in dry THF and react at roo']",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(Cl)cc2)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(Cl)cc2)C=C(c2ccccc2)C(=O)O1>>,54358764,1,43,half reaction|has preparation,,C23H19ClN2O3,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0086,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C23H19ClN2O3,77 percent,77,,,,,,2,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@]12CCCN1c1ccc(Br)cc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1ccc(Br)cc1C[C@@]21Oc2ccccc2C1=O>>,54590675,1,43,half reaction|has preparation,,"(2R*,3a'R*)-7'-bromo-2',3',3a',5'-tetrahydro-1'H,3H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0117-0123,,scandium tris(trifluoromethanesulfonate),"(2R*,3a'R*)-7'-bromo-2',3',3a',5'-tetrahydro-1'H,3H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",75 percent,75,,,,,,11,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20mol%, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its catal",
[H][C@]12CCCN1c1cccc(Br)c1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cccc(Br)c1C[C@@]21Oc2ccccc2C1=O>>,54590678,1,43,half reaction|has preparation,,"(2R,3a'R)-6'-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0138-0144,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-6'-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",75 percent,75,,,,,,14,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@@]12CCCN1c1ccccc1C[C@]21Oc2ccc(OC)cc2C1=O,,[H][C@@]12CCCN1c1ccccc1C[C@]21Oc2ccc(OC)cc2C1=O>>,54590687,1,43,half reaction|has preparation,,"(2R,3a'R)-5-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0201-0207,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-5-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",75 percent,75,,,,,,23,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@@]12CCCN1c1ccccc1C[C@]21Sc2ccccc2C1=O,,[H][C@@]12CCCN1c1ccccc1C[C@]21Sc2ccccc2C1=O>>,54590689,1,43,half reaction|has preparation,,"(2R,3a'R)-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216-0224,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinolin]-3-one",84 percent,84,,,,,,25,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cc(C#N)ccc1C[C@@]21Sc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(C#N)ccc1C[C@@]21Sc2ccccc2C1=O>>,54590690,1,43,half reaction|has preparation,,"(2R,3a'R)-3-oxo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinoline]-8'-carbonitrile",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0225-0231,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-3-oxo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzo[b]thiophene-2,4'-pyrrolo[1,2-a]quinoline]-8'-carbonitrile",84 percent,84,,,,,,26,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
O=C1c2ccccc2SC12Cc1ccccc1N1CCc3ccccc3C12,,O=C1c2ccccc2SC12Cc1ccccc1N1CCc3ccccc3C12>>,54590695,1,43,half reaction|has preparation,,C24H19NOS,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0260-0266,,scandium tris(trifluoromethanesulfonate),C24H19NOS,81 percent,81,,,,,,31,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cc(C#N)ccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(C#N)ccc1C[C@@]21Oc2ccccc2C1=O>>,54590701,1,43,half reaction|has preparation,,"(2R,3a'R)-3-oxo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinoline]-8'-carbonitrile",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0068-0074,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-3-oxo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinoline]-8'-carbonitrile",82 percent,82,,,,,,4,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(C)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(C)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21>>,56433254,1,43,half reaction|has preparation,,C31H27ClN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0049,,QD-4,C31H27ClN2O7,76 percent,76,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(C)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(C)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>,56433259,1,43,half reaction|has preparation,,C31H28N2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032-0033,,QD-4,C31H28N2O7,83 percent,83,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
COc1ccc2c(c1)[C@@](Cc1coc3ccccc3c1=O)(C[C@@H]1CCOC1=O)C(=O)N2C(=O)OC(C)(C)C,,COc1ccc2c(c1)[C@@](Cc1coc3ccccc3c1=O)(C[C@@H]1CCOC1=O)C(=O)N2C(=O)OC(C)(C)C>>,69528489,1,43,half reaction|has preparation,,C29H29NO8,,Preparation,1,20,Michael Addition,,dichloromethane,136756749; Patent; GUIZHOU UNIVERSITY; CN118666820; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0024; 0027; 0031,,"1,8-diazabicyclo[5.4.0]undec-7-ene",C29H29NO8,80 percent,80,,,90.476 percent de,2,,,Embodiment of the present invention,"General procedure: in a sealed tube equipped with a magnetic stirrer, 3-chromogenic ketone-oxidized indole 1 (0.3mmol) and tulipin A (0.4mmol) are added, and then 4mL of dichloromethane and DBU (0.09m",
CC(C)(C)OC(=O)N1C(=O)[C@](Cc2coc3ccc(F)cc3c2=O)(C[C@@H]2CCOC2=O)c2cc(F)ccc21,,CC(C)(C)OC(=O)N1C(=O)[C@](Cc2coc3ccc(F)cc3c2=O)(C[C@@H]2CCOC2=O)c2cc(F)ccc21>>,69528490,1,43,half reaction|has preparation,,C28H25F2NO7,,Preparation,1,20,Michael Addition,,dichloromethane,136756749; Patent; GUIZHOU UNIVERSITY; CN118666820; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0024; 0027; 0032,,"1,8-diazabicyclo[5.4.0]undec-7-ene",C28H25F2NO7,79 percent,79,,,90.476 percent de,2,,,Embodiment of the present invention,"General procedure: in a sealed tube equipped with a magnetic stirrer, 3-chromogenic ketone-oxidized indole 1 (0.3mmol) and tulipin A (0.4mmol) are added, and then 4mL of dichloromethane and DBU (0.09m",
Cc1ccc2occ(C[C@]3(C[C@@H]4CCOC4=O)C(=O)N(C(=O)OC(C)(C)C)c4ccc(F)cc43)c(=O)c2c1,,Cc1ccc2occ(C[C@]3(C[C@@H]4CCOC4=O)C(=O)N(C(=O)OC(C)(C)C)c4ccc(F)cc43)c(=O)c2c1>>,69528491,1,43,half reaction|has preparation,,C29H28FNO7,,Preparation,1,20,Michael Addition,,dichloromethane,136756749; Patent; GUIZHOU UNIVERSITY; CN118666820; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0024; 0027; 0033,,"1,8-diazabicyclo[5.4.0]undec-7-ene",C29H28FNO7,78 percent,78,,,90.476 percent de,2,,,Embodiment of the present invention,"General procedure: in a sealed tube equipped with a magnetic stirrer, 3-chromogenic ketone-oxidized indole 1 (0.3mmol) and tulipin A (0.4mmol) are added, and then 4mL of dichloromethane and DBU (0.09m",
CC(C)(C)OC(=O)N1C(=O)[C@](Cc2coc3ccc(Cl)cc3c2=O)(C[C@@H]2CCOC2=O)c2ccccc21,,CC(C)(C)OC(=O)N1C(=O)[C@](Cc2coc3ccc(Cl)cc3c2=O)(C[C@@H]2CCOC2=O)c2ccccc21>>,69528492,1,43,half reaction|has preparation,,C28H26ClNO7,,Preparation,1,20,Michael Addition,,dichloromethane,136756749; Patent; GUIZHOU UNIVERSITY; CN118666820; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0024; 0027-0028,,"1,8-diazabicyclo[5.4.0]undec-7-ene",C28H26ClNO7,79 percent,79,,,90.476 percent de,2,,,Embodiment of the present invention,"General procedure: in a sealed tube equipped with a magnetic stirrer, 3-chromogenic ketone-oxidized indole 1 (0.3mmol) and tulipin A (0.4mmol) are added, and then 4mL of dichloromethane and DBU (0.09m",
Cc1ccc2occ(C[C@]3(C[C@@H]4CCOC4=O)C(=O)N(C(=O)OC(C)(C)C)c4ccccc43)c(=O)c2c1,,Cc1ccc2occ(C[C@]3(C[C@@H]4CCOC4=O)C(=O)N(C(=O)OC(C)(C)C)c4ccccc43)c(=O)c2c1>>,69528493,1,43,half reaction|has preparation,,C29H29NO7,,Preparation,1,20,Michael Addition,,dichloromethane,136756749; Patent; GUIZHOU UNIVERSITY; CN118666820; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0024; 0027; 0029,,"1,8-diazabicyclo[5.4.0]undec-7-ene",C29H29NO7,80 percent,80,,,90.476 percent de,2,,,Embodiment of the present invention,"General procedure: in a sealed tube equipped with a magnetic stirrer, 3-chromogenic ketone-oxidized indole 1 (0.3mmol) and tulipin A (0.4mmol) are added, and then 4mL of dichloromethane and DBU (0.09m",
CC(C)c1ccc2occ(C[C@]3(C[C@@H]4CCOC4=O)C(=O)N(C(=O)OC(C)(C)C)c4ccccc43)c(=O)c2c1,,CC(C)c1ccc2occ(C[C@]3(C[C@@H]4CCOC4=O)C(=O)N(C(=O)OC(C)(C)C)c4ccccc43)c(=O)c2c1>>,69528494,1,43,half reaction|has preparation,,C31H33NO7,,Preparation,1,20,Michael Addition,,dichloromethane,136756749; Patent; GUIZHOU UNIVERSITY; CN118666820; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0024; 0027; 0030,,"1,8-diazabicyclo[5.4.0]undec-7-ene",C31H33NO7,75 percent,75,,,90.476 percent de,2,,,Embodiment of the present invention,"General procedure: in a sealed tube equipped with a magnetic stirrer, 3-chromogenic ketone-oxidized indole 1 (0.3mmol) and tulipin A (0.4mmol) are added, and then 4mL of dichloromethane and DBU (0.09m",
Cc1ccc(-c2nc(-c3ccccc3)nc(C)c2-c2ccccc2)cc1,,Cc1ccc(-c2nc(-c3ccccc3)nc(C)c2-c2ccccc2)cc1>>,70507570,1,43,half reaction|has preparation,,C24H20N2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C24H20N2,84 percent,84,,,,,,3,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1nc(-c2ccccc2)nc(-c2ccc(F)cc2)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2ccc(F)cc2)c1-c1ccccc1>>,70507571,1,43,half reaction|has preparation,,C23H17FN2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C23H17FN2,78 percent,78,,,,,,6,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1nc(-c2ccccc2)nc(-c2ccc(Cl)cc2)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2ccc(Cl)cc2)c1-c1ccccc1>>,70507572,1,43,half reaction|has preparation,,C23H17ClN2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C23H17ClN2,77 percent,77,,,,,,7,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1ccc(-c2c(C)nc(-c3ccccc3)nc2-c2ccccc2)cc1,,Cc1ccc(-c2c(C)nc(-c3ccccc3)nc2-c2ccccc2)cc1>>,70507578,1,43,half reaction|has preparation,,C24H20N2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C24H20N2,78 percent,78,,,,,,14,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1c(Cc2ccccc2)nc(-c2ccccc2)nc1-c1ccccc1,,Cc1c(Cc2ccccc2)nc(-c2ccccc2)nc1-c1ccccc1>>,70507581,1,43,half reaction|has preparation,,C24H20N2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056-0057,,potassium carbonate,C24H20N2,81 percent,81,,,,,,25,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
CCCCCC(C(=O)N(C)C)c1ccccc1,,CCCCCC(C(=O)N(C)C)c1ccccc1>>,7199616,3,42,half reaction|has preparation,,"N, N-dimethyl-2-phenylheptanamide",,"['Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1']",40,Michael Addition,,acetone,"['74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);', '2564623; Patent; DELALANDE; US3573304; A; (1968); Chem.Abstr.; vol. 75; 63807;', '4012486; Patent; DELALANDE; GB1178400; A; (1970); Chem.Abstr.; vol. 76; 3536j; (1972);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,"['Entspr. Saeure, 1.)SOCl2, 2.)Dimethylamin', 'analog Bsp. I']","dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","N, N-dimethyl-2-phenylheptanamide",27 percent,27,,,,,,73,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccccc1,,COC(=O)C(C(=O)OC)C(C[N+](=O)[O-])c1ccccc1>>,7324026,3,42,half reaction|has preparation,,(2-nitro-1-phenyl-ethyl)-malonic acid dimethyl ester,,"['Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1']",20,Michael Addition,,dichloromethane|water,"['66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);', '4205871; Patent; LE G PED I IM A I GERZENA LE; DE2317180; A1; (1974); Chem.Abstr.; vol. 83; 43750;', '2542541; Patent; Perekalin V.V.et al.; SU236479; A1; (1977); Ref. Zh., Khim.; vol. 21; O93P; (1978);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0116-0117,"['Malonsaeurediaethylester, 1) Na in CH3OH, 2) Nitrostyrol 3) HCl/H2O', 'Malonester, 1.) Na, Me., 8-12grad, 2.) C6H5CHCHNO2/Me., 30 min, 3.) HCl/Eis']",potassium hydroxide,(2-nitro-1-phenyl-ethyl)-malonic acid dimethyl ester,30 percent,30,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
CCCCCC(Cc1ccccc1)C(=O)O,,CCCCCC(Cc1ccccc1)C(=O)O>>,8022276,2,42,half reaction|has preparation,,2-benzylheptanoic acid,,"['Preparation', 'Preparation (half reaction)']","['1', '1']",40,Michael Addition,,acetone,"['74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);', '4173259; Article; Patil et al.; Journal of the Karnatak University, Science; vol. 11; (1966); p. 42,43-51; Chem.Abstr.; vol. 67; 53847;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzylheptanoic acid,46 percent,46,,,,,,71,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCCC(C=O)CN(Cc1ccccc1)[C@@H](C)c1ccccc1,C=C(C=O)CCC.[H][C@@](C)(NCc1ccccc1)c1ccccc1,CCCC(C=O)CN(Cc1ccccc1)[C@@H](C)c1ccccc1>>C=C(C=O)CCC.[H][C@@](C)(NCc1ccccc1)c1ccccc1,10580315,1,42,full reaction,C21H27NO,2-methylidenepentanal|(S)-N-benzyl-1-phenylethylamine,,Chemical behaviour,1,,Retro-Michael reaction,Reactivity,,8939058; Patent; WARF; WO2007/112358; A1; (2007);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Figure 21,,,,,,,,,,,,,,
CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccc(F)cc1,,CC(=O)C(C(C)=O)C(C[N+](=O)[O-])c1ccc(F)cc1>>,39933731,1,42,half reaction|has preparation,,"3-[1-(4-fluorophenyl)-2-nitroethyl]pentane-2,4-dione",,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.266667,,,Paragraph 0093; 0106-0107,,potassium hydroxide,"3-[1-(4-fluorophenyl)-2-nitroethyl]pentane-2,4-dione",69 percent,69,,,,,,,,"General procedure: [0093] To further explore the methodology of this Example, this Example carried o",
CC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)CCCC1=O,,CC(=O)C1(C(C[N+](=O)[O-])c2ccccc2)CCCC1=O>>,39933737,1,42,half reaction|has preparation,,2-acetyl-2-((R)-2-nitro-1-phenylethyl)cyclopentan-1-one,,Preparation,1,20,Michael Addition,,dichloromethane|water,66108522; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; US2015/119583; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.583333,,,Paragraph 0094; 0124-0125,,potassium hydroxide,2-acetyl-2-((R)-2-nitro-1-phenylethyl)cyclopentan-1-one,66 percent,66,,,,,,,,"General procedure: Next, this Example evaluated the scope of the reaction with a variety of 1,3-dicarbonyl compounds as Michael donors, with substituents including methyl, methoxyl, tert-butyl, and cy",
CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,,CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1>>,44715963,3,42,half reaction|has preparation,,"(2R,3S)-2-nitro-1-(phenylethyl)pentanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']",20,Michael Addition,,"['dichloromethane|water', 'water|water']","['70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,"['Page/Page column 30; 31', 'Paragraph 0075; 0090; 0094; 0120; 0130']",,"['4-nitro-phenol', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(2R,3S)-2-nitro-1-(phenylethyl)pentanal",97 percent,97,,,97 percent ee,2,,"['3.B', '1.35', '1']","['B) Flow production of a library of compounds', '(35)', 'In Case of Aldehyde']","['General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m', '(35) (R)-2-[(S)-2-Nitro-1-phenylethyl]pentanal (Chemical Formula 3-35) [α]D20+15.40 (c 0.2, CH2Cl2);', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
Cc1ccccc1C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1,,Cc1ccccc1C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1>>,46311877,1,42,half reaction|has preparation,,"5-methyl-7-phenyl-4-(o-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","5-methyl-7-phenyl-4-(o-tolyl)-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",69percent,69,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc3ccccc3c1)CS(=O)(=O)O2,,Cc1nn(-c2ccccc2)c2c1C(/C=C/c1ccc3ccccc3c1)CS(=O)(=O)O2>>,46311912,1,42,half reaction|has preparation,,"(E)-5-methyl-4-(2-(naphthalen-2-yl)vinyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-5-methyl-4-(2-(naphthalen-2-yl)vinyl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",68percent,68,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
Cc1ccc(-c2cc(C3C(=O)N(Cc4ccccc4)c4ccccc43)c(-c3ccc(Cl)cc3)c3c2c2ccccc2n3C)cc1,,Cc1ccc(-c2cc(C3C(=O)N(Cc4ccccc4)c4ccccc43)c(-c3ccc(Cl)cc3)c3c2c2ccccc2n3C)cc1>>,46362247,1,42,half reaction|has preparation,,1-benzyl-3-(1-(4-chlorophenyl)-9-methyl-4-(p-tolyl)-9H-carbazol-2-yl)indolin-2-one,,Preparation,1,80,Michael Addition,,toluene,72289018; Patent; YANGZHOU UNIVERSITY; CN107162954; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,36,Inert atmosphere|Schlenk technique,,Paragraph 0019; 0020; 0025; 0026,,trifluorormethanesulfonic acid,1-benzyl-3-(1-(4-chlorophenyl)-9-methyl-4-(p-tolyl)-9H-carbazol-2-yl)indolin-2-one,70percent,70,,,,,,4,Example 1: Preparation of 1-benzyl-3- (9-methyl-4-phenyl-1- (p-methylphenyl) -9H-carbazol-2-yl) indoline-2-one,"General procedure: Under the protection of nitrogen,To a 10 mL Schlenck tube was added 0.5 mmol (0.066 g)N-methylindole,1.5 mmolketone,2 mL dry toluene,0.5 mmol (0.176 g)1-benzyl-3- (2-oxo-2- (p-methy",
Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410279,1,42,half reaction|has preparation,,C28H23Cl2N3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0032,,tetrabutylammomium bromide|potassium carbonate,C28H23Cl2N3O4,72 percent,72,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-],,Cc1noc(CC(c2ccccc2Cl)C2(Cc3ccc(Br)cc3)C(=O)N(C)c3ccccc32)c1[N+](=O)[O-]>>,46410285,1,42,half reaction|has preparation,,C28H23BrClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022; 0037,,tetrabutylammomium bromide|potassium carbonate,C28H23BrClN3O4,74 percent,74,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
CCCC(=O)CC[C@]1(C(=O)OC)Oc2ccccc2C1=O,,CCCC(=O)CC[C@]1(C(=O)OC)Oc2ccccc2C1=O>>,46690572,1,42,half reaction|has preparation,,"methyl (S)-3-oxo-2-(3-oxohexyl)-2,3-dihydrobenzofuran-2-carboxylate",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0082-0084,enantioselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),"methyl (S)-3-oxo-2-(3-oxohexyl)-2,3-dihydrobenzofuran-2-carboxylate",73 percent,73,,,99 percent ee,2,,31,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CC(C)CCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,CC(C)CCN[C@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,CC(C)CCN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F>>CC(C)CCN[C@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,48084638,1,42,half reaction|has preparation,,"(R)-3-methyl-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)butan-1-amine|(S)-3-methyl-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)butan-1-amine",,Preparation,1,-78|-78|70,Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0115; 0116; 0117; 0118; 0119; 0145; 0146-0149,,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-3-methyl-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)butan-1-amine|(S)-3-methyl-N-(1,1,1-trifluoro-3-nitro-2-phenylpropan-2-yl)butan-1-amine",79 percent|79 percent,79|79,,,89 percent ee|89 percent ee,3,,10,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
Cc1ccccc1CN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F,,Cc1ccccc1CN[C@@](C[N+](=O)[O-])(c1ccccc1)C(F)(F)F>>,48084643,1,42,half reaction|has preparation,,"(R)-1,1,1-trifluoro-N-(2-methylbenzyl)-3-nitro-2-phenylpropan-2-amine",,Preparation,1,-78|-78|70,Michael Addition|Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0099; 0100; 0101; 0102; 0103; 0104; 0105-0109,enantioselective reaction,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(R)-1,1,1-trifluoro-N-(2-methylbenzyl)-3-nitro-2-phenylpropan-2-amine",67 percent,67,,,91 percent ee,3,,2,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
CCOC(=O)C1C(=O)Oc2ccccc2C1C(C)(C)C,,CCOC(=O)C1C(=O)Oc2ccccc2C1C(C)(C)C>>,48936254,1,42,half reaction|has preparation,,ethyl 4-(tert-butyl)-2-oxochromane-3-carboxylate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",ethyl 4-(tert-butyl)-2-oxochromane-3-carboxylate,72 percent,72,,,,,,24,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CC(C)(C)CCS(=O)(=O)c1ccccc1,,CC(C)(C)CCS(=O)(=O)c1ccccc1>>,48936265,1,42,half reaction|has preparation,,"3,3-dimethyl-1-phenylsulphonyl butane",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","3,3-dimethyl-1-phenylsulphonyl butane",74 percent,74,,,,,,35,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CN(C)C(=O)C(CC1CCCC1)c1ccccc1,,CN(C)C(=O)C(CC1CCCC1)c1ccccc1>>,48936273,1,42,half reaction|has preparation,,"3-cyclopentyl-N,N-dimethyl-2-phenylpropanamide",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0112,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","3-cyclopentyl-N,N-dimethyl-2-phenylpropanamide",65 percent,65,,,,,,45,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
Cc1ccc(C(C#N)CC2CCCC2)cc1,,Cc1ccc(C(C#N)CC2CCCC2)cc1>>,48936274,1,42,half reaction|has preparation,,3-cyclopentyl-2-(p-tolyl)propanenitrile,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0112,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",3-cyclopentyl-2-(p-tolyl)propanenitrile,66 percent,66,,,,,,46,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
COC(=O)C(CC1CCCCC1)c1ccccc1,,COC(=O)C(CC1CCCCC1)c1ccccc1>>,48936276,1,42,half reaction|has preparation,,methyl 3-cyclohexyl-2-phenylpropanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0121,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 3-cyclohexyl-2-phenylpropanoate,68 percent,68,,,,,,49,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
O=C(O)C(Cc1ccccc1)CC1CCCCC1,,O=C(O)C(Cc1ccccc1)CC1CCCCC1>>,48936280,1,42,half reaction|has preparation,,2-benzyl-3-cyclohexylpropanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0122,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-3-cyclohexylpropanoic acid,68 percent,68,,,,,,53,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCCCC(c1ccccc1)C(C(=O)OCC)C(=O)OCC,,CCCCC(c1ccccc1)C(C(=O)OCC)C(=O)OCC>>,48936292,1,42,half reaction|has preparation,,diethyl 2-(1-phenylpentyl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(1-phenylpentyl)malonate,67 percent,67,,,,,,67,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCCCCC(C(=O)OC)c1ccccc1Br,,CCCCCC(C(=O)OC)c1ccccc1Br>>,48936294,1,42,half reaction|has preparation,,methyl 2-(2-bromophenyl)heptanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 2-(2-bromophenyl)heptanoate,69 percent,69,,,,,,69,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
COP(=O)(c1ccccc1)C(c1ccc(-c2ccccc2)cc1)c1ccccc1O,,COP(=O)(c1ccccc1)C(c1ccc(-c2ccccc2)cc1)c1ccccc1O>>,50300917,1,42,half reaction|has preparation,,"methyl ([1,1'-biphenyl]-4-yl(2-hydroxyphenyl)methyl)(phenyl)phosphinate",,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00385-00386; 00395; 00411; 00412,diastereoselective reaction,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide","methyl ([1,1'-biphenyl]-4-yl(2-hydroxyphenyl)methyl)(phenyl)phosphinate",69 percent,69,,,60 percent de,,,g.x,Methyl ((2-hydroxyphenyl)(phenyl)methyl)(phenyl)phosphinate (4a as example):,"General procedure: A mixture of alcohol 1 (20.2 mg, 0.1 mmol), dimethyl phenylphosphonite 2d (173 mg, 0.1 mmol), NHPA1 (0.4 mg, 0.015 mmol) and DCM (0.5 mL) in a 2-dram vial with a PTFE cap was stirre",
[H][C@]12C[C@](c3ccco3)(Oc3ccccc31)N1C(=O)c3ccccc3[C@@]12C(=O)OCC,,[H][C@]12C[C@](c3ccco3)(Oc3ccccc31)N1C(=O)c3ccccc3[C@@]12C(=O)OCC>>,50394875,1,42,half reaction|has preparation,,C24H19NO5,,Preparation,1,35,Michael Addition,,acetonitrile,75713776; Patent; HENAN UNIVERSITY; CN108948034; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0023; 0024; 0025; 0026; 0027; 0028-0033; 0050,,toluene-4-sulfonic acid,C24H19NO5,68 percent,68,,,,,,1,Example 1,"General procedure: Preparation of chroman bridged isoindole 3a:Add isoxanthone 1a to a 10 mL hard glass reaction tube(0.22 mmol, 45.2 mg), o-hydroxychalcone 2a (0.20 mmol, 44.9 mg), p-toluenesulfonic",
[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)NCc3cccnc3)C(=O)O[C@]21[H],,[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)NCc3cccnc3)C(=O)O[C@]21[H]>>,51490859,1,42,half reaction|has preparation,,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxir",,Preparation,1,20,Michael Addition,,methanol|dichloromethane|methanol|dichloromethane,76478382; Patent; NANKAI UNIVERSITY; CN109651388; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|8,Cooling,,Paragraph 0014; 0015; 0034; 0035; 0038; 0039,,triethylamine,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxir",68percent,68,,,,2,,1,Synthesis of Compound 10:,"General procedure: The reaction vial was placed in an ice water bath, and the reaction solvent dichloromethane (2 mL) and methanol (0.5 mL), carbon disulfide (0.lmL, l-5 mmol) and triethylamine (0.15",
Cc1ccc(S(=O)(=O)N2N=C(c3ccccc3)CC2C(=O)c2ccc(Br)cc2)cc1,,Cc1ccc(S(=O)(=O)N2N=C(c3ccccc3)CC2C(=O)c2ccc(Br)cc2)cc1>>,51864136,1,42,half reaction|has preparation,,"(4-bromophenyl)(3-phenyl-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0055; 0056,,Trimethylacetic acid,"(4-bromophenyl)(3-phenyl-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)methanone",72 percent,72,,,,,,4,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
CC(C)(C)c1ccc(S(=O)(=O)N2N=C(c3ccccc3)CC2C(=O)c2ccccc2)cc1,,CC(C)(C)c1ccc(S(=O)(=O)N2N=C(c3ccccc3)CC2C(=O)c2ccccc2)cc1>>,51864137,1,42,half reaction|has preparation,,"(1-((4-(tert-butyl)phenyl)sulfonyl)-3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methanone",,Preparation,1,100,Michael Addition,,toluene,77424575; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN109988114; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,Schlenk technique,,Paragraph 0036-0043; 0058; 0059,,Trimethylacetic acid,"(1-((4-(tert-butyl)phenyl)sulfonyl)-3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methanone",71 percent,71,,,,,,5,,"General procedure: Add 3 parts of divalent copper salt, pivalic acid, sulfur ylide (II), benzenesulfonyl hydrazide (III) and organic solvent in a 35 ml Schlenk tube according to the raw material ratio",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(C#N)cc2)C=C(c2ccc(Br)cc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(C#N)cc2)C=C(c2ccc(Br)cc2)C(=O)O1>>,54358759,1,42,half reaction|has preparation,,C24H18BrN3O3,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0118-0122,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C24H18BrN3O3,72 percent,72,,,,,,9,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@]12CCCN1c1cc(Cl)ccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(Cl)ccc1C[C@@]21Oc2ccccc2C1=O>>,54590670,1,42,half reaction|has preparation,,"(2R,3a'R)-8'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0082-0088,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-8'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",74 percent,74,,,,,,6,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cc(Br)ccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(Br)ccc1C[C@@]21Oc2ccccc2C1=O>>,54590671,1,42,half reaction|has preparation,,"(2R,3a'R)-8'-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0089-0095,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-8'-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",73 percent,73,,,,,,7,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1c(Cl)cccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1c(Cl)cccc1C[C@@]21Oc2ccccc2C1=O>>,54590672,1,42,half reaction|has preparation,,"(2R,3a'R)-9'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0096-0102,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-9'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",73 percent,73,,,,,,8,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cccc(Cl)c1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cccc(Cl)c1C[C@@]21Oc2ccccc2C1=O>>,54590677,1,42,half reaction|has preparation,,"(2R,3a'R)-6'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0131-0137,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-6'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",73 percent,73,,,,,,13,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@@]12CCCN1c1ncccc1C[C@]21Oc2ccccc2C1=O,,[H][C@@]12CCCN1c1ncccc1C[C@]21Oc2ccccc2C1=O>>,54590686,1,42,half reaction|has preparation,,"(2R,6a'R)-6a',7',8',9'-tetrahydro-3H,5'H-spiro[benzofuran-2,6'-pyrrolo[1,2-a][1,7]naphthyridin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0194-0200,,scandium tris(trifluoromethanesulfonate),"(2R,6a'R)-6a',7',8',9'-tetrahydro-3H,5'H-spiro[benzofuran-2,6'-pyrrolo[1,2-a][1,7]naphthyridin]-3-one",69 percent,69,,,,,,22,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
O=C1c2ccccc2SC12Cc1ccccc1N1CCSCC12,,O=C1c2ccccc2SC12Cc1ccccc1N1CCSCC12>>,54590697,1,42,half reaction|has preparation,,"1',2',4',4a'-tetrahydro-3H,6'H-spiro[benzo[b]thiophene-2,5'-[1,4]thiazino[4,3-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0274-0280,,scandium tris(trifluoromethanesulfonate),"1',2',4',4a'-tetrahydro-3H,6'H-spiro[benzo[b]thiophene-2,5'-[1,4]thiazino[4,3-a]quinolin]-3-one",69 percent,69,,,,,,33,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cc(OC)ccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(OC)ccc1C[C@@]21Oc2ccccc2C1=O>>,54590700,1,42,half reaction|has preparation,,"(2R,3a'R)-8'-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0061-0067,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-8'-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",71 percent,71,,,,,,3,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21>>,56433253,1,42,half reaction|has preparation,,C30H25ClN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0048,,QD-4,C30H25ClN2O7,74 percent,74,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(OC)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(OC)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21>>,56433256,1,42,half reaction|has preparation,,C31H27ClN2O8,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0051,,QD-4,C31H27ClN2O8,70 percent,70,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
Cc1nc(-c2ccccc2)nc(-c2ccc(Br)cc2)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2ccc(Br)cc2)c1-c1ccccc1>>,70507573,1,42,half reaction|has preparation,,C23H17BrN2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C23H17BrN2,68 percent,68,,,,,,8,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1nc(-c2ccccc2)nc(-c2ccco2)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2ccco2)c1-c1ccccc1>>,70507574,1,42,half reaction|has preparation,,C21H16N2O,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C21H16N2O,71 percent,71,,,,,,9,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1nc(-c2ccccc2)nc(-c2ccccc2)c1-c1ccc(F)cc1,,Cc1nc(-c2ccccc2)nc(-c2ccccc2)c1-c1ccc(F)cc1>>,70507579,1,42,half reaction|has preparation,,C23H17FN2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056-0057,,potassium carbonate,C23H17FN2,73 percent,73,,,,,,17,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
CCCCCCCC(CC(=O)CCc1ccc(O)c(OC)c1)SC[C@H](N)C(=O)O,,CCCCCCCC(CC(=O)CCc1ccc(O)c(OC)c1)SC[C@H](N)C(=O)O>>,42359480,1,41,half reaction|has preparation,,5-cysteinyl-[8]-shogaol,,Preparation,1,20,Michael Addition,,methanol|water,68457569; Patent; UNIVERSITY OF NORTH CAROLINA SYSTEM; US9272994; B1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Page/Page column 48; 49; 60,,sodium hydrogencarbonate,5-cysteinyl-[8]-shogaol,55 percent,55,,,,,,,Synthesis of 5-Cysteinyl-[6]-Shogaol (M2),"General procedure: Synthesis of 5-Cysteinyl-[6]-Shogaol (M2) General procedure A was followed using [6]-shogaol (200 mg, 0.72 mmol), L-cysteine (263 mg, 2.17 mmol), and NaHCO3 (3 mg, 0.036 mmol) in me",
Cc1cc(CC(C[N+](=O)[O-])c2cccc(Br)n2)nc(-n2c(C)ccc2C)c1,,Cc1cc(CC(C[N+](=O)[O-])c2cccc(Br)n2)nc(-n2c(C)ccc2C)c1>>,43038331,1,41,half reaction|has preparation,,"2-(2-(6-bromopyridin-2-yl)-3-nitropropyl)-6-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methylpyridine",,Preparation,1,0|-78,Michael Addition,,tetrahydrofuran|hexane|tetrahydrofuran|hexane,68915737; Patent; NORTHWESTERN UNIVERSITY ILLINOIS; WO2016/73623; A2; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0285; 0289,,n-butyllithium,"2-(2-(6-bromopyridin-2-yl)-3-nitropropyl)-6-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methylpyridine",60 percent,60,,,,2,,127,"2-(2,5-Dimethyl-1H-pyrrol-1-yl)-6-(3-(1-(6-(2,5-dimethyl-1H-pyrrol-1-yl)-4- methylpyridin-2-yl)-3-nitropropan-2-yl)phenethyl)-4-methylpyridine (23).","General procedure: The title compound (531 mg, 61%) was prepared according to a similar procedures described in the synthesis of 19a- b using n-BuLi (1.6 M, 1.21 mL, 1.94 mmol), 9 (387 mg, 1.94 mmol),",
COc1ccccc1C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1,,COc1ccccc1C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1>>,46311878,1,41,half reaction|has preparation,,"4-(2-methoxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(2-methoxyphenyl)-5-methyl-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",62percent,62,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
O=S1(=O)CC(c2ccccc2)c2c(-c3ccccc3)nn(-c3ccccc3)c2O1,,O=S1(=O)CC(c2ccccc2)c2c(-c3ccccc3)nn(-c3ccccc3)c2O1>>,46311890,1,41,half reaction|has preparation,,"4,5,7-triphenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0036; 0037; 0038; 0049,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4,5,7-triphenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",55percent,55,,,,,,,Example 1,"General procedure: 250 mL of reaction flask was added 2-phenyl-vinyl-sulfonyl fluoride (3.72 g, 20 mmol)1-phenyl-3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.15 g, 1.0 mmol, 5 mol%), NaHCO3 (1.68 g",
Cc1ccccc1/C=C/C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1,,Cc1ccccc1/C=C/C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1>>,46311909,1,41,half reaction|has preparation,,"(E)-5-methyl-4-(2-methylstyryl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","(E)-5-methyl-4-(2-methylstyryl)-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazole 2,2-dioxide",57percent,57,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
CCOC(=O)/C=C/C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1,,CCOC(=O)/C=C/C1CS(=O)(=O)Oc2c1c(C)nn2-c1ccccc1>>,46311913,1,41,half reaction|has preparation,,"ethyl (E)-3-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)acrylate",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0042; 0043; 0044; 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","ethyl (E)-3-(5-methyl-2,2-dioxido-7-phenyl-4,7-dihydro-3H-[1,2]oxathiino[6,5-c]pyrazol-4-yl)acrylate",61percent,61,,,,,,,Example 3,"General procedure: (1E, 3E) -4-phenyl-1,3-diene-1-sulfonyl fluoride (4.24 g, 20 mmol), 1-benzene 3-methyl-5-pyrazolone (3.48 g, 20 mmol), DBU (0.61 g, 4.0 mmol, 20 mol%), NaHCO3 (1.68 g, 20 mmol), DCM",
CCOC(=O)C(C(=O)OCC)C(c1ccc(OC)cc1)C(C)(C)C,,CCOC(=O)C(C(=O)OCC)C(c1ccc(OC)cc1)C(C)(C)C>>,48936252,1,41,half reaction|has preparation,,"diethyl 2-(1-(4-methoxyphenyl)-2,2-dimethylpropyl)malonate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","diethyl 2-(1-(4-methoxyphenyl)-2,2-dimethylpropyl)malonate",60 percent,60,,,,,,22,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CCOC(=O)C(C(=O)OCC)C(CCc1ccccc1)C(C)(C)C,,CCOC(=O)C(C(=O)OCC)C(CCc1ccccc1)C(C)(C)C>>,48936253,1,41,half reaction|has preparation,,"diethyl 2-(4,4-dimethyl-1-phenylpentan-3-yl)malonate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","diethyl 2-(4,4-dimethyl-1-phenylpentan-3-yl)malonate",60 percent,60,,,,,,23,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CCOC(=O)C1C(=O)Oc2ccc(Br)cc2C1C(C)(C)C,,CCOC(=O)C1C(=O)Oc2ccc(Br)cc2C1C(C)(C)C>>,48936255,1,41,half reaction|has preparation,,C16H19BrO4,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",C16H19BrO4,62 percent,62,,,,,,25,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
COC(=O)C(CC(C)(C)C)c1ccc(OC)cc1,,COC(=O)C(CC(C)(C)C)c1ccc(OC)cc1>>,48936257,1,41,half reaction|has preparation,,"methyl 2-(4-methoxyphenyl)-4,4-dimethylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0088,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","methyl 2-(4-methoxyphenyl)-4,4-dimethylpentanoate",61 percent,61,,,,,,27,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
COC(=O)C(CC(C)(C)C)c1ccc(Cl)cc1,,COC(=O)C(CC(C)(C)C)c1ccc(Cl)cc1>>,48936259,1,41,half reaction|has preparation,,"methyl 2-(4-chlorophenyl)-4,4-dimethylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","methyl 2-(4-chlorophenyl)-4,4-dimethylpentanoate",63 percent,63,,,,,,29,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
COC(=O)C(CC1CCCCC1)c1ccc(OC)cc1,,COC(=O)C(CC1CCCCC1)c1ccc(OC)cc1>>,48936278,1,41,half reaction|has preparation,,methyl 3-cyclohexyl-2-(4-methoxyphenyl)propanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0122,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 3-cyclohexyl-2-(4-methoxyphenyl)propanoate,62 percent,62,,,,,,51,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1,,CCOC(=O)C(C(=O)OCC)C(c1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1>>,48936287,1,41,half reaction|has preparation,,diethyl 2-((1-(tert-butoxycarbonyl)piperidin-4-yl)(phenyl)methyl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0138,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-((1-(tert-butoxycarbonyl)piperidin-4-yl)(phenyl)methyl)malonate,60 percent,60,,,,,,61,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(C)CCNC(=O)OC(C)(C)C,,CCOC(=O)C(C(=O)OCC)C(C)CCNC(=O)OC(C)(C)C>>,48936297,1,41,half reaction|has preparation,,diethyl 2-(4-((tert-butoxycarbonyl)amino)butan-2-yl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(4-((tert-butoxycarbonyl)amino)butan-2-yl)malonate,62 percent,62,,,,,,74,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(C)CCO[Si](C)(C)C(C)(C)C,,CCOC(=O)C(C(=O)OCC)C(C)CCO[Si](C)(C)C(C)(C)C>>,48936304,1,41,half reaction|has preparation,,diethyl 2-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0166,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(4-((tert-butyldimethylsilyl)oxy)butan-2-yl)malonate,55 percent,55,,,,,,81,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCOP(=O)(OCC)C(c1ccccc1O)c1ccccc1OC,,CCOP(=O)(OCC)C(c1ccccc1O)c1ccccc1OC>>,50300910,1,41,half reaction|has preparation,,diethyl ((2-hydroxyphenyl)(2-methoxyphenyl)methyl)phosphonate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00377; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",diethyl ((2-hydroxyphenyl)(2-methoxyphenyl)methyl)phosphonate,64 percent,64,,,,,,f.xiv,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
COP(=O)(c1ccccc1)C(c1ccc2ccccc2c1)c1ccccc1O,,COP(=O)(c1ccccc1)C(c1ccc2ccccc2c1)c1ccccc1O>>,50300919,1,41,half reaction|has preparation,,methyl ((2-hydroxyphenyl)(naphthalen-2-yl)methyl)(phenyl)phosphinate,,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00385-00386; 00396; 00411; 00412,diastereoselective reaction,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide",methyl ((2-hydroxyphenyl)(naphthalen-2-yl)methyl)(phenyl)phosphinate,58 percent,58,,,98 percent de,,,g.xi,Methyl ((2-hydroxyphenyl)(phenyl)methyl)(phenyl)phosphinate (4a as example):,"General procedure: A mixture of alcohol 1 (20.2 mg, 0.1 mmol), dimethyl phenylphosphonite 2d (173 mg, 0.1 mmol), NHPA1 (0.4 mg, 0.015 mmol) and DCM (0.5 mL) in a 2-dram vial with a PTFE cap was stirre",
[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(F)cc2)C=C(c2ccccc2)C(=O)O1,,[H][C@@]1([C@@H](CC(=O)c2nccn2C)c2ccc(F)cc2)C=C(c2ccccc2)C(=O)O1>>,54358765,1,41,half reaction|has preparation,,C23H19FN2O3,,Preparation,1,40,Michael Addition,,toluene,80020652; Patent; SUN YAT SEN UNIVERSITY CHINA; CN111233843; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0075-0081; 0087-0091,,"bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]}",C23H19FN2O3,61 percent,61,,,,,,3,,"General procedure: 3-phenyl-cyclopropene-3-carboxylic acid (48.0 mg, 0.3 mmol, 1.5 equiv.), 3-(4-bromophenyl)-1-(1-methylimidazolyl)-propenone (29.1 mg, 0.2 mmol, 1.0 equiv.) and Rh2(esp) 2 (3.0 mg, 2",
[H][C@]12CCCN1c1cc(C(F)(F)F)ccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(C(F)(F)F)ccc1C[C@@]21Oc2ccccc2C1=O>>,54590669,1,41,half reaction|has preparation,,"(2R,3a'R)-8'-(trifluoromethyl)-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0075-0081,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-8'-(trifluoromethyl)-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",62 percent,62,,,,,,5,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1ccc(F)cc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1ccc(F)cc1C[C@@]21Oc2ccccc2C1=O>>,54590673,1,41,half reaction|has preparation,,"(2R,3a'R)-7'-fluoro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0103-0109,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-7'-fluoro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",61 percent,61,,,,,,9,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1ccc(Cl)cc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1ccc(Cl)cc1C[C@@]21Oc2ccccc2C1=O>>,54590674,1,41,half reaction|has preparation,,"(2R,3a'R)-7'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0110-0116,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-7'-chloro-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",57 percent,57,,,,,,10,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1cccc(OC)c1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cccc(OC)c1C[C@@]21Oc2ccccc2C1=O>>,54590679,1,41,half reaction|has preparation,,"(2R,3a'R)-6'-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0145-0151,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-6'-methoxy-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",58 percent,58,,,,,,15,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
O=C1c2ccccc2OC12Cc1ccccc1N1CCCCC12,,O=C1c2ccccc2OC12Cc1ccccc1N1CCCCC12>>,54590681,1,41,half reaction|has preparation,,C20H19NO2,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0159-0165,,scandium tris(trifluoromethanesulfonate),C20H19NO2,62 percent,62,,,,,,17,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12CCCN1c1ccc3ccccc3c1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1ccc3ccccc3c1C[C@@]21Oc2ccccc2C1=O>>,54590685,1,41,half reaction|has preparation,,"(2R,12a'R)-1',2',3',12a'-tetrahydro-3H,11'H-spiro[benzofuran-2,12'-benzo[f]pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0187-0193,,scandium tris(trifluoromethanesulfonate),"(2R,12a'R)-1',2',3',12a'-tetrahydro-3H,11'H-spiro[benzofuran-2,12'-benzo[f]pyrrolo[1,2-a]quinolin]-3-one",64 percent,64,,,,,,21,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@@]12CCCN1c1ccccc1C[C@@]21C(=O)c2ccccc2N1C(C)=O,,[H][C@@]12CCCN1c1ccccc1C[C@@]21C(=O)c2ccccc2N1C(C)=O>>,54590698,1,41,half reaction|has preparation,,"(2R,3a'R)-1-acetyl-1',2',3',3a'-tetrahydro-5'H-spiro[indoline-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0216; 0217; 0281-0287,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-1-acetyl-1',2',3',3a'-tetrahydro-5'H-spiro[indoline-2,4'-pyrrolo[1,2-a]quinolin]-3-one",63 percent,63,,,,,,34,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(F)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(F)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>,56433247,1,41,half reaction|has preparation,,C30H25FN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032; 0038,,QD-4,C30H25FN2O7,63 percent,63,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3cc(C)ccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,,[H][C@]12C(=O)c3cc(C)ccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>,56433248,1,41,half reaction|has preparation,,C31H28N2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032; 0039,,QD-4,C31H28N2O7,55 percent,55,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(OC)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(OC)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21>>,56433249,1,41,half reaction|has preparation,,C32H30N2O8,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032; 0043,,QD-4,C32H30N2O8,62 percent,62,,,96 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1C)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1C)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>,56433260,1,41,half reaction|has preparation,,C31H28N2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032; 0034,,QD-4,C31H28N2O7,60 percent,60,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(OC)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(OC)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>,56433261,1,41,half reaction|has preparation,,C31H28N2O8,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032; 0036,,QD-4,C31H28N2O8,63 percent,63,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(Cl)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(Cl)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccccc21>>,56433262,1,41,half reaction|has preparation,,C30H25ClN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0032; 0037,,QD-4,C30H25ClN2O7,55 percent,55,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
CCCCN1C(=O)[C@@]([C@H](CC(=O)c2ccccc2)c2ccccc2)(n2ccc(=O)[nH]2)c2ccccc21,,CCCCN1C(=O)[C@@]([C@H](CC(=O)c2ccccc2)c2ccccc2)(n2ccc(=O)[nH]2)c2ccccc21>>,60137754,1,41,half reaction|has preparation,,"(±)-(S)-1-butyl-3-((R)-3-oxo-1,3-diphenylpropyl)-3-(3-oxo-2,3-dihydro-1H-pyrazol-1-yl)indolin-2-one",,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0095-0096; 0098-0100,,sodium tertiary butoxide,"(±)-(S)-1-butyl-3-((R)-3-oxo-1,3-diphenylpropyl)-3-(3-oxo-2,3-dihydro-1H-pyrazol-1-yl)indolin-2-one",55 percent,55,,,,,,8,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
Cc1nc(-c2ccccc2)nc(-c2cccs2)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2cccs2)c1-c1ccccc1>>,70507575,1,41,half reaction|has preparation,,C21H16N2S,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C21H16N2S,57 percent,57,,,,,,10,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
Cc1nc(-c2ccccc2)nc(-c2ccccc2)c1-c1ccc(Br)cc1,,Cc1nc(-c2ccccc2)nc(-c2ccccc2)c1-c1ccc(Br)cc1>>,70507580,1,41,half reaction|has preparation,,C23H17BrN2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056-0057,,potassium carbonate,C23H17BrN2,64 percent,64,,,,,,19,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(OC)cc1,,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(OC)cc1>>,40051224,1,40,half reaction|has preparation,,(S)-ethyl-2-carboethoxy-4-nitro-3-(4-methoxyphenyl)butyrate,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H44CuF12N7O3S(2+)*2ClO4(1-)|triethylamine,(S)-ethyl-2-carboethoxy-4-nitro-3-(4-methoxyphenyl)butyrate,46 percent,46,,,,,,11.2,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,40051226,1,40,half reaction|has preparation,,(S)-2-[1-(4-bromophenyl)-2-nitroethyl]malonic acid diethyl ester,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H44CuF12N7O3S(2+)*2ClO4(1-)|triethylamine,(S)-2-[1-(4-bromophenyl)-2-nitroethyl]malonic acid diethyl ester,45 percent,45,,,,,,11.4,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(O)cc1,,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1ccc(O)cc1>>,40051227,1,40,half reaction|has preparation,,C15H19NO7,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H44CuF12N7O3S(2+)*2ClO4(1-)|triethylamine,C15H19NO7,51 percent,51,,,,,,11.5,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
CCCCCCCCCC(CC(=O)CCc1ccc(O)c(OC)c1)SC[C@H](N)C(=O)O,,CCCCCCCCCC(CC(=O)CCc1ccc(O)c(OC)c1)SC[C@H](N)C(=O)O>>,42359481,1,40,half reaction|has preparation,,5-cysteinyl-[10]-shogaol,,Preparation,1,20,Michael Addition,,methanol|water,68457569; Patent; UNIVERSITY OF NORTH CAROLINA SYSTEM; US9272994; B1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Page/Page column 48; 49; 60,,sodium hydrogencarbonate,5-cysteinyl-[10]-shogaol,54 percent,54,,,,,,,Synthesis of 5-Cysteinyl-[6]-Shogaol (M2),"General procedure: Synthesis of 5-Cysteinyl-[6]-Shogaol (M2) General procedure A was followed using [6]-shogaol (200 mg, 0.72 mmol), L-cysteine (263 mg, 2.17 mmol), and NaHCO3 (3 mg, 0.036 mmol) in me",
Cc1cc(CC(C[N+](=O)[O-])c2cncc(Br)c2)nc(-n2c(C)ccc2C)c1,,Cc1cc(CC(C[N+](=O)[O-])c2cncc(Br)c2)nc(-n2c(C)ccc2C)c1>>,43038332,1,40,half reaction|has preparation,,"2-(2-(5-bromopyridin-3-yl)-3-nitropropyl)-6-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methylpyridine",,Preparation,1,0|-78,Michael Addition,,tetrahydrofuran|hexane|tetrahydrofuran|hexane,68915737; Patent; NORTHWESTERN UNIVERSITY ILLINOIS; WO2016/73623; A2; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0285; 0290,,n-butyllithium,"2-(2-(5-bromopyridin-3-yl)-3-nitropropyl)-6-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methylpyridine",51 percent,51,,,,2,,128,"2-(2,5-Dimethyl-1H-pyrrol-1-yl)-6-(3-(1-(6-(2,5-dimethyl-1H-pyrrol-1-yl)-4- methylpyridin-2-yl)-3-nitropropan-2-yl)phenethyl)-4-methylpyridine (23).","General procedure: The title compound (531 mg, 61%) was prepared according to a similar procedures described in the synthesis of 19a- b using n-BuLi (1.6 M, 1.21 mL, 1.94 mmol), 9 (387 mg, 1.94 mmol),",
Cc1cccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1,,Cc1cccc(C(Cc2onc(C)c2[N+](=O)[O-])C2(Cc3ccc(Cl)cc3)C(=O)N(C)c3ccccc32)c1>>,46410282,1,40,half reaction|has preparation,,C29H26ClN3O4,,Preparation,1,50,Michael Addition,,dichloromethane,72379859; Patent; GUIZHOU UNIVERSITY; CN107235969; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,,Paragraph 0018; 0019; 0020; 0021; 0022,,tetrabutylammomium bromide|potassium carbonate,C29H26ClN3O4,50 percent,50,,,,,,,"Preparation of key intermediate 3 of hexahydropyridine-2,3-indol-2-one skeleton compound","General procedure: Compound 3aa: 94.8 mg was added to the reaction flaskN-methyl-3-benzyloxyindole 1a (0.4 mmol) and138mgNitroisoxazole olefins2a (0.6 mmol),Was dissolved in 5.0 mL of dichloromethane,",
O=[N+]([O-])C[C@](NC1CC1)(c1ccc(C(F)(F)F)cc1)C(F)(F)F,O=[N+]([O-])C[C@@](NC1CC1)(c1ccc(C(F)(F)F)cc1)C(F)(F)F,O=[N+]([O-])C[C@](NC1CC1)(c1ccc(C(F)(F)F)cc1)C(F)(F)F>>O=[N+]([O-])C[C@@](NC1CC1)(c1ccc(C(F)(F)F)cc1)C(F)(F)F,48084650,1,40,half reaction|has preparation,,"(R)-N-(1,1,1-trifluoro-3-nitro-2-(4-(trifluoromethyl)phenyl)propan-2-yl)cyclopropanamine|(S)-N-(1,1,1-trifluoro-3-nitro-2-(4-(trifluoromethyl)phenyl)propan-2-yl)cyclopropanamine",,Preparation,1,-78|-78|70,Michael Addition,,toluene|toluene|ethanol,73410962; Patent; SHENZHEN GRADUATE SCHOOL; CN105367427; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5|36|2,Inert atmosphere|Molecular sieve,,Paragraph 0115; 0116; 0117; 0118; 0119; 0180;0181-0184,,"1,1,1,3',3',3'-hexafluoro-propanol|Lithium 1,1,1,3,3,3-hexamethyldisilazide|chloro-trimethyl-silane|zinc","(S)-N-(1,1,1-trifluoro-3-nitro-2-(4-(trifluoromethyl)phenyl)propan-2-yl)cyclopropanamine|(R)-N-(1,1,1-trifluoro-3-nitro-2-(4-(trifluoromethyl)phenyl)propan-2-yl)cyclopropanamine",64 percent|64 percent,64|64,,,84 percent ee|84 percent ee,3,,17,Example 1,"General procedure: In the dry 10mLAdd mesitylene-substituted sterol-derived triazole carbene reminder to test tube(0.01mmol, 0.2eq),100mg preactivated powdered molecular sieves and 0.4mL anhydrous tol",
CC(CC(C)(C)C)C(=O)OCCO,,CC(CC(C)(C)C)C(=O)OCCO>>,48936261,1,40,half reaction|has preparation,,"2-Hydroxyethyl 2,4,4-trimethylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","2-Hydroxyethyl 2,4,4-trimethylpentanoate",45 percent,45,,,,,,31,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CC(C)CCS(=O)(=O)c1ccccc1,,CC(C)CCS(=O)(=O)c1ccccc1>>,48936285,1,40,half reaction|has preparation,,1-phenylsulphonyl-3-methyl butane,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0132,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",1-phenylsulphonyl-3-methyl butane,49 percent,49,,,,,,59,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
COC(=O)CC(c1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1,,COC(=O)CC(c1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1>>,48936289,1,40,half reaction|has preparation,,tert-butyl 4-(3-methoxy-3-oxo-1-phenylpropyl)piperidine-1-carboxylate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0138,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",tert-butyl 4-(3-methoxy-3-oxo-1-phenylpropyl)piperidine-1-carboxylate,51 percent,51,,,,,,63,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CC(C)(C)OC(=O)N1CCC(C2CCC(=O)C2)CC1,,CC(C)(C)OC(=O)N1CCC(C2CCC(=O)C2)CC1>>,48936290,1,40,half reaction|has preparation,,tert-butyl 4-(3-oxocyclopentyl)piperidine-1-carboxylate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0138,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",tert-butyl 4-(3-oxocyclopentyl)piperidine-1-carboxylate,49 percent,49,,,,,,64,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CC(=O)CC(C)C1CCN(C(=O)OC(C)(C)C)CC1,,CC(=O)CC(C)C1CCN(C(=O)OC(C)(C)C)CC1>>,48936291,1,40,half reaction|has preparation,,tert-butyl 4-(4-oxopentan-2-yl)piperidine-1-carboxylate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0138,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",tert-butyl 4-(4-oxopentan-2-yl)piperidine-1-carboxylate,47 percent,47,,,,,,65,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCCCCC(CC(=O)OCC)C(=O)OCC,,CCCCCC(CC(=O)OCC)C(=O)OCC>>,48936295,1,40,half reaction|has preparation,,diethyl 2-pentylsuccinate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-pentylsuccinate,45 percent,45,,,,,,70,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
COC(=O)C(CCCNC(=O)OC(C)(C)C)c1ccccc1,,COC(=O)C(CCCNC(=O)OC(C)(C)C)c1ccccc1>>,48936298,1,40,half reaction|has preparation,,methyl 5-((tert-butoxycarbonyl)amino)-2-phenylpentanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 5-((tert-butoxycarbonyl)amino)-2-phenylpentanoate,53 percent,53,,,,,,75,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
COC(=O)C(CCCOCc1ccccc1)c1ccccc1Br,,COC(=O)C(CCCOCc1ccccc1)c1ccccc1Br>>,48936308,1,40,half reaction|has preparation,,methyl 5-(benzyloxy)-2-(2-bromophenyl)pentanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0171,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 5-(benzyloxy)-2-(2-bromophenyl)pentanoate,51 percent,51,,,,,,85,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCCC(C#N)CCC(=O)OCC,,CCCC(C#N)CCC(=O)OCC>>,50902496,1,40,half reaction|has preparation,,ethyl 4-cyanoheptanoate,,Preparation,1,20,Michael Addition,,benzene,71941370; Patent; YEDA RESEARCH AND DEVELOPMENT; WO2017/137984; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,40,Inert atmosphere,,Paragraph 00308; 00310,,C25H42MnNO2P2,ethyl 4-cyanoheptanoate,48 percent,48,,,,,,11,,"General procedure: A stock solution containing 5 mg / mL (O.Olmmol / mL) of c-[Mn(PNP*tBu)(CO)2] (2) in the particular reaction media (solvent: C6,THF, DCM, or -pentane) was prepared. To 0.5 mL of the",
O=C1c2ccccc2OC12Cc1ccccc1N1CCOCC12,,O=C1c2ccccc2OC12Cc1ccccc1N1CCOCC12>>,54590683,1,40,half reaction|has preparation,,C19H17NO3,,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0173-0179,,scandium tris(trifluoromethanesulfonate),C19H17NO3,52 percent,52,,,,,,19,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@@]12CCCN1c1ccccc1C[C@]21Oc2ccc(Br)cc2C1=O,,[H][C@@]12CCCN1c1ccccc1C[C@]21Oc2ccc(Br)cc2C1=O>>,54590688,1,40,half reaction|has preparation,,"(2R,3a'R)-5-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051; 0052; 0208-0214,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-5-bromo-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",54 percent,54,,,,,,24,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(OC)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(OC)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21>>,56433250,1,40,half reaction|has preparation,,C32H30N2O8,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0044,,QD-4,C32H30N2O8,53 percent,53,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(Cl)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(Cl)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21>>,56433251,1,40,half reaction|has preparation,,C31H27ClN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0045,,QD-4,C31H27ClN2O7,48 percent,48,,,96 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(Br)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(Br)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2ccc(C)cc21>>,56433252,1,40,half reaction|has preparation,,C31H27BrN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0047,,QD-4,C31H27BrN2O7,54 percent,54,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1C)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccccc1C)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21>>,56433255,1,40,half reaction|has preparation,,C31H27ClN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0050,,QD-4,C31H27ClN2O7,51 percent,51,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(OC)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1cccc(OC)c1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21>>,56433257,1,40,half reaction|has preparation,,C31H27ClN2O8,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0052,,QD-4,C31H27ClN2O8,54 percent,54,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(F)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21,,[H][C@]12C(=O)c3ccccc3O[C@@]1([H])[C@H]([N+](=O)[O-])[C@@H](c1ccc(F)cc1)[C@@]21C(=O)N(C(=O)OC(C)(C)C)c2cc(Cl)ccc21>>,56433258,1,40,half reaction|has preparation,,C30H24ClFN2O7,,Preparation,1,20,Michael Addition,,diethyl ether,82881820; Patent; GUIZHOU UNIVERSITY; CN112390804; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,120,,,Paragraph 0027-0029; 0030-0032; 0053,,QD-4,C30H24ClFN2O7,49 percent,49,,,> 99 percent ee,,,,,"General procedure: Embodiments of the present invention:Add the bifunctional oxidized indole-chromone 3C synthon 1a (0.10 mmol) to the reaction tube in sequence, Nitrostyrene 2a (0.15mmol), chiral thi",
COc1cccc([C@@H](CC(=O)c2ccccc2)[C@@]2(n3ccc(=O)[nH]3)C(=O)Nc3ccccc32)c1,,COc1cccc([C@@H](CC(=O)c2ccccc2)[C@@]2(n3ccc(=O)[nH]3)C(=O)Nc3ccccc32)c1>>,60137756,1,40,half reaction|has preparation,,(±)-(S)-3-((R)-1-(3-methoxyphenyl)-3-oxo-3-phenylprop,,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0065-0069,,sodium tertiary butoxide,(±)-(S)-3-((R)-1-(3-methoxyphenyl)-3-oxo-3-phenylprop,48 percent,48,,,,,,2,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
COC(=O)CCN(CCC[Si](C)(C)CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)(CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC(=O)OC,,COC(=O)CCN(CCC[Si](C)(C)CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)(CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC[Si](C)(C)CCCN(CCC(=O)OC)CCC(=O)OC)CCC(=O)OC>>,35142951,1,39,half reaction|has preparation,,C144H292N8O32Si13,,Preparation,1,20,Michael Addition,,methanol,35464637; Patent; INSTITUTO DE INVESTIGACION SANITARIA GREGORIO MARANON; US2013/59818; A1; (2013);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,Paragraph 0157,,,C144H292N8O32Si13,92 percent,92,,,,,,1.2,Synthesis of G2-Si(CH2)3N(CH2CH2COOMe)2]8 (7),"General procedure: This second-generation dendrimer was prepared using a similar method to that described for 6, starting from G2-[(CH2)3NH2]8 (0.65 g, 0.39 mmol) dissolved in methanol and excess of m",
[N-]=[N+]=NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCS(=O)(=O)CCSC[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O,,[N-]=[N+]=NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCS(=O)(=O)CCSC[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O>>,39950711,1,39,half reaction|has preparation,,C52H89N11O21S2,,Preparation,1,20,Michael Addition,,aq. phosphate buffer,66155919; Patent; ARIZONA BOARD OF REGENTS; WO2015/65985; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,Inert atmosphere,8,Paragraph 58; 59; 65,,,C52H89N11O21S2,100 percent,100,,,,,,7,Example 7: Reaction of cyclo-RGD with molecular linkers (P-lb).,"General procedure: 58] A solution of cyclo(RGDfC) (4 mM , 10 μΕ) in a phosphate buffer (0.1 M, pR 8.",
COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccccc1,,COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccccc1>>,40051228,1,39,half reaction|has preparation,,dimethyl [(1S)-2-nitro-1-phenylethyl]malonate,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H44CuF12N7O3S(2+)*2ClO4(1-)|triethylamine,dimethyl [(1S)-2-nitro-1-phenylethyl]malonate,35 percent,35,,,,,,11.6,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1ccc(O)cc1,,CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1ccc(O)cc1>>,40051233,1,39,half reaction|has preparation,,C15H19NO7,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H45CuF12N7O3S(1+)*F6P(1-)|triethylamine,C15H19NO7,44 percent,44,,,,,,11.5,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1cccc(Cl)c1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1cccc(Cl)c1>>,43705730,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(3-chlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(3-chlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",87 percent,87,,,,,,6,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccccc1Cl,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccccc1Cl>>,43705731,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(2-chlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(2-chlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",85 percent,85,,,,,,7,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
Cc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1,,Cc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1>>,43705733,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(p-tolyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(p-tolyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",85 percent,85,,,,,,9,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(O)cc1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(O)cc1>>,43705735,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(4-hydroxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(4-hydroxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",88 percent,88,,,,,,11,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1cccs1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1cccs1>>,43705741,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(thiphen-2-yl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(thiphen-2-yl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",96 percent,96,,,,,,17,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
COc1ccc(CN2CC3=C(OC(N)=C(C#N)C3c3ccccc3)C2=O)cc1,,COc1ccc(CN2CC3=C(OC(N)=C(C#N)C3c3ccccc3)C2=O)cc1>>,43705742,1,39,half reaction|has preparation,,"2-amino-6-(4-methoxybenzyl)-7-oxo-4-phenyl-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-(4-methoxybenzyl)-7-oxo-4-phenyl-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",90 percent,90,,,,,,18,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(Br)cc1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(Br)cc1>>,43705759,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(4-bromophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(4-bromophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",85 percent,85,,,,,,2,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(Cl)cc1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(Cl)cc1>>,43705760,1,39,half reaction|has preparation,,"2-amino-6-benzyl-4-(4-chlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(4-chlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",93 percent,93,,,,,,3,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,,CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,44715971,1,39,half reaction|has preparation,,"(2R,3S)-2-ethyl-4-nitro-3-(4-bromophenyl)butyraldehyde",,Preparation,1,,Michael Addition,,dichloromethane|water,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,Page/Page column 30; 31,,4-nitro-phenol,"(2R,3S)-2-ethyl-4-nitro-3-(4-bromophenyl)butyraldehyde",90 percent,90,,,96 percent ee,,,3.B,B) Flow production of a library of compounds,"General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m",
CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,,CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,44715972,1,39,half reaction|has preparation,,(2R)-2-((1S)-1-(4-bromophenyl)-2-nitroethyl)pentanal,,Preparation,1,,Michael Addition,,dichloromethane|water,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,Page/Page column 30; 31,,4-nitro-phenol,(2R)-2-((1S)-1-(4-bromophenyl)-2-nitroethyl)pentanal,97 percent,97,,,96 percent ee,,,3.B,B) Flow production of a library of compounds,"General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m",
C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1cccc(Cl)c1,,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1cccc(Cl)c1>>,44715973,1,39,half reaction|has preparation,,"(2R,3S)-2-methyl-4-nitro-3-(3-chlorophenyl)butanal",,Preparation,1,,Michael Addition,,dichloromethane|water,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,Page/Page column 30; 31,,4-nitro-phenol,"(2R,3S)-2-methyl-4-nitro-3-(3-chlorophenyl)butanal",89 percent,89,,,94 percent ee,,,3.B,B) Flow production of a library of compounds,"General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m",
C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(F)cc1,,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(F)cc1>>,44715974,1,39,half reaction|has preparation,,"(2R,3S)-3-(4-fluorophenyl)-2-methyl-4-nitrobutanal",,Preparation,1,,Michael Addition,,dichloromethane|water,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,Page/Page column 30; 31,,4-nitro-phenol,"(2R,3S)-3-(4-fluorophenyl)-2-methyl-4-nitrobutanal",93 percent,93,,,96 percent ee,,,3.B,B) Flow production of a library of compounds,"General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccccc4)CCN3C2Oc2ccccc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccccc4)CCN3C2Oc2ccccc21>>,45125986,1,39,half reaction|has preparation,,"3-benzyl-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,,,Paragraph 0085; 0108; 0109,,,"3-benzyl-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",95 percent,95,,,,,,9,"synthesis of 3-(4-methoxybenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: A solution of 1-(4-methoxybenzyl)-2-(nitromethylidene)imidazolidine(1 mmol, 249 mg) and chromone-3 -carboxaldehyde (2 mmol, 348 mg ) was added into 25ml of round bottom flask ,then",
Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4ccccc4OC23)cc1,,Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4ccccc4OC23)cc1>>,45125987,1,39,half reaction|has preparation,,"3-(4-methylbenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,,,Paragraph 0085; 0111; 0112,,,"3-(4-methylbenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",97 percent,97,,,,,,10,"synthesis of 3-(4-methoxybenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: A solution of 1-(4-methoxybenzyl)-2-(nitromethylidene)imidazolidine(1 mmol, 249 mg) and chromone-3 -carboxaldehyde (2 mmol, 348 mg ) was added into 25ml of round bottom flask ,then",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cccc(F)c4)CCN3C2Oc2ccccc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cccc(F)c4)CCN3C2Oc2ccccc21>>,45125988,1,39,half reaction|has preparation,,"3-(3-fluorobenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,,,Paragraph 0085; 0114; 0115,,,"3-(3-fluorobenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,11,"synthesis of 3-(4-methoxybenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: A solution of 1-(4-methoxybenzyl)-2-(nitromethylidene)imidazolidine(1 mmol, 249 mg) and chromone-3 -carboxaldehyde (2 mmol, 348 mg ) was added into 25ml of round bottom flask ,then",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cc(F)cc(F)c4)CCN3C2Oc2ccccc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cc(F)cc(F)c4)CCN3C2Oc2ccccc21>>,45125989,1,39,half reaction|has preparation,,"3-(3,4-difluorobenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,,,Paragraph 0085; 0117; 0118,,,"3-(3,4-difluorobenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,12,"synthesis of 3-(4-methoxybenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: A solution of 1-(4-methoxybenzyl)-2-(nitromethylidene)imidazolidine(1 mmol, 249 mg) and chromone-3 -carboxaldehyde (2 mmol, 348 mg ) was added into 25ml of round bottom flask ,then",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C2Oc2ccccc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C2Oc2ccccc21>>,45125990,1,39,half reaction|has preparation,,"3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,,,Paragraph 0085; 0120; 0121,,,"3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,13,"synthesis of 3-(4-methoxybenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: A solution of 1-(4-methoxybenzyl)-2-(nitromethylidene)imidazolidine(1 mmol, 249 mg) and chromone-3 -carboxaldehyde (2 mmol, 348 mg ) was added into 25ml of round bottom flask ,then",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cnc(Cl)s4)CCN3C2Oc2ccccc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cnc(Cl)s4)CCN3C2Oc2ccccc21>>,45125991,1,39,half reaction|has preparation,,"3-((2-chlorothiazol-5-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,,,Paragraph 0085; 0123; 0124,,,"3-((2-chlorothiazol-5-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",93 percent,93,,,,,,14,"synthesis of 3-(4-methoxybenzyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: A solution of 1-(4-methoxybenzyl)-2-(nitromethylidene)imidazolidine(1 mmol, 249 mg) and chromone-3 -carboxaldehyde (2 mmol, 348 mg ) was added into 25ml of round bottom flask ,then",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(C(F)(F)F)cc4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(C(F)(F)F)cc4)CCN3C2Oc2ccc(F)cc21>>,45125992,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0126; 0127,,,"8-fluoro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",95 percent,95,,,,,,15,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
N#Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(F)ccc4OC23)cc1,,N#Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(F)ccc4OC23)cc1>>,45125993,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(4-cyanobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0129; 0130,,,"8-fluoro-4-nitro-3-(4-cyanobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,16,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(F)cc4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(F)cc4)CCN3C2Oc2ccc(F)cc21>>,45125994,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(4-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0132; 0133,,,"8-fluoro-4-nitro-3-(4-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",95 percent,95,,,,,,17,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccccc4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccccc4)CCN3C2Oc2ccc(F)cc21>>,45125995,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-benzyl-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0135; 0136,,,"8-fluoro-4-nitro-3-benzyl-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",97 percent,97,,,,,,18,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(F)ccc4OC23)cc1,,Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(F)ccc4OC23)cc1>>,45125996,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(4-methylbenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0138; 0139,,,"8-fluoro-4-nitro-3-(4-methylbenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",96 percent,96,,,,,,19,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
COc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(F)ccc4OC23)cc1,,COc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(F)ccc4OC23)cc1>>,45125997,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(4-methoxybenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0141; 0142,,,"8-fluoro-4-nitro-3-(4-methoxybenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",95 percent,95,,,,,,20,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cccc(F)c4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cccc(F)c4)CCN3C2Oc2ccc(F)cc21>>,45125998,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(3-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0144; 0145,,,"8-fluoro-4-nitro-3-(3-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,21,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cc(F)cc(F)c4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cc(F)cc(F)c4)CCN3C2Oc2ccc(F)cc21>>,45125999,1,39,half reaction|has preparation,,"8-fluoro-4-nitro-3-(3,4-difluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0147; 0148,,,"8-fluoro-4-nitro-3-(3,4-difluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",98 percent,98,,,,,,22,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C2Oc2ccc(F)cc21>>,45126000,1,39,half reaction|has preparation,,"8-fluoro-3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0150; 0151,,,"8-fluoro-3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",96 percent,96,,,,,,23,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cnc(Cl)s4)CCN3C2Oc2ccc(F)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cnc(Cl)s4)CCN3C2Oc2ccc(F)cc21>>,45126001,1,39,half reaction|has preparation,,"8-fluoro-3-((2-chlorothiazol-5-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,75,Michael Addition,,ethanol|water,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0088; 0153; 0154,,,"8-fluoro-3-((2-chlorothiazol-5-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",95 percent,95,,,,,,24,"synthesis of 3-(4-chlorobenzyl)-8-fluoro-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 1- (4-chlorobenzyl) -2- (nitromethylene)imidazolidine (1 mmol, 254 mg)and 6-fluorochromone-3-carbaldehyde (1.5 mmol, 288 mg)(17 ml) was added",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(F)cc4)CCN3C2Oc2ccc(Cl)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(F)cc4)CCN3C2Oc2ccc(Cl)cc21>>,45126002,1,39,half reaction|has preparation,,"8-chloro-4-nitro-3-(4-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0156; 0157,,,"8-chloro-4-nitro-3-(4-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",96 percent,96,,,,,,25,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccccc4)CCN3C2Oc2ccc(Cl)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccccc4)CCN3C2Oc2ccc(Cl)cc21>>,45126003,1,39,half reaction|has preparation,,"8-chloro-4-nitro-3-benzyl-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0159; 0160,,,"8-chloro-4-nitro-3-benzyl-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",95 percent,95,,,,,,26,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(Cl)ccc4OC23)cc1,,Cc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(Cl)ccc4OC23)cc1>>,45126004,1,39,half reaction|has preparation,,"8-chloro-4-nitro-3-(4-methylbenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0162; 0163,,,"8-chloro-4-nitro-3-(4-methylbenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",97 percent,97,,,,,,27,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
COc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(Cl)ccc4OC23)cc1,,COc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(Cl)ccc4OC23)cc1>>,45126005,1,39,half reaction|has preparation,,"8-chloro-4-nitro-3-(4-methoxybenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0165; 0166,,,"8-chloro-4-nitro-3-(4-methoxybenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",96 percent,96,,,,,,28,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cccc(F)c4)CCN3C2Oc2ccc(Cl)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cccc(F)c4)CCN3C2Oc2ccc(Cl)cc21>>,45126006,1,39,half reaction|has preparation,,"8-chloro-4-nitro-3-(3-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0168; 0169,,,"8-chloro-4-nitro-3-(3-fluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",97 percent,97,,,,,,29,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cc(F)cc(F)c4)CCN3C2Oc2ccc(Cl)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cc(F)cc(F)c4)CCN3C2Oc2ccc(Cl)cc21>>,45126007,1,39,half reaction|has preparation,,"8-chloro-4-nitro-3-(3,4-difluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0171; 0172,,,"8-chloro-4-nitro-3-(3,4-difluorobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",98 percent,98,,,,,,30,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C2Oc2ccc(Cl)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C2Oc2ccc(Cl)cc21>>,45126008,1,39,half reaction|has preparation,,"8-chloro-3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0174; 0175,,,"8-chloro-3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,31,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cnc(Cl)s4)CCN3C2Oc2ccc(Cl)cc21,,O=C1C2=CC([N+](=O)[O-])=C3N(Cc4cnc(Cl)s4)CCN3C2Oc2ccc(Cl)cc21>>,45126009,1,39,half reaction|has preparation,,"8-chloro-3-((2-chlorothiazol-5-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,80,Michael Addition,,acetonitrile,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,,Paragraph 0091; 0177; 0178,,,"8-chloro-3-((2-chlorothiazol-5-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",94 percent,94,,,,,,32,"synthesis of 8-chloro-4-nitro-3-(4-(trifluoromethyl)benzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a] pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 2- (nitromethylene) -1- (4- (trifluoromethyl) benzyl) imidazolidine(1 mmol, 479 mg) and 6-chlorochromone-3-carbaldehyde(1.2 mmol, 250 mg)Was",
COc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(C)ccc4OC23)cc1,,COc1ccc(CN2CCN3C2=C([N+](=O)[O-])C=C2C(=O)c4cc(C)ccc4OC23)cc1>>,45126010,1,39,half reaction|has preparation,,"8-methyl-4-nitro-3-(4-methoxybenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,50,Michael Addition,,methanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,Paragraph 0181; 0183; 0184,,,"8-methyl-4-nitro-3-(4-methoxybenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",98 percent,98,,,,,,34,"synthesis of 8-methyl-4-nitro-3-(4-cyanobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 4 - ((2- (nitromethylene) imidazolidin-1-yl) methyl) benzonitrile (1 mmol, 244 mg)And 6-methylchromone-3-carbaldehyde (2 mmol, 376 mg)Was add",
Cc1ccc2c(c1)C(=O)C1=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C1O2,,Cc1ccc2c(c1)C(=O)C1=CC([N+](=O)[O-])=C3N(Cc4ccc(Cl)nc4)CCN3C1O2>>,45126011,1,39,half reaction|has preparation,,"8-methyl-3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",,Preparation,1,50,Michael Addition,,methanol,71078466; Patent; YUNNAN UNIVERSITY; CN106518885; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,Paragraph 0181; 0186; 0187,,,"8-methyl-3-((6-chloropyridin-3-yl)methyl)-4-nitro-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one",97 percent,97,,,,,,35,"synthesis of 8-methyl-4-nitro-3-(4-cyanobenzyl)-1,2,3,11a-tetrahydro-6H-chromeno[3,2-e]imidazo[1,2-a]pyridin-6-one","General procedure: To a 25 ml round bottom flask was added 4 - ((2- (nitromethylene) imidazolidin-1-yl) methyl) benzonitrile (1 mmol, 244 mg)And 6-methylchromone-3-carbaldehyde (2 mmol, 376 mg)Was add",
CN(C)C(=O)C(CC(C)(C)C)c1ccccc1,,CN(C)C(=O)C(CC(C)(C)C)c1ccccc1>>,48936266,1,39,half reaction|has preparation,,"N,N,4,4-tetramethyl-2-phenylpentanamide",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","N,N,4,4-tetramethyl-2-phenylpentanamide",37 percent,37,,,,,,36,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
Cc1ccc(C(C#N)CC(C)(C)C)cc1,,Cc1ccc(C(C#N)CC(C)(C)C)cc1>>,48936267,1,39,half reaction|has preparation,,"4,4-dimethyl-2-(p-tolyl)pentanenitrile",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","4,4-dimethyl-2-(p-tolyl)pentanenitrile",42 percent,42,,,,,,38,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
O=S(=O)(CCC1CCCCC1)c1ccccc1,,O=S(=O)(CCC1CCCCC1)c1ccccc1>>,48936281,1,39,half reaction|has preparation,,1-(2-cyclohexylethylsulfonyl)benzene,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0108; 0109; 0122,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",1-(2-cyclohexylethylsulfonyl)benzene,40 percent,40,,,,,,54,Examples 39-66,"General procedure: In the following examples, Ib, Ic, Id, and Ie are radical precursors respectively, which react with Michael acceptor II to obtain an addition.Product III,Using the optimal reaction",
CCCCCC(C(=O)OC)c1ccccc1,,CCCCCC(C(=O)OC)c1ccccc1>>,48936293,1,39,half reaction|has preparation,,methyl 2-phenylheptanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 2-phenylheptanoate,44 percent,44,,,,,,68,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CC(C)(C)OC(=O)NCCCC(Cc1ccccc1)C(=O)O,,CC(C)(C)OC(=O)NCCCC(Cc1ccccc1)C(=O)O>>,48936300,1,39,half reaction|has preparation,,2-benzyl-5-((tert-butoxycarbonyl)amino)pentanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-5-((tert-butoxycarbonyl)amino)pentanoic acid,39 percent,39,,,,,,77,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
COC(=O)CC(CCNC(=O)OC(C)(C)C)c1ccccc1,,COC(=O)CC(CCNC(=O)OC(C)(C)C)c1ccccc1>>,48936301,1,39,half reaction|has preparation,,methyl 5-((tert-butoxycarbonyl)amino)-3-phenylpentanoate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",methyl 5-((tert-butoxycarbonyl)amino)-3-phenylpentanoate,37 percent,37,,,,,,78,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CC(C)(C)OC(=O)NCCC1CCC(=O)C1,,CC(C)(C)OC(=O)NCCC1CCC(=O)C1>>,48936302,1,39,half reaction|has preparation,,tert-butyl (2-(3-oxocyclopentyl)ethyl)carbamate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",tert-butyl (2-(3-oxocyclopentyl)ethyl)carbamate,37 percent,37,,,,,,79,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CC(=O)CC(C)CCNC(=O)OC(C)(C)C,,CC(=O)CC(C)CCNC(=O)OC(C)(C)C>>,48936303,1,39,half reaction|has preparation,,tert-butyl (3-methyl-5-oxohexyl)carbamate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0157,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",tert-butyl (3-methyl-5-oxohexyl)carbamate,35 percent,35,,,,,,80,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CC(C)(C)[Si](C)(C)OCCCC(Cc1ccccc1)C(=O)O,,CC(C)(C)[Si](C)(C)OCCCC(Cc1ccccc1)C(=O)O>>,48936306,1,39,half reaction|has preparation,,2-benzyl-5-((tert-butyldimethylsilyl)oxy)pentanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0166,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-5-((tert-butyldimethylsilyl)oxy)pentanoic acid,35 percent,35,,,,,,83,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(Cl)ccc1NCc1ccccc1,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(Cl)ccc1NCc1ccccc1>>,49105472,1,39,half reaction|has preparation,,ethyl 1-benzyl-4-(2-(benzylamino)-5-chlorophenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0032,,,ethyl 1-benzyl-4-(2-(benzylamino)-5-chlorophenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,87 percent,87,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(F)ccc1NC,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(F)ccc1NC>>,49105478,1,39,half reaction|has preparation,,ethyl 1-benzyl-4-(5-fluoro-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0023,,,ethyl 1-benzyl-4-(5-fluoro-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,88 percent,88,,,90 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CC(C)(C)OC(=O)CCOCCO,,CC(C)(C)OC(=O)CCOCCO>>,53390930,1,39,half reaction|has preparation,,3-(2-hydroxyethoxy)propionic acid tert-butyl ester,,Preparation,1,20,Michael Addition,,water|acetonitrile,79061590; Patent; YALE UNIVERSITY; WO2020/23851; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,Paragraph 00399; 00413; 00414,,N-benzyl-trimethylammonium hydroxide,3-(2-hydroxyethoxy)propionic acid tert-butyl ester,35 percent,35,,,,,,,GP1: Michael-Addition,"General procedure: To a solution of the diol (5.0 eq.) and tert-Butyl acrylate (1.0 eq.) in Acetonitrile (30 mL) was added Triton B (40 wt. % in water, 0.037 eq.) was added the reaction mixture was st",
[H][C@]12CCCN1c1cc(C)ccc1C[C@@]21Oc2ccccc2C1=O,,[H][C@]12CCCN1c1cc(C)ccc1C[C@@]21Oc2ccccc2C1=O>>,54590699,1,39,half reaction|has preparation,,"(2R,3a'R)-8'-methyl-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",,Preparation,1,80,Michael Addition,,dichloromethane,80037611; Patent; QINGDAO AGRICULTURAL UNIVERSITY; CN111233881; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3.5,,,Paragraph 0040-0048; 0051-0060,,scandium tris(trifluoromethanesulfonate),"(2R,3a'R)-8'-methyl-1',2',3',3a'-tetrahydro-3H,5'H-spiro[benzofuran-2,4'-pyrrolo[1,2-a]quinolin]-3-one",43 percent,43,,,,,,2,Example 1,"General procedure: Orange ketone compound 1a (0.1mmol) Under the action of catalyst (20molpercent, 0.02mmol), After trans-Michael addition in solvent (1.0 mL), the addition product 2a is obtained, Its",
O=C(C[C@H](c1ccc([N+](=O)[O-])cc1)[C@@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccccc21)c1ccccc1,,O=C(C[C@H](c1ccc([N+](=O)[O-])cc1)[C@@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccccc21)c1ccccc1>>,60137757,1,39,half reaction|has preparation,,(±)-(S)-3-((R)-1-(4-nitrophenyl)-3-oxo-3-phenylpropy,,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0070-0074,,sodium tertiary butoxide,(±)-(S)-3-((R)-1-(4-nitrophenyl)-3-oxo-3-phenylpropy,44 percent,44,,,,,,3,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
Cc1nc(-c2ccccc2)nc(-c2cccc3ccccc23)c1-c1ccccc1,,Cc1nc(-c2ccccc2)nc(-c2cccc3ccccc23)c1-c1ccccc1>>,70507577,1,39,half reaction|has preparation,,C27H20N2,,Preparation,1,80,Michael Addition,,toluene,136950672; Patent; FENGHUA TECH DEVELOPMENT; CN118724822; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Schlenk technique|Inert atmosphere,,Paragraph 0049-0053; 0056,,potassium carbonate,C27H20N2,42 percent,42,,,,,,12,Embodiment 1-41,"General procedure: In the 35mL Schlenk tube, according to the raw material ratio in Table 1, bienone (I.) was added, replacing amidine hydrochloride (II.) and alkali, nitrogen was withdrawn 3 times, 1",
CC(C)OC(=O)C(C(=O)OC(C)C)[C@H](C[N+](=O)[O-])c1ccccc1,,CC(C)OC(=O)C(C(=O)OC(C)C)[C@H](C[N+](=O)[O-])c1ccccc1>>,40051229,1,38,half reaction|has preparation,,(S)-1-methylethyl-2-(1-methylethoxycarbonyl)-4-nitro-3-phenylbutyrate,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H44CuF12N7O3S(2+)*2ClO4(1-)|triethylamine,(S)-1-methylethyl-2-(1-methylethoxycarbonyl)-4-nitro-3-phenylbutyrate,30 percent,30,,,,,,11.7,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
COc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1,,COc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1>>,43705734,1,38,half reaction|has preparation,,"2-amino-6-benzyl-4-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",82 percent,82,,,,,,10,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
COc1ccccc1C1C(C#N)=C(N)OC2=C1CN(Cc1ccccc1)C2=O,,COc1ccccc1C1C(C#N)=C(N)OC2=C1CN(Cc1ccccc1)C2=O>>,43705736,1,38,half reaction|has preparation,,"2-amino-6-benzyl-4-(2-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(2-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",78 percent,78,,,,,,12,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(Cl)cc1Cl,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(Cl)cc1Cl>>,43705737,1,38,half reaction|has preparation,,"2-amino-6-benzyl-4-(2,4-dichlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(2,4-dichlorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",81 percent,81,,,,,,13,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc2ccccc2c1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc2ccccc2c1>>,43705740,1,38,half reaction|has preparation,,"2-amino-6-benzyl-4-(naphthalen-2-yl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(naphthalen-2-yl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",83 percent,83,,,,,,16,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(F)cc1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc(F)cc1>>,43705761,1,38,half reaction|has preparation,,"2-amino-6-benzyl-4-(4-fluorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(4-fluorophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",80 percent,80,,,,,,4,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1cccc(Br)c1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1cccc(Br)c1>>,43705762,1,38,half reaction|has preparation,,"2-amino-6-benzyl-4-(3-bromophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(3-bromophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",80 percent,80,,,,,,5,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
CC(CC(C)(C)C)C(=O)OCC1CO1,,CC(CC(C)(C)C)C(=O)OCC1CO1>>,48936262,1,38,half reaction|has preparation,,"oxiran-2-ylmethyl 2,4,4-trimethylpentanoate",,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0085; 0086; 0089,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate","oxiran-2-ylmethyl 2,4,4-trimethylpentanoate",33 percent,33,,,90.476 percent de,,,32,Example 21-38,"General procedure: In the following examples, Ia-2 is used as a radical precursor and reacted with different Michael acceptor II to obtain an addition product III.Using the optimal reaction conditions",
CCCCCCS(=O)(=O)c1ccccc1,,CCCCCCS(=O)(=O)c1ccccc1>>,48936296,1,38,half reaction|has preparation,,phenyl hexyl sulfone,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0148,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",phenyl hexyl sulfone,33 percent,33,,,,,,72,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CCOC(=O)C(C(=O)OCC)C(C)CCOCc1ccccc1,,CCOC(=O)C(C(=O)OCC)C(C)CCOCc1ccccc1>>,48936307,1,38,half reaction|has preparation,,diethyl 2-(4-(benzyloxy)butan-2-yl)malonate,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0170,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",diethyl 2-(4-(benzyloxy)butan-2-yl)malonate,28 percent,28,,,,,,84,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
O=C(O)C(CCCOCc1ccccc1)Cc1ccccc1,,O=C(O)C(CCCOCc1ccccc1)Cc1ccccc1>>,48936309,1,38,half reaction|has preparation,,2-benzyl-5-(benzyloxy)pentanoic acid,,Preparation,1,40,Michael Addition,,acetone,74820782; Patent; SICHUAN UNIVERSITY; CN108456156; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,Paragraph 0145; 0146; 0171,,"dipotassium hydrogenphosphate|(4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate",2-benzyl-5-(benzyloxy)pentanoic acid,29 percent,29,,,,,,86,Examples 66-73,"General procedure: In the following examples, if, Ig, Ih, and Ii are radical precursors, respectively, and reacted with Michael acceptor II to obtain an addition product III.Using the optimal reaction",
CNc1ccc(C)cc1C1(Cc2onc(C)c2[N+](=O)[O-])C(=O)N(Cc2ccccc2)CC1C(=O)OC,,CNc1ccc(C)cc1C1(Cc2onc(C)c2[N+](=O)[O-])C(=O)N(Cc2ccccc2)CC1C(=O)OC>>,49105468,1,38,half reaction|has preparation,,methyl 1-benzyl-4-(5-methyl-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0028,,,methyl 1-benzyl-4-(5-methyl-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,83 percent,83,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1ccccc1NCc1ccccc1,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1ccccc1NCc1ccccc1>>,49105469,1,38,half reaction|has preparation,,ethyl 1-benzyl-4-(2-(benzylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0029,,,ethyl 1-benzyl-4-(2-(benzylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,82 percent,82,,,90.476 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(C)ccc1NCc1ccccc1,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(C)ccc1NCc1ccccc1>>,49105470,1,38,half reaction|has preparation,,ethyl1-benzyl-4-(2-(benzylamino)-5-methylphenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0030,,,ethyl1-benzyl-4-(2-(benzylamino)-5-methylphenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,79 percent,79,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(F)ccc1NCc1ccccc1,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(F)ccc1NCc1ccccc1>>,49105471,1,38,half reaction|has preparation,,ethyl 1-benzyl-4-(2-(benzylamino)-5-fluorophenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0031,,,ethyl 1-benzyl-4-(2-(benzylamino)-5-fluorophenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,82 percent,82,,,90.476 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
COC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1ccccc1NCc1ccccc1,,COC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1ccccc1NCc1ccccc1>>,49105473,1,38,half reaction|has preparation,,methyl 1-benzyl-4-(2-(benzylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0033,,,methyl 1-benzyl-4-(2-(benzylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,83 percent,83,,,86.667 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCCCN1CC(C(=O)OCC)C(Cc2onc(C)c2[N+](=O)[O-])(c2ccccc2NC)C1=O,,CCCCN1CC(C(=O)OCC)C(Cc2onc(C)c2[N+](=O)[O-])(c2ccccc2NC)C1=O>>,49105475,1,38,half reaction|has preparation,,ethyl 1-butyl-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-4-(2-(methylamino)phenyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0035,,,ethyl 1-butyl-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-4-(2-(methylamino)phenyl)-5-oxopyrrolidine-3-carboxylate,77 percent,77,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCCCN1CC(C(=O)OC)C(Cc2onc(C)c2[N+](=O)[O-])(c2ccccc2NC)C1=O,,CCCCN1CC(C(=O)OC)C(Cc2onc(C)c2[N+](=O)[O-])(c2ccccc2NC)C1=O>>,49105476,1,38,half reaction|has preparation,,methyl 1-butyl-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-4-(2-(methylamino)phenyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0036,,,methyl 1-butyl-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-4-(2-(methylamino)phenyl)-5-oxopyrrolidine-3-carboxylate,76 percent,76,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(C)ccc1NC,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(C)ccc1NC>>,49105477,1,38,half reaction|has preparation,,ethyl 1-benzyl-4-(5-methyl-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0022,,,ethyl 1-benzyl-4-(5-methyl-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,84 percent,84,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(Cl)ccc1NC,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cc(Cl)ccc1NC>>,49105479,1,38,half reaction|has preparation,,ethyl 1-benzyl-4-(5-chloro-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0024,,,ethyl 1-benzyl-4-(5-chloro-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,80 percent,80,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cccc(Cl)c1NC,,CCOC(=O)C1CN(Cc2ccccc2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1cccc(Cl)c1NC>>,49105480,1,38,half reaction|has preparation,,ethyl 1-benzyl-4-(3-chloro-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0025,,,ethyl 1-benzyl-4-(3-chloro-2-(methylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,80 percent,80,,,88.235 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CNc1ccccc1C1(Cc2onc(C)c2[N+](=O)[O-])C(=O)N(Cc2ccccc2)CC1C(=O)OC,,CNc1ccccc1C1(Cc2onc(C)c2[N+](=O)[O-])C(=O)N(Cc2ccccc2)CC1C(=O)OC>>,49105481,1,38,half reaction|has preparation,,methyl 1-benzyl-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-4-(2-(methylamino)phenyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0026,,,methyl 1-benzyl-4-((3-methyl-4-nitroisoxazol-5-yl)methyl)-4-(2-(methylamino)phenyl)-5-oxopyrrolidine-3-carboxylate,84 percent,84,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CNc1ccc(F)cc1C1(Cc2onc(C)c2[N+](=O)[O-])C(=O)N(Cc2ccccc2)CC1C(=O)OC,,CNc1ccc(F)cc1C1(Cc2onc(C)c2[N+](=O)[O-])C(=O)N(Cc2ccccc2)CC1C(=O)OC>>,49105482,1,38,half reaction|has preparation,,methyl 1-benzyl-4-(5-fluoro-2-(methylamino)phenyl)-4-((3-methyl-4 nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0027,,,methyl 1-benzyl-4-(5-fluoro-2-(methylamino)phenyl)-4-((3-methyl-4 nitroisoxazol-5-yl)methyl)-5-oxopyrrolidine-3-carboxylate,79 percent,79,,,88.235 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
CCOP(=O)(OCC)C(c1ccccc1)c1cc(C(C)(C)C)cc(C(C)(C)C)c1O,,CCOP(=O)(OCC)C(c1ccccc1)c1cc(C(C)(C)C)cc(C(C)(C)C)c1O>>,50300902,1,38,half reaction|has preparation,,"diethyl ((3,5-di-tert-butyl-2-hydroxyphenyl)(phenyl)methyl)phosphonate",,Preparation,1,20,Michael Addition,,dichloromethane,75712481; Patent; NEVADA SYSTEM OF HIGHER EDUCATION; WO2018/232315; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,Sealed tube,,Paragraph 00363-00364; 00369; 00409,,"2-hydroxy-1,3-diphenyl-1,3,2-diazaphospholidine 2-oxide","diethyl ((3,5-di-tert-butyl-2-hydroxyphenyl)(phenyl)methyl)phosphonate",25 percent,25,,,,,,f.vi,f. GENERAL PROCEDURE FOR THE SYNTHESIS OF DIARYL PHOSPHONATES 3,"General procedure: Diethyl ((2-hydroxyphenyl)(phenyl)methyl)phosphonate (3a as example): A mixture of alcohol la (20.1 mg, 0.1 mmol), triethyl phosphite 2a (17.6 xL, 0.1 mmol),NHPA1 (0.4 mg, 0.015 mmo",
CC(C)(C)OC(=O)CCOCCOCCO,,CC(C)(C)OC(=O)CCOCCOCCO>>,53390931,2,38,half reaction|has preparation,,tert-butyl 3-(2-(2-hydroxyethoxy)ethoxy)propanoate,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']",Michael Addition,,"['water|acetonitrile', 'tetrahydrofuran']","['79061590; Patent; YALE UNIVERSITY; WO2020/23851; A1; (2020);', '116897878; Patent; TSINGHUA UNIVERSITY CHINA; CN114349738; A; (2022);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,"['Paragraph 00399; 00413; 00415', 'Paragraph 0251-0253']",,"['N-benzyl-trimethylammonium hydroxide', 'N-benzyl-trimethylammonium hydroxide']",tert-butyl 3-(2-(2-hydroxyethoxy)ethoxy)propanoate,9 percent,9,,,,,,,"['GP1: Michael-Addition', '(25) Preparation of intermediates 24-1, 24-2, 24-3, 24-4']","['General procedure: To a solution of the diol (5.0 eq.) and tert-Butyl acrylate (1.0 eq.) in Acetonitrile (30 mL) was added Triton B (40 wt. % in water, 0.037 eq.) was added the reaction mixture was st', 'General procedure: tert-butyl acrylate (7.3ml, 50mmol), 4eq ethylene glycol/diethylene glycol/triethylene glycol/ethylene glycol,Mix 0.1eq benzyltrimethylammonium hydroxide in dry THF and react at roo']",
O=C(C[C@H](c1cccs1)[C@@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccccc21)c1ccccc1,,O=C(C[C@H](c1cccs1)[C@@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccccc21)c1ccccc1>>,60137752,1,38,half reaction|has preparation,,"(±)-(S)-3-(3-oxo-2,3-dihydro-1H-pyrazol-1-yl)-3-((S)",,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0085-0089,,sodium tertiary butoxide,"(±)-(S)-3-(3-oxo-2,3-dihydro-1H-pyrazol-1-yl)-3-((S)",34 percent,34,,,,,,6,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
O=C(C[C@H](c1ccccc1)[C@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccc(F)cc21)c1ccccc1,,O=C(C[C@H](c1ccccc1)[C@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccc(F)cc21)c1ccccc1>>,60137755,1,38,half reaction|has preparation,,"(±)-(S)-5-fluoro-3-((S)-3-oxo-1,3-diphenylpropyl)-",,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0106-0110,,sodium tertiary butoxide,"(±)-(S)-5-fluoro-3-((S)-3-oxo-1,3-diphenylpropyl)-",26 percent,26,,,,,,10,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
O=C(OCc1ccccc1)C(C(=O)OCc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1,,O=C(OCc1ccccc1)C(C(=O)OCc1ccccc1)[C@@H](C[N+](=O)[O-])c1ccccc1>>,37326750,3,37,half reaction|has preparation,,(R)-benzyl 2-carbobenzyloxy-4-nitro-3-phenylbutyrate,,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['-35', '0 - 20', '0 - 20']",Michael Addition,,"dichloromethane-d2|1,2-dichloro-ethane","['62686890; Patent; TEXAS A M UNIVERSITY SYSTEM; WO2014/18978; A2; (2014);', '132736901; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; WO2024/49236; A1; (2024);', '132736901; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; WO2024/49236; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Sealed tube', 'Inert atmosphere', 'Inert atmosphere']",,"['Paragraph 00194; 00195; 00196; 00197', 'Paragraph 210-214; 218-219; 222-225; 235-237', 'Paragraph 210-214; 218-219; 222-225; 235-237']",,"['Λ-[Co(en)2(S)-enCH2CH2CH2NMe2]3+3BArf-.6.5H2O', 'sodium tetrahydroborate|nickel(II) chloride hexahydrate', 'sodium tetrahydroborate|nickel(II) chloride hexahydrate']","['(R)-benzyl 2-carbobenzyloxy-4-nitro-3-phenylbutyrate', '(R)-benzyl 2-carbobenzyloxy-4-nitro-3-phenylbutyrate']","['94 percent', '94 percent']",,,,,,,"['12', '3.3.1; 3.3.1.5', '3.3.1; 3.3.1.5']",,"['General procedure: EXAMPLE 12 Procedures for reactions catalyzed using Type 2 Transition metal compl', 'General procedure: Under argon atmosphere, NaBH4 (10 equiv) was added to a suspension of the obtained Michael addition product (1.0 equiv, >99% ee) and NiCl2*6H2O (1.0 equiv) in MeOH (8.0 mL) at 0 C.', 'General procedure: Under argon atmosphere, NaBH4 (10 equiv) was added to a suspension of the obtained Michael addition product (1.0 equiv, >99% ee) and NiCl2*6H2O (1.0 equiv) in MeOH (8.0 mL) at 0 C.']",
CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1,,CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1ccc(OC)cc1>>,40051230,1,37,half reaction|has preparation,,(R)-ethyl 2-carboethoxy-4-nitro-3-(4-methoxyphenyl)butyrate,,Preparation,1,20,Michael Addition,,acetonitrile,66054824; Patent; NEW YORK UNIVERSITY; US2015/112066; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0115,,C55H45CuF12N7O3S(1+)*F6P(1-)|triethylamine,(R)-ethyl 2-carboethoxy-4-nitro-3-(4-methoxyphenyl)butyrate,20 percent,20,,,,,,11.2,,General procedure: Examples 1-9 demonstrate the ability to achieve consistent enantiomeric excess in the malonate/nitrostyrene reaction and that the absolute configuration of the product depends only,
N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc([N+](=O)[O-])cc1,,N#CC1=C(N)OC2=C(CN(Cc3ccccc3)C2=O)C1c1ccc([N+](=O)[O-])cc1>>,43705732,1,37,half reaction|has preparation,,"2-amino-6-benzyl-4-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",72 percent,72,,,,,,8,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
COc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1OC,,COc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1OC>>,43705738,1,37,half reaction|has preparation,,"2-amino-6-benzyl-4-(3,4-dimethoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(3,4-dimethoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",70 percent,70,,,,,,14,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1,46359680,3,37,half reaction|has preparation,,"(R)-3-[1-(4-chloro-phenyl)-2-nitro-ethyl]-pentane-2,4-dione|(+)-(S)-3-(1-(4-chlorophenyl)-2-nitroethyl)pentane-2,4-dione",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['0', '25', '25']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['toluene', 'water|toluene', 'dichloromethane']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);', '78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '4']",,,"['Paragraph 0080; 0083', 'Paragraph 0051; 0052; 0054; 0055', 'Paragraph 0035-0036; 0056-0061']","['Overall yield = 85 %; stereoselective reaction', 'Overall yield = 92 %', 'Overall yield = 98 percent']","['C20H29FeN3OS', 'C53H73N3O4S', 'C68H90N6O8']",,,,,,"['74 percent ee', '70 percent ee', '82 percent ee']",,,"['12.11', '4', '4']","['This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The', 'Example 2']","['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to', 'General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf']",
CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1,46359681,3,37,half reaction|has preparation,,"(S)-3-[1-(4-bromo-phenyl)-2-nitro-ethyl]-pentane-2,4-dione|(R)-3-[1-(4-bromophenyl)-2-nitroethyl]-pentane-2,4-dione",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['0', '25', '25']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['toluene', 'water|toluene', 'dichloromethane']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);', '78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '4']",,,"['Paragraph 0080; 0084', 'Paragraph 0051; 0052; 0054; 0055', 'Paragraph 0035-0036; 0056-0061']","['Overall yield = 92 %; stereoselective reaction', 'Overall yield = 93 %', 'Overall yield = 95 percent']","['C20H29FeN3OS', 'C53H73N3O4S', 'C68H90N6O8']",,,,,,"['80 percent ee', '64 percent ee', '86 percent ee']",,,"['12.12', '4', '4']","['This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The', 'Example 2']","['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to', 'General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf']",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(F)cc1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(F)cc1>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(F)cc1,46359682,3,37,half reaction|has preparation,,"(R)-3-[1-(4-fluorophenyl)-2-nitroethyl]-pentane-2,4-dione|(S)-3-[1-(4-fluoro-phenyl)-2-nitro-ethyl]-pentane-2,4-dione",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['0', '25', '25']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['toluene', 'water|toluene', 'dichloromethane']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);', '78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '4']",,,"['Paragraph 0080; 0084', 'Paragraph 0051; 0052; 0054; 0055', 'Paragraph 0035-0036; 0056-0061']","['Overall yield = 97 %; stereoselective reaction', 'Overall yield = 90 %', 'Overall yield = 80 percent']","['C20H29FeN3OS', 'C53H73N3O4S', 'C68H90N6O8']",,,,,,"['71 percent ee', '68 percent ee', '72 percent ee']",,,"['12.13', '4', '4']","['This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The', 'Example 2']","['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to', 'General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf']",
COc1ccc([C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1,COc1ccc([C@@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1,COc1ccc([C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1>>COc1ccc([C@@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)cc1,46359684,3,37,half reaction|has preparation,,"(R)-3-[1-(4-methoxyphenyl)-2-nitroethyl]-pentane-2,4-dione|(S)-3-(1-(4-methoxyphenyl)-2-nitroethyl)pentane-2,4-dione",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['0', '25', '25']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['toluene', 'water|toluene', 'dichloromethane']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);', '78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '4']",,,"['Paragraph 0080; 0084', 'Paragraph 0051; 0052; 0054; 0055', 'Paragraph 0035-0036; 0056-0061']","['Overall yield = 93 %; stereoselective reaction', 'Overall yield = 97 %', 'Overall yield = 81 percent']","['C20H29FeN3OS', 'C53H73N3O4S', 'C68H90N6O8']",,,,,,"['77 percent ee', '46 percent ee', '81 percent ee']",,,"['12.15', '4', '4']","['This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The', 'Example 2']","['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to', 'General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf']",
CCOC(=O)C1CN(CCCN2CCOCC2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1ccccc1NCc1ccccc1,,CCOC(=O)C1CN(CCCN2CCOCC2)C(=O)C1(Cc1onc(C)c1[N+](=O)[O-])c1ccccc1NCc1ccccc1>>,49105474,1,37,half reaction|has preparation,,ethyl4-(2-(benzylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl) methyl)-1-(3-morpholinopropyl)-5-oxopyrrolidine-3-carboxylate,,Preparation,1,20,Michael Addition,,ethanol,74795237; Patent; GUIZHOU UNIVERSITY; CN105111198; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0019; 0020; 0021; 0034,,,ethyl4-(2-(benzylamino)phenyl)-4-((3-methyl-4-nitroisoxazol-5-yl) methyl)-1-(3-morpholinopropyl)-5-oxopyrrolidine-3-carboxylate,72 percent,72,,,92.308 percent de,,,1,"Embodiment 1 of the present invention: Preparation of nitroisoxazole spliced 2-pyrrolidone compounds,","General procedure: In a round bottom flask,First add 10 ml of organic solvent ethanol,Then were added 3- (2-ethyl methacrylate) -N- methyl-isoxazol-3-nitro-oxindole 1.0 mmol (385 mg)And benzylamine 1.",
COc1ccc([C@H](CC(=O)c2ccccc2)[C@@]2(n3ccc(=O)[nH]3)C(=O)Nc3ccccc32)cc1OC,,COc1ccc([C@H](CC(=O)c2ccccc2)[C@@]2(n3ccc(=O)[nH]3)C(=O)Nc3ccccc32)cc1OC>>,60137753,1,37,half reaction|has preparation,,"(±)-(S)-3-((S)-1-(3,4-dimethoxyphenyl)-3-oxo-3-phenylpr",,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0090-0094,,sodium tertiary butoxide,"(±)-(S)-3-((S)-1-(3,4-dimethoxyphenyl)-3-oxo-3-phenylpr",21 percent,21,,,,,,7,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
COc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1O,,COc1ccc(C2C(C#N)=C(N)OC3=C2CN(Cc2ccccc2)C3=O)cc1O>>,43705739,1,36,half reaction|has preparation,,"2-amino-6-benzyl-4-(3-hydroxy-4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",,Preparation,1,25,Michael Addition,,,69876128; Patent; CHENGDU UNIVERSITY; CN105541853; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0030; 031; 0032; 0034; 0035; 0036; 0037-0039,,piperidine,"2-amino-6-benzyl-4-(3-hydroxy-4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydropyrano[2,3-c]pyrrole-3-carbonitrile",62 percent,62,,,,,,15,Example 1 Preparation of compound a,"General procedure: Into a clean reaction tube, were added secondary amine catalyst piperidine (0.001 mmol), pyrrolidone electron-deficienct diene compound 1 (0.2 mmol), malononitrile (0.22 mmol), and",
O=C(C[C@@H](c1ccco1)[C@@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccccc21)c1ccccc1,,O=C(C[C@@H](c1ccco1)[C@@]1(n2ccc(=O)[nH]2)C(=O)Nc2ccccc21)c1ccccc1>>,60137751,1,36,half reaction|has preparation,,(±)-(S)-3-((R)-1-(furan-2-yl)-3-oxo-3-phenylpropyl),,Preparation,1,20,Michael Addition,,"N,N-dimethyl-formamide",112000299; Patent; SICHUAN AGRICULTURAL UNIVERSITY; CN113773306; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0057-0058; 0063-0064; 0080-0084,,sodium tertiary butoxide,(±)-(S)-3-((R)-1-(furan-2-yl)-3-oxo-3-phenylpropyl),11 percent,11,,,,,,5,,"General procedure: 3) isatin N,N'-cyclic azomethine imine (1.0mmol), chalcone (2.2mmol) and N,N-dimethylformamide (6.0mL) were added to 25mL In the reaction test tube, stir evenly at room temperature,",
CC(=O)C[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,,CC(=O)C[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,66544146,3,36,half reaction|has preparation,,(S)-4-(4-bromophenyl)-5-nitropentan-2-one,,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090-0092; 0096; 0105', 'Paragraph 0075; 0090-0092; 0095; 0105; 0148-0149']",enantiospecific reaction,"['4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea', '4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea']",(S)-4-(4-bromophenyl)-5-nitropentan-2-one,99 percent,,,,98 percent ee,2,,"['1.10', '1', '4']","['(10)', 'In Case of Ketone', '1.3.1 In Case of Ketone']","['(10) (S)-4-(4-Bromophenyl)-5-nitropentan-2-one (Chemical Formula 3-10) [α]D20-0.6 (c 0.4, CHCl3); 1H', 'General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo', 'General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo']",
CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1,,CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1>>,66544208,3,36,half reaction|has preparation,,"(R)-3-(4-chlorophenyl)-2,2-dimethyl-4-nitrobutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120-0121', 'Paragraph 0075; 0090; 0093-0094; 0120-0121; 0154-0156,']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-3-(4-chlorophenyl)-2,2-dimethyl-4-nitrobutanal",94 percent,,,,99 percent ee,2,,"['1.26', '1', '4']","['(26)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(26) (R)-3-(4-Chlorophenyl)-2,2-dimethyl-4-nitrobutanal (Chemical Formula 3-26) [α]D22-5.83 (c 0.2,', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,,CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>,66544213,3,36,half reaction|has preparation,,"(R)-3-(4-bromophenyl)-2,2-dimethyl-4-nitrobutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120; 0122', 'Paragraph 0075; 0090; 0093-0094; 0120; 0122; 0154-0156']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-3-(4-bromophenyl)-2,2-dimethyl-4-nitrobutanal",94 percent,,,,98 percent ee,2,,"['1.27', '1', '4']","['(27)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(27) (R)-3-(4-Bromophenyl)2,2-dimethyl-4-nitrobutanal (Chemical Formula 3-27) [α]D23-14.86 (c 0.1, C', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
Cc1ccc([C@@H](C[N+](=O)[O-])C(C)(C)C=O)cc1,,Cc1ccc([C@@H](C[N+](=O)[O-])C(C)(C)C=O)cc1>>,66544219,3,36,half reaction|has preparation,,"(R)-2,2-dimethyl-4-nitro-3-p-tolylbutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120; 0123', 'Paragraph 0075; 0090; 0093-0094; 0120; 0123; 0154-0156']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-2,2-dimethyl-4-nitro-3-p-tolylbutanal",94 percent,,,,99 percent ee,2,,"['1.28', '1', '4']","['(28)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(28) (R)-2,2-Dimethyl-4-nitro-3-p-tolylbutanal (Chemical Formula 3-28) [α]D22-15.07 (c 0.4, CH2Cl2);', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccco1,,CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccco1>>,66544225,3,36,half reaction|has preparation,,"(R)-3-(furan-2-yl)-2,2-dimethyl-4-nitrobutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120; 0124', 'Paragraph 0075; 0090; 0093-0094; 0120; 0124; 0154-0156']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-3-(furan-2-yl)-2,2-dimethyl-4-nitrobutanal",99 percent,,,,99 percent ee,2,,"['1.29', '1', '4']","['(29)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(29) (R)-3-(Furan-2-yl)-2,2-dimethyl-4-nitrobutanal (Chemical Formula 3-29) [α]D22-12.06 (c 0.3, CH2', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
COc1ccc([C@@H](C[N+](=O)[O-])C(C)(C)C=O)cc1,,COc1ccc([C@@H](C[N+](=O)[O-])C(C)(C)C=O)cc1>>,66544234,3,36,half reaction|has preparation,,"(R)-3-(4-methoxyphenyl)-2,2-dimethyl-4-nitrobutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120; 0125', 'Paragraph 0075; 0090; 0093-0094; 0120; 0125; 0154-0156']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-3-(4-methoxyphenyl)-2,2-dimethyl-4-nitrobutanal",97 percent,,,,99 percent ee,2,,"['1.30', '1', '4']","['(30)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(30) (R)-3-(4-Methoxyphenyl)-2,2-dimethyl-4-nitrobutanal (Chemical Formula 3-30) [α]D22-9.55 (c 0.2,', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
COc1ccccc1[C@@H](C[N+](=O)[O-])C(C)(C)C=O,,COc1ccccc1[C@@H](C[N+](=O)[O-])C(C)(C)C=O>>,66544239,3,36,half reaction|has preparation,,"(R)-3-(2-methoxyphenyl)-2,2-dimethyl-4-nitrobutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120; 0126', 'Paragraph 0075; 0090; 0093-0094; 0120; 0126; 0154-0156']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-3-(2-methoxyphenyl)-2,2-dimethyl-4-nitrobutanal",96 percent,,,,99 percent ee,2,,"['1.31', '1', '4']","['(31)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(31) (R)-3-(2-Methoxyphenyl)-2,2-dimethyl-4-nitrobutanal (Chemical Formula 3-31) [α]D20-14.39 (c 0.3', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccc(O)cc1,,CC(C)(C=O)[C@H](C[N+](=O)[O-])c1ccc(O)cc1>>,66544245,3,36,half reaction|has preparation,,"(R)-3-(4-hydroxyphenyl)-2,2-dimethyl-4-nitrobutanal",,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['20', '20']",Michael Addition,,"['water|water', 'water']","['132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);', '132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,"['Paragraph 0075; 0090; 0094; 0120; 0127', 'Paragraph 0075; 0090; 0093-0094; 0120; 0127; 0154-0156']",stereoselective reaction,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","(R)-3-(4-hydroxyphenyl)-2,2-dimethyl-4-nitrobutanal",96 percent,,,,99 percent ee,2,,"['1.32', '1', '4']","['(32)', 'In Case of Aldehyde', '1.3.2 In Case of Aldehyde']","['(32) (R)-3-(4-Hydroxyphenyl)-2,2-dimethyl-4-nitrobutanal (Chemical Formula 3-32) [α]D22-13.37 (c 0.2', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene', 'General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene']",
[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c2ccccc2)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)CC(SC[C@H](N)C(=O)NCCCCCC(=O)NC[C@H]3CC[C@H](C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC3)C2=O)C(C)C)cc1)C(C)C,,[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c2ccccc2)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)CC(SC[C@H](N)C(=O)NCCCCCC(=O)NC[C@H]3CC[C@H](C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC3)C2=O)C(C)C)cc1)C(C)C>>,66980816,3,36,half reaction|has preparation,,C110H166N18O26S,,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['37', '37', '37']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['aq. phosphate buffer|dimethyl sulfoxide', 'aq. phosphate buffer|dimethyl sulfoxide', 'aq. phosphate buffer|water|dimethyl sulfoxide']","['132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);', '132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);', '132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Page/Page column 31; 32; 51; 52', 'Page/Page column 31; 32; 51; 52', 'Page/Page column 31; 32; 51; 52']",,"['sodium hydrogencarbonate', 'sodium hydrogencarbonate', 'sodium hydrogencarbonate']","['C110H166N18O26S', 'C110H166N18O26S', 'C110H166N18O26S']","['61 percent', '61 percent', '61 percent']",,,,,,,"['1', '1', '1']","['Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)', 'Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)', 'Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)']","['General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1', 'General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1', 'General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1']",
[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c2ccccc2)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)CC(SC[C@H](N)C(=O)NCCCCCC(=O)NC[C@H]2CC[C@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC2)C1=O)C(C)C,,[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c2ccccc2)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)CC(SC[C@H](N)C(=O)NCCCCCC(=O)NC[C@H]2CC[C@H](C(=O)N[C@@H](Cc3ccc4ccccc4c3)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC2)C1=O)C(C)C>>,66980817,3,36,half reaction|has preparation,,C91H139N13O21S,,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['37', '37', '37']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['aq. phosphate buffer|dimethyl sulfoxide', 'aq. phosphate buffer|dimethyl sulfoxide', 'aq. phosphate buffer|water|dimethyl sulfoxide']","['132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);', '132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);', '132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Page/Page column 31; 32; 51; 54', 'Page/Page column 31; 32; 51; 54', 'Page/Page column 31; 32; 51; 54']",,"['sodium hydrogencarbonate', 'sodium hydrogencarbonate', 'sodium hydrogencarbonate']","['C91H139N13O21S', 'C91H139N13O21S', 'C91H139N13O21S']","['56 percent', '56 percent', '56 percent']",,,,,,,"['1', '1', '1']","['Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)', 'Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)', 'Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)']","['General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1', 'General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1', 'General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1']",
[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)CCCCCN2C(=O)CC(SC[C@H](N)C(=O)NCCCCCC(=O)NC[C@H]3CC[C@H](C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC3)C2=O)cc1)C(C)C,,[H][C@@]1([C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)CCCCCN2C(=O)CC(SC[C@H](N)C(=O)NCCCCCC(=O)NC[C@H]3CC[C@H](C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC3)C2=O)cc1)C(C)C>>,66980818,3,36,half reaction|has preparation,,C106H154N16O26S,,"['Preparation', 'Preparation', 'Preparation']","['1', '1', '1']","['37', '37', '37']","['Michael Addition', 'Michael Addition', 'Michael Addition']",,"['aq. phosphate buffer|dimethyl sulfoxide', 'aq. phosphate buffer|dimethyl sulfoxide', 'aq. phosphate buffer|water|dimethyl sulfoxide']","['132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);', '132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);', '132159033; Patent; PHILOCHEM; WO2024/28258; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Page/Page column 31; 32; 51', 'Page/Page column 31; 32; 51', 'Page/Page column 31; 32; 51; 55']",,"['sodium hydrogencarbonate', 'sodium hydrogencarbonate', 'sodium hydrogencarbonate']","['C106H154N16O26S', 'C106H154N16O26S', 'C106H154N16O26S']","['48 percent', '48 percent', '48 percent']",,,,,,,"['1', '1', '1']","['Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)', 'Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)', 'Michael addition between Compound 12 (thiol) and maleimide (linker-payload derivative) (GP2)']","['General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1', 'General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1', 'General procedure: The maleimido-containing linker-payload derivative (1 equiv.) was dissolved in DMSO (0.01 M). The solution was transferred into an Eppendorf tube, containing a mixture of compound 1']",
COc1cccc([C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)c1,COc1cccc([C@@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)c1,COc1cccc([C@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)c1>>COc1cccc([C@@H](C[N+](=O)[O-])C(C(C)=O)C(C)=O)c1,46359679,2,35,half reaction|has preparation,,"3-((R)-1-(3-methoxyphenyl)-2-nitroethyl)pentane-2,4-dione|(S)-3-[1-(3-methoxy-phenyl)-2-nitro-ethyl]-pentane-2,4-dione",,"['Preparation', 'Preparation']","['1', '1']","['0', '25']","['Michael Addition', 'Michael Addition']",,"['toluene', 'water|toluene']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,"['Paragraph 0080; 0083', 'Paragraph 0051; 0052; 0054; 0055']","['Overall yield = 95 %; stereoselective reaction', 'Overall yield = 99 %']","['C20H29FeN3OS', 'C53H73N3O4S']",,,,,,"['82 percent ee', '63 percent ee']",,,"['12.10', '4']",This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to']",
CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(C)cc1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(C)cc1>>CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(C)cc1,46359683,2,35,half reaction|has preparation,,"3-((S)-2-nitro-1-p-tolylethyl)pentane-2,4-dione|(R)-3-(2-nitro-1-(4-methylphenyl)-ethyl)pentane-2,4-dione",,"['Preparation', 'Preparation']","['1', '1']","['0', '25']","['Michael Addition', 'Michael Addition']",,"['toluene', 'dichloromethane']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,"['24', '4']",,,"['Paragraph 0080; 0084', 'Paragraph 0035-0036; 0056-0061']","['Overall yield = 91 %; stereoselective reaction', 'Overall yield = 84 percent']","['C20H29FeN3OS', 'C68H90N6O8']",,,,,,"['70 percent ee', '79 percent ee']",,,"['12.14', '4']",Example 2,"['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf']",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1F,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1F,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1F>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1F,46359696,2,35,half reaction|has preparation,,"(R)-3-[1-(2-fluorophenyl)-2-nitroethyl]pentane-2,4-dione|(S)-3-[1-(2-fluoro-phenyl)-2-nitro-ethyl]-pentane-2,4-dione",,"['Preparation', 'Preparation']","['1', '1']","['0', '25']","['Michael Addition', 'Michael Addition']",,"['toluene', 'water|toluene']","['72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);', '75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,"['Paragraph 0080; 0083', 'Paragraph 0051; 0052; 0054; 0055']","['Overall yield = 97 %; stereoselective reaction', 'Overall yield = 91 %']","['C20H29FeN3OS', 'C53H73N3O4S']",,,,,,"['88 percent ee', '59 percent ee']",,,"['12.4', '4']",This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"['General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti', 'General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to']",
COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccccc1,COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccccc1,COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccccc1>>COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccccc1,50118001,2,35,half reaction|has preparation,,dimethyl [(1S)-2-nitro-1-phenylethyl]malonate|methyl (R)-2-methoxycarbonyl-4-nitro-3-phenylbutanoate,,"['Preparation', 'Preparation']","['1', '1']","['25', '25']","['Michael Addition', 'Michael Addition']",,"['water|toluene', 'dichloromethane']","['75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);', '78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,"['Paragraph 0051; 0052; 0054; 0055', 'Paragraph 0035-0036; 0056-0061']","['Overall yield = 92 %', 'Overall yield = 61 percent']","['C53H73N3O4S', 'C68H90N6O8']",,,,,,"['75 percent ee', '73 percent ee']",,,"['4', '4']","['This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The', 'Example 2']","['General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to', 'General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf']",
Cc1cccnc1C(=O)CCC(C(=O)OC(C)(C)C)C(=O)c1cccc(Cc2cscn2)n1,,Cc1cccnc1C(=O)CCC(C(=O)OC(C)(C)C)C(=O)c1cccc(Cc2cscn2)n1>>,59701814,2,35,half reaction|has preparation,,C25H27N3O4S,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['acetonitrile', 'acetonitrile']","['111958701; Patent; X4 PHARMACEUTICALS; WO2021/263203; A1; (2021);', '111958701; Patent; X4 PHARMACEUTICALS; WO2021/263203; A1; (2021);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 00340; 00391; 00408', 'Paragraph 00340; 00391; 00408']",,"['potassium carbonate', 'potassium carbonate']",,,,,,,,,"['9', '9']","['General procedure L (Michael addition reaction):', 'General procedure L (Michael addition reaction):']","['General procedure: A mixture of 3-oxopropanoate (concentration 0.1-1 M), 2-en-1-one (1.5 equiv.) and K2CO3 (2 equiv.) in CH3CN was stirred at room temperature overnight. After completion of the reacti', 'General procedure: A mixture of 3-oxopropanoate (concentration 0.1-1 M), 2-en-1-one (1.5 equiv.) and K2CO3 (2 equiv.) in CH3CN was stirred at room temperature overnight. After completion of the reacti']",
CC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(Cc2ccccc2)c2ccccc21,,CC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(Cc2ccccc2)c2ccccc21>>,63743556,2,35,half reaction|has preparation,,C28H24N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0041', 'Paragraph 0017; 0032-0035; 0038; 0041']",,"['triethylamine', 'triethylamine']","['C28H24N4OS', 'C28H24N4OS']","['79 percent', '79 percent']",,,,"['33.333 percent de', '33.333 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cc(F)ccc21,,CN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cc(F)ccc21>>,63743557,2,35,half reaction|has preparation,,C22H19FN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0042', 'Paragraph 0017; 0032-0035; 0038; 0042']",,"['triethylamine', 'triethylamine']","['C22H19FN4OS', 'C22H19FN4OS']","['76 percent', '76 percent']",,,,"['60 percent de', '60 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cccc(F)c21,,CN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cccc(F)c21>>,63743558,2,35,half reaction|has preparation,,C22H19FN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0043', 'Paragraph 0017; 0032-0035; 0038; 0043']",,"['triethylamine', 'triethylamine']","['C22H19FN4OS', 'C22H19FN4OS']","['80 percent', '80 percent']",,,,"['33.333 percent de', '33.333 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccccc45)C31C)C(=O)N2C,,Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccccc45)C31C)C(=O)N2C>>,63743559,2,35,half reaction|has preparation,,C23H22N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0044', 'Paragraph 0017; 0032-0035; 0038; 0044']",,"['triethylamine', 'triethylamine']","['C23H22N4OS', 'C23H22N4OS']","['81 percent', '81 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cccc(F)c21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cccc(F)c21>>,63743560,2,35,half reaction|has preparation,,C23H21FN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0045', 'Paragraph 0017; 0032-0035; 0038; 0045']",,"['triethylamine', 'triethylamine']","['C23H21FN4OS', 'C23H21FN4OS']","['82 percent', '82 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cc(C)ccc21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2cc(C)ccc21>>,63743561,2,35,half reaction|has preparation,,C24H24N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0046', 'Paragraph 0017; 0032-0035; 0038; 0046']",,"['triethylamine', 'triethylamine']","['C24H24N4OS', 'C24H24N4OS']","['78 percent', '78 percent']",,,,"['60 percent de', '60 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccccc45)C31C)C(=O)N2Cc1ccccc1,,Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccccc45)C31C)C(=O)N2Cc1ccccc1>>,63743562,2,35,half reaction|has preparation,,C29H26N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0047', 'Paragraph 0017; 0032-0035; 0038; 0047']",,"['triethylamine', 'triethylamine']","['C29H26N4OS', 'C29H26N4OS']","['81 percent', '81 percent']",,,,"['66.667 percent de', '66.667 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C31C)C(=O)N2C,,Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C31C)C(=O)N2C>>,63743563,2,35,half reaction|has preparation,,C23H21ClN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0048', 'Paragraph 0017; 0032-0035; 0038; 0048']",,"['triethylamine', 'triethylamine']","['C23H21ClN4OS', 'C23H21ClN4OS']","['85 percent', '85 percent']",,,,"['66.667 percent de', '66.667 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CC12c3[nH]c4ccc(Cl)cc4c3CCN1C(=S)NC21C(=O)N(Cc2ccccc2)c2ccccc21,,CC12c3[nH]c4ccc(Cl)cc4c3CCN1C(=S)NC21C(=O)N(Cc2ccccc2)c2ccccc21>>,63743564,2,35,half reaction|has preparation,,C28H23ClN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0049', 'Paragraph 0017; 0032-0035; 0038; 0049']",,"['triethylamine', 'triethylamine']","['C28H23ClN4OS', 'C28H23ClN4OS']","['75 percent', '75 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C31C)C(=O)N2Cc1ccccc1,,Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C31C)C(=O)N2Cc1ccccc1>>,63743565,2,35,half reaction|has preparation,,C29H25ClN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0050', 'Paragraph 0017; 0032-0035; 0038; 0050']",,"['triethylamine', 'triethylamine']","['C29H25ClN4OS', 'C29H25ClN4OS']","['77 percent', '77 percent']",,,,"['60 percent de', '60 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C32C)c2cc(C)ccc21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C32C)c2cc(C)ccc21>>,63743566,2,35,half reaction|has preparation,,C24H23ClN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0051', 'Paragraph 0017; 0032-0035; 0038; 0051']",,"['triethylamine', 'triethylamine']","['C24H23ClN4OS', 'C24H23ClN4OS']","['84 percent', '84 percent']",,,,"['33.333 percent de', '33.333 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C32C)c2cccc(F)c21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccc(Cl)cc45)C32C)c2cccc(F)c21>>,63743567,2,35,half reaction|has preparation,,C23H20ClFN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0052', 'Paragraph 0017; 0032-0035; 0038; 0052']",,"['triethylamine', 'triethylamine']","['C23H20ClFN4OS', 'C23H20ClFN4OS']","['74 percent', '74 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CC12c3[nH]c4ccc(Cl)cc4c3CCN1C(=S)NC21C(=O)N(c2ccccc2)c2ccccc21,,CC12c3[nH]c4ccc(Cl)cc4c3CCN1C(=S)NC21C(=O)N(c2ccccc2)c2ccccc21>>,63743568,2,35,half reaction|has preparation,,C27H21ClN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0053', 'Paragraph 0017; 0032-0035; 0038; 0053']",,"['triethylamine', 'triethylamine']","['C27H21ClN4OS', 'C27H21ClN4OS']","['75 percent', '75 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(C)c2ccccc21,,CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(C)c2ccccc21>>,63743569,2,35,half reaction|has preparation,,C23H22N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0054', 'Paragraph 0017; 0032-0038; 0054']",,"['triethylamine', 'triethylamine']","['C23H22N4OS', 'C23H22N4OS']","['85 percent', '85 percent']",,,,"['87.5 percent de', '87.5 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(Cc2ccccc2)c2ccccc21,,CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(Cc2ccccc2)c2ccccc21>>,63743570,2,35,half reaction|has preparation,,C29H26N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0055', 'Paragraph 0017; 0032-0038; 0055']",,"['triethylamine', 'triethylamine']","['C29H26N4OS', 'C29H26N4OS']","['80 percent', '80 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(C)c2c(F)cccc21,,CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(C)c2c(F)cccc21>>,63743571,2,35,half reaction|has preparation,,C23H21FN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0056', 'Paragraph 0017; 0032-0038; 0056']",,"['triethylamine', 'triethylamine']","['C23H21FN4OS', 'C23H21FN4OS']","['80 percent', '80 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(C)c2ccc(C)cc21,,CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21C(=O)N(C)c2ccc(C)cc21>>,63743572,2,35,half reaction|has preparation,,C24H24N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0057', 'Paragraph 0017; 0032-0038; 0057']",,"['triethylamine', 'triethylamine']","['C24H24N4OS', 'C24H24N4OS']","['80 percent', '80 percent']",,,,"['33.333 percent de', '33.333 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32CC)c2cc(C)ccc21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32CC)c2cc(C)ccc21>>,63743573,2,35,half reaction|has preparation,,C25H26N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0058', 'Paragraph 0017; 0032-0038; 0058']",,"['triethylamine', 'triethylamine']","['C25H26N4OS', 'C25H26N4OS']","['81 percent', '81 percent']",,,,"['75 percent de', '75 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32CC)c2cccc(F)c21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32CC)c2cccc(F)c21>>,63743574,2,35,half reaction|has preparation,,C24H23FN4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0059', 'Paragraph 0017; 0032-0038; 0059']",,"['triethylamine', 'triethylamine']","['C24H23FN4OS', 'C24H23FN4OS']","['79 percent', '79 percent']",,,,"['60 percent de', '60 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
O=C1N(Cc2ccccc2)c2ccccc2C12NC(=S)N1CCc3c([nH]c4ccccc34)C12C1CC1,,O=C1N(Cc2ccccc2)c2ccccc2C12NC(=S)N1CCc3c([nH]c4ccccc34)C12C1CC1>>,63743575,2,35,half reaction|has preparation,,C30H26N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0060', 'Paragraph 0017; 0032-0038; 0060']",,"['triethylamine', 'triethylamine']","['C30H26N4OS', 'C30H26N4OS']","['79 percent', '79 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccccc45)C31C1CC1)C(=O)N2C,,Cc1ccc2c(c1)C1(NC(=S)N3CCc4c([nH]c5ccccc45)C31C1CC1)C(=O)N2C>>,63743576,2,35,half reaction|has preparation,,C25H24N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0061', 'Paragraph 0017; 0032-0038; 0061']",,"['triethylamine', 'triethylamine']","['C25H24N4OS', 'C25H24N4OS']","['80 percent', '80 percent']",,,,"['33.333 percent de', '33.333 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C2CC2)c2cc(C)ccc21,,CCN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C2CC2)c2cc(C)ccc21>>,63743577,2,35,half reaction|has preparation,,C26H26N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0062', 'Paragraph 0017; 0032-0038; 0062']",,"['triethylamine', 'triethylamine']","['C26H26N4OS', 'C26H26N4OS']","['78 percent', '78 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CC12c3[nH]c4ccccc4c3CCN1C(=S)NC21Cc2ccccc2C1=O,,CC12c3[nH]c4ccccc4c3CCN1C(=S)NC21Cc2ccccc2C1=O>>,63743578,2,35,half reaction|has preparation,,C22H19N3OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0063', 'Paragraph 0017; 0032-0038; 0063']",,"['triethylamine', 'triethylamine']","['C22H19N3OS', 'C22H19N3OS']","['82 percent', '82 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CC12c3[nH]c4ccc(Cl)cc4c3CCN1C(=S)NC21Cc2ccccc2C1=O,,CC12c3[nH]c4ccc(Cl)cc4c3CCN1C(=S)NC21Cc2ccccc2C1=O>>,63743579,2,35,half reaction|has preparation,,C22H18ClN3OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0064', 'Paragraph 0017; 0032-0038; 0064']",,"['triethylamine', 'triethylamine']","['C22H18ClN3OS', 'C22H18ClN3OS']","['83 percent', '83 percent']",,,,"['33.333 percent de', '33.333 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21Cc2ccccc2C1=O,,CCC12c3[nH]c4ccccc4c3CCN1C(=S)NC21Cc2ccccc2C1=O>>,63743580,2,35,half reaction|has preparation,,C23H21N3OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0065', 'Paragraph 0017; 0032-0038; 0065']",,"['triethylamine', 'triethylamine']","['C23H21N3OS', 'C23H21N3OS']","['75 percent', '75 percent']",,,,"['60 percent de', '60 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
COc1ccc2c3c([nH]c2c1)C1(C)N(CC3)C(=S)NC12CCSC2=O,,COc1ccc2c3c([nH]c2c1)C1(C)N(CC3)C(=S)NC12CCSC2=O>>,63743581,2,35,half reaction|has preparation,,C18H19N3O2S2,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0067', 'Paragraph 0017; 0032-0038; 0067']",,"['triethylamine', 'triethylamine']","['C18H19N3O2S2', 'C18H19N3O2S2']","['88 percent', '88 percent']",,,,"['81.818 percent de', '81.818 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CC12c3[nH]c4ccccc4c3CCN1C(=S)NC21CCSC1=O,,CC12c3[nH]c4ccccc4c3CCN1C(=S)NC21CCSC1=O>>,63743582,2,35,half reaction|has preparation,,C17H17N3OS2,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0068', 'Paragraph 0017; 0032-0038; 0068']",,"['triethylamine', 'triethylamine']","['C17H17N3OS2', 'C17H17N3OS2']","['88 percent', '88 percent']",,,,"['77.778 percent de', '77.778 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CCC12c3[nH]c4ccccc4c3CCN1C(=S)N[C@@]21CCSC1=O,,CCC12c3[nH]c4ccccc4c3CCN1C(=S)N[C@@]21CCSC1=O>>,63743583,2,35,half reaction|has preparation,,C18H19N3OS2,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0038; 0066; 0069', 'Paragraph 0017; 0032-0038; 0066; 0069']",,"['triethylamine', 'triethylamine']","['C18H19N3OS2', 'C18H19N3OS2']","['89 percent', '89 percent']",,,,"['90.476 percent de', '90.476 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
COc1ccc2c3c([nH]c2c1)C1(C)N(CC3)C(=S)NC12C(=O)N(Cc1ccccc1)c1ccccc12,,COc1ccc2c3c([nH]c2c1)C1(C)N(CC3)C(=S)NC12C(=O)N(Cc1ccccc1)c1ccccc12>>,63743584,2,35,half reaction|has preparation,,C29H26N4O2S,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038-0039', 'Paragraph 0017; 0032-0035; 0038-0039']",,"['triethylamine', 'triethylamine']","['C29H26N4O2S', 'C29H26N4O2S']","['79 percent', '79 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
CN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2ccccc21,,CN1C(=O)C2(NC(=S)N3CCc4c([nH]c5ccccc45)C32C)c2ccccc21>>,63743585,2,35,half reaction|has preparation,,C22H20N4OS,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['toluene', 'toluene']","['124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);', '124784380; Patent; GUIZHOU UNIVERSITY; CN115850277; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0017; 0032-0035; 0038; 0040', 'Paragraph 0017; 0032-0035; 0038; 0040']",,"['triethylamine', 'triethylamine']","['C22H20N4OS', 'C22H20N4OS']","['81 percent', '81 percent']",,,,"['50 percent de', '50 percent de']",,,,"['Embodiments of the present invention:', 'Embodiments of the present invention:']","['General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso', 'General procedure: In the reaction tube, sequentially add camel skeletal compound 1 (0.2mmol), α-iso']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc(F)cc3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc(F)cc3)c(-c3ccccc3)c2C)cc1>>,66437930,2,35,half reaction|has preparation,,(4-fluorophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-fluorophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone', '(4-fluorophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone']","['79 percent', '79 percent']",,,,,"['2', '2']",,"['7', '7']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc(Cl)cc3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc(Cl)cc3)c(-c3ccccc3)c2C)cc1>>,66437931,2,35,half reaction|has preparation,,(4-chlorophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-chlorophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone', '(4-chlorophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone']","['33 percent', '33 percent']",,,,,"['2', '2']",,"['8', '8']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc(Br)cc3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc(Br)cc3)c(-c3ccccc3)c2C)cc1>>,66437932,2,35,half reaction|has preparation,,(4-bromophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-bromophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone', '(4-bromophenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone']","['40 percent', '40 percent']",,,,,"['2', '2']",,"['9', '9']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3cccc4ccccc34)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3cccc4ccccc34)c(-c3ccccc3)c2C)cc1>>,66437933,2,35,half reaction|has preparation,,(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(naphthalen-1-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(naphthalen-1-yl)methanone', '(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(naphthalen-1-yl)methanone']","['51 percent', '51 percent']",,,,,"['2', '2']",,"['10', '10']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccco3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccco3)c(-c3ccccc3)c2C)cc1>>,66437934,2,35,half reaction|has preparation,,furan-2-yl(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['furan-2-yl(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone', 'furan-2-yl(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone']","['55 percent', '55 percent']",,,,,"['2', '2']",,"['11', '11']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3cccs3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3cccs3)c(-c3ccccc3)c2C)cc1>>,66437935,2,35,half reaction|has preparation,,(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(thiophen-2-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(thiophen-2-yl)methanone', '(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(thiophen-2-yl)methanone']","['79 percent', '79 percent']",,,,,"['2', '2']",,"['12', '12']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
CCCCC(=O)c1[nH]c(S(=O)(=O)c2ccc(C)cc2)c(C)c1-c1ccccc1,,CCCCC(=O)c1[nH]c(S(=O)(=O)c2ccc(C)cc2)c(C)c1-c1ccccc1>>,66437936,2,35,half reaction|has preparation,,1-(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)pentan-1-one,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['1-(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)pentan-1-one', '1-(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)pentan-1-one']","['91 percent', '91 percent']",,,,,"['2', '2']",,"['14', '14']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(-c2c(C(=O)c3ccccc3)[nH]c(S(=O)(=O)c3ccc(C)cc3)c2C)cc1,,Cc1ccc(-c2c(C(=O)c3ccccc3)[nH]c(S(=O)(=O)c3ccc(C)cc3)c2C)cc1>>,66437937,2,35,half reaction|has preparation,,(4-methyl-3-(p-tolyl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-(p-tolyl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(4-methyl-3-(p-tolyl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['68 percent', '68 percent']",,,,,"['2', '2']",,"['15', '15']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccccc3C)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccccc3C)c2C)cc1>>,66437938,2,35,half reaction|has preparation,,(4-methyl-3-(o-tolyl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-(o-tolyl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(4-methyl-3-(o-tolyl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['68 percent', '68 percent']",,,,,"['2', '2']",,"['16', '16']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
COc1ccc(-c2c(C(=O)c3ccccc3)[nH]c(S(=O)(=O)c3ccc(C)cc3)c2C)cc1,,COc1ccc(-c2c(C(=O)c3ccccc3)[nH]c(S(=O)(=O)c3ccc(C)cc3)c2C)cc1>>,66437939,2,35,half reaction|has preparation,,(3-(4-methoxyphenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(3-(4-methoxyphenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(3-(4-methoxyphenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['38 percent', '38 percent']",,,,,"['2', '2']",,"['17', '17']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc(F)cc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc(F)cc3)c2C)cc1>>,66437940,2,35,half reaction|has preparation,,(3-(4-fluorophenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(3-(4-fluorophenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(3-(4-fluorophenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['50 percent', '50 percent']",,,,,"['2', '2']",,"['18', '18']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc(Br)cc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc(Br)cc3)c2C)cc1>>,66437941,2,35,half reaction|has preparation,,(3-(4-bromophenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(3-(4-bromophenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(3-(4-bromophenyl)-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['40 percent', '40 percent']",,,,,"['2', '2']",,"['19', '19']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc(C(F)(F)F)cc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc(C(F)(F)F)cc3)c2C)cc1>>,66437942,2,35,half reaction|has preparation,,(4-methyl-5-tosyl-3-(4-(trifluoromethyl)phenyl)-1H-pyrrol-2-yl)-(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-5-tosyl-3-(4-(trifluoromethyl)phenyl)-1H-pyrrol-2-yl)-(phenyl)methanone', '(4-methyl-5-tosyl-3-(4-(trifluoromethyl)phenyl)-1H-pyrrol-2-yl)-(phenyl)methanone']","['25 percent', '25 percent']",,,,,"['2', '2']",,"['20', '20']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc4ccccc4c3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccc4ccccc4c3)c2C)cc1>>,66437943,2,35,half reaction|has preparation,,(4-methyl-3-(naphthalen-2-yl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-(naphthalen-2-yl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(4-methyl-3-(naphthalen-2-yl)-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['54 percent', '54 percent']",,,,,"['2', '2']",,"['21', '21']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
CCCCc1c(C(=O)c2ccccc2)[nH]c(S(=O)(=O)c2ccc(C)cc2)c1C,,CCCCc1c(C(=O)c2ccccc2)[nH]c(S(=O)(=O)c2ccc(C)cc2)c1C>>,66437944,2,35,half reaction|has preparation,,(3-butyl-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(3-butyl-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(3-butyl-4-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['72 percent', '72 percent']",,,,,"['2', '2']",,"['22', '22']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
CCCCc1c(C(=O)C2CC2)[nH]c(S(=O)(=O)c2ccc(C)cc2)c1C,,CCCCc1c(C(=O)C2CC2)[nH]c(S(=O)(=O)c2ccc(C)cc2)c1C>>,66437945,2,35,half reaction|has preparation,,(3-butyl-4-methyl-5-tosyl-1H-pyrrol-2-yl)(cyclopropyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(3-butyl-4-methyl-5-tosyl-1H-pyrrol-2-yl)(cyclopropyl)methanone', '(3-butyl-4-methyl-5-tosyl-1H-pyrrol-2-yl)(cyclopropyl)methanone']","['45 percent', '45 percent']",,,,,"['2', '2']",,"['23', '23']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccccc3)c2C2CC2)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccccc3)c2C2CC2)cc1>>,66437946,2,35,half reaction|has preparation,,(4-cyclopropyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-cyclopropyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(4-cyclopropyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['87 percent', '87 percent']",,,,,"['2', '2']",,"['24', '24']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(C)c2Cc2ccccc2)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(C)c2Cc2ccccc2)cc1>>,66437947,2,35,half reaction|has preparation,,(4-benzyl-3-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-benzyl-3-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone', '(4-benzyl-3-methyl-5-tosyl-1H-pyrrol-2-yl)(phenyl)methanone']","['69 percent', '69 percent']",,,,,"['2', '2']",,"['25', '25']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
COC(=O)c1[nH]c(S(=O)(=O)c2ccc(C)cc2)c(C)c1-c1ccccc1,,COC(=O)c1[nH]c(S(=O)(=O)c2ccc(C)cc2)c(C)c1-c1ccccc1>>,66437948,2,35,half reaction|has preparation,,methyl 4-methyl-3-phenyl-5-tosyl-1H-pyrrole-2-carboxylate,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['methyl 4-methyl-3-phenyl-5-tosyl-1H-pyrrole-2-carboxylate', 'methyl 4-methyl-3-phenyl-5-tosyl-1H-pyrrole-2-carboxylate']","['18 percent', '18 percent']",,,,,"['2', '2']",,"['26', '26']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
CCOP(=O)(OCC)c1[nH]c(S(=O)(=O)c2ccc(C)cc2)c(C)c1-c1ccccc1,,CCOP(=O)(OCC)c1[nH]c(S(=O)(=O)c2ccc(C)cc2)c(C)c1-c1ccccc1>>,66437949,2,35,half reaction|has preparation,,diethyl (4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)phosphonate,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043-0044; 0046-0047', 'Paragraph 0039-0040; 0043-0044; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['diethyl (4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)phosphonate', 'diethyl (4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)phosphonate']","['87 percent', '87 percent']",,,,,"['2', '2']",,"['27', '27']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3)c(-c3ccccc3)c2C)cc1>>,66437950,2,35,half reaction|has preparation,,(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)-(phenyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0042-0043; 0046-0047', 'Paragraph 0039-0040; 0042-0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)-(phenyl)methanone', '(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)-(phenyl)methanone']","['75 percent', '75 percent']",,,,,"['2', '2']",,"['1', '1']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(C(=O)c2[nH]c(S(=O)(=O)c3ccc(C)cc3)c(C)c2-c2ccccc2)cc1,,Cc1ccc(C(=O)c2[nH]c(S(=O)(=O)c3ccc(C)cc3)c(C)c2-c2ccccc2)cc1>>,66437951,2,35,half reaction|has preparation,,(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(p-tolyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(p-tolyl)methanone', '(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(p-tolyl)methanone']","['76 percent', '76 percent']",,,,,"['2', '2']",,"['2', '2']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3cccc(C)c3)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3cccc(C)c3)c(-c3ccccc3)c2C)cc1>>,66437952,2,35,half reaction|has preparation,,(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(m-tolyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(m-tolyl)methanone', '(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(m-tolyl)methanone']","['71 percent', '71 percent']",,,,,"['2', '2']",,"['3', '3']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3C)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccccc3C)c(-c3ccccc3)c2C)cc1>>,66437953,2,35,half reaction|has preparation,,(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(o-tolyl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(o-tolyl)methanone', '(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)(o-tolyl)methanone']","['64 percent', '64 percent']",,,,,"['2', '2']",,"['4', '4']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
COc1ccc(C(=O)c2[nH]c(S(=O)(=O)c3ccc(C)cc3)c(C)c2-c2ccccc2)cc1,,COc1ccc(C(=O)c2[nH]c(S(=O)(=O)c3ccc(C)cc3)c(C)c2-c2ccccc2)cc1>>,66437954,2,35,half reaction|has preparation,,(4-methoxyphenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone,,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(4-methoxyphenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone', '(4-methoxyphenyl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone']","['73 percent', '73 percent']",,,,,"['2', '2']",,"['5', '5']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc4c(c3)CCO4)c(-c3ccccc3)c2C)cc1,,Cc1ccc(S(=O)(=O)c2[nH]c(C(=O)c3ccc4c(c3)CCO4)c(-c3ccccc3)c2C)cc1>>,66437955,2,35,half reaction|has preparation,,"(2,3-dihydrobenzofuran-5-yl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone",,"['Preparation', 'Preparation']","['1', '1']","['80|80', '80|80']","['Michael Addition|Michael Addition', 'Michael Addition|Michael Addition']",,"['acetonitrile|acetonitrile', 'acetonitrile|acetonitrile']","['128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);', '128336304; Patent; ZHEJIANG SCI TECH UNIVERSITY; CN116803979; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,"['Schlenk technique|Inert atmosphere|Inert atmosphere', 'Schlenk technique|Inert atmosphere|Inert atmosphere']",,"['Paragraph 0039-0040; 0043; 0046-0047', 'Paragraph 0039-0040; 0043; 0046-0047']",,"['caesium carbonate', 'caesium carbonate']","['(2,3-dihydrobenzofuran-5-yl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone', '(2,3-dihydrobenzofuran-5-yl)(4-methyl-3-phenyl-5-tosyl-1H-pyrrol-2-yl)methanone']","['83 percent', '83 percent']",,,,,"['2', '2']",,"['6', '6']",,"['General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1', 'General procedure: Purge the 35 ml Schlenk tube with nitrogen, add cesium carbonate, p-toluenesulfonylmethyl isonitrile (III) and 2 mL of organic solvent according to the raw material ratio in Table 1']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCSC(=S)N3CCc4ccccc4C3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCSC(=S)N3CCc4ccccc4C3)cc2OC)ncc1Cl>>,66458478,2,35,half reaction|has preparation,,"2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl 3,4-dihydroisoquinoline-2(1H)-carbodithioate",,"['Preparation', 'Preparation']","['1', '1']","['20|20', '20|20']","['Michael Addition', 'Michael Addition']",,"['N,N-dimethyl-formamide|N,N-dimethyl-formamide', 'N,N-dimethyl-formamide|N,N-dimethyl-formamide']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0124-0130', 'Paragraph 0124-0130']",,"['triethylamine', 'triethylamine']","['2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl 3,4-dihydroisoquinoline-2(1H)-carbodithioate', '2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl 3,4-dihydroisoquinoline-2(1H)-carbodithioate']","['60 percent', '60 percent']",,,,,"['2', '2']",,"['17', '17']","['Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide', 'Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide']","['General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h', 'General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h']",
CCN(CC)C(=S)SCCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1,,CCN(CC)C(=S)SCCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1>>,66458479,2,35,half reaction|has preparation,,2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl diethylcarbamodithioate,,"['Preparation', 'Preparation']","['1', '1']","['20|20', '20|20']","['Michael Addition', 'Michael Addition']",,"['N,N-dimethyl-formamide|N,N-dimethyl-formamide', 'N,N-dimethyl-formamide|N,N-dimethyl-formamide']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0124-0128; 0131-0132', 'Paragraph 0124-0128; 0131-0132']",,"['triethylamine', 'triethylamine']","['2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl diethylcarbamodithioate', '2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl diethylcarbamodithioate']","['59 percent', '59 percent']",,,,,"['2', '2']",,"['18', '18']","['Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide', 'Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide']","['General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h', 'General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCSC(=S)N3C[C@@H](C)O[C@@H](C)C3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCSC(=S)N3C[C@@H](C)O[C@@H](C)C3)cc2OC)ncc1Cl>>,66458480,2,35,half reaction|has preparation,,"2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl (2S,6R)-2,6-dimethylmorpholine-4-carbodithioate",,"['Preparation', 'Preparation']","['1', '1']","['20|20', '20|20']","['Michael Addition', 'Michael Addition']",,"['N,N-dimethyl-formamide|N,N-dimethyl-formamide', 'N,N-dimethyl-formamide|N,N-dimethyl-formamide']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0124-0128; 0133-0134', 'Paragraph 0124-0128; 0133-0134']",,"['triethylamine', 'triethylamine']","['2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl (2S,6R)-2,6-dimethylmorpholine-4-carbodithioate', '2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl (2S,6R)-2,6-dimethylmorpholine-4-carbodithioate']","['67 percent', '67 percent']",,,,,"['2', '2']",,"['19', '19']","['Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide', 'Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide']","['General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h', 'General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCSC(=S)N3CCOCC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCSC(=S)N3CCOCC3)cc2OC)ncc1Cl>>,66458481,2,35,half reaction|has preparation,,2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl morpholine-4-carbodithioate,,"['Preparation', 'Preparation']","['1', '1']","['20|20', '20|20']","['Michael Addition', 'Michael Addition']",,"['N,N-dimethyl-formamide|N,N-dimethyl-formamide', 'N,N-dimethyl-formamide|N,N-dimethyl-formamide']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0124-0128; 0135-0136', 'Paragraph 0124-0128; 0135-0136']",,"['triethylamine', 'triethylamine']","['2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl morpholine-4-carbodithioate', '2-(N-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)sulfamoyl)ethyl morpholine-4-carbodithioate']","['73 percent', '73 percent']",,,,,"['2', '2']",,"['20', '20']","['Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide', 'Prepare 2-((5-chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methyl according to the method of Example 1 benzamide']","['General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h', 'General procedure: Dissolve thiomorpholine (0.11g, 1mmol) in 10mL N,N-dimethylformamide, add triethylamine (0.29mL, 2mmol) and carbon disulfide (0.12g, 1.5mmol), and react at room temperature for 0.5h']",
Cc1ccc(N2C(=O)C[C@H](C(C)(C)C=O)C2=O)cc1,,Cc1ccc(N2C(=O)C[C@H](C(C)(C)C=O)C2=O)cc1>>,66583016,2,35,half reaction|has preparation,,"(R)-2-(2,5-dioxo-1-p-tolylpyrrolidin-3-yl)-2-methylpropanal",,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['water', 'water']","['132547083; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/67619; A1; (2024);', '132547083; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/67619; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0088-0092; 0095; 0096; 0116; 0123', 'Paragraph 0088-0092; 0095; 0096; 0103-0104; 0114-0116']",,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","['(R)-2-(2,5-dioxo-1-p-tolylpyrrolidin-3-yl)-2-methylpropanal', '(R)-2-(2,5-dioxo-1-p-tolylpyrrolidin-3-yl)-2-methylpropanal']","['99 percent', '99 percent']",,,,"['99 percent ee', '99 percent ee']",,,"['1.3', '1.3; 1.4; 1.2']","['1.3. Asymmetric Michael Addition Reaction of Aldehyde and Maleimide', '1.3. Asymmetric Michael Addition Reaction of Aldehyde and Maleimide']","['General procedure: An N-mono-thiourea catalyst (Chemical Formula 4, 0.01 mol %) and maleimide (Chemical Formula 2, 2.88 mmol) were added in a reaction container at room temperature and dissolved in wa', 'General procedure: An N-mono-thiourea catalyst (Chemical Formula 4, 0.01 mol %) and maleimide (Chemical Formula 2, 2.88 mmol) were added in a reaction container at room temperature and dissolved in wa']",
CC(C)(C=O)[C@H]1CC(=O)N(c2ccc(Br)cc2)C1=O,,CC(C)(C=O)[C@H]1CC(=O)N(c2ccc(Br)cc2)C1=O>>,66583017,2,35,half reaction|has preparation,,"(R)-2-(1-(4-bromophenyl)-2,5-dioxopyrrolidin-3-yl)-2-methylpropanal",,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['water', 'water']","['132547083; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/67619; A1; (2024);', '132547083; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/67619; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0088-0092; 0097; 0098; 0116; 0123', 'Paragraph 0088-0092; 0097; 0098; 0103-0104; 0114-0116']",,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","['(R)-2-(1-(4-bromophenyl)-2,5-dioxopyrrolidin-3-yl)-2-methylpropanal', '(R)-2-(1-(4-bromophenyl)-2,5-dioxopyrrolidin-3-yl)-2-methylpropanal']","['98 percent', '98 percent']",,,,"['99 percent ee', '99 percent ee']",,,"['1.3', '1.3; 1.4; 1.2']","['1.3. Asymmetric Michael Addition Reaction of Aldehyde and Maleimide', '1.3. Asymmetric Michael Addition Reaction of Aldehyde and Maleimide']","['General procedure: An N-mono-thiourea catalyst (Chemical Formula 4, 0.01 mol %) and maleimide (Chemical Formula 2, 2.88 mmol) were added in a reaction container at room temperature and dissolved in wa', 'General procedure: An N-mono-thiourea catalyst (Chemical Formula 4, 0.01 mol %) and maleimide (Chemical Formula 2, 2.88 mmol) were added in a reaction container at room temperature and dissolved in wa']",
CC(C)(C=O)[C@H]1CC(=O)N(c2ccc([N+](=O)[O-])cc2)C1=O,,CC(C)(C=O)[C@H]1CC(=O)N(c2ccc([N+](=O)[O-])cc2)C1=O>>,66583018,2,35,half reaction|has preparation,,"(R)-2-methyl-2-(1-(4-nitrophenyl)-2,5-dioxopyrrolidin-3-yl)propanal",,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['water', 'water']","['132547083; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/67619; A1; (2024);', '132547083; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/67619; A1; (2024);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0088-0092; 0099; 0100; 0116; 0123', 'Paragraph 0088-0092; 0099; 0100; 0103-0104; 0114-0116']",,"['1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea', '1-[2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea']","['(R)-2-methyl-2-(1-(4-nitrophenyl)-2,5-dioxopyrrolidin-3-yl)propanal', '(R)-2-methyl-2-(1-(4-nitrophenyl)-2,5-dioxopyrrolidin-3-yl)propanal']","['97 percent', '97 percent']",,,,"['99 percent ee', '99 percent ee']",,,"['1.3', '1.3; 1.4; 1.2']","['1.3. Asymmetric Michael Addition Reaction of Aldehyde and Maleimide', '1.3. Asymmetric Michael Addition Reaction of Aldehyde and Maleimide']","['General procedure: An N-mono-thiourea catalyst (Chemical Formula 4, 0.01 mol %) and maleimide (Chemical Formula 2, 2.88 mmol) were added in a reaction container at room temperature and dissolved in wa', 'General procedure: An N-mono-thiourea catalyst (Chemical Formula 4, 0.01 mol %) and maleimide (Chemical Formula 2, 2.88 mmol) were added in a reaction container at room temperature and dissolved in wa']",
COC(=O)CCNc1ccccc1,,COC(=O)CCNc1ccccc1>>,7367074,4,34,half reaction|has preparation,,methyl 3-(phenylamino)propanoate,,"['Preparation (half reaction)', 'Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1', '1']",120,Michael Addition,,,"['9001736; Patent; GOVERNMENT OF THE UNITED STATES; US2011/54180; A1; (2011);', '77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);', '7136519; Patent; TAKEDA CHEMICAL INDUSTRIES; US4962113; A; (1990);', '2500414; Article; Szeimies; Huisgen; Chemische Berichte; vol. 99; (1966); p. 491,501; |2562160; Article; Aelony; McKillip; Journal of Heterocyclic Chemistry; vol. 9; (1972); p. 687; |2562315; Patent;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,2,,,"['Page/Page column 8-9', 'Paragraph 0039-0043']",,Imidazole hydrochloride,"['methyl 3-(phenylamino)propanoate', 'methyl 3-(phenylamino)propanoate', 'methyl 3-(phenylamino)propanoate']","['92 percent', '88 percent', '70.7percent']","['92', '88', '70.7']",,,,,,"['3', '1', 'P.106.i']",(i),"(i) Synthesis of methyl 3-anilinopropionate(290) To a solution of 2-anilinopropionic acid[4.95. g(30 mmol.)]in methanol(10 ml) was added a 14M hydrogen chloride methanol solution(30 ml), and the mixtu",
CC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538615,1,34,half reaction|has preparation,,"4-(1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538616,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-propionylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538617,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-butyrylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C(C)C)c1O,,CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C(C)C)c1O>>,44538618,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-isobutyrylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538619,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-pentanoylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CC(C)CC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538620,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-(3-methylbutanoyl)phenyl)butyl)-cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538621,1,34,half reaction|has preparation,,"4-(1-(3-hexanoyl-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538622,1,34,half reaction|has preparation,,"4-(1-(3-heptanoyl-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538623,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-octanoylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538624,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-nonanoylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538625,1,34,half reaction|has preparation,,"4-(1-(3-decanoyl-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538626,1,34,half reaction|has preparation,,"4-(1-(3-undecanoyl-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538627,1,34,half reaction|has preparation,,"4-(1-(3-dodecanoyl-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538628,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-tetradecanoylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CCCCCCCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O,,CCCCCCCCCCCCCCCC(=O)c1c(O)cc(O)c(C(CC(C)C)C2=C(O)C(C)(C)C(=O)C(C)(C)C2=O)c1O>>,44538629,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-palmitoylphenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C2CCC2)c1O,,CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C2CCC2)c1O>>,44538630,1,34,half reaction|has preparation,,"4-(1-(3-(cyclobutanecarbonyl)-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C2CCCC2)c1O,,CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C2CCCC2)c1O>>,44538631,1,34,half reaction|has preparation,,"4-(1-(3-(cyclopentanecarbonyl)-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C2CCCCC2)c1O,,CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)C2CCCCC2)c1O>>,44538632,1,34,half reaction|has preparation,,"4-(1-(3-(cyclohexanecarbonyl)-2,4,6-trihydroxyphenyl)-3-methylbutyl)-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)Cc2ccccc2)c1O,,CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)Cc2ccccc2)c1O>>,44538633,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-(2-phenylacetyl)phenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)CCc2ccccc2)c1O,,CC(C)CC(C1=C(O)C(C)(C)C(=O)C(C)(C)C1=O)c1c(O)cc(O)c(C(=O)CCc2ccccc2)c1O>>,44538634,1,34,half reaction|has preparation,,"5-hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-(3-phenylpropanoyl)phenyl)butyl)cyclohex-4-ene-1,3-dione",,Preparation,1,20,Michael Addition,,tetrahydrofuran|mineral oil,70668650; Patent; SOUTH CHINA BOTANICAL GARDEN CAS; CN105859537; A; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.5,,,Paragraph 0029; 0065-0066,,sodium hydride,,,,,,,,,,Synthesis of Compound 11,"General procedure: Sodium hydride (30.0 mg, 0.75 mmol, 60% mineral oil)Was slowly added to a solution of the acyl phloroglucinolate compound (compound 6) (0.5 mmol) in tetrahydrofuran (5 mL)A solution",
CC[C@H](CC(=O)c1ccccc1)c1ccc(OC)cc1,,CC[C@H](CC(=O)c1ccccc1)c1ccc(OC)cc1>>,45069363,1,34,half reaction|has preparation,,(R)-1-phenyl-3-(4-methoxyphenyl)-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0083,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccc(OC)cc1)c1ccc(Cl)cc1,,CC[C@H](CC(=O)c1ccc(OC)cc1)c1ccc(Cl)cc1>>,45069364,1,34,half reaction|has preparation,,(R)-1-(4-methoxyphenyl)-3-(4-chlorophenyl)-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0084,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccccc1)c1ccc(C(F)(F)F)cc1,,CC[C@H](CC(=O)c1ccccc1)c1ccc(C(F)(F)F)cc1>>,45069365,1,34,half reaction|has preparation,,(R)-1-phenyl-3-(4-(trifluoromethyl)phenyl)pentan-1-one,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0085,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccccc1)c1ccccc1Cl,,CC[C@H](CC(=O)c1ccccc1)c1ccccc1Cl>>,45069366,1,34,half reaction|has preparation,,(R)-1-phenyl-3-(2-chlorophenyl)-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0086,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccc(OC)cc1)c1ccccc1,,CC[C@H](CC(=O)c1ccc(OC)cc1)c1ccccc1>>,45069367,1,34,half reaction|has preparation,,(R)-1-(4-methoxyphenyl)-3-phenyl-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0087,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1,,CC[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1>>,45069369,1,34,half reaction|has preparation,,(R)-(-)-3-(4-fluorophenyl)-1-phenyl-pentan-1-one,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0088,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1,,CC[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1>>,45069370,1,34,half reaction|has preparation,,(R)-1-phenyl-3-(4-methylphenyl)-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0089,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CC[C@H](CC(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1,,CC[C@H](CC(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1>>,45069371,1,34,half reaction|has preparation,,(R)-1-(4-chlorophenyl)-3-(4-chlorophenyl)-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0090,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
[H][C@](CC)(CC(=O)c1ccc(Cl)cc1)[C@]12=[C@]3([H])[C@]4([H])=[C@]5([H])[C@@-]1([H])[Fe+2]34251678[C@]2([H])=[C@@]1([H])[C@@-]6([H])[C@@]7([H])=[C@@]28[H],,[H][C@](CC)(CC(=O)c1ccc(Cl)cc1)[C@]12=[C@]3([H])[C@]4([H])=[C@]5([H])[C@@-]1([H])[Fe+2]34251678[C@]2([H])=[C@@]1([H])[C@@-]6([H])[C@@]7([H])=[C@@]28[H]>>,45069372,1,34,half reaction|has preparation,,(S)-1-(4-chlorophenyl)-3-ferrocenyl-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0091,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
[H][C@](CC)(CC(=O)c1ccc(OC)cc1)[C@]12=[C@]3([H])[C@]4([H])=[C@]5([H])[C@@-]1([H])[Fe+2]34251678[C@]2([H])=[C@@]1([H])[C@@-]6([H])[C@@]7([H])=[C@@]28[H],,[H][C@](CC)(CC(=O)c1ccc(OC)cc1)[C@]12=[C@]3([H])[C@]4([H])=[C@]5([H])[C@@-]1([H])[Fe+2]34251678[C@]2([H])=[C@@]1([H])[C@@-]6([H])[C@@]7([H])=[C@@]28[H]>>,45069373,1,34,half reaction|has preparation,,(S)-1-(4-methoxyphenyl)-3-ferrocenyl-1-pentanone,,Preparation,1,20 - 40,Michael Addition,,hexane|toluene,71037436; Patent; ZHENGZHOU UNIVERSITY; CN104530122; B; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,Schlenk technique,,Paragraph 0078; 0079; 0080; 0081; 0082; 0092,,copper(II) bis(trifluoromethanesulfonate),,,,,,,,,6,Example 6,"General procedure: In a dry Schlenk tube,0.005 mmol (2.5 mol%) of Cu (OTf) 2 and 0.01 mmol (5 mol%) of the ligand of the present invention were weighed,After evacuation of nitrogen, 1.5 mL of toluene",
CCCCCCCCCCCCCCSCC(C)C(=O)OCCOC(=O)CCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCN(CCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSCC(C)C(=O)OCCOC(=O)CCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCN(CCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCN(CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC>>,45215914,1,34,half reaction|has preparation,,C144H270N4O24S6,,Preparation,1,60,Michael Addition,,dimethylsulfoxide-d6,70975372; Patent; THE UNIVERSITY OF TEXAS SYSTEM; WO2017/48789; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,Page/Page column 29; 88; 89,,Dimethyl(phenyl)phosphine,,,,,,,,,3; 4,,General procedure: FIG. 4 shows sulfa-Michael addition of 6A3-G1 (125 mM) with 2- (butylamino)ethanethiol (6 x 1.2 eq.) or 1-tetradecanethiol (6 x 1.2 eq.) at 60 C in 400 DMSO-D6 for 48 hours. Without,
CCCCCCCCCCCCCCSCC(C)C(=O)OCCOC(=O)CCN(CCCCCCCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSCC(C)C(=O)OCCOC(=O)CCN(CCCCCCCCCCCCCC)CCC(=O)OCCOC(=O)C(C)CSCCCCCCCCCCCCCC>>,45215915,1,34,half reaction|has preparation,,C60H115NO8S2,,Preparation,1,60,Michael Addition,,dimethylsulfoxide-d6,70975372; Patent; THE UNIVERSITY OF TEXAS SYSTEM; WO2017/48789; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,Page/Page column 29; 30; 88; 89,,Dimethyl(phenyl)phosphine,,,,,,,,,3; 5,,General procedure: FIG. 5 shows sulfa-Michael addition of 2H4-G1 (125 mM) with 2- (butylamino)ethanethiol (2 x 1.2 eq.) or 1-tetradecanethiol (2 x 1.2 eq.) at 60 C in DMSO-D6 for 48 hours. Without add,
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1,,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1>>,46359700,1,34,half reaction,,"(R)-3-(1-(3-nitrophenyl)-2-nitroethyl)pentane-2,4-dione",,Chemical behaviour,1,0,Michael Addition,Catalytic behavior,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0083,stereoselective reaction,C20H29FeN3OS,"(R)-3-(1-(3-nitrophenyl)-2-nitroethyl)pentane-2,4-dione",96 percent,96,,,94 percent ee,,,12.7,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
CCCSC1CC(=O)N(c2ccc(-n3c4ccccc4c4ccccc43)cc2)C1=O,,CCCSC1CC(=O)N(c2ccc(-n3c4ccccc4c4ccccc43)cc2)C1=O>>,48917661,1,34,half reaction|has preparation,,C25H22N2O2S,,Preparation,1,40,Michael Addition,,acetonitrile,74747979; Patent; QUFU NORMAL UNIVERSITY; CN108383832; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,7.4,Paragraph 0048; 0049; 0050; 0051,,ammonium acetate|sodium hydroxide,,,,,,,,,2,,General procedure: Prepare ammonium acetate-sodium hydroxide buffer solution with pH=7.4 and concent,
CCCCSC1CC(=O)N(c2ccc(-n3c4ccccc4c4ccccc43)cc2)C1=O,,CCCCSC1CC(=O)N(c2ccc(-n3c4ccccc4c4ccccc43)cc2)C1=O>>,48917662,1,34,half reaction|has preparation,,C26H24N2O2S,,Preparation,1,40,Michael Addition,,acetonitrile,74747979; Patent; QUFU NORMAL UNIVERSITY; CN108383832; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667,,7.4,Paragraph 0048; 0049; 0050; 0051,,ammonium acetate|sodium hydroxide,,,,,,,,,2,,General procedure: Prepare ammonium acetate-sodium hydroxide buffer solution with pH=7.4 and concent,
[H][C@]1(C(N)=O)NC(=O)[C@]2([H])CCCN2C(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@]([H])(CC(=O)O)NC(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)[C@]2([H])CSCCC(=O)N3CC45CN(CC4(C3)CN(C5)C(=O)CCS1)C(=O)CCSC[C@H](NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N2,,[H][C@]1(C(N)=O)NC(=O)[C@]2([H])CCCN2C(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@]([H])(CC(=O)O)NC(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)[C@]2([H])CSCCC(=O)N3CC45CN(CC4(C3)CN(C5)C(=O)CCS1)C(=O)CCSC[C@H](NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N2>>,49850781,1,34,half reaction|has preparation,,C113H164N30O32S3,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCC(=O)N2CCN3CCN(CC2)C(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc4ccccc24)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCC3=O,,[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCC(=O)N2CCN3CCN(CC2)C(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc4ccccc24)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCC3=O>>,49850784,1,34,half reaction|has preparation,,C92H124N20O28S3,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCC(=O)N2CC34CN5CC3(C2)CN(C4)C(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc3ccccc23)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCC5=O,,[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCC(=O)N2CC34CN5CC3(C2)CN(C4)C(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc3ccccc23)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCC5=O>>,49850785,1,34,half reaction|has preparation,,C94H124N20O28S3,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCS(=O)(=O)N2CCN3CCN(CC2)S(=O)(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc4ccccc24)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCS3(=O)=O,,[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCS(=O)(=O)N2CCN3CCN(CC2)S(=O)(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc4ccccc24)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCS3(=O)=O>>,49850788,1,34,half reaction|has preparation,,C89H124N20O31S6,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCS(=O)(=O)c2cc3cc(c2)S(=O)(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc4ccccc24)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCS3(=O)=O,,[H][C@]1(C)NC(=O)[C@@]([H])(NC(=O)[C@H](C)N)CSCCS(=O)(=O)c2cc3cc(c2)S(=O)(=O)CCSC[C@]([H])(NC(=O)[C@@]([H])(C)NC(=O)[C@]([H])(Cc2cccc4ccccc24)NC(=O)[C@]([H])(CCC(=O)O)NC(=O)[C@]([H])(CC(N)=O)NC1=O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@]([H])(C(N)=O)CSCCS3(=O)=O>>,49850790,1,34,half reaction|has preparation,,C89H115N17O31S6,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
[H][C@]1(C(N)=O)NC(=O)[C@]2([H])CCCN2C(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@]([H])(CC(=O)O)NC(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)[C@]2([H])CSCCS(=O)(=O)N3CCN(CCN(CC3)S(=O)(=O)CCS1)S(=O)(=O)CCSC[C@H](NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N2,,[H][C@]1(C(N)=O)NC(=O)[C@]2([H])CCCN2C(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@]([H])(CC(=O)O)NC(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)[C@]2([H])CSCCS(=O)(=O)N3CCN(CCN(CC3)S(=O)(=O)CCS1)S(=O)(=O)CCSC[C@H](NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N2>>,49850791,1,34,half reaction|has preparation,,C108H164N30O35S6,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
[H][C@]1(C(N)=O)NC(=O)[C@]2([H])CCCN2C(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@]([H])(CC(=O)O)NC(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)[C@]2([H])CSCCS(=O)(=O)c3cc(cc(c3)S(=O)(=O)CCS1)S(=O)(=O)CCSC[C@H](NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N2,,[H][C@]1(C(N)=O)NC(=O)[C@]2([H])CCCN2C(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)[C@]([H])(CC(=O)O)NC(=O)[C@]([H])(C(C)C)NC(=O)[C@]([H])(Cc2c[nH]c3ccccc23)NC(=O)[C@]2([H])CSCCS(=O)(=O)c3cc(cc(c3)S(=O)(=O)CCS1)S(=O)(=O)CCSC[C@H](NC(=O)[C@H](C)NC(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CN(C)C(=O)CCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N2>>,49850793,1,34,half reaction|has preparation,,C108H155N27O35S6,,Preparation,1,20,Michael Addition,,water|acetonitrile,75340465; Patent; BICYCLETX; US2018/311300; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0361-0362; 0373-0375,,ammonium bicarbonate,,,,,,,,,2; 6,Example 2: Peptide Synthesis-Molecular Scaffold Reagent Containing Michael Acceptors Example 6: Cyclization Protocol,"General procedure: Alternatively, peptides were purified using HPLC and following isolation they were modified with a molecular scaffold reagent containing Michael acceptors. For this, linear peptide",
O=C1CCC(N2C(=O)C=C(Nc3cc[nH]n3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cc[nH]n3)C2=O)C(=O)N1>>,54421232,1,34,half reaction|has preparation,,"3-(3-((1H-pyrazol-3-yl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 00164; 00175-00176; 00189-00190,,aluminum (III) chloride,,,,,,,,,12,Method B: Lewis-acid promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.383 mmol, 1.1 equiv), which is commercially available, was dissolved in dioxane (1 mL). A solution of 3-(3-bromo-2,5-dioxo-2,5-dihydro-1H-pyrrol-",
CC(NC(=O)c1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)c1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421233,1,34,half reaction|has preparation,,"N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)-3-(trifluoromethyl)benzamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00369-00370,,triethylamine,,,,,,,,,102,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)Cc1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)Cc1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421234,1,34,half reaction|has preparation,,"N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)-2-(3-(trifluoromethyl)phenyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00371-00372,,triethylamine,,,,,,,,,103,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)c1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)c1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421235,1,34,half reaction|has preparation,,"3-chloro-N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)-4-(trifluoromethyl)benzamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00373-00374,,triethylamine,,,,,,,,,104,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)Cc1ccc(F)c(F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)Cc1ccc(F)c(F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421238,1,34,half reaction|has preparation,,"2-(3,4-difluorophenyl)-N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00381-00382,,triethylamine,,,,,,,,,108,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4cccc(C(F)(F)F)c4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4cccc(C(F)(F)F)c4)c3)C2=O)C(=O)N1>>,54421239,1,34,half reaction|has preparation,,"3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N-(3-(trifluoromethyl)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00383-00384,,triethylamine,,,,,,,,,109,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(C(F)(F)F)cc4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(C(F)(F)F)cc4)c3)C2=O)C(=O)N1>>,54421240,1,34,half reaction|has preparation,,"3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N-(4-(trifluoromethyl)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00385-00386,,triethylamine,,,,,,,,,110,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(F)c(F)c4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(F)c(F)c4)c3)C2=O)C(=O)N1>>,54421241,1,34,half reaction|has preparation,,"N-(3,4-difluorophenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00387-00388,,triethylamine,,,,,,,,,111,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(F)cc4F)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(F)cc4F)c3)C2=O)C(=O)N1>>,54421242,1,34,half reaction|has preparation,,"N-(2,4-difluorophenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00389-00390,,triethylamine,,,,,,,,,112,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)Cc1ccc(C(F)(F)F)cc1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)Cc1ccc(C(F)(F)F)cc1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421243,1,34,half reaction|has preparation,,"N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)-2-(4-(trifluoromethyl)phenyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00391-00392,,triethylamine,,,,,,,,,113,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4cccc(Cl)c4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4cccc(Cl)c4)c3)C2=O)C(=O)N1>>,54421244,1,34,half reaction|has preparation,,"N-(3-chlorophenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00393-00394,,triethylamine,,,,,,,,,114,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(Cl)cc4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(Cl)cc4)c3)C2=O)C(=O)N1>>,54421245,1,34,half reaction|has preparation,,"N-(4-chlorophenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00395-00396,,triethylamine,,,,,,,,,115,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)Cc1cccc(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)Cc1cccc(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421246,1,34,half reaction|has preparation,,"2-(3-chlorophenyl)-N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00397-00398,,triethylamine,,,,,,,,,116,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)Cc1ccc(Cl)cc1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)Cc1ccc(Cl)cc1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421247,1,34,half reaction|has preparation,,"2-(4-chlorophenyl)-N-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00399-00400,,triethylamine,,,,,,,,,117,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(C)(NC(=O)Cc1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(C)(NC(=O)Cc1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421248,1,34,half reaction|has preparation,,"2-(3-chloro-4-(trifluoromethyl)phenyl)-N-(2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propan-2-yl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00401-00402,,triethylamine,,,,,,,,,118,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C)CCOC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,CN(C)CCOC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421249,1,34,half reaction|has preparation,,"3-(3-(2-(dimethylamino)ethoxy)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162-00163; 00191-00194,,triethylamine,,,,,,,,,14,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C)CCCNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,CN(C)CCCNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421250,1,34,half reaction|has preparation,,"3-(3-((3-(dimethylamino)propyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00195-00198,,triethylamine,,,,,,,,,16,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
COC(=O)CNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,COC(=O)CNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421251,1,34,half reaction|has preparation,,"(1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)glycine methyl ester",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00195-00196; 00199-00200,,triethylamine,,,,,,,,,17,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
COC(=O)CCNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,COC(=O)CCNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421252,1,34,half reaction|has preparation,,"methyl 3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)propanoate",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00195-00196; 00201-00202,,triethylamine,,,,,,,,,18,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
COC(=O)CN(C)C1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,COC(=O)CN(C)C1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421253,1,34,half reaction|has preparation,,"methyl N-(1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-N-methylglycinate",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00195-00196; 00203-00204,,triethylamine,,,,,,,,,19,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CCOC(=O)CNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,CCOC(=O)CNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421254,1,34,half reaction|has preparation,,"(1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)glycine ethyl ester",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00195-00196; 00205-00206,,triethylamine,,,,,,,,,20,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CCOC(=O)CN(C)C1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,CCOC(=O)CN(C)C1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421255,1,34,half reaction|has preparation,,"ethyl N-(1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-N-methylglycinate",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00195-00196; 00207-00208,,triethylamine,,,,,,,,,21,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3nc[nH]n3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3nc[nH]n3)C2=O)C(=O)N1>>,54421256,1,34,half reaction|has preparation,,"3-(3-((1H-1,2,4-triazol-3-yl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00209-00210,,triethylamine,,,,,,,,,22,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3nccs3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3nccs3)C2=O)C(=O)N1>>,54421257,1,34,half reaction|has preparation,,"3-(2,5-dioxo-3-(thiazol-2-ylamino)-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00211-00212,,triethylamine,,,,,,,,,23,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
COC(=O)c1n[nH]c(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)n1,,COC(=O)c1n[nH]c(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)n1>>,54421258,1,34,half reaction|has preparation,,"methyl 5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)-1H-1,2,4-triazole-3-carboxylate",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00213-00214,,triethylamine,,,,,,,,,24,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C(O)CCCCNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O,,O=C(O)CCCCNC1=CC(=O)N(C2CCC(=O)NC2=O)C1=O>>,54421259,1,34,half reaction|has preparation,,"5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)pentanoic acid",,Preparation,1,75,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00215-00218,,triethylamine,,,,,,,,,26,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1C,,Cc1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1C>>,54421260,1,34,half reaction|has preparation,,"3-(3-((3,4-dimethylphenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,50,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00219-00222,,triethylamine,,,,,,,,,28,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3ccc(Cl)cc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccc(Cl)cc3)C2=O)C(=O)N1>>,54421261,1,34,half reaction|has preparation,,"3-(3-((4-chlorophenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,50,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00219-00220; 00223-00224,,triethylamine,,,,,,,,,29,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cnc4ccccc4c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cnc4ccccc4c3)C2=O)C(=O)N1>>,54421262,1,34,half reaction|has preparation,,"3-(2,5-dioxo-3-(quinolin-3-ylamino)-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00227-00228,,triethylamine,,,,,,,,,31,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C1=CC(=O)N(C2CCC(=O)NC2=O)C1=O)c1ccccc1,,CN(C1=CC(=O)N(C2CCC(=O)NC2=O)C1=O)c1ccccc1>>,54421263,1,34,half reaction|has preparation,,"3-(3-(methyl(phenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00229-00230,,triethylamine,,,,,,,,,32,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3ccc(-n4ccnc4)cc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccc(-n4ccnc4)cc3)C2=O)C(=O)N1>>,54421264,1,34,half reaction|has preparation,,"3-(3-((4-(1H-imidazol-1-yl)phenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00231-00232,,triethylamine,,,,,,,,,33,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CCOC(=O)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CCOC(=O)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421265,1,34,half reaction|has preparation,,"ethyl 3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzoate",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00233-00234,,triethylamine,,,,,,,,,34,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(-c4cc[nH]n4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(-c4cc[nH]n4)c3)C2=O)C(=O)N1>>,54421266,1,34,half reaction|has preparation,,"3-(3-((3-(1H-pyrazol-3-yl)phenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,50,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00219-00220; 00235-00236,,triethylamine,,,,,,,,,35,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3ccc4cn[nH]c4c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccc4cn[nH]c4c3)C2=O)C(=O)N1>>,54421267,1,34,half reaction|has preparation,,"3-(3-((1H-indazol-6-yl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,50,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00219-00220; 00237-00238,,triethylamine,,,,,,,,,36,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C)C(=O)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CN(C)C(=O)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421268,1,34,half reaction|has preparation,,"3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)-N,N-dimethylbenzamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00239-00240,,triethylamine,,,,,,,,,37,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C)C(=O)c1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1,,CN(C)C(=O)c1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1>>,54421269,1,34,half reaction|has preparation,,"4-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)-N,N-dimethylbenzamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00241-00242,,triethylamine,,,,,,,,,38,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C)C(=O)Cc1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CN(C)C(=O)Cc1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421270,1,34,half reaction|has preparation,,"2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N,N-dimethylacetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00243-00244,,triethylamine,,,,,,,,,39,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CN(C)C(=O)Cc1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1,,CN(C)C(=O)Cc1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1>>,54421271,1,34,half reaction|has preparation,,"2-(4-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N,N-dimethylacetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00245-00246,,triethylamine,,,,,,,,,40,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3ccc4cc[nH]c4c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccc4cc[nH]c4c3)C2=O)C(=O)N1>>,54421272,1,34,half reaction|has preparation,,"3-(3-((1H-indol-6-yl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00247-00248,,triethylamine,,,,,,,,,41,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3ccccc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccccc3)C2=O)C(=O)N1>>,54421273,1,34,half reaction|has preparation,,"3-(2,5-dioxo-3-(phenylamino)-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 00164; 00175-00178,,aluminum (III) chloride,,,,,,,,,6,Method B: Lewis-acid promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.383 mmol, 1.1 equiv), which is commercially available, was dissolved in dioxane (1 mL). A solution of 3-(3-bromo-2,5-dioxo-2,5-dihydro-1H-pyrrol-",
O=C1CCC(N2C(=O)C=C(Nc3ccc(-c4ccccc4)cc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccc(-c4ccccc4)cc3)C2=O)C(=O)N1>>,54421274,1,34,half reaction|has preparation,,"3-(3-([1,1'-biphenyl]-4-ylamino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00249-00250,,triethylamine,,,,,,,,,42,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3ccc(Cc4ccccc4)cc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3ccc(Cc4ccccc4)cc3)C2=O)C(=O)N1>>,54421275,1,34,half reaction|has preparation,,"3-(3-((4-benzylphenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00251-00252,,triethylamine,,,,,,,,,43,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCCNC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1Cl,,Cc1ccc(NC(=O)NCCNC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1Cl>>,54421276,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(2-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)ethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00253-00254,,triethylamine,,,,,,,,,44,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)Nc2ccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)cc2)cc1Cl,,Cc1ccc(NC(=O)Nc2ccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)cc2)cc1Cl>>,54421277,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(4-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00255-00256,,triethylamine,,,,,,,,,45,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)Nc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)Nc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421278,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00257-00258,,triethylamine,,,,,,,,,46,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421279,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00259-00260,,triethylamine,,,,,,,,,47,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2ccccc2NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1Cl,,Cc1ccc(NC(=O)NCc2ccccc2NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1Cl>>,54421280,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(2-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00261-00262,,triethylamine,,,,,,,,,48,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2ccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)cc2)cc1Cl,,Cc1ccc(NC(=O)NCc2ccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)cc2)cc1Cl>>,54421281,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(4-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00263-00264,,triethylamine,,,,,,,,,49,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCCCNC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1Cl,,Cc1ccc(NC(=O)NCCCNC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1Cl>>,54421282,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)propyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00265-00266,,triethylamine,,,,,,,,,50,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)OCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)OCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421283,1,34,half reaction|has preparation,,"3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl (3-chloro-4-methylphenyl)carbamate",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00267-00268,,triethylamine,,,,,,,,,51,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421284,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00269-00270,,triethylamine,,,,,,,,,52,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)Cc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)Cc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421285,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00271-00272,,triethylamine,,,,,,,,,53,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)Oc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)Oc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421286,1,34,half reaction|has preparation,,"3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl (3-chloro-4-methylphenyl)carbamate",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00273-00274,,triethylamine,,,,,,,,,54,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)N(C)Cc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)N(C)Cc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421287,1,34,half reaction|has preparation,,"3-(3-chloro-4-methylphenyl)-1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)-1-methylurea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00275-00276,,triethylamine,,,,,,,,,55,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421288,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00277-00278,,triethylamine,,,,,,,,,56,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421289,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00279-00280,,triethylamine,,,,,,,,,57,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)Nc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C,,Cc1ccc(NC(=O)Nc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C>>,54421290,1,34,half reaction|has preparation,,"1-(3,4-dimethylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00281-00282,,triethylamine,,,,,,,,,58,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)c3)C2=O)C(=O)N1>>,54421291,1,34,half reaction|has preparation,,"1-(3,4-dichlorophenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00283-00284,,triethylamine,,,,,,,,,59,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)/C=C/c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)/C=C/c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421292,1,34,half reaction|has preparation,,"(E)-N-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)acrylamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00285-00286,,triethylamine,,,,,,,,,60,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C,,Cc1ccc(NC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C>>,54421293,1,34,half reaction|has preparation,,"1-(3,4-dimethylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00287-00288,,triethylamine,,,,,,,,,61,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1cc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)ccc1Cl,,Cc1cc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)ccc1Cl>>,54421294,1,34,half reaction|has preparation,,"3-(3-((4-chloro-3-methylphenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00182,,triethylamine,,,,,,,,,8,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CNC(=O)Nc4ccc(Cl)c(Cl)c4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CNC(=O)Nc4ccc(Cl)c(Cl)c4)c3)C2=O)C(=O)N1>>,54421295,1,34,half reaction|has preparation,,"1-(3,4-dichlorophenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00289-00290,,triethylamine,,,,,,,,,62,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(CC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C,,Cc1ccc(CC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C>>,54421296,1,34,half reaction|has preparation,,"2-(3,4-dimethylphenyl)-N-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00291-00292,,triethylamine,,,,,,,,,63,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C(Cc1ccc(Cl)c(Cl)c1)NCc1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,O=C(Cc1ccc(Cl)c(Cl)c1)NCc1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421297,1,34,half reaction|has preparation,,"2-(3,4-dichlorophenyl)-N-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00293-00294,,triethylamine,,,,,,,,,64,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NCCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421298,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00295-00296,,triethylamine,,,,,,,,,65,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421299,1,34,half reaction|has preparation,,"3-(3-((3-(((3-chloro-4-methylphenyl)amino)methyl)phenyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00297-00298,,triethylamine,,,,,,,,,66,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cccc(OC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NCc2cccc(OC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421300,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)oxy)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00299-00300,,triethylamine,,,,,,,,,67,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NC(C)(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NC(C)(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421301,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propan-2-yl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00301-00302,,triethylamine,,,,,,,,,68,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)N[C@H](C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)N[C@H](C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421302,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-((1R)-1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00303-00304,,triethylamine,,,,,,,,,69,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)N[C@@H](C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)N[C@@H](C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421303,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-((1S)-1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00305-00306,,triethylamine,,,,,,,,,70,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CCC(NC(=O)Nc1ccc(C)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CCC(NC(=O)Nc1ccc(C)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421304,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00307-00308,,triethylamine,,,,,,,,,71,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1C#N,,Cc1ccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)cc1C#N>>,54421305,1,34,half reaction|has preparation,,"5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)-2-methylbenzonitrile",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00183-00184,,triethylamine,,,,,,,,,9,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NC(CC(=O)N(C)C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NC(CC(=O)N(C)C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421306,1,34,half reaction|has preparation,,"3-(3-(3-chloro-4-methylphenyl)ureido)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N,N-dimethylpropanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00309-00310,,triethylamine,,,,,,,,,72,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)ccc2Cl)cc1Cl,,Cc1ccc(NC(=O)NCc2cc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)ccc2Cl)cc1Cl>>,54421307,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(2-chloro-5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00311-00312,,triethylamine,,,,,,,,,73,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)CNc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)CNc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421308,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-2-((3-((1-(2,6-dioxopiperidin- 3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)amino)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00313-00314,,triethylamine,,,,,,,,,74,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CNC(=O)NCc4ccccc4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CNC(=O)NCc4ccccc4)c3)C2=O)C(=O)N1>>,54421309,1,34,half reaction|has preparation,,"1-benzyl-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00315-00316,,triethylamine,,,,,,,,,75,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1cc(CNC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)ccc1Cl,,Cc1cc(CNC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)ccc1Cl>>,54421310,1,34,half reaction|has preparation,,"1-(4-chloro-3-methylbenzyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00317-00318,,triethylamine,,,,,,,,,76,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)ccc2OC(=O)N(C)C)cc1Cl,,Cc1ccc(NC(=O)NCc2cc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)ccc2OC(=O)N(C)C)cc1Cl>>,54421311,1,34,half reaction|has preparation,,"2-((3-(3-chloro-4-methylphenyl)ureido)methyl)-4-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl dimethylcarbamate",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00319-00320,,triethylamine,,,,,,,,,77,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)N2Cc3ccc(NC4=CC(=O)N(C5CCC(=O)NC5=O)C4=O)cc3C2)cc1Cl,,Cc1ccc(NC(=O)N2Cc3ccc(NC4=CC(=O)N(C5CCC(=O)NC5=O)C4=O)cc3C2)cc1Cl>>,54421312,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)isoindoline-2-carboxamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00321-00322,,triethylamine,,,,,,,,,78,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)N2CCc3ccc(NC4=CC(=O)N(C5CCC(=O)NC5=O)C4=O)cc3C2)cc1Cl,,Cc1ccc(NC(=O)N2CCc3ccc(NC4=CC(=O)N(C5CCC(=O)NC5=O)C4=O)cc3C2)cc1Cl>>,54421313,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-7-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)-3,4-dihydroisoquinoline-2(1H)-carboxamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00323-00324,,triethylamine,,,,,,,,,79,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)OCCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)OCCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421314,1,34,half reaction|has preparation,,"3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenethyl (3-chloro-4-methylphenyl)carbamate",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00325-00326,,triethylamine,,,,,,,,,80,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cc(NC(=O)N(C)C)cc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)NCc2cc(NC(=O)N(C)C)cc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421315,1,34,half reaction|has preparation,,"3-(3-((3-(3-chloro-4-methylphenyl)ureido)methyl)-5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-1,1-dimethylurea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00327-00328,,triethylamine,,,,,,,,,81,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(NCc3cccnc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(NCc3cccnc3)C2=O)C(=O)N1>>,54421316,1,34,half reaction|has preparation,,"3-(2,5-dioxo-3-((pyridin-3-ylmethyl)amino)-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 00164; 00175-00176; 00185-00186,,aluminum (III) chloride,,,,,,,,,10,Method B: Lewis-acid promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.383 mmol, 1.1 equiv), which is commercially available, was dissolved in dioxane (1 mL). A solution of 3-(3-bromo-2,5-dioxo-2,5-dihydro-1H-pyrrol-",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CNC(=O)Nc4ccccc4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CNC(=O)Nc4ccccc4)c3)C2=O)C(=O)N1>>,54421317,1,34,half reaction|has preparation,,"1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)-3-phenylurea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00329-00330,,triethylamine,,,,,,,,,82,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1cc(CNC(=O)NC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)ccc1Cl,,Cc1cc(CNC(=O)NC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)ccc1Cl>>,54421318,1,34,half reaction|has preparation,,"1-(4-chloro-3-methylbenzyl)-3-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00331-00332,,triethylamine,,,,,,,,,83,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(CNC(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(CNC(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421319,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylbenzyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00333-00334,,triethylamine,,,,,,,,,84,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(CNC(=O)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(CNC(=O)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421320,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylbenzyl)-3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00335-00336,,triethylamine,,,,,,,,,85,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(CNC(=O)Cc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(CNC(=O)Cc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421321,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylbenzyl)-2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00337-00338,,triethylamine,,,,,,,,,86,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)Nc2cccc3c(NC4=CC(=O)N(C5CCC(=O)NC5=O)C4=O)cccc23)cc1Cl,,Cc1ccc(NC(=O)Nc2cccc3c(NC4=CC(=O)N(C5CCC(=O)NC5=O)C4=O)cccc23)cc1Cl>>,54421322,1,34,half reaction|has preparation,,"1-(3-chloro-4-methylphenyl)-3-(5-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)naphthalen-1-yl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00339-00340,,triethylamine,,,,,,,,,87,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)COc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)COc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421323,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenoxy)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00341-00342,,triethylamine,,,,,,,,,88,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F,,Cc1ccc(NC(=O)NCCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F>>,54421324,1,34,half reaction|has preparation,,"1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenethyl)-3-(4-methyl-3-(trifluoromethyl)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00343-00344,,triethylamine,,,,,,,,,89,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(N(C)C(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(N(C)C(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421325,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N-methylpropanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00345-00346,,triethylamine,,,,,,,,,90,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F,,Cc1ccc(NC(=O)NCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F>>,54421326,1,34,half reaction|has preparation,,"1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzyl)-3-(4-methyl-3-(trifluoromethyl)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00347-00348,,triethylamine,,,,,,,,,91,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
O=C1CCC(N2C(=O)C=C(NCCCn3ccnc3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(NCCCn3ccnc3)C2=O)C(=O)N1>>,54421327,1,34,half reaction|has preparation,,"3-(3-((3-(1H-imidazol-1-yl)propyl)amino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)piperidine-2,6-dione",,Preparation,1,20,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Paragraph 00164; 00175-00176; 00187-00188,,aluminum (III) chloride,,,,,,,,,11,Method B: Lewis-acid promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.383 mmol, 1.1 equiv), which is commercially available, was dissolved in dioxane (1 mL). A solution of 3-(3-bromo-2,5-dioxo-2,5-dihydro-1H-pyrrol-",
O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(C(F)(F)F)c(Cl)c4)c3)C2=O)C(=O)N1,,O=C1CCC(N2C(=O)C=C(Nc3cccc(CCC(=O)Nc4ccc(C(F)(F)F)c(Cl)c4)c3)C2=O)C(=O)N1>>,54421328,1,34,half reaction|has preparation,,"N-(3-chloro-4-(trifluoromethyl)phenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00349-00350,,triethylamine,,,,,,,,,92,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F,,Cc1ccc(NC(=O)CCc2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F>>,54421329,1,34,half reaction|has preparation,,"3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N-(4-methyl-3-(trifluoromethyl)phenyl)propanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00351-00352,,triethylamine,,,,,,,,,93,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)NC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F,,Cc1ccc(NC(=O)NC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1C(F)(F)F>>,54421330,1,34,half reaction|has preparation,,"1-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)-3-(4-methyl-3-(trifluoromethyl)phenyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00353-00354,,triethylamine,,,,,,,,,94,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(NC(=O)Nc1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(NC(=O)Nc1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421331,1,34,half reaction|has preparation,,"1-(3-chloro-4-(trifluoromethyl)phenyl)-3-(1-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)ethyl)urea",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00355-00356,,triethylamine,,,,,,,,,95,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CCC(CC(=O)Nc1ccc(C)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CCC(CC(=O)Nc1ccc(C)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421332,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)pentanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00357-00358,,triethylamine,,,,,,,,,96,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)CC(C)(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)CC(C)(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421333,1,34,half reaction|has preparation,,"N-(3-chloro-4-methylphenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-3-methylbutanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00359-00360,,triethylamine,,,,,,,,,97,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
Cc1ccc(NC(=O)CC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl,,Cc1ccc(NC(=O)CC(C)c2cccc(NC3=CC(=O)N(C4CCC(=O)NC4=O)C3=O)c2)cc1Cl>>,54421334,1,34,half reaction|has preparation,,C26H25ClN4O5,,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00361-00362,,triethylamine,,,,,,,,,98,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CCC(CC(=O)Nc1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CCC(CC(=O)Nc1ccc(C(F)(F)F)c(Cl)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421335,1,34,half reaction|has preparation,,"N-(3-chloro-4-(trifluoromethyl)phenyl)-3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)pentanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00363-00364,,triethylamine,,,,,,,,,99,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(C)(NC(=O)Cc1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(C)(NC(=O)Cc1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421336,1,34,half reaction|has preparation,,"N-(2-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)propan-2-yl)-2-(3-(trifluoromethyl)phenyl)acetamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00365-00366,,triethylamine,,,,,,,,,100,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
CC(CC(=O)Nc1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1,,CC(CC(=O)Nc1cccc(C(F)(F)F)c1)c1cccc(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)c1>>,54421337,1,34,half reaction|has preparation,,"3-(3-((1-(2,6-dioxopiperidin-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)phenyl)-N-(3-(trifluoromethyl)phenyl)butanamide",,Preparation,1,65,Michael Addition,,"1,4-dioxane",80164639; Patent; DANA FARBER CANCER INSTITUTE; WO2020/117759; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 00162; 00179-00180; 00367-00368,,triethylamine,,,,,,,,,101,Method A: Base-promoted Michael addition,"General procedure: In an 8-mL vial, nucleophile NR2 (0.348 mmol, 1.0 equiv), which was commercially available or prepared in advance as described below, was dissolved in dioxane (1 mL). A solution of",
N#Cc1ccn2c(-c3ccccc3)c(C(=O)c3ccc(Br)cc3)nc2c1,,N#Cc1ccn2c(-c3ccccc3)c(C(=O)c3ccc(Br)cc3)nc2c1>>,55656485,1,34,half reaction|has preparation,,C21H12BrN3O,,Preparation,1,120,Michael Addition,,"1,2-dichloro-ethane",81619467; Patent; GUANGDONG UNIVERSITY OF TECHNOLOGY; CN111875602; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,Sealed tube,,Paragraph 0070-0076; 0080-0085,,iodine,,,,,,,,,2,,"General procedure: Weigh 150 mg of (E)-4-(3-(4-bromophenylhydrazine))benzonitrile,2-aminopyridine 80mg iodine 60mg and 3mL dichloroethane in a 10mL sealed tube,The Michael cyclization reaction was car",
N#Cc1ccc(-c2c(C(=O)c3ccc(Br)cc3)nc3cc(C#N)ccn23)cc1,,N#Cc1ccc(-c2c(C(=O)c3ccc(Br)cc3)nc3cc(C#N)ccn23)cc1>>,55656487,1,34,half reaction|has preparation,,C22H11BrN4O,,Preparation,1,120,Michael Addition,,"1,2-dichloro-ethane",81619467; Patent; GUANGDONG UNIVERSITY OF TECHNOLOGY; CN111875602; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,Sealed tube,,Paragraph 0070-0076; 0086-0091,,iodine,,,,,,,,,3,,"General procedure: Weigh 150 mg of (E)-4-(3-(4-bromophenylhydrazine))benzonitrile,2-aminopyridine 80mg iodine 60mg and 3mL dichloroethane in a 10mL sealed tube,The Michael cyclization reaction was car",
O=C(c1ccc(Br)cc1)c1nc2ccccn2c1-c1ccccc1,,O=C(c1ccc(Br)cc1)c1nc2ccccn2c1-c1ccccc1>>,55656488,1,34,half reaction|has preparation,,"(4-bromophenyl)(3-phenylimidazo[1,2-a]pyridin-2-yl)methanone",,Preparation,1,120,Michael Addition,,"1,2-dichloro-ethane",81619467; Patent; GUANGDONG UNIVERSITY OF TECHNOLOGY; CN111875602; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,Sealed tube,,Paragraph 0070-0076; 0093-0098,,iodine,,,,,,,,,1,,"General procedure: Weigh 150 mg of (E)-4-(3-(4-bromophenylhydrazine))benzonitrile,2-aminopyridine 80mg iodine 60mg and 3mL dichloroethane in a 10mL sealed tube,The Michael cyclization reaction was car",
CC(=O)C[C@H](C[N+](=O)[O-])c1ccco1,,CC(=O)C[C@H](C[N+](=O)[O-])c1ccco1>>,68465103,1,34,half reaction|has preparation,,4-(furan-2-yl)-5-nitropentan-2-one,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0107; 0148-0149,enantioselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",4-(furan-2-yl)-5-nitropentan-2-one,95 percent,,,,98 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
Cn1ccnc1C1=Nc2c(c(-c3ccc(F)cc3)nn2C(C)(C)C)[C@H](c2ccccc2)C1,,Cn1ccnc1C1=Nc2c(c(-c3ccc(F)cc3)nn2C(C)(C)C)[C@H](c2ccccc2)C1>>,69269690,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-3-(4-fluorophenyl)-6-(1-methyl-1H-imidazol-2-yl)-4-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0098,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-3-(4-fluorophenyl)-6-(1-methyl-1H-imidazol-2-yl)-4-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",85 percent,,,,96 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
Cn1ccnc1C1=Nc2c(c(-c3ccccc3Cl)nn2C(C)(C)C)[C@H](c2ccccc2)C1,,Cn1ccnc1C1=Nc2c(c(-c3ccccc3Cl)nn2C(C)(C)C)[C@H](c2ccccc2)C1>>,69269691,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-3-(2-chlorophenyl)-6-(1-methyl-1H-imidazol-2-yl)-4-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0099,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-3-(2-chlorophenyl)-6-(1-methyl-1H-imidazol-2-yl)-4-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",89 percent,,,,95 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
Cn1ccnc1C1=Nc2c(c(-c3cccs3)nn2C(C)(C)C)[C@H](c2ccccc2)C1,,Cn1ccnc1C1=Nc2c(c(-c3cccs3)nn2C(C)(C)C)[C@H](c2ccccc2)C1>>,69269692,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-4-phenyl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0100,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-4-phenyl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",91 percent,,,,98 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
Cc1ccc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc1,,Cc1ccc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc1>>,69269693,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4-(p-tolyl)-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0101,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4-(p-tolyl)-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",92 percent,,,,96 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
COc1ccc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc1,,COc1ccc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc1>>,69269694,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-4-(4-methoxyphenyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0102,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-4-(4-methoxyphenyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",93 percent,,,,96 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
C#Cc1ccc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc1,,C#Cc1ccc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc1>>,69269695,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-4-(4-ethynylphenyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0103,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-4-(4-ethynylphenyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",94 percent,,,,98 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
COc1cc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc(OC)c1OC,,COc1cc([C@@H]2CC(c3nccn3C)=Nc3c2c(-c2ccccc2)nn3C(C)(C)C)cc(OC)c1OC>>,69269696,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0104,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-3-phenyl-4-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",90 percent,,,,98 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
Cn1ccnc1C1=Nc2c(c(-c3ccccc3)nn2C(C)(C)C)[C@H](c2ccc3ccccc3c2)C1,,Cn1ccnc1C1=Nc2c(c(-c3ccccc3)nn2C(C)(C)C)[C@H](c2ccc3ccccc3c2)C1>>,69269697,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-4-(naphthalen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0105,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-6-(1-methyl-1H-imidazol-2-yl)-4-(naphthalen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",94 percent,,,,95 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
CC(C)n1ccnc1C1=Nc2c(c(-c3ccccc3)nn2C(C)(C)C)[C@H](c2ccccc2)C1,,CC(C)n1ccnc1C1=Nc2c(c(-c3ccccc3)nn2C(C)(C)C)[C@H](c2ccccc2)C1>>,69269698,1,34,half reaction|has preparation,,"(S)-1-(tert-butyl)-6-(1-isopropyl-1H-imidazol-2-yl)-3,4-diphenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",,Preparation,1,25,Michael Addition,,dichloromethane,133554565; Patent; SHIHEZI UNIVERSITY; CN117886834; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0080-0096; 0106,,nickel(II) triflate|C40H40N6O4,"(S)-1-(tert-butyl)-6-(1-isopropyl-1H-imidazol-2-yl)-3,4-diphenyl-4,5-dihydro-1H-pyrazolo[3,4-b]pyridine",96 percent,,,,96 percent ee,,,4,,"General procedure: Compound 1a, compound 2a, Ni(OTf)2, the bipyridine chiral tetradentate dinitrogen oxide ligand and the solvent were mixed and reacted at room temperature for 24 hours. After the rea",
COc1ccc2c(=O)c3ccccc3oc2c1OC,,COc1ccc2c(=O)c3ccccc3oc2c1OC>>,5515371,3,33,half reaction|has preparation,,"3,4-dimethoxyxanthen-9-one",,"['Preparation (half reaction)', 'Preparation (half reaction)', 'Preparation']","['1', '1', '1']",,Michael Addition,,methanol|water,"['3160056; Article; Gunasekera; Sultanbawa; Journal of the Chemical Society. Perkin transactions I; (1975); p. 2215,2220;', '3160049; Article; Gunasekera et al.; Journal of the Chemical Society. Perkin transactions I; (1975); p. 2447;', '70498077; Patent; SHENYANG PHARMACEUTICAL UNIVERSITY; CN105294637; A; (2016);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,Reflux,,Paragraph 0127-0129,"['ausIXa, CH2N2', 'aus IIIa, CH2N2']",potassium carbonate,,,,,,,,,6.2,"(4) Preparation of 1,3-dimethoxyxanthone","General procedure: To a 100 mL two-necked flask equipped with a stir bar was added 2 g of 2-hydroxy-2 ', 4', 6'-trimethoxybenzophenone 4 g (0.014 mol), MeOH 40 mL, 40 mL of H 2 O, 9.5 g (0.07 mol) of",
CCCC(C=O)C(C[N+](=O)[O-])c1ccccc1,CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,CCCC(C=O)C(C[N+](=O)[O-])c1ccccc1>>CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,44715964,1,33,half reaction|has preparation,,"(2RS,3RS)-2-propyl-4-nitro-3-phenylbutanal|(2R,3S)-2-nitro-1-(phenylethyl)pentanal",,Preparation,1,20,Michael Addition,,dichloromethane,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1.5,,,Page/Page column 26; 27; 28,Overall yield = 97 %,4-nitro-phenol,,,,,,97 percent ee,,,2.B,B) Substrate scope study,"General procedure: Nitroalkene (0.15 mmol), catalyst la (10 mol%) and 4-nitrophenol (2.1 mg, 0.015 mmol) were weighed in a vial and CH2CI2 (0.3 ml_) was added, followed by the aldehyde (0.45 mmol). Th",
C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1Br,CC(C=O)C(C[N+](=O)[O-])c1ccccc1Br,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1Br>>CC(C=O)C(C[N+](=O)[O-])c1ccccc1Br,44715966,1,33,half reaction|has preparation,,"(2R,3S)-3-(2-bromophenyl)-2-methyl-4-nitrobutanal|3-(2-bromophenyl)-2-methyl-4-nitrobutyraldehyde",,Preparation,1,20,Michael Addition,,dichloromethane,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1.5,,,Page/Page column 26; 27; 28,Overall yield = 98 %,4-nitro-phenol,,,,,,94 percent ee,,,2.B,B) Substrate scope study,"General procedure: Nitroalkene (0.15 mmol), catalyst la (10 mol%) and 4-nitrophenol (2.1 mg, 0.015 mmol) were weighed in a vial and CH2CI2 (0.3 ml_) was added, followed by the aldehyde (0.45 mmol). Th",
C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccco1,CC(C=O)C(C[N+](=O)[O-])c1ccco1,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccco1>>CC(C=O)C(C[N+](=O)[O-])c1ccco1,44715968,1,33,half reaction|has preparation,,"(2R,3R)-3-(furan-2-yl)-2-methyl-4-nitrobutanal|3-(furan-2-yl)-2-methyl-4-nitrobutanal",,Preparation,1,20,Michael Addition,,dichloromethane,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Page/Page column 26; 27; 28,Overall yield = 95 %,4-nitro-phenol,,,,,,95 percent ee,,,2.B,B) Substrate scope study,"General procedure: Nitroalkene (0.15 mmol), catalyst la (10 mol%) and 4-nitrophenol (2.1 mg, 0.015 mmol) were weighed in a vial and CH2CI2 (0.3 ml_) was added, followed by the aldehyde (0.45 mmol). Th",
CC(C=O)C(C[N+](=O)[O-])c1cccs1,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1cccs1,CC(C=O)C(C[N+](=O)[O-])c1cccs1>>C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1cccs1,44715969,1,33,half reaction|has preparation,,"C9H11NO3S|(2R,3S)-2-methyl-4-nitro-3-thiophen-2-yl-butyraldehyde",,Preparation,1,20,Michael Addition,,dichloromethane,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,,Page/Page column 26; 27; 28,Overall yield = 99 %,4-nitro-phenol,,,,,,93 percent ee,,,2.B,B) Substrate scope study,"General procedure: Nitroalkene (0.15 mmol), catalyst la (10 mol%) and 4-nitrophenol (2.1 mg, 0.015 mmol) were weighed in a vial and CH2CI2 (0.3 ml_) was added, followed by the aldehyde (0.45 mmol). Th",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccc(Cl)c1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccc(Cl)c1,46359677,1,33,half reaction|has preparation,,"3-((R)-1-(3-chlorophenyl)-2-nitroethyl)pentane-2,4-dione|(S)-3-[1-(3-chlorophenyl)-2-nitroethyl]-pentane-2, 4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0083,Overall yield = 90 %; stereoselective reaction,C20H29FeN3OS,,,,,,86 percent ee,,,12.8,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc(Br)c1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccc(Br)c1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc(Br)c1>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccc(Br)c1,46359678,1,33,half reaction|has preparation,,"(R)-3-[1-(3-bromo-phenyl)-2-nitro-ethyl]-pentane-2,4-dione|(S)-3-[1-(3-bromo-phenyl)-2-nitro-ethyl]-pentane-2,4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0083,Overall yield = 96 %; stereoselective reaction,C20H29FeN3OS,,,,,,68 percent ee,,,12.9,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccco1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccco1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccco1>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccco1,46359685,1,33,half reaction|has preparation,,"(S)-3-[1-(furan-2-yl)-2-nitroethyl]-pentane-2,4-dione|(R)-3-[1-(furan-2-yl)-2-nitroethyl]-pentane-2,4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0085-0087,Overall yield = 98 %; stereoselective reaction,C20H29FeN3OS,,,,,,86 percent ee,,,13,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccs1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccs1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccs1>>CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccs1,46359686,1,33,half reaction|has preparation,,"(R)-3-(2-nitro-1-(thiophen-2-yl)ethyl)pentane-2,4-dione|(S)-3-(2-nitro-1-(thiophen-2-yl)ethyl)pentane-2,4-dione",,Preparation,1,0,Michael Addition,,toluene,72249843; Patent; SHAANXI NORMAL UNIVERSITY; CN104592313; B; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,,Paragraph 0080; 0088-0090,Overall yield = 98 %; stereoselective reaction,C20H29FeN3OS,,,,,,78 percent ee,,,14,,"General procedure: The nitrostyrene compound and 0.0125mmol shown in Table 1 0.125mmol placed on ferrocene hydrogen bifunctional organic catalyst 10mL dry reaction flask, 1mL of toluene was added, sti",
CCCCC(=O)C[C@H](C)[C@]1(C(=O)OC)Oc2ccccc2C1=O,CCCCC(=O)CC(C)C1(C(=O)OC)Oc2ccccc2C1=O,CCCCC(=O)C[C@H](C)[C@]1(C(=O)OC)Oc2ccccc2C1=O>>CCCCC(=O)CC(C)C1(C(=O)OC)Oc2ccccc2C1=O,46690575,1,33,half reaction|has preparation,,"methyl (S)-3-oxo-2-(4-oxooctan-2-yl)-2,3-dihydrobenzofuran-2-carboxylate|C18H22O5",,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0091-0093; 0094-0096,Overall yield = 95 %; stereoselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),,,,,,84 percent de,2,,35,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
COC(=O)[C@@]1(C2CCC(=O)C2)Oc2ccccc2C1=O,COC(=O)C1(C2CCC(=O)C2)Oc2ccccc2C1=O,COC(=O)[C@@]1(C2CCC(=O)C2)Oc2ccccc2C1=O>>COC(=O)C1(C2CCC(=O)C2)Oc2ccccc2C1=O,46690576,1,33,half reaction|has preparation,,C15H14O5|C15H14O5,,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0091-0093; 0097-0099,Overall yield = 90 %; stereoselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),,,,,,54 percent de,2,,36,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
COC(=O)[C@@]1(C2CCCC(=O)C2)Oc2ccccc2C1=O,COC(=O)C1(C2CCCC(=O)C2)Oc2ccccc2C1=O,COC(=O)[C@@]1(C2CCCC(=O)C2)Oc2ccccc2C1=O>>COC(=O)C1(C2CCCC(=O)C2)Oc2ccccc2C1=O,46690577,1,33,half reaction|has preparation,,C16H16O5|C16H16O5,,Preparation,1,20|20,Michael Addition|Michael Addition,,toluene|toluene,72289637; Patent; ZHEJIANG UNIVERSITY OF TECHNOLOGY; CN107188874; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.166667|8,,,Paragraph 0024-0027; 0091-0093; 0100-0102,Overall yield = 93 %; stereoselective reaction,C42H33N3O2|copper(II) bis(trifluoromethanesulfonate),,,,,,60 percent de,2,,37,Example 1,"General procedure: A complex of 0.02 mmol of oxazoline ligand (6)-an and copper trifluoromethanesulfonate is added, 3-oxo -2,3-dihydrobenzofuran-2-carboxylate (0.2 mmol)) adding into a 10 ml test tube",
CCSC(=O)C(C(=O)SCC)[C@@H](C[N+](=O)[O-])c1ccccc1,CCSC(=O)C(C(=O)SCC)[C@H](C[N+](=O)[O-])c1ccccc1,CCSC(=O)C(C(=O)SCC)[C@@H](C[N+](=O)[O-])c1ccccc1>>CCSC(=O)C(C(=O)SCC)[C@H](C[N+](=O)[O-])c1ccccc1,47883735,1,33,half reaction|has preparation,,(R)-2-(2-nitro-1-phenylethyl)-malonic acid diethyl dithioester|(S)-2-(2-nitro-1-phenylethyl)malonic acid diethyl dithioester,,Preparation,1,25,Michael Addition,,toluene,73791457; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2018/29618; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12,,,Paragraph 0088-0093; 0100-0105; 0112-0114,Overall yield = 93 %; enantioselective reaction,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",,,,,,89 percent ee,,,,,"General procedure: All reactions except Reaction 2 were carried out between 0.30 mmol and 0.15 mmol of trans-Nitrostyrene (1a) at 25  C and 1.5 mL of toluene, and Reaction 2 was carried out using CH2C",
O=[N+]([O-])C[C@@H](c1ccc(Cl)cc1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@H](c1ccc(Cl)cc1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@@H](c1ccc(Cl)cc1)P(=O)(c1ccccc1)c1ccccc1>>O=[N+]([O-])C[C@H](c1ccc(Cl)cc1)P(=O)(c1ccccc1)c1ccccc1,48593676,1,33,half reaction|has preparation,,1-(4-chlorophenyl)-2-nitroethyldiphenylphosphine oxide|1-(4-chlorophenyl)-2-nitroethyldiphenylphosphine oxide,,Preparation,1,-40|-40 - 20,Michael Addition|Michael Addition,,dichloromethane|dichloromethane|water,74452628; Patent; NIPPON CHEMICAL INDUSTRIAL; CN104513274; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|2,,,Paragraph 0180-0184,Overall yield = 96 %; Optical yield = 83 %ee; stereoselective reaction,"(S,S)-2,6-bis((tert-butylmethylphosphino)methylene)-3,5-dimethylphenylpalladium(II) acetate|dihydrogen peroxide",,,,,,,2,,24,Example 24,"General procedure: That is, the diarylphosphine represented by the formula (VII) (0.315 mmol, 1.05 equiv.) at -40  C. Add dropwise to a palladium complex (I-b-B4) (3.0 mg, 2 mol%) in dichloromethane (",
O=[N+]([O-])C[C@@H](c1ccc(Br)cc1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@H](c1ccc(Br)cc1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@@H](c1ccc(Br)cc1)P(=O)(c1ccccc1)c1ccccc1>>O=[N+]([O-])C[C@H](c1ccc(Br)cc1)P(=O)(c1ccccc1)c1ccccc1,48593677,1,33,half reaction|has preparation,,1-(4-bromophenyl)-2-nitroethyldiphenylphosphine oxide|1-(4-bromophenyl)-2-nitroethyldiphenylphosphine oxide,,Preparation,1,-40|-40 - 20,Michael Addition|Michael Addition,,dichloromethane|dichloromethane|water,74452628; Patent; NIPPON CHEMICAL INDUSTRIAL; CN104513274; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|2,,,Paragraph 0180-0184,Overall yield = 92 %; Optical yield = 81 %ee; stereoselective reaction,"(S,S)-2,6-bis((tert-butylmethylphosphino)methylene)-3,5-dimethylphenylpalladium(II) acetate|dihydrogen peroxide",,,,,,,2,,24,Example 24,"General procedure: That is, the diarylphosphine represented by the formula (VII) (0.315 mmol, 1.05 equiv.) at -40  C. Add dropwise to a palladium complex (I-b-B4) (3.0 mg, 2 mol%) in dichloromethane (",
COc1ccc([C@H](C[N+](=O)[O-])P(=O)(c2ccccc2)c2ccccc2)cc1,COc1ccc([C@@H](C[N+](=O)[O-])P(=O)(c2ccccc2)c2ccccc2)cc1,COc1ccc([C@H](C[N+](=O)[O-])P(=O)(c2ccccc2)c2ccccc2)cc1>>COc1ccc([C@@H](C[N+](=O)[O-])P(=O)(c2ccccc2)c2ccccc2)cc1,48593678,1,33,half reaction|has preparation,,1-(4-methoxyphenyl)-2-nitroethyldiphenylphosphine oxide|1-(4-methoxyphenyl)-2-nitroethyldiphenylphosphine oxide,,Preparation,1,-40|-40 - 20,Michael Addition|Michael Addition,,dichloromethane|dichloromethane|water,74452628; Patent; NIPPON CHEMICAL INDUSTRIAL; CN104513274; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|2,,,Paragraph 0180-0184,Overall yield = 92 %; Optical yield = 72 %ee; stereoselective reaction,"(S,S)-2,6-bis((tert-butylmethylphosphino)methylene)-3,5-dimethylphenylpalladium(II) acetate|dihydrogen peroxide",,,,,,,2,,24,Example 24,"General procedure: That is, the diarylphosphine represented by the formula (VII) (0.315 mmol, 1.05 equiv.) at -40  C. Add dropwise to a palladium complex (I-b-B4) (3.0 mg, 2 mol%) in dichloromethane (",
O=[N+]([O-])C[C@@H](c1cccc(Cl)c1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@H](c1cccc(Cl)c1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@@H](c1cccc(Cl)c1)P(=O)(c1ccccc1)c1ccccc1>>O=[N+]([O-])C[C@H](c1cccc(Cl)c1)P(=O)(c1ccccc1)c1ccccc1,48593679,1,33,half reaction|has preparation,,1-(3-chlorophenyl)-2-nitroethyldiphenylphosphine oxide|1-(3-chlorophenyl)-2-nitroethyldiphenylphosphine oxide,,Preparation,1,-40|-40 - 20,Michael Addition|Michael Addition,,dichloromethane|dichloromethane|water,74452628; Patent; NIPPON CHEMICAL INDUSTRIAL; CN104513274; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|2,,,Paragraph 0180-0184; 0185,Overall yield = 95 %; Optical yield = 28 %ee; stereoselective reaction,"(S,S)-2,6-bis((tert-butylmethylphosphino)methylene)-3,5-dimethylphenylpalladium(II) acetate|dihydrogen peroxide",,,,,,,2,,24,Example 24,"General procedure: That is, the diarylphosphine represented by the formula (VII) (0.315 mmol, 1.05 equiv.) at -40  C. Add dropwise to a palladium complex (I-b-B4) (3.0 mg, 2 mol%) in dichloromethane (",
O=[N+]([O-])C[C@@H](c1cccs1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@H](c1cccs1)P(=O)(c1ccccc1)c1ccccc1,O=[N+]([O-])C[C@@H](c1cccs1)P(=O)(c1ccccc1)c1ccccc1>>O=[N+]([O-])C[C@H](c1cccs1)P(=O)(c1ccccc1)c1ccccc1,48593680,1,33,half reaction|has preparation,,2-nitro-1-(thiophen-2-yl)ethyldiphenylphosphine oxide|2-nitro-1-(thiophen-2-yl)ethyldiphenylphosphine oxide,,Preparation,1,-40|-40 - 20,Michael Addition|Michael Addition,,dichloromethane|dichloromethane|water,74452628; Patent; NIPPON CHEMICAL INDUSTRIAL; CN104513274; B; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.0833333|2,,,Paragraph 0180-0184; 0185,Overall yield = 95 %; Optical yield = 69 %ee; stereoselective reaction,"(S,S)-2,6-bis((tert-butylmethylphosphino)methylene)-3,5-dimethylphenylpalladium(II) acetate|dihydrogen peroxide",,,,,,,2,,24,Example 24,"General procedure: That is, the diarylphosphine represented by the formula (VII) (0.315 mmol, 1.05 equiv.) at -40  C. Add dropwise to a palladium complex (I-b-B4) (3.0 mg, 2 mol%) in dichloromethane (",
CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(C(F)(F)F)cc1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(C(F)(F)F)cc1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc(C(F)(F)F)cc1>>CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(C(F)(F)F)cc1,50117998,1,33,half reaction|has preparation,,"(S)-3-(-2-nitro-1-(4-trifluoromethylphenyl)-ethyl)pentane-2,4-dione|(R)-3-(-2-nitro-1-(4-trifluoromethylphenyl)-ethyl)pentane-2,4-dione",,Preparation,1,25,Michael Addition,,water|toluene,75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0051; 0052; 0054; 0055,Overall yield = 99 %,C53H73N3O4S,,,,,,76 percent ee,,,4,This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1Br,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1Br,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1Br>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1Br,50117999,1,33,half reaction|has preparation,,"3-((R)-1-(2-bromophenyl)-2-nitroethyl)pentane-2,4-dione|(S)-3-[1-(2-bromo-phenyl)-2-nitro-ethyl]-pentane-2,4-dione",,Preparation,1,25,Michael Addition,,water|toluene,75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0051; 0052; 0054; 0055,Overall yield = 95 %,C53H73N3O4S,,,,,,70 percent ee,,,4,This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1Cl,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1Cl>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1Cl,50118000,1,33,half reaction|has preparation,,"(R)-3-(1-(2-chlorophenyl)-2-nitroethyl)pentane-2,4-dione|(S)-3-[1-(2-chloro-phenyl)-2-nitro-ethyl]-pentane-2,4-dione",,Preparation,1,25,Michael Addition,,water|toluene,75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0051; 0052; 0054; 0055,Overall yield = 90 %,C53H73N3O4S,,,,,,72 percent ee,,,4,This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to",
COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1cccc(OC)c1,COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1cccc(OC)c1,COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1cccc(OC)c1>>COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1cccc(OC)c1,50118002,1,33,half reaction|has preparation,,(S)(+)-2-[1-(3-methoxyphenyl)-2-nitroethyl]malonic acid dimethyl ester|(R)(-)-2-[1-(3-methoxyphenyl)-2-nitroethyl]malonic acid dimethyl ester,,Preparation,1,25,Michael Addition,,water|toluene,75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0051; 0052; 0054; 0055,Overall yield = 93 %,C53H73N3O4S,,,,,,64 percent ee,,,4,This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to",
COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1,COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1,COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccc(Cl)cc1>>COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccc(Cl)cc1,50118003,1,33,half reaction|has preparation,,(R)(-)-2-[1-(4-chlorophenyl)-2-nitroethyl]malonic acid dimethyl ester|(S)(+)-2-[1-(4-chlorophenyl)-2-nitroethyl]malonic acid dimethyl ester,,Preparation,1,25,Michael Addition,,water|toluene,75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0051; 0052; 0054; 0055,Overall yield = 94 %,C53H73N3O4S,,,,,,69 percent ee,,,4,This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to",
COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1,COC(=O)C(C(=O)OC)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1,50118004,1,33,half reaction|has preparation,,(S)(+)-2-[1-(4-bromophenyl)-2-nitroethyl]malonic acid dimethyl ester|(R)(-)-2-[1-(4-bromophenyl)-2-nitroethyl]malonic acid dimethyl ester,,Preparation,1,25,Michael Addition,,water|toluene,75347026; Patent; CHANGZHOU UNIVERSITY; CN108727241; A; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0051; 0052; 0054; 0055,Overall yield = 91 %,C53H73N3O4S,,,,,,76 percent ee,,,4,This example refers to the aromatic nitroolefin of the asymmetric Michael addition reaction catalyzed by cup [4] thiourea cyclohexanediamine I and the optimum experimental conditions in Example 3.The,"General procedure: The experimental method is:Aromatic nitroolefin (0.5mmol),1,3-Dicarbonyl ketone (1 mmol) and cup [4] thiourea cyclohexanediamine derivative I (0.025 mmol) were respectively added to",
[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@@H](C)Sc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@H](C)Sc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@@H](C)Sc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2>>[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@H](C)Sc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,51102153,1,33,half reaction|has preparation,,"(1S,4S,5R)-3,3-dibenzyl-6,8-dioxabicyclo[3.2.1]octan-4-yl (R)-3-(phenylthio)butanoate|(1S,4S,5R)-3,3-dibenzyl-6,8-dioxabicyclo[3.2.1]octan-4-yl (S)-3-(phenylthio)butanoate",,Preparation,1,-20 - -13,Michael Addition,,tetrahydrofuran,76437481; Patent; GREATREX; WO2019/60953; A1; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Schlenk technique|Inert atmosphere,,Page/Page column 58; 59; 60,Overall yield = 93 %; Overall yield = 118 mg; diastereoselective reaction,potassium hydride,,,,,,62 percent de,,,8,Example 8 - Michael reaction of a dienophile-chiral auxiliary and a thiol,"General procedure: In a dry Schlenk tube under N2 atmosphere was added KH (1.0 equiv, 35 % w/w in paraffin) and the suspension washed two times with hexanes (1 mL/ 100 mg KH) and dried in vacuo. The s",
[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)[C@@H](C)CSc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)[C@H](C)CSc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)[C@@H](C)CSc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2>>[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)[C@H](C)CSc1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,51102154,1,33,half reaction|has preparation,,"(1S,4S,SR)-3,3-dibenzyl-6,8-dioxabicyclo[3.2.1]octan-4-yl (2R)-2-methyl-3-(phenylthio)propanoate|(1S,4S,SR)-3,3-dibenzyl-6,8-dioxabicyclo[3.2.1]octan-4-yl (2S)-2-methyl-3-(phenylthio)propanoate",,Preparation,1,-20 - -13,Michael Addition,,tetrahydrofuran,76437481; Patent; GREATREX; WO2019/60953; A1; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Schlenk technique|Inert atmosphere,,Page/Page column 58; 59; 60,Overall yield = 94 %; Overall yield = 120 mg; diastereoselective reaction,potassium hydride,,,,,,42 percent de,,,8,Example 8 - Michael reaction of a dienophile-chiral auxiliary and a thiol,"General procedure: In a dry Schlenk tube under N2 atmosphere was added KH (1.0 equiv, 35 % w/w in paraffin) and the suspension washed two times with hexanes (1 mL/ 100 mg KH) and dried in vacuo. The s",
[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@H](SCCCc1ccccc1)c1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@@H](SCCCc1ccccc1)c1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@H](SCCCc1ccccc1)c1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2>>[H][C@]12CO[C@]([H])(O1)[C@@H](OC(=O)C[C@@H](SCCCc1ccccc1)c1ccccc1)C(Cc1ccccc1)(Cc1ccccc1)C2,51102155,1,33,half reaction|has preparation,,C38H40O4S|C38H40O4S,,Preparation,1,-20 - -13,Michael Addition,,tetrahydrofuran,76437481; Patent; GREATREX; WO2019/60953; A1; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Schlenk technique|Inert atmosphere,,Page/Page column 58; 59; 61,Overall yield = 91 %; Overall yield = 124 mg; diastereoselective reaction,potassium hydride,,,,,,42 percent de,,,8,Example 8 - Michael reaction of a dienophile-chiral auxiliary and a thiol,"General procedure: In a dry Schlenk tube under N2 atmosphere was added KH (1.0 equiv, 35 % w/w in paraffin) and the suspension washed two times with hexanes (1 mL/ 100 mg KH) and dried in vacuo. The s",
CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1cccc(Cl)c1,CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,CCOC(=O)C(C(=O)OCC)[C@H](C[N+](=O)[O-])c1cccc(Cl)c1>>CCOC(=O)C(C(=O)OCC)[C@@H](C[N+](=O)[O-])c1cccc(Cl)c1,52469903,1,33,half reaction|has preparation,,(S)-ethyl 2-carboethoxy-4-nitro-3-(3-chlorophenyl)butyrate|(R)-ethyl 2-carboethoxy-4-nitro-3-(3-chlorophenyl)butyrate,,Preparation,1,20,Michael Addition,,toluene,77728702; Patent; NANNING NORMAL UNIVERSITY; CN110078658; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Paragraph 0063-0070,Overall yield = 71 percent; Optical yield = 88 percent ee; enantioselective reaction,C26H25F6N5OS|copper(II) bis(trifluoromethanesulfonate),,,,,,,,,3,Example 3,"General procedure: Catalytic effect experiments: The thiourea-dipyridylamide chiral catalysts 6a-6d of the present invention are used in an asymmetric reaction, for example, compound 6d is in an asymm",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc(Br)c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc(Br)c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc(Br)c1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc(Br)c1,52945315,1,33,half reaction|has preparation,,C35H26BrFN2O4|C35H26BrFN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 87 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,77.778 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(F)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(F)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1,52945316,1,33,half reaction|has preparation,,C35H27FN2O4|C35H27FN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 80 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,80 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc(F)c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc(F)c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc(F)c1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc(F)c1,52945317,1,33,half reaction|has preparation,,C35H27FN2O4|C35H27FN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 89 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,80 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccccc1F,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccccc1F,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccccc1F>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccccc1F,52945318,1,33,half reaction|has preparation,,C35H27FN2O4|C35H27FN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,71.429 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(F)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(F)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1,52945319,1,33,half reaction|has preparation,,C35H26ClFN2O4|C35H26ClFN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 79 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,80 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccccc1F,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccccc1F,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccccc1F>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccccc1F,52945320,1,33,half reaction|has preparation,,C36H29FN2O4|C36H29FN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 88 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,75 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,52945321,1,33,half reaction|has preparation,,C35H27ClN2O4|C35H27ClN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,80 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,52945322,1,33,half reaction|has preparation,,C35H26ClFN2O4|C35H26ClFN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 84 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,75 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,52945323,1,33,half reaction|has preparation,,C36H29ClN2O4|C36H29ClN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,77.778 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc([N+](=O)[O-])c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc([N+](=O)[O-])c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc([N+](=O)[O-])c1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc([N+](=O)[O-])c1,52945324,1,33,half reaction|has preparation,,C35H26FN3O6|C35H26FN3O6,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,81.818 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
COc1cccc([C@H](CC(=O)c2ccccc2)[C@@]2(Cc3coc4ccc(C)cc4c3=O)C(=O)N(c3ccccc3)N=C2C)c1,COc1cccc([C@@H](CC(=O)c2ccccc2)[C@@]2(Cc3coc4ccc(C)cc4c3=O)C(=O)N(c3ccccc3)N=C2C)c1,COc1cccc([C@H](CC(=O)c2ccccc2)[C@@]2(Cc3coc4ccc(C)cc4c3=O)C(=O)N(c3ccccc3)N=C2C)c1>>COc1cccc([C@@H](CC(=O)c2ccccc2)[C@@]2(Cc3coc4ccc(C)cc4c3=O)C(=O)N(c3ccccc3)N=C2C)c1,52945325,1,33,half reaction|has preparation,,C37H32N2O5|C37H32N2O5,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,66.667 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(C)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(C)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1,52945326,1,33,half reaction|has preparation,,C37H32N2O4|C37H32N2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,77.778 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1Br)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1Br)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1Br)c1ccccc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1Br)c1ccccc1,52945327,1,33,half reaction|has preparation,,C35H27BrN2O4|C35H27BrN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,81.818 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1cccc(Cl)c1)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1cccc(Cl)c1)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1cccc(Cl)c1)c1ccccc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1cccc(Cl)c1)c1ccccc1,52945328,1,33,half reaction|has preparation,,C35H26ClFN2O4|C35H26ClFN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,75 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccc(F)cc1)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccc(F)cc1)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@@H](CC(=O)c1ccc(F)cc1)c1ccccc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(F)cc2c1=O)[C@H](CC(=O)c1ccc(F)cc1)c1ccccc1,52945329,1,33,half reaction|has preparation,,C35H26F2N2O4|C35H26F2N2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0028,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,80 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccccc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccccc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(Cl)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccccc1,52945330,1,33,half reaction|has preparation,,C35H27ClN2O4|C35H27ClN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 80 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,80 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Br)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Br)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Br)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Br)cc1,52945331,1,33,half reaction|has preparation,,C35H27BrN2O4|C35H27BrN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 83 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,81.818 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc(Br)c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc(Br)c1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@H](CC(=O)c1ccccc1)c1cccc(Br)c1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccccc2c1=O)[C@@H](CC(=O)c1ccccc1)c1cccc(Br)c1,52945332,1,33,half reaction|has preparation,,C35H27BrN2O4|C35H27BrN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 90 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,81.818 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Br)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Br)cc1,CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@H](CC(=O)c1ccccc1)c1ccc(Br)cc1>>CC1=NN(c2ccccc2)C(=O)[C@]1(Cc1coc2ccc(C)cc2c1=O)[C@@H](CC(=O)c1ccccc1)c1ccc(Br)cc1,52945333,1,33,half reaction|has preparation,,C36H29BrN2O4|C36H29BrN2O4,,Preparation,1,20,Michael Addition,,chloroform,78380871; Patent; GUIZHOU UNIVERSITY; CN110452230; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,96,,,Paragraph 0023-0026,Overall yield = 86 percent,"1,4-diaza-bicyclo[2.2.2]octane",,,,,,81.818 percent de,,,,,"General procedure: Pyrazolinone-chromone synth 1a (0.10 mmol) was sequentially added to the reaction tube.Chalcone 2a (0.12 mmol), DABCO (10 mol%, 0.01 mmol) and 2.0 mL of chloroform. After stirring f",
CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1>>CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc([N+](=O)[O-])cc1,52963902,1,33,half reaction|has preparation,,"(S)-3-[1-(4-nitrophenyl)-2-nitroethyl]-pentane-2,4-dione|(R)-3-[1-(4-nitrophenyl)-2-nitroethyl]-pentane-2,4-dione",,Preparation,1,25,Michael Addition,,dichloromethane,78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,Paragraph 0035-0036; 0056-0061,Overall yield = 85 percent,C68H90N6O8,,,,,,86 percent ee,,,4,Example 2,"General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf",
CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1,CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1,CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1>>CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1cccc([N+](=O)[O-])c1,52963903,1,33,half reaction|has preparation,,"(S)-3-[1-(3-nitrophenyl)-2-nitroethyl]-pentane-2,4-dione|(R)-3-(1-(3-nitrophenyl)-2-nitroethyl)pentane-2,4-dione",,Preparation,1,25,Michael Addition,,dichloromethane,78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,Paragraph 0035-0036; 0056-0061,Overall yield = 82 percent,C68H90N6O8,,,,,,75 percent ee,,,4,Example 2,"General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf",
CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-]>>CC(=O)C(C(C)=O)[C@H](C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],52963904,1,33,half reaction|has preparation,,"(R)-3-(1-(2-nitrophenyl)-2-nitroethyl)pentane-2,4-dione|(S)-3-[2-nitro-1-(2-nitro-phenyl)-ethyl]-pentane-2,4-dione",,Preparation,1,25,Michael Addition,,dichloromethane,78250542; Patent; CHANGZHOU UNIVERSITY; CN110372514; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,Paragraph 0035-0036; 0056-0061,Overall yield = 80 percent,C68H90N6O8,,,,,,81 percent ee,,,4,Example 2,"General procedure: In this example, β-nitrostyrene and acetylacetone were used as substrates to conf",
[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)CSCCC1=O,O=C1CCSCC1C(C[N+](=O)[O-])c1ccccc1,[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2)CSCCC1=O>>O=C1CCSCC1C(C[N+](=O)[O-])c1ccccc1,68465102,1,33,half reaction|has preparation,,(R)-3-((S)-2-nitro-1-phenylethyl)-tetrahydro-thiopyran-4-one|C13H15NO3S,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095-0097; 0100; 0141-0144; 0153,Overall yield = 85 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,94 percent ee,,,,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2cccc(C)c2)CCCCC1=O,Cc1cccc(C(C[N+](=O)[O-])C2CCCCC2=O)c1,[H][C@]1([C@H](C[N+](=O)[O-])c2cccc(C)c2)CCCCC1=O>>Cc1cccc(C(C[N+](=O)[O-])C2CCCCC2=O)c1,68465104,1,33,half reaction|has preparation,,(R)-2-[(S)-1-(3-methylphenyl)-2-nitroethyl]cyclohexanone|C15H19NO3,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0096-0097; 0108; 0141-0144; 0153,Overall yield = 98 percent; enantiospecific reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,99 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O,O=C1CCCCC1C(C[N+](=O)[O-])c1ccc(F)cc1,[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(F)cc2)CCCCC1=O>>O=C1CCCCC1C(C[N+](=O)[O-])c1ccc(F)cc1,68465106,1,33,half reaction|has preparation,,(R)-2-((S)-1-(4-fluorophenyl)-2-nitroethyl)cyclohexanone|C14H16FNO3,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0096-0097; 0110; 0141-0144;....,Overall yield = 92 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,99 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)CCCCC1=O,O=C1CCCCC1C(C[N+](=O)[O-])c1ccc(Cl)cc1,[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(Cl)cc2)CCCCC1=O>>O=C1CCCCC1C(C[N+](=O)[O-])c1ccc(Cl)cc1,68465107,1,33,half reaction|has preparation,,(R)-2-((S)-1-(4-chlorophenyl)-2-nitroethyl)cyclohexan-1-one|C14H16ClNO3,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0111; 0141-0144; ....,Overall yield = 99 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,90 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(Br)cc2)CCCCC1=O,O=C1CCCCC1C(C[N+](=O)[O-])c1ccc(Br)cc1,[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(Br)cc2)CCCCC1=O>>O=C1CCCCC1C(C[N+](=O)[O-])c1ccc(Br)cc1,68465108,1,33,half reaction|has preparation,,(R)-2-((S)-1-(4-bromophenyl)-2-nitroethyl)cyclohexan-1-one|C14H16BrNO3,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0112; 0141-0144; 0151....,Overall yield = 97 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,96 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2cccc(Cl)c2)CCCCC1=O,O=C1CCCCC1C(C[N+](=O)[O-])c1cccc(Cl)c1,[H][C@]1([C@H](C[N+](=O)[O-])c2cccc(Cl)c2)CCCCC1=O>>O=C1CCCCC1C(C[N+](=O)[O-])c1cccc(Cl)c1,68465109,1,33,half reaction|has preparation,,(R)-2-[(S)-1-(3-chlorophenyl)-2-nitroethyl]cyclohexanone|C14H16ClNO3,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0113; 0141-0144; 0151.....,Overall yield = 93 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,96 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O,O=C1CCCCC1C(C[N+](=O)[O-])c1ccco1,[H][C@]1([C@H](C[N+](=O)[O-])c2ccco2)CCCCC1=O>>O=C1CCCCC1C(C[N+](=O)[O-])c1ccco1,68465110,1,33,half reaction|has preparation,,(2R)-2-((1R)-1-(furan-2-yl)-2-nitroethyl)cyclohexanone|2-(1-(furan-2-yl)-2-nitro-ethyl)-cyclohexanone,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0114; 0141-0144; 0151-0153,Overall yield = 92 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,96 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
O=C1CCCCC1C(C[N+](=O)[O-])c1cccs1,O=C1CCCC[C@@H]1[C@H](C[N+](=O)[O-])c1cccs1,O=C1CCCCC1C(C[N+](=O)[O-])c1cccs1>>O=C1CCCC[C@@H]1[C@H](C[N+](=O)[O-])c1cccs1,68465111,1,33,half reaction|has preparation,,2-(1'-thien-2-yl-2'-nitro-ethyl)-cyclohexanone|(R)-2-((R)-2-nitro-1-(thiophen-2-yl)ethyl)cyclohexan-1-one,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0141-0144; 0115; 0151-0153,Overall yield = 99 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,98 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
O=C1CCCCC1C(C[N+](=O)[O-])c1ccc2ccccc2c1,O=C1CCCC[C@@H]1[C@H](C[N+](=O)[O-])c1ccc2ccccc2c1,O=C1CCCCC1C(C[N+](=O)[O-])c1ccc2ccccc2c1>>O=C1CCCC[C@@H]1[C@H](C[N+](=O)[O-])c1ccc2ccccc2c1,68465112,1,33,half reaction|has preparation,,C18H19NO3|(R)-2-((S)-1-naphthalen-2-yl-2-nitro-ethyl)-cyclohexanone,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0116; 0141-0144; 0151-0153,Overall yield = 92 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,92 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
COc1ccc(C(C[N+](=O)[O-])C2CCCCC2=O)cc1,[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(OC)cc2)CCCCC1=O,COc1ccc(C(C[N+](=O)[O-])C2CCCCC2=O)cc1>>[H][C@]1([C@H](C[N+](=O)[O-])c2ccc(OC)cc2)CCCCC1=O,68465113,1,33,half reaction|has preparation,,C15H19NO4|(2R)-2-[(1S)-1-(4-methoxyphenyl)-2-nitroethyl]cyclohexanone,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0117; 0141-0144; 0151-0153,Overall yield = 99 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,99 percent ee,,,2; 4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
COc1ccccc1C(C[N+](=O)[O-])C1CCCCC1=O,COc1ccccc1[C@@H](C[N+](=O)[O-])[C@H]1CCCCC1=O,COc1ccccc1C(C[N+](=O)[O-])C1CCCCC1=O>>COc1ccccc1[C@@H](C[N+](=O)[O-])[C@H]1CCCCC1=O,68465114,1,33,half reaction|has preparation,,C15H19NO4|(R)-2-((S)-1-(2-methoxy-phenyl)-2-nitro-ethyl)-cyclohexanone,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0118; 0141-0144; 0151-0153,Overall yield = 94 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,99 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2[N+](=O)[O-])CCCCC1=O,O=C1CCCCC1C(C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],[H][C@]1([C@H](C[N+](=O)[O-])c2ccccc2[N+](=O)[O-])CCCCC1=O>>O=C1CCCCC1C(C[N+](=O)[O-])c1ccccc1[N+](=O)[O-],68465115,1,33,half reaction|has preparation,,(R)-2-((S)-2-nitro-(2-nitrophenyl)ethyl)cyclohexanone|C14H16N2O5,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095; 0119; 0141-0144; 0151-0153,Overall yield = 95 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,94 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
CCCC(C=O)C(C[N+](=O)[O-])c1ccccc1,CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,CCCC(C=O)C(C[N+](=O)[O-])c1ccccc1>>CCC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,68465116,1,33,half reaction|has preparation,,"C13H17NO3|(2R,3S)-2-nitro-1-(phenylethyl)pentanal",,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090; 0093-0094; 0128; 0130; 0146-0147,Overall yield = 94 percent; stereoselective reaction,"1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea",,,,,,98 percent ee,,,3,1.3.2 In Case of Aldehyde,"General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene",
CC(C)C(C=O)C(C[N+](=O)[O-])c1ccccc1,CC(C)[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,CC(C)C(C=O)C(C[N+](=O)[O-])c1ccccc1>>CC(C)[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccccc1,68465117,1,33,half reaction|has preparation,,"C13H17NO3|(2R,3S)-2-(1-methylethyl)-4-nitro-3-phenylbutanal",,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090; 0093-0094; 0128; 0131 0146-0147,Overall yield = 93 percent; stereoselective reaction,"1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea",,,,,,99 percent ee,,,,1.3.2 In Case of Aldehyde,"General procedure: A thiourea catalyst (Chemical Formula 4, 5 mol %) and α,β-unsaturated nitroalkene",
[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)N(C)c3cccnc3)C(=O)O[C@]21[H],,[H][C@@]12O[C@]1(C)CC/C=C(\C)CC[C@@]1([H])[C@H](CSC(=S)N(C)c3cccnc3)C(=O)O[C@]21[H]>>,51490861,1,32,half reaction|has preparation,,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxir",,Preparation,1,,Michael Addition,,tetrahydrofuran|tetrahydrofuran|tetrahydrofuran,76478382; Patent; NANKAI UNIVERSITY; CN109651388; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1|2,Inert atmosphere|Cooling|Inert atmosphere|Inert atmosphere,,Paragraph 0014; 0015; 0042; 0043; 0044; 0045,,n-butyllithium,"((3S,3aS,9aR,10aS,10bS,E)-6,9a-dimethyl-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxir",18percent,18,,,,3,,1,Synthesis of Compound 14:,"General procedure: Take 2-methylaminopyridine (123 μL, 1.2 mmol) into a reaction vial, replace it th",
O=C1CCOCC1C(C[N+](=O)[O-])c1ccccc1,C[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)COCCC1=O.C[C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)COCCC1=O,O=C1CCOCC1C(C[N+](=O)[O-])c1ccccc1>>C[C@]1([C@@H](C[N+](=O)[O-])c2ccccc2)COCCC1=O.C[C@@]1([C@H](C[N+](=O)[O-])c2ccccc2)COCCC1=O,68465101,1,32,half reaction|has preparation,,3-(2-nitro-1-phenylethyl)tetrahydro-4H-pyran-4-one|(S)-3-[(S)-2-nitro-1-phenylethyl]tetrahydropyran-4-one|C14H17NO4,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095-0096; 0099; 0141-0144,,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,66 percent ee,,,,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
CC(C)c1ccc([C@@H](C[N+](=O)[O-])[C@@]2(C)CCCCC2=O)cc1,CC(C)c1ccc(C(C[N+](=O)[O-])C2(C)CCCCC2=O)cc1.CC(C)c1ccc([C@H](C[N+](=O)[O-])[C@]2(C)CCCCC2=O)cc1,CC(C)c1ccc([C@@H](C[N+](=O)[O-])[C@@]2(C)CCCCC2=O)cc1>>CC(C)c1ccc(C(C[N+](=O)[O-])C2(C)CCCCC2=O)cc1.CC(C)c1ccc([C@H](C[N+](=O)[O-])[C@]2(C)CCCCC2=O)cc1,68465105,1,32,half reaction|has preparation,,(R)-2-[(S)-1-(4-isopropylphenyl)-2-nitroethyl]cyclohexanone|C18H25NO3|C18H25NO3,,Preparation,1,20,Michael Addition,,water,132686848; Patent; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; US2024/76263; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere,,Paragraph 0075; 0090-0092; 0095-0096; 00109; 0141-0144,Overall yield = 88 percent; stereoselective reaction,"4-nitro-phenol|1-[(1R,2R)-2-amino-1,2-diphenylethyl]-3-isopropylthiourea",,,,,,82 percent ee,,,4,1.3.1 In Case of Ketone,"General procedure: A thiourea catalyst (Chemical Formula 4, 7.3 mg, 0.020 mmol), 4-nitrophenol (5 mo",
NC(=O)CCNc1ccccc1,,NC(=O)CCNc1ccccc1>>,7808974,6,30,half reaction|has preparation,,3-(phenylamino)propanamide,,"['Preparation', 'Preparation (half reaction)', 'Preparation (half reaction)', 'Preparation (half reaction)', 'Preparation (half reaction)', 'Preparation (half reaction)']","['1', '1', '1', '1', '1', '1']",120,Michael Addition,,,"['77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);', '3553599; Article; Solomko et al.; Chemistry of Heterocyclic Compounds; vol. 5; (1969); p. 400; Khimiya Geterotsiklicheskikh Soedinenii; vol. 5; (1969); p. 536;', '3553599; Article; Solomko et al.; Chemistry of Heterocyclic Compounds; vol. 5; (1969); p. 400; Khimiya Geterotsiklicheskikh Soedinenii; vol. 5; (1969); p. 536;', ""5381818; Article; Gergel' et al.; Journal of Organic Chemistry USSR (English Translation); vol. 4; (1968); p. 55; Zhurnal Organicheskoi Khimii; vol. 4; (1968); p. 59;"", ""5381818; Article; Gergel' et al.; Journal of Organic Chemistry USSR (English Translation); vol. 4; (1968); p. 55; Zhurnal Organicheskoi Khimii; vol. 4; (1968); p. 59;"", '5249604; Article; Buckus et al.; Journal of Organic Chemistry USSR (English Translation); vol. 4; (1968); p. 1707; Zhurnal Organicheskoi Khimii; vol. 4; (1968); p. 1770;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,Paragraph 0039-0043,"['3-Anilino-propionitril / Hydrolyse / H2SO4', '(yield)72percent', 'N-Phenyl-β-alaninmethylester, NH3', '(yield)90-92percent', 'Acrylamid, Anilin / Kochen in W.,A. oder CH3OH']",Imidazole hydrochloride,3-(phenylamino)propanamide,84 percent,84,,,,,,1,,,
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCCCC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCCCC3)cc2OC)ncc1Cl>>,66458464,2,30,half reaction|has preparation,,2-((5-chloro-2-((2-methoxy-4-((2-(piperidin-1-yl)ethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095-0097', 'Paragraph 0090; 0095-0097']",,,"['2-((5-chloro-2-((2-methoxy-4-((2-(piperidin-1-yl)ethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((2-methoxy-4-((2-(piperidin-1-yl)ethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['59 percent', '59 percent']",,,,,,,"['2', '2']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCN(C)CC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCN(C)CC3)cc2OC)ncc1Cl>>,66458465,2,30,half reaction|has preparation,,2-((5-chloro-2-((2-methoxy-4-((2-(4-methylpiperazin-1-yl)ethyl)sulfonamido) phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0098-0099', 'Paragraph 0090; 0095; 0098-0099']",,,"['2-((5-chloro-2-((2-methoxy-4-((2-(4-methylpiperazin-1-yl)ethyl)sulfonamido) phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((2-methoxy-4-((2-(4-methylpiperazin-1-yl)ethyl)sulfonamido) phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['47 percent', '47 percent']",,,,,,,"['3', '3']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCN(C(C)C)CC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCN(C(C)C)CC3)cc2OC)ncc1Cl>>,66458466,2,30,half reaction|has preparation,,2-((5-chloro-2-((4-((2-(4-isopropylpiperazin-1-yl)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0100-0101', 'Paragraph 0090; 0095; 0100-0101']",,,"['2-((5-chloro-2-((4-((2-(4-isopropylpiperazin-1-yl)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-(4-isopropylpiperazin-1-yl)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['42 percent', '42 percent']",,,,,,,"['4', '4']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN(C)C)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN(C)C)cc2OC)ncc1Cl>>,66458467,2,30,half reaction|has preparation,,2-((5-chloro-2-((4-((2-(dimethylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0102-0103', 'Paragraph 0090; 0095; 0102-0103']",,,"['2-((5-chloro-2-((4-((2-(dimethylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-(dimethylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['59 percent', '59 percent']",,,,,,,"['5', '5']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CCN(CC)CCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1,,CCN(CC)CCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1>>,66458468,2,30,half reaction|has preparation,,2-((5-chloro-2-((4-((2-(diethylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0104-0105', 'Paragraph 0090; 0095; 0104-0105']",,,"['2-((5-chloro-2-((4-((2-(diethylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-(diethylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['64 percent', '64 percent']",,,,,,,"['6', '6']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCCC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCCC3)cc2OC)ncc1Cl>>,66458469,2,30,half reaction|has preparation,,2-((5-chloro-2-((2-methoxy-4-((2-(pyrrolidin-1-yl)ethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 090; 0095; 0106-0107', 'Paragraph 090; 0095; 0106-0107']",,,"['2-((5-chloro-2-((2-methoxy-4-((2-(pyrrolidin-1-yl)ethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((2-methoxy-4-((2-(pyrrolidin-1-yl)ethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['60 percent', '60 percent']",,,,,,,"['7', '7']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCSCC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCSCC3)cc2OC)ncc1Cl>>,66458470,2,30,half reaction|has preparation,,2-((5-chloro-2-((2-methoxy-4-((2-thiomorpholinoethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0108-0109', 'Paragraph 0090; 0095; 0108-0109']",,,"['2-((5-chloro-2-((2-methoxy-4-((2-thiomorpholinoethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((2-methoxy-4-((2-thiomorpholinoethyl)sulfonamido)phenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['64 percent', '64 percent']",,,,,,,"['8', '8']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3C[C@@H](C)O[C@@H](C)C3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3C[C@@H](C)O[C@@H](C)C3)cc2OC)ncc1Cl>>,66458471,2,30,half reaction|has preparation,,"2-((5-chloro-2-((4-((2-((2S,6R)-2,6-dimethylmorpholino)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide",,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0110-0111', 'Paragraph 0090; 0095; 0110-0111']",,,"['2-((5-chloro-2-((4-((2-((2S,6R)-2,6-dimethylmorpholino)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-((2S,6R)-2,6-dimethylmorpholino)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['56 percent', '56 percent']",,,,,,,"['9', '9']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CCCN(CCC)CCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1,,CCCN(CCC)CCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1>>,66458472,2,30,half reaction|has preparation,,2-((5-chloro-2-((4-((2-(dipropylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0112-0113', 'Paragraph 0090; 0095; 0112-0113']",,,"['2-((5-chloro-2-((4-((2-(dipropylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-(dipropylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['61 percent', '61 percent']",,,,,,,"['10', '10']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
C=CCN(CC=C)CCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1,,C=CCN(CC=C)CCS(=O)(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NC)n2)c(OC)c1>>,66458473,2,30,half reaction|has preparation,,2-((5-chloro-2-((4-((2-(diallylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0114-0115', 'Paragraph 0090; 0095; 0114-0115']",,,"['2-((5-chloro-2-((4-((2-(diallylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-(diallylamino)ethyl)sulfonamido)-2-methoxyphenyl) amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['54 percent', '54 percent']",,,,,,,"['11', '11']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCc4ccccc4C3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCc4ccccc4C3)cc2OC)ncc1Cl>>,66458474,2,30,half reaction|has preparation,,"2-((5-chloro-2-((4-((2-(3,4-dihydroisoquinolin-2(1H)-yl)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide",,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0116-0117', 'Paragraph 0090; 0095; 0116-0117']",,,"['2-((5-chloro-2-((4-((2-(3,4-dihydroisoquinolin-2(1H)-yl)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((4-((2-(3,4-dihydroisoquinolin-2(1H)-yl)ethyl)sulfonamido)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['51 percent', '51 percent']",,,,,,,"['12', '12']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN(C)Cc3cccnc3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN(C)Cc3cccnc3)cc2OC)ncc1Cl>>,66458475,2,30,half reaction|has preparation,,2-((5-chloro-2-((2-methoxy-4-((2-(methyl(pyridin-3-ylmethyl)amino)ethyl) sulfonamido)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0118-0119', 'Paragraph 0090; 0095; 0118-0119']",,,"['2-((5-chloro-2-((2-methoxy-4-((2-(methyl(pyridin-3-ylmethyl)amino)ethyl) sulfonamido)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((2-methoxy-4-((2-(methyl(pyridin-3-ylmethyl)amino)ethyl) sulfonamido)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['49 percent', '49 percent']",,,,,,,"['13', '13']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCN(C(C)=O)CC3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCN(C(C)=O)CC3)cc2OC)ncc1Cl>>,66458476,2,30,half reaction|has preparation,,2-((2-((4-((2-(4-acetylpiperazin-1-yl)ethyl)sulfonamido)-2-methoxyphenyl) amino)-5-chloropyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0120-0121', 'Paragraph 0090; 0095; 0120-0121']",,,"['2-((2-((4-((2-(4-acetylpiperazin-1-yl)ethyl)sulfonamido)-2-methoxyphenyl) amino)-5-chloropyrimidin-4-yl)amino)-N-methylbenzamide', '2-((2-((4-((2-(4-acetylpiperazin-1-yl)ethyl)sulfonamido)-2-methoxyphenyl) amino)-5-chloropyrimidin-4-yl)amino)-N-methylbenzamide']","['49 percent', '49 percent']",,,,,,,"['14', '14']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCNC(=O)C3)cc2OC)ncc1Cl,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCNC(=O)C3)cc2OC)ncc1Cl>>,66458477,2,30,half reaction|has preparation,,2-((5-chloro-2-((2-methoxy-4-((2-(3-oxopiperazin-1-yl)ethyl)sulfonamido)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0122-0123', 'Paragraph 0090; 0095; 0122-0123']",,,"['2-((5-chloro-2-((2-methoxy-4-((2-(3-oxopiperazin-1-yl)ethyl)sulfonamido)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide', '2-((5-chloro-2-((2-methoxy-4-((2-(3-oxopiperazin-1-yl)ethyl)sulfonamido)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide']","['49 percent', '49 percent']",,,,,,,"['15', '15']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
[2H]C([2H])([2H])NC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCSCC3)cc2OC)ncc1Cl,,[2H]C([2H])([2H])NC(=O)c1ccccc1Nc1nc(Nc2ccc(NS(=O)(=O)CCN3CCSCC3)cc2OC)ncc1Cl>>,66458482,2,30,half reaction|has preparation,,C25H27(2)H3ClN7O4S2,,"['Preparation', 'Preparation']","['1', '1']","['20', '20']","['Michael Addition', 'Michael Addition']",,"['methanol|dichloromethane', 'methanol|dichloromethane']","['129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);', '129880952; Patent; PEKING UNIVERSITY; CN116969897; A; (2023);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,"['Paragraph 0090; 0095; 0137; 0142', 'Paragraph 0090; 0095; 0137; 0142']",,,"['C25H27(2)H3ClN7O4S2', 'C25H27(2)H3ClN7O4S2']","['67 percent', '67 percent']",,,,,,,"['21', '21']",,"['General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan', 'General procedure: 2-((5-Chloro-2-((2-methoxy-4-(vinylsulfonamide)phenyl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide (0.25 g, 0.5 mmol) was dissolved in 4 mL of methylene chloride and 2 mL of methan']",
CNCCS(=O)(=O)N[C@H]1CCc2c(-c3noc(-c4ccc(OC(C)C)c(C#N)c4)n3)cccc21,,CNCCS(=O)(=O)N[C@H]1CCc2c(-c3noc(-c4ccc(OC(C)C)c(C#N)c4)n3)cccc21>>,40026698,1,29,half reaction|has preparation,,C24H27N5O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 137,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN(C)C)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN(C)C)no2)cc1C#N>>,40026699,1,29,half reaction|has preparation,,C25H29N5O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 137,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCC3)no2)cc1C#N>>,40026700,1,29,half reaction|has preparation,,C26H29N5O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 149,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CCC3)no2)cc1C#N>>,40026701,1,29,half reaction|has preparation,,C26H29N5O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 150,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCCC3)no2)cc1C#N>>,40026702,1,29,half reaction|has preparation,,C27H31N5O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 150,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CC[C@@H](O)C3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CC[C@@H](O)C3)no2)cc1C#N>>,40026703,1,29,half reaction|has preparation,,C27H31N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 150,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CC[C@H](O)C3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CC[C@H](O)C3)no2)cc1C#N>>,40026704,1,29,half reaction|has preparation,,C27H31N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 150,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CC[C@@H](O)C3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CC[C@@H](O)C3)no2)cc1C#N>>,40026705,1,29,half reaction|has preparation,,C27H31N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 150,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CC[C@H](O)C3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CC[C@H](O)C3)no2)cc1C#N>>,40026706,1,29,half reaction|has preparation,,C27H31N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 150,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCCCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCCCC3)no2)cc1C#N>>,40026707,1,29,half reaction|has preparation,,C28H33N5O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 151,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCOCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCOCC3)no2)cc1C#N>>,40026708,1,29,half reaction|has preparation,,C27H31N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 151,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CCOCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NS(=O)(=O)CCN3CCOCC3)no2)cc1C#N>>,40026709,1,29,half reaction|has preparation,,C27H31N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 151,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCC(O)CC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCC(O)CC3)no2)cc1C#N>>,40026710,1,29,half reaction|has preparation,,C28H33N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 151,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCNCC3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CCNCC3)no2)cc1C#N>>,40026711,1,29,half reaction|has preparation,,C27H32N6O4S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 151,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCNCCO)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCNCCO)no2)cc1C#N>>,40026712,1,29,half reaction|has preparation,,C25H29N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 151,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CC(O)C3)no2)cc1C#N,,CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@H]4NS(=O)(=O)CCN3CC(O)C3)no2)cc1C#N>>,40026713,1,29,half reaction|has preparation,,C26H29N5O5S,,Preparation,1,80,Michael Addition,,"N,N-dimethyl-formamide",66155959; Patent; RECEPTOS; WO2015/66515; A1; (2015);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Page/Page column 92; 152,,,,,,,,,,,,GENERAL PROCEDURE 8B. PREPARATION OF INDANE SULFONAMIDES VIA MICHAEL ADDITION,General procedure: To a stirred solution of the (R)- or (5)-indane vinyl sulfonamide (1 eq) in DMF (0.1M) was added the appropriate amine (10 eq). The reaction mixture was stirred at 80C for 18 h. The,
CSc1nccc(CCNCCCc2cccc(F)c2)n1,,CSc1nccc(CCNCCCc2cccc(F)c2)n1>>,42111729,1,29,half reaction|has preparation,,3-(3-fluorophenyl)-N-2-[2-(methylthio)pyrimidin-4-yl]ethylpropan-1-amine,,Preparation,1,20,Michael Addition,,ethanol,68016864; Patent; NORTHWESTERN UNIVERSITY ILLINOIS; WO2016/7966; A2; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0024,,acetic acid,3-(3-fluorophenyl)-N-2-[2-(methylthio)pyrimidin-4-yl]ethylpropan-1-amine,88 percent,88,,,,,,,,,
[H][C@]12C(=O)NC(=O)[C@@]1(SC(C)=O)CC[C@@H]2O,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(C)=O)CC[C@@H]2O>>,42589670,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) ethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) ethanethioate",57 mg,,,,,,,10,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 10Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)Cc1ccccc1)CC[C@@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)Cc1ccccc1)CC[C@@H]2O>>,42589671,1,29,half reaction|has preparation,,"S-((3aR*,6R*,6aS*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenylethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aR*,6R*,6aS*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenylethanethioate",25 mg,,,,,,,11,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 11Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)Cc1ccccc1)CC[C@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)Cc1ccccc1)CC[C@H]2O>>,42589672,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenyl ethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenyl ethanethioate",35 mg,,,,,,,12,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 12Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccc(F)cc1)CC[C@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccc(F)cc1)CC[C@H]2O>>,42589673,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 4-fluorobenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 4-fluorobenzothioate",50 mg,,,,,,,13,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 13Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1cccs1)CC[C@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1cccs1)CC[C@H]2O>>,42589674,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) thiophene-2-carbothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) thiophene-2-carbothioate",70 mg,,,,,,,14,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 14Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1Cl)CC[C@@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1Cl)CC[C@@H]2O>>,42589675,1,29,half reaction|has preparation,,"S-((3aS*,6S*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-chlorobenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6S*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-chlorobenzothioate",26 mg,,,,,,,15,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 15Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1Cl)CC[C@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1Cl)CC[C@H]2O>>,42589676,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-chlorobenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-chlorobenzothioate",82 mg,,,,,,,16,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 16Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1)CC[C@@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1)CC[C@@H]2O>>,42589677,1,29,half reaction|has preparation,,"S-((3aR*,6R*,6aS*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) benzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aR*,6R*,6aS*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) benzothioate",26 mg,,,,,,,17,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 17Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1)CC[C@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1)CC[C@H]2O>>,42589678,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) benzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) benzothioate",36 mg,,,,,,,18,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.Example 18Synthesis o",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1O)CC[C@H]2O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1O)CC[C@H]2O>>,42589679,1,29,half reaction|has preparation,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-hydroxybenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aS*,6R*,6aR*)-6-hydroxy-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-hydroxybenzothioate",23 mg,,,,,,,19,,"General procedure: Fig. 6 represents general outline for Synthesis of compounds 7 to 17, wherein the average yield of the reactions is 70-80% combined yield of both diastereomers.ExampleSynthesis of p",
[H][C@]12CCC[C@@]1(SC(=O)Cc1ccccc1)C(=O)NC2=O,,[H][C@]12CCC[C@@]1(SC(=O)Cc1ccccc1)C(=O)NC2=O>>,42589680,1,29,half reaction|has preparation,,"S-((3aR*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenylethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aR*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenylethanethioate",80 mg,,,,,,,21,,"General procedure: Fig. 7 represents general outline for synthesis of compounds 18 to 21, wherein the average yield of the reactions is 40-70%.Example 21Synthesis of 2- phenylethanethioate (19)80 mg o",
[H][C@]12CCC[C@@]1(SC(=O)c1ccc(F)cc1)C(=O)NC2=O,,[H][C@]12CCC[C@@]1(SC(=O)c1ccc(F)cc1)C(=O)NC2=O>>,42589681,1,29,half reaction|has preparation,,"S-((3aR*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 4-fluorobenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aR*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 4-fluorobenzothioate",40 mg,,,,,,,22,,"General procedure: Fig. 7 represents general outline for synthesis of compounds 18 to 21, wherein the average yield of the reactions is 40-70%.Example 22Synthesis of 4- fluorobenzothioate (20)0NH40 mg",
[H][C@]12CCC[C@@]1(SC(=O)c1ccccc1Cl)C(=O)NC2=O,,[H][C@]12CCC[C@@]1(SC(=O)c1ccccc1Cl)C(=O)NC2=O>>,42589682,1,29,half reaction|has preparation,,"S-((3aR*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-chlorobenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 4/5,,,"S-((3aR*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-chlorobenzothioate",31 mg,,,,,,,23,,"General procedure: Fig. 7 represents general outline for synthesis of compounds 18 to 21, wherein th",
[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)c1ccc(F)cc1)CCC2SC(=O)c1ccc(F)cc1,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)c1ccc(F)cc1)CCC2SC(=O)c1ccc(F)cc1>>,42589683,1,29,half reaction|has preparation,,"S,S-((3aR*,6aR*)-1,3-dioxohexahydrocyclopenta[c]pyrrole-3a,6(1H)-diyl) bis(4-fluorobenzothioate)",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S,S-((3aR*,6aR*)-1,3-dioxohexahydrocyclopenta[c]pyrrole-3a,6(1H)-diyl) bis(4-fluorobenzothioate)",31 mg,,,,,,,25,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein th",
O=C1NC(=O)C2=C1CCC2SC(=O)c1ccccc1,,O=C1NC(=O)C2=C1CCC2SC(=O)c1ccccc1>>,42589684,1,29,half reaction|has preparation,,"S-(1,3-dioxo-1,2,3,4,5,6-hexahydrocyclopenta[c]pyrrol-4-yl) benzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S-(1,3-dioxo-1,2,3,4,5,6-hexahydrocyclopenta[c]pyrrol-4-yl) benzothioate",35 mg,,,,,,,26,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein the average yield of the reactions is 40-50%.Example 26Synthesis of benzothioate (24)S-(1,3-Dioxo-1 ,2",
[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)c1ccccc1)CCC2SC(=O)c1ccccc1,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)c1ccccc1)CCC2SC(=O)c1ccccc1>>,42589685,1,29,half reaction|has preparation,,"S,S-((3aS*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrole-3a,6(1H)-diyl) dibenzothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S,S-((3aS*,6aS*)-1,3-dioxohexahydrocyclopenta[c]pyrrole-3a,6(1H)-diyl) dibenzothioate",35 mg,,,,,,,27,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein th",
CC(=O)SC12CCC=C1C(=O)NC2=O,,CC(=O)SC12CCC=C1C(=O)NC2=O>>,42589686,1,29,half reaction|has preparation,,"S-(1,3-dioxo-2,3,4,5-tetrahydrocyclopenta[c]pyrrol-3a(1H)-yl) ethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S-(1,3-dioxo-2,3,4,5-tetrahydrocyclopenta[c]pyrrol-3a(1H)-yl) ethanethioate",30 mg,,,,,,,28,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein the average yield of the reactions is 40-50%.Example 28Synthesis of S-(1 ,3-Dioxo-2,3,4,5-tetrahydrocy",
O=C(Cc1ccccc1)SC12CCC=C1C(=O)NC2=O,,O=C(Cc1ccccc1)SC12CCC=C1C(=O)NC2=O>>,42589687,1,29,half reaction|has preparation,,"S-(1,3-dioxo-2,3,4,5-tetrahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenylethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S-(1,3-dioxo-2,3,4,5-tetrahydrocyclopenta[c]pyrrol-3a(1H)-yl) 2-phenylethanethioate",35 mg,,,,,,,29,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein the average yield of the reactions is 40-50%.Example 29Synthesis of S-(1,3-Dioxo-2,3,4,5-tetrahydrocyc",
[H][C@]12C(=O)NC(=O)[C@@]1(SC(C)=O)CCC2SC(C)=O,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(C)=O)CCC2SC(C)=O>>,42589688,1,29,half reaction|has preparation,,"S,S-((3aR*,6aR*)-1,3-dioxohexahydrocyclopenta[c]pyrrole-3a,6(1H)-diyl) diethanethioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S,S-((3aR*,6aR*)-1,3-dioxohexahydrocyclopenta[c]pyrrole-3a,6(1H)-diyl) diethanethioate",30 mg,,,,,,,30,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein th",
O=C1NC(=O)C2=C1CCC2SC(=O)c1cccs1,,O=C1NC(=O)C2=C1CCC2SC(=O)c1cccs1>>,42589689,1,29,half reaction|has preparation,,"S-(1,3-dioxo-1,2,3,4,5,6-hexahydrocyclopenta[c]pyrrol-4-yl) thiophene-2-carbothioate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"S-(1,3-dioxo-1,2,3,4,5,6-hexahydrocyclopenta[c]pyrrol-4-yl) thiophene-2-carbothioate",38 mg,,,,,,,31,,"General procedure: Fig. 8 represents general outline for synthesis of compounds 22 to 29, wherein the average yield of the reactions is 40-50%.Example 31Synthesisof S-(1,3-Dioxo-1 ,2,3,4,5,6-hexahydro",
[H][C@]12C(=O)NC(=O)[C@@]1(SC(C)=O)CCC2OC(C)=O,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(C)=O)CCC2OC(C)=O>>,42589690,1,29,half reaction|has preparation,,"(3aS*,6aR*)-6a-(acetylthio)-1,3-dioxooctahydrocyclopenta[c]pyrrol-4-yl acetate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"(3aS*,6aR*)-6a-(acetylthio)-1,3-dioxooctahydrocyclopenta[c]pyrrol-4-yl acetate",60 mg,,,,,,,33,,"General procedure: Fig. 9 represents general outline for synthesis of compounds 30 to 35, wherein the average yield of the reactions is 50-65% and all the acetates compounds are isolated as inseparabl",
[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)Cc1ccccc1)CCC2OC(C)=O,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)Cc1ccccc1)CCC2OC(C)=O>>,42589691,1,29,half reaction|has preparation,,"(3aS*,6aR*)-1,3-dioxo-6a-((2-phenylacetyl)thio)octahydrocyclopenta[c]pyrrol-4-yl acetate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"(3aS*,6aR*)-1,3-dioxo-6a-((2-phenylacetyl)thio)octahydrocyclopenta[c]pyrrol-4-yl acetate",45 mg,,,,,,,34,,"General procedure: Fig. 9 represents general outline for synthesis of compounds 30 to 35, wherein the average yield of the reactions is 50-65% and all the acetates compounds are isolated as inseparabl",
[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)c1ccc(F)cc1)CCC2OC(C)=O,,[H][C@]12C(=O)NC(=O)[C@@]1(SC(=O)c1ccc(F)cc1)CCC2OC(C)=O>>,42589692,1,29,half reaction|has preparation,,"(3aS*,6aR*)-6a-((4-fluorobenzoyl)thio)-1,3-dioxooctahydrocyclopenta[c]pyrrol4-yl acetate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"(3aS*,6aR*)-6a-((4-fluorobenzoyl)thio)-1,3-dioxooctahydrocyclopenta[c]pyrrol4-yl acetate",45 mg,,,,,,,35,,"General procedure: Fig. 9 represents general outline for synthesis of compounds 30 to 35, wherein the average yield of the reactions is 50-65% and all the acetates compounds are isolated as inseparabl",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1Cl)CCC2OC(C)=O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1Cl)CCC2OC(C)=O>>,42589693,1,29,half reaction|has preparation,,"(3aS*,6aR*)-6a-((2-chlorobenzoyl)thio)-1,3-dioxooctahydrocyclopenta[c]pyrrol-4-yl acetate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"(3aS*,6aR*)-6a-((2-chlorobenzoyl)thio)-1,3-dioxooctahydrocyclopenta[c]pyrrol-4-yl acetate",35 mg,,,,,,,36,,"General procedure: Fig. 9 represents general outline for synthesis of compounds 30 to 35, wherein the average yield of the reactions is 50-65% and all the acetates compounds are isolated as inseparabl",
[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1)CCC2OC(C)=O,,[H][C@@]12C(=O)NC(=O)[C@]1(SC(=O)c1ccccc1)CCC2OC(C)=O>>,42589694,1,29,half reaction|has preparation,,"(3aS*,6aR*)-6a-(benzoylthio)-1,3-dioxooctahydrocyclopenta[c]pyrrol-4-yl acetate",,Preparation,1,25,Michael Addition,,tetrahydrofuran|water,68727038; Patent; COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH IN; WO2016/51425; A1; (2016);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,16,,,Sheet 5/5,,,"(3aS*,6aR*)-6a-(benzoylthio)-1,3-dioxooctahydrocyclopenta[c]pyrrol-4-yl acetate",25 mg,,,,,,,37,,"General procedure: Fig. 9 represents general outline for synthesis of compounds 30 to 35, wherein the average yield of the reactions is 50-65% and all the acetates compounds are isolated as inseparabl",
C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCSCCO,,C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCSCCO>>,47555244,1,29,half reaction|has preparation,,C19H26O9S,,Preparation,1,40,Michael Addition,,,73409341; Patent; CALIFORNIA INSTITUTE OF TECHNOLOGY; US2018/64747; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,14,,,Paragraph 0033; 0184; 0185,,hexan-1-amine,,,,,,,,,2.2,Example 2.2. Other Polymer Linkages,"General procedure: The general Michael addition of thiols to acrylate linkages were used to prepare a host of pendant reactive groups, three of which are shown above. The functionalized acrylate was s",
C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCSCCCN(CCNC(=O)OC(C)(C)C)C(=O)OC(C)(C)C,,C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)CCSCCCN(CCNC(=O)OC(C)(C)C)C(=O)OC(C)(C)C>>,47555245,1,29,half reaction|has preparation,,C32H50N2O12S,,Preparation,1,40,Michael Addition,,,73409341; Patent; CALIFORNIA INSTITUTE OF TECHNOLOGY; US2018/64747; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,14,,,Paragraph 0033; 0184; 0185,,hexan-1-amine,,,,,,,,,2.2,Example 2.2. Other Polymer Linkages,"General procedure: The general Michael addition of thiols to acrylate linkages were used to prepare a host of pendant reactive groups, three of which are shown above. The functionalized acrylate was s",
COC(=O)CCN([C@@H](C)c1ccc(OC)cc1)[C@H]1CCCc2cccnc21,,COC(=O)CCN([C@@H](C)c1ccc(OC)cc1)[C@H]1CCCc2cccnc21>>,51681970,1,29,half reaction|has preparation,,"methyl 3-(((S)-1-(4-methoxyphenyl)ethyl)((S)-5,6,7,8-tetrahydroquinolin-8-yl)amino)propanoate",,Preparation,1,80,Michael Addition,,methanol,77223788; Patent; X4 PHARMACEUTICALS; WO2019/126106; A1; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Sealed tube,,Paragraph 00194; 00216-00217; 00220,,,,,,,,,,,6,General Procedure B (Michael addition of methyl acrylate by secondary amine):,"General procedure: A mixture of the secondary (concentration 0.1-1 M), methyl acrylate (4 eq) in MeOH was stirred at 80 C overnight in a sealed tube. After the reaction was completed, the solvent was",
COc1cc(-c2cnc3cc(OC[C@H]4CCCN(CCC#N)C4)ccn23)cc(OC(F)F)c1C(=O)NC1CC1,,COc1cc(-c2cnc3cc(OC[C@H]4CCCN(CCC#N)C4)ccn23)cc(OC(F)F)c1C(=O)NC1CC1>>,53051276,1,29,half reaction|has preparation,,"4-[7-[[(3S)-1-(2-cyanoethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide",,Preparation,1,20,Michael Addition,,,78741076; Patent; GALAPAGOS; WO2019/238424; A1; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0339; 0554,,"N-ethyl-N,N-diisopropylamine",,,,,,,,,,1.2.14. Method L: Michael addition,"General procedure: To a mixture of amine derivative (free base or hydrochloride salt, 1 eq.) and acrylonitrile derivative (14.7 to 20 eq.) is added DIPEA (2 to 4.8 eq.). The mixture is stirred at RT f",
CC(=O)N1CCN(CCC#N)CC1,,CC(=O)N1CCN(CCC#N)CC1>>,53072729,1,29,half reaction|has preparation,,3-[(4-acetyl)piperazinyl]propanenitrile,,Preparation,1,20,Michael Addition,,methanol,78862152; Patent; GOVERNMENT OF THE UNITED STATES; WO2020/6510; A1; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,18,,,Paragraph 00412-00413; 00415-00416; 00419-00420,,,,,,,,,,,20,General Procedure for the Preparation of 3-Aminopropanenitriles 44:,"General procedure: To a solution of amine NHR4R5 (10.0 mmol) m MeOH was added acrylonitrile (1.5 mL). After 18 h at rt, the mixture was dry loaded onto silica gel. Elution with EtOAc provided the pure",
COC(=O)C1=C[C@@H](c2ccccc2)[C@H](C(=O)Sc2ccc(Cl)cc2)C(=O)O1,,COC(=O)C1=C[C@@H](c2ccccc2)[C@H](C(=O)Sc2ccc(Cl)cc2)C(=O)O1>>,55317638,1,29,half reaction|has preparation,,"(3S,4R)-methyl 3-((4-chlorophenylthio)carbonyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate",,Preparation,1,20,Michael Addition,,tert-butyl methyl ether,81374848; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2020/88080; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,Paragraph 0101-0103,,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea","(3S,4R)-methyl 3-((4-chlorophenylthio)carbonyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate",90 percent,90,,,,,,,,,
COC(=O)C1=C[C@@H](c2ccccc2)[C@H](C(=O)Sc2ccc(OC)cc2)C(=O)O1,,COC(=O)C1=C[C@@H](c2ccccc2)[C@H](C(=O)Sc2ccc(OC)cc2)C(=O)O1>>,55317639,1,29,half reaction|has preparation,,"(3S,4R)-methyl 3-((4-methoxyphenylthio)carbonyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate",,Preparation,1,20,Michael Addition,,tert-butyl methyl ether,81374848; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2020/88080; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,Paragraph 0101-0103,,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea","(3S,4R)-methyl 3-((4-methoxyphenylthio)carbonyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate",97 percent,97,,,,,,,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1,,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(C)cc1>>,56087709,1,29,half reaction|has preparation,,C22H24BOP,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0151,stereoselective reaction,potassium acetate|C39H47ClNiO2P2,C22H24BOP,87 percent,87,,,94 percent ee,2,,27,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccco1,,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccco1>>,56087714,1,29,half reaction|has preparation,,C19H20BO2P,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0152,stereoselective reaction,potassium acetate|C39H47ClNiO2P2,C19H20BO2P,89 percent,89,,,94 percent ee,2,,27,,,
N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1ccc(F)cc12,,N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1ccc(F)cc12>>,56452128,1,29,half reaction|has preparation,,"2′-amino-1-benzyl-5-fluoro-5′-hydroxy-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-1-benzyl-5-fluoro-5′-hydroxy-2,6′-dioxo-8′-phenyl-6",85 percent,85,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1ccc(Cl)cc12,,N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1ccc(Cl)cc12>>,56452132,1,29,half reaction|has preparation,,"2′-amino-1-benzyl-5-chloro-5′-hydroxy-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-1-benzyl-5-chloro-5′-hydroxy-2,6′-dioxo-8′-phenyl-6",86 percent,86,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1c(Cl)cccc12,,N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1c(Cl)cccc12>>,56452150,1,29,half reaction|has preparation,,"2′-amino-1-benzyl-7-chloro-5′-hydroxy-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-1-benzyl-7-chloro-5′-hydroxy-2,6′-dioxo-8′-phenyl-6",85 percent,85,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccc(OC)cc5OC)cc(=O)c4c(O)c32)c2cc(Cl)ccc21,,CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccc(OC)cc5OC)cc(=O)c4c(O)c32)c2cc(Cl)ccc21>>,56452180,1,29,half reaction|has preparation,,"2′-amino-5-chloro-8′-(2,4-dimethoxyphenyl)-1-ethyl-5′-hydroxy-2,6′-d",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-5-chloro-8′-(2,4-dimethoxyphenyl)-1-ethyl-5′-hydroxy-2,6′-d",85 percent,85,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccc(OC)cc5OC)cc(=O)c4c(O)c32)c2cc(Br)ccc21,,CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccc(OC)cc5OC)cc(=O)c4c(O)c32)c2cc(Br)ccc21>>,56452183,1,29,half reaction|has preparation,,"2′-amino-5-bromo-8′-(2,4-dimethoxyphenyl)-1-ethyl-5′-hydroxy-2,6′-d",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-5-bromo-8′-(2,4-dimethoxyphenyl)-1-ethyl-5′-hydroxy-2,6′-d",86 percent,86,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cccc(Cl)c21,,CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cccc(Cl)c21>>,56452195,1,29,half reaction|has preparation,,"2′-amino-7-chloro-5′-hydroxy-1-methyl-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-7-chloro-5′-hydroxy-1-methyl-2,6′-dioxo-8′-phenyl-6",86 percent,86,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cc(Br)ccc21,,CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cc(Br)ccc21>>,56452204,1,29,half reaction|has preparation,,"2′-amino-5-bromo-5′-hydroxy-1-methyl-2,6′-dioxo-8′-phenyl-6′",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-5-bromo-5′-hydroxy-1-methyl-2,6′-dioxo-8′-phenyl-6′",87 percent,87,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CCCCOC(=O)CCN(CCCN(CCCCN(CCCN(CCC(=O)OCCCC)CCC(=O)OCCCC)CCCN(CCC(=O)OCCCC)CCC(=O)OCCCC)CCCN(CCC(=O)OCCCC)CCC(=O)OCCCC)CCC(=O)OCCCC,,CCCCOC(=O)CCN(CCCN(CCCCN(CCCN(CCC(=O)OCCCC)CCC(=O)OCCCC)CCCN(CCC(=O)OCCCC)CCC(=O)OCCCC)CCCN(CCC(=O)OCCCC)CCC(=O)OCCCC)CCC(=O)OCCCC>>,65881670,1,29,half reaction|has preparation,,C72H136N6O16,,Preparation,1,55,Michael Addition,,isopropyl alcohol,130945388; Patent; MULDER WILLEM JAN MENNO; WO2023/233042; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Sealed tube,,Page/Page column 84-86,,,C72H136N6O16,53 percent,,,,,,,A4,,"General procedure: G2 PPI dendrimer (n-butylene core; 0.20 g; 0.258 mmol; 2.06 mmol primary amine groups) was dissolved in iso-propanol (1 mL). An excess of n-octyl acrylate (1.73 mL, 1.53 g, 8.27 mmo",
CC(C)CCCCCCCOC(=O)CCN(CCCN(CCCCN(CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C,,CC(C)CCCCCCCOC(=O)CCN(CCCN(CCCCN(CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCCN(CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C)CCC(=O)OCCCCCCCC(C)C>>,65881671,1,29,half reaction|has preparation,,C120H232N6O16,,Preparation,1,55,Michael Addition,,isopropyl alcohol,130945388; Patent; MULDER WILLEM JAN MENNO; WO2023/233042; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Sealed tube,,Page/Page column 84-87,,,C120H232N6O16,67 percent,,,,,,,A6,,"General procedure: G2 PPI dendrimer (n-butylene core; 0.20 g; 0.258 mmol; 2.06 mmol primary amine groups) was dissolved in iso-propanol (1 mL). An excess of n-octyl acrylate (1.73 mL, 1.53 g, 8.27 mmo",
CCCCC(CC)COC(=O)CCN(CCCN(CCCCN(CCCN(CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC)CCCN(CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC)CCCN(CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC,,CCCCC(CC)COC(=O)CCN(CCCN(CCCCN(CCCN(CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC)CCCN(CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC)CCCN(CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC)CCC(=O)OCC(CC)CCCC>>,65881675,1,29,half reaction|has preparation,,C104H200N6O16,,Preparation,1,55,Michael Addition,,isopropyl alcohol,130945388; Patent; MULDER WILLEM JAN MENNO; WO2023/233042; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Inert atmosphere|Sealed tube,,Page/Page column 84-85; 90,,,C104H200N6O16,73 percent,,,,,,,A13,,"General procedure: G2 PPI dendrimer (n-butylene core; 0.20 g; 0.258 mmol; 2.06 mmol primary amine groups) was dissolved in iso-propanol (1 mL). An excess of n-octyl acrylate (1.73 mL, 1.53 g, 8.27 mmo",
C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1,CC(C=O)C(C[N+](=O)[O-])c1ccc(Br)cc1,C[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccc(Br)cc1>>CC(C=O)C(C[N+](=O)[O-])c1ccc(Br)cc1,44715965,1,28,half reaction|has preparation,,"(2R,3S)-(4-bromophenyl)-2-methyl-4-nitrobutanal|(2R,3S)-3-(4-bromophenyl)-2-methyl-4-nitrobutanal",,Preparation,1,,Michael Addition,,dichloromethane|water,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,Page/Page column 30; 31,Overall yield = 94 %,4-nitro-phenol,,,,,,95 percent ee,,,3.B,B) Flow production of a library of compounds,"General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m",
CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccco1,CCC(C=O)C(C[N+](=O)[O-])c1ccco1,CC[C@@H](C=O)[C@H](C[N+](=O)[O-])c1ccco1>>CCC(C=O)C(C[N+](=O)[O-])c1ccco1,44715970,1,28,half reaction|has preparation,,"(2R,3S)-2-ethyl-3-(furan-2-yl)-4-nitrobutyraldehyde|C10H13NO4",,Preparation,1,,Michael Addition,,dichloromethane|water,70543602; Patent; FUNDACIO PRIVADA INSTITUT CATALA D INVESTIGACIO QUIMICA; WO2017/8832; A1; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Flow reactor,,Page/Page column 30; 31,Overall yield = 70 %,4-nitro-phenol,,,,,,94 percent ee,,,3.B,B) Flow production of a library of compounds,"General procedure: The set-up and the way to prepare the solutions were identical to the ones previously described (example 3-A), except that a different batch of catalyst la was used (500 mg, 0.575 m",
CC1(C)CC(=O)C2=C(C1)OS(=O)(=O)CC2c1ccc([N+](=O)[O-])cc1,,CC1(C)CC(=O)C2=C(C1)OS(=O)(=O)CC2c1ccc([N+](=O)[O-])cc1>>,46311897,1,28,half reaction|has preparation,,"7,7-dimethyl-4-(4-nitrophenyl)-4,6,7,8-tetrahydrobenzo[e][1,2]oxathiin-5(3H)-one 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","7,7-dimethyl-4-(4-nitrophenyl)-4,6,7,8-tetrahydrobenzo[e][1,2]oxathiin-5(3H)-one 2,2-dioxide",83percent,83,,,,,,,,,
CC(=O)C1=C(C)OS(=O)(=O)CC1c1ccc([N+](=O)[O-])cc1,,CC(=O)C1=C(C)OS(=O)(=O)CC1c1ccc([N+](=O)[O-])cc1>>,46311899,1,28,half reaction|has preparation,,"1-(6-methyl-4-(4-nitrophenyl)-2,2-dioxido-3,4-dihydro-1,2-oxathiin-5-yl)ethan-1-one",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","1-(6-methyl-4-(4-nitrophenyl)-2,2-dioxido-3,4-dihydro-1,2-oxathiin-5-yl)ethan-1-one",77percent,77,,,,,,,,,
CC(=O)C[C@H](C[N+](=O)[O-])C(=O)OC(C)(C)C,,CC(=O)C[C@H](C[N+](=O)[O-])C(=O)OC(C)(C)C>>,47773848,1,28,half reaction|has preparation,,tert-butyl 2-(nitromethyl)-4-oxopentanoate,,Preparation,1,24,Michael Addition,,dichloromethane,73440178; Patent; OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY; WO2018/25295; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,Paragraph 0079; 0081; 0087-0088,,"1-((1R,2R)-2-aminocyclohexyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea",tert-butyl 2-(nitromethyl)-4-oxopentanoate,79 percent,79,,,93percent ee,,,4,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1cccc(OC)c1,,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1cccc(OC)c1>>,56087712,1,28,half reaction|has preparation,,C22H24BO2P,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0152,stereoselective reaction,potassium acetate|C39H47ClNiO2P2,C22H24BO2P,84 percent,84,,,94 percent ee,2,,27,,,
N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1ccc(Br)cc12,,N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(Cc1ccccc1)c1ccc(Br)cc12>>,56452137,1,28,half reaction|has preparation,,"2′-amino-1-benzyl-5-bromo-5′-hydroxy-2,6′-dioxo-8′-phenyl-6′",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-1-benzyl-5-bromo-5′-hydroxy-2,6′-dioxo-8′-phenyl-6′",84 percent,84,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
Cc1cccc2c1N(Cc1ccccc1)C(=O)C21C(C#N)=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c21,,Cc1cccc2c1N(Cc1ccccc1)C(=O)C21C(C#N)=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c21>>,56452143,1,28,half reaction|has preparation,,"2′-amino-1-benzyl-5′-hydroxy-7-methyl-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-1-benzyl-5′-hydroxy-7-methyl-2,6′-dioxo-8′-phenyl-6",75 percent,75,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(c1ccccc1)c1ccccc12,,N#CC1=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2C12C(=O)N(c1ccccc1)c1ccccc12>>,56452154,1,28,half reaction|has preparation,,"2′-amino-5′-hydroxy-2,6′-dioxo-1,8′-diphenyl-6′H-spiro",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-5′-hydroxy-2,6′-dioxo-1,8′-diphenyl-6′H-spiro",81 percent,81,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cc(C)ccc21,,CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cc(C)ccc21>>,56452162,1,28,half reaction|has preparation,,"2′-amino-1-ethyl-5′-hydroxy-5-methyl-2,6′-dioxo-8′-phenyl-6′",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-1-ethyl-5′-hydroxy-5-methyl-2,6′-dioxo-8′-phenyl-6′",75 percent,75,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CC(C)(C)OC(=O)CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2ccccc21,,CC(C)(C)OC(=O)CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2ccccc21>>,56452167,1,28,half reaction|has preparation,,"tert-butyl 2-(2′-amino-3′-cyano-5′-hydroxy-2,6′-dioxo-8′-pheny",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"tert-butyl 2-(2′-amino-3′-cyano-5′-hydroxy-2,6′-dioxo-8′-pheny",77 percent,77,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cc(Cl)ccc21,,CN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cc(Cl)ccc21>>,56452201,1,28,half reaction|has preparation,,"2′-amino-5-chloro-5′-hydroxy-1-methyl-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-5-chloro-5′-hydroxy-1-methyl-2,6′-dioxo-8′-phenyl-6",84 percent,84,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
Cc1ccc2c(c1)C1(C(=O)N2Cc2ccccc2)C(C#N)=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c21,,Cc1ccc2c(c1)C1(C(=O)N2Cc2ccccc2)C(C#N)=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c21>>,56452207,1,28,half reaction|has preparation,,"2′-amino-1-benzyl-5′-hydroxy-5-methyl-2,6′-dioxo-8′-phenyl-6",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-1-benzyl-5′-hydroxy-5-methyl-2,6′-dioxo-8′-phenyl-6",78 percent,78,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CCOC(=O)[C@@H](CC(=O)CC)C[N+](=O)[O-],,CCOC(=O)[C@@H](CC(=O)CC)C[N+](=O)[O-]>>,47773849,1,27,half reaction|has preparation,,ethyl 2-(nitromethyl)-4-oxohexanoate,,Preparation,1,24,Michael Addition,,dichloromethane,73440178; Patent; OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY; WO2018/25295; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,Paragraph 0079; 0081; 0086; 0089,,"1-((1R,2R)-2-aminocyclohexyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea|acetic acid",ethyl 2-(nitromethyl)-4-oxohexanoate,70 percent,70,,,94 percent ee,,,4,,,
CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cccc(C)c21,,CCN1C(=O)C2(C(C#N)=C(N)Oc3cc4oc(-c5ccccc5)cc(=O)c4c(O)c32)c2cccc(C)c21>>,56452157,1,27,half reaction|has preparation,,"2′-amino-1-ethyl-5′-hydroxy-7-methyl-2,6′-dioxo-8′-phenyl-6′",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-1-ethyl-5′-hydroxy-7-methyl-2,6′-dioxo-8′-phenyl-6′",73 percent,73,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
COc1ccc(-c2cc(=O)c3c(O)c4c(cc3o2)OC(N)=C(C#N)C42C(=O)N(C)c3ccc(C)cc32)c(OC)c1,,COc1ccc(-c2cc(=O)c3c(O)c4c(cc3o2)OC(N)=C(C#N)C42C(=O)N(C)c3ccc(C)cc32)c(OC)c1>>,56452175,1,27,half reaction|has preparation,,"2′-amino-8′-(2,4-dimethoxyphenyl)-5′-hydroxy-1,5-dimethyl-2,6′-dio",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-8′-(2,4-dimethoxyphenyl)-5′-hydroxy-1,5-dimethyl-2,6′-dio",70 percent,70,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
COc1ccc(-c2cc(=O)c3c(O)c4c(cc3o2)OC(N)=C(C#N)C42C(=O)N(Cc3ccccc3)c3ccccc32)c(OC)c1,,COc1ccc(-c2cc(=O)c3c(O)c4c(cc3o2)OC(N)=C(C#N)C42C(=O)N(Cc3ccccc3)c3ccccc32)c(OC)c1>>,56452185,1,27,half reaction|has preparation,,"2′-amino-1-benzyl-8′-(2,4-dimethoxyphenyl)-5′-hydroxy-2,6′-dioxo",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-1-benzyl-8′-(2,4-dimethoxyphenyl)-5′-hydroxy-2,6′-dioxo",73 percent,73,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
Cc1ccc2c(c1)C1(C(=O)N2Cc2ccccc2)C(C#N)=C(N)Oc2cc3oc(-c4ccccc4F)cc(=O)c3c(O)c21,,Cc1ccc2c(c1)C1(C(=O)N2Cc2ccccc2)C(C#N)=C(N)Oc2cc3oc(-c4ccccc4F)cc(=O)c3c(O)c21>>,56452191,1,27,half reaction|has preparation,,"2′-amino-1-benzyl-8′-(2-fluorophenyl)-5′-hydroxy-5-methyl-2,6′-dio",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0040; 0044-0045,,,"2′-amino-1-benzyl-8′-(2-fluorophenyl)-5′-hydroxy-5-methyl-2,6′-dio",71 percent,71,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
Cc1ccc2c(c1)C1(C(=O)N2C)C(C#N)=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c21,,Cc1ccc2c(c1)C1(C(=O)N2C)C(C#N)=C(N)Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c21>>,56452198,1,27,half reaction|has preparation,,"2′-amino-5′-hydroxy-1,5-dimethyl-2,6′-dioxo-8′-phenyl-6′H-",,Preparation,1,,Michael Addition,,,83037462; Patent; GUIZHOU UNIVERSITY; CN112430240; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,Reflux,,Paragraph 0039-0042; 0045,,,"2′-amino-5′-hydroxy-1,5-dimethyl-2,6′-dioxo-8′-phenyl-6′H-",71 percent,71,,,,,,,,"General procedure: Add isatin 1 (0.8 mmol) to the reaction tube in sequence,Malononitrile (1.0mmol), Ca(OH)2 (0.8mmol, 59.2mg) and 5.0mL methanol,After stirring the reaction at room temperature for 10",
CC1(C)CC(=O)C2=C(C1)OS(=O)(=O)CC2C=Cc1ccc(Cl)cc1,,CC1(C)CC(=O)C2=C(C1)OS(=O)(=O)CC2C=Cc1ccc(Cl)cc1>>,46311901,1,26,half reaction|has preparation,,C18H19ClO4S,,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene",C18H19ClO4S,58percent,58,,,,,,,,,
CCC(=O)C[C@@H](C[N+](=O)[O-])C(=O)OCc1ccccc1,,CCC(=O)C[C@@H](C[N+](=O)[O-])C(=O)OCc1ccccc1>>,47773850,1,26,half reaction|has preparation,,benzyl 2-(nitromethyl)-4-oxohexanoate,,Preparation,1,24,Michael Addition,,dichloromethane,73440178; Patent; OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY; WO2018/25295; A1; (2018);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,48,,,Paragraph 0079; 0081; 0086; 0090,,"1-((1R,2R)-2-aminocyclohexyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea|acetic acid",benzyl 2-(nitromethyl)-4-oxohexanoate,60 percent,60,,,95percent ee,,,4,,,
CCN(CC)C(=O)CCNCc1ccccc1,,CCN(CC)C(=O)CCNCc1ccccc1>>,7719828,2,25,half reaction|has preparation,,"3-benzylamino-N,N-diethyl-propionamide",,"['Preparation', 'Preparation (half reaction)']","['1', '1']",120,Michael Addition,,,"['77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);', '249872; Article; Larizza,A.; Brancaccio,G.; Gazzetta Chimica Italiana; vol. 90; (1960); p. 848 - 862;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,5,,,Paragraph 0039-0043,,Imidazole hydrochloride,"3-benzylamino-N,N-diethyl-propionamide",84 percent,84,,,,,,1,,,
CCOC(=O)CCNc1ccc(C)cc1,,CCOC(=O)CCNc1ccc(C)cc1>>,24827507,2,25,half reaction|has preparation,,3-p-tolylaminopropionic acid ethyl ester,,"['Preparation', 'Preparation (half reaction)']","['1', '1']",120,Michael Addition,,,"['77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);', '7135033; Patent; SLOAN KETTERING INSTITUTE; US4925939; A; (1990);']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,8,,,Paragraph 0039-0043,,Imidazole hydrochloride,3-p-tolylaminopropionic acid ethyl ester,82 percent,82,,,,,,1,,"By following the same procedure but using the corresponding amines instead of p-anisidine, the following ethyl N-substituted b-aminopropionates are obtained: ... ethyl N-(3,5-dimethoxyphenyl)-b-aminop",
O=C1CCC2=C1C(c1ccc([N+](=O)[O-])cc1)CS(=O)(=O)O2,,O=C1CCC2=C1C(c1ccc([N+](=O)[O-])cc1)CS(=O)(=O)O2>>,46311898,1,25,half reaction|has preparation,,"4-(4-nitrophenyl)-3,4,6,7-tetrahydro-5H-cyclopenta[e][1,2]oxathiin-5-one 2,2-dioxide",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","4-(4-nitrophenyl)-3,4,6,7-tetrahydro-5H-cyclopenta[e][1,2]oxathiin-5-one 2,2-dioxide",45percent,45,,,,,,,,,
CC1(C)CC(=O)C2=C(C1)OS(=O)(=O)CC2C=Cc1ccccc1,,CC1(C)CC(=O)C2=C(C1)OS(=O)(=O)CC2C=Cc1ccccc1>>,46311902,1,25,half reaction|has preparation,,C18H20O4S,,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene",C18H20O4S,50percent,50,,,,,,,,,
CC(C)C(=O)C1=C(C(C)C)OS(=O)(=O)CC1c1ccc([N+](=O)[O-])cc1,,CC(C)C(=O)C1=C(C(C)C)OS(=O)(=O)CC1c1ccc([N+](=O)[O-])cc1>>,46311900,1,24,half reaction|has preparation,,"1-(6-isopropyl-4-(4-nitrophenyl)-2,2-dioxido-3,4-dihydro-1,2-oxathiin-5-yl)-2-methylpropan-1-one",,Preparation,1,20,Michael Addition,,dichloromethane,72288816; Patent; WUHAN UNIVERSITY OF TECHNOLOGY; CN107163062; A; (2017);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0050,,"sodium hydrogencarbonate|1,8-diazabicyclo[5.4.0]undec-7-ene","1-(6-isopropyl-4-(4-nitrophenyl)-2,2-dioxido-3,4-dihydro-1,2-oxathiin-5-yl)-2-methylpropan-1-one",44percent,44,,,,,,,,,
CCCCCCCCCOC(=O)CCN(CCCN1CCCCC1C)CCC(=O)OCCCCCCCCC,,CCCCCCCCCOC(=O)CCN(CCCN1CCCCC1C)CCC(=O)OCCCCCCCCC>>,65669366,1,24,half reaction|has preparation,,C33H64N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCCCCCCCOC(=O)CCN(CCCN1CCCCC1C)CCC(=O)OCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCOC(=O)CCN(CCCN1CCCCC1C)CCC(=O)OCCCCCCCCCCCCCC>>,65669367,1,24,half reaction|has preparation,,C43H84N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCCCN1CCCC1)CCC(=O)OCCCCCCCCC=CCCCCCCCC,,CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCCCN1CCCC1)CCC(=O)OCCCCCCCCC=CCCCCCCCC>>,65669368,1,24,half reaction|has preparation,,C50H94N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCCCCCCCC)CCC1CCCN1C,,CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCCCCCCCC)CCC1CCCN1C>>,65669369,1,24,half reaction|has preparation,,C49H92N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCCCCCCCC)CCN1CCCC1,,CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCCCCCCCC)CCN1CCCC1>>,65669370,1,24,half reaction|has preparation,,C48H90N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCCN1CCCC1)CCC(=O)OCCCCCCCCC=CCCCCCCCC,,CCCCCCCCC=CCCCCCCCCOC(=O)CCN(CCCN1CCCC1)CCC(=O)OCCCCCCCCC=CCCCCCCCC>>,65669371,1,24,half reaction|has preparation,,C49H92N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCC=CCC=CCCCCCCCCOC(=O)CCN(CCCN(C)C)CCC(=O)OCCCCCCCCC=CCC=CCCCCC,,CCCCCC=CCC=CCCCCCCCCOC(=O)CCN(CCCN(C)C)CCC(=O)OCCCCCCCCC=CCC=CCCCCC>>,65669372,1,24,half reaction|has preparation,,C47H86N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCC=CCC=CCCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCC=CCCCCC)CCC1CCCN1C,,CCCCC=CCC=CCCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCC=CCCCCC)CCC1CCCN1C>>,65669373,1,24,half reaction|has preparation,,C49H88N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCC=CCC=CCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCC=CCCCCC)CCN1CCCC1,,CCCCCC=CCC=CCCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCCC=CCC=CCCCCC)CCN1CCCC1>>,65669374,1,24,half reaction|has preparation,,C48H86N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCC=CCC=CCCCCCCCCOC(=O)CCN(CCCN1CCCC1)CCC(=O)OCCCCCCCCC=CCC=CCCCCC,,CCCCCC=CCC=CCCCCCCCCOC(=O)CCN(CCCN1CCCC1)CCC(=O)OCCCCCCCCC=CCC=CCCCCC>>,65669375,1,24,half reaction|has preparation,,C49H88N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCC)CCN(CCCC)CCCC,,CCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCC)CCN(CCCC)CCCC>>,65669376,1,24,half reaction|has preparation,,C32H64N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCOC(=O)CCN(CCCN(CCCC)CCCC)CCC(=O)OCCCCCCCC,,CCCCCCCCOC(=O)CCN(CCCN(CCCC)CCCC)CCC(=O)OCCCCCCCC>>,65669377,1,24,half reaction|has preparation,,C33H66N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCCCCCCCCOC(=O)CCN(CCCCN1CCCC1)CCC(=O)OCCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCCOC(=O)CCN(CCCCN1CCCC1)CCC(=O)OCCCCCCCCCCCCCCC>>,65669378,1,24,half reaction|has preparation,,C44H86N2O4,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
CCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCC)CCN1CCN(CCC(=O)OCCCCCCCC)CC1,,CCCCCCCCOC(=O)CCN(CCC(=O)OCCCCCCCC)CCN1CCN(CCC(=O)OCCCCCCCC)CC1>>,65669379,1,24,half reaction|has preparation,,C39H75N3O6,,Preparation,1,90,Michael Addition,,,126793375; Patent; SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY; WO2023/125184; A1; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 26; 29-30,,,,,,,,,,,1,,"General procedure: 100mg (0.20mmol-0.60mmol) acrylates (C8, C10i, C10, C12, C14, C16, C18, C181, C182, Cp2, Cp4) were placed in the reaction vessel, and A1, A2, A3, A4, A5, A6, A7, A8, A9, A1, A2, A3,",
C#CCNCCC(=O)Nc1sc2c(c1C#N)CCCC2,,C#CCNCCC(=O)Nc1sc2c(c1C#N)CCCC2>>,68473357,1,24,half reaction|has preparation,,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(prop-2-yn-1-ylamino)propanamide",,Preparation,1,0 - 20|0 - 20,Michael Addition,,,136097516; Patent; SCANDIEDGE THERAPEUTICS; EP4417601; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0175-0179; 0180-0182,,,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(prop-2-yn-1-ylamino)propanamide",82 percent,,,,,2,,,"Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29)","General procedure: Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29) Following general procedure for the Synthesis of Michael adducts, N-(3-cyano-4,",
N#Cc1c(NC(=O)CCNCCc2cccnc2)sc2c1CCCC2,,N#Cc1c(NC(=O)CCNCCc2cccnc2)sc2c1CCCC2>>,68473358,1,24,half reaction|has preparation,,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-((2-(pyridin-3-yl)ethyl)amino)propanamide",,Preparation,1,0 - 20|0 - 20,Michael Addition,,,136097516; Patent; SCANDIEDGE THERAPEUTICS; EP4417601; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0175-0179; 0183-0185,,,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-((2-(pyridin-3-yl)ethyl)amino)propanamide",72 percent,,,,,2,,,"Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29)","General procedure: Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29) Following general procedure for the Synthesis of Michael adducts, N-(3-cyano-4,",
COC(=O)CNCCC(=O)Nc1sc2c(c1C#N)CCCC2,,COC(=O)CNCCC(=O)Nc1sc2c(c1C#N)CCCC2>>,68473359,1,24,half reaction|has preparation,,"methyl (3-((3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-3-oxopropyl)glycinate",,Preparation,1,0 - 20|0 - 20,Michael Addition,,,136097516; Patent; SCANDIEDGE THERAPEUTICS; EP4417601; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0175-0179; 0186-0188,,,"methyl (3-((3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-3-oxopropyl)glycinate",75 percent,,,,,2,,,"Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29)","General procedure: Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29) Following general procedure for the Synthesis of Michael adducts, N-(3-cyano-4,",
N#Cc1c(NC(=O)CCNCCOc2ccccc2)sc2c1CCCC2,,N#Cc1c(NC(=O)CCNCCOc2ccccc2)sc2c1CCCC2>>,68473360,1,24,half reaction|has preparation,,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-((2-phenoxyethyl)amino)propanamide",,Preparation,1,0 - 20|0 - 20,Michael Addition,,,136097516; Patent; SCANDIEDGE THERAPEUTICS; EP4417601; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0175-0179; 0189-0191,,,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-((2-phenoxyethyl)amino)propanamide",74 percent,,,,,2,,,"Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29)","General procedure: Synthesis of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-(phenylamino)propanamide (PKL-A29) Following general procedure for the Synthesis of Michael adducts, N-(3-cyano-4,",
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521427,1,24,half reaction|has preparation,,C89H175N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521428,1,24,half reaction|has preparation,,C69H135N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521429,1,24,half reaction|has preparation,,C77H151N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521430,1,24,half reaction|has preparation,,C85H167N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521431,1,24,half reaction|has preparation,,C73H143N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521432,1,24,half reaction|has preparation,,C81H159N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521433,1,24,half reaction|has preparation,,C89H175N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(CCO)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(CCO)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521457,1,24,half reaction|has preparation,,C56H110N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCO)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCO)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521458,1,24,half reaction|has preparation,,C62H122N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCO)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCO)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521459,1,24,half reaction|has preparation,,C68H134N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521460,1,24,half reaction|has preparation,,C53H104N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521461,1,24,half reaction|has preparation,,C59H116N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521462,1,24,half reaction|has preparation,,C65H128N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521463,1,24,half reaction|has preparation,,C56H110N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521464,1,24,half reaction|has preparation,,C62H122N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCO)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521465,1,24,half reaction|has preparation,,C68H134N2O7S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCC,,CCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCC>>,68521466,1,24,half reaction|has preparation,,C49H96N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521467,1,24,half reaction|has preparation,,C55H108N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521468,1,24,half reaction|has preparation,,C61H120N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(C)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521470,1,24,half reaction|has preparation,,C67H132N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521471,1,24,half reaction|has preparation,,C52H102N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521472,1,24,half reaction|has preparation,,C58H114N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521473,1,24,half reaction|has preparation,,C64H126N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521474,1,24,half reaction|has preparation,,C55H108N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521475,1,24,half reaction|has preparation,,C61H120N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521476,1,24,half reaction|has preparation,,C67H132N2O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521477,1,24,half reaction|has preparation,,C59H117N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521478,1,24,half reaction|has preparation,,C65H129N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521479,1,24,half reaction|has preparation,,C71H141N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521480,1,24,half reaction|has preparation,,C56H111N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521481,1,24,half reaction|has preparation,,C62H123N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521482,1,24,half reaction|has preparation,,C68H135N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521483,1,24,half reaction|has preparation,,C59H117N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521484,1,24,half reaction|has preparation,,C65H129N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521485,1,24,half reaction|has preparation,,C71H141N3O6S9,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCCCCCCCCCC,,CCCCCCCCCCSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCCCCCCCCCC>>,68521486,1,24,half reaction|has preparation,,C37H74N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521487,1,24,half reaction|has preparation,,C41H82N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521488,1,24,half reaction|has preparation,,C45H90N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521490,1,24,half reaction|has preparation,,C49H98N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521491,1,24,half reaction|has preparation,,C39H78N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521492,1,24,half reaction|has preparation,,C43H86N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521493,1,24,half reaction|has preparation,,C47H94N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521494,1,24,half reaction|has preparation,,C41H82N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521495,1,24,half reaction|has preparation,,C45H90N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(CCO)CCO)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521496,1,24,half reaction|has preparation,,C49H98N2O6S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521497,1,24,half reaction|has preparation,,C75H147N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521498,1,24,half reaction|has preparation,,C83H163N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521500,1,24,half reaction|has preparation,,C91H179N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521501,1,24,half reaction|has preparation,,C71H139N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521502,1,24,half reaction|has preparation,,C79H155N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521503,1,24,half reaction|has preparation,,C87H171N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521504,1,24,half reaction|has preparation,,C75H147N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521505,1,24,half reaction|has preparation,,C83H163N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(CCCN(C)CCCN(CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521506,1,24,half reaction|has preparation,,C91H179N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(C)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(C)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521507,1,24,half reaction|has preparation,,C39H78N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(C)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(C)CCCN(C)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521508,1,24,half reaction|has preparation,,C43H86N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(C)CCCN(C)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC,,CCCCCCCCC(CCCCCC)CSSSCCOC(=O)CCN(C)CCCN(C)CCC(=O)OCCSSSCC(CCCCCC)CCCCCCCC>>,68521509,1,24,half reaction|has preparation,,C47H94N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(C)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(C)CSSSCCCCCCCCCC>>,68521510,1,24,half reaction|has preparation,,C37H74N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(C)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(C)CSSSCCCCCCCCCCCC>>,68521511,1,24,half reaction|has preparation,,C41H82N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(C)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(C)CSSSCCCCCCCCCCCCCC>>,68521512,1,24,half reaction|has preparation,,C45H90N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(CC)CSSSCCCCCCCCCC,,CCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(CC)CSSSCCCCCCCCCC>>,68521513,1,24,half reaction|has preparation,,C39H78N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(CC)CSSSCCCCCCCCCCCC>>,68521514,1,24,half reaction|has preparation,,C43H86N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCC(CC)OC(=O)CCN(C)CCCN(C)CCC(=O)OC(CC)CSSSCCCCCCCCCCCCCC>>,68521515,1,24,half reaction|has preparation,,C47H94N2O4S6,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCSSSCCOC(=O)CCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC,,CCCCCCCCCCCCSSSCCOC(=O)CCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSSCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCC>>,68521516,1,24,half reaction|has preparation,,C73H143N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCSSSCCOC(=O)CCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCN(C)CCN(CCC(=O)OCCSSSCCCCCCCCCCCCCC)CCC(=O)OCCSSSCCCCCCCCCCCCCC>>,68521517,1,24,half reaction|has preparation,,C81H159N3O8S12,,Preparation,1,90,Michael Addition,,,134790331; Patent; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; WO2024/130086; A1; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Page/Page column 81-82; 98,,,,,,,,,,,1,General Procedure for Michael addition of core amines to acrylates containing Trisulfide linker.,General procedure: A mixture of core amine and acylate (1.2 eq.) was warmed to 90 C and kept stirring for 12 h. The reaction mixture was purified via CombiFlash system eluted with dichloromethane and,
CCOCCSC(C)(C)SCCOC(=O)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCN(C)CCCN(C)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCC(=O)OCCSC(C)(C)SCCOCC,,CCOCCSC(C)(C)SCCOC(=O)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCN(C)CCCN(C)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCC(=O)OCCSC(C)(C)SCCOCC>>,69442612,1,24,half reaction|has preparation,,C57H112N4O12S8,,Preparation,1,70,Michael Addition,,,134076160; Patent; BEIJING YUNXI ZHIXIANG BIOLOGICAL TECH; CN118026900; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,Paragraph 0105-0106; 0110-0112; 0114,,,,,,,,,,,1,,"General procedure: YX-30 was synthesized from hydrophilic amine compounds N,N-bis(3-aminopropyl)methylamine and TK2, in which the hydrophilic amine compounds N,N-bis(3-aminopropyl)methylamine were mix",
CCOCCSC(C)(C)SCCOC(=O)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCN(C)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCC(=O)OCCSC(C)(C)SCCOCC,,CCOCCSC(C)(C)SCCOC(=O)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCN(C)CCN(CCC(=O)OCCSC(C)(C)SCCOCC)CCC(=O)OCCSC(C)(C)SCCOCC>>,69442613,1,24,half reaction|has preparation,,C53H103N3O12S8,,Preparation,1,70,Michael Addition,,,134076160; Patent; BEIJING YUNXI ZHIXIANG BIOLOGICAL TECH; CN118026900; A; (2024);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,72,,,Paragraph 0105-0106; 0110-0111; 0113-0114,,,,,,,,,,,1,,"General procedure: YX-30 was synthesized from hydrophilic amine compounds N,N-bis(3-aminopropyl)methylamine and TK2, in which the hydrophilic amine compounds N,N-bis(3-aminopropyl)methylamine were mix",
O=[N+]([O-])/C=C/c1ccccc1,CCOC(=O)CC(C)=O,O=[N+]([O-])/C=C/c1ccccc1>>CCOC(=O)CC(C)=O,10303140,1,23,half reaction,nitrostyrene|ethyl acetoacetate,,,Chemical behaviour,1,20,Michael addition,Kinetics,chloroform,"6373922; Article; Barnes, David M.; Wittenberger, Steven J.; Zhang, Ji; Ji, Jianguo; Fickes, Michael G.; Fitzgerald, Michael A.; King, Steven A.; Morton, Howard E.; Plagge, Frederick A.; Preskill, Mar",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,,,4-methyl-morpholine|4 A molecular sieve|magnesium triflate,,,,"Further Variations:|Reagents|reaction partners and catalyst quantities, time",,,,,,,,"(3aS,3'aS,8aR,8'aR)-2,2'-cyclopropylidenebis-[3a,8a]-dihydro-8H-indeno-[1,2-d]oxazole"
CCN(CC)C(=O)CCNc1ccccc1,,CCN(CC)C(=O)CCNc1ccccc1>>,52202567,1,23,half reaction|has preparation,,"N,N-diethyl-3-phenylaminopropionamide",,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,5,,,Paragraph 0039-0043,,Imidazole hydrochloride,"N,N-diethyl-3-phenylaminopropionamide",83 percent,83,,,,,,1,,,
CCN(CC)C(=O)CCNc1cccc(Cl)c1,,CCN(CC)C(=O)CCNc1cccc(Cl)c1>>,52202568,1,23,half reaction|has preparation,,"3-(3-chlorophenylamino)-N,N-diethylpropionamide",,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,Paragraph 0039-0043,,Imidazole hydrochloride,"3-(3-chlorophenylamino)-N,N-diethylpropionamide",76 percent,76,,,,,,1,,,
CC(C)(C)OC(=O)CCNc1ccc(Cl)cc1,,CC(C)(C)OC(=O)CCNc1ccc(Cl)cc1>>,52202571,1,23,half reaction|has preparation,,3-(4-chlorophenylamino)propionic acid tert-butyl ester,,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,,,Paragraph 0039-0043,,Imidazole hydrochloride,3-(4-chlorophenylamino)propionic acid tert-butyl ester,83 percent,83,,,,,,1,,,
Cc1ccc(NCCC(=O)OC(C)(C)C)cc1,,Cc1ccc(NCCC(=O)OC(C)(C)C)cc1>>,52202572,1,23,half reaction|has preparation,,3-p-tolylaminopropionic acid tert-butyl ester,,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,,,Paragraph 0039-0043,,Imidazole hydrochloride,3-p-tolylaminopropionic acid tert-butyl ester,81 percent,81,,,,,,1,,,
CC(C)(C)OC(=O)CCNc1ccccc1,,CC(C)(C)OC(=O)CCNc1ccccc1>>,52202573,1,23,half reaction|has preparation,,3-phenylaminopropionic acid tert-butyl ester,,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,7,,,Paragraph 0039-0043,,Imidazole hydrochloride,3-phenylaminopropionic acid tert-butyl ester,80 percent,80,,,,,,1,,,
CN(C)C(=O)CCNc1cccc2ccccc12,,CN(C)C(=O)CCNc1cccc2ccccc12>>,52202566,1,22,half reaction|has preparation,,"N,N-dimethyl-3-(naphthalen-1-ylamino)propionamide",,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,Paragraph 0039-0043,,Imidazole hydrochloride,"N,N-dimethyl-3-(naphthalen-1-ylamino)propionamide",73 percent,73,,,,,,1,,,
CCN(CC)C(=O)CCNc1ccccc1N,,CCN(CC)C(=O)CCNc1ccccc1N>>,52202569,1,21,half reaction|has preparation,,"3-(2-aminophenylamino)-N,N-diethylpropionamide",,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,,,Paragraph 0039-0043,,Imidazole hydrochloride,"3-(2-aminophenylamino)-N,N-diethylpropionamide",63 percent,63,,,,,,1,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(=O)OC)[C@@H]1N(C)c1ccccc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(=O)OC)[C@@H]1N(C)c1ccccc1>>,57753292,1,19,half reaction|has preparation,,"dimethyl (2R,3S)-2-(1,3-diethoxy-1,3-dioxopropan-2-yl)-5-methyl-3-(methyl (phenyl)amino)-2,3-dihydrofuran-2,4-dicarboxylate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"dimethyl (2R,3S)-2-(1,3-diethoxy-1,3-dioxopropan-2-yl)-5-methyl-3-(methyl (phenyl)amino)-2,3-dihydrofuran-2,4-dicarboxylate",82 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(S(=O)(=O)c2ccccc2)[C@@H]1N(C)c1ccccc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(S(=O)(=O)c2ccccc2)[C@@H]1N(C)c1ccccc1>>,57753293,1,19,half reaction|has preparation,,"diethyl 2-((2R,3R)-2-(methoxycarbonyl)-5-methyl-3-(methyl(phenyl)amino)-4-(phenylsulfonyl)-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3R)-2-(methoxycarbonyl)-5-methyl-3-(methyl(phenyl)amino)-4-(phenylsulfonyl)-2,3-dihydrofuran-2-yl)malonate",55 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(P(=O)(OC)OC)[C@@H]1N(C)c1ccccc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(P(=O)(OC)OC)[C@@H]1N(C)c1ccccc1>>,57753294,1,19,half reaction|has preparation,,"diethyl 2-((2R,3R)-4-(dimethoxyphosphoryl)-2-(methoxycarbonyl)-5-methyl-3-(methyl (phenyl)amino)-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3R)-4-(dimethoxyphosphoryl)-2-(methoxycarbonyl)-5-methyl-3-(methyl (phenyl)amino)-2,3-dihydrofuran-2-yl)malonate",53 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(C)cc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(C)cc1>>,57753295,1,19,half reaction|has preparation,,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-5-methyl-3-(methyl (p-tolyl)amino)-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-5-methyl-3-(methyl (p-tolyl)amino)-2,3-dihydrofuran-2-yl)malonate",53 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(OC)cc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(OC)cc1>>,57753296,1,19,half reaction|has preparation,,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-3-((4-methoxyphenyl)(methyl)amino)-5-methyl-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.666667,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-3-((4-methoxyphenyl)(methyl)amino)-5-methyl-2,3-dihydrofuran-2-yl)malonate",63 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(Br)cc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(Br)cc1>>,57753297,1,19,half reaction|has preparation,,"diethyl 2-((2R,3S)-4-acetyl-3-((4-bromophenyl)(methyl)amino)-2-(methoxycarbonyl)-5-methyl-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3S)-4-acetyl-3-((4-bromophenyl)(methyl)amino)-2-(methoxycarbonyl)-5-methyl-2,3-dihydrofuran-2-yl)malonate",76 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(C(=O)OC)cc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(C(=O)OC)cc1>>,57753298,1,19,half reaction|has preparation,,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-3-((4-(methoxycarbonyl)phenyl)(methyl)amino)-5-methyl-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-3-((4-(methoxycarbonyl)phenyl)(methyl)amino)-5-methyl-2,3-dihydrofuran-2-yl)malonate",77 percentSpectr.,,,,,,,,,,
CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(C(F)(F)F)cc1,,CCOC(=O)C(C(=O)OCC)[C@@]1(C(=O)OC)OC(C)=C(C(C)=O)[C@@H]1N(C)c1ccc(C(F)(F)F)cc1>>,57753299,1,19,half reaction|has preparation,,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-5-methyl-3-(methyl (4-(trifluoromethyl)phenyl)amino)-2,3-dihydrofuran-2-yl)malonate",,Preparation,1,20,Michael Addition,,acetonitrile,94177950; Patent; ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY; KR2021/82975; A; (2021);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,0.333333,Inert atmosphere,,Paragraph 0050; 0132-0145,,potassium phosphate|iodine,"diethyl 2-((2R,3S)-4-acetyl-2-(methoxycarbonyl)-5-methyl-3-(methyl (4-(trifluoromethyl)phenyl)amino)-2,3-dihydrofuran-2-yl)malonate",79 percentSpectr.,,,,,,,,,,
CCCCCCCCCCCCCCCCOCC(COCCC(=O)OC(C)(C)C)OCCCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCCCOCC(COCCC(=O)OC(C)(C)C)OCCCCCCCCCCCCCCCC>>,59714766,1,19,half reaction|has preparation,,C42H84O5,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0335-0336,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 110 to tert-butyl acrylate affords the ester 119. Treatment of the ester 119 with acid affords 123. Activation of the carboxylic acid 123 with peptid,
CCCCCCCCCCCCCCOCC(COCCC(=O)OC(C)(C)C)OCCCCCCCCCCCCCC,,CCCCCCCCCCCCCCOCC(COCCC(=O)OC(C)(C)C)OCCCCCCCCCCCCCC>>,59714767,1,19,half reaction|has preparation,,C38H76O5,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0335-0336,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 110 to tert-butyl acrylate affords the ester 119. Treatment of the ester 119 with acid affords 123. Activation of the carboxylic acid 123 with peptid,
CCCCCCCCCCCCOCC(COCCC(=O)OC(C)(C)C)OCCCCCCCCCCCC,,CCCCCCCCCCCCOCC(COCCC(=O)OC(C)(C)C)OCCCCCCCCCCCC>>,59714768,1,19,half reaction|has preparation,,C34H68O5,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0335-0336,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 110 to tert-butyl acrylate affords the ester 119. Treatment of the ester 119 with acid affords 123. Activation of the carboxylic acid 123 with peptid,
CCCCCCCCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C,,CCCCCCCCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C>>,59714769,1,19,half reaction|has preparation,,C27H54O3,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0337-0338,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 114 to tert-butyl acrylate affords the ester 127. Treatment of the ester 127 with acid affords the carboxylic acid 132. Activation of the carboxylic,
CCCCCCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C,,CCCCCCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C>>,59714770,1,19,half reaction|has preparation,,C25H50O3,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0337-0338,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 114 to tert-butyl acrylate affords the ester 127. Treatment of the ester 127 with acid affords the carboxylic acid 132. Activation of the carboxylic,
CCCCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C,,CCCCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C>>,59714771,1,19,half reaction|has preparation,,C23H46O3,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0337-0338,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 114 to tert-butyl acrylate affords the ester 127. Treatment of the ester 127 with acid affords the carboxylic acid 132. Activation of the carboxylic,
CCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C,,CCCCCCCCCCCCCCOCCC(=O)OC(C)(C)C>>,59714772,1,19,half reaction|has preparation,,C21H42O3,,Preparation,1,,Michael Addition,,,116211770; Patent; VERVE THERAPEUTICS; WO2022/60871; A1; (2022);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0326; 0337-0338,,,,,,,,,,,7,,General procedure: Michael addition of the alcohol 114 to tert-butyl acrylate affords the ester 127. Treatment of the ester 127 with acid affords the carboxylic acid 132. Activation of the carboxylic,
Cc1ccc(C(C[N+](=O)[O-])c2c[nH]c3ccccc23)cc1,,Cc1ccc(C(C[N+](=O)[O-])c2c[nH]c3ccccc23)cc1>>,62792149,1,19,half reaction|has preparation,,3-(2-nitro-1-(p-tolyl)ethyl)-1H-indole,,Preparation,1,40,Michael Addition,,chloroform,123628893; Patent; INDUSTRY UNIVERSITY COOPERATION FOUNDATION IUCF; KR2023/12723; A; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0164-0166,,salicylic acid,3-(2-nitro-1-(p-tolyl)ethyl)-1H-indole,96 percent,,,,,,,18,,,
O=[N+]([O-])CC(c1ccc(F)cc1)c1c[nH]c2ccccc12,,O=[N+]([O-])CC(c1ccc(F)cc1)c1c[nH]c2ccccc12>>,62792150,1,19,half reaction|has preparation,,3-(1-(4-fluorophenyl)-2-nitroethyl)-1H-indole,,Preparation,1,40,Michael Addition,,chloroform,123628893; Patent; INDUSTRY UNIVERSITY COOPERATION FOUNDATION IUCF; KR2023/12723; A; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0164-0166,,salicylic acid,3-(1-(4-fluorophenyl)-2-nitroethyl)-1H-indole,91 percent,,,,,,,18,,,
O=[N+]([O-])CC(c1ccc(Cl)cc1)c1c[nH]c2ccccc12,,O=[N+]([O-])CC(c1ccc(Cl)cc1)c1c[nH]c2ccccc12>>,62792151,1,19,half reaction|has preparation,,2-(4-chlorophenyl)-2-(indol-3-yl)-1-nitroethane,,Preparation,1,40,Michael Addition,,chloroform,123628893; Patent; INDUSTRY UNIVERSITY COOPERATION FOUNDATION IUCF; KR2023/12723; A; (2023);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,Paragraph 0164-0166,,salicylic acid,2-(4-chlorophenyl)-2-(indol-3-yl)-1-nitroethane,89 percent,,,,,,,18,,,
CCOC(=O)CCNc1ccccn1,,CCOC(=O)CCNc1ccccn1>>,52202570,1,18,half reaction|has preparation,,2-chloromethyl-1-methyl-1H-benzimidazole-5 ethyl acetate,,Preparation,1,120,Michael Addition,,,77357222; Patent; CHONGQING MEDICAL UNIVERSITY; CN110028422; A; (2019);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,4,,,Paragraph 0039-0043,,Imidazole hydrochloride,2-chloromethyl-1-methyl-1H-benzimidazole-5 ethyl acetate,33 percent,33,,,,,,1,,,
CCCSC(=O)C(C(=O)SCCC)[C@@H](CC(=O)C(=O)OC)c1ccccc1,CCCSC(=O)C(C(=O)SCCC)[C@H](CC(=O)C(=O)OC)c1ccccc1,CCCSC(=O)C(C(=O)SCCC)[C@@H](CC(=O)C(=O)OC)c1ccccc1>>CCCSC(=O)C(C(=O)SCCC)[C@H](CC(=O)C(=O)OC)c1ccccc1,55317664,1,18,half reaction|has preparation,,C20H26O5S2|C20H26O5S2,,Preparation,1,20,Michael Addition,,tert-butyl methyl ether,81374848; Patent; RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY; KR2020/88080; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,3,,,Sheet 0101-0103,Overall yield = 43 percent,"1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-((S)-1-methylpyrrolidin-2-yl) (phenyl)methyl)urea",,,,,,82 percent ee,,,,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1,[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc(F)cc1,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(F)cc1>>[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc(F)cc1,56087707,1,18,half reaction|has preparation,,C21H21BFOP|C21H21BFOP,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0151,Overall yield = 87 percent; stereoselective reaction,potassium acetate|C39H47ClNiO2P2,,,,,,94 percent ee,2,,27,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1,[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc(Cl)cc1,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(Cl)cc1>>[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc(Cl)cc1,56087708,1,18,half reaction|has preparation,,C21H21BClOP|C21H21BClOP,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0151,Overall yield = 81 percent; stereoselective reaction,potassium acetate|C39H47ClNiO2P2,,,,,,95 percent ee,2,,27,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(OC)cc1,[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc(OC)cc1,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc(OC)cc1>>[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc(OC)cc1,56087710,1,18,half reaction|has preparation,,C22H24BO2P|C22H24BO2P,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0151,Overall yield = 83 percent; stereoselective reaction,potassium acetate|C39H47ClNiO2P2,,,,,,95 percent ee,2,,27,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccccc1OC,[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccccc1OC,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccccc1OC>>[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccccc1OC,56087711,1,18,half reaction|has preparation,,C22H24BO2P|C22H24BO2P,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0152,Overall yield = 76 percent; stereoselective reaction,potassium acetate|C39H47ClNiO2P2,,,,,,97 percent ee,2,,27,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc2ccccc2c1,[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc2ccccc2c1,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)c1ccc2ccccc2c1>>[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)c1ccc2ccccc2c1,56087713,1,18,half reaction|has preparation,,C25H24BOP|C25H24BOP,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0152,Overall yield = 80 percent; stereoselective reaction,potassium acetate|C39H47ClNiO2P2,,,,,,92 percent ee,2,,27,,,
[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)C(C)C,[H][P@]([BH3])(c1ccccc1)[C@@H](CC(=O)c1ccccc1)C(C)C.[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)C(C)C,[H][P@@]([BH3])(c1ccccc1)[C@H](CC(=O)c1ccccc1)C(C)C>>[H][P@]([BH3])(c1ccccc1)[C@@H](CC(=O)c1ccccc1)C(C)C.[BH3][PH](c1ccccc1)C(CC(=O)c1ccccc1)C(C)C,56087715,1,17,half reaction|has preparation,,C18H24BOP|C18H24BOP|C18H24BOP,,Preparation,1,-40|-40,Michael Addition,,dichloromethane|dichloromethane,82156951; Patent; YANGZHOU UNIVERSITY; CN112142790; A; (2020);,Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,12|0.5,,,Paragraph 0147-0152,Overall yield = 77 percent; stereoselective reaction,potassium acetate|C39H47ClNiO2P2,,,,,,88 percent ee,2,,27,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=CCOC(=O)C(=C)C,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=CCOC(=O)C(=C)C,8494307,2,10,half reaction,GLUTATHIONE|allyl methacrylate,,,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['20', '20']",Michael addition,"['Kinetics', 'Kinetics']","['water', 'water|acetonitrile']","['6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;', '78321254; Article; Mayer, Robert J.; Ofial, Armin R.; Angewandte Chemie - International Edition; vol. 58; 49; (2019); p. 17704 - 17708; Angew. Chem.; vol. 131; (2019); p. 17868 - 17872,5;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,8.8,supporting information,,potassium hydroxide,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCC(C)C,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCC(C)C,8494308,2,10,half reaction,GLUTATHIONE|Isobutyl methacrylate,,,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['20', '20']",Michael addition,"['Kinetics', 'Kinetics']","['water', 'water|acetonitrile']","['6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;', '78321254; Article; Mayer, Robert J.; Ofial, Armin R.; Angewandte Chemie - International Edition; vol. 58; 49; (2019); p. 17704 - 17708; Angew. Chem.; vol. 131; (2019); p. 17868 - 17872,5;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,8.8,supporting information,,potassium hydroxide,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=CC(=O)OCC(C)C,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=CC(=O)OCC(C)C,8494309,2,10,half reaction,GLUTATHIONE|isobutyl acrylate,,,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['20', '20']",Michael addition,"['Kinetics', 'Kinetics']","['water', 'water|acetonitrile']","['6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;', '78321254; Article; Mayer, Robert J.; Ofial, Armin R.; Angewandte Chemie - International Edition; vol. 58; 49; (2019); p. 17704 - 17708; Angew. Chem.; vol. 131; (2019); p. 17868 - 17872,5;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Inert atmosphere,8.8,supporting information,,potassium hydroxide,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OC,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OC,8494713,2,10,half reaction,GLUTATHIONE|methacrylic acid methyl ester,,,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['20', '20']",Michael addition,"['Kinetics', 'Kinetics']","['water', 'water|acetonitrile']","['6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;', '78321254; Article; Mayer, Robert J.; Ofial, Armin R.; Angewandte Chemie - International Edition; vol. 58; 49; (2019); p. 17704 - 17708; Angew. Chem.; vol. 131; (2019); p. 17868 - 17872,5;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,Inert atmosphere,8.8,supporting information,,potassium hydroxide,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=CC(=O)OCC,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=CC(=O)OCC,8498990,2,10,half reaction,GLUTATHIONE|ethyl acrylate,,,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['20', '20']",Michael addition,"['Kinetics', 'Kinetics']","['water', 'water|acetonitrile']","['6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;', '78321254; Article; Mayer, Robert J.; Ofial, Armin R.; Angewandte Chemie - International Edition; vol. 58; 49; (2019); p. 17704 - 17708; Angew. Chem.; vol. 131; (2019); p. 17868 - 17872,5;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Inert atmosphere,8.8,supporting information,,potassium hydroxide,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=CC(=O)OCCO,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=CC(=O)OCCO,8500870,2,10,half reaction,GLUTATHIONE|2-hydroxyethyl acrylate,,,"['Chemical behaviour', 'Chemical behaviour']","['1', '1']","['20', '20']",Michael addition,"['Kinetics', 'Kinetics']","['water', 'water|acetonitrile']","['6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;', '78321254; Article; Mayer, Robert J.; Ofial, Armin R.; Angewandte Chemie - International Edition; vol. 58; 49; (2019); p. 17704 - 17708; Angew. Chem.; vol. 131; (2019); p. 17868 - 17872,5;']",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,Inert atmosphere,8.8,supporting information,,potassium hydroxide,,,,,Experimental part,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COCC(O)Cn1ccnc1[N+](=O)[O-],[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COCC(O)Cn1ccnc1[N+](=O)[O-],8516352,1,10,half reaction,GLUTATHIONE|2-nitroimidazole-1-(2-methoxymethyl)ethanol,,,Chemical behaviour,1,37,Addition|Michael addition,Kinetics,phosphate buffer,"6207737; Article; Zhou, Ling; Ino, Akira; Dai, Wei-Min; Nishimoto, Sei-Ichi; Bioorganic and Medicinal Chemistry; vol. 7; 11; (1999); p. 2591 - 2598;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.2,,,edetate disodium,,,,Further Variations:|Reaction partners,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COC(=O)C=CCn1cnc([N+](=O)[O-])n1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COC(=O)C=CCn1cnc([N+](=O)[O-])n1,8516609,1,10,half reaction,"GLUTATHIONE|methyl 4-(3'-nitro-1',2',4'-triazol-1'-yl)crotonate",,,Chemical behaviour,1,37,Addition|Michael addition,Kinetics,phosphate buffer,"6207737; Article; Zhou, Ling; Ino, Akira; Dai, Wei-Min; Nishimoto, Sei-Ichi; Bioorganic and Medicinal Chemistry; vol. 7; 11; (1999); p. 2591 - 2598;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.2,,,edetate disodium,,,,Further Variations:|Reaction partners,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,COC(=O)C=CCn1cc([N+](=O)[O-])nc1C,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>COC(=O)C=CCn1cc([N+](=O)[O-])nc1C,8516614,1,10,half reaction,GLUTATHIONE|methyl 4-(2'-methyl-4'-nitroimidazol-1'-yl)crotonate,,,Chemical behaviour,1,37,Addition|Michael addition,Kinetics,phosphate buffer,"6207737; Article; Zhou, Ling; Ino, Akira; Dai, Wei-Min; Nishimoto, Sei-Ichi; Bioorganic and Medicinal Chemistry; vol. 7; 11; (1999); p. 2591 - 2598;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.2,,,edetate disodium,,,,Further Variations:|Reaction partners,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,NC(=O)CCC(=O)C(F)=Cn1ccnc1[N+](=O)[O-],[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>NC(=O)CCC(=O)C(F)=Cn1ccnc1[N+](=O)[O-],8516686,1,10,half reaction,GLUTATHIONE|(Z)-5-Fluoro-6-(2-nitro-imidazol-1-yl)-4-oxo-hex-5-enoic acid amide,,,Chemical behaviour,1,37,Addition|Michael addition,Kinetics,phosphate buffer,"6207737; Article; Zhou, Ling; Ino, Akira; Dai, Wei-Min; Nishimoto, Sei-Ichi; Bioorganic and Medicinal Chemistry; vol. 7; 11; (1999); p. 2591 - 2598;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.2,,,edetate disodium,,,,Further Variations:|Reaction partners,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,O=C(O)C=CC(=O)NCC(O)Cn1ccnc1[N+](=O)[O-],[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>O=C(O)C=CC(=O)NCC(O)Cn1ccnc1[N+](=O)[O-],8516702,1,10,half reaction,GLUTATHIONE|(E)-3-[2-Hydroxy-3-(2-nitro-imidazol-1-yl)-propylcarbamoyl]-acrylic acid,,,Chemical behaviour,1,37,Addition|Michael addition,Kinetics,phosphate buffer,"6207737; Article; Zhou, Ling; Ino, Akira; Dai, Wei-Min; Nishimoto, Sei-Ichi; Bioorganic and Medicinal Chemistry; vol. 7; 11; (1999); p. 2591 - 2598;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.2,,,edetate disodium,,,,Further Variations:|Reaction partners,,,,,,,,
COC(=O)C(C)C(=O)OC,C=C(C#N)c1cccc(C23OCC(C)(C)C2(C(C)(C)C)OO3)c1,COC(=O)C(C)C(=O)OC>>C=C(C#N)c1cccc(C23OCC(C)(C)C2(C(C)(C)C)OO3)c1,9646664,1,10,half reaction,"methyl-malonic acid dimethylester|5-tert-butyl-1-[3-(1-cyanoethenyl)phenyl]-4,4-dimethyl-2,6,7-trioxabicyclo[3.2.0]heptane",,,Chemical behaviour,1,25,Michael addition,Kinetics,benzene,"6451127; Article; Matsumoto, Masakatsu; Mizuno, Toshiyuki; Watanabe, Nobuko; Tetrahedron Letters; vol. 45; 19; (2004); p. 3779 - 3782;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,,,18-crown-6 ether|potassium tert-butylate,,,,,,,,,,,,
COC(=O)C(Cl)C(=O)OC,C=C(C#N)c1cccc(C23OCC(C)(C)C2(C(C)(C)C)OO3)c1,COC(=O)C(Cl)C(=O)OC>>C=C(C#N)c1cccc(C23OCC(C)(C)C2(C(C)(C)C)OO3)c1,9646711,1,10,half reaction,"2-chlorodimethylmalonate|5-tert-butyl-1-[3-(1-cyanoethenyl)phenyl]-4,4-dimethyl-2,6,7-trioxabicyclo[3.2.0]heptane",,,Chemical behaviour,1,25,Michael addition,Kinetics,benzene,"6451127; Article; Matsumoto, Masakatsu; Mizuno, Toshiyuki; Watanabe, Nobuko; Tetrahedron Letters; vol. 45; 19; (2004); p. 3779 - 3782;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Irradiation,,,,18-crown-6 ether|potassium tert-butylate,,,,,,,,,,,,
C=CC(=O)OCCCCOC(=O)C=C,SCCCOc1ccc(C2(c3ccc(OCCCS)cc3)c3ccccc3-c3ccccc32)cc1,C=CC(=O)OCCCCOC(=O)C=C>>SCCCOc1ccc(C2(c3ccc(OCCCS)cc3)c3ccccc3-c3ccccc32)cc1,49388437,1,10,half reaction,"1,4-Butanediol diacrylate|9,9-bis(3-mercaptopropylphenylether)fluorene",,,Chemical behaviour,1,20,Michael Addition,Catalytic behavior,chloroform,"74934606; Article; Nakabayashi, Kazuhiro; Sobu, Shigeki; Kosuge, Yuji; Mori, Hideharu; Journal of Polymer Science, Part A: Polymer Chemistry; vol. 56; 19; (2018); p. 2175 - 2182;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,6,Inert atmosphere,,,,triethylamine,,,,Solvent|Temperature|Time,Experimental part,,,,,,,
O=C1CC(=O)c2ccccc21,CC1=CC=CC(=O)C1=O,O=C1CC(=O)c2ccccc21>>CC1=CC=CC(=O)C1=O,25933340,1,9,half reaction,"1H-indene-1,3(2H)-dione|6-methyl-1,2-benzoquinone",,,Chemical behaviour,1,25,Michael reaction,Kinetics,water|acetonitrile,"7170936; Article; Nematollahi, Davood; Ardakani, Mohammad Mazloum; Shekarlab, Nastaran; International Journal of Chemical Kinetics; vol. 39; 11; (2007); p. 605 - 613;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,4.8,,,acetate buffer,,,,,,,,,,,,
O=C1CC(=O)c2ccccc21,COC1=CC=CC(=O)C1=O,O=C1CC(=O)c2ccccc21>>COC1=CC=CC(=O)C1=O,25933341,1,9,half reaction,"1H-indene-1,3(2H)-dione|3-methoxy-[1,2]benzoquinone",,,Chemical behaviour,1,25,Michael reaction,Kinetics,water|acetonitrile,"7170936; Article; Nematollahi, Davood; Ardakani, Mohammad Mazloum; Shekarlab, Nastaran; International Journal of Chemical Kinetics; vol. 39; 11; (2007); p. 605 - 613;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,4.8,,,acetate buffer,,,,,,,,,,,,
O=C1CC(=O)c2ccccc21,CC1=CC(=O)C(=O)C=C1,O=C1CC(=O)c2ccccc21>>CC1=CC(=O)C(=O)C=C1,25933343,1,9,half reaction,"1H-indene-1,3(2H)-dione|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael reaction,Kinetics,water|acetonitrile,"7170936; Article; Nematollahi, Davood; Ardakani, Mohammad Mazloum; Shekarlab, Nastaran; International Journal of Chemical Kinetics; vol. 39; 11; (2007); p. 605 - 613;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,4.8,,,acetate buffer,,,,,,,,,,,,
O=C1CC(=O)c2ccccc21,CC(C)(C)C1=CC(=O)C(=O)C=C1,O=C1CC(=O)c2ccccc21>>CC(C)(C)C1=CC(=O)C(=O)C=C1,25933344,1,9,half reaction,"1H-indene-1,3(2H)-dione|4-t-butyl-1,2-benzoquinone",,,Chemical behaviour,1,25,Michael reaction,Kinetics,water|acetonitrile,"7170936; Article; Nematollahi, Davood; Ardakani, Mohammad Mazloum; Shekarlab, Nastaran; International Journal of Chemical Kinetics; vol. 39; 11; (2007); p. 605 - 613;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,4.8,,,acetate buffer,,,,,,,,,,,,
O=C1CC(=O)c2ccccc21,O=C(O)C1=CC=CC(=O)C1=O,O=C1CC(=O)c2ccccc21>>O=C(O)C1=CC=CC(=O)C1=O,25933346,1,9,half reaction,"1H-indene-1,3(2H)-dione|o-quinone-3-carboxilic acid",,,Chemical behaviour,1,25,Michael reaction,Kinetics,water|acetonitrile,"7170936; Article; Nematollahi, Davood; Ardakani, Mohammad Mazloum; Shekarlab, Nastaran; International Journal of Chemical Kinetics; vol. 39; 11; (2007); p. 605 - 613;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,4.8,,,acetate buffer,,,,,,,,,,,,
C=CS(=O)(=O)Oc1ccccc1,,C=CS(=O)(=O)Oc1ccccc1>>,28161932,1,9,half reaction,DEP1|phenyl vinylsulfonate,,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8679209; Article; Liu, Sijiu; Zhou, Bo; Yang, Heyi; He, Yantao; Jiang, Zhong-Xing; Kumar, Sanjai; Wu, Li; Zhang, Zhong-Yin; Journal of the American Chemical Society; vol. 130; 26; (2008); p. 8251 - 82",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,sodium succinate buffer,6,supporting information; body text,,,,,,,,,,,,,,
C=CS(=O)(=O)Oc1ccccc1,,C=CS(=O)(=O)Oc1ccccc1>>,28161933,1,9,half reaction,HePTP|phenyl vinylsulfonate,,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8679209; Article; Liu, Sijiu; Zhou, Bo; Yang, Heyi; He, Yantao; Jiang, Zhong-Xing; Kumar, Sanjai; Wu, Li; Zhang, Zhong-Yin; Journal of the American Chemical Society; vol. 130; 26; (2008); p. 8251 - 82",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,sodium succinate buffer,6,supporting information; body text,,,,,,,,,,,,,,
C=CS(=O)(=O)Oc1ccccc1,,C=CS(=O)(=O)Oc1ccccc1>>,28161934,1,9,half reaction,LMW PTP|phenyl vinylsulfonate,,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8679209; Article; Liu, Sijiu; Zhou, Bo; Yang, Heyi; He, Yantao; Jiang, Zhong-Xing; Kumar, Sanjai; Wu, Li; Zhang, Zhong-Yin; Journal of the American Chemical Society; vol. 130; 26; (2008); p. 8251 - 82",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,sodium succinate buffer,6,supporting information; body text,,,,,,,,,,,,,,
C=CS(=O)(=O)Oc1ccccc1,,C=CS(=O)(=O)Oc1ccccc1>>,28161935,1,9,half reaction,PRL1|phenyl vinylsulfonate,,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8679209; Article; Liu, Sijiu; Zhou, Bo; Yang, Heyi; He, Yantao; Jiang, Zhong-Xing; Kumar, Sanjai; Wu, Li; Zhang, Zhong-Yin; Journal of the American Chemical Society; vol. 130; 26; (2008); p. 8251 - 82",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,sodium succinate buffer,6,supporting information; body text,,,,,,,,,,,,,,
C=CS(=O)(=O)Oc1ccccc1,,C=CS(=O)(=O)Oc1ccccc1>>,28161936,1,9,half reaction,PTP1B|phenyl vinylsulfonate,,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8679209; Article; Liu, Sijiu; Zhou, Bo; Yang, Heyi; He, Yantao; Jiang, Zhong-Xing; Kumar, Sanjai; Wu, Li; Zhang, Zhong-Yin; Journal of the American Chemical Society; vol. 130; 26; (2008); p. 8251 - 82",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,sodium succinate buffer,6,supporting information; body text,,,,,,,,,,,,,,
C=CS(=O)(=O)Oc1ccccc1,,C=CS(=O)(=O)Oc1ccccc1>>,28161937,1,9,half reaction,VHR|phenyl vinylsulfonate,,,Chemical behaviour,1,25,Michael addition,Kinetics,,"8679209; Article; Liu, Sijiu; Zhou, Bo; Yang, Heyi; He, Yantao; Jiang, Zhong-Xing; Kumar, Sanjai; Wu, Li; Zhang, Zhong-Yin; Journal of the American Chemical Society; vol. 130; 26; (2008); p. 8251 - 82",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,sodium succinate buffer,6,supporting information; body text,,,,,,,,,,,,,,
C1CNCCN1,CCN1C(=O)C=CC1=O,C1CNCCN1>>CCN1C(=O)C=CC1=O,10080601,1,8,half reaction,piperazine|N-Ethylmaleimide,,,Chemical behaviour,1,25,Michael addition,Kinetics,"2,2,4-trimethylpentane|water","6532186; Article; Fernandez, Esperanza; Garcia-Rio, Luis; Leis, J. Ramon; Mejuto, Juan C.; Perez-Lorenzo, Moises; New Journal of Chemistry; vol. 29; 12; (2005); p. 1594 - 1600;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,sodium docusate,,,,Further Variations:|composition of microemulsion,,,,,,,,
c1c[nH]cn1,CCCCCC(=O)/C=C/[C@@H]1O[C@H]1CCCCCCCC(=O)O,c1c[nH]cn1>>CCCCCC(=O)/C=C/[C@@H]1O[C@H]1CCCCCCCC(=O)O,11239068,1,7,half reaction,"1H-imidazole|trans-13-oxo-9,10-epoxy-11(E)-octadecenoic acid",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCCC(=O)/C=C/[C@@H]1O[C@H]1CCCCCCCC(=O)O,CC(=O)NCCc1c[nH]cn1,CCCCCC(=O)/C=C/[C@@H]1O[C@H]1CCCCCCCC(=O)O>>CC(=O)NCCc1c[nH]cn1,11239069,1,7,half reaction,"trans-13-oxo-9,10-epoxy-11(E)-octadecenoic acid|N-acetylhistamine",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
c1c[nH]cn1,CCCCCC(=O)/C=C/[C@@H]1O[C@@H]1CCCCCCCC(=O)O,c1c[nH]cn1>>CCCCCC(=O)/C=C/[C@@H]1O[C@@H]1CCCCCCCC(=O)O,11239070,1,7,half reaction,"1H-imidazole|cis-13-oxo-9,10-epoxy-11(E)-octadecenoic acid",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCCC(=O)/C=C/[C@@H]1O[C@@H]1CCCCCCCC(=O)O,CC(=O)NCCc1c[nH]cn1,CCCCCC(=O)/C=C/[C@@H]1O[C@@H]1CCCCCCCC(=O)O>>CC(=O)NCCc1c[nH]cn1,11239071,1,7,half reaction,"cis-13-oxo-9,10-epoxy-11(E)-octadecenoic acid|N-acetylhistamine",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
c1c[nH]cn1,CCCCC[C@@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,c1c[nH]cn1>>CCCCC[C@@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,11239073,1,7,half reaction,"1H-imidazole|trans-9-oxo-12,13-epoxy-10(E)-octadecenoic acid",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCC[C@@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,CC(=O)NCCc1c[nH]cn1,CCCCC[C@@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O>>CC(=O)NCCc1c[nH]cn1,11239074,1,7,half reaction,"trans-9-oxo-12,13-epoxy-10(E)-octadecenoic acid|N-acetylhistamine",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
c1c[nH]cn1,CCCCC[C@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,c1c[nH]cn1>>CCCCC[C@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,11239075,1,7,half reaction,"1H-imidazole|cis-9-oxo-12,13-epoxy-10(E)-octadecenoic acid",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCC[C@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O,CC(=O)NCCc1c[nH]cn1,CCCCC[C@H]1O[C@H]1/C=C/C(=O)CCCCCCCC(=O)O>>CC(=O)NCCc1c[nH]cn1,11239076,1,7,half reaction,"cis-9-oxo-12,13-epoxy-10(E)-octadecenoic acid|N-acetylhistamine",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
c1c[nH]cn1,CCCCC[C@@H]1O[C@H]1C(=O)/C=C/CCCCCCCC(=O)O,c1c[nH]cn1>>CCCCC[C@@H]1O[C@H]1C(=O)/C=C/CCCCCCCC(=O)O,11239081,1,7,half reaction,"1H-imidazole|trans-12,13-epoxy-11-oxo-9(E)-octadecenoic acid",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCC[C@@H]1O[C@H]1C(=O)/C=C/CCCCCCCC(=O)O,CC(=O)NCCc1c[nH]cn1,CCCCC[C@@H]1O[C@H]1C(=O)/C=C/CCCCCCCC(=O)O>>CC(=O)NCCc1c[nH]cn1,11239082,1,7,half reaction,"trans-12,13-epoxy-11-oxo-9(E)-octadecenoic acid|N-acetylhistamine",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
c1c[nH]cn1,CCCCC/C=C/C(=O)[C@@H]1O[C@H]1CCCCCCCC(=O)O,c1c[nH]cn1>>CCCCC/C=C/C(=O)[C@@H]1O[C@H]1CCCCCCCC(=O)O,11239083,1,7,half reaction,"1H-imidazole|trans-9,10-epoxy-11-oxo-12(E)-octadecenoic acid",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
CCCCC/C=C/C(=O)[C@@H]1O[C@H]1CCCCCCCC(=O)O,CC(=O)NCCc1c[nH]cn1,CCCCC/C=C/C(=O)[C@@H]1O[C@H]1CCCCCCCC(=O)O>>CC(=O)NCCc1c[nH]cn1,11239084,1,7,half reaction,"trans-9,10-epoxy-11-oxo-12(E)-octadecenoic acid|N-acetylhistamine",,,Chemical behaviour,1,30,Michael addition,Kinetics,phosphate buffer|ethanol,"7068107; Article; Lin, De; Zhang, Jianye; Sayre, Lawrence M.; Journal of Organic Chemistry; vol. 72; 25; (2007); p. 9471 - 9480;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,,,,,,,,
C=C(C)C(=O)OCC1CCCO1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCC1CCCO1>>[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,8494299,1,6,half reaction,(tetrahydrofuran-2-yl)methyl 2-methylprop-2-enoate|GLUTATHIONE,,,Chemical behaviour,1,20,Michael addition,Kinetics,water,"6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,8.8,,,,,,,,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCCOCC,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCCOCC,8494312,1,6,half reaction,GLUTATHIONE|2-ethoxyethyl methacrylate,,,Chemical behaviour,1,20,Michael addition,Kinetics,water,"6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,8.8,,,,,,,,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=CC(=O)OCCCCCC,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=CC(=O)OCCCCCC,8494313,1,6,half reaction,GLUTATHIONE|n-hexyl acrylate,,,Chemical behaviour,1,20,Michael addition,Kinetics,water,"6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,8.8,,,,,,,,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=C(C)C(=O)OCc1ccccc1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=C(C)C(=O)OCc1ccccc1,8494370,1,6,half reaction,GLUTATHIONE|benzyl methacrylate,,,Chemical behaviour,1,20,Michael addition,Kinetics,water,"6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,24,,8.8,,,,,,,,,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,C=CC(=O)OCCCO,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>C=CC(=O)OCCCO,8494374,1,6,half reaction,GLUTATHIONE|3-hydroxypropyl acrylate,,,Chemical behaviour,1,20,Michael addition,Kinetics,water,"6182750; Article; Freidig, Andreas P.; Verhaar, Henk J. M.; Hermens, Joop L. M.; Environmental Toxicology and Chemistry; vol. 18; 6; (1999); p. 1133 - 1139;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,1,,8.8,,,,,,,,,,,,,,,
C/C=C/C(=O)SCCNC(C)=O,,C/C=C/C(=O)SCCNC(C)=O>>,34815760,1,4,half reaction,S-(2-acetamidoethyl) (E)-but-2-enethioate|baeL of bacillaene 1 type I modular polyketide synthase,,,Chemical behaviour,1,25,Michael Addition,Kinetics,dimethyl sulfoxide,"35458129; Article; Jenner, Matthew; Frank, Sarah; Kampa, Annette; Kohlhaas, Christoph; Pöplau, Petra",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.6,supporting information,,,,,,,Experimental part,,2,S-(2-acetamidoethyl) (E)-but-2-enethioate|baeL of bacillaene 1 type I modular polyketide synthase,,,,
C/C=C/C(=O)SCCNC(C)=O,,C/C=C/C(=O)SCCNC(C)=O>>,34815762,1,4,half reaction,S-(2-acetamidoethyl) (E)-but-2-enethioate|PsyA of psymberin 2 type I modular polyketide synthase,,,Chemical behaviour,1,25,Michael Addition,Kinetics,dimethyl sulfoxide,"35458129; Article; Jenner, Matthew; Frank, Sarah; Kampa, Annette; Kohlhaas, Christoph; Pöplau, Petra",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.6,supporting information,,,,,,,Experimental part,,2,S-(2-acetamidoethyl) (E)-but-2-enethioate|PsyA of psymberin 2 type I modular polyketide synthase,,,,
C/C=C/C(=O)SCCNC(C)=O,,C/C=C/C(=O)SCCNC(C)=O>>,34815765,1,4,half reaction,S-(2-acetamidoethyl) (E)-but-2-enethioate|PsyD of psymberin 2 type I modular polyketide synthase,,,Chemical behaviour,1,25,Michael Addition,Kinetics,dimethyl sulfoxide,"35458129; Article; Jenner, Matthew; Frank, Sarah; Kampa, Annette; Kohlhaas, Christoph; Pöplau, Petra",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.6,supporting information,,,,,,,Experimental part,,2,S-(2-acetamidoethyl) (E)-but-2-enethioate|PsyD of psymberin 2 type I modular polyketide synthase,,,,
C/C=C/C(=O)SCCNC(C)=O,,C/C=C/C(=O)SCCNC(C)=O>>,34815767,1,4,half reaction,S-(2-acetamidoethyl) (E)-but-2-enethioate|baeL of bacillaene 1 type I modular polyketide synthase (M239A),,,Chemical behaviour,1,25,Michael Addition,Kinetics,dimethyl sulfoxide,"35458129; Article; Jenner, Matthew; Frank, Sarah; Kampa, Annette; Kohlhaas, Christoph; Pöplau, Petra",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.6,supporting information,,,,,,,Experimental part,,2,S-(2-acetamidoethyl) (E)-but-2-enethioate|baeL of bacillaene 1 type I modular polyketide synthase (M239A),,,,
CC1=CC(=O)C(=O)C=C1,,CC1=CC(=O)C(=O)C=C1>>,42971884,1,4,half reaction,"4-methylbenzo-1,2-quinone|human serum albumin",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7,,,,,,,,Body text,,,,,,,
CC1=CC(=O)C(=O)C=C1,,CC1=CC(=O)C(=O)C=C1>>,42971885,1,4,half reaction,"4-methylbenzo-1,2-quinone|bovine serum albumin",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7,,,,,,,pH-value,Body text,,,,,,,
CC1=CC(=O)C(=O)C=C1,,CC1=CC(=O)C(=O)C=C1>>,42971886,1,4,half reaction,"4-methylbenzo-1,2-quinone|n-ethylmaleimide-bovine serum albumin",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7,,,,,,,,Body text,,,,,,,
CC1=CC(=O)C(=O)C=C1,,CC1=CC(=O)C(=O)C=C1>>,42971887,1,4,half reaction,"4-methylbenzo-1,2-quinone|α-lactalbumin",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCCCNC(C)=O)C(=O)O,CC1=CC(=O)C(=O)C=C1,[H][C@](N)(CCCCNC(C)=O)C(=O)O>>CC1=CC(=O)C(=O)C=C1,42971881,1,3,half reaction,"H-Lys(acetyl)-OH|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,8,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCCCN)C(=O)O,CC1=CC(=O)C(=O)C=C1,[H][C@](N)(CCCCN)C(=O)O>>CC1=CC(=O)C(=O)C=C1,42971882,1,3,half reaction,"L-lysine|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,8,,,,,,,,Body text,,,,,,,
[H][C@@](CCCCN)(NC(C)=O)C(=O)O,CC1=CC(=O)C(=O)C=C1,[H][C@@](CCCCN)(NC(C)=O)C(=O)O>>CC1=CC(=O)C(=O)C=C1,42971883,1,3,half reaction,"N-Ac-L-Lys-OH|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael Addition,Kinetics,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,8,,,,,,,,Body text,,,,,,,
[H][C@@](CS)(NC(C)=O)C(=O)O,CC1=CC(=O)C(=O)C=C1,[H][C@@](CS)(NC(C)=O)C(=O)O>>CC1=CC(=O)C(=O)C=C1,42971888,1,3,half reaction,"N-acetylcystein|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael Addition,Kinetics|Equilibrium constant,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CS)C(=O)O,CC1=CC(=O)C(=O)C=C1,[H][C@](N)(CS)C(=O)O>>CC1=CC(=O)C(=O)C=C1,42971889,1,3,half reaction,"L-Cysteine|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael Addition,Kinetics|Equilibrium constant,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,CC1=CC(=O)C(=O)C=C1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>CC1=CC(=O)C(=O)C=C1,42971890,1,3,half reaction,"GLUTATHIONE|4-methylbenzo-1,2-quinone",,,Chemical behaviour,1,25,Michael Addition,Kinetics|Equilibrium constant,aq. phosphate buffer,"69017830; Article; Li, Yuting; Jongberg, Sisse; Andersen, Mogens L.; Davies, Michael J.; Lund, Marianne N.; Free Radical Biology and Medicine; vol. 97; (2016); p. 148 - 157;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,Body text,,,,,,,
[H][C@](N)(CC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O,[H][C@]12[C@H](C)C[C@H]3OC(=O)C(=C)[C@@]3([H])C[C@]1(C)[C@H](O)C[C@@H]2O,[H][C@](N)(CC(=O)N[C@@]([H])(CS)C(=O)NCC(=O)O)C(=O)O>>[H][C@]12[C@H](C)C[C@H]3OC(=O)C(=C)[C@@]3([H])C[C@]1(C)[C@H](O)C[C@@H]2O,8516927,1,0,half reaction,"β-Asp-Cys-Gly|2α-hydroxy-2,3-dihydro-4βH-6-deoxyhelenalin",,,Chemical behaviour,1,,Michael addition,Kinetics,phosphate buffer|ethanol,"6222127; Article; Schmidt, Thomas J.; Lyss, Guido; Pahl, Heike L.; Merfort, Irmgard; Bioorganic and Medicinal Chemistry; vol. 7; 12; (1999); p. 2849 - 2855;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,8.0,,,,,,,Further Variations:|pH-values,,,,,,,,
C=CC(C)=O,,C=CC(C)=O>>,33157619,1,0,half reaction,human erythrocyte glyceraldehyde-3-phosphate dehydrogenase|methyl vinyl ketone,,,Chemical behaviour,1,30,Michael addition,Kinetics,,"20134774; Article; Martyniuk, Christopher J.; Fang, Bin; Koomen, John M.; Gavin, Terrence; Zhang, Lihai; Barber, David S.; Lopachin, Richard M.; Chemical Research in Toxicology; vol. 24; 12; (2011); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,aq. buffer,7.4,experimental part,,,,,,Concentration,,,,,,,,
C=CC(N)=O,,C=CC(N)=O>>,33157620,1,0,half reaction,human erythrocyte glyceraldehyde-3-phosphate dehydrogenase|2-propenamide,,,Chemical behaviour,1,30,Michael addition,Kinetics,,"20134774; Article; Martyniuk, Christopher J.; Fang, Bin; Koomen, John M.; Gavin, Terrence; Zhang, Lihai; Barber, David S.; Lopachin, Richard M.; Chemical Research in Toxicology; vol. 24; 12; (2011); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,aq. buffer,7.4,experimental part,,,,,,Concentration,,,,,,,,
C=CC=O,,C=CC=O>>,33157621,1,0,half reaction,human erythrocyte glyceraldehyde-3-phosphate dehydrogenase|acrolein,,,Chemical behaviour,1,30,Michael addition,Kinetics,,"20134774; Article; Martyniuk, Christopher J.; Fang, Bin; Koomen, John M.; Gavin, Terrence; Zhang, Lihai; Barber, David S.; Lopachin, Richard M.; Chemical Research in Toxicology; vol. 24; 12; (2011); p",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,aq. buffer,8.5,experimental part,,,,,,pH-value|Concentration,,,,,,,,
CCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS,C=CS(=O)(=O)CC,CCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS>>C=CS(=O)(=O)CC,36689251,1,0,half reaction,"2-ethyl-2-((3-mercaptopropanoyloxy)methyl)propane-1,3-diyl bis(3-mercaptopropanoate)|ethyl vinyl sulfone",,,Chemical behaviour,1,,Michael Addition,Kinetics,,"61510186; Article; Chatani, Shunsuke; Sheridan, Richard J.; Podgorski, Maciej; Nair, Devatha P.; Bowman, Christopher N.; Chemistry of Materials; vol. 25; 19; (2013); p. 3897 - 3901;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,methanesulfonic acid|triphenylphosphine,,,,Reagent/catalyst,Experimental part,,,,,,,
[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Nc1ccccc1,[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Nc1ccccc1,36724375,1,0,half reaction,levodopa|aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer,"61586818; Article; Khalafi, Lida; Rafiee, Mohammad; Khoshnam, Mojgan; Shoaei, Seyed Mohammad; Journal of the Iranian Chemical Society; vol. 10; 6; (2013); p. 1257 - 1262;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,5,,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Nc1cccc([N+](=O)[O-])c1,[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Nc1cccc([N+](=O)[O-])c1,36724377,1,0,half reaction,levodopa|3-nitro-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer,"61586818; Article; Khalafi, Lida; Rafiee, Mohammad; Khoshnam, Mojgan; Shoaei, Seyed Mohammad; Journal of the Iranian Chemical Society; vol. 10; 6; (2013); p. 1257 - 1262;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,5,,,,,,,,Scheme or table,,,,,,,
[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,CNc1ccccc1,[H][C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>CNc1ccccc1,36724378,1,0,half reaction,levodopa|N-methylaniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer,"61586818; Article; Khalafi, Lida; Rafiee, Mohammad; Khoshnam, Mojgan; Shoaei, Seyed Mohammad; Journal of the Iranian Chemical Society; vol. 10; 6; (2013); p. 1257 - 1262;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,5,,,,,,,,Scheme or table,,,,,,,
NCCc1ccc(O)c(O)c1,Cc1ccc(N)cc1,NCCc1ccc(O)c(O)c1>>Cc1ccc(N)cc1,41256595,1,0,half reaction,dopamine|p-toluidine,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,dopamine|p-toluidine,,,,
NCCc1ccc(O)c(O)c1,Nc1ccccc1,NCCc1ccc(O)c(O)c1>>Nc1ccccc1,41256596,1,0,half reaction,dopamine|aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,dopamine|aniline,,,,
NCCc1ccc(O)c(O)c1,Nc1ccc(Br)cc1,NCCc1ccc(O)c(O)c1>>Nc1ccc(Br)cc1,41256598,1,0,half reaction,dopamine|4-bromo-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,dopamine|4-bromo-aniline,,,,
NCCc1ccc(O)c(O)c1,Nc1cccc([N+](=O)[O-])c1,NCCc1ccc(O)c(O)c1>>Nc1cccc([N+](=O)[O-])c1,41256599,1,0,half reaction,dopamine|3-nitro-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,dopamine|3-nitro-aniline,,,,
NCCc1ccc(O)c(O)c1,CNc1ccccc1,NCCc1ccc(O)c(O)c1>>CNc1ccccc1,41256600,1,0,half reaction,dopamine|N-methylaniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,dopamine|N-methylaniline,,,,
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Cc1ccc(N)cc1,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Cc1ccc(N)cc1,41256601,1,0,half reaction,methyldopa|p-toluidine,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,methyldopa|p-toluidine,,,,
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Nc1ccccc1,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Nc1ccccc1,41256602,1,0,half reaction,methyldopa|aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,methyldopa|aniline,,,,
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Nc1ccc(Br)cc1,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Nc1ccc(Br)cc1,41256603,1,0,half reaction,methyldopa|4-bromo-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,methyldopa|4-bromo-aniline,,,,
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,Nc1cccc([N+](=O)[O-])c1,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>Nc1cccc([N+](=O)[O-])c1,41256604,1,0,half reaction,methyldopa|3-nitro-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,methyldopa|3-nitro-aniline,,,,
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,CNc1ccccc1,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O>>CNc1ccccc1,41256605,1,0,half reaction,methyldopa|N-methylaniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,methyldopa|N-methylaniline,,,,
CNC[C@H](O)c1ccc(O)c(O)c1,Cc1ccc(N)cc1,CNC[C@H](O)c1ccc(O)c(O)c1>>Cc1ccc(N)cc1,41256606,1,0,half reaction,L-epinephrine|p-toluidine,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,L-epinephrine|p-toluidine,,,,
CNC[C@H](O)c1ccc(O)c(O)c1,Nc1ccccc1,CNC[C@H](O)c1ccc(O)c(O)c1>>Nc1ccccc1,41256607,1,0,half reaction,L-epinephrine|aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,L-epinephrine|aniline,,,,
CNC[C@H](O)c1ccc(O)c(O)c1,Nc1ccc(Br)cc1,CNC[C@H](O)c1ccc(O)c(O)c1>>Nc1ccc(Br)cc1,41256608,1,0,half reaction,L-epinephrine|4-bromo-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,L-epinephrine|4-bromo-aniline,,,,
CNC[C@H](O)c1ccc(O)c(O)c1,Nc1cccc([N+](=O)[O-])c1,CNC[C@H](O)c1ccc(O)c(O)c1>>Nc1cccc([N+](=O)[O-])c1,41256609,1,0,half reaction,L-epinephrine|3-nitro-aniline,,,Chemical behaviour,1,,Michael Addition,Kinetics|Mechanism,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,L-epinephrine|3-nitro-aniline,,,,
CNC[C@H](O)c1ccc(O)c(O)c1,CNc1ccccc1,CNC[C@H](O)c1ccc(O)c(O)c1>>CNc1ccccc1,41256610,1,0,half reaction,L-epinephrine|N-methylaniline,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. acetate buffer|aq. acetate buffer,"64814754; Article; Khalafi, Lida; Rafiee, Mohammad; Norouznia, Maryam; Asl, Yosef Abdossalami; Research on Chemical Intermediates; vol. 41; 10; (2015); p. 7151 - 7162;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,Electrochemical reaction,5|5,,,,,,,,Body text,,2,L-epinephrine|N-methylaniline,,,,
NC(CCS)C(=O)O,CCN(CC)c1ccc2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,NC(CCS)C(=O)O>>CCN(CC)c1ccc2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,41832291,1,0,half reaction,2-amino-4-mercaptobutyric acid|(E)-7-(diethylamino)-3-(3-(4-nitrophenyl)acryloyl)-2H-benzopyran-2-one,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"67995773; Article; Liu, Mengqiang;Jiang, Qian;Lu, Zhiyun;Huang, Yan;Tan, Yanfei;Jiang, Qing; Luminescence; vol. 30; 8; (2015); p. 1395 - 1402;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Experimental part,,,,,,,
NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O,CCN(CC)c1ccc2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O>>CCN(CC)c1ccc2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c(=O)oc2c1,41832292,1,0,half reaction,glutathion|(E)-7-(diethylamino)-3-(3-(4-nitrophenyl)acryloyl)-2H-benzopyran-2-one,,,Chemical behaviour,1,,Michael Addition,Kinetics,aq. phosphate buffer|dimethyl sulfoxide,"67995773; Article; Liu, Mengqiang;Jiang, Qian;Lu, Zhiyun;Huang, Yan;Tan, Yanfei;Jiang, Qing; Luminescence; vol. 30; 8; (2015); p. 1395 - 1402;",Copyright (C) 2025 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,7.4,,,,,,,,Experimental part,,,,,,,
